Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,protein targeting to ER (GO:0045047),-0.614176050719899,-2.4471214887284427,0.0,0.0,0.0,77/99,30.33%,RPS12;RPL41;RPL3;RPS24;RPS14;RPL8;RPL27A;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL38;RPL35A;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPS23;RPL30;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;RPL18A;RPL4;RPL29;RPL26;RPL6;RPL13A;RPL36A;RPL7A;RPL19;RPS20;RPL13;RPL32;RPL5;RPL14;RPSA;RPLP0;RPS6;RPL22;ZFAND2B;RPS21;RPL37A;SPCS1;SGTB;RPL17;RPL23;RPLP2;RPL28;RPL31;RPS10;SGTA;RPS11;RPS27;EDEM1;RPS16;CHMP4B;CHMP4A;RPL10;RPL15;RPS8;SRPRA;RPL9;GET3;SEC61G;RPL12;RPS27A;RPS17;RPL10A
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6242253822207198,-2.4095930740748726,0.0,0.0,0.0,54/87,20.49%,RPS12;RPL41;RPL3;RPS24;RPS14;RPL8;RPL27A;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL38;RPL35A;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPS23;RPL30;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;RPL18A;RPL4;RPL29;RPL26;RPL6;RPL13A;RPL36A;RPL7A;RPL19;RPS20;RPL13;RPL32;RPL5;RPL14;RPSA;RPLP0;RPS6;RPL22;ZFAND2B;RPS21;RPL37A;RPL17;RPL23;RPLP2
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6063501412110804,-2.386706781626675,0.0,0.0,0.0,69/91,30.33%,RPS12;RPL41;RPL3;RPS24;RPS14;RPL8;RPL27A;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL38;RPL35A;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPS23;RPL30;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;RPL18A;RPL4;RPL29;RPL26;RPL6;RPL13A;RPL36A;RPL7A;RPL19;ARL6IP1;RPS20;RPL13;RPL32;RPL5;RPL14;RPSA;RPLP0;RPS6;RPL22;RPS21;RPL37A;RPL17;RPL23;RPLP2;RPL28;RPL31;RPS10;RPS11;RPS27;RPS16;RPL10;RPL15;RPS8;SRPRA;RPL9;RPL12;RPS27A;RPS17;RPL10A
prerank,cytoplasmic translation (GO:0002181),-0.5957023990978259,-2.3565706784185445,0.0,0.0,0.0,47/91,15.02%,RPS12;RPL41;RPL3;RPS24;RPS14;RPL8;RPL27A;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL38;RPL35A;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPS23;RPL30;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;RPL18A;RPL4;EIF4A1;RPL29;RPL26;RPL6;RPL13A;RPL36A;RPL7A;RPL19;RPS20;RPL13;RPL32;RPL5;RPL14;RPSA;RPLP0
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.563916647611827,-2.2989882114810327,0.0,0.0,0.0,58/110,20.49%,RPS12;RPL41;RPL3;RPS24;RPS14;RPL8;RPL27A;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL38;RPL35A;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPS23;RPL30;PABPC1;PNRC2;RPL36;RPLP1;RPS29;RPL37;RBM8A;RPS9;PPP2R2A;RPS5;RPL18A;RPL4;RPL29;RPL26;RPL6;RPL13A;RPL36A;RPL7A;RPL19;RPS20;RPL13;RPL32;RPL5;RPL14;RPSA;RPLP0;RPS6;SMG7;RPL22;RPS21;RPL37A;RPL17;RPL23;RPLP2
prerank,peptide biosynthetic process (GO:0043043),-0.5283552709502369,-2.285321665085107,0.0,0.0,0.0,91/153,29.48%,RPS12;RPL41;RPL3;RPS24;RPS14;RPL8;RPL27A;RPS19;RPL34;WARS1;RPS13;RPL21;RPL7;RPL18;RPL27;GGT5;RPL38;RPL35A;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPS23;RPL30;MRRF;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;RPL18A;RPL4;YARS2;RPL29;RPL26;RPL6;RPL13A;RPL36A;RPL7A;GGTA1;MRPS18A;RPL19;MRPS5;RPS20;RPL13;RPL32;EEF1A1;RPL5;MRPS12;RPL14;RPSA;RPLP0;MRPS33;RPS6;RPS6KB2;MRPL55;MRPL42;MRPS18B;RPL22;RPS21;RPL37A;GGT1;MRPS21;MRPS7;RPL17;RPL23;RPLP2;MRPL34;PCSK1;EIF4EBP2;RPL28;RPL31;EEF1A2;RPS10;PABPC4;RPS11;RPS27;RPS16;RPL10;RPL15;DMD;RPS8;MRPL28;CARNS1;RPL9;MRPL43;RPL12;RPS27A
prerank,extracellular structure organization (GO:0043062),0.6421005147643437,2.1579371650738355,0.0,0.0,0.0,56/204,6.22%,ITGA9;ADAMTS6;COL4A4;ADAMTS12;COL4A5;LAMA1;COL1A2;ADAMTSL3;COL4A6;FBN1;COL1A1;DDR2;FBLN5;COL4A3;THSD4;COL22A1;ELN;ADAMTS10;ADAMTS5;LOXL1;LUM;MATN3;SPARC;COL5A1;COL8A2;DCN;LOX;LAMA2;DAG1;BGN;FBN2;HSPG2;COL11A1;SERPINE1;ITGA11;ADAMTS2;ADAMTSL2;MMP2;RECK;LAMC1;ITGA3;MFAP5;NID1;MMP19;NID2;COL13A1;TGFBR1;VTN;COL9A2;ITGB8;MMP11;ITGB5;SMOC2;ECM2;ADAMTS9;TNC
prerank,external encapsulating structure organization (GO:0045229),0.6389853076312528,2.1478847447974214,0.0,0.0,0.0,55/205,6.22%,ITGA9;ADAMTS6;COL4A4;ADAMTS12;COL4A5;LAMA1;COL1A2;ADAMTSL3;COL4A6;FBN1;COL1A1;DDR2;FBLN5;COL4A3;THSD4;COL22A1;ELN;ADAMTS10;ADAMTS5;LOXL1;LUM;MATN3;SPARC;COL5A1;COL8A2;DCN;LOX;LAMA2;DAG1;BGN;FBN2;HSPG2;COL11A1;SERPINE1;ITGA11;ADAMTS2;ADAMTSL2;MMP2;RECK;LAMC1;ITGA3;MFAP5;NID1;MMP19;NID2;COL13A1;VTN;COL9A2;ITGB8;MMP11;ITGB5;SMOC2;ECM2;ADAMTS9;TNC
prerank,translation (GO:0006412),-0.46588020628500015,-2.117387173571982,0.0,0.0029118193876001165,0.018,85/208,20.59%,RPS12;RPL41;RPL3;RPS24;RPS14;RPL8;RPL27A;RPS19;RPL34;WARS1;RPS13;RPL21;RPL7;RPL18;RPL27;EEF2;RPL38;RPL35A;RPS15;RPS3;RPL39;RPS7;WARS2;RPS4X;RPL11;RPS23;RPL30;MRRF;RPL36;RPLP1;RPS29;RPL37;LARS1;GTPBP1;NOA1;RPS9;RPS5;RPL18A;GFM2;RPL4;YARS2;RPL29;RPL26;YARS1;RPL6;QARS1;RPL13A;RPL36A;RPL7A;MRPS18A;RPL19;MRPS5;RPS20;RPL13;RPL32;EEF1A1;RPL5;EEF1B2;MRPS12;RPL14;KARS1;RPSA;FASTKD2;RPLP0;NDUFA7;MRPS33;FARS2;RPS6;RPS6KB2;AIMP1;MRPL55;MRPL57;MRPL42;MRPS18B;RPL22;RPS21;MARS2;RPL37A;MRPS21;MRPS7;AIMP2;RPL17;RPL23;RPLP2;MRPL34
prerank,heme catabolic process (GO:0042167),-0.8146488679432445,-2.07530596000921,0.0,0.005823638775200233,0.047,4/14,3.24%,ABCG2;HMOX2;SLCO2B1;ABCC1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.8146488679432445,-2.07530596000921,0.0,0.005823638775200233,0.047,4/14,3.24%,ABCG2;HMOX2;SLCO2B1;ABCC1
prerank,extracellular matrix organization (GO:0030198),0.589504995812193,2.016627936239985,0.0,0.014538371970607027,0.038,69/276,7.80%,ITGA9;ADAMTS6;COL4A4;ADAMTS12;COL4A5;LAMA1;COL1A2;ADAMTSL3;COL4A6;FBN1;COL1A1;DDR2;FBLN5;COL4A3;THSD4;COL22A1;ELN;ADAMTS10;ADAMTS5;LOXL1;LUM;MATN3;SPARC;GSN;COL5A1;COL8A2;DCN;LOX;LAMA2;DAG1;BGN;FBN2;HSPG2;COL11A1;SERPINE1;DPT;ITGA11;ADAMTS2;ADAMTSL2;MMP2;RECK;LAMC1;ITGA3;MFAP5;NID1;MMP19;NID2;COL13A1;TGFBR1;VTN;GAS6;SH3PXD2B;COL9A2;ITGB8;CYP1B1;MMP11;ITGB5;SMOC2;SCUBE1;ECM2;COL20A1;ADAMTS9;SERPINH1;TNC;TIMP2;FLRT2;COLQ;SMOC1;COL11A2
prerank,retinoid metabolic process (GO:0001523),0.6788976643893188,2.015072191865703,0.0,0.011918083999160412,0.041,15/71,7.31%,ALDH1A1;RBP4;GPC6;LRP1;AKR1B1;CYP26B1;HSPG2;DHRS3;RBP1;APOE;CYP1B1;APOA1;ALDH1A2;SDC1;ADH1A
prerank,regulation of exocytosis (GO:0017157),-0.5749817205425237,-2.005991245620445,0.0,0.020091553774440805,0.16,23/46,24.56%,STXBP6;IL1RAPL1;RAB27A;STXBP5L;RAB3C;RIMS2;RAB21;SYT1;CADPS;RAB12;RAB8B;RAB27B;LGI3;NSF;CPLX1;CFTR;RAB3A;RAB15;CLASP1;ANXA1;HAP1;EXPH5;STXBP5
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.7195929272338083,2.0008162177261886,0.0,0.012577382262943753,0.055,15/43,8.88%,IGF1;NELL1;BMP6;DDR2;FBN2;IL6R;BMPR1A;RUNX2;CCN1;YAP1;WNT4;ACVR1;WWTR1;CCN4;BMP2
prerank,diterpenoid metabolic process (GO:0016101),0.6956073795053149,1.9709265099172686,0.0,0.023498066324585773,0.117,10/55,4.39%,ALDH1A1;RBP4;GPC6;LRP1;AKR1B1;HSPG2;DHRS3;RBP1;APOE;APOA1
prerank,collagen fibril organization (GO:0030199),0.6334497275988941,1.9569016852017345,0.0,0.02811073915911392,0.155,22/88,6.16%,COL4A4;COL4A5;COL1A2;COL4A6;COL1A1;DDR2;COL4A3;COL22A1;LOXL1;LUM;COL5A1;COL8A2;LOX;COL11A1;DPT;ADAMTS2;COL13A1;TGFBR1;COL9A2;CYP1B1;COL20A1;SERPINH1
prerank,negative regulation of reproductive process (GO:2000242),0.835352792427714,1.952361242063105,0.0,0.027766599955490745,0.172,3/17,3.74%,IGF1;GJA1;SULF1
prerank,skeletal system development (GO:0001501),0.5974017886570472,1.94214216198271,0.0,0.030879952867800972,0.204,28/148,5.51%,IGF1;RBP4;BMP6;COL1A2;FBN1;COL1A1;IGF2;GJA1;TRPS1;CDH11;MATN3;SOX5;AHSG;GLI2;SULF2;FGFR1;ANKH;FGFR2;GNAS;COL13A1;TGFBR1;SULF1;NPR3;SH3PXD2B;COL9A2;ITGB8;CREB3L2;TBX3
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.8285581230226857,1.928688420460537,0.0,0.03915217381851846,0.276,3/18,0.49%,IGF1;IGFBP2;IGF2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.8816822092635103,1.9233096811045112,0.0,0.039650105374382794,0.301,5/13,3.96%,LTBP1;GREM2;FBN1;FBN2;FSTL1
prerank,regulation of activated T cell proliferation (GO:0046006),0.7439253099377277,1.9232337360438665,0.0,0.036430455344951325,0.302,3/30,0.49%,IGF1;IGFBP2;IGF2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.8291278995501041,1.9010944110020531,0.0,0.0555527057767739,0.447,9/17,9.77%,IGF1;NRP1;DOCK4;PDGFRB;VTN;IGFBP5;DOCK5;CCN4;S100A11
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.7248695286532503,-1.8944551416593487,0.0,0.09820772661814937,0.591,7/15,6.40%,KCNJ2;ATP1A1;KCNJ3;KCND3;KCNN2;KCNQ1;ATP1B1
prerank,positive regulation of nuclear division (GO:0051785),0.7578307354615004,1.8912106154267705,0.0,0.06324916310800631,0.506,13/25,12.98%,IGF1;IGF2;TGFA;EPGN;PDGFRB;PHIP;SIRT2;CD28;NPM2;DRD3;RGCC;EGF;INSR
prerank,regulation of phospholipase activity (GO:0010517),0.8926791187225771,1.8910229573723882,0.003669724770642202,0.05937065390787427,0.509,4/10,3.04%,PDPK1;LRP1;FGFR1;FGFR2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.7800019008926385,-1.8806677279210195,0.004618937644341801,0.10765643346932655,0.658,6/11,6.40%,KCNJ2;ATP1A1;KCNJ3;KCND3;KCNQ1;ATP1B1
prerank,chloride transport (GO:0006821),-0.48597886774647114,-1.8784578826487384,0.0,0.10124172024578869,0.661,24/74,10.59%,SLC4A10;SLC12A2;SLC26A7;SLC12A7;CLIC4;GABRG3;ANO1;ANO4;CLCN3;CLIC5;GABRA2;GABRB3;GABRB1;GLRA1;GABRG2;SLC1A1;GLRA2;SLC12A6;CLIC1;GABRB2;SLC4A8;GABRA3;SLC26A6;ANO3
prerank,cellular response to zinc ion (GO:0071294),-0.7157248243071381,-1.8674028487240084,0.0,0.1079453044403186,0.714,10/15,5.81%,GLRA1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;GLRA2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.7800006518618113,1.8637358363968188,0.0,0.09407679071677687,0.672,5/19,4.82%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,neuron cell-cell adhesion (GO:0007158),-0.7048784375879025,-1.8598211372502382,0.002512562814070352,0.1095491160712666,0.741,9/14,19.95%,NLGN1;NRXN3;NCAM2;CNTN4;NRXN1;RET;NLGN3;CDK5R1;ASTN1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.8186500849788233,1.859022568155336,0.0,0.09635897701448844,0.707,6/16,5.06%,IGF1;IGFBP2;CILP;IGFBP4;IGFBP5;PHIP
prerank,positive regulation of neutrophil migration (GO:1902624),0.7869662214296032,1.8564391923705779,0.0,0.0949502200405924,0.72,5/18,4.82%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,membrane repolarization during action potential (GO:0086011),-0.7239970623994079,-1.855855618120952,0.002421307506053269,0.10840460928419601,0.757,5/13,6.40%,KCNJ2;ATP1A1;KCND3;KCNQ1;ATP1B1
prerank,eye development (GO:0001654),0.6477583449533204,1.8513966912806934,0.0,0.09838758705689872,0.756,12/54,7.62%,RBP4;LAMA1;FBN1;COL5A1;PBX1;FBN2;SHROOM2;SH3PXD2B;CPAMD8;SKI;CACNA1C;SMOC1
prerank,negative regulation of peptidase activity (GO:0010466),0.6674256334937254,1.848946043121629,0.0,0.0983875870568987,0.774,13/47,7.04%,TIMP3;LRP1;AHSG;SERPINE1;SERPING1;FETUB;VTN;SERPIND1;SERPINF1;SERPINH1;CST3;CRB2;TIMP2
prerank,regulation of bone mineralization (GO:0030500),0.6295133068728717,1.8426721324875657,0.0026845637583892616,0.10413531551039451,0.811,18/55,9.31%,NELL1;BMP6;ENPP1;DDR2;SLC8A1;ADGRV1;AHSG;FBN2;BMPR1A;ANKH;CCN1;KL;WNT4;ACVR1;BCOR;OSR1;BMP2;TRPM4
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5595282414439181,-1.8422890799217309,0.006688963210702341,0.12315283174614611,0.822,18/37,16.52%,GRM7;GRID2;GRM3;GRIA4;PTK2B;GRIK1;GRIK2;GRIN2A;GRM5;GRIN2B;GRIN3A;GRIA2;GRM8;HOMER1;APP;GRM1;HOMER3;CDK5R1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.79082443682223,1.8411826019782562,0.0,0.10175323553635214,0.821,5/17,4.82%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,primary alcohol metabolic process (GO:0034308),0.7452555199567991,1.8385549938250272,0.0015432098765432098,0.10094539971906821,0.83,5/25,7.31%,IGF1;RBP4;DHRS3;CYP1B1;ADH1A
prerank,establishment of endothelial barrier (GO:0061028),-0.5778185506173785,-1.835685231695115,0.0,0.12483077559804204,0.846,13/29,11.01%,PDE4D;PECAM1;RAP1A;F11R;PPP1R16B;TJP2;TJP1;RDX;PDE2A;RAP1B;ROBO4;SOX18;MSN
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.611018736799183,1.8310398980186389,0.0012658227848101266,0.10950267958093839,0.87,15/74,6.32%,IGF1;TCF7L2;EYA2;GDNF;AR;EYA1;SERPINE1;BCL2;SH3RF1;CFLAR;TGFBR1;RFFL;ACVR1;PHIP;SRC
prerank,regulation of epithelial cell proliferation (GO:0050678),0.6063090671132874,1.8273501378303785,0.0012091898428053204,0.11161412453341377,0.887,18/85,8.41%,IGF1;TCF7L2;BMP6;MTSS1;ANGPT1;TGFBR3;MCC;TGFA;LAMC1;EPGN;FGFR2;YAP1;NUPR1;SFRP1;ZFP36L1;NR1D1;OSR1;EGFR
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5323970253346048,-1.8231832375940178,0.0,0.137366356723802,0.883,22/46,17.51%,GRM7;MEF2C;SHANK3;GRM3;CDH2;NLGN1;PTK2B;GRIK1;TSHZ3;NRXN1;GRM5;CDK5;OPHN1;SYT1;TPRG1L;GRM8;HOMER1;GRM1;NLGN3;DGKZ;CACNG3;CACNG4
prerank,regulation of stress fiber assembly (GO:0051492),0.6031319939620622,1.818560659984166,0.0012755102040816326,0.12405730643970575,0.92,21/74,7.44%,NRP1;PHLDB2;CCN2;ROCK2;PPM1E;PIK3R1;CGNL1;ARHGAP6;DLC1;TPM1;ARHGAP28;ARHGEF10L;TGFBR1;ASAP3;APOA1;SFRP1;CDC42;ALMS1;CARMIL1;LPAR1;ARHGEF18
prerank,cellular response to copper ion (GO:0071280),-0.6757085543105147,-1.816476992745211,0.0024390243902439024,0.14093205835984565,0.894,8/16,4.61%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,positive regulation of protein processing (GO:0010954),0.7533070150879277,1.81400361623194,0.0,0.1298310427142581,0.936,3/19,1.25%,CCBE1;CLEC3B;GSN
prerank,regulation of osteoblast differentiation (GO:0045667),0.5892560467914691,1.8122392406326795,0.0,0.12878051251372422,0.942,24/82,12.72%,IGF1;NELL1;BMP6;DDR2;FBN2;IL6R;BMPR1A;RUNX2;CCN1;FGFR2;YAP1;WNT4;ACVR1;SKI;WWTR1;SMOC1;CCN4;BMP2;TRPM4;DNAI3;TMEM119;REST;TMEM64;LRP3
prerank,regulation of smooth muscle cell migration (GO:0014910),0.7531158733888627,1.810883319986339,0.0,0.12727779214363827,0.946,8/20,4.91%,IGF1;NRP1;LRP1;SERPINE1;BMPR1A;PDGFRB;VTN;IGFBP5
prerank,cell junction assembly (GO:0034329),-0.4554378562233074,-1.8107512220954154,0.0,0.14355731774422162,0.908,28/100,6.80%,PKP4;DNM3;FN1;ADGRL3;SHANK3;CTNND2;CLDN5;CDH2;GPM6A;ITGA6;NLGN1;LIMS2;CDH1;ACTB;SPOCK2;KIRREL3;TJP1;NRCAM;GJC1;DNER;MYO9A;CDH12;NRXN1;CDH6;CDH8;CDH9;CDK5;OPHN1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.8056847268907935,1.808041377796529,0.0034662045060658577,0.12844482585194442,0.95,3/13,4.09%,IGF1;CCL19;SLC2A10
prerank,positive regulation of biomineral tissue development (GO:0070169),0.6503989612522028,1.807598858416033,0.0,0.12498855422592388,0.95,11/40,4.60%,NELL1;BMP6;SLC8A1;ADGRV1;FBN2;BMPR1A;CCN1;KL;WNT4;WNT6;ACVR1
prerank,actin cytoskeleton reorganization (GO:0031532),0.6262050727270113,1.807464323804676,0.0,0.12127284409783971,0.95,13/63,5.09%,NRP1;AUTS2;PHACTR1;NRK;ANTXR1;GSN;NEDD9;PARVA;DTNBP1;KIT;THSD7A;MCU;PTK7
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.6145442139436506,1.8019971220170081,0.0,0.12826348040875926,0.961,18/65,10.72%,LTBP1;PDPK1;FBN1;SMAD3;LDLRAD4;FBN2;ADAMTSL2;PMEPA1;NKX2-1;TGFBR1;SLC2A10;SMURF2;SKI;EMILIN1;SPRY2;LEMD3;FAM89B;SPRED3
prerank,regulation of osteoblast proliferation (GO:0033688),0.7816133969364039,1.7991383127825782,0.0016750418760469012,0.12974154521238707,0.964,6/17,4.62%,NELL1;MN1;CCN1;FGFR2;NPR3;SFRP1
prerank,response to copper ion (GO:0046688),-0.6320062029898821,-1.7965532183512736,0.002631578947368421,0.16138538363395796,0.942,8/20,4.61%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.6061934936851766,1.7938429884593523,0.0,0.13748180058849116,0.968,28/74,14.97%,EPHA3;PHLDB2;COL1A1;SMAD3;LDLRAD4;DAG1;OLFM1;NKX2-1;TGFBR1;SFRP1;AXIN2;PDPN;CRB2;WWTR1;DAB2;SPRY2;BMP2;USF3;FOXA1;SPRED3;RGCC;VASN;MDK;PTEN;SPRED1;HPN;BMP5;GLIPR2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.66665933385174,1.7910041760237438,0.005780346820809248,0.1395232906946628,0.971,12/34,12.98%,IGF1;IGF2;TGFA;EPGN;PDGFRB;PHIP;CD28;DRD3;ANAPC5;RGCC;EGF;INSR
prerank,regulation of glucose import (GO:0046324),0.6878873996140252,1.789478055812453,0.00291970802919708,0.13931616534498723,0.972,7/30,5.17%,IGF1;ENPP1;PID1;PIK3R1;PRKAG2;APPL2;OSBPL8
prerank,positive regulation of bone mineralization (GO:0030501),0.6571488489746161,1.7839246291831343,0.004464285714285714,0.1474479193983474,0.979,10/35,4.60%,NELL1;BMP6;SLC8A1;ADGRV1;FBN2;BMPR1A;CCN1;KL;WNT4;ACVR1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.6379041189640227,1.781676414507134,0.0026845637583892616,0.14829659566440298,0.981,13/47,7.04%,TIMP3;AHSG;SERPINE1;SERPING1;RECK;FETUB;VTN;MT3;SERPIND1;SERPINF1;SERPINH1;CRB2;TIMP2
prerank,regulation of AMPA receptor activity (GO:2000311),-0.585169509260016,-1.7757068329099472,0.0,0.19627350683663974,0.971,12/25,22.10%,MEF2C;SHANK3;NLGN1;SHANK1;ADRB2;GSG1L;NLGN3;CACNG3;CACNG4;SHISA9;RELN;MINK1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.6192059287515459,-1.773464384116375,0.010666666666666666,0.1929889183003855,0.976,7/20,16.62%,PLCE1;CAV1;KCNB2;CHRM3;ADRB2;CHRM2;CTTN
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.6641185355798078,1.7727476424286215,0.0029154518950437317,0.16525564557984765,0.991,12/33,6.80%,TCF7L2;PDPK1;ANGPT1;SERPINE1;YAP1;GAS6;NUPR1;SEMA5A;CAST;NEUROD1;CDH5;NFE2L2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.5216839602078964,1.772053309113466,0.0,0.1627093688894199,0.991,60/248,13.38%,IGFBP2;TCF7L2;LYPD6;WLS;COL1A1;BICC1;LRRK1;RNF220;DAAM2;CDK14;TBL1XR1;RBMS3;ZEB2;MCC;IGFBP4;LGR4;DACT1;NKD1;GLI3;KANK1;FGFR2;APOE;SEMA5A;TMEM170B;TLE1;SMURF2;PRICKLE1;SFRP1;PSME4;AXIN2;PTK7;MLLT3;DKK3;USP47;LRRK2;ZNRF3;ADGRA2;WWTR1;STK4;EGFR;DAB2;BMP2;TRPM4;STK11;PRKN;DDX3X;INVS;LZTS2;EGF;JADE1;GLI1;TMEM64;WNK1;KLHL12;BTRC;UBAC2;TNKS2;ATP6AP2;SFRP4;MDK
prerank,myoblast differentiation (GO:0045445),0.7801402484435768,1.7685198908289639,0.010084033613445379,0.16784333088989842,0.993,5/14,6.93%,IGF1;TCF7L2;EPAS1;SDC1;DDX17
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.6870857330668614,1.7652378383419585,0.005813953488372093,0.17203084929416504,0.993,10/30,6.12%,NREP;TGFBR3;SMAD3;ITGA3;FSTL1;TWSG1;SMURF2;DKK3;ENG;BCL9
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.6401630558816883,1.7640525094985595,0.0013280212483399733,0.17054155788353717,0.993,10/46,8.21%,IGF1;TCF7L2;OGN;ELN;IL6R;PDGFRB;IGFBP5;VIP;IL12B;CCN4
prerank,positive regulation of phospholipase activity (GO:0010518),0.7251634421098165,1.763808477746443,0.006279434850863423,0.167270168052519,0.993,11/22,10.39%,PDPK1;FGFR1;FGFR2;PDGFRA;KIT;PDGFRB;NTF3;AGTR1;NTRK3;FGF2;ARL1
prerank,synapse assembly (GO:0007416),-0.47620606106148955,-1.7631880675296436,0.0,0.2088745107371817,0.986,19/67,7.86%,DNM3;ADGRL3;GRID2;SHANK3;CDH2;GPM6A;NLGN1;CDH1;SPOCK2;KIRREL3;NRCAM;GABRA2;DNER;GABRB3;NRXN1;GABRG2;LRRTM3;CDK5;GABRB2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.7006639334067475,1.76177718355606,0.007621951219512195,0.16901408668559587,0.995,5/26,2.07%,EYA2;GDNF;EYA1;BCL2;FGFR1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.637697730376423,-1.7611938280350286,0.005221932114882507,0.2054325908969672,0.987,12/18,28.49%,SHANK3;NLGN1;PTK2B;TSHZ3;NRXN1;NLGN3;CACNG3;CACNG4;RELN;CCL2;CACNG5;CACNG7
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.7451213002291985,1.7600930085027613,0.0062402496099844,0.16984213865711623,0.995,5/21,4.91%,IGF1;GJA1;BMPR1A;MMP2;IGFBP5
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.7678047536748309,-1.7579416087844473,0.0,0.20512149908205266,0.991,3/10,1.99%,CAV1;ANK3;KCNAB1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.8499343861820411,1.756145553243586,0.0017921146953405018,0.17600305253370047,0.997,5/10,4.80%,LYN;GAS6;CCL19;RAPGEF2;AXL
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.7265985210203717,1.75555354394571,0.004777070063694267,0.17058581846628068,0.998,4/21,1.85%,EYA2;GDNF;EYA1;BCL2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.7265985210203717,1.75555354394571,0.004777070063694267,0.17058581846628068,0.998,4/21,1.85%,EYA2;GDNF;EYA1;BCL2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.7285426824763372,1.7537797650590266,0.006125574272588055,0.17129821858117417,0.998,8/23,6.12%,NREP;TGFBR3;SMAD3;ITGA3;SMURF2;DKK3;ENG;BCL9
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.49708584360700303,-1.75313281015899,0.0,0.20760578943258448,0.991,23/54,21.42%,NSA2;RPL3;RPL7;RPL35A;PAK1IP1;RPL11;MAK16;RPL26;RPL6;MALSU1;NVL;RPL7A;PPAN;SNU13;RPL5;RPL14;RPLP0;NPM1;RRP15;NOP16;RPF2;RPF1;RRS1
prerank,negative regulation of receptor binding (GO:1900121),-0.7267355069805006,-1.7485801708087256,0.014527845036319613,0.2100191569792038,0.991,3/10,6.48%,B2M;ADAM15;ATP2A3
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.7883878298030814,1.7433207526996155,0.0034129692832764505,0.19357621212384274,0.999,2/13,0.49%,IGF1;IGF2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.5511277053782146,1.7430668852496294,0.0,0.1905171035112676,0.999,23/113,9.95%,IGF1;TCF7L2;NRP1;BMP6;AREG;TGFA;LAMC1;EPGN;FGFR2;YAP1;VASH2;TGFBR1;SEMA5A;NOTCH2;SFRP1;VIP;AKT3;OSR1;EGFR;BMP2;ARNT;ITGB3;FGF2
prerank,defense response to tumor cell (GO:0002357),0.8239466124167443,1.7392099501895664,0.009983361064891847,0.19651220614533682,1.0,3/10,1.83%,RBMS3;DAPK1;DLEC1
prerank,cAMP biosynthetic process (GO:0006171),0.831483768905913,1.7327515681600705,0.012195121951219513,0.2099980232084172,1.0,5/10,3.66%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,positive regulation of protein secretion (GO:0050714),0.5843288627917455,1.731681291215298,0.0,0.20956266241684796,1.0,9/69,4.82%,IGF1;TCF7L2;RBP4;BMP6;WLS;SLC30A8;MYO18A;MYH10;MCU
prerank,regulation of dendrite extension (GO:1903859),-0.6212764641636878,-1.7280043720571,0.007731958762886598,0.24912232538356555,0.995,6/18,7.38%,SMURF1;RIMS1;NEDD4L;RIMS2;SYT1;ITSN2
prerank,retinol metabolic process (GO:0042572),0.7767571324373223,1.727809882798814,0.011864406779661017,0.2174171710365687,1.0,4/14,7.31%,RBP4;DHRS3;CYP1B1;ADH1A
prerank,positive regulation of dendrite extension (GO:1903861),-0.6293342274807704,-1.726521136265056,0.007518796992481203,0.24490592741729153,0.995,6/17,7.38%,SMURF1;RIMS1;NEDD4L;RIMS2;SYT1;ITSN2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.7947044615709409,1.7264884542945331,0.005208333333333333,0.21744601092525395,1.0,2/12,0.49%,IGF1;IGF2
prerank,regulation of small molecule metabolic process (GO:0062012),0.6729333470450798,1.7260779120779883,0.005891016200294551,0.21494670644284547,1.0,7/28,10.17%,PDK1;RORA;EPHX2;APOE;GNB3;PRKN;NCOR2
prerank,regulation of neuroinflammatory response (GO:0150077),0.7331586597812636,1.725407929106871,0.0015552099533437014,0.21352811204736902,1.0,5/19,9.06%,IGF1;DAGLA;NUPR1;NR1D1;CD200
prerank,positive regulation of stress fiber assembly (GO:0051496),0.6138386319929041,1.7253922899693384,0.0055248618784530384,0.21016067480347184,1.0,15/44,11.55%,NRP1;CCN2;ROCK2;PPM1E;TPM1;ARHGEF10L;TGFBR1;APOA1;SFRP1;CDC42;CARMIL1;LPAR1;SYNPO2L;ARHGEF10;RGCC
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.6935335015067828,1.7246634901972746,0.006144393241167435,0.2088323160594134,1.0,3/24,0.56%,IGF1;IGF2;ENPP1
prerank,neurotransmitter uptake (GO:0001504),0.8130007806599501,1.7219679160662524,0.003484320557491289,0.212698152938748,1.0,4/12,4.32%,SLC1A3;GLUL;ATP1A2;SLC22A2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7592451721149643,1.72180795717992,0.007974481658692184,0.20972341165011932,1.0,8/17,14.11%,ADRA1B;ADCY9;RAPGEF2;ADRA2C;ADRB3;DRD3;ADRA2A;AKAP13
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.5272720031938113,1.7207731083767812,0.0022701475595913734,0.2094773939178126,1.0,28/152,6.72%,LYPD6;WLS;COL1A1;LRRK1;RNF220;DAAM2;TBL1XR1;ZEB2;LGR4;DACT1;SULF2;SALL1;KANK1;FGFR2;MACF1;SULF1;SEMA5A;LBX2;SMURF2;SFRP1;PSME4;AXIN2;PTK7;USP47;SKI;LRRK2;ADGRA2;WNT5B
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.3764467732788013,-1.720689979788629,0.0,0.2525093375184476,0.996,85/224,23.03%,GRM7;DLG2;SLC12A7;EXOC4;UNC13B;GRM3;GRIA4;RIT2;NLGN1;GABRG3;KCND2;GRIK1;GRIK2;GRIN2A;SDCBP;GABRA2;GABRB3;GABRB1;SYPL1;NRXN1;GLRA1;AMPH;GABRG2;PRKACB;SLC1A1;CHRM3;LRP6;GLRA2;GRM5;SLC12A6;CDK5;GRIN2B;PRKAR1A;CAMK4;SYT1;HCRTR2;GABRB2;GRIA2;PRKAR2B;PAFAH1B1;HTR2A;RPS6KA1;KCNQ3;CALM1;GABRA3;PRKAR2A;PRKAR1B;HOMER1;HRH1;CPLX1;SYN2;PCDHB14;CHRM2;SLC12A5;PLP1;GIPC1;GRM1;NLGN3;GPR176;SYNJ2BP;SLC1A2;APBA2;CACNA1A;SYN1;CACNB3;KIF5A;KCNIP2;GRIN1;GABRG1;GABRA4;GAD1;PTCHD1;PNOC;GLRA3;NPY5R;GABARAP;CAMKK1;HAP1;MINK1;GABRR2;KCNC4;GRIK4;SYT5;MAPK1;CHRM1
prerank,regulation of membrane repolarization (GO:0060306),-0.6788808666020085,-1.720106587679736,0.007246376811594203,0.24635756758119773,0.996,8/13,19.51%,CAV1;KCNJ2;NEDD4L;KCNQ1;AKAP6;CASQ2;CACNA2D1;CACNB3
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.7956536236093167,1.7195893285629733,0.0018148820326678765,0.20942325036306764,1.0,3/11,1.19%,IGF1;GHR;PIK3R1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.6164754523368795,1.7193493771581267,0.0013568521031207597,0.20691822432584886,1.0,9/49,6.96%,IGF1;GHR;IL31RA;LYN;IL6R;KIT;TSLP;PIBF1;IL12B
prerank,eye morphogenesis (GO:0048592),0.708930360944093,1.7188490691012828,0.011272141706924315,0.2052326880406109,1.0,8/19,5.96%,FBN1;COL5A1;FBN2;NKD1;SHROOM2;MFAP5;RARG;SKI
prerank,regulation of protein processing (GO:0070613),0.6919522691587442,1.7178344624618955,0.008038585209003215,0.20506601515669162,1.0,8/21,15.66%,CCBE1;RUNX1;LRRK2;RNF139;SNX12;CLN3;GAS1;NLRC4
prerank,positive regulation of behavior (GO:0048520),-0.7154052256856962,-1.7174225666265885,0.006564551422319475,0.24553488777204513,0.996,3/10,1.44%,MEF2C;SGIP1;NLGN1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5139607604573662,-1.7149929274377467,0.006896551724137931,0.24423231758661168,0.996,10/37,4.00%,HMCN1;GRID2;CADM1;NLGN1;IL1RAPL1;TENM2;TENM3;TENM4;PTPRD;NECTIN1
prerank,regulation of mitotic nuclear division (GO:0007088),0.5979381064307584,1.7145245548989037,0.0,0.21062768268911336,1.0,15/55,12.98%,IGF1;IGF2;TGFA;OBSL1;EPGN;PDGFRB;PHIP;TOM1L2;CD28;DRD3;L3MBTL1;RGCC;EGF;NME6;INSR
prerank,angiogenesis involved in wound healing (GO:0060055),-0.7192260685284451,-1.7141457047967437,0.009302325581395349,0.23936233817697997,0.996,7/11,9.63%,ADIPOR2;CD34;KDR;PRCP;GATA2;MCAM;VEGFA
prerank,protein oxidation (GO:0018158),0.8058648474800755,1.71060419794092,0.005016722408026756,0.21843272921445933,1.0,3/11,4.39%,LOXL1;LOX;APOA1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.6430561863588029,1.7084921300617706,0.008759124087591242,0.22151294657541173,1.0,6/32,5.53%,IGF1;ZBTB20;PID1;PFKFB4;NUPR1;PRKAA2
prerank,rRNA processing (GO:0006364),-0.38544705075298763,-1.7082542885406304,0.0,0.247032461018291,0.997,66/172,21.02%,NSA2;RPL41;RPL3;RPS24;RPS14;RPL8;RPL27A;RPS19;RPL34;RPL21;RIOK1;RPL7;RPL18;RPL27;RPL38;RPL35A;RPS15;RPL39;RPS7;RPL11;RPL30;RPL36;WDR36;RPLP1;RPL37;RPS9;MAK16;UTP4;RPL18A;RPL4;RPL29;RPL26;RPL6;RPL13A;RPL36A;NVL;RPL7A;RPL19;LSM6;RPL13;SNU13;RPL32;RRP1;RPL5;POP4;RPL14;NOL9;RPLP0;PRKDC;KRR1;RPS6;MPHOSPH10;UTP15;RPL22;IMP4;RRP36;FCF1;EXOSC5;RPL37A;RRP15;RRP12;RPL17;RPL23;RPLP2;WDR46;RPF1
prerank,lipid oxidation (GO:0034440),-0.6777337363939895,-1.7078415719703819,0.017241379310344827,0.24185980509811847,0.997,3/12,6.68%,ADIPOR2;PLA2G7;PPARGC1A
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.686063914414496,1.7063149164773972,0.007633587786259542,0.22502287422489403,1.0,7/24,9.15%,CCBE1;RORA;SULF2;SULF1;CYP1B1;EIF2AK3;ARNT
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.5296116627251766,1.704354542335714,0.002320185614849188,0.22687536095929053,1.0,21/129,6.47%,LYPD6;WLS;COL1A1;LRRK1;RNF220;DAAM2;TBL1XR1;ZEB2;LGR4;DACT1;KANK1;FGFR2;SEMA5A;SMURF2;SFRP1;PSME4;AXIN2;PTK7;USP47;LRRK2;ADGRA2
prerank,camera-type eye development (GO:0043010),0.672214467126519,1.7035260122810851,0.009404388714733543,0.22602773092535372,1.0,7/25,6.40%,LAMA1;FBN1;FBN2;SHROOM2;CYP1B1;SKI;CACNA1C
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.674571284469261,1.7031571106719634,0.006033182503770739,0.22386779507493476,1.0,7/26,9.15%,CCBE1;RORA;SULF2;SULF1;CYP1B1;EIF2AK3;ARNT
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7195494908286751,-1.701876346913302,0.009852216748768473,0.2499933824653263,0.999,6/12,11.06%,PDE4D;CAV1;GJD3;CAMK2D;CALM1;CALM3
prerank,organic anion transport (GO:0015711),-0.44273455624504465,-1.7010746491364501,0.0,0.2453693137284365,0.999,19/76,12.92%,SLC4A10;ABCG2;SLC26A7;ABCC4;LRRC8C;SLCO2A1;SLCO1C1;LRRC8D;SLCO2B1;CA4;SLC22A6;SLC39A8;SLC4A8;ABCC6;SLC26A6;SLC52A3;SLC35A2;SLC25A4;CFTR
prerank,positive regulation of T cell proliferation (GO:0042102),0.5934669177570989,1.7003008673265532,0.004032258064516129,0.22861381354565233,1.0,6/55,7.30%,IGF1;IGFBP2;IGF2;CCL19;IL12B;CD28
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.7184992524282084,-1.6990153998321371,0.004618937644341801,0.24423772863309276,0.999,6/10,16.96%,KDR;IL33;NAMPT;JAK2;NOD2;TLR4
prerank,lung development (GO:0030324),0.6482842862658761,1.6985444695478547,0.01278409090909091,0.23048131020307597,1.0,15/33,15.79%,RBP4;ERRFI1;GLI2;ITGA3;NKX2-1;FGFR2;PDPN;CEBPA;DNAAF1;FGF2;RCN3;CCDC40;ABCA3;SHH;BMP4
prerank,response to iron ion (GO:0010039),0.7714044148082061,1.69496334065655,0.013468013468013467,0.2376683575636503,1.0,4/12,6.43%,BMP6;BCL2;SLC11A2;ACO1
prerank,diol biosynthetic process (GO:0034312),-0.63773629381954,-1.6932366506227812,0.009925558312655087,0.25224213187027994,0.999,6/15,10.91%,ACER3;ACER2;GCH1;DHFR;SPTLC2;SPR
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.5503938199165843,-1.691846059674543,0.011299435028248588,0.24967158330422393,0.999,12/28,18.64%,OCLN;NAV3;MET;RPS3;MECP2;PAK1;FES;GIT1;DCTN1;CDK5RAP2;CDK5R1;CLASP1
prerank,regulation of steroid metabolic process (GO:0019218),0.6975110426305906,1.6902439378495437,0.004622496147919877,0.24789614718253655,1.0,6/23,6.67%,RORA;EPHX2;APOE;STAR;GNB3;NR5A1
prerank,acylglycerol metabolic process (GO:0006639),-0.5047096124696768,-1.689323719516588,0.012232415902140673,0.24997528257791304,0.999,16/37,19.78%,CAV1;MGLL;ABHD2;DGKB;DGKH;DGKK;PLAAT3;PGS1;PNPLA3;DGKG;DGKQ;PNPLA2;ABHD6;DGKZ;LYPLA2;DGKI
prerank,regulation of protein autophosphorylation (GO:0031952),0.6277775316300872,1.6832811643342764,0.007194244604316547,0.2661361063663317,1.0,10/36,13.08%,EPHA7;ENPP1;ERRFI1;PDGFD;ENG;DDX3X;RAP2A;PPP2R5D;IMPACT;MVP
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.5899210509733496,1.680855993732689,0.0027662517289073307,0.27053494047289817,1.0,16/51,11.55%,NRP1;CCN2;ROCK2;PPM1E;TPM1;ARHGEF10L;TGFBR1;APOA1;SFRP1;SYNPO2;CDC42;CARMIL1;LPAR1;SYNPO2L;ARHGEF10;RGCC
prerank,sympathetic nervous system development (GO:0048485),0.7581244781941031,1.6804181738735,0.008488964346349746,0.26861974302542424,1.0,3/15,3.29%,NRP1;GDNF;ASCL1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.4622153674699734,-1.6795680524532879,0.00425531914893617,0.2673481578466922,0.999,19/54,14.40%,CAV1;DPP10;FHL1;KCNIP4;KCNJ2;KCNAB1;NEDD4L;KCNJ3;KCNMA1;KCNN2;KCNQ1;AKAP6;KCNMB2;DPP6;KCNJ15;GNB1;KCNJ10;GNG2;CACNA1D
prerank,cell-matrix adhesion (GO:0007160),0.5437409123140662,1.6772937821946339,0.0012004801920768306,0.2752147624203284,1.0,26/95,11.59%,ITGBL1;ADAMTS12;FBLN5;ACTN2;DLC1;ITGA11;RHOD;ITGA3;NID2;COL13A1;VTN;ITGB8;ITGB5;ECM2;ADAMTS9;SRC;EMILIN1;VCL;CD63;ITGB6;LYVE1;ITGB3;ITGAV;TRIP6;COL3A1;SGCE
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6783304525475043,1.6756797311816187,0.016129032258064516,0.27647568278002266,1.0,8/21,11.78%,IGF1;APOA1;MT3;CTSH;ZFP36L1;MAP2K1;ITGAV;EGF
prerank,positive regulation of protein maturation (GO:1903319),0.7708812253257179,1.6752103981824267,0.017123287671232876,0.2746171873690757,1.0,1/11,0.19%,CCBE1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.4512638689592096,-1.674774614014715,0.0,0.2732046190626544,0.999,26/63,14.03%,SLC12A2;SLC12A7;SLC26A2;GABRG3;ANO1;ANO4;CLCN3;SLC5A6;GABRA2;GABRB3;GABRB1;GLRA1;GABRG2;SLC1A1;GLRA2;SLC12A6;GABRB2;SLC37A3;SLC4A8;SLC25A30;GABRA3;ANO3;ANO2;CFTR;SLC25A11;SLC12A5
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.5141032082966882,-1.674476467921142,0.01818181818181818,0.26840366369247315,0.999,13/33,11.10%,GRID2;NRG3;NLGN1;NGF;GRIK1;GRIK2;PXK;LRRC4C;SLC4A8;LRP8;BCR;GRID1;CX3CR1
prerank,positive regulation of ossification (GO:0045778),0.608906457346262,1.672828440611575,0.011627906976744186,0.27895719818822323,1.0,10/39,4.60%,NELL1;BMP6;SLC8A1;ADGRV1;FBN2;BMPR1A;CCN1;KL;WNT4;ACVR1
prerank,proteoglycan metabolic process (GO:0006029),0.6708594904038987,1.670318386904595,0.004524886877828055,0.28376335587556106,1.0,5/26,3.74%,IGF1;ADAMTS12;GAL3ST3;SULF2;SULF1
prerank,response to histamine (GO:0034776),-0.7161374592822772,-1.670199573811586,0.018306636155606407,0.27302350952344984,0.999,6/10,12.26%,DIAPH1;GABRB3;GABRB1;GABRG2;GABRB2;HRH1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.5485400438493009,-1.669187322018267,0.013850415512465374,0.2700861044212762,0.999,7/27,7.59%,UTRN;NEDD4L;YWHAH;CAMK2D;FGF12;NOS1;ATP2B4
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.6926496544927964,1.6682625854809188,0.007751937984496124,0.28743580831252663,1.0,9/21,10.04%,BMP6;CILP;BMPR1A;TGFBR1;SLC2A10;WWTR1;DAB2;RBPMS;FAM89B
prerank,cellular biogenic amine catabolic process (GO:0042402),0.7996225188399008,1.6674935093449677,0.012773722627737226,0.28678910971785815,1.0,7/10,11.61%,SMOX;SLC44A1;COMT;HNMT;ALDH7A1;LRTOMT;SARDH
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.7511250202287154,1.6643927389633115,0.01309328968903437,0.29317873596438276,1.0,5/13,9.95%,PDPK1;IGF2;FGFR1;AKT3;FGF2
prerank,ethanol metabolic process (GO:0006067),0.761369575568171,1.6642595588023141,0.014900662251655629,0.29035583737455006,1.0,3/12,8.86%,ALDH1A1;ADH1A;ALDH2
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.5694850252601983,1.6641858463851502,0.007947019867549669,0.28748458122522924,1.0,12/63,6.57%,IGF1;TCF7L2;AR;FGFR1;SH3RF1;SP100;CFLAR;TGFBR1;ACVR1;PHIP;SRC;PML
prerank,modulation by symbiont of entry into host (GO:0052372),-0.6362833973583952,-1.6634806119686771,0.013020833333333334,0.27815640003281383,0.999,9/16,21.16%,CAV1;TRIM14;HS3ST5;TRIM25;EXOC2;TRIM68;TRIM6;TRIM62;NECTIN2
prerank,sulfur compound catabolic process (GO:0044273),0.621481545559324,1.6613092275958004,0.00847457627118644,0.29338233214411263,1.0,11/38,8.32%,FMOD;OGN;LUM;DCN;BGN;GALNS;CHAC2;NUDT7;DPEP1;OMD;CSPG5
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6833289269957131,1.6597587777583713,0.007763975155279503,0.2952481763303766,1.0,8/22,14.16%,SH3D19;TIMP3;APOE;SNX33;TIMP2;ADRA2A;PTPN3;SNX9
prerank,rRNA metabolic process (GO:0016072),-0.37978029146697806,-1.659139814475375,0.0,0.2841022210332977,0.999,62/160,21.02%,RPL41;RPL3;RPS24;RPS14;RPL8;RPL27A;RPS19;RPL34;RPL21;RPL7;RPL18;RPL27;RPL38;RPL35A;RPS15;RPL39;RPS7;RPL11;RPL30;RPL36;WDR36;RPLP1;RPL37;NIFK;RPS9;UTP4;RPL18A;RPL4;RPL29;RPL26;RPL6;RPL13A;RPL36A;NVL;RPL7A;RPL19;RPL13;SNU13;RPL32;DEDD2;RRP1;RPL5;POP4;RPL14;NOL9;RPLP0;KRR1;RPS6;MPHOSPH10;UTP15;RPL22;IMP4;RRP36;FCF1;EXOSC5;RPL37A;RRP12;RPL17;RPL23;RPLP2;WDR46;RPF1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.7440684601284486,1.6572434229650228,0.014184397163120567,0.29975883079803195,1.0,4/14,9.06%,IGF1;LDLR;NR1D1;CD200
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.795775695586246,1.6565184758404452,0.015437392795883362,0.2987180571213121,1.0,6/10,11.80%,AREG;TGFA;EPGN;HBEGF;EGF;ADRA2A
prerank,respiratory tube development (GO:0030323),0.6500069521333598,1.654121725615109,0.01624815361890694,0.303484202365073,1.0,13/28,15.79%,RBP4;GLI2;ITGA3;NKX2-1;FGFR2;PDPN;CEBPA;DNAAF1;FGF2;CCDC40;ABCA3;SHH;BMP4
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.6830613778707352,1.6533105389077856,0.019417475728155338,0.300071997473329,1.0,4/20,5.53%,IGF1;ZBTB20;PFKFB4;PRKAA2
prerank,positive regulation of glycolytic process (GO:0045821),0.6830613778707352,1.6533105389077856,0.019417475728155338,0.300071997473329,1.0,4/20,5.53%,IGF1;ZBTB20;PFKFB4;PRKAA2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.7366051218049126,1.652180536317652,0.013468013468013467,0.3005958207397256,1.0,2/15,0.75%,IGF1;ROCK2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.5211142873229784,1.6520589514871982,0.001199040767386091,0.2981559553999388,1.0,26/108,9.90%,WLS;TRABD2B;DAAM2;CDK14;LRP1;RUNX1;DACT1;SULF2;SALL1;NKD1;KANK1;ITGA3;FGFR2;MACF1;MDFI;SULF1;TLE1;SFRP1;PTK7;SKI;LRRK2;TCF7L1;BMP2;CBY1;PRKN;TAX1BP3
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.4163385712071164,-1.6513661236129609,0.0,0.2986294768090658,0.999,33/107,11.60%,GRM7;SLC12A2;GRID2;MEF2C;MCTP1;GRM3;CDH2;NRG3;NLGN1;RIMS1;NGF;GRIK1;GRIK2;PXK;DLGAP2;GRM5;RIMS2;CDK5;OPHN1;SYT1;TMEM108;CLSTN2;LRRC4C;SLC4A8;LRP8;TPRG1L;SYN3;BCR;GRID1;GRM8;CLSTN3;CX3CR1;HOMER1
prerank,negative regulation of cell development (GO:0010721),0.6518425662657285,1.649735393375138,0.014771048744460856,0.3028242107483428,1.0,3/25,4.43%,IGF1;FBN1;APPL2
prerank,negative regulation of protein catabolic process (GO:0042177),0.6138150465389304,1.6496623679223918,0.0136986301369863,0.30006848641748635,1.0,13/40,14.66%,NELL1;TIMP3;CDK5RAP3;SNRNP70;CST3;TIMP2;SIRT2;IRAK3;EGFR;SNX12;PTPN3;BANP;FLNA
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.8026008549659359,1.649530491269768,0.010309278350515464,0.2975681130781255,1.0,3/10,4.27%,NELL1;EPHA4;CDK5RAP3
prerank,regulation of multicellular organism growth (GO:0040014),0.72930912418088,1.6491776773665487,0.022033898305084745,0.29589956764836406,1.0,2/15,1.00%,IGF1;GHR
prerank,pigment granule transport (GO:0051904),-0.6027331292190476,-1.6486966436250954,0.01818181818181818,0.2950823388038958,0.999,8/18,18.89%,RAB27A;RAB11A;RAB27B;ARL6;BLOC1S5;MLPH;BBS7;MREG
prerank,melanosome transport (GO:0032402),-0.6027331292190476,-1.6486966436250954,0.01818181818181818,0.2950823388038958,0.999,8/18,18.89%,RAB27A;RAB11A;RAB27B;ARL6;BLOC1S5;MLPH;BBS7;MREG
prerank,activation of protein kinase B activity (GO:0032148),0.6501322367166591,1.6485243590792138,0.010248901903367497,0.2952196380877731,1.0,8/29,8.07%,IGF1;PDPK1;GAS6;MT3;NTF3;OSBPL8;ADRA2C;NTRK3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6594648896172483,1.6479374648079095,0.02377179080824089,0.2945053412495447,1.0,7/23,12.98%,IGF1;ZBTB20;PFKFB4;PRKAA2;ARNT;EGF;INSR
prerank,respiratory system development (GO:0060541),0.637387892294383,1.647838029166614,0.01327433628318584,0.292166373860347,1.0,16/32,17.63%,RBP4;GLI2;ITGA3;NKX2-1;FGFR2;PDPN;CEBPA;DNAAF1;FGF2;CCDC40;ABCA3;SPEF2;SHH;BMP4;CHD7;SMCHD1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5184467657066637,1.6462791108395065,0.0011574074074074073,0.2943789800179467,1.0,21/121,6.96%,IGF1;NRP1;BMP6;IGF2;ANGPT1;GHR;IL31RA;LYN;NEDD9;IL34;IL6R;EPHA4;KIT;VTN;GAS6;ACVR1;NTF3;TSLP;SRC;PIBF1;IL12B
prerank,keratan sulfate catabolic process (GO:0042340),0.7770967006876516,1.6434228033252436,0.01854974704890388,0.30079169714423104,1.0,5/11,8.15%,FMOD;OGN;LUM;GALNS;OMD
prerank,tight junction assembly (GO:0120192),-0.46588904829679256,-1.6432139860218897,0.0036496350364963502,0.30374688060226185,1.0,9/49,3.92%,MPP7;OCLN;PECAM1;CLDN5;ESAM;F11R;LSR;CLDN11;RAMP2
prerank,chemical synaptic transmission (GO:0007268),-0.35183950005316483,-1.6414013886595489,0.0,0.30293320985996924,1.0,103/284,23.03%,GRM7;DLG2;GRID2;SLC12A7;EXOC4;UNC13B;GRM3;GRIA4;RIT2;NLGN1;GABRG3;RIMS1;KCND2;LIN7A;GRIK1;GRIK2;GRIN2A;HSPA8;SDCBP;GABRA2;GABRB3;GABRB1;SYPL1;NRXN1;GLRA1;AMPH;DLGAP2;GABRG2;PRKACB;SLC1A1;CDH8;CHRM3;LRP6;GLRA2;GRM5;SLC12A6;LIN7C;CDK5;GRIN2B;PRKAR1A;CAMK4;SYT1;HCRTR2;GABRB2;NAAA;GRIA2;PRKAR2B;PAFAH1B1;SYN3;HTR2A;RPS6KA1;GRID1;KCNQ3;CALM1;GABRA3;PRKAR2A;PRKAR1B;HOMER1;HRH1;CPLX1;SYN2;PCDHB14;CHRM2;SLC1A4;SLC12A5;PLP1;GIPC1;GRM1;NLGN3;GPR176;SYNJ2BP;RAB3A;STX1A;CBLN2;SLC1A2;APBA2;CACNA1A;SYN1;DVL1;CACNB3;KIF5A;KCNIP2;GRIN1;GABRG1;GABRA4;GAD1;PTCHD1;PNOC;GLRA3;NPY5R;GABARAP;CAMKK1;HAP1;MINK1;GABRR2;SNPH;KCNC4;GRIK4;STXBP2;SYT5;KIF1B;MAPK1;CHRM1
prerank,intestinal absorption (GO:0050892),-0.6381782629771642,-1.6388703728075593,0.02403846153846154,0.304549062849287,1.0,5/13,11.39%,F11R;TJP2;KCNQ1;SLC26A6;UGCG
prerank,epidermis development (GO:0008544),0.5817683839209934,1.638385169663182,0.009510869565217392,0.31482397725137795,1.0,5/56,4.38%,SVEP1;CCN2;FGFR2;TGM5;EDAR
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.6101294858180446,-1.637610210656645,0.009925558312655087,0.30231044389078227,1.0,7/15,18.07%,REEP1;RTN3;TMEM33;ATL2;ARL6IP1;ZFYVE27;REEP2
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5746581728305318,1.6375603535157286,0.014473684210526316,0.3146589603393472,1.0,14/55,9.95%,GPC6;FMOD;OGN;CEMIP;LUM;DCN;BGN;HSPG2;GALNS;SDC1;OMD;CSPG5;LYVE1;FGF2
prerank,lipid phosphorylation (GO:0046834),-0.7029708781608704,-1.637259145075762,0.017130620985010708,0.2980255368687216,1.0,7/10,19.78%,DGKB;DGKH;DGKK;DGKG;DGKQ;DGKZ;DGKI
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.7060165095448074,1.6359845626649236,0.02155887230514096,0.3166589096902718,1.0,8/19,8.65%,ROBO1;CCBE1;DCN;SMOC2;IL12B;CD63;MYO1C;SPRY2
prerank,positive regulation of phosphorylation (GO:0042327),0.4814264479934447,1.6351730364857668,0.0010695187165775401,0.31663074744559455,1.0,47/240,10.19%,IGF1;EPHA3;NRP1;EPHA7;ZBTB20;IGF2;DDR2;ROCK2;ANGPT1;AR;LYN;FGFR1;IL34;LEPR;EPHA4;PELI2;EPHA8;CCN1;FGFR2;FGFR4;PDGFRA;KIT;PFKFB4;PDGFRB;GAS6;ROR1;MT3;AXL;AXIN2;MUSK;PRKAA2;SLCO3A1;ENG;LRRK2;NTRK3;STK4;DSCAM;EGFR;EPHB2;ARRB1;DAB2;BMP2;ARNT;ITGB3;FGF2;LMO4;RYK
prerank,determination of bilateral symmetry (GO:0009855),-0.5450860825222207,-1.631900181592369,0.0026041666666666665,0.30748812733057235,1.0,11/24,22.97%,NOTCH1;TBX1;ZIC3;GALNT11;DNAH11;STIL;ARL6;CITED2;BBS7;DLL1;ODAD3
prerank,positive regulation of cell differentiation (GO:0045597),0.48522998506953624,1.6309009828052392,0.0,0.3280664662982388,1.0,48/237,9.31%,IGF1;TCF4;NELL1;BMP6;COL1A1;RIN2;DDR2;GJA1;CCN2;GDNF;SMAD3;AR;SOX5;FBN2;FGFR1;SP7;IL6R;OLFM1;BMPR1A;ZEB1;RUNX2;CCN1;MEDAG;YAP1;WNT4;RIPOR2;ASCL1;TGFBR1;CSF1;RAPGEF2;ACVR1;SFRP1;NEUROD4;AXIN2;NEUROD1;PDPN;ZFP36L1;ADRA2C;CDC42;CRB2;WWTR1;AGTR1;PPP1R13L;CCN4;DAB2;BMP2;CREBL2;TRPM4
prerank,negative regulation of interleukin-1 production (GO:0032692),0.6668359565695324,1.6286069460901507,0.013975155279503106,0.33315151846061863,1.0,3/23,4.39%,IGF1;GAS6;APOA1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7860196948874483,1.6278526856936224,0.007259528130671506,0.3326920469552864,1.0,2/10,2.70%,RUNX1;SH3RF1
prerank,bicellular tight junction assembly (GO:0070830),-0.4676865557149779,-1.6269601032153505,0.0035460992907801418,0.31490610655734375,1.0,12/46,12.94%,MPP7;OCLN;PECAM1;CLDN5;ESAM;F11R;CLDN11;RAMP2;PATJ;PDCD6IP;PAK2;STRN
prerank,melanocyte differentiation (GO:0030318),0.774266210751369,1.6267408274724973,0.02276707530647986,0.33356997483078327,1.0,5/11,5.98%,ENPP1;LRMDA;MITF;KIT;SLC24A5
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7093450200502409,1.6258462589533016,0.02618657937806874,0.3336302790999011,1.0,4/16,9.87%,PDK1;RORA;GNB3;PRKN
prerank,chordate embryonic development (GO:0043009),0.5635024063773143,1.6248089794257383,0.013513513513513514,0.33425122657465955,1.0,12/55,5.73%,RBP4;COL1A1;IGF2;ARNT2;DACT1;SULF2;FGFR1;FGFR2;TGFBR1;SULF1;LIG4;ALDH1A2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5718847553517497,1.6233686989936031,0.005312084993359893,0.3361506607980842,1.0,9/57,6.96%,IGF1;GHR;IL31RA;LYN;IL6R;KIT;TSLP;PIBF1;IL12B
prerank,activation of protein kinase activity (GO:0032147),0.5177296841889486,1.6232717287953122,0.008333333333333333,0.3337888157993537,1.0,28/106,12.98%,IGF1;PDPK1;ADCY1;NRK;ANGPT1;ADCY2;GHR;ADCY7;ADCY5;GAS6;ADCY9;MT3;NTF3;OSBPL8;ADRA2C;PIBF1;TLR6;NTRK3;MAP4K4;STK4;PRRC1;ITGB3;STK11;TAOK3;ADRA2A;TNFSF15;STRADA;INSR
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.6273754364008975,1.6227946383691847,0.026470588235294117,0.3326756871968799,1.0,13/29,16.38%,LDLRAD4;NKX2-1;SFRP1;SPRY2;USF3;FOXA1;SPRED3;VASN;PTEN;SPRED1;HPN;BMP5;SDHAF2
prerank,activation of adenylate cyclase activity (GO:0007190),0.6189671184802018,1.6217786056363042,0.01585014409221902,0.33338988880987547,1.0,8/35,6.24%,ADCY1;ADCY2;ADCY7;LGR4;ADCY5;ADCY9;LHCGR;ADRB3
prerank,energy reserve metabolic process (GO:0006112),0.6857762558185547,1.6199074624516567,0.027777777777777776,0.3372966697499637,1.0,9/19,11.32%,PID1;PHKB;LEPR;PRKAG2;MT3;ADRB3;GFPT1;PYGM;PPP1R3C
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.6481868711004669,1.619492397719694,0.024132730015082957,0.33609436143586424,1.0,5/26,2.94%,ERRFI1;CBLB;AREG;TGFA;EPGN
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.7603493704885582,1.619337010107733,0.0189328743545611,0.33401539803763997,1.0,1/12,0.17%,RBP4
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6505854586168542,1.6170025812910318,0.015822784810126583,0.3387936027417607,1.0,5/23,6.22%,TGFBR3;TPM1;FGFR2;ADAMTS9;TNNC1
prerank,regulation of cell differentiation (GO:0045595),0.5009178966113766,1.6166417903448311,0.0011389521640091116,0.3374436758623166,1.0,27/148,7.95%,EPHA3;PHLDB2;IGF2;CCN2;NREP;TRPS1;GDNF;AR;DAG1;RUNX1;FGFR1;RUNX2;FGFR2;TGFBR1;CSF1;CDK5RAP3;NTF3;NEUROD4;NEUROD1;BCL6;GNB3;ZFP36L1;SIK1;DDX17;SMOC1;NR1D1;PPP1R13L
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5278349702316072,1.6157920979944482,0.00853658536585366,0.3375622596143554,1.0,14/86,6.96%,IGF1;NRP1;EPHA7;BMP6;IGF2;ANGPT1;GHR;IL6R;VTN;ACVR1;SFRP1;NTF3;SRC;IL12B
prerank,neurotransmitter secretion (GO:0007269),-0.4744589399231319,-1.6157749250143685,0.01090909090909091,0.33971226188668024,1.0,21/44,22.44%,RIMS1;LIN7A;HSPA8;NRXN1;RIMS2;LIN7C;CDK5;SYT1;NAAA;SYN3;PCLO;CPLX1;SYN2;RAB3A;STX1A;SYN1;DVL1;GAD1;OTOF;SNPH;STXBP2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.6801182827351069,1.6153755689007234,0.02465331278890601,0.336280535174247,1.0,4/18,2.07%,PDPK1;IGF2;COL4A3;FGFR1
prerank,positive regulation of signal transduction (GO:0009967),0.4814400679522811,1.6130882383683802,0.0021413276231263384,0.34094376148869965,1.0,51/238,9.62%,IGF1;NRP1;ROBO1;CCBE1;BMP6;PTGIS;WLS;IGF2;ESM1;MN1;PIK3R1;SASH1;DACT1;SULF2;SALL1;KANK1;FGFR2;MACF1;YAP1;MAML3;TGFBR1;VTN;GAS6;SMO;SULF1;SFRP1;MT3;NTF3;AXL;PHIP;SMOC2;CUX2;SKI;TSLP;LRRK2;SRC;ENHO;ING5;CD63;TRAF7;DRD3;RBPJ;MYO1C;NTRK3;ZMIZ1;BMP2;TEDC1;KAT2B;ARNT;ITGB3;ITGAV
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.7355748775851684,1.6104826052673633,0.0338680926916221,0.34727078927499616,1.0,4/12,6.96%,LYN;IL34;CSF1;IL12B
prerank,bicarbonate transport (GO:0015701),-0.5438897543228322,-1.6104210618049148,0.01791044776119403,0.34986511361381506,1.0,7/25,12.92%,SLC4A10;SLC26A7;CA4;SLC39A8;SLC4A8;SLC26A6;CFTR
prerank,supramolecular fiber organization (GO:0097435),0.4669967540184184,1.610308790375366,0.0,0.3452093222540106,1.0,61/333,10.56%,COL4A4;MFAP4;COL4A5;COL1A2;COL4A6;COL1A1;DDR2;FBLN5;RHOH;COL4A3;COL22A1;LOXL1;LUM;GSN;COL5A1;CGNL1;COL8A2;FIGN;LOX;HSPG2;COL11A1;DPT;RHOD;BFSP1;ADAMTS2;TPM1;TMOD4;SHROOM2;NCKAP5;COL13A1;RHOBTB1;TGFBR1;MYO1B;COL9A2;CYP1B1;APOA1;CLIP4;DYNC1H1;RHOBTB3;DES;COL20A1;CDC42;SERPINH1;CST3;EMILIN1;RHOBTB2;LTBP2;LTBP3;CARMIL1;COL11A2;SNCAIP;MYO1C;FAT1;KATNB1;MARCKSL1;MPRIP;PRKN;FGF13;GGA2;COL6A3;SHROOM3
prerank,phosphate ion homeostasis (GO:0055062),0.7559017501003629,1.6090004159087596,0.03052064631956912,0.34710114475652415,1.0,2/10,3.18%,ENPP1;FGFR4
prerank,cellular response to BMP stimulus (GO:0071773),0.5478578336896145,1.607875932853958,0.009079118028534372,0.3482990176465305,1.0,17/66,13.55%,BMP6;ADAMTS12;TGFBR3;SMAD3;BMPR1A;RUNX2;ACVR1;SFRP1;ENG;RGMA;BMP2;SMAD1;BMP15;USP9X;USP9Y;PDCD4;HIVEP1
prerank,outflow tract septum morphogenesis (GO:0003148),0.6576523475419287,1.6071125475620545,0.00966183574879227,0.34825942401986965,1.0,7/24,5.78%,NRP1;ROBO1;BMPR1A;PARVA;FGFR2;ACVR1;ENG
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6386139525807071,1.6058922857433382,0.016417910447761194,0.3496725346124401,1.0,5/27,5.16%,IGF1;DDR2;PDGFRA;GAS6;LIG4
prerank,regulation of axon guidance (GO:1902667),0.7626247694166025,1.6050552743597255,0.027675276752767528,0.34995696742337107,1.0,2/10,0.50%,NRP1;MYCBP2
prerank,cAMP metabolic process (GO:0046058),0.727976765398057,1.6023816103740183,0.023140495867768594,0.3567907832746993,1.0,5/13,3.66%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,chloride transmembrane transport (GO:1902476),-0.4543512494313771,-1.6015012604410828,0.007434944237918215,0.3709688231254503,1.0,21/48,14.03%,SLC12A2;SLC12A7;GABRG3;ANO1;ANO4;CLCN3;GABRA2;GABRB3;GABRB1;GLRA1;GABRG2;SLC1A1;GLRA2;SLC12A6;GABRB2;SLC4A8;GABRA3;ANO3;ANO2;CFTR;SLC12A5
prerank,dorsal/ventral pattern formation (GO:0009953),0.6681391015569147,1.5999266085951263,0.02694136291600634,0.3626569030394805,1.0,6/20,4.62%,GLI2;BMPR1A;WNT8B;MDFI;ACVR1;SFRP1
prerank,purine nucleotide catabolic process (GO:0006195),-0.6189845945843777,-1.59871821253447,0.03931203931203931,0.3739672038105503,1.0,7/13,18.48%,NT5E;NT5C2;NT5C1A;GDA;NT5C;PNP;GPX1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6730926377217611,1.5976482593082775,0.015748031496062992,0.367540162823684,1.0,2/19,4.39%,IGF1;APOA1
prerank,protein secretion (GO:0009306),0.5595964557506603,1.5934439558550608,0.017980636237897647,0.3794627784886346,1.0,20/56,16.80%,WLS;STEAP3;ABCA1;SLC30A8;NEUROD1;TVP23B;VIP;FAM3B;ARFGAP3;LTBP2;MIA2;MIA3;RCN3;MTTP;CYB5R4;TVP23A;TANGO2;GOLPH3;MAFA;COPG1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.621860581482019,-1.5925525904560236,0.033419023136246784,0.38811022958663977,1.0,7/13,15.11%,SEMA7A;PLCG2;TGFB2;SIRT1;TGFB1;GPRC5B;CUEDC2
prerank,microtubule anchoring at centrosome (GO:0034454),0.760535569820069,1.5922275057889095,0.03525046382189239,0.3808960186871804,1.0,2/10,2.63%,CCDC68;NINL
prerank,metal ion homeostasis (GO:0055065),-0.47610575637473995,-1.591885512840319,0.009584664536741214,0.3845774591175139,1.0,7/40,6.42%,TMTC2;SLC12A2;SLC12A7;CAV1;ANK3;LETM1;SLC12A6
prerank,adherens junction organization (GO:0034332),-0.4583470610795678,-1.5898993212963777,0.022058823529411766,0.38465990527664484,1.0,18/48,12.57%,CADM2;CDH2;CADM1;CDH1;ACTB;TJP1;RAMP2;NECTIN1;CDH12;CDH6;CDH8;CDH9;CDH13;CDH10;CSK;JUP;PVR;PAK2
prerank,sensory perception of sound (GO:0007605),0.5201472232169069,1.588928785828653,0.003592814371257485,0.39043101292265575,1.0,19/88,11.53%,ATP6V0A4;COL1A1;CEMIP;COL4A3;ADGRV1;EYA1;COL11A1;GRXCR1;EML2;KIT;RIPOR2;ROR1;USH2A;COL11A2;ALDH7A1;TIMM9;LRTOMT;GSDME;TPRN
prerank,positive regulation of dendrite development (GO:1900006),-0.6862305954221768,-1.5886722207685005,0.01694915254237288,0.3827846820066395,1.0,8/10,20.45%,COBL;ALK;LRP8;ZDHHC15;PTN;PACSIN1;VLDLR;DAB2IP
prerank,potassium ion homeostasis (GO:0055075),-0.5465016489833524,-1.5854752396841754,0.02601156069364162,0.3873413075838536,1.0,7/23,6.42%,SLC12A2;SLC12A7;KCNJ2;ATP1A1;KCNMA1;ATP1B1;SLC12A6
prerank,positive regulation of protein export from nucleus (GO:0046827),0.6939029109403637,1.5852262270603188,0.02901023890784983,0.40132668672350097,1.0,4/15,12.09%,TCF7L2;GAS6;RBM22;YWHAE
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.47347662874267654,-1.5827172590068876,0.022727272727272728,0.3903615146146541,1.0,16/39,19.67%,RPS24;RPS14;RPS19;RIOK1;RPS15;RPS7;UTP4;RPS5;METTL17;LSM6;SNU13;RPSA;RPS6;RRP36;NPM1;MRPS7
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.6220808131039959,1.5812400464535523,0.042488619119878605,0.41318537448268083,1.0,7/26,12.98%,IGF1;PIK3R1;OSBPL8;CREBL2;BRAF;RHOQ;INSR
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.5255682702611132,1.5806728050483434,0.007623888182973317,0.41248858023425733,1.0,10/77,6.32%,IGF1;TCF7L2;AR;BCL2;SH3RF1;CFLAR;TGFBR1;ACVR1;PHIP;SRC
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6842684785063665,1.5795214110009614,0.04591836734693878,0.41430979099492676,1.0,4/16,3.47%,NRP1;PDGFD;PDGFRA;PDGFRB
prerank,neurotransmitter biosynthetic process (GO:0042136),0.7039151180790664,1.579500499004515,0.03209459459459459,0.41164662456618195,1.0,3/14,4.32%,MOXD1;DAGLA;SLC22A2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.6018297917486469,1.5786005184894856,0.020833333333333332,0.41220822217028946,1.0,6/37,4.91%,IGF1;GJA1;TPM1;BMPR1A;MMP2;IGFBP5
prerank,muscle cell differentiation (GO:0042692),-0.4883800323650097,-1.5785048711898715,0.026143790849673203,0.39823174319025484,1.0,8/32,6.37%,NEBL;SYNE1;MRTFB;SGCZ;MEF2C;TBX1;KDM1A;HEY2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7412881933048002,1.5755331942433632,0.037037037037037035,0.4204658932347379,1.0,2/11,4.30%,PDK1;CYP1B1
prerank,myofibril assembly (GO:0030239),0.5636448471521157,1.5753109213540324,0.02401129943502825,0.41856548115316067,1.0,12/42,10.44%,ACTN2;OBSL1;TPM1;TMOD4;TNNT1;PDGFRA;CFLAR;PDGFRB;CSRP2;CSRP3;SYNPO2L;TNNT3
prerank,regulation of extracellular matrix organization (GO:1903053),0.6973295250263805,1.5738014736053656,0.037996545768566495,0.42117216432118776,1.0,6/15,4.09%,DDR2;LRP1;RUNX1;AEBP1;FGFR4;SLC2A10
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.5832444173448199,1.5730486251292572,0.02021563342318059,0.4213917206686232,1.0,7/43,4.91%,IGF1;GJA1;IL6R;BMPR1A;MMP2;PDGFRB;IGFBP5
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4794143076684186,1.572837131103002,0.0022271714922048997,0.41953464628674825,1.0,27/150,8.65%,TCF7L2;PDPK1;IGF2;ANGPT1;PIK3R1;AREG;TGFA;FGFR1;KL;EPGN;FGFR2;FGFR4;PDGFRA;KIT;PDGFRB;TGFBR1;GAS6;SEMA5A;CCL19;AXL;FRS2;OSBPL8;ENG;SRC;CD28;EGFR;SPRY2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.48719381218464763,1.572387217992121,0.0034562211981566822,0.41831736577069256,1.0,36/138,10.67%,EPHA3;EPHA7;MTSS1;DDR2;ANGPTL1;IL31RA;LYN;FGFR1;NEDD9;EPHA4;GFRA2;EPHA8;FGFR2;FGFR4;PDGFRA;KIT;PDGFRB;CSF1;POLR1G;CD7;ROR1;NTF3;AXL;FRS2;GUCY2C;MUSK;SRC;BDKRB2;GUCY2D;NTRK3;EGFR;EPHB2;RAPGEF1;RYK;EFS;EPHB3
prerank,cardiac conduction system development (GO:0003161),0.6341486073788754,1.5719211411736973,0.029780564263322883,0.4174917742941539,1.0,9/24,15.79%,GJA1;GJB6;BMPR1A;NOTCH2;MSC;SMAD1;CACNA1G;GATA6;BMP4
prerank,Rho protein signal transduction (GO:0007266),0.5413225802493684,1.5712795641572945,0.014511873350923483,0.4173231221620904,1.0,15/53,12.93%,COL1A2;ROCK2;ARHGAP6;RHOD;CTNNAL1;CDC42EP4;ARHGAP29;PDPN;CDC42;AGTR1;ARHGEF11;NTN1;TAX1BP3;ADRA2A;ARHGAP5
prerank,iron ion transport (GO:0006826),0.5627828941312537,1.5701134881116763,0.01227830832196453,0.41868117263496946,1.0,6/47,5.92%,ATP6V0A4;CP;STEAP3;SCARA5;HEPH;SLC11A2
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.5644161334398063,-1.5693303207671419,0.033419023136246784,0.42247973078079315,1.0,5/17,10.51%,PDE3B;SORL1;MFSD2A;ALK;GPLD1
prerank,signal release from synapse (GO:0099643),-0.4620977954640238,-1.5671376971861273,0.017605633802816902,0.4236041393780782,1.0,20/43,22.44%,RIMS1;LIN7A;HSPA8;NRXN1;LIN7C;CDK5;SYT1;NAAA;SYN3;PCLO;CPLX1;SYN2;RAB3A;STX1A;SYN1;DVL1;GAD1;OTOF;SNPH;STXBP2
prerank,cardiac muscle tissue development (GO:0048738),0.5472003322812906,1.5655873914654785,0.019444444444444445,0.43235690700185087,1.0,17/50,15.79%,RBP4;GJA1;GJB6;BMPR1A;NOTCH2;MSC;ADAMTS9;SIK1;BMP2;CBY1;SMAD1;CSRP3;CACNA1G;GATA6;AKAP13;BMP5;BMP4
prerank,embryonic organ morphogenesis (GO:0048562),0.5637572799482375,1.5652070777783387,0.025280898876404494,0.43108585674237654,1.0,9/42,5.07%,RBP4;FBN1;FBN2;MFAP5;FGFR2;PDGFRA;ACVR1;NEUROD1;RARG
prerank,regulation of biomineral tissue development (GO:0070167),0.6203204815747927,1.5648796531864229,0.014814814814814815,0.4295581764803774,1.0,6/26,3.61%,ENPP1;DDR2;ROCK2;AHSG;ANKH;GAS6
prerank,cellular response to organonitrogen compound (GO:0071417),-0.3885421772631262,-1.5641138525157434,0.0,0.4278433286847105,1.0,28/99,12.92%,SLIT2;MEF2C;RAP1A;CDH1;ACTB;DIAPH1;SH3BP4;GABRB3;GABRB1;GLRA1;P2RX7;PDE2A;GABRG2;KCNQ1;GLRA2;AKAP6;SPAAR;RAP1B;TAF1;INPP5K;GABRB2;LARS1;IPO5;SLC26A6;JUP;MTOR;HRH1;CFTR
prerank,GPI anchor metabolic process (GO:0006505),-0.5101351444176406,-1.5634605322433444,0.034782608695652174,0.4242827355037328,1.0,11/26,18.44%,DPM1;PIGP;PGAP2;GPLD1;PIGB;DPM3;PIGL;PIGU;DPM2;PIGO;PIGV
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.5118485660992929,-1.562782997896216,0.02849002849002849,0.4207515988688498,1.0,11/26,18.64%,OCLN;NAV3;MET;RPS3;PAK1;FES;DCTN1;TRPV4;CDK5RAP2;CDK5R1;CLASP1
prerank,C4-dicarboxylate transport (GO:0015740),-0.6218724947419063,-1.562377008707401,0.0412621359223301,0.41658927118836203,1.0,11/14,29.42%,LRRC8D;SLC25A13;SLC25A12;SLC1A1;SLC25A30;SLC25A11;SLC1A2;SLC25A22;SLC25A10;LRRC8E;SLC25A14
prerank,positive regulation of kinase activity (GO:0033674),0.49030312886062455,1.5612589633602079,0.005917159763313609,0.4404973024514958,1.0,34/107,14.16%,EPHA3;EPHA7;DDR2;FGFR1;EPHA4;EPHA8;CCN1;FGFR2;FGFR4;PDGFRA;KIT;PDGFRB;PRKAG2;GAS6;CCL19;CSF1;RAPGEF2;ROR1;AXL;MUSK;ALS2;NTRK3;EGFR;EPHB2;LMO4;RYK;EPHB3;MRNIP;F2;DUSP19;INSR;MERTK;DSTYK;SNX9
prerank,mRNA destabilization (GO:0061157),0.5788648608751942,1.561181742289759,0.02351313969571231,0.43816143834698484,1.0,14/38,21.01%,POLR2D;ROCK2;ZFP36L1;CPEB3;TUT7;METTL14;PLEKHN1;TUT4;RC3H2;METTL3;RC3H1;FTO;YTHDF2;ZFP36L2
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.5847712137015509,1.5608620008557377,0.018156424581005588,0.4366552747874325,1.0,4/39,4.82%,TCF7L2;RBP4;SLC30A8;MCU
prerank,regulation of plasminogen activation (GO:0010755),0.717746112197176,1.5594719915529813,0.05169340463458111,0.43920011171171436,1.0,7/12,15.92%,CLEC3B;RUNX1;SERPINE1;CTSZ;PLGRKT;HPN;MELTF
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.4722976820773634,1.5592578130216954,0.002244668911335578,0.4375315742358273,1.0,41/186,13.41%,IGFBP2;TCF7L2;BICC1;TRABD2B;RBMS3;LRP1;MCC;IGFBP4;DACT1;NKD1;GLI3;MDFI;APOE;TMEM170B;TLE1;PRICKLE1;SFRP1;RNF213;PSME4;AXIN2;MLLT3;DKK3;ZNRF3;WWTR1;STK4;DAB2;BMP2;CBY1;STK11;PRKN;TAX1BP3;INVS;LZTS2;JADE1;GLI1;TMEM64;KLHL12;UBAC2;SFRP4;MDK;TSC2
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.3639467299284467,-1.5576165890067175,0.0,0.42704227119917665,1.0,73/168,20.67%,RPS12;RPL41;RPL3;RPS24;RPS14;RPL8;RPL27A;RPS19;CNOT6L;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;CSDE1;RPL38;RPL35A;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPS23;RPL30;PAN3;PABPC1;PNRC2;RPL36;RPLP1;RPS29;RPL37;RBM8A;RPS9;PPP2R2A;RPS5;RPL18A;RPL4;PNLDC1;RPL29;RPL26;RPL6;RPL13A;RPL36A;RPL7A;RPL19;RPS20;RPL13;THRAP3;RPL32;RPL5;RPL14;DIS3L2;RPSA;RPLP0;NBAS;RPS6;SMG7;AGO1;RPL22;DDX5;RPS21;EXOSC5;CNOT7;RPL37A;TENT2;RPL17;RPL23;DCP2;RPLP2;CNOT8;DCPS
prerank,protein kinase B signaling (GO:0043491),0.6298954521194918,1.5571694301474666,0.03732503888024884,0.442773974256668,1.0,5/23,7.23%,IGF1;GAS6;MT3;ZFP36L1;SIRT2
prerank,regulation of MAPK cascade (GO:0043408),0.4743771513218573,1.556938261244863,0.008978675645342313,0.44109812044970254,1.0,34/157,11.80%,IGF1;EPHA7;IGF2;ADRA1B;NRK;ROCK2;TGFBR3;KSR1;DAG1;LYN;FGFR1;PELI2;EPHA8;CCN1;FGFR2;KIT;LBH;ROR1;ADRA2C;ADRB3;MAP2K1;LPAR1;TRAF7;NTRK3;MAP4K4;STK4;EGFR;BMP2;FGF2;RYK;TAOK3;GSDME;EGF;ADRA2A
prerank,positive regulation of glucose import (GO:0046326),0.6387734407310801,1.556731671122858,0.04205607476635514,0.43927663389285454,1.0,6/21,12.98%,IGF1;PIK3R1;OSBPL8;CREBL2;RHOQ;INSR
prerank,embryonic digestive tract development (GO:0048566),0.6575868103321777,1.5563381617921335,0.056074766355140186,0.4381797691606211,1.0,6/18,3.57%,GLI2;SALL1;GLI3;FGFR2;PDGFRA;RARB
prerank,renal system development (GO:0072001),0.5464543971708459,1.5544107396778892,0.01907356948228883,0.4431696835178142,1.0,10/52,7.56%,RBP4;GLI2;SULF2;SALL1;WNT4;TGFBR1;SULF1;GREB1L;AGTR1;IFT27
prerank,smooth muscle cell differentiation (GO:0051145),-0.6300046363513977,-1.5544017668440835,0.02823529411764706,0.43158016356546397,1.0,6/12,14.79%,MRTFB;MEF2C;HEY2;APLNR;HEY1;EDNRB
prerank,positive regulation of cell cycle process (GO:0090068),0.5044127951350676,1.5533051246405445,0.020606060606060607,0.44460176895202286,1.0,16/91,7.90%,IGF1;IGF2;SVIL;TGFA;EPGN;PDGFRB;PHIP;DYNC1H1;MAP3K20;CDC42;INO80;SIRT2;CD28;NPM2;UBXN2B;DRD3
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5200426925317636,-1.5518753717649556,0.03197674418604651,0.4341127274649261,1.0,5/24,5.44%,MEF2C;CDH2;SPAG9;CDON;TCF3
prerank,response to organophosphorus (GO:0046683),-0.5848833340673286,-1.5516482450889704,0.04534005037783375,0.42946968634266275,1.0,6/16,13.36%,TRPC3;ABCC9;P2RX7;TRIM16;DGKQ;TYMS
prerank,triglyceride catabolic process (GO:0019433),-0.5610813299984665,-1.5515096682973681,0.0215633423180593,0.4247046446540603,1.0,10/19,38.34%,PNPLA3;PNPLA2;FABP7;FABP3;LIPH;LIPC;LPL;FABP4;FABP12;FABP5
prerank,regulation of catabolic process (GO:0009894),-0.5535762202815715,-1.5493286780235258,0.03723404255319149,0.42699751448164563,1.0,4/18,4.23%,ZDHHC2;NEDD4L;FAP;FAF1
prerank,anterior/posterior axis specification (GO:0009948),0.6918198349020629,1.549045559998554,0.05952380952380952,0.4573593550161365,1.0,3/15,5.96%,WLS;TBX3;SKI
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6166701557108188,1.5488111246884653,0.024390243902439025,0.45573813404747165,1.0,4/26,7.88%,IGF1;FHL2;LMCD1;RCAN1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.6706500619981445,1.5487790365419007,0.03265940902021773,0.4533145676792776,1.0,7/18,11.55%,DDR2;SMAD3;RUNX1;PDPN;EMILIN1;BMP2;RGCC
prerank,axonal fasciculation (GO:0007413),0.7168776056425843,1.5481041376441014,0.04865771812080537,0.453150684613269,1.0,6/12,10.67%,EPHA3;EPHA4;SEMA5A;ARHGAP35;EPHB2;EPHB3
prerank,regulation of histone modification (GO:0031056),0.7181243163955885,1.5478861780086508,0.02613240418118467,0.4514164496873482,1.0,6/13,14.26%,IGF2;NNMT;HPF1;MTHFR;SETD5;AKAP8L
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.49145604112239755,1.5477703629226882,0.004733727810650888,0.44935953997445677,1.0,25/112,8.19%,COL1A2;CILP;CLEC3B;TGFBR3;SMAD3;SOX5;BMPR1A;WNT4;TGFBR1;PDCD5;TWSG1;APOA1;APPL2;ACVR1;SFRP1;PDE3A;ITGB5;ENG;ZFP36L1;CDH5;SKI;SRC;LTBP2;ARHGEF18;ZMIZ1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5287416090072851,-1.547562874987954,0.04568527918781726,0.4276948829904406,1.0,9/20,14.13%,RPS6KA5;DIP2B;NOS1;PPARGC1A;BRD7;RPS6KA4;TADA2A;MAPK3;DIP2A
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.5617434706920397,1.5473173316022673,0.029005524861878452,0.4484955856125481,1.0,6/43,2.46%,IGF2;ENPP1;PID1;AHSG;OGT;KANK1
prerank,negative regulation of proteolysis (GO:0045861),0.5863992262426894,1.5459425280739039,0.03183791606367583,0.451315850582786,1.0,13/34,16.32%,TIMP3;DNAJC1;EPHA4;CST3;LRRK2;TIMP2;SNX12;CLN3;F2;PTPN3;TM4SF20;GAS1;AKT1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5017074351854057,1.545089568996701,0.006016847172081829,0.4519224996924929,1.0,24/95,10.72%,PDPK1;NREP;TGFBR3;SMAD3;ZEB2;LDLRAD4;ADAMTSL2;ITGA3;PMEPA1;NKX2-1;TGFBR1;SLC2A10;SMURF2;DKK3;ENG;SKI;BCL9;EMILIN1;DAB2;SPRY2;LEMD3;STK11;FAM89B;SPRED3
prerank,hematopoietic stem cell differentiation (GO:0060218),0.7324515897060908,1.544287406793619,0.04819277108433735,0.4524896940543801,1.0,5/10,11.79%,SP7;SFRP1;MLLT3;BATF;UFL1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.6344915952851571,1.543749974410615,0.03379416282642089,0.4519165129693079,1.0,4/21,5.80%,ERRFI1;ROCK2;RUNX1;ZFP36L1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.6195527213471477,-1.5432592189186383,0.03316326530612245,0.4364907550985833,1.0,7/13,16.96%,KDR;IL33;NAMPT;JAK2;EDN1;NOD2;TLR4
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.6342633108118186,1.542185161450277,0.04451510333863275,0.45525480769941135,1.0,5/23,4.82%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,negative regulation of cell migration (GO:0030336),0.47765362079460844,1.5406751503211924,0.00903954802259887,0.4579964837504428,1.0,27/137,7.57%,ROBO1;PHLDB2;GJA1;LRP1;MCC;LDLRAD4;MITF;DAG1;SERPINE1;DLC1;PODN;TPM1;EPHA4;BMPR1A;KANK1;RECK;NKX2-1;DPYSL3;SULF1;CYP1B1;SFRP1;IGFBP5;ENG;ATP1B2;VCL;DPEP1;AFDN
prerank,regulation of kinase activity (GO:0043549),0.49535919187433414,1.5394518599768008,0.020757020757020756,0.45987194321200303,1.0,23/89,10.68%,EPHA3;EPHA7;LDB2;DDR2;FGFR1;EPHA4;EPHA8;FGFR2;FGFR4;PDGFRA;KIT;PDGFRB;TSPYL2;ROR1;AXL;MUSK;NTRK3;EGFR;EPHB2;LMO4;RYK;EPHB3;RBL2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.6232115467261622,1.5392171030676618,0.048589341692789965,0.45832706995024325,1.0,2/22,0.75%,IGF1;ROCK2
prerank,cellular response to ketone (GO:1901655),0.5828605671669372,1.5391695553261906,0.030478955007256895,0.4561133191952272,1.0,8/35,7.00%,ADCY1;ROCK2;ADCY2;AR;ADCY5;SFRP1;SRC;SPHK2
prerank,response to amyloid-beta (GO:1904645),0.5523122470221214,1.5388092836948968,0.031073446327683617,0.45509013568602547,1.0,6/44,5.12%,IGF1;GJA1;LRP1;EPHA4;MMP2;CACNB1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5549638207957497,-1.5386723568571417,0.018134715025906734,0.44500632847736954,1.0,8/18,10.77%,SHANK3;NLGN1;PTK2B;RIMS1;NRXN1;RIMS2;SHANK1;PRKCZ
prerank,cytoskeleton organization (GO:0007010),0.4867388140079739,1.537431459240361,0.015513126491646777,0.4578404690794213,1.0,28/114,8.42%,SH3D19;MICAL3;RHOH;RHOD;OBSL1;TPM1;NEDD9;MARK1;ANK1;APOE;PALLD;RHOBTB1;CNN2;WDPCP;FGD1;BRWD1;FGD4;PHIP;RHOBTB3;DES;ARHGAP10;RANBP9;RHOBTB2;WTIP;MAST2;PLD2;CSPG5;CAPZB
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.7140846142350207,1.5373893586026832,0.04569420035149385,0.45564254632982304,1.0,5/11,9.70%,GRK3;ADRB3;DRD3;ARRB1;ADM
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4681640449713885,1.5371070851636823,0.006734006734006734,0.4543566338577903,1.0,34/161,13.38%,IGFBP2;TCF7L2;BICC1;RBMS3;MCC;IGFBP4;DACT1;NKD1;GLI3;APOE;TMEM170B;TLE1;PRICKLE1;SFRP1;PSME4;AXIN2;MLLT3;DKK3;ZNRF3;WWTR1;STK4;DAB2;BMP2;STK11;PRKN;INVS;LZTS2;JADE1;GLI1;TMEM64;KLHL12;UBAC2;SFRP4;MDK
prerank,odontogenesis (GO:0042476),0.5714337379519322,1.5360997005350359,0.02877697841726619,0.4557903813400145,1.0,9/35,8.88%,COL1A2;GLI2;FGFR2;WNT6;AXIN2;BCOR;OSR1;AQP6;BMP2
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6992167339135589,1.5359511415002474,0.06368330464716007,0.45412031913854556,1.0,2/13,1.00%,ERRFI1;CBLB
prerank,wound healing (GO:0042060),0.5282715898840683,1.535761080274358,0.03259452411994785,0.45259007231541937,1.0,15/62,11.46%,IGF1;SMAD3;TPM1;PPP3CA;MACF1;PPL;PDGFRA;CFLAR;TGFBR1;FUT10;MIA3;ITGB3;FGF2;ANXA6;COL3A1
prerank,negative regulation of cellular protein localization (GO:1903828),0.5800007776979064,1.5353603759058314,0.04011887072808321,0.451712331126951,1.0,9/34,9.90%,ROCK2;ACTN2;LEPROT;RIPOR2;SNX33;UBXN2B;COMMD1;PICALM;TAX1BP3
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.6351622691239593,1.5345662455215139,0.04447852760736196,0.45218224997835804,1.0,7/21,7.13%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9;GUCY2C;GUCY2D
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7243282524280061,1.53354824483666,0.03873239436619718,0.4513406278763571,1.0,2/12,6.38%,IGF1;LMCD1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.7243282524280061,1.53354824483666,0.03873239436619718,0.4513406278763571,1.0,2/12,6.38%,IGF1;LMCD1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.49024850209632753,1.5330726040278804,0.015853658536585366,0.4509310322843429,1.0,24/95,12.37%,GPC6;FMOD;OGN;CEMIP;ANGPT1;LUM;UST;DCN;BGN;HSPG2;PXYLP1;ST3GAL3;DSE;HS6ST1;SDC1;B4GALT1;OMD;CSPG5;EXT1;ABCC5;CHST15;NDST1;GALNT5;PRELP
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5363418694965612,1.5326793334088737,0.024265644955300127,0.45009785315978146,1.0,13/61,10.17%,IGF1;ROBO1;AUTS2;LYN;NOTCH2;APOA1;LPAR1;ALS2;MAP4K4;ARRB1;MAPRE2;RAPGEF1;SYNPO2L
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.44192533903212305,1.5324027873077053,0.0,0.4488670806035631,1.0,70/390,10.67%,IGF1;EPHA3;NRP1;POLR2D;EPHA7;ATP6V0A4;COL4A6;COL1A1;IGF2;MTSS1;DDR2;ROCK2;ANGPT1;GHR;ANGPTL1;PIK3R1;PDGFD;IL31RA;LYN;SULF2;FGFR1;NEDD9;EPHA4;MMP2;GFRA2;EPHA8;KL;FGFR2;FGFR4;PDGFRA;KIT;RBFOX2;PDGFRB;EFNB2;ANGPT2;SULF1;CSF1;POLR1G;CD7;RAPGEF2;ROR1;NTF3;AXL;FRS2;PHIP;MUSK;CDC42;SRC;BDKRB2;EFNA2;FLRT2;SIRT2;EIF2AK3;NTRK3;EGFR;AAMP;EPHB2;FOXC2;ZNF106;EFNB1;HNRNPA1;RAPGEF1;ITGB3;ITGAV;POLR2C;FGF2;RYK;ATP6V1E1;EFS;EPHB3
prerank,embryonic eye morphogenesis (GO:0048048),0.7094477688181171,1.530641748009769,0.05084745762711865,0.45297582056218155,1.0,4/11,5.07%,FBN1;FBN2;MFAP5;RARG
prerank,positive regulation of proteolysis (GO:0045862),0.5218002283203509,1.5306121087030038,0.023778071334214,0.45089533210761307,1.0,8/55,6.51%,CCBE1;SH3D19;OGT;ASPH;FGFR4;APOE;CTSH;SNX33
prerank,embryonic limb morphogenesis (GO:0030326),0.5732521230495168,1.5285699335629712,0.03283582089552239,0.45607640102515407,1.0,11/34,8.39%,CYP26B1;SALL1;GLI3;WDPCP;RARG;TBX3;MAP3K20;SKI;CACNA1C;OSR1;AFF3
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6931239885626179,1.528209895671489,0.0628099173553719,0.4552773604989259,1.0,2/13,0.20%,NRP1;PLXNA2
prerank,carbohydrate homeostasis (GO:0033500),0.5178734529136645,1.5277605161587524,0.018541409147095178,0.4547177710301754,1.0,10/67,7.08%,TCF7L2;RBP4;LEPR;SLC30A8;FGFR4;APPL2;MCU;NEUROD1;PRKAA2;CEBPA
prerank,regulation of acute inflammatory response (GO:0002673),0.66374717903078,1.5272578024204029,0.05396825396825397,0.45444229942951686,1.0,2/18,2.33%,PTGES;OSMR
prerank,chondrocyte differentiation (GO:0002062),0.5880981313097896,1.5268727343227668,0.03443328550932568,0.4536000761575276,1.0,11/32,8.88%,SOX5;RUNX1;SULF2;RUNX2;NFIB;SULF1;CREB3L2;WNT5B;EIF2AK3;OSR1;BMP2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6608550274156879,1.5268091833105033,0.0547945205479452,0.4516609781513805,1.0,2/17,1.32%,BMP6;SASH1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.6653508219508333,1.5267253014446964,0.052202283849918436,0.44981583844594175,1.0,2/17,3.41%,IGF1;APOE
prerank,positive regulation of MAPK cascade (GO:0043410),0.45394243085923014,1.5265973544316058,0.0010582010582010583,0.44820959462611937,1.0,49/245,11.80%,IGF1;NRP1;ROBO1;IGF2;ADRA1B;CCN2;ROCK2;ANGPT1;KSR1;PDGFD;FGFR1;IL34;PELI2;EPHA8;EPGN;FGFR2;FGFR4;PDGFRA;KIT;APOE;PDGFRB;GAS6;CCL19;NOTCH2;RAPGEF2;ROR1;MT3;ADRA2C;ADRB3;LRRK2;CCL4;MAP2K1;LPAR1;TRAF7;NTRK3;MTURN;SLC30A10;EGFR;ARRB1;SPRY2;BMP2;FGF2;RYK;TAOK3;BRAF;CARD9;GSDME;EGF;ADRA2A
prerank,sprouting angiogenesis (GO:0002040),0.5345711486599914,1.5263830551763495,0.02021563342318059,0.4468436245500817,1.0,12/51,6.47%,NRP1;ROBO1;CCBE1;ESM1;ANGPT1;PARVA;RECK;EFNB2;SEMA5A;RNF213;ENG;ADGRA2
prerank,sphingolipid catabolic process (GO:0030149),-0.5809207874427603,-1.5261822599998875,0.04567307692307692,0.480990650279748,1.0,4/15,3.34%,ACER3;ENPP2;ACER2;PPT1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.6753614091553988,1.522891355468865,0.05305466237942122,0.4571617631288888,1.0,2/15,3.63%,MOXD1;SMOX
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.644229860047152,1.522191145163002,0.04461538461538461,0.45742830068688556,1.0,2/20,4.96%,IGF1;NEUROD1
prerank,ribosomal large subunit assembly (GO:0000027),-0.5176216920216277,-1.5220212124347752,0.041884816753926704,0.4898509042428256,1.0,11/24,26.73%,RPL3;RPL11;RPL6;PPAN;RPL5;FASTKD2;RPLP0;RPF2;RRS1;DDX28;RPL10
prerank,negative regulation of stress fiber assembly (GO:0051497),0.6059597342217006,1.5198946032792289,0.05007587253414264,0.4634910793929777,1.0,6/24,2.22%,PHLDB2;PIK3R1;CGNL1;ARHGAP6;DLC1;ARHGAP28
prerank,T cell differentiation (GO:0030217),0.5647263898469868,1.5197676591892708,0.04096045197740113,0.46184073901891554,1.0,11/40,10.02%,RHOH;LEPR;GLI3;KIT;LIG4;TCF7;ZFP36L1;CD28;NHEJ1;GPR89A;GPR89B
prerank,endothelial cell development (GO:0001885),-0.48832359611970994,-1.5196340502501808,0.03519061583577713,0.4921406145694212,1.0,12/25,11.01%,PDE4D;PECAM1;RAP1A;PPP1R16B;MET;RDX;PDE2A;RAP1B;COL15A1;ROBO4;SOX18;MSN
prerank,nucleotide catabolic process (GO:0009166),-0.5614115809354026,-1.5187361606640946,0.056847545219638244,0.48972962337604153,1.0,7/16,18.48%,NT5E;NT5C2;NT5C1A;GDA;NT5C;PNP;GPX1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6704266280725628,1.5180434374982807,0.04854368932038835,0.46584138166199385,1.0,1/15,0.01%,IGF1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.7000857238080651,1.5179484047069223,0.06607142857142857,0.46407652979211095,1.0,6/11,8.55%,NKD1;LBX2;SFRP1;MLLT3;WNT5B;DAB2
prerank,regulation of endopeptidase activity (GO:0052548),0.5236493165104247,1.5178902481481091,0.036410923276983094,0.46222289177089176,1.0,12/59,9.05%,TIMP3;AHSG;SERPINE1;SERPING1;FETUB;VTN;SERPIND1;SERPINF1;SERPINH1;CRB2;TIMP2;PICALM
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.6386995476269133,-1.516869484996015,0.03712871287128713,0.4906521168808645,1.0,3/11,6.44%,SLIT2;CCN3;RIN3
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6465738242618484,-1.5165648981384552,0.04691358024691358,0.4865138801876955,1.0,7/10,20.28%,GABRG3;GABRA2;GABRG2;GABRB2;GABRA3;GABRG1;GABRA4
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.5212426570657291,1.5151897784806065,0.023989898989898988,0.4698224633042886,1.0,14/66,6.20%,ROBO1;MTSS1;TGFBR3;SPARC;MCC;NR2F2;FGFR2;NFIB;APOE;NUPR1;SULF1;SFRP1;CASK;ATOH8
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.6647370315186831,1.5149979520815489,0.05289256198347107,0.4684736791272813,1.0,2/16,0.75%,IGF1;ROCK2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5559411127088618,1.5138007294947253,0.0340599455040872,0.47070933904422674,1.0,11/40,8.88%,TCF7L2;COL1A1;SMAD3;OLFM1;TGFBR1;AXIN2;PDPN;CRB2;WWTR1;DAB2;BMP2
prerank,regulation of gastrulation (GO:0010470),0.6847369253581068,1.5137782064542404,0.058823529411764705,0.4687116907901133,1.0,4/14,8.10%,PHLDB2;DAG1;CRB2;OSR1
prerank,C-terminal protein amino acid modification (GO:0018410),-0.6123886373245705,-1.5126991414006903,0.06398104265402843,0.49409031743281273,1.0,7/11,30.20%,AGBL4;GPLD1;ATG7;TTL;LCMT1;AGTPBP1;AGBL1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5089796988862128,-1.5114970598679163,0.056179775280898875,0.49305786605682117,1.0,11/21,26.90%,PDE4D;CAV1;INPP5K;DDIT4;NLRP2B;RACK1;NCK2;DMTN;RASSF2;MLXIPL;DMD
prerank,apical junction assembly (GO:0043297),-0.4217620546907574,-1.5113015853692193,0.01953125,0.4885689175937515,1.0,13/53,12.94%,MPP7;OCLN;PECAM1;CLDN5;ESAM;F11R;CLDN11;RAMP2;PATJ;PDCD6IP;WDR1;PAK2;STRN
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6845309525895975,1.5107795936350676,0.07253886010362694,0.47742625555128665,1.0,5/12,8.50%,MYCBP2;GLI2;EPHA4;NFIB;EPHB2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.667779889618681,1.5096500792911518,0.0632279534109817,0.47966440159995444,1.0,5/15,6.21%,DDR2;LRP1;FGFR4;PDPN;CST3
prerank,amide transport (GO:0042886),-0.4947638195858456,-1.508951524759049,0.02710027100271003,0.49163718890363073,1.0,7/26,10.32%,CERT1;ABCG2;PLTP;SLC5A6;SLC38A5;PLEKHA3;AQP11
prerank,membrane lipid biosynthetic process (GO:0046467),-0.40932960199431495,-1.5085140699206567,0.011904761904761904,0.48819524235913253,1.0,13/58,11.64%,SGMS1;CERT1;ACER3;SGMS2;ELOVL7;ACER2;DEGS2;SPNS2;ELOVL5;ST8SIA6;DEGS1;SPTLC2;SPTSSB
prerank,inositol lipid-mediated signaling (GO:0048017),0.5277063959487331,1.5083127663739928,0.036585365853658534,0.4825137186309484,1.0,9/50,7.14%,IGF1;PIK3R1;FGFR1;OGT;PDGFRA;PDGFRB;PLCD1;ADAP2;PLCB4
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6708357694106658,1.5076858986357211,0.07142857142857142,0.4825062158665341,1.0,5/13,10.77%,PGM3;SLC35A3;GFPT1;UAP1;RENBP
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.7003303263452989,1.5061155305901726,0.06854130052724078,0.48619749350500074,1.0,2/11,4.15%,RUNX1;TWSG1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.4493507636907673,-1.50589304621342,0.02120141342756184,0.49189159028509444,1.0,12/41,14.03%,SLC12A2;SLC12A7;KCNJ2;ATP1A1;KCNJ3;ABCC9;ATP1B1;SLC12A6;ATP1A3;KCNJ15;KCNJ10;SLC12A5
prerank,regulation of amyloid-beta formation (GO:1902003),0.5710140960148993,1.5054143012752392,0.04005722460658083,0.48654427038632553,1.0,4/34,3.41%,IGF1;ROCK2;EPHA4;APOE
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.7102144502835387,1.505263455362604,0.0776173285198556,0.48501118560976786,1.0,3/10,4.43%,ENPP1;PID1;APPL2
prerank,artery development (GO:0060840),0.6190804321899244,1.5044925169239256,0.03686635944700461,0.4855327069803726,1.0,5/23,5.78%,NRP1;ROBO1;TGFBR1;SLC2A10;ENG
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5408410560861895,-1.504196142231742,0.04639175257731959,0.4928836677390718,1.0,8/17,18.80%,NLGN1;RAB27A;SLC4A8;CACNA1H;RAB3A;STX1A;RAB15;SYT4
prerank,sensory perception of mechanical stimulus (GO:0050954),0.4948082487053768,1.5027873034872947,0.013333333333333334,0.4892990230683073,1.0,18/85,11.53%,ATP6V0A4;COL1A1;CEMIP;COL4A3;ADGRV1;EYA1;COL11A1;GRXCR1;EML2;RIPOR2;ROR1;USH2A;COL11A2;ALDH7A1;TIMM9;LRTOMT;GSDME;TPRN
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5362767087565492,-1.502756443662285,0.03768844221105527,0.49270290429788116,1.0,7/18,9.18%,GRID2;UNC13B;GRIK1;GRIK2;CDH8;GRIA2;GRID1
prerank,negative regulation of cartilage development (GO:0061037),0.6801109954302268,1.5022724234185032,0.0548885077186964,0.4890148537254931,1.0,3/13,4.50%,ADAMTS12;TGFBR1;CHADL
prerank,positive regulation of secretion (GO:0051047),-0.6247792278439739,-1.5020884161427008,0.06320541760722348,0.4902799683245778,1.0,6/11,30.45%,NPR1;GPLD1;ACSL3;AQP1;XBP1;SCIN
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.6007285828097131,-1.5003548551604928,0.05,0.49156034477272653,1.0,5/13,14.68%,ELOVL7;ELOVL5;TECR;TECRL;HACD2
prerank,embryonic organ development (GO:0048568),0.5131389396363568,1.500260190397476,0.034255599472990776,0.4944694360517031,1.0,13/61,4.96%,RBP4;TEAD1;GDNF;PBX1;GLI2;SALL1;GLI3;BMPR1A;FGFR2;KIT;COL13A1;RARB;NEUROD1
prerank,cell-cell junction organization (GO:0045216),-0.39352232567926726,-1.4991304772510858,0.024752475247524754,0.490520241002803,1.0,27/79,13.86%,PKP4;CADM2;OCLN;CTNND2;CLDN5;CDH2;CADM1;LIMS2;CDH1;TJP2;TJP1;GJC1;NECTIN1;TGFB2;CDH12;CDH6;CDH8;CDH9;CDH13;CDH10;CSK;JUP;CXADR;TGFB1;PVR;TRPV4;DSG2
prerank,bone development (GO:0060348),0.5462257481587874,1.4979441389470018,0.04275862068965517,0.5007993113693318,1.0,8/39,5.96%,GJA1;CYP26B1;SULF2;FGFR2;GNAS;SULF1;SH3PXD2B;SKI
prerank,cellular response to amyloid-beta (GO:1904646),0.5545205735619455,1.4963347476873545,0.049926578560939794,0.5047815726155037,1.0,5/35,5.12%,IGF1;GJA1;LRP1;EPHA4;CACNB1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6556513086305156,1.4959371076802574,0.06587837837837837,0.5041937702295117,1.0,5/15,14.16%,SH3D19;APOE;SNX33;ADRA2A;SNX9
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5304680839254975,1.4959107934776672,0.0407055630936228,0.5022234911606813,1.0,23/50,19.30%,RORA;ZIC1;GLI3;FGFR2;MGRN1;SMO;FBXL17;SFRP1;TULP3;TEDC1;IFT81;GLIS2;TTC23;PTCH2;GLI1;BTRC;SUFU;GAS1;SHH;INTU;EVC;HHIP;PDCL
prerank,myotube cell development (GO:0014904),0.7065205440342979,1.4957317619276456,0.08133086876155268,0.5008830203068912,1.0,2/10,5.96%,IGF1;SKI
prerank,cyclooxygenase pathway (GO:0019371),0.712310598346779,1.4951608420720628,0.08928571428571429,0.5007008655496593,1.0,2/10,1.81%,PTGIS;PTGES
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.6975792842886418,1.4949927441191313,0.062157221206581355,0.4992906116831072,1.0,6/11,9.90%,ACTN2;LEPROT;SNX33;COMMD1;PICALM;TAX1BP3
prerank,aorta development (GO:0035904),0.6696356449153149,1.4948909400898058,0.07950530035335689,0.4976444318265583,1.0,4/14,6.05%,ROBO1;LRP1;PDGFRB;ADAMTS9
prerank,epithelial structure maintenance (GO:0010669),0.7073649405416573,1.4919719038956578,0.06445993031358885,0.5064502994340441,1.0,2/11,8.66%,RBP4;PIWIL4
prerank,endothelial cell proliferation (GO:0001935),-0.5476468177167996,-1.4918638184100612,0.0425531914893617,0.5095221734746617,1.0,9/17,19.43%,TEK;BMPER;CD34;ACVRL1;THAP1;PRKX;ERN1;BMPR2;ITGB1BP1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5771955401762442,-1.4915295988771382,0.05620608899297424,0.5056951236446278,1.0,8/15,17.54%,TEC;PTK2B;KDR;BMX;AATK;IGF1R;MAPK3;TXK
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6328800688119879,1.4911623136146512,0.07109004739336493,0.5075083353479128,1.0,2/19,3.41%,IGF1;APOE
prerank,detection of mechanical stimulus (GO:0050982),-0.5465775899148243,-1.4901199819009663,0.05759162303664921,0.5060034550751081,1.0,3/19,1.59%,PIEZO2;CDH2;PIEZO1
prerank,axon guidance (GO:0007411),0.44893824417893,1.4894049406163543,0.009761388286334056,0.511947036746982,1.0,42/201,10.67%,EPHA3;NRP1;ROBO1;EPHA7;PLXNA2;LAMA1;RHOH;PIK3R1;GDNF;LAMA2;DAG1;SEMA3D;GLI2;EPHA4;GFRA2;EPHA8;NFIB;PALLD;EFNB2;SMO;SEMA5A;NOTCH2;NCAM1;LRTM1;FRS2;SRC;RANBP9;EFNA2;ALCAM;ARHGAP35;SPTAN1;DSCAM;EPHB2;EFNB1;NTN1;RYK;PTPRM;GFRA4;SLIT3;SLIT1;NEXN;EPHB3
prerank,regulation of glucose metabolic process (GO:0010906),0.5590668233900824,1.489280425791941,0.04747774480712166,0.5103617716896638,1.0,5/34,5.63%,PDK1;RORA;OGT;SLC45A3;GNB3
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.7015598636583085,1.4890884391262822,0.08876811594202899,0.5090356426339715,1.0,3/10,3.21%,LYN;PIGR;KIT
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5170178195085412,1.48805336971798,0.034210526315789476,0.5107388033561174,1.0,13/56,8.88%,BMP6;LDLRAD4;BMPR1A;PMEPA1;INHBE;TGFBR1;TWSG1;ACVR1;ENG;EMILIN1;DAB2;RBPMS;BMP2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6986334329268874,1.487734569903833,0.07958477508650519,0.5098025328121225,1.0,3/10,8.76%,IGF2;DNMT3A;PCGF3
prerank,Golgi ribbon formation (GO:0090161),0.6815256382847446,1.4869241808451312,0.07005253940455342,0.5106346916202513,1.0,4/13,8.56%,OPTN;MYO18A;STX16;TRIP11
prerank,sphingolipid metabolic process (GO:0006665),-0.3647291629548037,-1.4869001492857346,0.0,0.511797192855097,1.0,20/108,12.21%,ST6GALNAC3;SGMS1;CERT1;ESYT2;ACER3;ENPP2;SGMS2;ELOVL7;ACER2;DEGS2;PPT1;SPNS2;ELOVL5;HEXB;DEGS1;SPTLC2;TECR;UGCG;SPTSSB;ORMDL3
prerank,cellular response to growth factor stimulus (GO:0071363),0.45256149204708634,1.4863192182545057,0.012345679012345678,0.510967093015652,1.0,27/151,9.39%,NRP1;BMP6;ADAMTS12;PDPK1;CILP;CLEC3B;SMAD3;SOX5;BMPR1A;RUNX2;WNT4;TGFBR1;PDCD5;APPL2;RAPGEF2;ACVR1;SFRP1;PDE3A;ZFP36L1;ACAP2;SIRT2;NTRK3;EGFR;SPRY2;STAT5B;BMP2;RAPGEF1
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.5312094821107924,-1.4846239488994677,0.06527415143603134,0.5146796598895998,1.0,7/18,15.44%,PLCG2;DYSF;LBP;FCER1G;IFI35;KARS1;SBNO2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.452809727627285,-1.4834078488397628,0.038834951456310676,0.5140243588625599,1.0,11/38,16.34%,CAV1;KCNJ2;CTNNA3;KCNJ3;KCND3;CAMK2D;KCNQ1;JUP;DSG2;CACNA1D;CACNA2D1
prerank,regulation of chromatin organization (GO:1902275),0.657741980742859,1.4825352662768787,0.0831889081455806,0.5229178218501302,1.0,7/14,15.71%,IGF2;HPF1;MLLT3;SETD1A;SETD5;TLK1;METTL4
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.6103347160621682,-1.4809524987191596,0.07276995305164319,0.5178316640651017,1.0,5/11,10.91%,NOS3;GCH1;DHFR;CALM1;SPR
prerank,regulation of protein kinase B signaling (GO:0051896),0.4443211912652845,1.4795288432712699,0.0065005417118093175,0.5317602608251935,1.0,31/193,8.65%,TCF7L2;PDPK1;IGF2;ANGPT1;PIK3R1;AREG;DAG1;TGFA;FGFR1;KL;EPGN;FGFR2;FGFR4;PDGFRA;KIT;PDGFRB;TGFBR1;GAS6;SEMA5A;CCL19;AXL;FRS2;OSBPL8;ENG;SRC;CD28;GRM2;DRD3;NTRK3;EGFR;SPRY2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.6640039826194486,1.4785427674876177,0.07599309153713299,0.5332217222134672,1.0,2/13,3.14%,ENPP1;TPST1
prerank,response to glucose (GO:0009749),0.5345899593411656,1.4785001072717447,0.0380952380952381,0.5313156842737511,1.0,7/46,5.53%,TCF7L2;ZBTB20;NKX6-1;SLC30A8;GAS6;NEUROD1;PRKAA2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6773107439820301,1.477894858050036,0.0743801652892562,0.5315309416699204,1.0,4/12,9.05%,ROCK2;APOE;RANBP9;PICALM
prerank,cellular zinc ion homeostasis (GO:0006882),-0.49404347708228125,-1.476402164368456,0.045714285714285714,0.5287032059485355,1.0,10/26,4.61%,SLC39A10;SLC39A8;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,regulation of stem cell proliferation (GO:0072091),0.6325460995660471,1.4763582179755956,0.08404802744425385,0.5351955183919052,1.0,4/17,5.80%,GJA1;YAP1;FBLN1;ZFP36L1
prerank,positive regulation of DNA binding (GO:0043388),0.56688075554906,1.4760716426709195,0.044412607449856735,0.5341516068540388,1.0,7/31,12.54%,IGF1;NEUROD1;SKI;SIRT2;PRKN;EGF;NIBAN2
prerank,cellular response to interleukin-6 (GO:0071354),0.5863236247732551,1.475797053549624,0.06534954407294832,0.5331233471531236,1.0,6/26,7.08%,PTGIS;PID1;IL6R;YAP1;SRC;CEBPA
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.5598669799536643,1.4757654734981875,0.05128205128205128,0.5312422548561928,1.0,8/35,6.09%,IRAG1;ADCY1;ADCY2;KSR1;APOE;RAPGEF2;PDE3A;PDE7B
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.579645716670953,-1.4747635683474738,0.060453400503778336,0.5295560144080307,1.0,9/14,29.88%,ENTPD1;ENTPD2;ENTPD6;ENTPD3;ADPRM;NUDT16;NUDT9;ENTPD5;NUDT1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5892111812572269,1.4737630186840947,0.06821705426356589,0.536846768544116,1.0,2/25,0.61%,PDPK1;CEMIP
prerank,regulation of cell migration (GO:0030334),0.4289499279940935,1.472254042842741,0.0,0.5405178073527398,1.0,88/382,11.96%,IGF1;ROBO1;PLXNA2;LDB2;COL1A1;PHACTR1;CEMIP;ROCK2;AMOTL2;PDGFD;SASH1;SYNE2;LDLRAD4;MITF;DAG1;SEMA3D;SERPINE1;DLC1;RHOD;PODN;TPM1;NEDD9;NKD1;DOCK10;EPHA4;KANK1;RECK;CCN1;PPP3CA;NKX2-1;MACF1;PDGFRA;KIT;MYLK;PDGFRB;TGFBR1;SMO;DPYSL3;SULF1;SEMA5A;CSF1;CYP1B1;RFFL;APPL2;ACVR1;SFRP1;NTF3;IGFBP5;CTSH;TBCCD1;PDPN;CXCL16;ENG;CDH5;SRC;BEX4;WNT5B;VCL;DPEP1;CARMIL1;AFDN;MYO1C;NTRK3;MAP4K4;PARD6B;EGFR;EPHB2;DAB2;SPRY2;BMP2;CAMK2B;MIA3;ACTN4;MYADM;FGF2;FAM89B;LMO4;AMOTL1;NEXN;DNAI3;TRIP6;MGAT3;PLXNC1;HBEGF;CLN3;EGF;ADRA2A;RAP2A
prerank,catecholamine metabolic process (GO:0006584),0.6669867670446236,1.471954212428484,0.06290322580645161,0.5395988745955037,1.0,5/14,10.55%,COMT;SNCAIP;DRD3;PRKN;LRTOMT
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5639494190502106,1.4718699550962686,0.05393586005830904,0.5379033624581371,1.0,11/34,14.66%,NRP1;NEDD9;APOA1;CDC42;CARMIL1;DOCK5;CSPG5;MYADM;MDK;P4HB;FLNA
prerank,integrin-mediated signaling pathway (GO:0007229),0.48797047944377664,1.4715933077966783,0.03836317135549872,0.5368350724127078,1.0,16/73,9.62%,ITGBL1;NRP1;FYB1;PLPP3;ITGA11;NEDD9;FBLN1;ITGB8;APOA1;ITGB5;CDC42;SRC;DAB2;ITGB6;ITGB3;ITGAV
prerank,cation transport (GO:0006812),-0.3354474980684428,-1.4713385616930115,0.0,0.5365495496700928,1.0,29/167,7.77%,TRPM3;PIEZO2;SLC6A6;SLC12A2;SLC47A1;KCNB2;KCNJ2;PIEZO1;KCNK5;ANO1;KCNAB1;NEDD4L;SLC9B2;SLC7A1;KCNJ3;SCN1A;KCND3;KCNMA1;SLC5A6;ABCC9;SLC38A5;SCN3A;KCNN2;SLC1A1;ATP1B1;SCN2A;KCNMB2;TRPM7;NDFIP2
prerank,positive regulation of transferase activity (GO:0051347),0.45298473381011334,1.4712005921203504,0.016910935738444193,0.5362818481374768,1.0,26/142,10.67%,EPHA3;EPHA7;IGF2;DDR2;ARRDC4;FGFR1;EPHA4;EPHA8;FGFR2;FGFR4;PDGFRA;KIT;PDGFRB;CHTF8;ROR1;AXL;MUSK;PARM1;NTRK3;EGFR;EPHB2;CD200;LMO4;RYK;PARN;EPHB3
prerank,positive regulation of endothelial cell migration (GO:0010595),0.4850979774120182,1.471157623415123,0.03164556962025317,0.53446388971598,1.0,18/84,9.95%,NRP1;PDPK1;RIN2;ROCK2;ANGPT1;SPARC;SASH1;PLPP3;FGFR1;SEMA5A;SMOC2;ATOH8;AKT3;AAMP;FOXC2;ANXA3;ITGB3;FGF2
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5907459961168631,1.4710608442583526,0.07280832095096583,0.5329352492665868,1.0,3/25,2.68%,ERRFI1;CBLB;SLC6A9
prerank,positive regulation of axon extension (GO:0045773),0.6024259301843167,1.4709313982347496,0.07741935483870968,0.5314252384543406,1.0,7/22,12.68%,NRP1;MACF1;SEMA5A;GOLGA4;DSCAM;NTN1;MAP3K13
prerank,response to interleukin-6 (GO:0070741),0.6873638197407559,1.470874237097535,0.08141592920353982,0.5296634187556674,1.0,2/10,0.89%,PTGIS;PID1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5834990726395414,1.4704171010258245,0.059006211180124224,0.5294008301949685,1.0,6/26,8.15%,FMOD;OGN;LUM;ST3GAL3;B4GALT1;OMD
prerank,regulation of actomyosin structure organization (GO:0110020),0.671362178067984,1.4696602173360522,0.08421052631578947,0.5302205997986021,1.0,4/13,6.27%,ROCK2;ASAP3;CDC42;ALMS1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.590958008712694,1.4692690880100514,0.059375,0.5296649556219541,1.0,5/24,4.50%,ADAMTS12;TRPS1;SOX5;TGFBR1;CHADL
prerank,diacylglycerol metabolic process (GO:0046339),-0.5012971096360597,-1.4690729493772756,0.05013192612137203,0.5396656332247509,1.0,11/23,19.78%,PLCE1;DGKB;DGKH;LIPE;DGKK;PGS1;DGKG;DGKQ;PNPLA2;DGKZ;DGKI
prerank,ribosome biogenesis (GO:0042254),-0.33014850080980224,-1.4687561690663677,0.0,0.5361931321729617,1.0,70/187,21.60%,RPL41;RPL3;RPS24;RPS14;RPL8;RPL27A;RPS19;RPL34;RPL21;RIOK1;RPL7;RPL18;RPL27;RPL38;RPL35A;RPS15;RPL39;RPS7;PAK1IP1;RPL11;RPL30;RPL36;WDR36;RPLP1;RPL37;RPS9;UTP4;RPL18A;METTL17;RPL4;RPL29;RPL26;RPL6;RPL13A;RPL36A;MALSU1;NVL;RPL7A;RPL19;RPL13;SNU13;RPL32;RRP1;RPL5;POP4;RPL14;NOL9;RPLP0;KRR1;RPS6;MPHOSPH10;UTP15;RPL22;IMP4;RRP36;FCF1;EXOSC5;RPL37A;NPM1;RRP12;URB2;NOP16;RPL17;RPL23;RPLP2;RPF2;WDR46;RPF1;RRS1;RPL28
prerank,actin filament depolymerization (GO:0030042),0.6802379351920655,1.4676436519625695,0.10498220640569395,0.5335317383123304,1.0,2/11,1.25%,MICAL3;GSN
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6455352631869681,1.4676064559441635,0.08925619834710743,0.5317430452385262,1.0,7/15,6.72%,DAAM2;DACT1;LBX2;SFRP1;RNF213;ZNRF3;WNT5B
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.5985879670169172,-1.467526583667671,0.0681265206812652,0.5359406829530425,1.0,4/11,3.08%,SEMA6A;THBS1;EPN2;KLF2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5398311704630651,1.467417757300772,0.04794520547945205,0.5305249963054836,1.0,13/41,13.46%,AREG;TGFA;NEDD9;IL34;EPHA4;EPGN;GAS6;SRC;HBEGF;EGF;ADRA2A;NOX4;DLG4
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5375717066334575,-1.467403400717156,0.07329842931937172,0.5318512140758077,1.0,2/16,3.00%,CLDN5;CLDN11
prerank,positive regulation of phosphatase activity (GO:0010922),-0.5189926721241988,-1.4670167635091271,0.04607046070460705,0.5287929258736437,1.0,10/21,12.18%,MEF2C;ITGA1;HSP90AB1;PPP1R15B;CALM1;MTMR9;GPLD1;PLEK;CALM3;MTOR
prerank,protein localization to synapse (GO:0035418),-0.5839545259024006,-1.4655875895972632,0.07092198581560284,0.5292555272450723,1.0,5/12,9.87%,NLGN1;NRXN1;SHANK1;ZDHHC15;PCLO
prerank,ceramide catabolic process (GO:0046514),-0.5537083870073244,-1.4635996223599412,0.0705596107055961,0.5316597167789204,1.0,7/14,24.73%,ACER3;ACER2;HEXB;HEXA;NEU1;GLA;NEU2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.4881884938943701,-1.4634140187714266,0.0700280112044818,0.5277712418978594,1.0,7/25,10.27%,AFAP1L2;CCDC88A;BCAR3;CBL;HIP1R;ARAP1;SHKBP1
prerank,regulation of cell size (GO:0008361),-0.4876178074687155,-1.4633271012690703,0.06318681318681318,0.5237723898427039,1.0,9/23,12.64%,VAV3;RDX;RAP1GAP2;LARS1;EDN1;PLEK;MSN;MTOR;DEPTOR
prerank,regulation of cellular respiration (GO:0043457),-0.529792860143593,-1.4626393409876335,0.06933333333333333,0.5219357977558489,1.0,9/17,28.60%,CBFA2T3;PRDM16;NOA1;PNPT1;IL10RB;IFNAR1;VCP;IFNLR1;NOS2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.49023309131888965,1.462583870841736,0.03638644918444166,0.546313347524473,1.0,13/72,6.32%,IGF1;PIK3R1;PDGFD;DCN;LYN;FGFR1;PDGFRA;KIT;PDGFRB;NEDD4;ROR1;NTF3;SRC
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.45104936353078534,1.4622493003243582,0.01122334455667789,0.5455594220083455,1.0,36/166,12.43%,IGF1;SAMD4A;IGF2;SMAD3;ZEB2;PLD1;GLI2;NOS1AP;SLC6A9;NNMT;FGFR4;PDGFRB;CCL19;APOA1;SLC25A37;SLC45A3;LDLR;STAR;SMOC2;CPEB3;CD28;NPM2;SREBF1;NR1D1;TLR6;EGFR;LPGAT1;METTL14;ARNT;FGF2;EIF6;DDX3X;RGCC;EGF;NMD3;GLI1
prerank,cardiac muscle contraction (GO:0060048),0.5450693443268939,1.462081444612085,0.06069364161849711,0.5442481182685538,1.0,8/34,10.11%,SLC8A1;GSN;ATP1A2;TPM1;TNNC1;MYL4;GAA;CSRP3
prerank,autonomic nervous system development (GO:0048483),0.635347930538458,1.4620325820487718,0.07178631051752922,0.5425210409722697,1.0,3/17,3.29%,NRP1;GDNF;ASCL1
prerank,regulation of actin filament-based process (GO:0032970),0.49585712357825223,1.4619651884911997,0.02796271637816245,0.5408025245516747,1.0,14/70,7.82%,EPHA3;RHOH;ROCK2;LRP1;DLC1;RHOD;ARHGAP18;PDGFRB;RHOBTB1;CNN2;IQGAP2;RHOBTB3;RHOBTB2;ARHGAP35
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.4537381278522111,-1.4614849236421168,0.046052631578947366,0.5216039129654342,1.0,10/34,9.70%,GRID2;MEF2C;GABRG3;GRIN2A;GABRA2;GLRA1;GABRG2;GRIN2B;GSK3A;GABRA3
prerank,pancreas development (GO:0031016),0.6721904461260554,1.4612291213025121,0.0823327615780446,0.5415927765498544,1.0,3/12,7.72%,TCF7L2;NKX6-1;DNAAF1
prerank,ncRNA processing (GO:0034470),-0.3219538028271153,-1.4604332349098923,0.0,0.5213928445759627,1.0,73/200,21.63%,RPL41;RPL3;RPS24;RPS14;RPL8;RPL27A;RPS19;RPL34;INTS6;RPL21;RPL7;RPL18;RPL27;RPL38;RPL35A;RPS15;RPL39;RPS7;RPL11;LIN28B;RPL30;RPL36;WDR36;RPLP1;RPL37;RPS9;UTP4;RPL18A;RPL4;RPL29;RPL26;ADAR;RPL6;RPL13A;RPL36A;NVL;RPL7A;RPL19;RPL13;SNU13;RPL32;RRP1;RPL5;POP4;RPL14;KARS1;HNRNPA2B1;NOL9;RPLP0;MRPL44;RPP21;FARS2;KRR1;INTS8;RPS6;SRRT;MPHOSPH10;UTP15;AGO1;RPL22;IMP4;RRP36;FCF1;EXOSC5;RPL37A;RRP12;RPL17;RPL23;RPLP2;WDR46;RPF1;RPL28;INTS1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.5969343576476975,1.460406193266126,0.06366459627329192,0.5426143105425442,1.0,4/20,11.14%,AKR1B1;STAR;HSD3B2;TSPO
prerank,regulation of fibroblast proliferation (GO:0048145),0.531940256356519,1.4596152505582096,0.06188466947960619,0.5433646086165681,1.0,7/45,5.96%,IGF1;DDR2;PDGFRA;GAS6;SFRP1;LIG4;SKI
prerank,protein localization to membrane (GO:0072657),-0.3282016130987718,-1.458997747099455,0.0,0.5218652888789669,1.0,42/187,10.50%,DLG2;CAV1;DPP10;SHANK3;KCNB2;KCNIP4;RAP1A;SMURF1;NLGN1;F11R;CDH1;ANK3;BSG;EFR3B;LIN7A;ZDHHC2;RAMP2;NRXN1;SPTBN1;RDX;LRRC7;LRP6;EMP2;RAB3C;ITGA4;ATP1B1;LIN7C;TTC7A;EHD4;NUP54;INPP5K;RAB12;GAK;RAB11A;RAB8B;MAP7;ARL3;ZDHHC15;PTN;SCRIB;JUP;AGRN
prerank,peptidyl-tyrosine modification (GO:0018212),0.5042260629703962,1.458564934484419,0.04794520547945205,0.5452573881639002,1.0,14/56,8.50%,EPHA3;DDR2;LYN;FGFR1;EPHA4;FGFR2;TPST1;FGFR4;PDGFRA;KIT;PDGFRB;SRC;EGFR;EPHB2
prerank,ketone body metabolic process (GO:1902224),0.7096596840280618,1.4579465943137342,0.08375209380234507,0.5455177236287748,1.0,4/10,3.17%,SLC27A5;ACSS3;OXCT1;HMGCLL1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.5848470771767574,1.4578051781066375,0.07153965785381027,0.5441659299158951,1.0,2/25,4.96%,IGF1;NEUROD1
prerank,renal water homeostasis (GO:0003091),0.5884230447816673,1.4576005345252487,0.07339449541284404,0.5430978132033611,1.0,5/23,3.66%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5230398653126637,1.4567851906456775,0.04371584699453552,0.5440482884728929,1.0,6/46,4.26%,TCF7L2;PIK3R1;SMAD3;ZIC1;GAS6;NEDD4
prerank,sarcomere organization (GO:0045214),0.5737459734745711,1.4563836145107305,0.06840390879478828,0.5435777909219037,1.0,7/27,10.44%,ACTN2;TPM1;TNNT1;CSRP2;CSRP3;SYNPO2L;TNNT3
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.47394873132209936,-1.4560901503481734,0.06162464985994398,0.527190966415392,1.0,8/27,13.86%,PDE4D;CAV1;PDE4B;CTNNA3;CAMK2D;JUP;RYR2;DSG2
prerank,glucose homeostasis (GO:0042593),0.47750053651517566,1.4556868343818485,0.027744270205066344,0.544166048071294,1.0,20/83,15.97%,TCF7L2;RBP4;PIK3R1;LEPR;SLC30A8;FGFR4;APPL2;MCU;NEUROD1;PRKAA2;CEBPA;NR1D1;STK11;ADRA2A;INSR;CYB5R4;FOXK2;LRRC8A;SLC2A4;PIK3R2
prerank,replicative senescence (GO:0090399),0.6663895856628417,1.4551909565811534,0.09917355371900827,0.5441403768150311,1.0,2/12,2.06%,SERPINE1;PLA2R1
prerank,regulation of transmembrane transport (GO:0034762),-0.4622488197404942,-1.4550649441974925,0.04046242774566474,0.526459954910543,1.0,7/31,3.07%,OCLN;SLC2A1;KCNJ2;ACTB;CTTNBP2NL;NEDD4L;KCNJ3
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6686762158307128,1.4547169241502522,0.10278745644599303,0.5439304593344164,1.0,5/12,8.32%,UST;DCN;BGN;DSE;CSPG5
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6864385757282829,1.4543731111103184,0.09302325581395349,0.5433509465103448,1.0,3/11,7.23%,PTGIS;DLC1;SIRT2
prerank,regulation of protein export from nucleus (GO:0046825),0.5948556280908831,1.4540368874094602,0.06913183279742766,0.5425615935836385,1.0,6/23,12.09%,TCF7L2;SP100;GAS6;RBM22;IFI27;YWHAE
prerank,response to ATP (GO:0033198),-0.5241608425015445,-1.4531404288424719,0.07323232323232323,0.5287864007881812,1.0,5/18,12.18%,TRPC3;ABCC9;P2RX7;TAF1;DGKQ
prerank,glycoprotein biosynthetic process (GO:0009101),0.47376485170512295,1.452760371818585,0.03676470588235294,0.5453715238015805,1.0,11/79,7.70%,IGF1;GAL3ST3;GAL3ST2;GALNTL5;B3GALT1;ST3GAL5;ST3GAL3;LARGE1;FUT10;ALG5;B3GALNT1
prerank,positive regulation of insulin secretion (GO:0032024),0.542878845859402,1.4525115604152221,0.052781740370898715,0.5445672237269584,1.0,5/36,5.48%,TCF7L2;RBP4;SLC30A8;MCU;BAIAP3
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5231547758824453,-1.4520382006411916,0.0481283422459893,0.5284470589867764,1.0,8/19,13.17%,CSGALNACT1;EXTL3;NDST3;XYLT1;HS6ST3;HS3ST5;HS6ST2;UGDH
prerank,regulation of developmental growth (GO:0048638),0.5724928471786072,1.4519569275960458,0.06515151515151515,0.5447388930274274,1.0,5/29,5.44%,IGF1;GHR;OLFM1;APOE;MUSK
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6658254951154219,1.4516024248401107,0.09061488673139159,0.5441729701058963,1.0,6/13,18.71%,GAS6;AXL;IL12B;ZBTB1;IL23A;IL18
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.5126640589635224,-1.451344600961141,0.05804749340369393,0.5265172405280464,1.0,5/18,16.40%,CD34;NAV3;TNFAIP3;PTPRC;HOMER3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6559381602430359,1.4511471851449398,0.08040201005025126,0.5438810292651569,1.0,3/14,4.50%,ADAMTS12;TGFBR1;CHADL
prerank,cellular amide metabolic process (GO:0043603),0.45757101872301165,1.4503912640513155,0.031363088057901084,0.5447649361429975,1.0,22/102,15.23%,CPXM2;PCCA;PLPP3;AEBP1;NNMT;ACOT11;ACOT6;CPXM1;ACOT2;PCCB;SMPD2;MTHFR;ALDH1L1;ABCB9;NSMAF;NAPEPLD;ACSF2;FOLR2;CERK;THOP1;ACOT9;VNN1
prerank,substrate-dependent cell migration (GO:0006929),0.646798101030747,1.4501752021418468,0.07465277777777778,0.5437702477569929,1.0,3/14,2.67%,NRP1;ITGA11;EPHA8
prerank,dermatan sulfate metabolic process (GO:0030205),0.6529603796534815,1.4501090999659059,0.10101010101010101,0.5422567153266901,1.0,5/13,8.32%,UST;DCN;BGN;DSE;CSPG5
prerank,response to retinoic acid (GO:0032526),0.48704799947154925,1.450056872609319,0.05194805194805195,0.5406706810760314,1.0,10/59,6.72%,EPHA3;RBP4;LYN;WNT8B;ASCL1;WNT6;CTSH;RARG;PTK7;WNT5B
prerank,regulation of transforming growth factor beta production (GO:0071634),0.624290200096565,1.4497500570308848,0.07792207792207792,0.5399680681980005,1.0,6/18,9.62%,LTBP1;SMAD3;ITGB8;ITGB6;CD200;ITGAV
prerank,cellular response to glucagon stimulus (GO:0071377),0.628854203821815,1.4487570681558375,0.08745874587458746,0.5417763032941604,1.0,5/17,3.66%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,retinoic acid metabolic process (GO:0042573),0.6503062444250622,1.4486255768998861,0.08557046979865772,0.5404973804958227,1.0,3/14,7.31%,CYP26B1;ALDH1A2;ADH1A
prerank,manganese ion transport (GO:0006828),-0.5623515806736082,-1.4483156547430165,0.0591016548463357,0.5324396759396414,1.0,6/14,5.84%,TRPC3;TRPC4;SLC39A8;TRPC5;ATP2C1;TRPC1
prerank,maturation of LSU-rRNA (GO:0000470),-0.4809055742301025,-1.4480076526619203,0.04788732394366197,0.529407878657475,1.0,11/26,21.85%,NSA2;RPL7;NIFK;MAK16;RPL7A;SNU13;RPL7L1;RRP15;RPF2;RPF1;ZNHIT3
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.4779658861257076,1.447728060754166,0.03870162297128589,0.5419574771314881,1.0,21/88,16.67%,NELL1;SAMD4A;DAPK1;DNAJC1;APOE;IGF2BP2;CDK5RAP3;IGFBP5;CST3;CPEB3;EIF2AK3;RNF139;DDX3X;CLN3;F2;LARP1;TM4SF20;ENC1;SYNCRIP;AKT1;IGF2BP1
prerank,embryonic digit morphogenesis (GO:0042733),0.6171823930787002,1.4475946257079626,0.0743801652892562,0.5407866058584434,1.0,6/18,8.10%,SALL1;GLI3;WDPCP;TBX3;MAP3K20;OSR1
prerank,protein localization to cell periphery (GO:1990778),-0.3412724945501504,-1.4472400221100075,0.008264462809917356,0.5279883465856537,1.0,30/133,8.51%,CAV1;DPP10;KCNB2;KCNIP4;RAP1A;SMURF1;F11R;CDH1;ANK3;BSG;EFR3B;LIN7A;ZDHHC2;RAMP2;SPTBN1;RDX;LRP6;EMP2;RAB3C;ATP1B1;LIN7C;TTC7A;EHD4;INPP5K;RAB12;GAK;RAB11A;RAB8B;MAP7;ARL3
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5855834549148229,-1.4468149373611277,0.09817351598173515,0.5256262203351681,1.0,3/12,3.61%,PODXL;PROM1;IQGAP1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.46062925493734286,1.446807524609364,0.02023809523809524,0.5416679537604591,1.0,17/102,9.03%,PDPK1;ENPP1;ADCY1;TBC1D4;ADCY2;PIK3R1;ADCY7;ADCY5;ADCY9;INSIG2;CPEB1;ZFP36L1;LHCGR;SRC;TRARG1;SLC30A10;KAT2B
prerank,ganglion development (GO:0061548),0.6900655729268124,1.446146821692292,0.09281961471103327,0.5421862840334023,1.0,2/11,3.29%,NRP1;ASCL1
prerank,carbohydrate derivative transport (GO:1901264),-0.5213001611574737,-1.4457316828123805,0.05675675675675676,0.5251122656679635,1.0,8/18,14.83%,PLTP;SLC15A2;LBP;NPC2;MFSD2A;ABCG1;SCARB1;VLDLR
prerank,activation of protein kinase A activity (GO:0034199),0.6344982828354643,1.4454607101192363,0.0732899022801303,0.5430223163366449,1.0,5/16,3.66%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.4326544057840521,1.4453246177326975,0.016666666666666666,0.5418084654438101,1.0,45/182,13.80%,IGF1;ROBO1;CILP;SLC24A3;ROCK2;RBMS3;RUNX1;OLFM1;BMPR1A;OPTN;YAP1;WNT4;APOE;SMO;NOTCH2;SLC2A10;ITGB8;SFRP1;LDLR;PRKAA2;TNRC6B;ENG;ATOH8;EMILIN1;CD28;MAP2K1;TET1;TNRC6A;BMP2;PICALM;SNX12;MYADM;PARP14;PRKN;FGF2;RBL2;TTBK1;TCEAL1;REST;TERF2;LRP3;CCDC3;MYCN;DLG4;SETDB1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.6635562097640655,1.4447153856440555,0.09151414309484193,0.542331032863173,1.0,5/13,8.83%,BMP6;BMPR1A;TGFBR1;DAB2;RBPMS
prerank,B cell homeostasis (GO:0001782),0.6779282731290691,1.442876706953195,0.1,0.5470156518278022,1.0,4/10,3.00%,LYN;DOCK10;DOCK11;GAPT
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6569803413814759,1.442749784377705,0.10880829015544041,0.5457056105179399,1.0,4/12,8.65%,ADAMTS12;DCN;IL12B;SPRY2
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.6854046637489581,1.4422925221993173,0.09107468123861566,0.5455128313422293,1.0,7/10,21.89%,CPEB1;CPEB3;PAF1;CDC73;HSF1;LEO1;NCBP2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.47893280412687,1.4420629909977212,0.04736842105263158,0.544568395825784,1.0,15/67,8.50%,EPHA3;DDR2;GHR;LYN;FGFR1;EPHA4;FGFR2;FGFR4;PDGFRA;KIT;PDGFRB;SRC;PIBF1;EGFR;EPHB2
prerank,response to prostaglandin E (GO:0034695),0.6983697776488558,1.4420529141071272,0.09407665505226481,0.5429044074026343,1.0,3/10,4.62%,TGFBR3;CCL19;SFRP1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.5900046911177667,1.4417201042724783,0.07219662058371736,0.5424090018026086,1.0,10/23,17.28%,GJA1;GDNF;SMO;LBX2;WNT5B;FGF2;EGF;MDK;BMP4;LIF
prerank,actin filament bundle assembly (GO:0051017),0.5467109445019706,1.441267757978613,0.07062146892655367,0.5423504553076525,1.0,8/33,5.64%,CALD1;RHOD;NEDD9;SHROOM2;DPYSL3;MYO1B;FSCN3;LIMA1
prerank,regulation of cellular catabolic process (GO:0031329),0.49731912827763286,1.4407144252121917,0.057034220532319393,0.542706079551378,1.0,15/62,16.55%,DAPK2;ITPR1;DAPK1;NUPR1;LRRK2;MTMR3;WDR91;PRKN;LONP2;RRAGD;USP10;TPCN2;PIK3R2;ATM;PIP4K2C
prerank,digestive tract development (GO:0048565),0.5550537274555423,1.4404843269887944,0.07278020378457059,0.5418094830855219,1.0,15/32,16.89%,GLI2;SALL1;GLI3;FGFR2;KIT;RARB;SMO;CLMP;DNAAF1;EPHB3;GLI1;CCDC40;GATA6;NPY;NIPBL
prerank,Golgi organization (GO:0007030),0.4578512991146046,1.440345153083194,0.023121387283236993,0.5405225273215485,1.0,38/112,17.76%,OBSL1;USP6NL;LMAN2L;OPTN;RAB30;MYO18A;GORASP2;ARHGAP21;TMED1;GOLGB1;LMAN1;CDC42;LRRK2;STX16;ZW10;UBXN2B;TRIP11;GOSR2;TJAP1;PLEKHM2;TMED4;ARL1;GOLPH3L;GORASP1;GOLGA8B;GOLGA5;TANGO2;ATP8B2;TBC1D20;SEC16B;BAG5;HACE1;CUL7;HUWE1;GOLPH3;ARFGEF1;TMED10;CSNK1A1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.43188747396929705,1.4401667704614916,0.017543859649122806,0.5394900345157037,1.0,49/173,16.87%,SEC24D;AREG;TGFA;DYNLL1;LMAN2L;ANK1;SEC31A;GAS6;TMED1;GOLGB1;YIF1B;DYNC1H1;LMAN1;ARFGAP3;ZW10;DCTN6;TRAPPC4;MIA2;COPZ2;COPB1;COG8;SPTAN1;CAPZB;TRIP11;GOSR2;MIA3;BCAP31;KDELR3;TMED4;ERGIC2;COPA;TRAPPC6B;ERGIC3;GORASP1;F2;KLHL12;CTSZ;SEC23A;USO1;DYNC1I2;ARF4;TBC1D20;ERGIC1;SEC16B;BET1L;PROS1;SEC24A;COPG1;YIF1A
prerank,positive regulation of response to stimulus (GO:0048584),-0.4305967387933499,-1.4401395006197533,0.040145985401459854,0.5394883920446361,1.0,20/40,34.78%,IFIH1;B2M;IL15;TGFB2;SIRT1;HOMER1;CGAS;ABI3;CD80;DHX9;HMGA2;NSMCE1;FMR1;ACOX2;IER5;ARG2;FCGR2B;ANKLE1;GATA3;HMGA1
prerank,BMP signaling pathway (GO:0030509),0.4936641937647171,1.4390837511434895,0.05194805194805195,0.5415927765498543,1.0,17/62,15.79%,BMP6;TGFBR3;SMAD3;BMPR1A;RUNX2;ACVR1;ENG;RGMA;BMP2;SMAD1;BMP15;USP9X;USP9Y;PDCD4;HIVEP1;BMP5;BMP4
prerank,negative regulation of multicellular organismal process (GO:0051241),0.4361588948657149,1.4389527300433682,0.011815252416756176,0.5404652292899457,1.0,47/199,16.50%,ALDH1A1;ROBO1;GJA1;ROCK2;ADAMTS5;MCC;LDLRAD4;LGR4;WWC2;IL17D;TNNT1;NKX2-1;ACOT11;NFIB;GAS6;NPR3;TWSG1;APOA1;SFRP1;NR1D1;RBPJ;EGFR;FOXC2;SPRY2;BMP2;ADM;STK11;USF3;FOXA1;SPRED3;RGCC;VASN;MAP2K6;MDK;SYT11;PTPN23;PTEN;SPRED1;HPN;BMP5;NR1H3;CHSY1;ASB1;SHH;BMP4;SDHAF2;ZNF423
prerank,artery morphogenesis (GO:0048844),0.5574723559689133,1.4389383229349986,0.06515151515151515,0.5388648181932615,1.0,7/30,6.05%,NRP1;LRP1;BMPR1A;PDGFRB;TGFBR1;ENG;ADAMTS9
prerank,maintenance of blood-brain barrier (GO:0035633),-0.4527289653233436,-1.438883932685388,0.05448717948717949,0.539629262047331,1.0,11/30,2.58%,SLC12A2;OCLN;PECAM1;CLDN5;JAM2;ESAM;F11R;ACTB;TJP2;LSR;TJP1
prerank,keratan sulfate metabolic process (GO:0042339),0.5570164200863751,1.437027559074426,0.060117302052785926,0.5439903632345676,1.0,7/31,8.15%,FMOD;OGN;LUM;ST3GAL3;GALNS;B4GALT1;OMD
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.6634212215324726,1.4369657579004396,0.09482758620689655,0.5425742284688485,1.0,9/11,27.15%,ZFP36L1;PAF1;ZC3H3;CDC73;LEO1;NCBP2;PAPOLA;AHCYL1;NCBP1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.6504756891483117,1.436903348254923,0.11386138613861387,0.5411968260008712,1.0,3/13,6.84%,PTGIS;NNMT;PARP16
prerank,blood vessel morphogenesis (GO:0048514),0.4996361554927048,1.4355563944294627,0.05313351498637602,0.5441867189363346,1.0,10/54,5.78%,NRP1;CCBE1;LAMA1;TGFBR3;LOX;TGFBR1;EFNB2;ITGB8;CYP1B1;ENG
prerank,hippo signaling (GO:0035329),0.5724550994261703,1.4354410300021128,0.0736196319018405,0.5429631964847629,1.0,9/26,12.09%,AMOTL2;TEAD1;YAP1;DCHS1;WWTR1;STK4;AMOTL1;TEAD3;YWHAE
prerank,regulation of focal adhesion assembly (GO:0051893),0.49986536948271243,1.4352937633712468,0.0534045393858478,0.5418399417863288,1.0,11/54,8.12%,EPHA3;NRP1;PHLDB2;ROCK2;ARHGAP6;DLC1;MACF1;SFRP1;SRC;VCL;MAP4K4
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.5841989292253701,-1.434594774621405,0.0966183574879227,0.5504517236125868,1.0,7/12,23.12%,UBASH3B;PTK2B;DIAPH1;RYR2;CASQ2;MTLN;CASQ1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.6009423019643932,1.4339279777286094,0.0875,0.5450737549646768,1.0,6/19,3.55%,RBP4;TGFBR3;RUNX1;BMPR1A;FGFR2;TGFBR1
prerank,regulation of cellular component movement (GO:0051270),0.5018072486973147,1.433860955153808,0.07547169811320754,0.5437271563672033,1.0,16/49,13.85%,MYCBP2;ROCK2;TGFBR3;LYN;SP100;ARHGAP18;TGFBR1;PDPN;MEMO1;EGFR;ZSWIM6;ACTN4;HBEGF;EGF;IGBP1;ETS1
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.41269381384914466,-1.433654353830554,0.05084745762711865,0.5497762818204986,1.0,15/42,20.52%,WARS1;WARS2;LARS1;TARS3;YARS2;YARS1;QARS1;TARS2;KARS1;FARS2;AIMP1;NARS2;MARS2;AIMP2;AARS2
prerank,positive regulation of signaling receptor activity (GO:2000273),0.542067170546252,1.433032189241949,0.07670850767085077,0.5450000680507062,1.0,9/36,11.80%,NRP1;AREG;TGFA;EPGN;ADRA2C;EPHB2;HBEGF;EGF;ADRA2A
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6531579678807913,1.4328937222154527,0.08904109589041095,0.5438988240900903,1.0,3/13,7.70%,GAL3ST3;B3GALT1;B3GALNT1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5099462334238122,1.4318243828344834,0.06391478029294274,0.5458971881181094,1.0,12/47,9.57%,NRP1;NEDD9;KANK1;FBLN1;APOA1;PDPN;CDC42;CARMIL1;DOCK5;CSPG5;ACTN4;MYADM
prerank,negative regulation of cell differentiation (GO:0045596),0.43566054445870717,1.4313193146151488,0.017718715393133997,0.546038134496912,1.0,51/181,16.38%,ADAMTS12;IGF2;RORA;ENPP1;RUNX1T1;ADGRV1;SMAD3;COL5A1;LDLRAD4;ABCA1;NKX2-1;YAP1;ASCL1;TGFBR1;CHADL;SFRP1;TBX3;SKI;WWTR1;SIRT2;USH2A;OSR1;EGFR;SPRY2;METTL14;TRPM4;ITGB3;ITGAV;USF3;ANKRD26;FOXA1;SPRED3;COL5A2;REST;TMEM64;LRP3;VASN;PAF1;PDCD4;SUFU;PTEN;SPRED1;HPN;TWIST2;BMP5;NR1H3;TRIO;SHH;BMP4;RIOX1;SDHAF2
prerank,toxin transport (GO:1901998),0.6679214245922906,1.4304256181756916,0.10649819494584838,0.5473836697624872,1.0,3/10,4.32%,ANTXR1;ANTXR2;SLC22A2
prerank,anion transport (GO:0006820),-0.4460581839261082,-1.4283799486614968,0.036585365853658534,0.5639155194751108,1.0,6/33,3.90%,ABCG2;SLC26A7;LRRC8C;LRRC8D;SLCO2B1;SLC22A6
prerank,phospholipid homeostasis (GO:0055091),0.6606939443080383,1.4272016551633593,0.11764705882352941,0.5565632364187922,1.0,4/11,11.56%,ABCA1;APOA1;TLCD1;RCN3
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6728887495915011,1.4260283071896291,0.10508474576271186,0.55905452776833,1.0,8/12,28.30%,INSIG2;KDELR3;INSIG1;RER1;HSPA5;KDELR2;OS9;TAPT1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.4653505646135115,-1.4249492564773374,0.06705539358600583,0.5716057569387968,1.0,13/27,28.25%,GPCPD1;ENPP2;PLA2G7;INPP5F;PNPLA8;PLA2G4C;PNPLA6;PLA2G4F;PLA2G4E;GDPD1;LIPC;PLA2G4B;PLA2G5
prerank,regulation of glycolytic process (GO:0006110),0.47811727063035625,1.4237564306044663,0.05297157622739018,0.5652447904233744,1.0,14/68,11.13%,IGF1;ZBTB20;OGT;PFKFB4;PRKAG2;NUP107;NUPR1;PRKAA2;NUP42;NCOR1;ARNT;EIF6;RAE1;NUP98
prerank,actin filament bundle organization (GO:0061572),0.5394032801435757,1.4237134063731443,0.08264462809917356,0.5637734000670939,1.0,8/33,5.64%,CALD1;RHOD;NEDD9;SHROOM2;DPYSL3;MYO1B;FSCN3;LIMA1
prerank,zinc ion homeostasis (GO:0055069),-0.4654190482738236,-1.4236882818698648,0.057803468208092484,0.5718489741759119,1.0,10/28,4.61%,SLC39A10;SLC39A8;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5633342813257155,1.4232549338376392,0.09640287769784173,0.5637768129149343,1.0,6/29,9.62%,IGF1;LYN;NOTCH2;SRC;RAPGEF1;ITGAV
prerank,lipid homeostasis (GO:0055088),0.4873227821492346,1.423214547056228,0.06596306068601583,0.5623150990634964,1.0,14/57,16.31%,ZBTB20;ABCA1;RBP1;APOE;APOA1;PRKAA2;CEBPA;TLCD1;NR1D2;DDX3X;RCN3;NR1H3;DGAT2;THADA
prerank,regulation of endothelial cell migration (GO:0010594),0.47119761848536973,1.4229563443897648,0.044136191677175286,0.5616166560735888,1.0,20/85,10.29%,NRP1;RIN2;ROCK2;ANGPT1;SPARC;GLUL;SASH1;DCN;NR2F2;SP100;APOE;SMOC2;ADAMTS9;ATOH8;AAMP;FOXC2;ANXA3;ITGB3;FGF2;PTPRM
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.6123259465236487,1.4228649105515032,0.10372771474878444,0.5603647335138966,1.0,7/19,15.02%,RHOH;GAS6;AXL;ZMIZ1;ZBTB1;MDK;MMP14
prerank,phospholipid transport (GO:0015914),-0.39761663046284385,-1.4227004074080298,0.01509433962264151,0.5712186377950711,1.0,21/52,17.72%,PITPNC1;ATP8A1;ATP8B1;ATP11C;PLTP;ABCC1;PITPNA;ATP11B;TNFAIP8L3;NPC2;ATP11A;MFSD2A;OSBPL2;ABCG1;SCARB1;PCTP;ATP10A;SCARB2;PITPNB;PRELID2;ABCB4
prerank,cGMP-mediated signaling (GO:0019934),0.6450074750637896,1.4221528909109848,0.11627906976744186,0.5612917574265005,1.0,3/13,4.79%,IRAG1;APOE;PDE3A
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.5629033845204401,1.421693282152499,0.07644305772230889,0.5613278275238966,1.0,7/24,6.80%,PDPK1;ANGPT1;SERPINE1;GAS6;SEMA5A;CDH5;NFE2L2
prerank,regulation of receptor binding (GO:1900120),0.6899815452072002,1.4216308164468763,0.11301369863013698,0.5599533551333956,1.0,1/10,0.07%,GREM2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.5029617989516442,-1.4214517894461656,0.09476309226932668,0.5715077107164822,1.0,5/20,6.87%,ZBTB16;CDK6;PTK2B;HOXA5;MEIS2
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5894690716211617,1.4212722555972794,0.10047095761381476,0.5579045939680671,1.0,13/20,26.67%,IVD;BCKDHB;DBT;ECHS1;ALDH6A1;ACADSB;MCCC2;BCKDK;HIBADH;DLD;HIBCH;BCAT2;ACAD8
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5894690716211617,1.4212722555972794,0.10047095761381476,0.5579045939680671,1.0,13/20,26.67%,IVD;BCKDHB;DBT;ECHS1;ALDH6A1;ACADSB;MCCC2;BCKDK;HIBADH;DLD;HIBCH;BCAT2;ACAD8
prerank,purine ribonucleotide transport (GO:0015868),-0.5396787388402208,-1.420833595537055,0.08136482939632546,0.5697063769167819,1.0,5/16,12.30%,ABCC4;LRRC8C;LRRC8D;ABCC6;SLC25A4
prerank,gland development (GO:0048732),0.4901407234156893,1.419606772919894,0.06282722513089005,0.5618882520393595,1.0,18/59,11.26%,TGFBR3;PRKCSH;GLI2;SALL1;ARID5B;NKX2-1;FGFR2;WNT4;TGFBR1;CDK5RAP3;TBX3;DKK3;CEBPA;ARHGAP35;ZBTB1;PHF2;EPHB3;NKX2-8
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.4341438096395023,-1.4189837512543766,0.05387205387205387,0.5721725096634229,1.0,11/34,15.22%,PTPRB;PTPRJ;UBASH3B;PTPRT;PTPN12;DUSP22;PTPN2;DUSP7;PTPN22;DUSP8;PTPN6
prerank,platelet degranulation (GO:0002576),0.44877099482029004,1.4189097869801233,0.0330188679245283,0.5629223816851667,1.0,25/118,11.91%,IGF1;IGF2;CLEC3B;ACTN2;TIMP3;SPARC;AHSG;SERPINE1;LYN;SERPING1;GAS6;APOA1;APLP2;PHACTR2;TLN1;VCL;CD63;NHLRC2;ACTN4;ITGB3;ISLR;MANF;STXBP1;EGF;ANXA5
prerank,cell chemotaxis (GO:0060326),0.49674011384142797,1.4187231503047772,0.058823529411764705,0.5619418400028484,1.0,12/60,7.40%,NRP1;DOCK4;PARVA;XCR1;PDGFRA;KIT;PDGFRB;SEMA5A;ACKR2;CCR9;AGTR1;LPAR1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.5680321713067472,-1.4184602443108452,0.08557457212713937,0.570019587275052,1.0,8/13,21.49%,NOTCH1;HEY2;GSK3A;TGFBR2;RYR2;CPE;FOXF1;NPY5R
prerank,cholesterol homeostasis (GO:0042632),0.47828442892984374,1.4184563630786022,0.04903225806451613,0.5613253649671569,1.0,10/64,7.73%,RORA;CYP7B1;ABCA1;EPHX2;FGFR4;APOE;APOA1;LDLR;LIMA1;NR1D1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.49452380500054127,1.418439224315321,0.06476683937823834,0.5598376929023584,1.0,10/57,7.90%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9;INSL3;HTR1A;MTNR1A;LPAR1;DRD3
prerank,regulation of tissue remodeling (GO:0034103),0.6085872760045805,1.4169636865214652,0.09485530546623794,0.5634352930704318,1.0,5/18,6.96%,DDR2;RUNX1;LEPR;CST3;IL12B
prerank,central nervous system neuron differentiation (GO:0021953),-0.4395844747444664,-1.4168312772209581,0.04081632653061224,0.5720107419196674,1.0,8/33,12.10%,GRID2;MDGA2;MAP2;SPOCK1;LRP6;OPHN1;ZC4H2;ATP7A
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.579287479692053,-1.4158760609965646,0.09131403118040089,0.5712308285590445,1.0,7/11,27.12%,UQCRH;CYCS;UQCR10;UQCR11;UQCRQ;UQCRFS1;UQCRC1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5376449585277554,1.4135865244352972,0.09051724137931035,0.5738826653264038,1.0,7/34,7.23%,RORA;ENPP1;RUNX1T1;SMAD3;YAP1;WWTR1;SIRT2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5253075618923584,-1.4130263378747996,0.08418367346938775,0.5770063852695924,1.0,5/17,10.19%,PODXL;PIEZO1;TGFB2;RET;SKAP1
prerank,endocrine system development (GO:0035270),0.589807543513199,1.412017186764042,0.08360128617363344,0.5776688801778844,1.0,6/21,5.66%,GLI2;SALL1;NKX2-1;WNT4;TGFBR1;DKK3
prerank,protein autophosphorylation (GO:0046777),0.4262943953940946,1.4114718369965638,0.030371203599550055,0.5778995948881543,1.0,29/157,10.67%,STK17B;DAPK2;PDPK1;DDR2;DAPK1;LYN;GRK5;FGFR1;EPHA4;EPHA8;FGFR2;FGFR4;PDGFRA;KIT;PDGFRB;MUSK;LRRK2;SRC;ULK2;SIK1;EIF2AK3;OXSR1;STK4;EGFR;CAMK2B;NEK6;STK11;TAOK3;EPHB3
prerank,sterol homeostasis (GO:0055092),0.4755003421751596,1.4108039300050945,0.05310880829015544,0.5787712651433163,1.0,10/65,7.73%,RORA;CYP7B1;ABCA1;EPHX2;FGFR4;APOE;APOA1;LDLR;LIMA1;NR1D1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.41974785512685414,1.4104222015418701,0.016181229773462782,0.5785744275835278,1.0,38/214,10.78%,NRP1;EPHA7;CCN2;ANGPT1;TIMP3;TGFBR3;PDGFD;LYN;CCN1;FGFR2;FGFR4;PDGFRA;APOE;PDGFRB;GAS6;CCL19;NOTCH2;FBLN1;RAPGEF2;ROR1;MT3;CCL4;EMILIN1;RANBP9;MAP2K1;TRAF7;NTRK3;MTURN;SLC30A10;EGFR;EPHB2;ARRB1;SPRY2;BMP2;FGF2;SPRED3;BRAF;CARD9
prerank,establishment of vesicle localization (GO:0051650),-0.5046044214172205,-1.4103039160839306,0.06887052341597796,0.582947510164161,1.0,8/18,23.80%,LIMK2;RAB27A;CDK5;RAB11A;TESK1;SYNJ1;KIF5A;TMEM230
prerank,neuromuscular junction development (GO:0007528),0.5661362702601496,1.4102750864781932,0.10194902548725637,0.5775397963443633,1.0,7/24,6.25%,PDZRN3;PPFIBP2;UNC13C;NEDD4;CACNB1;MUSK;LRRK2
prerank,adenine nucleotide transport (GO:0051503),-0.5292742027007634,-1.4099595441331085,0.09308510638297872,0.5803155197257159,1.0,5/17,12.30%,ABCC4;LRRC8C;LRRC8D;ABCC6;SLC25A4
prerank,regulation of interleukin-2 production (GO:0032663),-0.4043615133622673,-1.4099100743424218,0.07272727272727272,0.5767594079460403,1.0,17/43,22.34%,PDE4D;PDE4B;CD34;PLCG2;NAV3;SPTBN1;RPS3;CD80;TNFAIP3;PTPRC;HOMER3;PNP;CD86;ANXA1;TRAF2;MAP3K7;MALT1
prerank,positive regulation of cell migration (GO:0030335),0.4202404295152937,1.4089509022395943,0.009584664536741214,0.5807566070470042,1.0,56/253,11.80%,IGF1;NRP1;COL1A1;DDR2;CEMIP;ROCK2;PDGFD;SYNE2;SEMA3D;RHOD;NEDD9;CCN1;PPP3CA;PDGFRA;KIT;MYLK;PDGFRB;TGFBR1;VTN;SMO;SEMA5A;CSF1;INSL3;SMURF2;RAPGEF2;ACVR1;NTF3;CTSH;PDPN;CXCL16;CDH5;SRC;WNT5B;CARMIL1;DOCK5;RAB25;MYO1C;NTRK3;MAP4K4;CCN4;SYDE1;EGFR;EPHB2;DAB2;SPRY2;BMP2;MIA3;ACTN4;MYADM;S100A11;FAM89B;TRIP6;CAPN7;HBEGF;EGF;ADRA2A
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5473292155125331,1.408916205412212,0.08494783904619971,0.5793208581865967,1.0,8/31,7.99%,TGFBR3;TPM1;BMPR1A;FGFR2;TGFBR1;ENG;TNNC1;RBPJ
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.5793375507666264,-1.408879973613319,0.0963302752293578,0.5763286963106812,1.0,5/12,17.28%,ACTB;LAMA5;SCRIB;FUZ;ACTG1
prerank,regulation of insulin secretion (GO:0050796),0.44884038726786657,1.4086305747449024,0.03654080389768575,0.5787330764824177,1.0,13/101,7.73%,TCF7L2;RBP4;ITPR1;RAPGEF4;ADCY5;SLC30A8;SFRP1;CDK16;MCU;NEUROD1;ADRA2C;CACNA1C;NR1D1
prerank,positive regulation of T cell differentiation (GO:0045582),0.5163279252047311,1.4071365584149207,0.07625899280575539,0.5823331242197571,1.0,11/36,16.45%,RHOH;GLI2;GLI3;BCL6;IL12B;ZMIZ1;ZBTB1;MDK;VNN1;SHH;IL23A
prerank,proteoglycan biosynthetic process (GO:0030166),0.5389153816549214,1.4065568022168935,0.08127721335268505,0.582781797797016,1.0,3/31,2.18%,IGF1;GAL3ST3;PXYLP1
prerank,muscle contraction (GO:0006936),0.43828593118252146,1.40581758351399,0.040697674418604654,0.5838053754364645,1.0,23/126,7.58%,ROCK2;ACTN2;CALD1;SLC8A1;SNTB1;TPM1;TMOD4;TNNT1;MYL10;MYH13;ASPH;MYLK;LTB4R;MYL12A;ITGB5;TLN1;DES;SMTN;TNNC1;BDKRB2;VCL;MYL4;DTNA
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.5008413004197249,-1.405795009736305,0.08403361344537816,0.5832479330878085,1.0,9/20,22.34%,DENND1B;B2M;CD55;PRKCZ;CD81;FZD5;TRAF2;MAP3K7;MALT1
prerank,synaptic vesicle localization (GO:0097479),-0.5558600634347822,-1.4054723593858214,0.1065989847715736,0.5806868169866587,1.0,7/13,27.39%,NLGN1;RAB27A;CDK5;SYNJ1;KIF5A;TMEM230;SYNDIG1
prerank,cell projection organization (GO:0030030),0.5401714371904577,1.4045590861019952,0.09172932330827067,0.5864539442896305,1.0,7/30,8.32%,RHOH;GSN;PARVA;CDC42;NPHP1;ATP1B2;CSPG5
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5220333112037809,1.4042420801261246,0.07428571428571429,0.5859060504632843,1.0,14/43,13.08%,ERRFI1;CBLB;AREG;TGFA;EPGN;CDC42;EPS15;EGFR;SPRY2;HBEGF;EGF;EPS15L1;PTPN3;MVP
prerank,UV protection (GO:0009650),0.6695752489543821,1.4039864415781926,0.11347517730496454,0.5852245583033526,1.0,1/10,0.31%,MFAP4
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5905736929516233,1.4034357579177346,0.09902597402597403,0.5840453503072114,1.0,5/19,19.09%,POLR2D;POLR2C;TERF2;POLR2L;ATRX
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5905736929516233,1.4034357579177346,0.09902597402597403,0.5840453503072114,1.0,5/19,19.09%,POLR2D;POLR2C;TERF2;POLR2L;ATRX
prerank,prostanoid biosynthetic process (GO:0046457),0.6287865907002634,1.4028677069034596,0.11900826446280992,0.5845530115662615,1.0,3/15,5.15%,PTGIS;PTGES;PLA2G4A
prerank,negative regulation of bone mineralization (GO:0030502),0.638011093126809,1.40282104150303,0.11054421768707483,0.5831644759253644,1.0,4/13,9.31%,ENPP1;AHSG;BCOR;TRPM4
prerank,cellular response to cadmium ion (GO:0071276),-0.48032628911952946,-1.402544785615744,0.08659217877094973,0.5866980321640403,1.0,11/24,13.57%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;MAPK8;JUN;MAPK3
prerank,histone H3-K4 methylation (GO:0051568),0.5576667823004917,1.4024609391719607,0.07917888563049853,0.5829453967443944,1.0,10/26,20.74%,OGT;SETD1A;WDR82;KMT2A;SETD4;WDR5;SETD1B;RBBP5;TET3;CXXC1
prerank,sensory organ development (GO:0007423),0.4998403330102337,1.4024185450697593,0.08391608391608392,0.5815419043136055,1.0,7/51,7.62%,RBP4;PBX1;SHROOM2;ASCL1;SH3PXD2B;CPAMD8;SMOC1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.3653842198115764,-1.4024002290737876,0.03773584905660377,0.5835771355981901,1.0,24/75,15.88%,PLCE1;RGS5;MGLL;RGS3;KCTD8;GIT2;NMT2;RGS6;CRY1;FNTA;SYP;RGS12;FNTB;CALM1;EDN1;RGS4;PLEK;DGKQ;RGS16;GIT1;RGS11;PDE6A;METAP2;GPER1
prerank,smooth muscle contraction (GO:0006939),0.62393125726387,1.4012583746359064,0.10413223140495868,0.5841109332865991,1.0,5/14,6.46%,ROCK2;SLC8A1;MYLK;SMTN;BDKRB2
prerank,T cell differentiation in thymus (GO:0033077),0.6197039899156215,1.4011748211027857,0.12353923205342238,0.5829082530648793,1.0,3/14,5.80%,GLI3;LIG4;ZFP36L1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.4058624154984855,1.4006622838333669,0.007172131147540984,0.5830972919712062,1.0,79/348,14.20%,IGF1;ROBO1;BMP6;SLC24A3;GJA1;ROCK2;ANGPT1;PID1;RBMS3;GSN;SMAD3;AR;MITF;OLFM1;NOS1AP;EPHX2;NKX2-1;DTNBP1;YAP1;FGFR4;TGFBR1;GAS6;SMO;WNT6;TLE1;RESF1;SLC2A10;PDCD5;CSF1;ITGB8;SLC22A2;MT3;NTF3;CTSH;MUSK;TNRC6B;CDH5;CUX2;EMILIN1;NR5A1;NFE2L2;EIF2AK3;CD28;CD63;MAP2K1;AFDN;TLR6;RBPJ;NTRK3;OSR1;EPHB2;ARRB1;SPRY2;TNRC6A;BMP2;SMAD1;PRKN;FGF2;ITCH;PPHLN1;BRAF;TTBK1;DDX3X;RGCC;TMEM119;EGF;C1QTNF1;TERF2;DNAJA4;LRP3;HMGN5;INSR;SFRP4;MYCN;MTPN;SETDB1;ETS1;TADA3;PDCL3
prerank,glycerolipid metabolic process (GO:0046486),-0.5792477258803218,-1.4004086377107392,0.11316397228637413,0.5870179656509287,1.0,5/11,16.94%,DGKB;PNPLA3;DGKG;DGKQ;DGKZ
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6260511098797321,1.400297370749579,0.13310580204778158,0.5828316595369101,1.0,7/14,16.72%,SEC24D;SEC31A;MIA3;SEC23B;SEC23A;TBC1D20;SEC24A
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5083438416335914,1.4000200330878234,0.06862745098039216,0.5823593267517735,1.0,11/45,10.79%,BMP6;BMPR1A;INHBE;TGFBR1;TWSG1;ACVR1;ENG;DAB2;RBPMS;BMP2;BMP15
prerank,cell projection assembly (GO:0030031),0.565511266882463,1.399670382625797,0.10461538461538461,0.5821073169521905,1.0,4/22,6.01%,RHOH;GSN;PARVA;CDC42
prerank,amino acid import across plasma membrane (GO:0089718),0.5787725580054477,1.3993459601986789,0.08936825885978428,0.5818488303784637,1.0,6/24,4.32%,SLC1A3;SLC7A2;SLC1A5;SLC6A9;SLC6A13;SLC22A2
prerank,protein trimerization (GO:0070206),0.6249877754952687,1.3986349100053155,0.11925042589437819,0.5813641117352626,1.0,4/14,9.47%,SLC1A5;SCARA5;MLKL;CLYBL
prerank,protein homotrimerization (GO:0070207),0.6249877754952687,1.3986349100053155,0.11925042589437819,0.5813641117352626,1.0,4/14,9.47%,SLC1A5;SCARA5;MLKL;CLYBL
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4523610797677636,1.3985840371382499,0.04932182490752158,0.5800797576968139,1.0,19/87,9.27%,FMOD;COL1A2;TGFBR3;SMAD3;BMPR1A;TGFBR1;TWSG1;APOA1;APPL2;ACVR1;ITGB5;ENG;CDH5;SKI;SRC;LTBP2;ARHGEF18;ZMIZ1;SMAD1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4408077488081645,1.3982967681077214,0.04065040650406504,0.579598478329253,1.0,27/122,14.18%,IGF1;SAMD4A;IGF2;AR;PLD1;GLI2;SLC6A9;FGFR4;PDGFRB;CCL19;SLC25A37;SMOC2;CPEB3;CD28;NPM2;EGFR;METTL14;FGF2;EIF6;DDX3X;RGCC;EGF;NMD3;GLI1;INSR;MTPN;PLXNB2
prerank,cellular potassium ion homeostasis (GO:0030007),-0.5498589812828364,-1.3973353683135592,0.11224489795918367,0.5938433959287515,1.0,5/13,6.40%,SLC12A2;KCNJ2;ATP1A1;KCNMA1;ATP1B1
prerank,negative regulation of cell junction assembly (GO:1901889),0.5577501731790651,1.3971324636293014,0.08549618320610687,0.5821906427758579,1.0,4/25,1.83%,PHLDB2;ROCK2;ARHGAP6;DLC1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.675632864563743,1.3970880846332159,0.11764705882352941,0.5809036990665295,1.0,2/10,1.81%,ADGRV1;GRXCR1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5056113969674471,1.3967779282957413,0.06,0.5804798999175138,1.0,9/46,9.71%,ALDH1A1;ADAMTS5;LGR4;ACOT11;NPR3;NR1D1;RBPJ;FOXC2;STK11
prerank,apoptotic cell clearance (GO:0043277),0.5417424266378592,1.396561977033287,0.10287443267776097,0.5797589997829877,1.0,8/30,9.62%,RHOH;LRP1;RHOBTB1;GAS6;TXNDC5;RHOBTB2;ITGB3;ITGAV
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.5983303570538243,1.3960442931997765,0.11019736842105263,0.580174883812474,1.0,6/17,12.45%,NRP1;ROBO1;EFNB2;MIA3;FGF2;NR4A1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.5015021553189746,1.3954654965515612,0.06858710562414266,0.5806214996758328,1.0,9/48,7.13%,ADCY1;AMPD3;ADCY2;ADCY7;ADCY5;NUDT2;ADCY9;GUCY2C;GUCY2D
prerank,negative regulation of immune system process (GO:0002683),0.6040254152190808,1.3954305941705403,0.11461794019933555,0.5792914945176619,1.0,4/16,11.46%,LYN;IL17D;CD200;COL3A1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6426974036274004,1.3952680329441738,0.13297872340425532,0.5783923744062733,1.0,4/11,10.77%,PGM3;GFPT1;UAP1;RENBP
prerank,inner dynein arm assembly (GO:0036159),0.6727158789140836,1.3946315357225576,0.11867364746945899,0.5790003684996895,1.0,5/10,15.74%,CFAP73;DNAAF1;DNAI3;CCDC40;DNAAF5
prerank,adrenergic receptor signaling pathway (GO:0071875),0.595973912244204,1.3945773507537318,0.11746522411128284,0.577791610293643,1.0,8/20,14.11%,ADRA1B;ADCY9;RAPGEF2;ADRA2C;ADRB3;DRD3;ADRA2A;AKAP13
prerank,axon extension (GO:0048675),0.5638570547736365,1.3943135040931636,0.11574074074074074,0.5771918922142398,1.0,8/23,12.44%,NRP1;AUTS2;SEMA5A;ULK2;ALCAM;SLIT3;SLIT1;USP9X
prerank,visual system development (GO:0150063),0.5239140783341464,1.3934984037142721,0.10410557184750734,0.5786311820969096,1.0,5/37,7.62%,RBP4;PBX1;SH3PXD2B;CPAMD8;SMOC1
prerank,Ras protein signal transduction (GO:0007265),0.4327325995669266,1.3934572661763542,0.040229885057471264,0.577365233733035,1.0,22/137,9.95%,IGF1;COL1A2;RHOH;ROCK2;KSR1;PLD1;ARHGAP6;RHOD;CTNNAL1;CCNA2;RRAS2;CDC42EP4;ARHGAP29;RAPGEF2;PDPN;MRAS;AGTR1;ARHGEF11;RAPGEF1;NTN1;TAX1BP3;FGF2
prerank,cartilage development (GO:0051216),0.4981661038035872,1.3928347199141773,0.0793010752688172,0.5780623272435536,1.0,14/49,9.95%,SOX5;RUNX1;SULF2;RUNX2;NFIB;SULF1;ITGB8;CREB3L2;WNT5B;COL11A2;OSR1;TRIP11;BMP2;FGF2
prerank,ribosome assembly (GO:0042255),-0.40993117764151304,-1.392544607785962,0.0457516339869281,0.606742177259972,1.0,20/47,26.73%,RPL3;RPS14;RPS19;RPS15;RPL11;RPS5;RPL6;PPAN;RPL5;RPSA;RPLP0;MTERF3;NPM1;C1QBP;MRPS7;RPF2;RRS1;EFL1;RPS27;RPL10
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6658711752256349,1.3923059778398112,0.09481216457960644,0.5784672848063783,1.0,2/11,7.23%,NRP1;SIRT2
prerank,modified amino acid transport (GO:0072337),0.6086847526004644,1.3920528854431988,0.1232876712328767,0.5778559715345865,1.0,5/15,12.75%,SLC16A12;SLC6A13;PDPN;MGST1;FOLR2
prerank,positive regulation of cell junction assembly (GO:1901890),-0.38485102984493685,-1.3917136774228875,0.04184100418410042,0.6059306758969008,1.0,17/56,10.64%,TEK;CNTNAP2;GRID2;CAV1;PTPRJ;CLDN5;NLGN1;IL1RAPL1;KDR;PTPRD;EPHB1;NRXN1;MYOC;CLSTN2;VEGFA;ACE2;CLSTN3
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.4613378406756548,-1.3902761757746351,0.07428571428571429,0.6073231697656543,1.0,5/24,11.01%,PECAM1;F11R;NT5E;ITGA4;MSN
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5436842048375524,1.3899929976766536,0.11624441132637854,0.5834243186862192,1.0,6/27,2.22%,PHLDB2;PIK3R1;CGNL1;ARHGAP6;DLC1;ARHGAP28
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4585493811821812,1.389715481329047,0.048721071863580996,0.5829191356768919,1.0,9/84,8.14%,IGF1;SAMD4A;DAPK1;APOE;IGF2BP2;IGFBP5;CPEB3;EIF2AK3;RNF139
prerank,cellular response to glucose starvation (GO:0042149),0.5069620446200951,1.389000384201628,0.08789625360230548,0.5840148342335569,1.0,25/41,27.79%,PRKAG2;PRKAA2;NUAK1;SIK1;EIF2AK3;BRSK1;MTMR3;HNRNPA1;IMPACT;PIK3R4;ITFG2;TBL2;SESN2;FOXO3;BECN1;PRKAG1;SZT2;CPEB4;HSPA5;PMAIP1;PRKAG3;SH3GLB1;RRP8;SESN3;ASNS
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5665613022747974,1.388059773627801,0.11009174311926606,0.585656305717335,1.0,6/22,9.05%,ROCK2;LYN;EPHA4;RANBP9;SLC2A13;PICALM
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5842946469840468,1.3879538011869672,0.12598425196850394,0.5846629274028657,1.0,3/18,4.27%,NELL1;DACT1;CDK5RAP3
prerank,negative regulation of signal transduction (GO:0009968),0.412026927487884,1.3878771571933501,0.014830508474576272,0.5835723862791581,1.0,68/249,17.10%,ADAMTS12;CILP;ENPP1;TRABD2B;PID1;LRP1;CYP26B1;DCN;AHSG;LYN;BCL2;LGR4;DACT1;SULF2;NKD1;LEPROT;GLI3;KANK1;MDFI;MGRN1;SULF1;TLE1;SLC2A10;NEDD4;ACVR1;SFRP1;IGFBP5;DKK3;LRRK2;EMILIN1;IL12B;IRAK3;TULP3;CBLN1;EGFR;ARRB1;SPRY2;BMP2;CBY1;NTN1;TAX1BP3;GLIS2;FGF2;IGFBP3;EGF;PTCH2;NIBAN2;BTRC;NDRG4;SFRP4;TSC2;SUFU;PTEN;FSTL3;BMP5;MMP14;CXXC4;GRB10;TMBIM6;AKT1;CREB3L1;PIP4K2C;CD47;KANK2;CX3CL1;SMPDL3B;TNS2;GPR108
prerank,thyroid hormone generation (GO:0006590),0.676078511295286,1.3876868752651994,0.1252336448598131,0.5827146035187932,1.0,4/10,15.93%,CPQ;SLC5A5;DIO2;TG
prerank,B cell receptor signaling pathway (GO:0050853),-0.43220071803717025,-1.3876701510207905,0.04610951008645533,0.6124936070467369,1.0,12/32,16.35%,MEF2C;TEC;PLCG2;VAV3;CD38;BMX;NFATC2;PLEKHA1;BCAR1;BLNK;BTK;PTPRC
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6544961736509538,1.3865729433724376,0.14886164623467601,0.5850052510039758,1.0,5/11,13.64%,GAS6;CCL19;AXL;SELENOS;MERTK
prerank,response to cadmium ion (GO:0046686),-0.46784241238504265,-1.3863637858580082,0.0771513353115727,0.6131617436575344,1.0,11/26,13.57%,MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;MAPK8;JUN;MAPK3
prerank,acylglycerol homeostasis (GO:0055090),0.5755118508952966,1.3862133504900396,0.13517665130568357,0.584803462701007,1.0,3/20,4.39%,RORA;APOE;APOA1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5255118968404261,1.386133862446609,0.09659090909090909,0.5837181183051531,1.0,9/32,10.51%,ZBTB20;APOE;PRKAG2;APOA1;STAR;PRKAA2;NR5A1;CREBL2;EIF6
prerank,positive chemotaxis (GO:0050918),0.6096100979540277,1.3861176832816224,0.11145996860282574,0.5823909234875677,1.0,3/17,3.86%,NRP1;ANGPT1;SEMA5A
prerank,prostaglandin biosynthetic process (GO:0001516),0.59594084571619,1.385755962075577,0.12140575079872204,0.5822397889176344,1.0,3/18,5.15%,PTGIS;PTGES;PLA2G4A
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5170255555181039,-1.3855210411862795,0.09476309226932668,0.6123717939866801,1.0,7/16,6.76%,GUCY1B1;NOS3;GUCY1A1;KCNC2;DDAH1;NOS1;DDAH2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4624891098822791,1.3854276864431783,0.06641604010025062,0.5819509427663127,1.0,19/75,14.20%,NRP1;PDPK1;IGF2;FGFR1;VASH2;TGFBR1;SEMA5A;VIP;AKT3;AGTR1;BMP2;ARNT;ITGB3;FGF2;FGFBP1;EGF;NR4A1;MDK;PDCL3
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5504297481478522,-1.384941202578089,0.10945273631840796,0.610603356669589,1.0,4/13,13.81%,TMSB4X;HEY2;TAF1;HEY1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.669383123248248,1.3849313208891232,0.12564543889845095,0.5822872740982267,1.0,5/10,13.08%,ENPP1;ERRFI1;ENG;IMPACT;MVP
prerank,embryonic skeletal system development (GO:0048706),0.52305036832279,1.3849293916932104,0.08658008658008658,0.5809307299318693,1.0,6/35,4.09%,RBP4;COL1A1;SULF2;PDGFRA;SULF1;SLC2A10
prerank,androgen receptor signaling pathway (GO:0030521),0.6533914929758222,1.3847477970605835,0.13485113835376533,0.5801564035423473,1.0,4/11,8.19%,AR;PMEPA1;DDX17;ZMIZ1
prerank,organophosphate catabolic process (GO:0046434),-0.569617986003818,-1.3842848747637932,0.11574074074074074,0.609243967082418,1.0,1/11,0.93%,ENPP2
prerank,transferrin transport (GO:0033572),0.5225485704072746,1.3842296742814784,0.08974358974358974,0.5805749537925579,1.0,2/33,0.82%,ATP6V0A4;STEAP3
prerank,arachidonic acid metabolic process (GO:0019369),0.5241955520283691,1.383755623792154,0.08714285714285715,0.5808712560042057,1.0,7/35,7.26%,PTGIS;PTGES;DAGLA;EPHX2;CYP1B1;PLA2G4A;ALOXE3
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4237358376201964,-1.3837253666263867,0.08536585365853659,0.6075882934235222,1.0,14/36,10.91%,CAV1;NOSTRIN;NOS3;DDAH1;GCH1;NOSIP;DDAH2;ATP2B4;CYGB;DHFR;CALM1;S100A1;SCARB1;SPR
prerank,negative regulation of cell motility (GO:2000146),0.4433142043650085,1.3830408880403577,0.04404761904761905,0.5819051433022461,1.0,22/108,7.57%,ROBO1;LDLRAD4;MITF;DAG1;SERPINE1;DLC1;PODN;TPM1;EPHA4;KANK1;RECK;NKX2-1;DPYSL3;SULF1;FBLN1;CYP1B1;SFRP1;IGFBP5;ENG;VCL;DPEP1;AFDN
prerank,NAD biosynthetic process (GO:0009435),0.5803176372284977,1.382670662849328,0.13258785942492013,0.5818025426493213,1.0,4/20,6.98%,PTGIS;NNMT;PARP16;KYNU
prerank,regulation of pH (GO:0006885),0.6515089164408313,1.3815977996450988,0.11559633027522936,0.5840358942075914,1.0,1/11,0.21%,ATP6V0A4
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.4769857759863688,-1.381443767206988,0.07428571428571429,0.6117472952549725,1.0,10/24,20.83%,DACH1;ACVRL1;RPS3;MSH3;SUB1;ZRANB3;DFFA;BMPR2;CDKN1A;MSH2
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.52993725705808,-1.3813097225077884,0.11224489795918367,0.6086936817319836,1.0,6/15,16.77%,ENTPD1;AK5;ENTPD2;ENTPD6;AK7;ENTPD3
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.43189726357193575,-1.3812705152516915,0.05714285714285714,0.6053460535294342,1.0,13/30,25.08%,ACKR3;RPS3;KDM1A;PTTG1IP;TPT1;SIRT1;BCL2L1;CD44;CLU;TWIST1;MIF;SNAI2;CCAR2
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.5129813410976327,-1.381262976172807,0.11025641025641025,0.6018980258688378,1.0,8/17,18.71%,ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;ATP5PD;VPS9D1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.5075602911041416,1.380639260900515,0.09192200557103064,0.5859738266052541,1.0,5/40,9.87%,IGF1;MOAP1;PDCD5;BCL2L11;PRKN
prerank,regulation of dendritic spine development (GO:0060998),-0.4950496931341704,-1.3801512377225573,0.09433962264150944,0.6021620434319256,1.0,8/19,10.61%,MEF2C;SHANK3;PPFIA2;NLGN1;GRIN3A;TANC2;SHANK1;KIF1A
prerank,multivesicular body organization (GO:0036257),-0.43263313546309196,-1.3800168776516581,0.075,0.5992261084369167,1.0,16/31,28.39%,RAB27A;RAB11A;PDCD6IP;VPS37B;VPS37A;VPS28;VPS36;VPS4A;CHMP2B;VPS37C;SNF8;CHMP4B;CHMP4A;HGS;MVB12A;CHMP4C
prerank,glycerolipid catabolic process (GO:0046503),-0.4951118566326777,-1.3795412090823986,0.11195928753180662,0.5974900703687176,1.0,10/19,23.06%,GPCPD1;MGLL;ABHD2;PLA2G4C;ABHD6;PNPLA6;LYPLA2;PLA2G4F;PLA2G4E;GDPD1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5451919349623614,1.3795036477286349,0.11684370257966616,0.5883412152769197,1.0,5/28,4.43%,ENPP1;PID1;AHSG;KANK1;APPL2
prerank,aorta morphogenesis (GO:0035909),0.6007399594079966,1.379463627170949,0.1302170283806344,0.5871104545906916,1.0,7/17,7.99%,LRP1;BMPR1A;MYLK;PDGFRB;ENG;ADAMTS9;RBPJ
prerank,triglyceride biosynthetic process (GO:0019432),0.5801093469037719,1.3788178544138743,0.12214983713355049,0.5879603580013282,1.0,7/18,21.72%,AGMO;LPGAT1;MOGAT3;DGAT2;GK;LPIN3;LPIN2
prerank,sterol metabolic process (GO:0016125),0.4722806647685764,1.3784652763859573,0.07197943444730077,0.5878360750861513,1.0,9/60,7.26%,CYP7B1;CYP26B1;ABCA1;APOE;PRKAG2;INSIG2;CYP1B1;APOA1;CYP27A1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5026187951703582,1.3764248262261964,0.11715481171548117,0.5932529129151211,1.0,10/40,9.95%,ARHGAP6;FGFR1;PDGFRA;KIT;PDGFRB;NTF3;LPAR1;NTRK3;EGFR;FGF2
prerank,regulation of ion transmembrane transport (GO:0034765),-0.4260365474339225,-1.375636565847203,0.08517350157728706,0.6072688802150836,1.0,16/33,25.14%,KCNJ2;NEDD4L;KCNJ3;P2RX7;KCNQ1;CHRM3;AKAP6;KCNJ15;KCNJ10;CASQ2;ANO6;KCNJ8;KCNJ6;KCNJ13;WWP2;KCNJ16
prerank,activin receptor signaling pathway (GO:0032924),0.5880339753272827,1.3755545556374815,0.13562091503267973,0.5948645373112853,1.0,3/15,4.60%,SMAD3;TGFBR1;ACVR1
prerank,actin filament network formation (GO:0051639),-0.5630483749528585,-1.375150843793636,0.10757946210268948,0.6056368635883236,1.0,5/11,10.39%,COBL;PLS3;SPIRE1;FHOD3;PLS1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.46996022323413145,1.3750715928498356,0.08190224570673713,0.5923816079148511,1.0,19/61,17.61%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;TRAPPC10;TRAPPC9;TRAPPC6B;GORASP1;KLHL12;CTSZ;SEC23A;USO1;TBC1D20;SEC16B;SEC24A;TMED10
prerank,vesicle coating (GO:0006901),0.46996022323413145,1.3750715928498356,0.08190224570673713,0.5923816079148511,1.0,19/61,17.61%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;TRAPPC10;TRAPPC9;TRAPPC6B;GORASP1;KLHL12;CTSZ;SEC23A;USO1;TBC1D20;SEC16B;SEC24A;TMED10
prerank,COPII vesicle coating (GO:0048208),0.46996022323413145,1.3750715928498356,0.08190224570673713,0.5923816079148511,1.0,19/61,17.61%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;TRAPPC10;TRAPPC9;TRAPPC6B;GORASP1;KLHL12;CTSZ;SEC23A;USO1;TBC1D20;SEC16B;SEC24A;TMED10
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.4956799550930262,-1.374587792760005,0.1046831955922865,0.6041086797607572,1.0,8/18,23.03%,CHRM3;AGRN;GNB1;CHRM2;GNA11;CDK5R1;RGS10;CHRM1
prerank,regulation of phospholipase C activity (GO:1900274),0.6153223377005312,1.3739324549396201,0.12071778140293637,0.594816791872224,1.0,7/15,9.95%,FGFR1;PDGFRA;KIT;PDGFRB;NTF3;NTRK3;FGF2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.5283921541206624,1.3738698757679235,0.1111111111111111,0.5936989412883218,1.0,6/29,8.88%,TGFBR3;TPM1;FGFR2;ENG;TNNC1;BMP2
prerank,regulation of blood circulation (GO:1903522),0.5127807335435347,1.373193034315948,0.10237388724035608,0.594701134136905,1.0,6/34,7.09%,CELF2;TPM1;DMPK;DES;BDKRB2;AGTR1
prerank,monocarboxylic acid transport (GO:0015718),-0.3803712347187401,-1.3728993536490088,0.04198473282442748,0.6065010470223642,1.0,11/51,7.31%,ABCG2;ATP8B1;ABCC4;SLCO2A1;SLCO1C1;SLC16A6;SLCO2B1;SLC5A6;SLC16A9;SLC16A1;SLC16A4
prerank,entry into host (GO:0044409),-0.5438920903115158,-1.3726222680509148,0.11221945137157108,0.6040566667646217,1.0,4/13,5.09%,CDH1;MET;CBL;PPIA
prerank,COPII-coated vesicle budding (GO:0090114),0.46783730618422836,1.37235279542545,0.0764163372859025,0.5962638584498797,1.0,19/68,14.89%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;MIA3;SEC23B;TRAPPC10;TRAPPC9;TRAPPC6B;GORASP1;KLHL12;CTSZ;SEC23A;USO1;TBC1D20;SEC16B
prerank,positive regulation of lipid localization (GO:1905954),0.6417544781461548,1.370701085692956,0.13403880070546736,0.6006632828923357,1.0,2/11,10.91%,LRP1;IKBKE
prerank,positive regulation of cellular catabolic process (GO:0031331),0.42609097309625166,1.3701823887415783,0.040183696900114814,0.6011214325782284,1.0,25/132,14.67%,IGF1;ZBTB20;SH3D19;DAPK1;DCN;DACT1;OPTN;PFKFB4;APOE;APOA1;PRKAA2;LRRK2;SNX33;DXO;ARNT;STK11;ITCH;RNF152;UFL1;ADRA2A;INSR;ABCD2;SNX9;PLK2;NPRL2
prerank,positive regulation of endopeptidase activity (GO:0010950),0.5440173772582797,1.3698960379871663,0.10752688172043011,0.6007706100486471,1.0,6/26,11.36%,ROCK2;LYN;EPHA4;PICALM;TTBK1;APH1B
prerank,glycoprotein catabolic process (GO:0006516),0.5926153730236533,1.3695126169928944,0.1480891719745223,0.6006889758618208,1.0,5/17,16.57%,ADAMTS12;ADAMTS9;NGLY1;CTSL;NEU4
prerank,hepaticobiliary system development (GO:0061008),0.5662445613871085,1.3694874349971626,0.11829652996845426,0.599452023494581,1.0,8/20,11.26%,TGFBR3;PRKCSH;ARID5B;WNT4;CDK5RAP3;CEBPA;PHF2;NKX2-8
prerank,regulation of hemopoiesis (GO:1903706),0.6608156852708389,1.3688639589355673,0.1336996336996337,0.6001551008029609,1.0,2/10,2.84%,RUNX1;IL17D
prerank,tRNA modification (GO:0006400),0.46522029026068207,1.3688580269633972,0.07253886010362694,0.5988644513965599,1.0,21/62,19.19%,TRMT44;PUS3;ADAT2;TRMO;NSUN2;BCDIN3D;URM1;TRMT13;TRMT9B;TRMT112;THUMPD3;THUMPD2;DTWD1;OSGEP;THADA;ELP5;ALKBH1;ANKRD16;PUSL1;TRUB1;METTL1
prerank,action potential (GO:0001508),-0.39868204993444223,-1.368685792883837,0.07829181494661921,0.6140984888167667,1.0,15/44,15.88%,KCNJ2;ANK3;KCND2;YWHAH;SCN1A;SCN3A;KCNQ1;GNA14;AKAP6;SCN2A;KCNMB2;KCNA2;CACNA1H;GNA11;GPER1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.44209524233639047,1.368218483514821,0.06698564593301436,0.599839926364477,1.0,20/101,11.80%,ROBO1;CEMIP;PDGFD;FGFR1;IL34;EPGN;KIT;PDGFRB;RAPGEF2;LRRK2;SRC;PARP16;MAP2K1;EGFR;TELO2;FGF2;DDX3X;RGCC;EGF;ADRA2A
prerank,regulation of establishment of cell polarity (GO:2000114),0.5886274636830033,1.3679724212502802,0.1064891846921797,0.5993630690544548,1.0,5/16,5.87%,ROCK2;GSN;KANK1;RIPOR2;CDH5
prerank,positive regulation of histone modification (GO:0031058),-0.4196597159986861,-1.3677822528804329,0.0967741935483871,0.6140528668913832,1.0,11/33,13.57%,RPS6KA5;KDM1A;CTBP1;NOS1;PPARGC1A;BRD7;RPS6KA4;CHTOP;TADA2A;APLNR;MAPK3
prerank,regulation of cation channel activity (GO:2001257),-0.3458550284732533,-1.367743473384897,0.02512562814070352,0.6108610919925758,1.0,32/89,22.10%,DLG2;PDE4D;MEF2C;GRIA4;NLGN1;PTK2B;ANK3;KCNAB1;GRIN2A;CAMK2D;FGF12;LRRC7;NOS1;GRIN2B;STAC;GRIA2;CALM1;SHANK1;HOMER1;APP;GSG1L;CACNG3;CACNG4;AHNAK;HPCA;CACNB3;CTSS;FKBP1A;GRIN1;SHISA9;RELN;MINK1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6192963521254455,1.3675259163239146,0.15630550621669628,0.5995608028517525,1.0,2/12,1.80%,RUNX1;LYN
prerank,negative regulation of metabolic process (GO:0009892),0.4824378024471691,1.3673456884427098,0.07884362680683311,0.5988541001506957,1.0,9/54,9.71%,ALDH1A1;ADAMTS5;LGR4;ACOT11;NPR3;NR1D1;RBPJ;FOXC2;STK11
prerank,peptide metabolic process (GO:0006518),0.4459723329623056,1.3671555207694581,0.0845959595959596,0.5981327982453526,1.0,15/75,14.39%,CPXM2;CPQ;AEBP1;CPXM1;GSTM4;GSTM2;DPEP1;NAALADL1;SEC11C;GSTT1;APEH;ABCB9;MGAT3;GSTK1;THOP1
prerank,negative regulation of transposition (GO:0010529),0.5962682282330286,1.3671254791537932,0.1288244766505636,0.5969185049792257,1.0,7/16,17.88%,UBR2;TUT7;PIWIL4;SPOCD1;TUT4;MYBL1;DDX4
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.5946488833379994,1.3669939058077045,0.1371900826446281,0.5960703171578058,1.0,6/17,18.61%,NKX6-1;ATOH8;FGF2;SFRP4;BMP4;AHI1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5651037552275757,-1.3663505399984683,0.1193058568329718,0.6121204916895625,1.0,8/10,39.39%,GALNT13;GALNT2;GALNT3;POGLUT3;GALNT4;MGAT5B;POGLUT1;GALNT16
prerank,sulfur compound biosynthetic process (GO:0044272),0.43064506685406073,1.366154803013086,0.06793802145411204,0.597719849855286,1.0,21/104,12.37%,FMOD;OGN;ANGPT1;LUM;UST;DCN;BGN;ST3GAL3;DSE;CHAC2;GSTM4;GSTM2;B4GALT1;OMD;CSPG5;MGST1;GSTT1;CDO1;LIAS;CHST15;PRELP
prerank,cortical cytoskeleton organization (GO:0030865),0.49880447434826675,1.3656114267697856,0.103397341211226,0.5981420241030768,1.0,13/41,17.36%,RHOH;ROCK2;RHOD;RHOBTB1;RHOBTB3;RHOBTB2;FMNL1;RHOQ;LLGL1;RND3;EPB41L3;ARF6;RHOG
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.6480992835806181,1.3651295404190393,0.1542649727767695,0.5971115501284228,1.0,2/10,6.01%,CDC42EP4;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),0.6480992835806181,1.3651295404190393,0.1542649727767695,0.5971115501284228,1.0,2/10,6.01%,CDC42EP4;CDC42
prerank,histone H3-K4 trimethylation (GO:0080182),0.6454577796083902,1.3649789150354006,0.12110726643598616,0.5963090513184158,1.0,6/11,19.93%,OGT;SETD1A;WDR82;KMT2A;SETD1B;TET3
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5654759075467256,1.3643214375677992,0.12149532710280374,0.5971628504072463,1.0,12/21,24.51%,LRRK2;EIF2AK3;BCL2L11;CREB3;PRKN;SELENOS;TMBIM6;CREB3L1;OPA1;DDIT3;TXNDC12;PMAIP1
prerank,purine-containing compound salvage (GO:0043101),0.6203128253660711,1.3641482556861648,0.13884297520661157,0.5964308583344156,1.0,2/12,2.85%,AMPD3;ADK
prerank,actin-myosin filament sliding (GO:0033275),0.5024540927745205,1.364139114515159,0.08974358974358974,0.593920909927196,1.0,7/38,10.44%,ACTN2;TPM1;TNNT1;DES;TNNC1;MYL4;TNNT3
prerank,muscle filament sliding (GO:0030049),0.5024540927745205,1.364139114515159,0.08974358974358974,0.593920909927196,1.0,7/38,10.44%,ACTN2;TPM1;TNNT1;DES;TNNC1;MYL4;TNNT3
prerank,negative regulation of gene expression (GO:0010629),0.39793668239846797,1.3641105565207998,0.021897810218978103,0.5927525324452102,1.0,64/302,14.28%,IGF1;ROBO1;SAMD4A;CILP;SLC24A3;ROCK2;RBMS3;DAPK1;RUNX1;LGR4;OLFM1;BMPR1A;YAP1;WNT4;APOE;DNMT3A;SMO;NOTCH2;SLC2A10;IGF2BP2;TWSG1;ITGB8;SFRP1;IGFBP5;PRKAA2;TNRC6B;ENG;ATOH8;EMILIN1;CPEB3;EIF2AK3;CD28;MAP2K1;DXO;RNF139;NCOR1;TNRC6A;BMP2;KAT2B;PICALM;SNX12;MYADM;PARP14;PRKN;FGF2;PHF1;NCOR2;RBBP7;PPHLN1;RBL2;TTBK1;DDX3X;TCEAL1;RGCC;REST;TERF2;LARP1;LRP3;CCDC3;MYCN;SYT11;SETDB1;ENC1;ZNF148
prerank,gene expression (GO:0010467),-0.2844651213645513,-1.363064162078698,0.0,0.6201297619531703,1.0,125/348,21.60%,BICD1;NUP93;RPS12;RPL41;TAF1B;RPL3;RPS24;RPS14;RPL8;RPL27A;RPS19;RPL34;NUP35;WARS1;RPS13;RPL21;RPL7;RPL18;RPL27;NUP160;NUP153;EIF4E;RPL38;RPL35A;RPS15;SORL1;RPS3;RPL39;RPS7;GALNT2;RNGTT;RPS4X;APOBEC1;RPL11;ELAVL4;RPS23;RPL30;MRRF;PWP1;HNRNPK;RPL36;NUP54;BAZ2A;RPLP1;RPS29;RPL37;RBM8A;RPS9;ALYREF;HHEX;CHTOP;HNRNPD;RPS5;PTMA;RPL18A;RPL4;YARS2;RPL29;RPL26;ADAR;RPL6;RPL13A;RPL36A;RPL7A;SNRNP40;PAX8;MRPS18A;RPL19;MRPS5;THAP1;RPS20;RPL13;RPL32;DEDD2;EEF1A1;RPL5;MRPS12;DUSP11;YTHDC1;CLP1;SRSF7;RPL14;TSPAN17;RPSA;HNRNPA2B1;NOL9;ADARB2;FASTKD2;RPLP0;MRPL44;SEC13;MRPS33;NUP155;RPS6;DDX19B;RPS6KB2;MPHOSPH10;MRPL55;RANBP2;SMG7;MRPL42;MRPS18B;DHX38;POLR2E;RPL22;GLE1;TASP1;NUP88;RPS21;MCM3AP;RPL37A;MRPS21;THOC6;MRPS7;SRSF4;RPL17;RPL23;RPLP2;NUP62;MRPL34;DDX25;DTX1;EIF4EBP2;NUP85;RPL28
prerank,cellular response to nitrogen compound (GO:1901699),0.5701573455815276,1.3625159954530288,0.12580645161290321,0.5966928650910339,1.0,8/20,19.82%,ROCK2;RIOK3;DDI1;RTF2;TIMELESS;EPG5;ATRX;HSF1
prerank,cellular response to sterol (GO:0036315),0.6222506694679716,1.3622847638199842,0.13402061855670103,0.5962247889657799,1.0,3/13,3.77%,RORA;SMO;INSIG2
prerank,positive regulation of wound healing (GO:0090303),0.5169738384229744,1.3622548285560352,0.11013215859030837,0.5950717850777489,1.0,11/36,12.01%,PLPP3;SERPINE1;KANK1;MYLK;VTN;INSL3;SMOC2;FOXC2;HBEGF;ADRA2A;F2
prerank,regulation of signal transduction (GO:0009966),0.41204022170919724,1.3619785187657378,0.030434782608695653,0.5947457568548546,1.0,31/190,9.02%,IGFBP2;RORA;GDNF;SLC8A3;GRK3;IGFBP4;RUNX1;GRK5;DHRS3;ZIC1;OGT;ITGA3;FGFR2;SP100;DTNBP1;SULF1;SEMA5A;IRAK2;FBXL17;TSPYL2;NCAM1;ACVR1;IGFBP5;USP20;LRRK2;SRC;WWTR1;CD63;TULP3;TCF7L1;IFT81
prerank,positive regulation of epithelial cell migration (GO:0010634),0.4423871633736345,1.3617687113128423,0.06985294117647059,0.5941930929579624,1.0,22/92,11.78%,NRP1;RIN2;ROCK2;ANGPT1;SPARC;SASH1;INSL3;CTSH;SMOC2;ATOH8;SRC;DOCK5;RAB25;MAP4K4;AAMP;FOXC2;ANXA3;MAPRE2;ITGB3;FGF2;CAPN7;EGF
prerank,epithelial cell migration (GO:0010631),0.5071078016097675,1.3615339762645253,0.11016949152542373,0.5936959069506379,1.0,7/37,6.47%,NRP1;ZEB2;KANK1;KIT;FSTL1;CYP1B1;ADGRA2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4230434775719385,1.3611347400587492,0.05104408352668213,0.5937822229262106,1.0,34/128,15.96%,BMP6;COL1A2;TGFBR3;SMAD3;BMPR1A;RUNX2;TGFBR1;TWSG1;SMURF2;APOA1;APPL2;ACVR1;ITGB5;ENG;CDH5;SKI;SRC;LTBP2;ARHGEF18;ZMIZ1;RGMA;BMP2;SMAD1;BMP15;COL3A1;USP9X;ACVR1B;USP9Y;PDCD4;HIVEP1;BMP5;BMP4;PARD3;TGFBRAP1
prerank,RNA stabilization (GO:0043489),0.5219661477283227,1.3610978783056862,0.11494252873563218,0.5926887048125091,1.0,9/33,12.61%,GDNF;TENT5A;PHAX;AXIN2;VIP;TENT5D;NSUN2;PARN;LARP1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5009827578419047,-1.3609265431566933,0.1226158038147139,0.6237558779857322,1.0,8/18,24.29%,JAM2;SLC39A8;ITGA4;CX3CR1;ROCK1;VCAM1;SELP;ITGB7
prerank,positive regulation of cell motility (GO:2000147),0.40888063234192024,1.3608906925912412,0.030501089324618737,0.5920751985029711,1.0,45/205,12.04%,IGF1;COL1A1;CEMIP;ROCK2;PDGFD;SYNE2;SEMA3D;RHOD;NEDD9;CCN1;PPP3CA;PDGFRA;KIT;MYLK;PDGFRB;TGFBR1;SMO;SEMA5A;CCL19;CSF1;ACVR1;NTF3;CTSH;PDPN;CXCL16;CDH5;WNT5B;CARMIL1;MYO1C;NTRK3;MAP4K4;EGFR;EPHB2;DAB2;SPRY2;BMP2;ACTN4;NTN1;MYADM;FAM89B;TRIP6;HBEGF;EGF;ADRA2A;CCDC25
prerank,regulation of steroid biosynthetic process (GO:0050810),0.6362276649726539,1.3606594776913052,0.15080789946140036,0.5915485928451325,1.0,5/11,8.88%,FGFR4;WNT4;STAR;NR5A1;BMP2
prerank,cristae formation (GO:0042407),-0.44444112294513305,-1.3604835708510654,0.10397553516819572,0.6219850550116488,1.0,8/27,16.45%,LETM1;ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;ATP5PD
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6610806053778151,1.3600722445858824,0.15384615384615385,0.5921436956574114,1.0,3/10,4.39%,ABCA1;APOE;APOA1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3173556305410222,-1.3599983164271112,0.018691588785046728,0.6203547357079787,1.0,47/159,15.54%,ADGRL3;HMCN1;GRID2;PECAM1;CLDN5;CDH2;CADM1;NLGN1;CDH1;IL1RAPL1;TENM2;BSG;KIRREL3;TENM3;LRFN5;CLDN11;TENM4;PTPRD;NECTIN1;TGFB2;CNTN4;CDH12;NTNG1;ATP2C1;CDH6;PTPRT;CDH8;CDH9;CDH13;CNTN6;LRRC4C;ROBO4;TGFBR2;CDH10;FAT2;EMB;UNC5D;CXADR;PVR;IGSF11;PCDHB14;DSG2;CEACAM1;MAG;PLXNB3;LRRC4B;CDH3
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6232224458004536,1.3596739760300875,0.11775043936731107,0.5921504313754031,1.0,2/13,2.35%,RUNX1;GLI3
prerank,organophosphate ester transport (GO:0015748),-0.44424623358820164,-1.3589427457122558,0.08498583569405099,0.6205461202883283,1.0,10/24,16.97%,PITPNC1;PLTP;PITPNA;TNFAIP8L3;NPC2;OSBPL2;SCARB1;PCTP;PITPNB;PRELID2
prerank,skin development (GO:0043588),0.4607685799441839,1.358901924749587,0.07692307692307693,0.5933977768064476,1.0,7/65,4.09%,COL1A2;COL1A1;ERRFI1;TXNIP;COL5A1;ITGA3;SLC2A10
prerank,sodium ion transport (GO:0006814),0.44428685015852676,1.3582558090123868,0.06109725685785536,0.5942300738353923,1.0,9/85,4.61%,SLC24A3;SCN7A;NALCN;SLC8A1;SLC8A3;ATP1A2;SLC6A9;SLC6A13;SLC24A1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.41530068747353227,1.358056010353584,0.05829596412556054,0.5937128002208489,1.0,36/150,13.95%,PDPK1;ENPP1;ERRFI1;PID1;PPM1E;LDLRAD4;PTPN13;PLPP3;LYN;PMEPA1;DTNBP1;PRKAG2;FBLN1;CDK5RAP3;SFRP1;NTF3;ENG;LRRK2;EMILIN1;WWTR1;SIRT2;NTRK3;DNAJC3;EPHB2;SPRY2;MYADM;PRKN;SPRED3;IGFBP3;IMPACT;DUSP19;MVP;CNKSR3;TSC2;PTEN;IBTK
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.41734736598814487,1.357766890237098,0.048406139315230225,0.5934704927356834,1.0,32/138,15.33%,POLR2D;RORA;CCN2;TBL1XR1;TEAD1;AR;THRB;YAP1;MAML3;RARB;NOTCH2;RARG;GTF2E1;GTF2H5;NR5A1;WWTR1;NR1D1;DR1;RBPJ;NCOR1;KAT2B;POLR2C;NCOR2;NR1D2;TEAD3;MNAT1;NR4A1;NRBF2;TAF9;GTF2E2;NR1H3;RXRA
prerank,liver development (GO:0001889),0.5132105589695242,1.3575653956308074,0.11607142857142858,0.5929049332662193,1.0,11/32,12.66%,TGFBR3;PRKCSH;ARID5B;WNT4;CDK5RAP3;CEBPA;DNAAF1;PHF2;NKX2-8;CEBPB;CCDC40
prerank,regulation of protein secretion (GO:0050708),0.422016886397358,1.357564544866096,0.05868544600938967,0.5916924487401125,1.0,13/119,7.90%,IGF1;BMP6;ITPR1;DNAJC1;RAPGEF4;APOE;MYO18A;MYH10;NEUROD1;ADRA2C;CACNA1C;IL12B;DRD3
prerank,vasodilation (GO:0042311),-0.5409988175974113,-1.3572897570456497,0.1240506329113924,0.6228728674459627,1.0,6/13,15.88%,NOS3;KLF2;KCNMA1;NOS1;ADRB2;GPER1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6497071599896942,1.3568047848548066,0.16893203883495145,0.592884055007126,1.0,8/10,25.82%,VTN;MT3;ARNT;ITGB3;GRB10;PRKCB;PRKD2;ITGA5
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.44143429256310524,1.3565233766412295,0.06140350877192982,0.5926020277046674,1.0,15/87,7.82%,EPHA3;RHOH;ROCK2;LRP1;DLC1;RHOD;ARHGAP18;PDGFRA;PDGFRB;RHOBTB1;NOTCH2;IQGAP2;RHOBTB3;RHOBTB2;ARHGAP35
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.5924824303154127,-1.356141606732751,0.107981220657277,0.6236346646820738,1.0,6/10,25.79%,ATP5F1A;ATP5MG;ATP5F1C;ATP5PD;VPS9D1;ATP5MC2
prerank,reverse cholesterol transport (GO:0043691),0.6122080985430248,1.3557146855462396,0.15025041736227046,0.5939663001207588,1.0,3/13,4.39%,ABCA1;APOE;APOA1
prerank,connective tissue development (GO:0061448),0.5122958726426695,1.355422706533289,0.12732474964234622,0.5936955662049501,1.0,11/35,11.00%,SOX5;SULF2;ARID5B;SULF1;SH3PXD2B;ITGB8;CREB3L2;COL11A2;TRIP11;PGRMC2;SLC39A13
prerank,amino sugar biosynthetic process (GO:0046349),0.6165544769248403,1.3553341649973623,0.16291161178509533,0.5927894211783279,1.0,4/12,10.77%,PGM3;GFPT1;UAP1;RENBP
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.38836484009396244,1.3549521336090338,0.006054490413723511,0.5927864927059728,1.0,91/509,12.11%,IGF1;TCF7L2;PDPK1;WLS;IGF2;ADRA1B;GJA1;ROCK2;ANGPT1;PIK3R1;ADGRV1;KSR1;PDGFD;SASH1;AREG;DCN;TGFA;LYN;BCL2;FGFR1;PELI2;NOS1AP;EPHA8;KL;EPGN;FGFR2;FGFR4;PDGFRA;KIT;CFLAR;PDGFRB;TGFBR1;GAS6;NUPR1;SEMA5A;CCL19;NEDD4;CDK5RAP3;EDAR;RAPGEF2;ROR1;NTF3;AXL;FRS2;OSBPL8;ENG;ADRA2C;ADRB3;CCL4;SRC;IL12B;SPHK2;RNF31;DDX60;CD28;LPAR1;TRAF7;TLR6;NMI;NTRK3;EGFR;BCL2L11;SPRY2;BMP2;RUNDC3A;NEK6;SLC20A1;ACTN4;BCAP31;ITGAV;LTBR;PRKN;SLC38A9;FGF2;GPR89A;RYK;CXXC5;TMED4;P2RX5;CARD9;DDX3X;IKBKE;TRIP6;GSDME;TNIP2;HBEGF;LAMTOR2;EGF;ADRA2A;TBK1;RRAGD
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.5893260206396884,1.3547421025944881,0.14052287581699346,0.5922068945581438,1.0,4/16,3.04%,IGF1;TGFBR3;BMPR1A;FGFR2
prerank,Wnt signaling pathway (GO:0016055),0.4370493136658314,1.3545117254975396,0.06954436450839328,0.5918031014869708,1.0,21/92,13.81%,TCF7L2;WLS;PLPP3;FZD2;WNT8B;WNT4;WNT6;SFRP1;FZD1;RARG;TCF7;BCL9;LRRK2;WNT5B;TCF7L1;RYK;DDX3X;KLHL12;BTRC;SFRP4;PTEN
prerank,presynapse assembly (GO:0099054),-0.4961465890298672,-1.3543899321309423,0.11928934010152284,0.6264941180165406,1.0,7/16,18.92%,NLGN1;IL1RAPL1;PTPRD;LRRTM3;PCLO;NLGN3;DVL1
prerank,response to interleukin-1 (GO:0070555),0.4513156696207267,1.3541757449414948,0.08919597989949749,0.5916208998383531,1.0,9/73,7.97%,ADAMTS12;PTGIS;IRAK2;CCL19;SFRP1;CCL4;SRC;NR1D1;IRAK3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5410793466536987,1.3540990991488768,0.12942989214175654,0.5906405870273378,1.0,4/27,2.46%,ENPP1;PID1;AHSG;KANK1
prerank,sphingosine biosynthetic process (GO:0046512),-0.5672577640395686,-1.3536172574599337,0.12351543942992874,0.622621874501547,1.0,3/11,9.90%,ACER3;ACER2;SPTLC2
prerank,sphingoid biosynthetic process (GO:0046520),-0.5672577640395686,-1.3536172574599337,0.12351543942992874,0.622621874501547,1.0,3/11,9.90%,ACER3;ACER2;SPTLC2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.514114832339127,-1.353605194860605,0.11597938144329897,0.6195557524252794,1.0,7/16,16.45%,ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;ATP5PD
prerank,cardiocyte differentiation (GO:0035051),0.6432887296966565,1.353465450507815,0.15742397137745975,0.5914534295249724,1.0,6/10,14.11%,SIK1;BMP2;EEF1AKMT4-ECE2;CBY1;GATA6;AKAP13
prerank,macrophage activation involved in immune response (GO:0002281),-0.53289017466367,-1.3534548166249565,0.11694510739856802,0.6169935553290029,1.0,6/13,15.44%,PLCG2;DYSF;LBP;IFI35;CX3CR1;SBNO2
prerank,response to glucagon (GO:0033762),0.5695274041552515,1.3530268290299174,0.13875598086124402,0.5916313641351594,1.0,5/19,3.66%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.3899638014528005,-1.3529712112040042,0.06862745098039216,0.6156605322172306,1.0,15/41,14.37%,KCNJ2;ANK3;KCNJ3;KCNMA1;KCNN2;KCNQ1;AKAP6;NOS1;STAC;KCNMB2;ACE2;KCNJ15;GNB1;KCNJ10;GNG2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.5268466443903965,-1.352543667940481,0.12082262210796915,0.6139834353143941,1.0,9/13,30.97%,KDM1A;PTTG1IP;SIRT1;CD44;TWIST1;MIF;SNAI2;PSMD10;SNAI1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.45098173762994326,1.352328961877406,0.0922882427307206,0.5926774168527126,1.0,12/72,11.11%,POLR2D;FGFR1;KL;FGFR2;FGFR4;RBFOX2;FRS2;FLRT2;HNRNPA1;POLR2C;FGF2;FGFBP1
prerank,regulation of cardiac conduction (GO:1903779),0.46861145730603626,1.3516492384341947,0.09128065395095368,0.5935902536124283,1.0,7/54,4.20%,ITPR1;SLC8A1;SLC8A3;ATP1A2;DMPK;ASPH;STIM1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.45862020765995204,-1.3514399697310069,0.10285714285714286,0.6147686794176722,1.0,11/24,13.29%,PDE4D;PDE3B;PDE2A;PRKAR1A;PRKAR2B;PRKAR2A;PRKAR1B;CGAS;PEX5L;UBE2B;APLNR
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5569508598304389,-1.351406149242846,0.12663755458515283,0.6118311072175266,1.0,6/11,25.53%,NOTCH1;ATP2B4;GSK3A;FOXO1;RGS2;MLIP
prerank,positive regulation of integrin activation (GO:0033625),-0.5678563696002354,-1.3513476773385793,0.11764705882352941,0.6090603131145075,1.0,5/11,10.97%,PIEZO1;RASIP1;RAP1B;SKAP1;PLEK
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5351581215501732,-1.3513006559900267,0.12698412698412698,0.6062171231699899,1.0,4/12,26.26%,JAM2;APP;AIF1;DOCK8
prerank,regulation of macromolecule metabolic process (GO:0060255),0.41366072398948966,1.3512970078433373,0.030577576443941108,0.5936079260905701,1.0,15/170,5.80%,IGF1;NELL1;ROCK2;SLC8A1;GDNF;C1D;AFF1;PRDM5;ASCL1;ZNF462;APOE;IGF2BP2;LDLR;GNB3;ZFP36L1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.45852428623633,1.3509754072849218,0.09771573604060914,0.5934327101984306,1.0,16/66,12.77%,ROBO1;PDGFD;SASH1;FGFR1;IL34;EPGN;KIT;PDGFRB;LRRK2;TLR6;EGFR;FGF2;TAOK3;EGF;ADRA2A;DUSP19
prerank,fatty acid elongation (GO:0030497),-0.5459864791224797,-1.3508846953377271,0.14108910891089108,0.6045276289751543,1.0,4/13,14.68%,ELOVL7;ELOVL5;TECR;HACD2
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.4884665400795056,1.3498430776309625,0.10990502035278155,0.5958420587413065,1.0,11/46,10.67%,NRP1;ATRNL1;ANTXR1;PIK3R1;PARVA;LAMC1;USH2A;ATRN;ITGB3;ITGAV;EPHB3
prerank,negative regulation of inflammatory response (GO:0050728),0.4110309274420104,1.3494883500750248,0.03761061946902655,0.5957891653648858,1.0,21/182,7.73%,IGF1;PTGIS;RORA;ADCY1;ADCY2;ADCY7;LYN;ADCY5;APOE;ADCY9;INSL3;APOA1;MVK;VIP;CDH5;LHCGR;ADRB3;SRC;CD247;DPEP1;NR1D1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.6038961934129418,1.3491571295693967,0.15944540727902945,0.5955807404827543,1.0,3/14,1.80%,GHR;PIK3R1;LYN
prerank,positive regulation of binding (GO:0051099),0.43858241531073766,1.3490678036837493,0.08641975308641975,0.5947294793096897,1.0,14/84,9.87%,IGF1;TCF7L2;LRP1;DACT1;APOE;VTN;RAPGEF2;SKI;LRRK2;DERL1;SIRT2;STK4;BMP2;PRKN
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.5171683949362929,-1.3489602112408776,0.13043478260869565,0.6080028926752528,1.0,8/14,11.42%,PRKAR1A;ATP2B4;PRKAR2B;PKIB;PRKAR2A;PRKAR1B;ADRB2;SIRT1
prerank,regulation of actin filament-based movement (GO:1903115),-0.5699726718730164,-1.347922462693981,0.1464968152866242,0.608378930542252,1.0,2/10,1.14%,PDE4D;PDE4B
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.4658559134052383,-1.3469609990143219,0.11711711711711711,0.6085563198582445,1.0,12/23,28.25%,MBOAT1;PLAAT3;PNPLA8;PLA2G4C;LPCAT3;PLA2G4F;PLA2G4E;ABHD4;PLA2G4B;LPCAT4;MBOAT2;PLA2G5
prerank,negative regulation of receptor internalization (GO:0002091),-0.5438820452205427,-1.3469384664857764,0.1262135922330097,0.6057323835893983,1.0,4/12,6.44%,ANKRD13A;SDCBP;MTMR2;RIN3
prerank,filopodium assembly (GO:0046847),-0.49725872889929645,-1.3466522919261679,0.09950248756218906,0.6038046202776919,1.0,3/16,3.29%,DNM3;FGD5;SPATA13
prerank,response to sterol (GO:0036314),0.6426511861085272,1.3463477213875286,0.1349911190053286,0.6024395064279815,1.0,2/11,3.55%,RORA;TGFBR1
prerank,response to purine-containing compound (GO:0014074),-0.5006724036054399,-1.3459874945817032,0.12142857142857143,0.6031174581552298,1.0,6/17,15.16%,TRPC3;ABCC9;P2RX7;DGKQ;RYR2;P2RY6
prerank,positive regulation of developmental process (GO:0051094),0.4126163568329146,1.3452855085316433,0.05511811023622047,0.6047520759502357,1.0,40/164,13.92%,PHLDB2;GJA1;CCN2;GDNF;AR;DCN;SOX5;DAG1;FGFR1;BMPR1A;APOE;ADGRL1;SMURF2;ACVR1;NEUROD4;MCU;NEUROD1;SRC;CPEB3;PPP1R13L;SYDE1;KMT5B;BMP2;CAMK2B;TRPM4;KRT10;PRKN;CEBPB;TMEM119;RBM19;REST;ACVR1B;NIBAN2;MAP3K13;INSR;MUL1;MDK;DLG4;HMCES;NCOA3
prerank,regulation of neuroblast proliferation (GO:1902692),-0.5165601724024058,-1.3443554354483882,0.11479591836734694,0.6058088082699491,1.0,7/15,12.39%,TAFA1;KDM1A;DISC1;VEGFA;PTN;CX3CR1;NF1
prerank,ion homeostasis (GO:0050801),-0.431677836731299,-1.3442304284711102,0.09627329192546584,0.6033815894236665,1.0,8/30,9.76%,SLC4A10;FHL1;NEDD4L;CAMK2D;KLHL3;UNC80;SLC4A8;WNK2
prerank,cardiac muscle cell development (GO:0055013),0.5653194759088017,1.3433105289465221,0.1413373860182371,0.6101757885766961,1.0,5/20,3.47%,PDLIM5;SLC8A1;OBSL1;PDGFRA;PDGFRB
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5500255776829351,1.343146830883223,0.13804173354735153,0.6095320700528675,1.0,10/21,23.49%,MT3;SIRT2;SLC30A10;PRKN;SLC18A2;ABCD2;SIRT5;AATF;HDAC6;BRCA1
prerank,regulation of sodium ion transport (GO:0002028),-0.43016987235830373,-1.3431392929971722,0.09060402684563758,0.6038571676043089,1.0,11/34,9.76%,NKAIN2;ATP1A1;ANK3;YWHAH;NKAIN1;P2RX7;NKAIN3;FGF12;NOS1;ATP2B4;WNK2
prerank,dendritic cell differentiation (GO:0097028),0.5548084942573054,1.3428905916097307,0.12417218543046357,0.6092283001587543,1.0,5/22,6.30%,LYN;GAS6;CCL19;AXL;BATF
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.531605319062137,1.3427790959125807,0.13500784929356358,0.6083860602917829,1.0,5/25,8.41%,NRP1;AR;SRC;DSCAM;EGFR
prerank,regulation of embryonic development (GO:0045995),0.5090501009040068,1.3425781784300659,0.1301859799713877,0.6077986954683158,1.0,8/34,12.98%,PHLDB2;DAG1;WDPCP;CRB2;TRIP12;RBM19;NIBAN2;INSR
prerank,positive regulation of gene expression (GO:0010628),0.388205968689559,1.3424486256221801,0.010183299389002037,0.6070370313754839,1.0,84/442,12.32%,IGF1;ROBO1;BMP6;SAMD4A;SLC24A3;GJA1;ROCK2;ANGPT1;PID1;RBMS3;PIK3R1;GSN;SMAD3;AR;MITF;PLD1;PLA2R1;OLFM1;NOS1AP;EPHX2;NKX2-1;DTNBP1;YAP1;FGFR4;HNRNPLL;TGFBR1;GAS6;SMO;WNT6;TLE1;SLC2A10;PDCD5;CSF1;POLR1G;ITGB8;SLC22A2;MT3;CTSH;MUSK;TNRC6B;CDH5;CUX2;BATF;EMILIN1;NR5A1;NFE2L2;SPHK2;CPEB3;EIF2AK3;CD28;MAP2K1;AFDN;TLR6;RBPJ;MYO1C;NTRK3;OSR1;EGFR;EPHB2;SPRY2;TNRC6A;RBM22;BMP2;METTL14;KAT2B;SMAD1;PRKN;FGF2;PHF2;BAZ1B;NFAM1;EIF6;TENT4A;BRAF;CARD9;TTBK1;DDX3X;RGCC;TMEM119;EGF;ADRA2A;C1QTNF1;TERF2;DNAJA4
prerank,alcohol catabolic process (GO:0046164),0.6374825793836529,1.3424205179893824,0.1589648798521257,0.6059473861621928,1.0,3/10,7.26%,APOE;MT3;CYP27A1
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.5077632098566844,-1.3414591612850058,0.13404825737265416,0.6061482294005285,1.0,8/17,21.47%,CAV1;KLF7;APOLD1;PRKX;CEACAM1;MAFG;DLL1;DSPP
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.36320743187720606,-1.340301507848345,0.05829596412556054,0.6070673774857921,1.0,20/59,13.88%,HMCN1;PECAM1;CDH2;CADM1;CDH1;BSG;KIRREL3;TENM3;NECTIN1;CNTN4;PTPRT;CDH13;CNTN6;ROBO4;FAT2;EMB;PVR;IGSF11;DSG2;CEACAM1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4336073783997504,1.3402883039149212,0.08204518430439953,0.6115516626791746,1.0,13/100,4.69%,IGF1;PIK3R1;PDGFD;DCN;PTPN13;LYN;FGFR1;PDGFRA;KIT;PDGFRB;NEDD4;ROR1;NTF3
prerank,MAPK cascade (GO:0000165),0.3887714824876189,1.3399814884754908,0.022774327122153208,0.6113313892132349,1.0,55/295,12.23%,IGF1;NRK;ANGPT1;ACTN2;PIK3R1;GDNF;KSR1;AREG;TGFA;IL31RA;FGFR1;GFRA2;KL;EPGN;FGFR2;FGFR4;PDGFRA;KIT;PDGFRB;ABHD17C;RASA3;APOA1;RAPGEF2;NCAM1;MT3;PSME4;FRS2;CTSH;MRAS;MAP3K20;ZFP36L1;LRRK2;RANBP9;MAP2K1;ARAF;MAP4K4;SPTAN1;EGFR;RGL1;MAP3K8;ARL2;CAMK2B;ITGAV;FGF13;FGF2;GFRA4;TAOK3;BRAF;TNIP2;HBEGF;LAMTOR2;EGF;KBTBD7;YWHAE;PTPN3
prerank,sodium ion transmembrane transport (GO:0035725),0.43895417204866843,1.3390141497686519,0.08438287153652393,0.6132262324458762,1.0,10/84,4.61%,SLC24A3;SCN7A;NALCN;SLC8A1;SLC8A3;ATP1A2;SLC6A9;SLC6A13;SLC9A9;SLC24A1
prerank,myotube differentiation (GO:0014902),0.5664930022282016,1.338908198070873,0.1495176848874598,0.6124128885790145,1.0,2/17,0.92%,IGF1;ADAMTS5
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4840150167313438,1.3388829613407092,0.10245901639344263,0.6113524727045017,1.0,14/48,15.76%,NRP1;OBSL1;NEDD9;APOA1;CUX2;CDC42;CARMIL1;DOCK5;CSPG5;MYADM;MDK;P4HB;FLNA;CUL7
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5883005158965608,1.337947370676488,0.15780998389694043,0.6132441701487756,1.0,6/15,14.52%,DACT1;ACVR1;SKI;LEMD3;ACVR1B;FSTL3
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4595955413639342,1.337663413561,0.10728476821192053,0.612984130510333,1.0,10/63,7.23%,NELL1;TIMP3;BCL2;LEPR;NUPR1;CDK5RAP3;MT3;CST3;TIMP2;SIRT2
prerank,gonad development (GO:0008406),0.49830345611081334,1.336430498013813,0.12198581560283688,0.615881766535369,1.0,8/41,6.67%,AR;NR2F2;SALL1;KIT;WNT4;NUP107;LHCGR;NR5A1
prerank,response to muramyl dipeptide (GO:0032495),-0.5484394483762561,-1.3361891866928806,0.1431980906921241,0.6170163091617538,1.0,7/12,17.28%,NOD1;ARHGEF2;VIM;PTPN22;NOD2;IRF5;ERBIN
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.6469377346280432,1.3337851838838877,0.17037037037037037,0.623456920130814,1.0,4/10,12.31%,GHR;LYN;STAT5B;STAT6
prerank,sodium-independent organic anion transport (GO:0043252),-0.5646530763237808,-1.333398943974884,0.13211845102505695,0.6233066286656092,1.0,3/10,2.73%,SLCO2A1;SLCO1C1;SLCO2B1
prerank,positive regulation of cellular senescence (GO:2000774),-0.5732120523970374,-1.3332339864483573,0.1378504672897196,0.6210160739666364,1.0,5/10,20.30%,B2M;SIRT1;CGAS;ABI3;HMGA2
prerank,calcium-mediated signaling (GO:0019722),0.44199385158171206,1.3326893086947276,0.08856088560885608,0.6257531988585613,1.0,19/93,9.52%,RCAN2;PDPK1;SLC8A1;DMPK;PPP3CA;XCR1;ADGRL1;MCTP2;MCU;ACKR2;CCR9;LRRK2;CACNA1C;AGTR1;EIF2AK3;RCAN1;EGFR;TRPM4;BCAP31
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.5398160169097863,1.332484579224546,0.13734567901234568,0.6252356386383336,1.0,4/21,6.99%,EPHA3;ROCK2;MACF1;VCL
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.6291921034783313,1.332260885089142,0.18006993006993008,0.6248061517131904,1.0,4/11,8.88%,TGFBR3;TGFBR1;ACVR1;BMP2
prerank,purine ribonucleotide metabolic process (GO:0009150),0.4448506523997798,1.331356133390277,0.0975609756097561,0.6264603774941939,1.0,8/68,6.25%,ENPP1;AMPD3;TPST1;ACOT11;ACOT6;ACOT2;RAB23;LRRK2
prerank,regulation of GTPase activity (GO:0043087),-0.30644408064520545,-1.3308311389552443,0.010526315789473684,0.6259445468762164,1.0,38/177,8.54%,PKP4;DOCK9;CHN2;FGD5;EFNA5;LRCH1;PLXNA4;RAP1A;ITGA6;ARHGAP44;F11R;CAV2;VAV3;SH3BP4;RABGAP1;SIPA1L1;RAP1GDS1;BCAR3;SNX13;NET1;RGS6;RASIP1;PRKG1;RDX;ARHGAP27;TBC1D15;TGM2;ERBB2;EPHA5;EZH2;CCL14;NGEF;CHN1;TBC1D30;ARAP1;RASGRF1;RGS7;LARS1
prerank,positive regulation of cellular component movement (GO:0051272),0.5280689221490207,1.3302454066858742,0.14423076923076922,0.6287756903162872,1.0,10/24,13.85%,LYN;TGFBR1;CCL19;PDPN;ACTN4;NTN1;STK11;CCDC25;TUBB2B;ETS1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.4939941988107901,1.32969942164238,0.12314540059347182,0.6294324044910465,1.0,13/39,16.80%,STEAP3;ABCA1;TVP23B;ARFGAP3;LTBP2;MIA2;MIA3;RCN3;MTTP;TVP23A;TANGO2;GOLPH3;COPG1
prerank,synaptic vesicle exocytosis (GO:0016079),-0.39530991451536196,-1.3285893503026507,0.08070175438596491,0.630369548504782,1.0,14/40,22.83%,UNC13B;RIMS1;STX3;RIMS2;CDK5;SYT1;PCLO;CPLX1;RAB3A;STX1A;RIMS3;OTOF;SNPH;SYT5
prerank,kidney development (GO:0001822),0.4476531114295119,1.3283215681285996,0.10079575596816977,0.6327192934430356,1.0,12/65,8.10%,GDNF;GLI2;SULF2;SALL1;WNT4;TGFBR1;SULF1;GREB1L;CTSH;AGTR1;IFT27;OSR1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.4058482601008779,-1.3277382577720864,0.06896551724137931,0.6302326213538442,1.0,6/39,5.65%,UTRN;FHL1;NEDD4L;YWHAH;FGF12;CHRM3
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5615896577079795,-1.3276788347394826,0.15271966527196654,0.627575073189993,1.0,3/10,7.60%,THBS1;CTTNBP2NL;INPP5K
prerank,response to insulin (GO:0032868),0.43690849024778,1.3275212404096748,0.10473815461346633,0.6341169566961519,1.0,20/80,18.44%,PDPK1;ENPP1;TBC1D4;PIK3R1;OGT;INSIG2;CPEB1;ZFP36L1;TRARG1;KAT2B;EIF6;SELENOS;RHOQ;INSR;SLC2A4;PIK3R2;AKT1;GCK;PRKCI;INSIG1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5630149011521279,-1.3273337525464821,0.14146341463414633,0.6259333231715214,1.0,4/10,15.54%,FN1;HSP90AB1;TSKU;CDH3
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5666512804545529,-1.3272992821886358,0.1543778801843318,0.6232968429819948,1.0,5/10,19.62%,SEC14L1;RNF125;TKFC;UFD1;C1QBP
prerank,protein prenylation (GO:0018342),-0.5698954075861672,-1.3271325567563466,0.14573991031390135,0.6210769652371033,1.0,5/10,14.24%,FNTA;FNTB;PTAR1;CHML;PGGT1B
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.45649452020963655,-1.3262863111143814,0.14804469273743018,0.6212094212507998,1.0,9/20,26.16%,CHRM3;AGRN;GNB1;CHRM2;GNA11;CDK5R1;RGS10;CHRM1;LY6G6D
prerank,regulation of trophoblast cell migration (GO:1901163),0.6021459081209349,1.3258141696021806,0.17045454545454544,0.6386810003392561,1.0,4/14,12.48%,GJA1;SMURF2;SYDE1;ACVR1B
prerank,regulation of immunoglobulin production (GO:0002637),0.5442138776415222,1.3256359992122684,0.14837712519319937,0.6380243020443596,1.0,1/23,0.17%,RBP4
prerank,protein autoubiquitination (GO:0051865),0.4508554893527792,1.3255213695031804,0.10403120936280884,0.6371796271499242,1.0,18/61,19.41%,RNF220;SH3RF3;SH3RF1;RNF213;BFAR;RNF10;RNF185;PRKN;ITCH;RNF181;ERCC8;RAD18;RNFT1;AMFR;RNF13;UBE3A;TRIM21;RNF11
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.42086444604570367,1.3255154325119074,0.07647740440324449,0.636023821293054,1.0,28/118,10.67%,PHLDB2;PDLIM5;SH3D19;HECW2;PID1;SPARC;GDNF;DAG1;KIF13B;EPHA4;FGFR2;SP100;VASH2;NEDD4;SFRP1;PHIP;BCL6;LRRK2;ADGRA2;CRB2;BRSK1;ARHGAP35;WTIP;CAPZB;STAT2;FGF2;PDZD8;EPHB3
prerank,sensory perception (GO:0007600),0.4759949795901509,1.3253512723263872,0.11961057023643949,0.6353850837371148,1.0,6/45,7.45%,ADGRV1;TRPA1;PTGES;GNAS;ALOXE3;USH2A
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.4947534546945131,-1.3249861303612038,0.125,0.6227139802419347,1.0,10/16,33.56%,ACKR3;RPS3;TPT1;BCL2L1;CLU;SNAI2;CCAR2;NACC2;SNAI1;DDIAS
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4918587247836258,1.324572850385526,0.14080459770114942,0.6368560621126848,1.0,10/36,11.85%,VAMP5;MACF1;OPTN;GORASP2;GOLGA4;TRARG1;AFDN;GGA2;GOLPH3L;GORASP1
prerank,regulation of fat cell differentiation (GO:0045598),0.44624381032463245,1.3245265913667772,0.10186335403726708,0.6358363780806687,1.0,19/74,12.72%,RORA;ENPP1;RUNX1T1;SMAD3;MEDAG;YAP1;SFRP1;GNB3;ZFP36L1;WWTR1;SIRT2;NR1D1;BMP2;CREBL2;TRPM4;ANKRD26;CEBPB;TMEM64;LRP3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.493966396031631,1.3243720536143535,0.12205882352941176,0.6351697592549684,1.0,10/37,15.53%,DYNLL1;WDR35;IFT43;IFT27;TRIP11;IFT81;DYNC2I1;DYNLRB2;IFT22;IFT74
prerank,calcium ion import across plasma membrane (GO:0098703),0.5937171772217835,1.3237661015439917,0.1733800350262697,0.6359114478256653,1.0,3/14,4.61%,SLC8A1;SLC8A3;SLC24A1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.5081571631746717,-1.323500189791831,0.13691931540342298,0.6243869173196204,1.0,6/15,16.46%,LEF1;CHD1;SNW1;JUN;EP300;TFAP4
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6386260861829498,1.3232086665667424,0.18297101449275363,0.6364978035727287,1.0,4/10,6.32%,DCN;BCL2;LRRK2;SRC
prerank,positive regulation of cell projection organization (GO:0031346),0.41801062274321876,1.3230984111190887,0.08028335301062574,0.6356868776670098,1.0,29/115,14.64%,EPHA3;ROBO1;PLXNA2;CAMK1D;LYN;OBSL1;APOE;TIAM2;DPYSL3;RAPGEF2;ROR1;FZD1;PTK7;CUX2;ATP1B2;CARMIL1;ARHGAP35;NTRK3;CAMK2B;RAPGEF1;PLXNC1;MAP3K13;NDRG4;MDK;DLG4;MARK2;PLXNA1;PLXNB2;CHODL
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.4216954524853091,-1.322565762096615,0.10679611650485436,0.6244949208092966,1.0,14/29,28.25%,LPCAT1;PLAAT3;PNPLA8;PLA2G4C;MBOAT7;LPCAT3;LPCAT2;PLA2G4F;PLA2G4E;DBI;PLA2G4B;LPCAT4;MBOAT2;PLA2G5
prerank,alpha-amino acid metabolic process (GO:1901605),0.4785341208953886,1.3218001767307646,0.12219101123595505,0.6387877924130493,1.0,9/45,8.07%,ASPG;GLUL;PYCR1;MTHFR;ASPA;DPEP1;PYCR3;ALDH18A1;MMUT
prerank,calcium ion import into cytosol (GO:1902656),0.5804994582308105,1.3213586214725361,0.1717687074829932,0.6390380762612407,1.0,3/15,4.61%,SLC8A1;SLC8A3;SLC24A1
prerank,regulation of lipid kinase activity (GO:0043550),0.6161860641150534,1.320772752215997,0.1741472172351885,0.6397511834111189,1.0,6/11,15.97%,PIK3R1;WDR91;WDR81;RBL2;F2;PIK3R2
prerank,dicarboxylic acid transport (GO:0006835),0.517345945449593,1.3206726584620831,0.14871016691957512,0.6389015119023803,1.0,4/28,5.32%,SLC1A3;GJA1;SLC13A3;PDPN
prerank,lung epithelium development (GO:0060428),0.6422880584168672,1.3199202972967001,0.16847826086956522,0.6401479640817138,1.0,4/10,15.79%,ERRFI1;ASCL1;RCN3;BMP4
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.518238062846892,-1.3197350116134863,0.1345646437994723,0.6310782811826896,1.0,5/13,20.54%,PRR5L;GTPBP1;PNPT1;CNOT7;CNOT8
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.453823773710904,-1.319135649412312,0.11904761904761904,0.630335997788411,1.0,6/22,15.88%,PDE3B;APOD;ALK;PPP2R5A;CEACAM1;GPER1
prerank,blood vessel endothelial cell migration (GO:0043534),0.5353436650773651,1.3189538703472192,0.1527777777777778,0.6421340913139991,1.0,6/22,9.95%,NRP1;ROBO1;EFNB2;CDH5;MIA3;FGF2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4449001496830238,1.3185411919432115,0.1111111111111111,0.6423228696219431,1.0,10/65,7.23%,PTGIS;RORA;SLC8A3;SFRP1;MT3;CPEB1;ZFP36L1;EPAS1;NDRG1;SIRT2
prerank,negative chemotaxis (GO:0050919),0.4941481687473077,1.318376473675082,0.14556040756914118,0.6416907342004361,1.0,10/33,10.48%,ROBO1;EPHA7;SEMA3D;APOA1;LRTM1;NTN1;ITGB3;ITGAV;SLIT3;SLIT1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.5394168176268896,1.318174557815247,0.1728,0.641238151676046,1.0,5/20,10.22%,ST6GALNAC5;B3GALT1;ST3GAL3;B4GALT1;ST6GALNAC6
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5312005004066083,1.3177937756006832,0.1712962962962963,0.6413034711049831,1.0,6/24,9.86%,PID1;LEPR;MT3;ADRB3;GFPT1;COQ10B
prerank,ceramide metabolic process (GO:0006672),-0.37469546769616013,-1.317677527312877,0.061224489795918366,0.6323501103404919,1.0,6/49,2.80%,ST6GALNAC3;SGMS1;ACER3;SGMS2;ACER2;DEGS2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5385251634653915,-1.3167158841963762,0.1597051597051597,0.6325049943504707,1.0,4/12,6.94%,UNC13B;RIMS1;RIMS2;SYT1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6357909595125169,1.3162716427137287,0.19413919413919414,0.6437655820518043,1.0,1/10,2.71%,TULP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6357909595125169,1.3162716427137287,0.19413919413919414,0.6437655820518043,1.0,1/10,2.71%,TULP1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5693305859567448,1.3162587677444455,0.15737704918032788,0.6426593066376333,1.0,5/17,6.90%,GJA1;SLC8A1;ATP1A2;CACNA1C;ATP1B2
prerank,neutrophil migration (GO:1990266),-0.3673171281223217,-1.3161503296208623,0.0888030888030888,0.6317661013672727,1.0,10/58,11.56%,PECAM1;PDE4B;BSG;TGFB2;PPIA;CCL14;FCER1G;CKLF;EDN1;CXADR
prerank,positive regulation of cell population proliferation (GO:0008284),0.38032720014215093,1.3157331462589157,0.01616161616161616,0.6430947410695897,1.0,53/423,8.41%,IGF1;TCF7L2;BMP6;IGF2;ESM1;DDR2;GJA1;PID1;TGFBR3;GDNF;PDGFD;AREG;AR;TGFA;IL31RA;LYN;BCL2;GRK5;FGFR1;IL34;IL6R;OSMR;BMPR1A;LAMC1;CCN1;EPGN;FGFR2;YAP1;FGFR4;PDGFRA;PDGFRB;TGFBR1;EFNB2;GAS6;CSF1;SFRP1;NTF3;HTR1A;PHIP;CTSH;LIG4;TBX3;VIP;TSLP;WWTR1;IL13RA1;RAB25;RBPJ;NTRK3;OSR1;TET1;CCN4;EGFR
prerank,peptide catabolic process (GO:0043171),0.5289351295208117,1.3153541613080009,0.1512481644640235,0.643045879049629,1.0,5/23,8.13%,CPQ;CHAC2;CTSH;DPEP1;NAALADL1
prerank,vascular transport (GO:0010232),0.4289657049913331,1.3150986052411113,0.09864364981504316,0.6426903726710115,1.0,17/81,7.48%,SLC1A3;SLC7A2;SLC24A3;SLC1A5;LRP1;SLC16A12;ATP1A2;SLC13A3;LEPR;SLC6A9;SLC6A13;SLC44A1;SLC2A10;SLC22A2;SLCO3A1;ATP1B2;SLC2A13
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5512593169701145,1.3147104024425393,0.15934959349593497,0.642797340711907,1.0,4/20,3.62%,OGT;MLKL;CFLAR;NUPR1
prerank,positive regulation of protein polymerization (GO:0032273),-0.35742497087557284,-1.3141630414467314,0.06607929515418502,0.6354318882436834,1.0,19/65,22.07%,OCLN;BAIAP2L1;PTK2B;NAV3;MET;RPS3;PAK1;FES;DCTN1;TPPP3;CDK5RAP2;CDK5R1;CTTN;PRKCE;LMOD1;CLASP1;NCK2;TENM1;HCK
prerank,monocarboxylic acid metabolic process (GO:0032787),0.413771309368412,1.3138642076927785,0.08,0.6444092012468926,1.0,21/117,13.62%,IGF1;PCCA;CYP26B1;ABAT;ACOT11;ACOT6;PDHA1;CPT1C;ACOT2;PCCB;ALDH1A2;HOGA1;KYNU;ADH1A;CKB;AASDH;ACSF2;SLC16A3;FASN;VDAC1;ACSF3
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5474157970378905,1.31381876054459,0.16203703703703703,0.6434212485487609,1.0,8/22,16.18%,AREG;FGFR2;NOTCH2;CASK;ZFP36L1;KLF9;MDK;EPPK1
prerank,positive regulation of nervous system process (GO:0031646),-0.47076080457665004,-1.3135800297841913,0.17369727047146402,0.6345808739329533,1.0,5/18,11.65%,UNC13B;RIMS1;TENM4;RIMS2;ATPSCKMT
prerank,negative regulation of cellular component organization (GO:0051129),0.4411115018064404,1.3134554638458749,0.10451612903225807,0.6434743886292051,1.0,17/74,15.00%,EPHA3;BMP6;AR;APOA1;CDC42;SRC;SNX33;CARMIL1;IRAK3;SPRY2;DDX3X;TERF2;DNAJA4;IMPACT;SYT11;RIOK3;RTEL1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5446578634382669,1.3132133660498493,0.15031645569620253,0.6430711723418042,1.0,6/20,12.09%,HECW2;ACTN2;NEDD4;OSR1;ADRA2A;YWHAE
prerank,striated muscle contraction (GO:0006941),0.4566763500074877,1.3128377078191045,0.1499330655957162,0.6431033126613183,1.0,11/53,10.44%,SLC8A1;ATP1A2;TPM1;TNNT1;TNNC1;MYL4;DTNA;GAA;ARHGEF11;CSRP3;TNNT3
prerank,visual perception (GO:0007601),0.43038802366231305,1.3127203190828138,0.09963547995139732,0.6422779046577414,1.0,8/84,4.61%,COL1A1;ADGRV1;COL11A1;EML2;DHRS3;TULP1;ZIC2;SLC24A1
prerank,secretory granule organization (GO:0033363),0.6208823545848696,1.312574268605558,0.17833333333333334,0.6416351205544257,1.0,3/10,9.82%,ABCA1;DTNBP1;BLOC1S1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4192656687321849,1.311934961974379,0.09049255441008018,0.6425453554558714,1.0,20/108,13.34%,ROBO1;COL4A3;UACA;DAPK1;GSN;SMAD3;DLC1;CASP12;CFLAR;PDCD5;SLC22A2;EIF2AK3;AIFM1;BCAP31;CARD9;DDX3X;REST;TNFSF15;CASP8AP2;MUL1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5074396965249683,1.3115466739893586,0.15080527086383602,0.6426863591703178,1.0,8/29,9.18%,ZBTB20;APOE;APOA1;SLC45A3;LDLR;SREBF1;LPGAT1;CREBL2
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.5373916810899443,1.3111364543320811,0.1696969696969697,0.6428959071926145,1.0,4/22,8.88%,SASH1;GADD45B;RELL1;BMP2
prerank,axonogenesis (GO:0007409),0.3895692633162955,1.3109697036323393,0.04029692470837752,0.6423307432021368,1.0,40/237,10.67%,EPHA3;NRP1;ROBO1;EPHA7;LAMA1;AUTS2;PIK3R1;GDNF;LAMA2;DAG1;SEMA3D;GLI2;EPHA4;GFRA2;EPHA8;FGFR2;PALLD;EFNB2;SEMA5A;NOTCH2;NCAM1;LRTM1;FRS2;SRC;RANBP9;ULK2;EFNA2;BRSK1;ARHGAP35;SPTAN1;PARD6B;DSCAM;EPHB2;EFNB1;RYK;GFRA4;SLIT3;SLIT1;NEXN;EPHB3
prerank,neuromuscular process controlling balance (GO:0050885),-0.5222377079509358,-1.3104493768151888,0.1509433962264151,0.6420622666381848,1.0,4/12,9.69%,PCDH15;NRXN1;PAFAH1B1;SHANK1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4406987342074797,1.3099384501566547,0.12804097311139565,0.6445899589715012,1.0,10/69,7.23%,IGF1;PIK3R1;FGFR1;OGT;PDGFRA;PDGFRB;PLCD1;ZFP36L1;PLCB4;SIRT2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5128295539967879,1.309917926915412,0.14285714285714285,0.6435289904067932,1.0,6/29,8.51%,TCF7L2;TLE1;AXIN2;TCF7;BCL9;TCF7L1
prerank,transport across blood-brain barrier (GO:0150104),0.4260759401562127,1.3088091839761051,0.1033210332103321,0.6460050669543067,1.0,17/83,7.48%,SLC1A3;SLC7A2;SLC24A3;SLC1A5;LRP1;SLC16A12;ATP1A2;SLC13A3;LEPR;SLC6A9;SLC6A13;SLC44A1;SLC2A10;SLC22A2;SLCO3A1;ATP1B2;SLC2A13
prerank,membrane repolarization (GO:0086009),-0.5012204499955213,-1.3087507823870692,0.1358974358974359,0.6449760827406137,1.0,5/15,6.40%,KCNJ2;ATP1A1;KCND3;KCNQ1;ATP1B1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4006838923011179,1.3086367647498363,0.06533776301218161,0.6454243961403526,1.0,27/151,10.78%,NRP1;CCN2;ANGPT1;PDGFD;FGFR2;FGFR4;PDGFRA;APOE;PDGFRB;GAS6;CCL19;NOTCH2;RAPGEF2;ROR1;MT3;CCL4;MAP2K1;NTRK3;MTURN;SLC30A10;EGFR;ARRB1;SPRY2;BMP2;FGF2;BRAF;CARD9
prerank,canonical Wnt signaling pathway (GO:0060070),0.44580198723111825,1.3086249821027747,0.11439588688946016,0.6443377026761019,1.0,13/68,6.72%,TCF7L2;PLPP3;FZD2;WNT8B;WNT4;WNT6;SFRP1;FZD1;RARG;TCF7;BCL9;LRRK2;WNT5B
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5451149779085632,1.308621588048265,0.1620745542949757,0.6432355196113261,1.0,8/20,9.64%,RUNX2;CHD6;MT3;NFE2L2;RBPJ;BMP2;SMAD1;CREB3
prerank,ceramide transport (GO:0035627),-0.5233873710453868,-1.3079634111537601,0.1662531017369727,0.644812938964183,1.0,3/12,6.85%,CERT1;PLTP;PLEKHA3
prerank,female gonad development (GO:0008585),0.5556480431033912,1.3078573139745402,0.1721311475409836,0.644675511876949,1.0,7/19,11.39%,NR2F2;KIT;NUP107;LHCGR;NR5A1;EIF2B4;CEBPB
prerank,regulation of heart contraction (GO:0008016),0.42297297570306547,1.3068657307878513,0.09339975093399751,0.6466543068609306,1.0,11/90,6.90%,CELF2;ITPR1;SLC8A1;SLC8A3;ATP1A2;TPM1;DMPK;ASPH;STIM1;DES;ATP1B2
prerank,sulfur amino acid metabolic process (GO:0000096),0.5199482774705727,1.3067865116292323,0.15606060606060607,0.645786955387666,1.0,8/24,17.18%,MTR;MTHFR;DPEP1;MMUT;CDO1;NOX4;SMS;ADO
prerank,regulation of MAP kinase activity (GO:0043405),0.42792862807518506,1.3063178865112524,0.1059850374064838,0.646213034280329,1.0,20/92,13.68%,ROBO1;KSR1;PDGFD;LYN;FGFR1;IL34;EPGN;KIT;APOE;PDGFRB;CDK5RAP3;LRRK2;IRAK3;EGFR;SPRY2;FGF2;EGF;ADRA2A;DUSP19;CDK12
prerank,protein localization to plasma membrane (GO:0072659),-0.30399754995640804,-1.3059705634538177,0.030303030303030304,0.6483891815953307,1.0,27/129,8.15%,DPP10;KCNB2;KCNIP4;RAP1A;SMURF1;F11R;CDH1;ANK3;BSG;EFR3B;ZDHHC2;CCDC88A;RAMP2;SPTBN1;RDX;LRP6;EMP2;RAB3C;ATP1B1;TTC7A;EHD4;INPP5K;RAB12;GAK;RAB11A;RAB8B;MAP7
prerank,positive regulation of histone methylation (GO:0031062),0.5265757159173198,1.3054603339912585,0.1841704718417047,0.6478357501163553,1.0,8/24,17.50%,AUTS2;OGT;TET1;PHF1;KMT2A;PAF1;WDR5;DNMT3B
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4908930190604597,1.305402892078023,0.1509433962264151,0.646898125264718,1.0,4/33,7.23%,IGF1;PIK3R1;ZFP36L1;SIRT2
prerank,negative regulation of macrophage activation (GO:0043031),0.5597169550376397,1.3053365960431498,0.18512396694214875,0.6460276290936391,1.0,7/16,16.92%,IL31RA;LDLR;NR1D1;CD200;SYT11;NR1H3;CX3CL1
prerank,acylglycerol catabolic process (GO:0046464),-0.40688766236150803,-1.305321217487643,0.11411411411411411,0.6479377305875558,1.0,12/30,26.75%,MGLL;ABHD2;LIPE;PNPLA3;PNPLA2;ABHD6;FABP7;LYPLA2;FABP3;LIPH;LIPC;FAAH
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5427967751810723,1.3027485596031336,0.17182662538699692,0.653290059040387,1.0,6/21,9.31%,ENPP1;ROCK2;AHSG;GAS6;BCOR;TRPM4
prerank,protein localization to cell-cell junction (GO:0150105),-0.4874527164663027,-1.3026747914505374,0.17553191489361702,0.6538466567484033,1.0,6/15,2.58%,MPP7;F11R;ACTB;TJP2;LSR;TJP1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4163533946298957,1.302411591906727,0.09857482185273159,0.6532623739712468,1.0,17/110,7.90%,ADRA1B;ADCY1;ADCY2;ABCA1;ADCY7;LGR4;ADCY5;GNAS;ADCY9;ADGRL1;RAPGEF2;VIP;ADRA2C;LHCGR;ADRB3;LPAR1;DRD3
prerank,protein kinase A signaling (GO:0010737),-0.5231220797365861,-1.3022563457684795,0.16585365853658537,0.6525684372039168,1.0,3/12,7.48%,RDX;PRKACB;MYOM1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6216971766333094,1.3019440224953547,0.18840579710144928,0.6536215939866988,1.0,3/10,7.18%,ACTN2;SEMA5A;CARMIL1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.524707874542362,1.3016521108050303,0.16030534351145037,0.6533583150889409,1.0,4/24,5.80%,ERRFI1;ROCK2;RUNX1;ZFP36L1
prerank,negative regulation of vascular permeability (GO:0043116),-0.5359256781784225,-1.3014281701346917,0.1473429951690821,0.6526697171780809,1.0,8/12,9.63%,SLIT2;PTPRJ;CLDN5;RAMP2;SH3GL2;PDE2A;DDAH1;VEGFA
prerank,regulation of neurotransmitter transport (GO:0051588),-0.48215270412198247,-1.300266845663379,0.16876574307304787,0.6536543327559765,1.0,3/16,1.86%,MEF2C;MCTP1;RIMS1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.5132771548429541,-1.3002100741011127,0.1952941176470588,0.6511830067022283,1.0,4/13,10.91%,NOS3;GCH1;CALM1;SPR
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.4975553680518596,-1.3000120933456052,0.1741424802110818,0.6491564146104222,1.0,8/15,19.06%,GRM7;GRM3;GRM5;GRM8;HOMER1;GRM1;HOMER3;DAGLB
prerank,transition metal ion homeostasis (GO:0055076),0.5159267813537506,1.299602309786167,0.15074626865671642,0.6587774044481285,1.0,8/28,9.87%,CP;MT3;HEPH;NEO1;CYBRD1;COMMD1;PICALM;PRKN
prerank,protein ADP-ribosylation (GO:0006471),0.5046974540835124,1.2994919927311968,0.17647058823529413,0.6579829171369562,1.0,8/28,13.79%,ART4;PARP11;HPF1;PARP16;SIRT2;PARP14;TNKS2;ARF4
prerank,regulation of actin filament depolymerization (GO:0030834),0.6016378127290374,1.2991158425158411,0.18584070796460178,0.6580858789936859,1.0,3/12,5.64%,PLEKHH2;SEMA5A;LIMA1
prerank,ureteric bud morphogenesis (GO:0060675),0.5648698301325584,1.298952503435641,0.1912479740680713,0.6574639911735659,1.0,6/16,15.79%,GDNF;SALL1;BMP2;FGF2;SHH;BMP4
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.2776154934507467,-1.2986384559303057,0.0,0.6510245786796341,1.0,142/306,31.04%,RAD17;RPS12;RPL41;TAF1B;RPL3;RPS24;RPS14;RPL8;RPL27A;RPS19;RPL34;WARS1;RPS13;RPL21;RPL7;RPL18;RPL27;EEF2;RPL38;RPL35A;RPS15;B4GALT5;RPS3;RPL39;RPS7;RPS4X;RPL11;RPS23;RPL30;MRRF;PWP1;RPL36;BAZ2A;RPLP1;RPS29;RPL37;GTPBP1;DBF4;RPS9;RPS5;ALAS1;TOPBP1;PTMA;RPL18A;ORC4;RAD1;RPL4;RMI1;YARS2;RPL29;RPL26;RPL6;RPL13A;RPL36A;RPL7A;PAX8;MRPS18A;RPL19;MRPS5;FAM111A;THAP1;RPS20;RPL13;TYMS;RPL32;EEF1A1;RPL5;EEF1B2;MRPS12;INHA;RPL14;RPSA;MCM8;HUS1;RPLP0;MRPS33;RPS6;RPS6KB2;MRPL55;NBN;INHBA;MRPL42;MRPS18B;POLR2E;RPL22;RPS21;MCM3;RPL37A;MRPS21;ALAS2;MRPS7;RPL17;RPL23;RPLP2;MRPL34;DTX1;EIF4EBP2;ST3GAL4;HELB;RPL28;MCM5;RPL31;EXO1;EEF1A2;RPS10;PABPC4;HOXD3;ORC5;RPS11;RPS27;RPS16;POLR2J;NFKBIB;RHNO1;RPL10;RPL15;EEF2K;POLR2B;E2F1;TOPORS;RPS8;MEF2A;DONSON;MRPL28;RPL9;SET;MRPL43;CDK1;RPL12;PIF1;RPS27A;FEN1;CDC6;TICRR;POLD2;RPS17;GRWD1;RPL10A;POLA1;XAB2;RNPS1;MRPS14
prerank,dopamine metabolic process (GO:0042417),0.5558118611283508,1.2983060838324922,0.1864951768488746,0.6585069016443144,1.0,6/18,10.55%,MOXD1;COMT;SNCAIP;DRD3;PRKN;LRTOMT
prerank,T cell proliferation (GO:0042098),-0.5128390938096827,-1.298181259174746,0.16786570743405277,0.6498461618932101,1.0,8/13,37.54%,CADM1;MSN;PIK3CG;DOCK8;LILRB1;CRTAM;TNFRSF4;LMBR1L
prerank,negative regulation of mitochondrion organization (GO:0010823),0.49075153176722286,1.2980610602690272,0.14348462664714495,0.6582516776978103,1.0,1/33,0.01%,IGF1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.34390038720033766,-1.2978883030126585,0.0391304347826087,0.6481994976155905,1.0,20/75,14.03%,SLC12A2;SLC12A7;SLC9A2;SLC24A2;KCNJ2;SLC39A10;ATP1A1;KCNJ3;SLC9A6;ABCC9;SLC39A8;ATP1B1;SLC12A6;ATP2B4;SLC9A7;ATP1A3;KCNJ15;KCNJ10;TRPV4;SLC12A5
prerank,alanine transport (GO:0032328),-0.5650964163462036,-1.2976690883757043,0.16121495327102803,0.6463586854311664,1.0,3/10,13.78%,SLC6A6;SLC36A4;SLC1A4
prerank,regulation of cytoskeleton organization (GO:0051493),0.41156510165396826,1.2974257552159754,0.09330143540669857,0.6591337360457886,1.0,16/108,8.29%,EPHA3;PHLDB2;RHOH;ROCK2;LRP1;DLC1;RHOD;ARHGAP18;PDGFRB;RHOBTB1;IQGAP2;RHOBTB3;PRKAA2;RHOBTB2;ARHGAP35;SYDE1
prerank,regulation of leukocyte activation (GO:0002694),0.57711818032642,1.2972408997872573,0.19137931034482758,0.6586717314664038,1.0,7/14,22.66%,LYN;MYO18A;CD200;CD33;PJA2;GPR137B;LCK
prerank,neuron projection extension (GO:1990138),0.5032379643696641,1.297171028786886,0.1495601173020528,0.657783568285009,1.0,5/32,6.86%,NRP1;AUTS2;SEMA5A;ULK2;ALCAM
prerank,stress fiber assembly (GO:0043149),0.5744542934054319,1.2963689458295677,0.20806451612903226,0.6582468911367771,1.0,5/15,13.19%,PHACTR1;ITGB5;SRC;ARRB1;TNFAIP1
prerank,contractile actin filament bundle assembly (GO:0030038),0.5744542934054319,1.2963689458295677,0.20806451612903226,0.6582468911367771,1.0,5/15,13.19%,PHACTR1;ITGB5;SRC;ARRB1;TNFAIP1
prerank,epithelial to mesenchymal transition (GO:0001837),0.46601758910402485,1.296292568825143,0.14380825565912117,0.6573958110818775,1.0,11/47,8.88%,ROCK2;TGFBR3;FGFR1;OLFM1;WNT4;TGFBR1;TBX3;ENG;DDX17;RBPJ;BMP2
prerank,protein depolymerization (GO:0051261),0.5051831915733977,1.2955601988206136,0.16515151515151516,0.6585728005893674,1.0,3/27,2.77%,MICAL3;GSN;NCKAP5
prerank,ribosomal small subunit assembly (GO:0000028),-0.4892924321465833,-1.2953750653615372,0.1683673469387755,0.6510744082397579,1.0,7/16,19.67%,RPS14;RPS19;RPS15;RPS5;RPSA;PRKDC;MRPS7
prerank,positive regulation of cell aging (GO:0090343),-0.5401512955738057,-1.2949875757321163,0.15813953488372093,0.6496630652221902,1.0,5/11,20.30%,B2M;SIRT1;CGAS;ABI3;HMGA2
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5957416031597335,1.294772102271621,0.18388791593695272,0.660084559741929,1.0,3/11,9.79%,PARP11;PARP16;PARP14
prerank,negative regulation of wound healing (GO:0061045),0.5050810258498729,1.2946056346902635,0.1564327485380117,0.6595141801987469,1.0,6/28,5.60%,PHLDB2;SERPINE1;APOE;VTN;TFPI;CASK
prerank,anion transmembrane transport (GO:0098656),0.43407224166096503,1.2945447438893196,0.12661498708010335,0.65861147735218,1.0,9/67,6.08%,SLC1A3;SLC7A2;SLC16A12;SLC13A3;SLC13A4;SLC6A9;SLC6A13;SFXN2;SLC35A3
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5861204148675665,1.2927762608289561,0.1986754966887417,0.6631953304437617,1.0,6/12,19.07%,DPYSL3;DPYD;CTPS2;CDA;ALDH6A1;DPYSL2
prerank,excitatory postsynaptic potential (GO:0060079),-0.46155529368483894,-1.2926987145944788,0.15656565656565657,0.6539498955633539,1.0,5/19,7.72%,GRID2;MEF2C;GRIN2A;GRIN2B;GSK3A
prerank,prostaglandin metabolic process (GO:0006693),0.5230545676786114,1.2924833451040318,0.17410714285714285,0.6630307063983185,1.0,3/26,5.15%,PTGIS;PTGES;PLA2G4A
prerank,lipid transport (GO:0006869),-0.3221798004892624,-1.292470111840219,0.06951871657754011,0.6522135527128432,1.0,29/97,16.97%,PITPNC1;CERT1;ATP8A1;ATP8B1;ABCC4;PLTP;SLCO2A1;SLCO1C1;SLCO2B1;PPARD;PITPNA;TNFAIP8L3;SPNS2;LBP;PLEKHA3;NPC2;MFSD2A;OSBPL2;ABCG1;SCARB1;UGCG;PCTP;CEACAM1;ABCD3;ABCC3;OSBP;MFSD2B;PITPNB;PRELID2
prerank,respiratory electron transport chain (GO:0022904),-0.4953695887477241,-1.2910986809645346,0.18095238095238095,0.6541135149364438,1.0,9/14,25.23%,SLC25A13;SLC25A12;PPARGC1A;NDUFA5;SDHB;SLC25A22;ETFRF1;GPD2;UQCRFS1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.5388363626326947,1.290629407865805,0.18770226537216828,0.6677169954593446,1.0,6/19,16.91%,AMPD3;ADK;POLL;CDA;AMPD2;DCK
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.48076606118155457,-1.290529209837348,0.16753926701570682,0.6533568073510357,1.0,7/17,21.15%,COX4I1;COX6A1;COX5B;CYCS;COX5A;COX6C;COX8A
prerank,water-soluble vitamin metabolic process (GO:0006767),0.4312281937541851,1.2903334023417123,0.12144702842377261,0.6675787113214291,1.0,11/68,8.49%,ENPP1;MMAB;PCCA;NNMT;MTR;PCCB;MTHFR;PDXK;MMUT;CYB5A;ALDH1L1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.4867200470023507,-1.2903264923976254,0.14074074074074075,0.6514374597363887,1.0,5/14,11.96%,SEMA7A;PLCG2;CAMK4;SIRT1;GPRC5B
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.47302343856441775,1.290242523828141,0.15967523680649526,0.6668094244959264,1.0,2/37,0.41%,EPHA3;PHLDB2
prerank,receptor signaling pathway via STAT (GO:0097696),0.5173455348224585,1.2901840382552021,0.19213313161875945,0.6659168936117604,1.0,7/25,13.84%,GHR;IL31RA;NMI;STAT5B;STAT2;STAT6;STAT4
prerank,limb development (GO:0060173),0.4983145299631407,1.2899065931073141,0.18088235294117647,0.665712834463048,1.0,6/28,9.03%,SALL1;GLI3;MAP3K20;ZNRF3;SMOC1;KAT2B
prerank,acute-phase response (GO:0006953),0.6038841324549364,1.2894645043015716,0.20677966101694914,0.666075140746158,1.0,2/12,2.23%,AHSG;IL6R
prerank,cellular response to fatty acid (GO:0071398),0.6033290384548459,1.289165332096849,0.21710526315789475,0.6659538171854704,1.0,1/12,0.89%,PID1
prerank,negative regulation of cell activation (GO:0050866),0.5665426805254483,1.2882456491592167,0.19402985074626866,0.6677036796235719,1.0,8/14,12.01%,PDGFRA;APOE;LDLR;EMILIN1;NR1D1;CD200;C1QTNF1;F2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.41813616935917836,1.2876360918756717,0.12227602905569007,0.6685090724872307,1.0,18/87,14.57%,POLR2D;FGFR1;KL;FGFR2;FGFR4;RBFOX2;SFRP1;FRS2;ZFP36L1;FLRT2;HNRNPA1;POLR2C;FGF2;FGFBP1;NR4A1;TIAL1;DSTYK;SPRED1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3796315194083359,1.2874831465680718,0.04407135362014691,0.6679108440603277,1.0,71/308,16.01%,COL1A1;ADRA1B;GJA1;GHR;GDNF;SMAD3;LRP1;SOX5;NKX6-1;ABCA1;SERPINE1;PLA2R1;LEPR;OGT;OLFM1;BMPR1A;ACSL1;GNAS;APOE;TGFBR1;GAS6;SMO;SMURF2;APPL2;ACVR1;AXIN2;PDPN;DYNC1H1;VIP;EPAS1;ADRB3;ALMS1;BATF;CRB2;IL12B;WWTR1;CD28;SYDE1;KMT5B;DAB2;BMP2;TRPM4;FGF2;NFAM1;MFAP2;CARD9;CEBPB;RGCC;TMEM119;EGF;ADRA2A;RBM19;REST;STAT6;ACVR1B;NIBAN2;MAP3K13;DECR1;MDK;DIO2;HMCES;NCOA3;G0S2;GLMN;CNOT3;GLIPR2;GRB10;IL4R;SHH;BMP4;SHLD3
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.4545976232134321,1.2864086691192422,0.16142270861833105,0.6702331263022696,1.0,13/45,11.78%,PDPK1;PIK3R1;AREG;TGFA;EPGN;PIGR;SRC;SLC30A10;EGFR;AAMP;BRAF;HBEGF;EGF
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5115983586217792,1.2862963421902198,0.16363636363636364,0.6694886808965446,1.0,10/26,19.93%,OGT;KMT5B;SETD1A;SETD5;WDR82;KMT2A;SETD4;EEF2KMT;SETD1B;TET3
prerank,nucleic acid metabolic process (GO:0090304),0.43496613457686306,1.2856220234015954,0.11711711711711711,0.6706023834087343,1.0,23/69,20.89%,POLR2D;ENPP1;RBFOX2;POLG;DXO;RECQL5;METTL14;HNRNPR;HNRNPA1;POLR2C;DNASE1L1;DNASE2;WTAP;LSM8;KPNA2;HNRNPC;DDX1;POLR2L;METTL3;EXD2;DDX24;HNRNPH1;HNRNPU
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.5788656240922918,1.2855545706173301,0.1847457627118644,0.669729487332076,1.0,7/14,23.49%,AUTS2;KMT2A;KMT2E;WDR5;DNMT3B;DNMT1;BRCA1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.5773857195776321,1.2850948981632102,0.20036429872495445,0.6701240192981275,1.0,8/13,25.98%,APOE;DKK3;BMP2;REST;BMP5;ERLIN1;ERLIN2;SCAP
prerank,sulfur compound transport (GO:0072348),-0.41980746750646386,-1.2850358953282957,0.12885154061624648,0.6658695024862566,1.0,7/27,9.81%,SLC6A6;ABCG2;SLC26A7;LRRC8D;SLC5A6;SLC25A30;SLC26A6
prerank,catecholamine biosynthetic process (GO:0042423),0.6052019958452853,1.2845764802857054,0.20634920634920634,0.6706308909242628,1.0,1/11,0.55%,MOXD1
prerank,miRNA metabolic process (GO:0010586),0.549737509306945,1.2845756599427873,0.19281045751633988,0.6695644564580316,1.0,9/20,18.32%,SND1;DDX17;TUT7;PARN;BCDIN3D;TUT4;PRKRA;TENT4B;DICER1
prerank,L-glutamate transmembrane transport (GO:0015813),0.6069152841261906,1.2841695362446257,0.22459893048128343,0.6697147072148251,1.0,1/10,0.14%,SLC1A3
prerank,cholesterol efflux (GO:0033344),0.5349872316116179,1.2831837641393102,0.19654088050314467,0.6716718159608142,1.0,3/20,4.39%,ABCA1;APOE;APOA1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.413003004484129,1.281211838418945,0.10308056872037914,0.6768155856360468,1.0,20/104,10.72%,PDPK1;CILP;SMAD3;LDLRAD4;ADAMTSL2;BMPR1A;PMEPA1;NKX2-1;TGFBR1;SLC2A10;SMURF2;ACVR1;SKI;EMILIN1;SPRY2;BMP2;LEMD3;SMAD1;FAM89B;SPRED3
prerank,protein O-linked glycosylation (GO:0006493),0.4160029622132504,1.2811699634841327,0.13730255164034022,0.6758491457166577,1.0,11/96,6.02%,TMTC1;GXYLT2;GALNT18;GALNT14;GALNT15;TMTC4;OGT;PGM3;ST3GAL3;LARGE1;LARGE2
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.5087561085760961,1.280569148784769,0.16199376947040497,0.6766796903987005,1.0,2/24,3.62%,EPHA7;NUPR1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5566853722834341,1.2804610320447916,0.20764119601328904,0.6759363969397244,1.0,5/15,8.32%,UST;DCN;BGN;DSE;CSPG5
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3728563479071213,1.2803383761388885,0.04020618556701031,0.675251535175314,1.0,57/348,12.01%,IGF1;NRP1;BMP6;IGF2;DDR2;CEMIP;ROCK2;ANGPT1;GHR;PDGFD;LYN;IL34;IL6R;LEPR;BMPR1A;PELI2;CCN1;INHBE;PRKAG2;TGFBR1;VTN;GAS6;CCL19;CSF1;TWSG1;RAPGEF2;ACVR1;MT3;NTF3;AXIN2;MUSK;SLCO3A1;ENG;LRRK2;SRC;ARAF;ALS2;NTRK3;STK4;EGFR;ARRB1;DAB2;SPRY2;RBPMS;BMP2;CREBL2;ITGB3;FGF2;MRNIP;BRAF;BMP15;DDX3X;TMEM119;EGF;RAP2A;TBK1;F2
prerank,histone deacetylation (GO:0016575),0.46483663661929914,1.2798282210917136,0.13802816901408452,0.6758135173068446,1.0,19/43,24.50%,TBL1XR1;PRDM5;MIDEAS;SIRT2;MTA2;MTA3;BRMS1L;HDAC8;REST;HDAC4;SUDS3;ELK4;MIER3;BRMS1;HDAC5;HDAC6;SMARCAD1;HDAC1;SFPQ
prerank,positive regulation of phagocytosis (GO:0050766),0.4591752983528629,1.2798220322195828,0.14171122994652408,0.6747620226971798,1.0,8/47,4.45%,CAMK1D;AHSG;TULP1;GAS6;MYO18A;APOA1;APPL2;C4B
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4907840935096546,-1.2797150389610537,0.17737789203084833,0.6806396341539367,1.0,5/15,4.08%,TMSB4X;THBS1;NOTCH1;MET;FGF1
prerank,mononuclear cell differentiation (GO:1903131),0.5160121674276273,1.2791351516550642,0.19236883942766295,0.6759593401300873,1.0,4/24,4.80%,IL31RA;LYN;GAS6;AXL
prerank,T cell activation (GO:0042110),0.43275541919783467,1.278766681656434,0.13399503722084366,0.6760971930984349,1.0,14/69,13.38%,RHOH;KIF13B;LEPR;PPP3CA;KIT;CCL19;CD7;CD28;NHEJ1;GPR89A;GPR89B;IFNK;DDOST;MDK
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.46289539277513747,1.2786182180762793,0.1631504922644163,0.6755382728611014,1.0,6/41,13.72%,IGF1;GAS6;IRAK3;SELENOS;CD33;SYT11
prerank,acidic amino acid transport (GO:0015800),0.54733164233242,1.2785391059383744,0.20333333333333334,0.6747271288946313,1.0,3/17,3.85%,SLC1A3;GJA1;SLC6A13
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.4571030998232984,-1.2784865755995036,0.168,0.6821149120288238,1.0,7/19,20.83%,HIPK2;SNW1;DDIT4;SIRT1;DYRK2;EP300;MSH2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4594761376963931,1.2781452269043945,0.15524475524475526,0.6748773549684146,1.0,6/43,13.72%,IGF1;GAS6;IRAK3;SELENOS;CD33;SYT11
prerank,positive regulation of protein kinase activity (GO:0045860),0.39306408744502236,1.2781168306532367,0.10514541387024609,0.6739162821700706,1.0,35/148,14.16%,DDR2;NRK;NEDD9;IL34;IL6R;EPHA4;CCN1;PRKAG2;GAS6;CCL19;CSF1;RAPGEF2;NAB2;SRC;PARP16;IL12B;MAP2K1;ALS2;MAP4K4;STK4;ITGB3;TELO2;STK11;TAOK3;MRNIP;TTBK1;DDX3X;ADRA2A;STRADA;DUSP19;INSR;NOX4;DLG4;MARK2;SNX9
prerank,actomyosin structure organization (GO:0031032),0.4260938875985365,1.277487977570089,0.14104193138500634,0.6749236168358634,1.0,16/75,10.44%,PHACTR1;ROCK2;ACTN2;TPM1;TMOD4;TNNT1;MYO18A;MYH10;FRMD6;CSRP2;ITGB5;SRC;ARRB1;CSRP3;SYNPO2L;TNNT3
prerank,regulation of melanin biosynthetic process (GO:0048021),0.601694056248655,1.2774284349461107,0.21232876712328766,0.6740522215801252,1.0,2/10,4.45%,ZEB2;RAPGEF2
prerank,bile acid and bile salt transport (GO:0015721),-0.4266359459116257,-1.276754709865705,0.14084507042253522,0.6853069871826537,1.0,4/24,2.73%,ATP8B1;ABCC4;SLCO1C1;SLCO2B1
prerank,proteolysis (GO:0006508),0.37287776449212234,1.2765954334667706,0.06296691568836713,0.6755964444656879,1.0,50/252,18.40%,CPXM2;ADAMTS12;TRABD2B;ADAM33;ADGRV1;CPQ;OGT;MMP2;AEBP1;MMP19;VASH2;CPXM1;ENDOU;CTSH;CTSF;MMEL1;ADAMTS9;SPRTN;PRSS48;CLPX;ATG4A;ECE2;EEF1AKMT4-ECE2;APEH;HTRA1;LONP2;CASP7;CAPN7;CLPP;APH1B;CLN3;RSPRY1;CPA2;CTSZ;CTSL;SENP6;SUFU;THOP1;HPN;MMP14;CUL7;DPP3;CASP1;PSEN2;LONP1;PSMB5;UBE3A;ST14;PRTN3;YME1L1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.4662077527434947,1.2765434540240064,0.1697054698457223,0.6746984018804922,1.0,5/41,4.61%,ITPR1;SLC8A1;SLC8A3;CCL19;SLC24A1
prerank,inhibitory synapse assembly (GO:1904862),-0.5292896697901358,-1.275643553241654,0.19338422391857507,0.6863432996515701,1.0,4/11,7.86%,GABRA2;GABRB3;GABRG2;GABRB2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.42904296152307153,-1.2755735753247608,0.1569767441860465,0.6839746976785451,1.0,8/26,10.91%,ACER3;ACER2;NOS3;GCH1;NOS1;DDAH2;SPTLC2;SPR
prerank,regulation of secretion by cell (GO:1903530),-0.3525204890449921,-1.2747777277749692,0.09056603773584905,0.6840449013534351,1.0,19/54,18.54%,MEF2C;MCTP1;RIMS1;STXBP5L;RAB3C;RIMS2;RAB21;VAMP8;SYT1;RAB12;RAB8B;LGI3;NSF;CPLX1;RAB3A;RAB15;RIC1;ARFIP1;SYN1
prerank,presynaptic endocytosis (GO:0140238),-0.42511269957491993,-1.2744949363926037,0.14792899408284024,0.6824667231335397,1.0,9/24,17.94%,NLGN1;AMPH;CDK5;OPHN1;SYT1;PACSIN1;NLGN3;STX1A;SYNJ1
prerank,fat cell differentiation (GO:0045444),0.43729676427437125,1.2744909723326712,0.14859437751004015,0.6799784672419997,1.0,10/57,12.50%,TCF7L2;PID1;OSBPL8;FAM120B;WNT5B;CEBPA;ALOXE3;CBY1;NR4A1;TMEM120B
prerank,lipid translocation (GO:0034204),-0.4385779741601254,-1.2737122481056062,0.15343915343915343,0.6824012908052938,1.0,6/21,7.28%,ATP8A1;ATP8B1;ATP11C;ABCC1;ATP11B;ATP11A
prerank,cellular response to peptide (GO:1901653),0.4399356972468269,1.2736062826611232,0.1446111869031378,0.6817368229309604,1.0,8/56,7.95%,IGF1;GJA1;LRP1;EPHA4;CACNB1;ZFP36L1;SRC;TLR6
prerank,regulation of cell morphogenesis (GO:0022604),0.499616166098355,1.2733806025399712,0.15074626865671642,0.6814047912748237,1.0,8/30,10.01%,SH3D19;SPARC;MACF1;PHIP;PDPN;WTIP;CAPZB;PDZD8
prerank,purine-containing compound catabolic process (GO:0072523),-0.49228004066787406,-1.2732250986908813,0.171990171990172,0.681473581860931,1.0,7/13,18.48%,NT5E;NT5C2;NT5C1A;GDA;NT5C;PNP;GPX1
prerank,RNA modification (GO:0009451),0.4429827636763856,1.2731311320521013,0.16395663956639567,0.681142549270837,1.0,17/54,19.19%,PUS3;ADAT2;NSUN2;FTSJ3;PARN;BCDIN3D;URM1;TRMT9B;NSUN5;NSUN4;DTWD1;ELP5;ALKBH1;ANKRD16;METTL3;TRUB1;METTL1
prerank,regulation of neutrophil migration (GO:1902622),0.6166839573031394,1.272863599959421,0.24485981308411214,0.6809528957514399,1.0,1/10,0.73%,RHOH
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4423616224605182,1.2727818116932057,0.1419098143236074,0.68017331551008,1.0,14/55,15.43%,PID1;PDGFRB;CYP1B1;MT3;SPHK2;AGTR1;SIRT2;DCXR;PRKN;EIF6;F2;NOXO1;ARF4;PIKFYVE
prerank,lipoprotein transport (GO:0042953),0.6138398802776348,1.2725172502168227,0.20107719928186715,0.6799857303047928,1.0,2/10,9.14%,LRP1;MIA3
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3993338267794838,-1.2718796049934162,0.14414414414414414,0.6831923392662945,1.0,10/32,20.83%,PPP1R13B;HIPK2;SNW1;DDIT4;SIRT1;DYRK2;EP300;FHIT;DDX5;MSH2
prerank,ventricular septum development (GO:0003281),0.4709118835642975,1.2717249185330526,0.16503496503496504,0.6814483244301801,1.0,6/37,4.60%,ROBO1;TGFBR3;SALL1;BMPR1A;TGFBR1;ACVR1
prerank,lipoprotein localization (GO:0044872),0.5978740747722133,1.2716762918215252,0.2007042253521127,0.6805769562771256,1.0,2/11,9.14%,LRP1;MIA3
prerank,negative regulation of protein binding (GO:0032091),-0.3431637756131563,-1.2710612914668242,0.09502262443438914,0.6832070342523509,1.0,24/71,20.41%,CAV1;MAP2;ACTB;B2M;ADAM15;SORL1;KDM1A;ITGA4;CTNNBIP1;ATP2A3;MAPK8;GTF2F1;DISC1;ADRB2;RALB;CARD16;PPP1CA;ZFPM1;RACK1;CDKN1A;DVL1;ITGB1BP1;EFHB;ROCK1
prerank,positive regulation of filopodium assembly (GO:0051491),0.5161724503799174,1.2708274062664666,0.17656500802568217,0.6822354942781367,1.0,6/24,6.01%,NRP1;PIK3R1;DOCK11;RIPOR2;DPYSL3;CDC42
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5847343274179793,1.270459828931017,0.19767441860465115,0.6823582410489722,1.0,2/14,6.90%,ACTN2;ATP1B2
prerank,negative regulation of response to wounding (GO:1903035),0.5358580587473416,1.2702602738994808,0.19242902208201892,0.6819310059612221,1.0,8/19,16.18%,SERPINE1;EPHA4;PTPRS;CASK;FGF2;MDK;CERS2;EPPK1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.32714125374919456,-1.269748345666027,0.07920792079207921,0.6848535203604978,1.0,30/75,23.92%,MEF2C;MAP2;ACTB;ANK3;NRCAM;KLF7;CNTN4;NTNG1;BTBD3;CDK5;DCDC2;OPHN1;MFSD2A;DCC;NEFH;APBB1;LMTK2;APP;MAP1B;SHTN1;RAB3A;UNK;DVL1;BRSK2;ADGRB1;MINK1;CTNNA2;S100B;PLPPR4;TBCD
prerank,tRNA wobble base modification (GO:0002097),0.5726442754230786,1.2694819107328228,0.18870967741935485,0.6832962889658976,1.0,6/14,20.00%,ADAT2;URM1;TRMT9B;ALKBH1;DPH3;ELP4
prerank,phospholipid catabolic process (GO:0009395),-0.427636287011517,-1.2689988557819734,0.16619718309859155,0.68455740247486,1.0,8/24,23.06%,GPCPD1;ENPP2;PLA2G4C;SMPDL3A;PNPLA6;PLA2G4F;PLA2G4E;GDPD1
prerank,regulation of angiogenesis (GO:0045765),0.38430992282352905,1.2685337271200483,0.09429824561403509,0.6852407692953489,1.0,28/192,6.57%,PTGIS;PDPK1;COL4A3;ROCK2;SPARC;GLUL;SASH1;DCN;RUNX1;HSPG2;SERPINE1;SP100;THBS2;VASH2;ISM1;SULF1;SEMA5A;STIM1;ITGB8;CYP1B1;SFRP1;CTSH;SMOC2;SERPINF1;CDH5;EMILIN1;ADGRA2;PML
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3462094240188858,-1.26722047340778,0.12663755458515283,0.6878352699559679,1.0,21/57,22.13%,DLG2;MEF2C;GRIA4;NLGN1;PTK2B;GRIN2A;DLGAP2;LRRC7;GRIN2B;GRIA2;SHANK1;LYNX1;APP;GSG1L;CACNG3;CACNG4;GRIN1;SHISA9;RELN;MINK1;BEGAIN
prerank,inorganic anion transport (GO:0015698),-0.3558634613082982,-1.266802466168707,0.11673151750972763,0.6865704380192584,1.0,10/53,9.81%,SLC4A10;SLC26A7;CLIC4;ANO1;ANO4;CLIC5;GLRA1;CLIC1;SLC25A30;SLC26A6
prerank,skeletal system morphogenesis (GO:0048705),0.4662460777375671,1.2661756421332528,0.15352112676056337,0.6917129933397946,1.0,14/42,18.42%,CYP26B1;FBN2;FGFR1;FGFR2;PDGFRA;TGFBR1;SKI;DYNC2I1;SFRP4;HOXC4;SPEF2;ANKRD11;SOX11;HHIP
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5471172861055842,1.2659845576361937,0.20097244732576985,0.6902207772847954,1.0,4/16,6.32%,PHLDB2;ARHGAP6;DLC1;SRC
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5471172861055842,1.2659845576361937,0.20097244732576985,0.6902207772847954,1.0,4/16,6.32%,PHLDB2;ARHGAP6;DLC1;SRC
prerank,positive regulation of receptor internalization (GO:0002092),0.5343971710982632,1.2658147462242515,0.19122257053291536,0.689698346854786,1.0,7/22,13.37%,ANGPT1;NTF3;CD63;ARRB1;EGF;INSR;SFRP4
prerank,regulation of microtubule-based process (GO:0032886),0.47449014030642356,1.265723342200213,0.1875,0.6889682132213952,1.0,5/36,7.51%,EPHA3;PHLDB2;MACF1;PRKAA2;MEMO1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.49762905925476614,-1.2653100600766038,0.17647058823529413,0.6889203487317196,1.0,3/13,6.84%,SLC4A10;GRIK2;SYP
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.58652506487966,1.2651176292369273,0.21541155866900175,0.688874545332597,1.0,2/12,7.88%,FHL2;RCAN1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.58652506487966,1.2651176292369273,0.21541155866900175,0.688874545332597,1.0,2/12,7.88%,FHL2;RCAN1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3586397248064403,1.2646862492930881,0.007,0.6891465080955076,1.0,154/834,15.63%,IGF1;TCF7L2;TCF4;BMP6;LDB2;AUTS2;NFIA;IGF2;RORA;TBL1XR1;PID1;TEAD1;CDK8;PIK3R1;GDNF;SMAD3;PBX1;ZEB2;ARNT2;AR;DCN;MITF;NKX6-1;GLIS3;RUNX1;SERPINE1;NR2F2;GLI2;SALL1;SP7;OGT;GLI3;BMPR1A;RUNX2;CCN1;PPP3CA;NKX2-1;FGFR2;THRB;YAP1;ASCL1;NFIB;ZNF462;SSBP3;MAML3;MLXIP;RARB;NFIX;CRTC3;IRF1;RLF;MEOX2;ACVR1;RFX5;NEUROD1;NCOA2;PHIP;RARG;KLF15;BRD8;TBX3;ENG;EPAS1;HLF;SKI;INO80;BCL9;ATOH8;SMARCA1;MED14;NR5A1;NFE2L2;DDX17;ATAD2B;WWTR1;CEBPA;ZBTB38;SIRT2;SREBF1;RNF10;NR1D1;DR1;MED16;RBPJ;OSR1;TET1;ZMIZ1;EGFR;FOXC2;ARRB1;DAB2;RGMA;STAT5B;BMP2;KAT2B;ARNT;MZF1;SMAD1;CCNK;CREB3L4;CREB3;PRKN;GLIS2;FGF2;RNASEL;CSRP3;FOXA1;ZSCAN21;NR1D2;DDX3X;KMT2A;NKX2-8;CEBPB;TNIP2;RGCC;HDAC8;TBK1;REST;RHOQ;STAT6;GLI1;NR4A1;ZNF513;NPAS2;RIPK2;SMARCD2;MYCN;GATA6;HELZ2;HIVEP1;CDK12;ARF4;ETS1;TCF12;NCOA3;TCERG1;AKAP8L;TAF9;HDAC4;MED19;FOXK2;FSTL3;TNFRSF1A;BMP5;NR1H3;FUBP3;SMARCB1;CAMTA2;HOXC4;SS18;RXRA;TFCP2;SHH;MYBL1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.40334147261686754,-1.2646620134014142,0.1388888888888889,0.6885684745840616,1.0,9/29,14.40%,DPP10;KCNIP4;KCNAB1;FGF12;KCNN2;ATP2B4;DPP6;HOMER1;CACNA1D
prerank,ephrin receptor signaling pathway (GO:0048013),0.4155893492675811,1.2645125597266744,0.1569620253164557,0.6886781857224112,1.0,13/82,9.16%,EPHA3;EPHA7;ROCK2;LYN;EPHA4;MMP2;EPHA8;EFNB2;CDC42;SRC;EFNA2;EPHB2;EFNB1
prerank,negative regulation of cell projection organization (GO:0031345),0.45702863364175156,1.2639646402569806,0.17695473251028807,0.6893195697996095,1.0,16/48,15.82%,EPHA4;KANK1;APOE;EFNB2;DPYSL3;RAPGEF2;MT3;PTPRS;DENND5A;LPAR1;PTPN9;SPRY2;GORASP1;PTEN;BAG5;STX1B
prerank,heart trabecula morphogenesis (GO:0061384),0.5352619229797974,1.2638182721889009,0.20093457943925233,0.6887373316077527,1.0,6/18,7.99%,RBP4;TGFBR3;BMPR1A;TGFBR1;ENG;RBPJ
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.382622952050067,1.2637465877930285,0.10204081632653061,0.6879225259018822,1.0,31/166,12.45%,POLR2D;RORA;CCN2;TBL1XR1;TEAD1;AR;THRB;YAP1;MAML3;RARB;NOTCH2;POLR1G;RARG;BRF1;GTF2E1;GTF3C1;GTF2H5;NR5A1;WWTR1;NR1D1;RBPJ;NCOR1;KAT2B;POLR2C;NCOR2;NR1D2;TFAM;POLRMT;TEAD3;MNAT1;NR4A1
prerank,muscle organ development (GO:0007517),0.4375558603178128,1.2637182461800456,0.15274151436031333,0.686980338320399,1.0,11/54,11.59%,IGF1;LAMA2;ITGA11;VAMP5;LARGE1;MRAS;SMTN;CHD2;COL6A3;HBEGF;SGCE
prerank,regulation of histone methylation (GO:0031060),0.5700873959241528,1.2636398580400103,0.2195540308747856,0.6862429074224289,1.0,5/13,12.87%,NNMT;MTHFR;TET1;NSD1;PAF1
prerank,carbohydrate biosynthetic process (GO:0016051),0.5135428028405177,1.262873587875499,0.20952380952380953,0.6876130248723252,1.0,5/21,10.22%,ST6GALNAC5;B3GALT1;ST3GAL3;B4GALT1;ST6GALNAC6
prerank,receptor clustering (GO:0043113),-0.4012544420424818,-1.2627109066823214,0.1270358306188925,0.6923659432738056,1.0,8/27,10.50%,DLG2;NLGN1;NRXN1;LRRC7;ITGA4;PTN;SCRIB;AGRN
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.4489176584430089,1.262391502516092,0.15323645970937913,0.6880729702293527,1.0,9/51,9.27%,GREM2;FBN1;BMPR1A;FSTL1;SMURF2;SKI;BMP2;LEMD3;SMAD1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.44574326803308967,1.2622299222204714,0.15,0.6875952732432646,1.0,11/52,17.34%,POLR2D;SAMD4A;EXOSC1;TUT7;PARN;EXOSC7;TUT4;RC3H2;CNOT3;DCP1A;PATL1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3960696138748232,-1.2610531315628812,0.1347305389221557,0.6954291310502054,1.0,12/31,18.00%,PPP1R13B;YWHAH;YWHAQ;HIP1R;GSK3A;MAPK8;YWHAG;CASP8;BBC3;BAK1;ZNF205;PPP3R1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5222244260315133,1.260939240834087,0.19815668202764977,0.6905289700861796,1.0,2/23,3.58%,IGF1;EFNB2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.45733106488907704,-1.260821921810001,0.195822454308094,0.6937003832383087,1.0,13/18,38.77%,HIP1R;TMEM14A;GSK3A;BAK1;ZNF205;ACAA2;GSK3B;FZD9;CHCHD10;BID;BAX;SLC35F6;HSPA1A
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.5898279801168427,1.260743825815879,0.21739130434782608,0.6900954365953317,1.0,4/12,16.45%,IL12B;ZBTB1;CARD9;IL23A
prerank,regulation of nervous system process (GO:0031644),0.5416014468913511,1.2605134335785957,0.20642978003384094,0.6898469201657353,1.0,2/18,1.36%,ROCK2;SLC8A3
prerank,intestinal lipid absorption (GO:0098856),0.5916967545388341,1.2603830322262317,0.2332155477031802,0.6892933515354217,1.0,2/11,5.64%,LDLR;LIMA1
prerank,plasma membrane tubulation (GO:0097320),-0.4911461405004857,-1.2600940930433921,0.21065989847715735,0.693536178015867,1.0,5/13,12.50%,FNBP1L;CAVIN2;PACSIN2;BIN3;PACSIN1
prerank,homeostasis of number of cells (GO:0048872),-0.5107082937917461,-1.2597429461178926,0.19285714285714287,0.6922344712559123,1.0,5/12,14.67%,NOTCH1;NOS3;CCN3;CX3CR1;LPCAT3
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.42186352972559876,1.2595707365841657,0.15683814303638646,0.6906702265757706,1.0,12/78,9.05%,EPHA3;PDPK1;PID1;PIK3R1;LRP1;AR;ITGA3;PTPN9;EGFR;EPHB2;DAB2;PICALM
prerank,regulation of DNA binding (GO:0051101),0.45636823936286325,1.2593676497278943,0.16242937853107345,0.6902762099514972,1.0,6/44,7.23%,IGF1;MDFI;SP100;SMO;SKI;SIRT2
prerank,transcription by RNA polymerase II (GO:0006366),0.3657020596055058,1.2593656176324455,0.05672268907563025,0.689268526789112,1.0,96/305,22.41%,POLR2D;RORA;CCN2;TBL1XR1;TEAD1;AR;SOX5;GLIS3;PRRX1;MAF;THRB;YAP1;MAML3;RARB;HSF2BP;NFIX;NOTCH2;PHAX;RARG;MLLT3;GTF2E1;GTF2H5;NR5A1;WWTR1;PMF1;NR1D1;SNAPC1;MED16;RBPJ;NCOR1;TRIP11;KAT2B;ZBTB1;RPAP2;CCNK;POLR2C;PAX1;NCOR2;NR1D2;WDR33;MBD1;TEAD3;NKX2-8;INTS4;TTF2;MNAT1;NR4A1;PAF1;NRBF2;CDK12;ELL2;TAF5L;SNAPC5;TAF9;NELFE;ADRM1;GTF2E2;SNAPC4;AFF4;NR1H3;PCF11;RXRA;TFCP2;TFDP1;COPS2;SP1;CCNT2;GTF2I;TSC22D1;CDC73;ELOF1;LSM10;POLR2L;MAML2;FIP1L1;TAF2;CPSF2;GTF2A1;NFE2L3;ELP4;DEAF1;IRF9;MLLT1;CCNT1;TAF8;LEO1;SCAF8;NCBP2;NOCT;MED23;CDK7;PAPOLA;MED26;HDAC5;RPAP1;ERCC3
prerank,negative regulation of response to external stimulus (GO:0032102),0.4016523339571256,1.2587624611659662,0.14502923976608187,0.6901500415116649,1.0,29/105,17.67%,PTGIS;RORA;SERPINE1;EPHA4;APOE;APOA1;MVK;PTPRS;CASK;CDH5;MAPKBP1;SIRT2;NR1D1;DRD3;IRAK3;NMI;FGF2;ITCH;TNFAIP6;SELENOS;MUL1;PTEN;CERS2;TNFRSF1A;NR1H3;EPPK1;SMPDL3B;FNDC4;DHX58
prerank,negative regulation of RNA splicing (GO:0033119),-0.44532040553540814,-1.2587102121038176,0.18766066838046272,0.6931394664992282,1.0,11/19,30.99%,RPS13;PTBP2;PTBP3;SRSF12;SRSF7;RBMX;C1QBP;SRSF4;U2AF2;PCBP4;RNPS1
prerank,synaptic vesicle transport (GO:0048489),-0.5189022633186176,-1.2583638847915153,0.19759036144578312,0.6918176357633918,1.0,5/11,23.80%,RAB27A;CDK5;SYNJ1;KIF5A;TMEM230
prerank,regulation of gene expression (GO:0010468),0.35625329505960673,1.258318998493631,0.005005005005005005,0.6906040108757786,1.0,187/903,16.50%,IGF1;NELL1;ROBO1;BMP6;CILP;NFIA;IGF2;RORA;SLC24A3;GJA1;RHOH;ROCK2;ANGPT1;PID1;ATXN1;SLC8A1;RBMS3;GDNF;GSN;SMAD3;ARNT2;C1D;AR;MITF;RUNX1;LYN;AFF1;WWC2;OLFM1;BMPR1A;NOS1AP;SON;EPHX2;PRDM5;NKX2-1;DTNBP1;YAP1;FGFR4;WNT4;ASCL1;HNRNPLL;ZNF462;APOE;NUP107;TGFBR1;GAS6;SMO;WNT6;NOTCH2;TLE1;SLC2A10;PDCD5;CSF1;IGF2BP2;OGG1;ITGB8;SLC22A2;ZC3H7B;MSC;SFRP1;MT3;NCOA2;CTSH;BCL6;MUSK;DENND4A;PRKAA2;GNB3;SNRNP70;TNRC6B;TCF7;ENG;ZFP36L1;CDH5;CUX2;ATOH8;NAB2;EMILIN1;APBB2;PML;NR5A1;NFE2L2;IL12B;WWTR1;CEBPA;ZBTB38;EIF2AK3;CD28;MAP2K1;SAP30;AFDN;REXO4;TLR6;WTIP;RBPJ;NTRK3;OSR1;CCN4;TULP3;AFF3;EPHB2;TCF7L1;SPRY2;TNRC6A;NONO;BMP2;PICALM;CREBL2;MZF1;SMAD1;SNX12;GTF2IRD1;ZBTB4;NSD1;MYADM;PARP14;PRKN;FGF2;PHF1;ZSCAN21;ACTR8;NR1D2;RBL2;RNF6;BRAF;TTBK1;DDX3X;TCEAL1;IFNK;CEBPB;RGCC;TMEM119;EGF;C1QTNF1;REST;TERF2;DNAJA4;ACVR1B;LARP1;LRP3;HMGN5;INSR;ZNF513;CCDC3;TRIP4;SFRP4;MYCN;YAF2;SUFU;SETDB1;ETS1;TAF5L;TADA3;PDCL3;ZNF148;HDAC4;FOXK2;GLMN;ZNF219;HPN;CLK4;AFF4;SEC16B;FUBP3;SAP30L;MYCBP;ERMAP;UBR5;CLK3;GPBP1;SHH;MYBL1;METTL4;FADS1;BMP4;STX1B;MYT1;TGFBRAP1;PSPC1;SLC38A2;AKT1;POGZ;ATM;MAFA;NWD1;CREB3L1;ZNF423
prerank,protein polyglutamylation (GO:0018095),-0.5275124523772657,-1.2576718981539206,0.17620137299771166,0.691658916421727,1.0,2/11,1.61%,TTLL7;TTLL5
prerank,positive regulation of lipid transport (GO:0032370),0.5771015585230218,1.2575556783990924,0.22800718132854578,0.692065047420262,1.0,2/12,3.41%,LRP1;APOE
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.5356397727425595,-1.256856683921485,0.21875,0.6920525534984463,1.0,4/10,16.92%,PRKCH;MED1;TRIM16;ETV4
prerank,transcription preinitiation complex assembly (GO:0070897),-0.5120166380269471,-1.2568538490654624,0.18055555555555555,0.6896630738885563,1.0,7/12,23.87%,TAF1B;TAF1;TBP;GTF2A2;BDP1;GTF2B;POLR1E
prerank,protein deacetylation (GO:0006476),0.4559600957629567,1.2563027156140567,0.18181818181818182,0.6951060362422767,1.0,16/41,24.02%,TBL1XR1;PRDM5;MIDEAS;SIRT2;MTA2;MTA3;BRMS1L;HDAC4;FLNA;SUDS3;SIRT5;MIER3;BRMS1;HDAC5;HDAC6;HDAC1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.599203749030084,1.2557473015176155,0.24686940966010734,0.6958545244022412,1.0,4/10,8.10%,HECW2;ATP1A2;NEDD4;OSR1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5155852374825244,1.2556348376975965,0.2015625,0.6951537254618215,1.0,6/20,15.46%,TGFBR1;EPAS1;ZMIZ1;PRKN;ITCH;DCUN1D2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.4528283598013085,-1.2555713779939202,0.19491525423728814,0.6914244438101486,1.0,6/18,8.07%,RAP1A;NLGN1;RIMS1;RIMS2;RAP1B;SLC4A8
prerank,regulation of synapse organization (GO:0050807),0.5077971721500869,1.2554267657967768,0.18250377073906485,0.6947783594236424,1.0,9/26,12.97%,PDLIM5;EPHA4;ABHD17C;NEDD4;CAMK2B;MDGA1;SETD5;CLN3;SLITRK2
prerank,regulation of chemotaxis (GO:0050920),0.49056035896771083,1.2548964909537805,0.20245398773006135,0.6954844394457863,1.0,7/30,8.58%,MYCBP2;PDGFRA;PDGFRB;EFNB2;CCL19;ADGRA2;ZSWIM6
prerank,positive regulation of translational initiation (GO:0045948),0.5384710441704269,1.2548373956631045,0.21639344262295082,0.6946758157946241,1.0,4/18,12.61%,POLR2D;CDC123;DDX3X;LARP1
prerank,negative regulation of hemostasis (GO:1900047),0.5815549469132085,1.2547085268984797,0.20804195804195805,0.6940641904336822,1.0,4/12,5.52%,SERPINE1;APOE;VTN;TFPI
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.46642167921775324,1.2546846141327708,0.18795888399412627,0.6931415592747342,1.0,5/38,11.30%,BMP6;SASH1;DDX60;NMI;IFNK
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.4684132420340644,1.2545795627727472,0.18518518518518517,0.692460929965852,1.0,13/39,13.08%,ERRFI1;AREG;TGFA;EPGN;CDC42;EPS15;EGFR;SPRY2;HBEGF;EGF;EPS15L1;PTPN3;MVP
prerank,cellular iron ion homeostasis (GO:0006879),0.44344543839081113,1.2545027596268594,0.16358839050131926,0.6917079324134873,1.0,7/55,6.43%,BMP6;CP;SCARA5;HEPH;SLC11A2;CYBRD1;ACO1
prerank,sensory perception of light stimulus (GO:0050953),0.40870122823084715,1.2541438067164714,0.1366906474820144,0.6918302419024823,1.0,8/87,4.61%,COL1A1;ADGRV1;COL11A1;EML2;DHRS3;TULP1;ZIC2;SLC24A1
prerank,positive regulation of axonogenesis (GO:0050772),0.45950336606085074,1.253486947496218,0.19405099150141644,0.6928996606391105,1.0,11/43,14.64%,ROBO1;PLXNA2;MACF1;TIAM2;GOLGA4;NTN1;PLXNC1;MAP3K13;PLXNA1;PLXNB2;CHODL
prerank,positive regulation of hydrolase activity (GO:0051345),-0.2932076639175135,-1.2534449875168772,0.06060606060606061,0.6961691587114793,1.0,31/137,12.39%,PKP4;DOCK9;RAP1A;ITGA6;F11R;CAV2;RAP1GDS1;BCAR3;SNX13;NET1;RGS6;ARHGAP27;TGM2;RPS3;ERBB2;FNTA;EZH2;CCL14;TBC1D30;ARAP1;RASGRF1;RGS7;LARS1;CALM1;MAPK8;MTMR9;AGRN;CALM3;EVI5;RGS16;NF1
prerank,multivesicular body assembly (GO:0036258),-0.3960416076534677,-1.2533038194443602,0.1609907120743034,0.6942170999291527,1.0,15/30,28.39%,RAB11A;PDCD6IP;VPS37B;VPS37A;VPS28;VPS36;VPS4A;CHMP2B;VPS37C;SNF8;CHMP4B;CHMP4A;HGS;MVB12A;CHMP4C
prerank,negative regulation of blood pressure (GO:0045776),-0.5082340442717561,-1.2532089211358088,0.19047619047619047,0.6921919875493561,1.0,3/13,6.50%,NOS3;PRCP;NOS1
prerank,response to hexose (GO:0009746),0.5043794100484801,1.252933876042985,0.208955223880597,0.693613407047232,1.0,7/25,16.42%,TCF7L2;SLC30A8;NEUROD1;EIF2B4;SELENOS;EIF2B3;MAFA
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.47347084172703063,1.2522903551965623,0.19910846953937592,0.6947366322170765,1.0,3/32,5.71%,PDPK1;CEMIP;GSTM2
prerank,negative regulation of ossification (GO:0030279),0.5080199400715689,1.252201460953182,0.1968503937007874,0.694029167383894,1.0,6/23,9.31%,ENPP1;AHSG;SFRP1;BCOR;RBPJ;TRPM4
prerank,membrane assembly (GO:0071709),-0.39204518845326325,-1.2513476660816871,0.15,0.6958320794352301,1.0,8/34,7.65%,NLGN1;IL1RAPL1;ANK3;PTPRD;NRXN1;SPTBN1;EMP2;GAK
prerank,steroid catabolic process (GO:0006706),-0.5217669023081739,-1.2512557522365124,0.23385300668151449,0.6937525239345675,1.0,5/10,28.08%,YWHAH;SPP1;HSD11B1;HSD17B11;HSD17B14
prerank,SNARE complex assembly (GO:0035493),-0.5329105793004685,-1.2511274084741721,0.20531400966183574,0.6918285453453972,1.0,2/10,6.64%,STXBP6;VAMP8
prerank,extracellular matrix assembly (GO:0085029),0.5116507176649275,1.2508522019762454,0.19806763285024154,0.697239340067994,1.0,5/23,6.83%,MFAP4;FBLN5;GAS6;EMILIN1;LTBP3
prerank,L-amino acid transport (GO:0015807),0.4872744458377477,1.2502137865893599,0.1849112426035503,0.6982732588584692,1.0,2/28,0.46%,SLC1A3;SLC7A2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.4189888056529322,-1.24944719779031,0.18699186991869918,0.6948886456561558,1.0,14/24,32.53%,PDE4D;CAMK2D;AKAP6;NOS1;CALM1;CALM3;CASQ2;FKBP1A;CALM2;DMD;SRI;GSTO1;JPH2;FKBP1B
prerank,response to UV-B (GO:0010224),0.583760306757602,1.2491826279112392,0.22563176895306858,0.7006412788166964,1.0,3/12,9.71%,MFAP4;IL12B;STK11
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.597358797797752,1.2488295654413475,0.22934232715008432,0.7007337029474668,1.0,3/11,11.45%,COLEC12;RFTN1;TNIP2
prerank,protein K48-linked deubiquitination (GO:0071108),-0.41686453943819607,-1.247732878036573,0.1786833855799373,0.6978202940683113,1.0,7/23,13.15%,OTUD7B;MINDY2;MINDY1;OTUD7A;OTUD4;YOD1;TNFAIP3
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.40651120610376956,1.2476885774568662,0.16219512195121952,0.7032553125493369,1.0,19/86,10.79%,BMP6;ZEB2;BMPR1A;CCN1;INHBE;TGFBR1;SULF1;SLC2A10;TWSG1;ACVR1;ENG;CDH5;CRB2;RBPJ;DAB2;RBPMS;BMP2;STK11;BMP15
prerank,neuron projection fasciculation (GO:0106030),0.6015324003164809,1.2471540699490942,0.23208191126279865,0.7039147727712608,1.0,5/10,10.67%,EPHA4;SEMA5A;ARHGAP35;EPHB2;EPHB3
prerank,cellular response to lipid (GO:0071396),0.37407778229234034,1.2469545213402333,0.08804347826086957,0.703512220795253,1.0,22/191,8.79%,EPHA3;RORA;ADCY1;ROCK2;PID1;ADCY2;AR;SERPINE1;LYN;ATP1A2;ADCY5;WNT8B;WNT6;SFRP1;AXL;PTK7;TFPI;WNT5B;SPHK2;NR1D1;EGFR;MGST1
prerank,cellular response to metal ion (GO:0071248),-0.2987205700589525,-1.2467550425765017,0.052980132450331126,0.6986314576980562,1.0,22/123,4.61%,DLG2;SLC12A2;MEF2C;CPNE8;CLIC4;NLGN1;CDH1;ANK3;PLCG2;B2M;IQGAP1;CPNE3;GLRA1;CAMK2D;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.42735986085558564,1.246749102848816,0.18375499334221038,0.7031780432056327,1.0,9/59,8.68%,TCF7L2;CDK8;MITF;RUNX2;TNRC6B;MED14;MED16;MED8;TNRC6A
prerank,positive regulation of biosynthetic process (GO:0009891),0.462506555668447,1.246334376645618,0.19915254237288135,0.7035048195244291,1.0,14/40,16.49%,ZBTB20;RUNX1;WNT4;APOE;APOA1;TLR6;CREBL2;SLC5A3;RGCC;F2;MTPN;BMP4;AKT1;CREB3L1
prerank,regulation of cholesterol esterification (GO:0010872),0.608276858690656,1.245115327245011,0.25089605734767023,0.7063043825578981,1.0,3/10,7.09%,APOE;APOA1;AGTR1
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.543428282769649,-1.2443439736082769,0.20941176470588235,0.7041831040066115,1.0,4/10,11.10%,KDM1A;DISC1;VEGFA;CX3CR1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5558178560570575,1.2442195089055017,0.2098976109215017,0.7081245142001749,1.0,5/14,4.91%,LRP1;SERPINE1;TPM1;BMPR1A;IGFBP5
prerank,leukocyte tethering or rolling (GO:0050901),-0.4639613916224413,-1.243727452905906,0.19473684210526315,0.7037640984988225,1.0,7/17,24.29%,JAM2;ITGA4;CX3CR1;ROCK1;VCAM1;SELP;ITGB7
prerank,cellular modified amino acid catabolic process (GO:0042219),0.5516777598230528,1.243593837734092,0.21475409836065573,0.709061803680645,1.0,5/15,11.61%,GGACT;CHAC2;HOGA1;DPEP1;SARDH
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4463517164645537,1.243382686846795,0.19205298013245034,0.7087023054114248,1.0,8/52,8.50%,EPHA3;PDPK1;PIK3R1;LRP1;ITGA3;PTPN9;EGFR;EPHB2
prerank,cGMP metabolic process (GO:0046068),-0.517390516475098,-1.2432814307922597,0.21975308641975308,0.702977047369187,1.0,5/12,8.63%,GUCY1B1;GUCY1A1;PDE2A;NPR1;PDE9A
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4476473676248789,1.2431259359379896,0.19078947368421054,0.7085140457423209,1.0,8/52,8.50%,EPHA3;PDPK1;PIK3R1;LRP1;ITGA3;PTPN9;EGFR;EPHB2
prerank,protein O-linked mannosylation (GO:0035269),0.5437382563311813,1.2427970971176394,0.22274881516587677,0.7085133067186601,1.0,4/18,6.02%,TMTC1;TMTC4;LARGE1;LARGE2
prerank,cAMP-mediated signaling (GO:0019933),0.5135866193627001,1.2427792792195451,0.2096530920060332,0.7075831438164993,1.0,6/24,6.09%,ADCY1;ADCY2;KSR1;RAPGEF2;PDE3A;PDE7B
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4182638585087577,1.2427235248280568,0.1647940074906367,0.7067601102978671,1.0,13/72,8.54%,NRP1;ROBO1;ABCA1;DLC1;KANK1;ITGA3;RIPOR2;APOE;APOA1;LPAR1;ARHGEF18;ARHGAP35;ARRB1
prerank,peptidyl-amino acid modification (GO:0018193),0.6053993759583222,1.2425276207546783,0.24471830985915494,0.7064020811102399,1.0,3/10,6.49%,FKBP7;APOA1;TTLL4
prerank,cellular amino acid catabolic process (GO:0009063),0.40635283433661556,1.2423453022445745,0.16503667481662593,0.7059957399540476,1.0,14/87,8.17%,GLUL;IVD;ABAT;HMGCLL1;BCKDHB;PHYKPL;TDO2;DDO;HOGA1;ASPA;HNMT;KYNU;DBT;ALDH7A1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5265848109188964,1.2418043881836194,0.24519230769230768,0.7067131548162102,1.0,9/18,24.51%,PIK3R1;RNF185;BCL2L11;TMEM259;RNFT1;BAG6;DDIT3;ATXN3;PMAIP1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.48069592885098805,-1.2416920697918705,0.19458128078817735,0.7057208882649104,1.0,6/14,16.84%,THBS1;ECSCR;ITGA4;CD40;GPER1;ANO6
prerank,positive regulation of potassium ion transport (GO:0043268),-0.35906675466483146,-1.2413068222144972,0.1437908496732026,0.704560988827814,1.0,12/38,14.37%,FHL1;KCNJ2;KCNJ3;KCNMA1;KCNN2;KCNQ1;AKAP6;KCNMB2;KCNJ15;GNB1;KCNJ10;GNG2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5665953186507298,1.2411241738235055,0.23117338003502627,0.707852848468788,1.0,2/12,2.63%,CCDC68;NINL
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.44902431626014283,1.2409937677599092,0.19759679572763686,0.7072778374005146,1.0,12/48,14.87%,ROBO1;DCST1;GAS6;RFFL;APOA1;IRAK3;STAT2;PARP14;SLIT3;CCDC3;MUL1;NR1H3
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5332514341460542,1.240571249218684,0.22022838499184338,0.7076192506429917,1.0,3/18,4.11%,ADCY1;CAMK1D;CRTC3
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3541348220446798,1.240409379189177,0.04573170731707317,0.7070951144653453,1.0,95/476,15.79%,IGF1;TCF4;COL1A1;RORA;TBL1XR1;TEAD1;SMAD3;ARNT2;AR;MITF;RUNX1;IL31RA;NR2F2;GLI2;SALL1;ZIC1;GLI3;RUNX2;FZD2;NKX2-1;SP100;YAP1;WNT4;NFIB;APOE;TGFBR1;LBH;IRF1;RLF;ZIC2;ACVR1;SFRP1;MT3;FZD1;CREB3L2;NEUROD1;PHIP;ARID1B;MLLT3;ATXN7L3;ATOH8;SMARCA1;MED14;PML;ING5;MAP2K1;RNF10;SMARCC2;NR1D1;RAI1;MED16;ZMIZ1;EGFR;FOXC2;BMP2;ARHGEF11;PICALM;CREBL2;NSD1;BICRAL;GLIS2;FGF2;NR1D2;ZKSCAN3;RNF6;TFAM;KMT2A;CEBPB;NFE2;EGF;REST;GLI1;NIBAN2;BTRC;ZNF318;HMGN5;NPAS2;KMT2E;TRIP4;MYCN;GATA6;YAF2;ETS1;TADA3;HDAC4;FOXK2;NR1H3;FUBP3;DYRK1A;RXRA;PHF8;CDKN1C;SHH;MYBL1;BMP4
prerank,aortic valve morphogenesis (GO:0003180),0.4816244569374688,1.2398806285070625,0.20238095238095238,0.7077711463049843,1.0,3/30,0.88%,ROBO1;ROCK2;ELN
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.5304515274958127,-1.2397887939681458,0.20634920634920634,0.7071346997218051,1.0,3/10,10.19%,PODXL;PIEZO1;SKAP1
prerank,RNA metabolic process (GO:0016070),0.3846493837254423,1.2392437421753952,0.14169570267131243,0.7086908722574883,1.0,40/127,22.22%,POLR2D;CELF2;RBMS1;ATXN1;RBFOX2;SND1;DDX17;RBMS2;RBPMS;METTL14;HNRNPR;HNRNPA1;POLR2C;RNASEL;PARN;DDX3X;EXOSC7;WTAP;MTREX;RBM39;RBM6;SYNCRIP;RBM5;RNASEH2C;LSM8;PAPOLG;ALKBH1;HNRNPC;DICER1;POLR2L;METTL3;FTO;AGO4;DDX24;HNRNPH1;HNRNPU;SIDT2;NCBP2;PAPOLA;RBM4
prerank,macrophage activation (GO:0042116),-0.3836791526592837,-1.2391811480745438,0.1492063492063492,0.7067033388449542,1.0,17/34,28.55%,CD93;PLCG2;DYSF;LBP;FOXP1;JAK2;IFI35;APP;SBNO2;TLR4;CLU;AGER;AIF1;IFNGR1;TREM2;TMEM106A;TLR1
prerank,neuron development (GO:0048666),-0.29196979830625114,-1.2391590377895072,0.04964539007092199,0.7044477733907649,1.0,33/141,9.10%,FRY;CNTNAP2;MEF2C;GPM6A;MAP2;PBX3;NLGN1;PPP1R9A;TENM2;ETV1;TENM3;PPT1;GPM6B;TENM4;STX3;SH3GL2;TGFB2;CNTN4;MYT1L;B4GALT5;MYOC;VSX1;EPHA5;CDK5;OPHN1;RP1;TMEM108;RASGRF1;RAB11A;ALK;ULK1;ARL3;BTG2
prerank,meiosis I (GO:0007127),0.4967693979734008,1.238971033673573,0.21865443425076453,0.7085854068123693,1.0,8/23,17.88%,HSF2BP;BCL2L11;ZSCAN21;SYCP3;MYBL1;FOXJ3;SGO1;DDX4
prerank,GPI anchor biosynthetic process (GO:0006506),-0.39352270255813726,-1.2389435346603295,0.1945288753799392,0.7028423806723334,1.0,10/30,18.44%,DPM1;PIGP;PGAP2;PIGB;DPM3;PIGL;PIGU;DPM2;PIGO;PIGV
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4369527373870105,1.2379379082962534,0.18096514745308312,0.7107912878296808,1.0,5/47,6.93%,PTGIS;ROCK2;WNT4;RAPGEF2;SIK1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5236883486596777,1.2379210770942042,0.23015873015873015,0.7098676216556175,1.0,5/18,11.02%,SETD7;ASH1L;SETD1A;KMT2A;SETD4
prerank,positive regulation of monooxygenase activity (GO:0032770),0.4944242793980815,1.2377257446580663,0.22848200312989045,0.7095223192519345,1.0,4/26,3.79%,GDNF;NOS1AP;APOE;NPR3
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.49337050802185334,-1.2374471666981768,0.2216867469879518,0.7052811017768876,1.0,7/13,13.72%,PDE4D;CAV1;ANK3;CAMK2D;CALM1;CALM3;CASQ2
prerank,iron ion homeostasis (GO:0055072),0.4331890144020751,1.2374059532492385,0.18169934640522875,0.7095562461864983,1.0,8/58,6.43%,BMP6;CP;SCARA5;HEPH;NEO1;SLC11A2;CYBRD1;ACO1
prerank,negative regulation of T cell differentiation (GO:0045581),0.6024127767004059,1.2372765615310342,0.23977695167286245,0.7089881396448091,1.0,4/10,15.79%,GLI3;IRF1;MDK;BMP4
prerank,cellular response to mechanical stimulus (GO:0071260),-0.35970349983180006,-1.2371627297134826,0.12734082397003746,0.7039472572782085,1.0,11/46,14.53%,PIEZO2;F11R;PIEZO1;CRADD;MAP3K1;PDE2A;MAPK8;CASP8;CD40;MAPK3;BAK1
prerank,establishment of spindle orientation (GO:0051294),0.47510941945230917,1.237057052045787,0.19530102790014683,0.7086620294066254,1.0,13/28,23.02%,GJA1;ZW10;SPDL1;UBXN2B;LLGL1;CENPA;HTT;NUMA1;NSFL1C;NDE1;FBXW11;LLGL2;ITGB1
prerank,smoothened signaling pathway (GO:0007224),0.47219414150760713,1.2370352398947337,0.21574344023323616,0.7077654837149688,1.0,8/32,12.43%,GLI2;GLI3;SMO;B9D1;IFT27;EVC2;PTCH2;GLI1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.4205081400655502,-1.237034325618377,0.18873239436619718,0.7020271303960328,1.0,6/25,7.72%,GRID2;MEF2C;GRIN2A;GLRA1;GRIN2B;GSK3A
prerank,cellular response to insulin stimulus (GO:0032869),0.38779517590636237,1.2368911684386588,0.12763466042154567,0.7072255541671072,1.0,14/124,9.03%,ATP6V0A4;PDPK1;IGF2;ENPP1;TBC1D4;PIK3R1;INSIG2;PHIP;CPEB1;ZFP36L1;TRARG1;FOXC2;ZNF106;KAT2B
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.4871553005591067,-1.2359347257358722,0.2099056603773585,0.703246514540297,1.0,8/13,16.51%,PTPRT;JAK2;HES1;MGAT5;CRLF2;PIGU;PTPRC;JAK3
prerank,apical protein localization (GO:0045176),-0.5413287867483662,-1.2358618760921902,0.2540045766590389,0.7011978398992295,1.0,3/10,2.18%,ATP8B1;ACTB;MAL
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.4705198088369689,-1.2357722032048724,0.1867612293144208,0.6992087705176511,1.0,4/16,7.72%,PRCP;KLK2;DDAH1;GSK3A
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.5301465142322725,1.2357553688277834,0.21951219512195122,0.7098290957488345,1.0,5/17,5.60%,ITGA3;SULF1;FSTL1;TWSG1;CASK
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.4717650446709001,1.2356134416718845,0.21333333333333335,0.709280961217173,1.0,7/31,12.34%,PYCR1;STAR;HSD3B2;PYCR3;SRD5A1;LIAS;MOCS1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4930210396332292,-1.2349245616915794,0.22528735632183908,0.6996496132139842,1.0,5/12,13.86%,CAV1;CTNNA3;JUP;RYR2;DSG2
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5393238201134657,1.23453629212668,0.2435064935064935,0.7115123255109278,1.0,3/16,6.83%,SOX5;SP7;LTBP3
prerank,positive regulation of protein localization to membrane (GO:1905477),0.4026138620016756,1.2340932442394446,0.1716686674669868,0.7118420052466905,1.0,14/98,9.87%,EPHA3;PDPK1;CEMIP;PIK3R1;LRP1;BCL2;ITGA3;PDCD5;PTPN9;MYO1C;EGFR;EPHB2;SLC5A3;PRKN
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.35202769769001874,1.2338531525024525,0.04048582995951417,0.7116273685817918,1.0,107/572,15.03%,TCF7L2;BMP6;LDB2;IGF2;FHL2;TRPS1;TBL1XR1;ATXN1;SMAD3;ZEB2;AR;MITF;NKX6-1;GLIS3;RUNX1;NR2F2;GLI2;DACT1;SALL1;KCNIP3;WWC2;GLI3;CBX7;ZEB1;AEBP1;ARID5B;PRDM5;NKX2-1;FGFR2;MDFI;THRB;SP100;YAP1;FOXP2;ASCL1;NFIB;DNMT3A;RARB;JDP2;NFIX;MXI1;NEDD4;SMURF2;ZHX2;ETV6;RARG;BCL6;TBX3;CUX2;SKI;BCOR;MBD2;CPEB3;SIRT2;SAP30;MTA2;NR1D1;DR1;RBPJ;OSR1;MTA3;NCOR1;FOXC2;DAB2;BMP2;BRMS1L;JAZF1;MZF1;GTF2IRD1;ZBTB4;NSD1;ZBTB1;HEXIM2;PRKN;GLIS2;IFI27;NCOR2;CXXC5;NR1D2;ZKSCAN3;ZNF177;CEBPB;BHLHE41;SPDEF;HDAC8;REST;PHF21A;PER3;IMPACT;USP9X;TCF25;PEX2;PAF1;GATA6;FRK;HIVEP1;IGBP1;SUFU;ZNF25;TCERG1;ZNF148;HDAC4;ZNF219;HSBP1;NR1H3;RNF2;UBE2D1
prerank,positive regulation of vasculature development (GO:1904018),0.3984193806839534,1.2338190997229763,0.16117216117216118,0.7107612572244605,1.0,13/94,5.87%,PTGIS;PDPK1;SASH1;RUNX1;SERPINE1;VASH2;SEMA5A;STIM1;ITGB8;CYP1B1;CTSH;SMOC2;CDH5
prerank,pseudouridine synthesis (GO:0001522),0.5513170319309443,1.2329963273469173,0.2218700475435816,0.7123055984648687,1.0,5/13,19.11%,PUS3;RPUSD2;TRUB2;PUSL1;TRUB1
prerank,engulfment of apoptotic cell (GO:0043652),0.5436487922523497,1.2329203010261802,0.24373956594323873,0.7116004114090327,1.0,3/15,6.79%,RHOH;RHOBTB1;RHOBTB2
prerank,positive regulation of B cell proliferation (GO:0030890),-0.3920591406740241,-1.2327458043177049,0.17261904761904762,0.7041611227613539,1.0,10/29,16.80%,MEF2C;VAV3;CD38;TFRC;NFATC2;CD81;CD40;GPR183;PTPRC;CD320
prerank,T cell mediated immunity (GO:0002456),-0.4952289905333622,-1.2327339918623994,0.23132530120481928,0.701963480172316,1.0,3/13,6.27%,CADM1;EMP2;CD55
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5651783711205938,1.2327158885305434,0.23024054982817868,0.7112837787157927,1.0,3/12,11.14%,AKR1B1;STAR;TSPO
prerank,triglyceride homeostasis (GO:0070328),0.48550326965537527,1.232556547748726,0.23851851851851852,0.710842906348874,1.0,3/26,4.39%,RORA;APOE;APOA1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5320675146405566,1.2325369737306264,0.22549019607843138,0.7099483386173369,1.0,5/17,11.52%,SLC8A1;ATP1A2;CACNA1C;TRPM4;CACNA1G
prerank,ventricular septum morphogenesis (GO:0060412),0.483522734577165,1.2311922655117182,0.2296718972895863,0.7132232207061558,1.0,5/27,4.60%,ROBO1;TGFBR3;BMPR1A;TGFBR1;ACVR1
prerank,regulation of lymphocyte migration (GO:2000401),-0.5186016377236615,-1.231009940510143,0.23129251700680273,0.7051103837550402,1.0,3/10,11.01%,JAM2;STK10;MSN
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.3710012114864698,-1.2306313383387162,0.15845070422535212,0.7039857508299833,1.0,9/39,7.26%,EFNA5;ACER2;THBS1;SPOCK1;NOTCH1;ADAM15;FZD4;MYOC;NEXMIF
prerank,regulation of cell adhesion (GO:0030155),0.3863992489318827,1.2300402532666692,0.1332560834298957,0.7158203772346906,1.0,30/129,14.18%,EPHA7;PLXNA2;ROCK2;ANGPT1;LYN;RHOD;TPM1;EPHA4;EPHA8;PPP3CA;RIPOR2;SEMA5A;FBLN1;NUAK1;SRC;IL12B;DSCAM;EPHB2;RSU1;MIA3;MYADM;ITGAV;EPHB3;PLXNC1;DACT2;SIPA1;MDK;P4HB;PLXNA1;PLXNB2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.4208834960151,1.2299925301741412,0.18181818181818182,0.715013362394793,1.0,13/61,13.03%,EYA2;EYA1;FGFR4;PDGFRB;SMOC2;PML;EGFR;FGF2;PPP1R10;RGCC;ERCC8;USP9X;NPAS2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.43618355245717433,1.229642920688745,0.2114047287899861,0.7151417653968825,1.0,15/45,16.14%,PIK3R1;HNRNPLL;BUD23;MAP2K1;DXO;EGFR;RBM22;DIMT1;NMD3;WDR43;MYCN;TRMT112;DYRK1A;BMP4;SLC38A2
prerank,regulation of potassium ion transport (GO:0043266),-0.3872398185096081,-1.2283811036396983,0.17751479289940827,0.7087922152353421,1.0,8/31,6.50%,DPP10;FHL1;KCNIP4;PTK2B;ANK3;KCNAB1;KCNN2;NOS1
prerank,pinocytosis (GO:0006907),0.5982479134722358,1.2280685196346006,0.2595978062157221,0.7190721219212768,1.0,3/10,7.18%,AHSG;SNX33;CARMIL1
prerank,positive regulation of calcium ion import (GO:0090280),0.5754206517849293,1.2278474851821315,0.268630849220104,0.7187273782993442,1.0,2/12,7.00%,PDGFRB;SPHK2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.5655519204670603,1.227089078346059,0.255,0.7201041010028295,1.0,4/12,14.87%,ABCA1;ITGB3;ITGAV;NR1H3
prerank,response to axon injury (GO:0048678),0.5251481419046853,1.2269096936522341,0.24006359300476948,0.7196890443306446,1.0,3/18,4.42%,NREP;DPYSL3;MTR
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.4665238293523253,1.22568401052819,0.2104499274310595,0.7225796270507516,1.0,4/35,3.86%,NRP1;PLXNA2;SEMA3D;SEMA5A
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5183962474009448,1.2256328776388792,0.2357473035439137,0.7218100028313006,1.0,7/20,8.88%,TGFBR3;OLFM1;TGFBR1;TBX3;ENG;RBPJ;BMP2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.4169893229106674,1.2243304728800284,0.1768617021276596,0.7248092544471151,1.0,24/62,23.03%,POLR2D;MLLT3;GTF2H5;CCNK;POLR2C;MNAT1;PAF1;CDK12;NELFE;ADRM1;AFF4;CCNT2;CDC73;ELOF1;POLR2L;ELP4;MLLT1;CCNT1;LEO1;NCBP2;CDK7;ERCC3;ERCC2;CDK13
prerank,regulation of postsynapse organization (GO:0099175),-0.39712824842964567,-1.2242310063437043,0.17008797653958943,0.7197774874531855,1.0,13/28,12.08%,SHANK3;PPFIA2;ARHGAP44;IL1RAPL1;SIPA1L1;SRCIN1;CDK5;TANC2;ZDHHC15;ABHD17B;KIF1A;HOMER1;ABI3
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.341809421035604,-1.2241272575052746,0.14785992217898833,0.7178557017758501,1.0,23/57,21.42%,RPS24;RPS19;RIOK1;RPL7;RPL38;RPL35A;RPS15;RPS7;PAK1IP1;RPL11;METTL17;RPL26;MALSU1;NVL;RPL5;RPL14;RPS6;RRP36;NPM1;URB2;NOP16;RPF2;RRS1
prerank,"wound healing, spreading of cells (GO:0044319)",0.4826047298654388,1.2236394832674267,0.23975720789074356,0.7260753489013916,1.0,4/24,7.82%,COL5A1;CCN1;PDPN;ARHGAP35
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5103015989298236,1.223582174233241,0.2391304347826087,0.7253121707094866,1.0,5/22,12.01%,ZBTB20;APOE;APOA1;CREBL2;F2
prerank,focal adhesion assembly (GO:0048041),0.5152550592710603,1.2234996611286628,0.24056603773584906,0.7246203068638185,1.0,4/21,6.32%,ACTN2;DLC1;RHOD;SRC
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.36613748138443325,1.223491883271446,0.12008733624454149,0.723694652649303,1.0,38/208,14.71%,PDPK1;WLS;RORA;GJA1;RHOH;PELI2;OPTN;CFLAR;CCL19;TLE1;EDAR;ROR1;MAPKBP1;SPHK2;RNF31;LPAR1;NR1D1;TLR6;NEK6;SLC20A1;LTBR;PRKN;GPR89A;CXXC5;TMED4;CARD9;IKBKE;TNIP2;UFL1;TBK1;RIPK2;USP10;MUL1;AKAP13;PLK2;FLNA;TNFRSF1A;RIOK3
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.4833050372099592,1.2230907788578433,0.2314540059347181,0.7239319598921151,1.0,4/27,4.32%,SLC1A3;SLC7A2;SLC6A9;SLC22A2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4090415894051175,1.2223263761265528,0.17813267813267813,0.7253502316040202,1.0,15/80,12.15%,EPHA7;UACA;DAPK1;SH3RF1;GAS6;PDCD5;MT3;USP47;SRC;DPEP1;BCAP31;CARD9;DDX3X;YWHAE;REST
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5217236192852084,1.2221648274067802,0.23491027732463296,0.7249085509327736,1.0,6/16,14.08%,ADCY7;APPL2;F2;PDCD4;CHID1;ABCD2
prerank,cellular copper ion homeostasis (GO:0006878),-0.47762815682066817,-1.222095273529936,0.22518159806295399,0.7219292496372831,1.0,8/14,27.09%,ATOX1;ARF1;ATP7A;APP;SLC31A1;MT2A;SLC31A2;PRNP
prerank,spliceosomal snRNP assembly (GO:0000387),-0.36534357546504015,-1.222002197694891,0.17301038062283736,0.7199826520235553,1.0,14/38,22.89%,SNRPB;PRMT7;SNRPD1;SRSF12;LSM2;SNUPN;PRPF31;USP4;SNRPD3;GEMIN8;STRAP;COIL;CD2BP2;GEMIN7
prerank,small GTPase mediated signal transduction (GO:0007264),0.39882085557804325,1.2219902953934512,0.17200474495848161,0.7244825892126703,1.0,18/103,9.95%,IGF1;RIN2;KSR1;PLD1;CCNA2;ARHGAP18;TIAM2;RRAS2;RAPGEF2;MRAS;ARHGAP32;ARHGEF18;PLD2;RGL1;ARFIP2;RUNDC3A;NTN1;FGF2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.37821285637671515,-1.2219774023073826,0.1760797342192691,0.7178323801194728,1.0,10/33,11.72%,MEF2C;THBS1;NOTCH1;ACVRL1;MECP2;ATP2B4;JUP;VASH1;KLF4;TGFB1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5881035509965858,1.221758997108919,0.24285714285714285,0.7233315510855686,1.0,4/10,14.70%,SMPD2;SPHK2;NSMAF;TNFRSF1A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5881035509965858,1.221758997108919,0.24285714285714285,0.7233315510855686,1.0,4/10,14.70%,SMPD2;SPHK2;NSMAF;TNFRSF1A
prerank,regulation of T cell differentiation (GO:0045580),0.4630166597964276,1.221526858525532,0.23652694610778444,0.7230886847723462,1.0,5/33,9.50%,RHOH;RUNX1;TCF7;ZMIZ1;ZBTB1
prerank,regulation of lipid metabolic process (GO:0019216),0.40278008014294736,1.2210891825054369,0.17980295566502463,0.7235459245615735,1.0,27/88,20.17%,RORA;TBL1XR1;FGFR4;CHD9;C1QTNF2;PRKAG2;MVK;NCOA2;GNB3;SREBF1;NR1D1;NCOR1;IDI1;NCOR2;NR1D2;CCDC3;FASN;HELZ2;CERS2;RXRA;HMGCS1;SP1;CARM1;SCD;NCOA6;ABCA7;PSAP
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.4247393014725925,-1.2205156452115,0.18904109589041096,0.720187008718339,1.0,6/20,6.40%,SLC12A2;KCNJ2;ATP1A1;NEDD4L;KCNMA1;ATP1B1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.48408529640635106,-1.2203824469195355,0.20705882352941177,0.7184274215009285,1.0,4/13,4.47%,NR3C2;ESR1;ABHD2;MED1
prerank,positive regulation of chemotaxis (GO:0050921),0.4508575100678212,1.2201015981049133,0.1906779661016949,0.7257595807305047,1.0,9/43,9.95%,NRP1;IL6R;PDGFRB;SEMA5A;CCL19;SMOC2;NTRK3;DSCAM;FGF2
prerank,protein neddylation (GO:0045116),-0.48484330195835734,-1.220047752724033,0.24317617866004962,0.717278175812162,1.0,3/13,10.26%,RBX1;UBA3;DCUN1D4
prerank,negative regulation of cell division (GO:0051782),0.5829734996786222,1.2199454335637938,0.23853211009174313,0.7253279440238672,1.0,1/11,1.04%,TXNIP
prerank,purine nucleotide metabolic process (GO:0006163),-0.4135468283533002,-1.218981168574331,0.1783625730994152,0.7182191906142524,1.0,9/24,18.48%,NT5E;NT5C2;PRPS2;NT5C1A;GDA;FHIT;NT5C;PNP;GPX1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.43165153042553656,-1.218973981816628,0.1830238726790451,0.7160627051052815,1.0,5/21,11.86%,PRKCH;SLC39A10;RPS3;FOXP1;CD81
prerank,cellular response to increased oxygen levels (GO:0036295),-0.4921746753433176,-1.2189543202002113,0.2085201793721973,0.7139369365956835,1.0,4/11,22.41%,CAV1;FOXO1;ATP6V0A2;ATG7
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.34376840483784715,1.2187598837058773,0.014014014014014014,0.7281161695299458,1.0,211/1082,16.65%,IGF1;TCF7L2;TCF4;BMP6;LDB2;AUTS2;COL1A1;NFIA;IGF2;RORA;TBL1XR1;PID1;TEAD1;CDK8;PIK3R1;GDNF;SMAD3;PBX1;ZEB2;ARNT2;AR;DCN;MITF;NKX6-1;GLIS3;RUNX1;IL31RA;SERPINE1;NR2F2;GLI2;SALL1;SP7;ZIC1;OGT;GLI3;BMPR1A;RUNX2;CCN1;PPP3CA;FZD2;NKX2-1;FGFR2;THRB;SP100;YAP1;WNT4;ASCL1;NFIB;ZNF462;SSBP3;APOE;MAML3;MLXIP;TGFBR1;RARB;NFIX;LBH;CRTC3;IRF1;RLF;MEOX2;ZIC2;ACVR1;SFRP1;RFX5;MT3;FZD1;CREB3L2;NEUROD1;NCOA2;PHIP;RARG;KLF15;ARID1B;MLLT3;BRD8;TBX3;ATXN7L3;ENG;EPAS1;HLF;SKI;INO80;BCL9;ATOH8;SMARCA1;MED14;PML;NR5A1;NFE2L2;ING5;DDX17;ATAD2B;WWTR1;CEBPA;ZBTB38;SIRT2;EIF2AK3;MAP2K1;SREBF1;RNF10;SMARCC2;NR1D1;RAI1;DR1;MED16;RBPJ;OSR1;TET1;ZMIZ1;EGFR;FOXC2;ARRB1;DAB2;RGMA;STAT5B;BMP2;ARHGEF11;KAT2B;PICALM;ARNT;CREBL2;MZF1;SMAD1;NSD1;BICRAL;CCNK;CREB3L4;CREB3;PRKN;GLIS2;FGF2;RNASEL;CSRP3;FOXA1;ZSCAN21;NR1D2;ZKSCAN3;RNF6;TFAM;DDX3X;KMT2A;NKX2-8;CEBPB;TNIP2;RGCC;NFE2;EGF;HDAC8;TBK1;REST;RHOQ;STAT6;GLI1;NR4A1;NIBAN2;WDR43;BTRC;ZNF318;HMGN5;ZNF513;NPAS2;RIPK2;KMT2E;TRIP4;SMARCD2;MYCN;GATA6;HELZ2;HIVEP1;YAF2;ARF4;ETS1;TCF12;NCOA3;TADA3;TCERG1;AKAP8L;TAF9;HDAC4;MED19;FOXK2;FSTL3;TNFRSF1A;BMP5;NR1H3;FUBP3;SMARCB1;CAMTA2;DYRK1A;HOXC4;SS18;RXRA;PHF8;TFCP2;CDKN1C;SHH;MYBL1;BMP4;MTF1;PIK3R2;ZBTB17;TFDP1;DYRK1B;AKT1;POGZ;ATM;NCOA7;ZNF423;PCBD2;FOXJ3
prerank,negative regulation of cellular component movement (GO:0051271),0.5419164944852175,1.2186031506527513,0.24717285945072698,0.7276288741395157,1.0,3/15,3.92%,TGFBR3;SP100;FBLN1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.4456616822743766,1.218133891478455,0.24204702627939143,0.728102172518536,1.0,4/38,2.52%,PTGIS;ROCK2;SMAD3;NOS1AP
prerank,regulation of cellular pH (GO:0030641),-0.39911563148855744,-1.217418663955046,0.17251461988304093,0.7166917066505104,1.0,6/29,9.81%,SLC4A10;SLC9A2;SLC9A6;SLC4A8;SLC9A7;SLC26A6
prerank,in utero embryonic development (GO:0001701),0.4855248030111334,1.2172118252462363,0.23950233281493002,0.7300146687540128,1.0,5/25,5.16%,IGF2;ARNT2;FGFR2;TGFBR1;LIG4
prerank,positive regulation of heart rate (GO:0010460),0.5214209666245551,1.2162588854186318,0.26,0.7321193594112797,1.0,4/17,9.70%,ADRA1B;TPM1;TRPM4;ADM
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3868736640845287,-1.2151533034471098,0.1853035143769968,0.7216605224607691,1.0,13/31,12.08%,SHANK3;PPFIA2;NLGN1;ARHGAP44;SIPA1L1;SRCIN1;CDK5;NGEF;TANC2;LRP8;ZDHHC15;KIF1A;ABI3
prerank,positive regulation of vascular permeability (GO:0043117),0.5560511068297657,1.214994839843062,0.2555366269165247,0.7350843189024355,1.0,4/12,7.48%,BMP6;ANGPT1;PDE3A;TJP3
prerank,establishment of mitotic spindle orientation (GO:0000132),0.4890981570790548,1.2147501744417806,0.23647604327666152,0.7348516182896957,1.0,11/23,23.02%,GJA1;ZW10;SPDL1;UBXN2B;CENPA;HTT;NUMA1;NSFL1C;NDE1;FBXW11;ITGB1
prerank,blood circulation (GO:0008015),0.43058562455058547,1.214664370017202,0.19515477792732167,0.7341747806051266,1.0,7/49,7.09%,COL4A3;ROCK2;ELN;SERPING1;MEOX2;BDKRB2;AGTR1
prerank,phasic smooth muscle contraction (GO:0014821),0.5788278536856795,1.2144232577002947,0.2549019607843137,0.7339776073548374,1.0,1/10,1.20%,GDNF
prerank,post-translational protein modification (GO:0043687),0.35061031869182363,1.213950117105988,0.09270833333333334,0.7345163743775969,1.0,82/332,20.63%,LTBP1;CP;FBN1;SPSB1;MATN3;AHSG;PRKCSH;IGFBP4;OBSL1;LAMC1;CCN1;APOE;GAS6;FSTL1;FBXL19;CSF1;APOA1;APLP2;PSME4;IGFBP5;SERPIND1;EPAS1;CST3;TNC;CUL4B;STT3A;CUL5;RCN1;FBXL3;DNAJC3;FN3KRP;COMMD1;MIA3;RBBP7;ASB12;BMP15;PDIA6;IGFBP3;FBXO9;DCAF8;FBXL12;FBXO11;ERCC8;FBXO4;KBTBD7;FEM1C;ITIH2;BTRC;GPS1;COPS3;P4HB;ASB6;FSTL3;WDR5;ASB1;CUL7;BMP4;KCTD7;MELTF;SENP8;KTN1;COPS2;CALU;CKAP4;HRC;PSMB5;LAMB2;PSMC2;PSMD4;MXRA8;FN3K;PSMD1;RABGGTA;FBXL18;RBBP5;ASB13;PRSS23;DCAF11;PSME3;DCAF6;HIF3A;FEM1B
prerank,epithelial cell-cell adhesion (GO:0090136),0.5695670987037065,1.2137310121313243,0.2921146953405018,0.7342622705165736,1.0,4/11,6.99%,PLEKHA7;KIT;ITGB5;VCL
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.44669340781693795,1.2136109647532147,0.2338935574229692,0.7337151321758416,1.0,9/34,9.95%,PIK3R1;EPHA8;PDGFRA;KIT;PDGFRB;CCL19;WDR91;WDR81;FGF2
prerank,negative regulation of GTPase activity (GO:0034260),-0.41086158815363344,-1.2133776949309907,0.19578313253012047,0.7248827171357344,1.0,4/22,4.65%,LRCH1;F11R;SH3BP4;RDX
prerank,response to muscle stretch (GO:0035994),0.5270899741760322,1.2127842308819952,0.26288659793814434,0.735209626835319,1.0,2/15,1.25%,SLC8A1;GSN
prerank,regulation of response to interferon-gamma (GO:0060330),-0.46707834947022847,-1.2127491157502666,0.21065989847715735,0.7246914006203137,1.0,4/14,15.29%,PTPN2;HSP90AB1;JAK2;CDC37
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.36339373364272104,-1.2123891916723175,0.17921146953405018,0.7237015624612262,1.0,8/35,7.36%,SGIP1;BICD1;B2M;PPT1;CBL;HIP1R;RAB21;HNRNPK
prerank,smooth muscle tissue development (GO:0048745),0.5868162223195563,1.2123153167603462,0.29381443298969073,0.735735051335534,1.0,6/10,19.53%,MYLK;SMO;ENG;SHH;BMP4;EFEMP2
prerank,cellular response to retinoic acid (GO:0071300),0.42751442222116365,1.2121837367833432,0.22496570644718794,0.7352061708150055,1.0,6/42,6.72%,EPHA3;LYN;WNT8B;WNT6;PTK7;WNT5B
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.38634408433040435,-1.212030708934549,0.17522658610271905,0.7227262823250725,1.0,7/30,5.35%,KCNJ2;ATP1A1;NEDD4L;GJC1;SCN1A;FGF12;KCNQ1
prerank,regulation of interleukin-4 production (GO:0032673),-0.4179903389993782,-1.211911967245799,0.22131147540983606,0.7209820331142924,1.0,6/21,18.55%,LEF1;SLC7A5;FCER1G;PRKCZ;ZFPM1;CD86
prerank,negative regulation of blood coagulation (GO:0030195),0.4442507275427532,1.211622981049377,0.2303448275862069,0.7360237452541222,1.0,6/38,5.52%,SERPINE1;SERPING1;PDGFRA;APOE;VTN;TFPI
prerank,regulation of endothelial cell proliferation (GO:0001936),0.3938256561160113,1.2114947917221102,0.1654501216545012,0.7354816983354812,1.0,20/88,12.45%,NRP1;ANGPT1;SPARC;NR2F2;VASH2;APOE;TGFBR1;SULF1;SEMA5A;VIP;ATOH8;AKT3;BMP2;ARNT;ITGB3;FGF2;PTPRM;RGCC;EGF;NR4A1
prerank,negative regulation of defense response (GO:0031348),0.40339226252853977,1.2108290541741982,0.1882793017456359,0.7365138384355916,1.0,20/77,17.67%,PTGIS;RORA;APOE;APOA1;MVK;CDH5;MAPKBP1;SIRT2;NR1D1;IRAK3;NMI;ITCH;TNFAIP6;SELENOS;MUL1;TNFRSF1A;NR1H3;SMPDL3B;FNDC4;DHX58
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5034025486335734,-1.210824626215386,0.23741007194244604,0.7224212414168878,1.0,5/11,10.14%,TBX1;LRP5;CTNNBIP1;TGFBR2;PDGFA
prerank,ncRNA transcription (GO:0098781),0.5513257931583747,1.2107673034578457,0.25996533795493937,0.7357648086942205,1.0,5/13,9.56%,POLR1G;BRF1;GTF3C1;USPL1;RPAP2
prerank,positive regulation of cellular process (GO:0048522),0.3477694959328443,1.2107542966355511,0.046464646464646465,0.7348857595618123,1.0,70/565,8.12%,IGF1;BMP6;IGF2;ESM1;CCN2;CAMK1D;COLEC12;GDNF;PDGFD;LRP1;AREG;AR;AHSG;TGFA;IL31RA;LYN;BCL2;RHOD;GRK5;FGFR1;TPM1;IL34;IL6R;EPHA4;OSMR;TULP1;PPP3CA;EPGN;FGFR2;FGFR4;PDGFRA;PDGFRB;TGFBR1;EFNB2;GAS6;NUPR1;CSF1;APOA1;SFRP1;MT3;NTF3;NEUROD4;AXIN2;NEUROD1;HTR1A;PHIP;CTSH;SLC30A2;PDPN;DYNC1H1;TBX3;PRKAA2;CXCL16;VIP;USP47;ZFP36L1;CDC42;INO80;TSLP;SMC5;IL12B;WWTR1;SIRT2;IL13RA1;RNF10;IL15RA;RAB25;PPP1R13L;NTRK3;TET1
prerank,protein destabilization (GO:0031648),0.46273000799651537,1.2101171070471421,0.2240117130307467,0.735813699689411,1.0,13/32,19.04%,GSN;CTSH;DERL1;NR1D1;FBXL3;RNF139;PRKN;BTRC;PEX2;MUL1;CDC73;TRIM21;HTT
prerank,bone morphogenesis (GO:0060349),0.5335403406778476,1.209895180648786,0.24915824915824916,0.7356151356622039,1.0,3/14,5.96%,CYP26B1;FGFR2;SKI
prerank,positive regulation of vasoconstriction (GO:0045907),0.5433898714338561,1.2098744485024937,0.26360544217687076,0.7347778676254755,1.0,2/13,9.31%,ADRA1B;TRPM4
prerank,regulation of ossification (GO:0030278),0.45530392507396295,1.2087687660001258,0.22158273381294963,0.7371474484133758,1.0,8/36,8.88%,ENPP1;DDR2;AHSG;ANKH;ACVR1;SFRP1;RBPJ;BMP2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5264212163342737,1.208445252950598,0.2685810810810811,0.7372584858523313,1.0,2/17,6.83%,GJA1;LTBP3
prerank,response to chemokine (GO:1990868),-0.4728724102038734,-1.208380364648386,0.24324324324324326,0.7279348048786789,1.0,2/13,0.72%,SLC12A2;LRCH1
prerank,positive regulation of protein transport (GO:0051222),0.40350720608329593,1.2083394422905236,0.19309462915601022,0.736666349417096,1.0,4/67,3.88%,IGF1;BMP6;MYO18A;MYH10
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.4009662541732636,-1.2083305012007077,0.2063953488372093,0.7259365564029376,1.0,13/25,22.34%,PDE4D;PDE4B;PLCG2;SPTBN1;RPS3;CD80;PTPRC;PNP;CD86;ANXA1;TRAF2;MAP3K7;MALT1
prerank,T cell migration (GO:0072678),-0.48535704995223405,-1.2083282434711125,0.2402745995423341,0.7238134029030027,1.0,4/13,14.35%,SLC12A2;S1PR1;MSN;GPR183
prerank,regulation of mRNA stability (GO:0043488),0.3723264958435669,1.2083078854680396,0.1552511415525114,0.7358497298518181,1.0,43/145,23.26%,SAMD4A;ROCK2;GDNF;TENT5A;CSDC2;IGF2BP2;PSME4;AXIN2;VIP;ZFP36L1;TENT5D;EXOSC1;METTL14;PARN;EXOSC7;SERBP1;LARP1;RC3H2;NUP214;MAPKAPK2;AKT1;IGF2BP1;DCP1A;PSMB5;PSMC2;PSMD4;METTL3;PRKCA;RC3H1;PSMD1;FTO;FASTKD3;YTHDF2;PSME3;HNRNPU;ZFP36L2;PSMA3;NOCT;EXOSC2;METTL16;PSMC5;XRN1;PSMA2
prerank,regulation of cellular response to heat (GO:1900034),-0.31159740024026517,-1.20732353896852,0.1201923076923077,0.724929506288741,1.0,30/77,25.08%,CD34;NUP93;HSPA8;NUP35;CAMK2D;NUP160;NUP153;HSP90AB1;NUP54;BAG4;CAMK2G;SIRT1;MTOR;MAPK3;DNAJB6;SEC13;EP300;NUP155;HIKESHI;RANBP2;NUP88;NUP62;AKT1S1;HSPH1;NUP85;MAPK1;GSK3B;NUP43;DNAJB1;CCAR2
prerank,transport along microtubule (GO:0010970),0.5502316636270872,1.206898169729301,0.2727272727272727,0.7392711431802613,1.0,5/13,16.80%,ARHGAP21;CDC42;APBA1;DYNC1I2;COPG1
prerank,limb morphogenesis (GO:0035108),0.4969616063428524,1.2061653540034676,0.23666666666666666,0.7406984577572607,1.0,4/20,5.96%,CYP26B1;GLI3;TBX3;SKI
prerank,regulation of histone acetylation (GO:0035065),-0.371620950958853,-1.2056474272156885,0.14411764705882352,0.7280680371580506,1.0,8/33,13.57%,RPS6KA5;CTBP1;NOS1;PPARGC1A;BRD7;RPS6KA4;TADA2A;MAPK3
prerank,response to progesterone (GO:0032570),-0.44110072040416676,-1.2051614582239134,0.23324396782841822,0.7274187561213042,1.0,4/18,4.12%,CAV1;THBS1;ABHD2;TGFB2
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.41414213332967237,-1.2049859194838144,0.2346368715083799,0.7258223260345211,1.0,6/22,6.35%,SLIT2;TMSB4X;KANK3;CYRIB;HIP1R;TMSB10
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.45237704645281596,1.204488561060647,0.23891273247496422,0.7448932133221733,1.0,7/32,8.12%,PHLDB2;SERPINE1;ARHGAP6;DLC1;CASK;SRC;MAP4K4
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4076471227277172,1.2039631116802771,0.21455938697318008,0.7455685057986206,1.0,12/70,10.67%,NRP1;ATRNL1;ANTXR1;PIK3R1;PARVA;LAMC1;USH2A;RAB25;ATRN;ITGB3;ITGAV;EPHB3
prerank,cellular response to cytokine stimulus (GO:0071345),0.3478049797495709,1.2037753988197957,0.0951417004048583,0.7452252902750128,1.0,48/416,8.96%,GREM2;ADAMTS12;PTGIS;COL1A2;RORA;PID1;GHR;PIK3R1;DAPK1;SMAD3;PTPN13;IL31RA;BCL2;IL34;IL6R;LEPR;OSMR;MMP2;ZEB1;PTPN20;KIT;RIPOR2;NUMBL;GAS6;DPYSL3;IRAK2;CCL19;CSF1;IRF1;SFRP1;AXL;BCL6;TCF7;ZFP36L1;CCL4;BATF;SDC1;NFE2L2;IL12B;CEBPA;IL13RA1;NR1D1;PTPN9;IRAK3;OXSR1;BCL2L11;STAT5B;CNTFR
prerank,steroid biosynthetic process (GO:0006694),0.4179588364834498,1.2033582623674137,0.20689655172413793,0.7455809709163675,1.0,8/56,7.50%,CYP7B1;SLC27A5;PRKAG2;INSIG2;STAR;HSD3B2;CYP27A1;SRD5A1
prerank,response to cytokine (GO:0034097),0.3712015388333355,1.203239352343368,0.17257142857142857,0.7450120718469938,1.0,28/141,14.34%,PID1;TIMP3;SMAD3;PTPN13;BCL2;IL6R;OSMR;PTPN20;SP100;DPYSL3;IRAK2;CXCL16;ALDH1A2;SRC;PML;KYNU;TIMP2;PTPN9;IRAK3;AFF3;IKBKE;COL3A1;TBK1;DDOST;IGBP1;PTPN23;TAF9;HDAC4
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.49346827857120634,-1.2027593780653274,0.23024830699774265,0.7309480176963388,1.0,5/11,11.01%,RDX;SORL1;MTMR2;RAB21;MSN
prerank,second-messenger-mediated signaling (GO:0019932),0.4017228033450502,1.2025013876705344,0.20828105395232122,0.746382697115708,1.0,14/82,7.88%,RCAN2;PDPK1;XCR1;APOE;MCTP2;INPP5A;MCU;NEUROD1;ACKR2;CCR9;LRRK2;AGTR1;EIF2AK3;RCAN1
prerank,B cell activation involved in immune response (GO:0002312),0.5406691792055583,1.2024635152153438,0.27787934186471663,0.7455757016576093,1.0,3/13,6.30%,GAPT;LIG4;BATF
prerank,protein phosphorylation (GO:0006468),0.34318196327633277,1.2022621681107803,0.07614213197969544,0.7453587223254212,1.0,83/478,13.97%,EPHA3;STK17B;DAPK2;PDPK1;PDK1;DDR2;NRK;ROCK2;CDK14;CAMK1D;TGFBR3;CDK8;DAPK1;GRK3;LYN;GRK5;FGFR1;EPHA4;BMPR1A;DMPK;MARK1;EPHA8;CCNA2;FGFR2;FGFR4;PDGFRA;KIT;PDGFRB;PRKAG2;TGFBR1;GAS6;ACVR1;CDK16;MUSK;PRKAA2;MAP3K20;NUAK1;LRRK2;SRC;AKT3;ULK2;GTF2H5;SIK1;EIF2AK3;MAP2K1;BRSK1;IRAK3;MAST2;OXSR1;MAP4K4;STK4;EGFR;EPHB2;BMP2;CAMK2B;NEK6;VRK3;STK11;RNASEL;RYK;BAZ1B;TAOK3;EPHB3;BRAF;TTBK1;IKBKE;IGFBP3;TBK1;MAP4K5;ACVR1B;WNK1;TLK1;STRADA;MAP3K13;GRK4;MAP2K6;INSR;PIK3R4;FRK;MERTK;CDK12;MARK2;STK16
prerank,phagosome acidification (GO:0090383),0.46232923809872656,1.202169790358449,0.23006134969325154,0.7446852153709175,1.0,1/26,0.21%,ATP6V0A4
prerank,regulation of cytoplasmic transport (GO:1903649),0.5607996012928491,1.201718072644911,0.28291814946619215,0.7451527428038699,1.0,4/11,7.36%,ATP9A;LRRK2;SRC;MAP2K1
prerank,negative regulation of hormone secretion (GO:0046888),0.5737890182963856,1.2016187182034659,0.2550335570469799,0.7445298650233285,1.0,1/10,0.63%,GJA1
prerank,regulation of filopodium assembly (GO:0051489),0.4448405385436034,1.201483198182929,0.22746781115879827,0.7440120709725797,1.0,7/38,6.01%,NRP1;PIK3R1;MYO10;DOCK11;RIPOR2;DPYSL3;CDC42
prerank,histone H3-K36 demethylation (GO:0070544),0.5797000741946283,1.201287341523023,0.30244755244755245,0.743677476087921,1.0,5/10,21.43%,KDM7A;PHF8;RIOX1;KDM4A;KDM4C
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.49692447355131114,1.2005858454888567,0.26973684210526316,0.7449466775923194,1.0,8/20,19.87%,SLC8A3;MCU;PMPCB;MICU2;YME1L1;PHB2;AFG3L2;STOML2
prerank,nucleosome assembly (GO:0006334),-0.38962704418721344,-1.2003067285614608,0.1676470588235294,0.7364581427101198,1.0,17/31,32.75%,NAP1L4;HIRA;NAP1L2;H3-3A;NAA60;CHAF1A;RSF1;HMGB2;NPM1;CABIN1;NASP;ASF1A;HAT1;ASF1B;GRWD1;NAP1L3;NAP1L1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5080812178810388,1.1999747598428054,0.2620578778135048,0.7460163710129442,1.0,3/19,4.13%,CAMK1D;IL34;CSF1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.485791084219761,1.1995936411208301,0.2770897832817337,0.7462516412376711,1.0,8/23,13.77%,ENPP1;GLI3;MGRN1;TULP3;GLIS2;PTCH2;BTRC;SUFU
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.5275905386079741,1.1993911515958102,0.2678260869565217,0.7459246245246773,1.0,4/16,6.40%,SLC8A1;ATP1A2;GSTM2;CACNA1C
prerank,aerobic electron transport chain (GO:0019646),-0.31747356162086804,-1.1993473551747107,0.13615023474178403,0.7374517290980926,1.0,30/68,27.56%,COX4I1;NDUFC1;UQCRH;COX6A1;SDHD;COX5B;NDUFA6;NDUFA5;CYCS;NDUFA8;NDUFB7;NDUFA7;NDUFA10;NDUFA3;COX5A;COX6C;NDUFS1;COX8A;NDUFS5;UQCR10;UQCR11;NDUFS7;NDUFB3;UQCRQ;NDUFAB1;UQCRFS1;NDUFV2;AFG1L;UQCRC1;NDUFB4
prerank,response to peptide hormone (GO:0043434),0.43510277854054163,1.199004836841794,0.2188365650969529,0.746173055385878,1.0,14/43,16.32%,ROCK2;TGFBR3;OGT;IGFBP5;ZFP36L1;SRC;STAT5B;STAT2;EIF6;EIF2B4;STAT6;STAT4;EIF2B3;AKT1
prerank,positive regulation of viral transcription (GO:0050434),0.472603024242469,1.198870292450285,0.25235109717868337,0.7456552037228733,1.0,1/25,0.16%,POLR2D
prerank,establishment of skin barrier (GO:0061436),-0.4507297828261473,-1.1987100326507023,0.24202127659574468,0.735248261175637,1.0,4/15,11.39%,LSR;MET;HRNR;UGCG
prerank,regulation of water loss via skin (GO:0033561),-0.4507297828261473,-1.1987100326507023,0.24202127659574468,0.735248261175637,1.0,4/15,11.39%,LSR;MET;HRNR;UGCG
prerank,DNA biosynthetic process (GO:0071897),-0.4379357763659488,-1.198626642146314,0.23399014778325122,0.7333968797156009,1.0,9/16,32.39%,PPIA;POLH;SIRT1;TYMS;POLD4;WRNIP1;POLD2;POLA1;TERT
prerank,positive regulation of synapse assembly (GO:0051965),-0.3947775093945386,-1.198392090730021,0.2191358024691358,0.7320909539846884,1.0,12/27,17.26%,GRID2;NLGN1;IL1RAPL1;PTPRD;EPHB1;NRXN1;CLSTN2;AGRN;CLSTN3;LRRC4B;NLGN3;VSTM5
prerank,regulation of endocytic recycling (GO:2001135),0.5752603842061823,1.1983516824369878,0.27238805970149255,0.7463011726789673,1.0,2/11,3.69%,ACTN2;ATP9A
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5736120828462343,1.1982370676410137,0.2676056338028169,0.7457437048606501,1.0,5/10,14.87%,APOA1;SLC45A3;LPGAT1;ABCD2;NR1H3
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5497835537788337,1.1980347096074502,0.27335640138408307,0.7455006336535392,1.0,6/12,24.38%,PARP11;PARP16;TNKS2;PARP12;TNKS;PARP10
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4020952085779286,1.1980000897509178,0.21071863580998781,0.7447054546647452,1.0,7/73,4.32%,ROBO1;COL4A3;SMAD3;DLC1;CASP12;CFLAR;SLC22A2
prerank,secretion (GO:0046903),0.5351073147086843,1.197744774110256,0.26578073089701,0.7445576702142667,1.0,5/14,7.90%,FBLN5;SLC22A2;VIP;SLC22A4;DRD3
prerank,epithelial tube morphogenesis (GO:0060562),-0.37895721589849185,-1.197540715617212,0.20303030303030303,0.7327061442576995,1.0,13/32,13.58%,SLIT2;PODXL;MEF2C;ACVRL1;MET;SOX17;RASIP1;PAK1;RHOB;SCRIB;HES1;RYR2;PRKX
prerank,oxoacid metabolic process (GO:0043436),0.4615461453627804,1.197406364982265,0.24691358024691357,0.7446509261427919,1.0,3/27,6.25%,ENPP1;TPST1;DDO
prerank,regulation of cell death (GO:0010941),0.38557965044869996,1.1971817645834404,0.20955882352941177,0.7444790352799784,1.0,19/94,13.13%,CCN2;LRP1;CCN1;RRAS2;MT3;SLC25A24;AXIN2;CCN5;LRRK2;PARP16;CCN4;PRKN;FGF2;RAD18;TBK1;IMPACT;CTSZ;NPAS2;RIPK2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.35514115654064393,-1.1963590357871143,0.16363636363636364,0.7344858768258893,1.0,7/39,4.80%,UTRN;ANK3;NEDD4L;HECW1;YWHAH;CAMK2D;FGF12
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.505552736097513,-1.1959216617660442,0.25721153846153844,0.7337702833670953,1.0,7/11,27.25%,HIRA;H3-3A;CABIN1;NASP;ASF1A;HAT1;ASF1B
prerank,positive regulation of synaptic transmission (GO:0050806),-0.30950416853903884,-1.1956208587804928,0.14563106796116504,0.7326033975141285,1.0,29/72,21.87%,SHANK3;SLC24A2;NLGN1;PTK2B;RIMS1;ZDHHC2;GRIK2;GRIN2A;TSHZ3;NRXN1;RIMS2;GRIN2B;SYT1;CLSTN2;CLSTN3;PRKCZ;ADCY8;LGMN;APP;LGI1;GPER1;NLGN3;CACNG3;CACNG4;MPP2;RIMS3;AGER;RELN;HAP1
prerank,negative regulation of cell population proliferation (GO:0008285),0.34825234024225415,1.194870762664523,0.11455108359133127,0.7504044147942944,1.0,81/351,17.09%,NELL1;RBP4;MTSS1;OGN;COL4A3;MN1;TGFBR3;AR;MCC;LYN;DLC1;PODN;PDS5B;NUPR1;FBLN1;PDCD5;IRF1;CYP1B1;APPL2;RAPGEF2;SFRP1;AXIN2;IGFBP5;RARG;PDPN;TBX3;VIP;ALDH1A2;SKI;PML;ING5;IL12B;P3H3;CEBPA;SIRT2;MAP2K1;NMI;RNF139;BMP2;KAT2B;CD200;STK11;S100A11;INCA1;FGFBP1;CGRRF1;IGFBP3;IFNK;GSDME;RGCC;REST;CD33;NIBAN2;PEX2;NDRG4;NOX4;SFRP4;TSC2;GATA6;FRK;PTEN;ETS1;CLMN;GLMN;HPN;BMP5;CDKN1C;RBM5;ADAMTS1;BMP4;PRKRA;EPPK1;SST;SPEG;ZBTB17;TFDP1;SLC16A2;CDK10;KANK2;ATF5;TNS2
prerank,glucan catabolic process (GO:0009251),0.5236891727209381,1.1947460875854914,0.26455906821963393,0.749873622178727,1.0,7/15,16.58%,PHKB;GAA;AGL;PYGM;PHKA2;PHKA1;PYGB
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.5139127384487334,1.1946060768275402,0.2689210950080515,0.7493783261002979,1.0,4/18,7.08%,IL6R;YAP1;SRC;CEBPA
prerank,regulation of monooxygenase activity (GO:0032768),-0.4054740170130358,-1.194566068689232,0.2096317280453258,0.7337676105327919,1.0,9/23,10.91%,CAV1;NOSTRIN;NOS3;DDAH1;NOSIP;DDAH2;CYGB;CALM1;SPR
prerank,fibrinolysis (GO:0042730),0.5386979798301178,1.1940525051728297,0.2809364548494983,0.7501951289207028,1.0,2/13,12.01%,SERPINE1;F2
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.46955646025989906,1.1937560171895276,0.2518740629685157,0.7501809689766121,1.0,5/29,7.85%,GDNF;TENT5A;AXIN2;VIP;TENT5D
prerank,cellular response to acid chemical (GO:0071229),-0.3911890451265182,-1.1935215442952585,0.2153392330383481,0.735093413424751,1.0,9/27,12.18%,SH3BP4;KLF2;GLRA1;GLRA2;SPAAR;LARS1;VEGFA;IPO5;MTOR
prerank,regulation of transposition (GO:0010528),0.5395651014564224,1.1930531724606108,0.2602965403624382,0.7514027609129674,1.0,5/13,17.88%,UBR2;PIWIL4;SPOCD1;MYBL1;DDX4
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.43474779250186796,1.1924950123806832,0.24328147100424327,0.75215338856031,1.0,7/39,6.80%,PDPK1;ANGPT1;SERPINE1;GAS6;SEMA5A;CDH5;NFE2L2
prerank,relaxation of muscle (GO:0090075),0.5519032636636696,1.1913151229778973,0.2920962199312715,0.7548725209850177,1.0,4/13,5.71%,SLC8A1;GSN;ATP1A2;GSTM2
prerank,protein stabilization (GO:0050821),0.358728992433951,1.1910893315896325,0.17991169977924945,0.75469996010198,1.0,29/168,15.83%,IGF1;PIK3R1;PLPP3;A1CF;EPHA4;PARVA;ZSWIM7;APOA1;MT3;ATP1B2;STK4;CREBL2;WDR81;TELO2;PRKN;PEX6;TNIP2;PER3;USP9X;SUGT1;MUL1;PTEN;PDCL3;TAF9;HYPK;FLNA;LAMP2;BAG5;PRKRA
prerank,regulation of actin filament bundle assembly (GO:0032231),0.47086158246640464,1.1906094064497752,0.2794348508634223,0.7552924787770625,1.0,8/26,13.15%,ROCK2;ASAP3;SYNPO2;CDC42;ALMS1;PRKN;SYNPO2L;SYNPO
prerank,regulation of axonogenesis (GO:0050770),0.42247965063093995,1.1905483820810665,0.22192866578599735,0.7546199384074093,1.0,14/51,14.64%,ROBO1;PLXNA2;KIF13B;EPHA4;TIAM2;BRSK1;ARHGAP35;EPHB3;PLXNC1;MARK2;PTEN;PLXNA1;PLXNB2;CHODL
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.333891770300845,1.1901491544351024,0.005,0.7548823069258488,1.0,345/1668,17.63%,IGF1;TCF7L2;TCF4;BMP6;ZBTB20;LDB2;AUTS2;NFIA;IGF2;FHL2;RORA;TRPS1;TBL1XR1;PID1;ZFHX4;TEAD1;ATXN1;CDK8;PIK3R1;GDNF;PKNOX2;SMAD3;PBX1;ZEB2;ARNT2;AR;DCN;SOX5;ZKSCAN2;MITF;NKX6-1;GLIS3;TGFA;RUNX1;SERPINE1;NR2F2;GLI2;DACT1;PRRX1;SALL1;KCNIP3;WWC2;SP7;ZIC1;VGLL3;OGT;GLI3;BMPR1A;IKZF2;CBX7;MAF;ZEB1;AEBP1;ARID5B;RUNX2;CCN1;PPP3CA;PRDM5;NKX2-1;FGFR2;MDFI;THRB;ARID4A;SP100;YAP1;KIT;FOXP2;ASCL1;NFIB;ZNF462;SSBP3;APOE;MAML3;DNMT3A;MLXIP;RARB;JDP2;SIX5;ZIC4;NFIX;MIDEAS;MXI1;LBX2;FBXL19;CRTC3;IRF1;RLF;MEOX2;SMURF2;IKZF4;BRWD1;ZIC2;MSC;ACVR1;RFX5;ZHX2;NEUROD4;ETV6;CREB3L2;ZNF83;NEUROD1;NCOA2;PHIP;RARG;KLF15;ARID1B;BCL6;BRD8;TBX3;ATXN7L3;SP4;TNRC6B;TCF7;ENG;EPAS1;HLF;ZBTB8B;CUX2;SKI;INO80;BCL9;BCOR;ATOH8;HES7;SMARCA1;BATF;ZNF23;MED14;ZNF483;GTF2H5;NR5A1;NFE2L2;DDX17;MBD2;ATAD2B;WWTR1;CEBPA;CPEB3;ZBTB38;ZNF697;SIRT2;SREBF1;SAP30;RNF10;SMARCC2;ZBTB24;TSHZ2;MTA2;NR1D1;BBX;RAI1;DR1;MED16;MED8;PPP1R13L;RBPJ;OSR1;TET1;ZMIZ1;SAFB2;CHD2;HIVEP2;LIN9;MTA3;EGFR;NCOR1;TCF7L1;FOXC2;ARRB1;DAB2;KDM5B;TNRC6A;RGMA;PCGF3;STAT5B;BMP2;BRMS1L;KAT2B;JAZF1;ARNT;MZF1;SMAD1;HOXC5;GTF2IRD1;ZBTB4;GMEB1;NSD1;ZBTB1;RPAP2;CCNK;CREB3L4;CREB3;STAT2;MED13L;HEXIM2;SP140;PRKN;PAX1;GLIS2;FGF2;PHF2;RNASEL;IFI27;CSRP3;NCOR2;CXXC5;FOXA1;ZSCAN21;NR1D2;BAZ1B;ZKSCAN3;DDX3X;ZNF177;ZBTB8A;KMT2A;CCNL2;KLF9;SP5;TEAD3;NKX2-8;CEBPB;TNIP2;MED29;RGCC;ZBTB37;NFE2;CCNL1;BHLHE41;SPDEF;HDAC8;TBK1;REST;PHF21A;PER3;ZFP30;RHOQ;STAT6;IMPACT;MNAT1;GLI1;USP9X;NR4A1;CAMTA1;TCF25;PEX2;PAF1;ZNF513;NPAS2;RIPK2;SMARCD2;ZNF182;MYCN;GATA6;HELZ2;FRK;HIVEP1;IGBP1;TIAL1;CDK12;SUFU;ARF4;PTEN;EBF1;STAT4;ETS1;TCF12;NCOA3;HOXC8;ZNF383;KDM7A;ZNF25;TADA3;TCERG1;AKAP8L;ZNF148;TAF9;HDAC4;MED19;FOXK2;FSTL3;HOXD1;ZNF219;TWIST2;HSBP1;TNFRSF1A;BMP5;NR1H3;RNF2;FUBP3;UBE2D1;SMARCB1;CAMTA2;HOXC4;SS18;RXRA;PHF8;SUDS3;TFCP2;SHH;ZNF276;MYBL1;TSHZ1;BMP4;CBX5;MYT1;MTF1;PIK3R2;ZNF585B;ZNF585A;FNIP1;BAZ2B;HDGFL3;ZBTB17;TFDP1;POGZ;MXD4;ATM;MAFA;NCOA7;CREB3L1;FOXJ3;EBF4;KANK2;NIPBL;KDM3B;CX3CL1;ATF5;PLAG1;ZSCAN20;CBX6;FOXO6;CCNQ;ABHD14B;NEUROD6;LIF;SP1;AHRR;CREB5;EFCAB7;DNMT3B;ZSCAN29;FOXO3;IRF2;PRPF6;ZIC5
prerank,proton transmembrane transport (GO:1902600),0.44091342604356165,1.190022367635982,0.25142857142857145,0.7543627943898161,1.0,2/36,1.88%,ATP6V0A4;ATP1A2
prerank,mesenchymal cell development (GO:0014031),-0.418194141748547,-1.1900065994990474,0.25139664804469275,0.7438522452278739,1.0,8/18,27.76%,CDH2;NOTCH1;HEY2;SOX8;HEYL;SNAI2;NOLC1;TBX20
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5044670189713134,-1.189252426328885,0.27802690582959644,0.7440884832105839,1.0,3/10,7.99%,HK2;PFKL;PFKP
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.5106771877129126,1.1890630615065017,0.2822085889570552,0.7563278158177948,1.0,3/18,2.23%,CAMK1D;LYN;IL6R
prerank,aortic valve development (GO:0003176),0.4506232209060226,1.1889929018613068,0.24780058651026393,0.7556090552861341,1.0,3/34,0.88%,ROBO1;ROCK2;ELN
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.4175911065049128,-1.1888180374894437,0.21983914209115282,0.7434253997682203,1.0,5/19,2.58%,PRKCH;OCLN;CLDN5;F11R;TJP1
prerank,cellular metal ion homeostasis (GO:0006875),0.3812900524340178,1.1884880194130663,0.20503597122302158,0.7562552355730842,1.0,16/102,7.90%,SLC24A3;SLC8A1;SLC8A3;ATP1A2;SLC41A1;DMPK;CCL19;STIM1;ATP13A3;SLC24A1;MT3;CDH5;SLC24A5;ATP1B2;TMEM203;DRD3
prerank,regulation of membrane depolarization (GO:0003254),-0.4369438889739621,-1.1883385360800882,0.2506393861892583,0.7428303293700158,1.0,3/18,4.48%,FHL1;NEDD4L;CAMK2D
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.49401449839974027,1.1882563805881257,0.26635514018691586,0.7560213811075758,1.0,3/19,7.08%,AR;NAB2;CEBPA
prerank,lipid biosynthetic process (GO:0008610),0.39628232508776096,1.1881592293781238,0.20930232558139536,0.7553943617449972,1.0,10/77,8.17%,PAM;ACSL1;MVK;STAR;HSD3B2;PRKAA2;AGPAT3;SREBF1;SRD5A1;DOLPP1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.3947925174236478,1.187950267801478,0.20715166461159062,0.7550997327187992,1.0,12/75,6.57%,COL4A3;ROCK2;SPARC;DCN;HSPG2;THBS2;WNT4;ISM1;SULF1;SERPINF1;EMILIN1;PML
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.528063872301784,1.1878710266474715,0.27197346600331673,0.7544668993679863,1.0,8/14,23.64%,LRRK2;CREB3;PRKN;SELENOS;TMBIM6;CREB3L1;OPA1;TXNDC12
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.3827832030330881,-1.1876478622249909,0.21893491124260356,0.7429765193697605,1.0,9/27,11.60%,IL1RAPL1;CCDC88A;MBOAT1;NTNG1;EFHC2;GSK3A;DISC1;CAMK2G;HOMER1
prerank,"phagocytosis, engulfment (GO:0006911)",0.4416457071711113,1.1876179821656163,0.24220963172804533,0.7542984548260273,1.0,6/36,7.63%,RHOH;GSN;RHOBTB1;CDC42;RHOBTB2;GULP1
prerank,regulation of phosphorylation (GO:0042325),0.37292341420716524,1.1875405515497337,0.20070838252656434,0.7536381883999073,1.0,34/120,18.87%,NRP1;LDB2;SRPX2;AR;LYN;DYNLL1;OGT;PRKAG2;NUP107;PHIP;CDH5;PML;SIRT2;NUP42;DSCAM;EGFR;STAT2;EIF6;RAE1;NUP98;EGF;NUP214;PLXNB2;GLMN;CDKN1C;BMP4;SESN2;FNIP1;GCK;KCTD20;CDKN2C;SEH1L;TPR;CDKN1B
prerank,actin nucleation (GO:0045010),-0.40984101148585556,-1.187414179792401,0.2344632768361582,0.7416979944491967,1.0,6/21,18.61%,ARPC1B;SPIRE1;ARPC5L;ARPC3;ARPC4;LMOD1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.3929207412466627,-1.1874135205622092,0.24709302325581395,0.7396659451493358,1.0,10/26,10.77%,SHANK3;NLGN1;PTK2B;RIMS1;NRXN1;MTMR2;RIMS2;TMEM108;SHANK1;PRKCZ
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.4952878301980399,1.187359169348055,0.27230046948356806,0.7533255325490835,1.0,11/21,24.84%,SMO;SFRP1;TEDC1;TTC23;GLI1;SHH;EVC;PDCL;STK36;TXNDC15;RAB34
prerank,cellular response to hexose stimulus (GO:0071331),0.4915289897926609,1.1872285399795837,0.26594090202177295,0.7528789270440946,1.0,3/23,5.53%,ZBTB20;GAS6;PRKAA2
prerank,regulation of cell-cell adhesion (GO:0022407),-0.3475688827619816,-1.1871367984919936,0.1945392491467577,0.7385280927091018,1.0,6/39,2.90%,PTPRG;PODXL;EFNA5;CDH1;ZDHHC2;TENM3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.42900791493527707,-1.1867601715138847,0.23641304347826086,0.7376714903423932,1.0,6/19,14.78%,SLCO1C1;KLF2;MAPK8;KLF4;PAX8;APP
prerank,ion transport (GO:0006811),-0.2942771578621872,-1.186699597252806,0.10191082802547771,0.73587794965397,1.0,17/111,5.19%,TRPM3;PIEZO2;SLC12A2;SLC26A7;SLC12A7;SLC9A2;SLC24A2;SLC26A2;PIEZO1;ANO1;SLC9A6;ATP11B;GABRB1;GLRA1;KCNN2;SLC1A1;SLC15A2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.5531179628734134,1.1866349176985203,0.2914485165794066,0.7537131561738538,1.0,1/12,0.49%,IGF2
prerank,neuropeptide signaling pathway (GO:0007218),-0.3227448592996393,-1.186619826841302,0.1694915254237288,0.7341625196685352,1.0,16/58,21.52%,SORCS2;GLRA1;SORL1;GLRA2;HCRTR2;CYSLTR1;CYSLTR2;SORCS1;GPR37;NXPH2;CPE;PPY;SORCS3;PNOC;GLRA3;NMUR2
prerank,amino acid transport (GO:0006865),0.4278880055757499,1.1864181612707523,0.2517385257301808,0.7534573998960372,1.0,8/49,9.93%,SLC7A11;SLC7A2;SLC1A5;PDPN;SLC7A13;SLC38A6;SLC43A1;SLC38A9
prerank,response to calcium ion (GO:0051592),-0.29637814454995876,-1.1860361281038363,0.1595744680851064,0.7339044021892879,1.0,27/102,13.83%,CAV1;MEF2C;CPNE8;CLIC4;NLGN1;TRPC3;THBS1;PLCG2;IQGAP1;KCNMA1;SLC25A13;SLC25A12;CPNE3;CAMK2D;TRPC1;SYT1;KCNMB2;ITPR3;CALM1;GPLD1;CALM3;ADCY8;LGMN;HOMER1;RYR2;CASQ2;SYT6
prerank,endomembrane system organization (GO:0010256),0.35984796849948425,1.185955126729209,0.18888888888888888,0.7539564389355753,1.0,52/178,17.76%,OBSL1;USP6NL;LMAN2L;DMPK;SEC31A;OPTN;RAB30;MYO18A;GORASP2;ARHGAP21;TMED1;GOLGB1;LMAN1;ARFGEF2;CDC42;LRRK2;SNX33;ZW10;EIF2AK3;UBXN2B;ALS2;RAB22A;TLCD1;TRIP11;MIA3;LEMD3;TJAP1;PLEKHM2;TMED4;ARL1;GOLPH3L;GORASP1;GOLGA8B;GOLGA5;TANGO2;HOOK2;ATP8B2;TBC1D20;TOR1B;SEC16B;FER1L5;BAG5;HACE1;CUL7;HUWE1;LAPTM4B;TOR1AIP2;GOLPH3;ARFGEF1;REEP4;TMED10;CSNK1A1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4978809287831735,1.1858055426196359,0.26782884310618066,0.7535408429524151,1.0,5/21,14.84%,SAMD4A;TUT7;PARN;TUT4;CNOT3
prerank,amino sugar metabolic process (GO:0006040),-0.5194179059000271,-1.1850080084708188,0.26107226107226106,0.7350211758900632,1.0,2/10,1.03%,CSGALNACT1;ST6GAL1
prerank,response to molecule of bacterial origin (GO:0002237),-0.31479206369473345,-1.18498740250624,0.14761904761904762,0.7331209780715777,1.0,19/69,19.61%,NOS3;TNFRSF11A;CYRIB;GGT5;GCH1;NOS1;LBP;FOXP1;JAK2;TNFAIP3;PTPN22;IRF5;TRIM6;TLR4;ERBIN;HMGB2;IFNAR1;GGT1;FZD5
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.41421653764495314,-1.1849851748804254,0.24022346368715083,0.7311685170909908,1.0,13/21,33.23%,KDM1A;DISC1;VEGFA;CX3CR1;DLL4;TOX;LRP2;FZD3;FZD9;DISP3;CTNNB1;NAP1L1;RASSF10
prerank,histone modification (GO:0016570),0.3775739965073889,1.1846662101411367,0.2126642771804062,0.7560162763368784,1.0,16/109,10.30%,TBL1XR1;EYA2;EYA1;CCNA2;PRDM5;MIDEAS;MT3;BRD8;ATXN7L3;SIRT2;UBE2U;MTA2;MTA3;BRMS1L;NSD1;BAZ1B
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.519937226528006,1.1845174766885296,0.30655737704918035,0.7555850440576979,1.0,2/15,9.13%,HECW2;NEK6
prerank,regulated exocytosis (GO:0045055),0.3596636033449004,1.1843425222729598,0.17841409691629956,0.7552694878293511,1.0,26/173,11.91%,IGF1;IGF2;CLEC3B;ACTN2;TIMP3;SPARC;AHSG;SERPINE1;LYN;SERPING1;GAS6;APOA1;APLP2;PHACTR2;TLN1;VCL;CD63;NHLRC2;SYT9;ACTN4;ITGB3;ISLR;MANF;STXBP1;EGF;ANXA5
prerank,membrane depolarization during action potential (GO:0086010),0.46397285792905757,1.184171148929698,0.24888888888888888,0.7549369543450537,1.0,4/26,6.40%,SCN7A;SLC8A1;ATP1A2;CACNA1C
prerank,negative regulation of protein depolymerization (GO:1901880),0.4642763406859385,1.1836319842119547,0.24434389140271492,0.7556548819489438,1.0,7/24,18.82%,PLEKHH2;LIMA1;KATNB1;FGF13;HDGFL3;CAMSAP1;TAOK1
prerank,pyruvate metabolic process (GO:0006090),-0.32728330053878363,-1.1834369130574622,0.17898832684824903,0.7338329849685803,1.0,13/52,11.78%,BSG;GPI;SLC16A1;HK2;DLAT;ME1;PDHX;PFKL;TPI1;ALDOA;PFKFB1;LDHB;ME2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3775077176286758,1.1831676924567203,0.215962441314554,0.7561708726088007,1.0,21/107,12.03%,ITPR1;PIK3R1;BCL2;GORASP2;CDK5RAP3;CREB3L2;ERLEC1;DERL1;ATG10;EIF2AK3;RNF185;RNF139;BCL2L11;AIFM1;BCAP31;PRKN;TMEM259;CEBPB;RCN3;UFL1;SELENOS
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.40138352585858034,1.182895329115486,0.21825396825396826,0.7560808484632987,1.0,24/64,23.03%,POLR2D;MLLT3;GTF2H5;CCNK;POLR2C;MNAT1;PAF1;CDK12;NELFE;ADRM1;AFF4;CCNT2;CDC73;ELOF1;POLR2L;ELP4;MLLT1;CCNT1;LEO1;NCBP2;CDK7;ERCC3;ERCC2;CDK13
prerank,glycogen catabolic process (GO:0005980),0.5198008895914253,1.1827563939821233,0.26865671641791045,0.7556031758720186,1.0,7/15,16.58%,PHKB;GAA;AGL;PYGM;PHKA2;PHKA1;PYGB
prerank,negative regulation of neurogenesis (GO:0050768),-0.3609190758318931,-1.1825190842589786,0.17832167832167833,0.7347206210148618,1.0,12/34,18.31%,NOTCH1;B2M;YWHAH;SORL1;GDI1;ARHGDIA;PTN;LINGO1;NF1;MAG;RTN4R;MCF2
prerank,regulation of dopamine secretion (GO:0014059),0.4838398897894136,1.1818580998095978,0.2706422018348624,0.7574686674734318,1.0,7/25,13.73%,GDNF;DTNBP1;DRD3;SYT9;PRKN;SYT11;SYT12
prerank,regulation of NMDA receptor activity (GO:2000310),-0.37006254779014275,-1.1817632901433899,0.20711974110032363,0.7351621161643727,1.0,9/32,8.31%,DLG2;MEF2C;GRIA4;NLGN1;PTK2B;GRIN2A;LRRC7;GRIN2B;GRIA2
prerank,heart morphogenesis (GO:0003007),0.4167388392056923,1.1816811491667107,0.23504867872044508,0.7571593503147825,1.0,11/50,10.17%,TGFBR3;DLC1;OLFM1;BMPR1A;TGFBR1;ACVR1;TBX3;ENG;FLRT2;BMP2;SYNPO2L
prerank,regulation of wound healing (GO:0061041),0.42645750979472735,1.1816750760995882,0.25587828492392806,0.756299087393235,1.0,11/42,12.01%,SERPINE1;KANK1;MYLK;VTN;INSL3;CASK;EPHB2;FGF2;HBEGF;ADRA2A;F2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5544523526987534,1.1815817281759529,0.28171334431630973,0.7557297747209153,1.0,4/12,7.19%,DOCK4;TPM1;IGFBP5;DOCK5
prerank,positive regulation of protein modification process (GO:0031401),0.35247918499126873,1.1814568072566545,0.17405405405405405,0.7552307185250886,1.0,43/203,16.32%,IGF2;TRABD2B;ROCK2;ANGPT1;LYN;DLC1;IL34;LEPR;PELI2;NOS1AP;CCN1;NNMT;GAS6;MT3;AXIN2;MUSK;SLCO3A1;ENG;CDH5;LRRK2;ATG10;NTRK3;STK4;EGFR;ARRB1;DAB2;BMP2;ITGB3;FGF2;DDX3X;TMEM119;RAP2A;F2;CAMTA1;INSR;RAB3GAP1;ALG10B;RSPO1;DYRK1A;BMP4;CDK2AP1;FNIP1;AKT1
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.4818325875478959,-1.181455689585985,0.25609756097560976,0.7341414976413227,1.0,2/12,2.61%,SLIT2;CCN3
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5084782728528014,1.18134811136372,0.2653061224489796,0.7547047978780336,1.0,4/18,9.05%,ROCK2;EPHA4;SLC2A13;PICALM
prerank,negative regulation of translation (GO:0017148),0.38856275840400767,1.180929020750506,0.2250300842358604,0.7551081170449709,1.0,10/87,8.93%,SAMD4A;ROCK2;DAPK1;IGF2BP2;IGFBP5;CPEB1;CPEB3;EIF2AK3;RNF139;METTL14
prerank,sensory perception of pain (GO:0019233),0.4869901610240795,1.179887537157053,0.26357827476038337,0.7574133509837976,1.0,4/21,12.02%,TRPA1;PTGES;ALOXE3;NIPSNAP1
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.33372397281998006,-1.179818543639823,0.16666666666666666,0.7372706147467779,1.0,12/48,23.21%,PDE4D;PDE4B;SLC7A5;CYRIB;SCRIB;PTPN22;ZFPM1;TLR4;TXK;FZD5;CD276;CEBPG
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5262976159700732,1.1797283932611515,0.2993527508090615,0.757012361611711,1.0,1/14,0.56%,ENPP1
prerank,modulation by symbiont of host process (GO:0044003),-0.504885153931903,-1.1795956278971564,0.28074245939675174,0.735986039159936,1.0,6/10,34.15%,B2M;HGS;RPS27A;UBC;PGK1;TLR2
prerank,regulation of collagen biosynthetic process (GO:0032965),0.4994259132736228,1.1793846888500807,0.288135593220339,0.7572071639344714,1.0,7/19,16.49%,RUNX1;WNT4;EMILIN1;RGCC;F2;BMP4;CREB3L1
prerank,positive regulation of cellular component organization (GO:0051130),0.3742587072702671,1.1792481999658824,0.2184873949579832,0.7567318934862011,1.0,16/107,10.12%,ASAP1;TRABD2B;FRMPD4;LRP1;AR;RUNX1;APOE;TGFBR1;ADGRL1;CCL19;LMAN1;CDH5;DAB2;BCL2L11;CAMK2B;PLEKHM2
prerank,vasculature development (GO:0001944),0.5017501020832412,1.1792294951179545,0.28885400313971743,0.75592385811769,1.0,5/16,9.71%,ERRFI1;PDGFRA;PDGFRB;CDH5;STK11
prerank,barbed-end actin filament capping (GO:0051016),0.49466311564043897,1.1787544135908998,0.2988313856427379,0.7555809076947522,1.0,2/18,1.25%,SVIL;GSN
prerank,actin filament capping (GO:0051693),0.49466311564043897,1.1787544135908998,0.2988313856427379,0.7555809076947522,1.0,2/18,1.25%,SVIL;GSN
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5422410838842442,1.1786422406553336,0.30017152658662094,0.7550646001647117,1.0,1/13,0.49%,IGF2
prerank,positive regulation of protein binding (GO:0032092),0.4084700960394556,1.178400838672916,0.24868421052631579,0.7549094937514812,1.0,11/56,9.87%,TCF7L2;LRP1;DACT1;APOE;VTN;RAPGEF2;LRRK2;DERL1;STK4;BMP2;PRKN
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.3170385521820468,-1.1783668953803426,0.18410041841004185,0.7377017791658906,1.0,23/63,24.07%,MEF2C;VAV3;CD38;SLC7A1;IL15;TFRC;NFATC2;CD81;CD80;CD40;GPR183;PTPRC;JAK3;CD320;PNP;CD86;NCK2;ANXA1;VCAM1;CD276;MIF;AIF1;IRS2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.283152746755292,-1.1781018620312773,0.12903225806451613,0.7365450962219781,1.0,39/119,18.44%,PIP5K1B;EFR3B;PLCG2;INPP5D;BMX;PIK3R6;DPM1;MTMR2;INPP4B;SOCS2;TTC7A;PLEKHA3;INPP5F;INPP5K;PIGP;PLEKHA1;PGAP2;IP6K1;PIK3R3;MTMR9;PIGB;ARF1;SACM1L;MTMR6;ARF3;MBOAT7;PIK3C2B;PIK3CA;RAB4A;PIK3R5;DPM3;PIGL;PIGU;PITPNM3;DPM2;PIGO;SYNJ1;INPP5E;PIGV
prerank,regulation of mitochondrial fusion (GO:0010635),0.5570579693332365,1.177915068410401,0.2864864864864865,0.7554878057545154,1.0,4/11,15.95%,PID1;PRKN;MUL1;HUWE1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4663329494193315,-1.1778063265490852,0.24739583333333334,0.7355037259581093,1.0,7/14,29.79%,DENND1B;PRKCZ;CD81;NOD2;CD86;RARA;NLRP3
prerank,tRNA methylation (GO:0030488),0.43824057711536873,1.1777468598865855,0.25037037037037035,0.755102308879305,1.0,11/34,19.19%,TRMT44;TRMO;NSUN2;BCDIN3D;TRMT13;TRMT112;PRORP;THUMPD3;THUMPD2;THADA;METTL1
prerank,microtubule-based transport (GO:0099111),0.5510022498688044,1.1777146273434913,0.2908777969018933,0.7543370342622934,1.0,6/12,19.95%,CCDC40;CABYR;DYNC1I2;SPEF2;HTT;ROPN1L
prerank,neutrophil chemotaxis (GO:0030593),-0.3340609836160827,-1.1775989481956632,0.18045112781954886,0.7342219742677708,1.0,9/53,11.56%,PDE4B;BSG;TGFB2;PPIA;CCL14;FCER1G;CKLF;EDN1;CXADR
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.49628930695309026,1.1772500045691912,0.2733118971061093,0.7548703790316632,1.0,7/20,16.49%,SULF2;SULF1;SMOC2;SPRY2;FGF2;DSTYK;CREB3L1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.4723509598463434,1.1768511712384484,0.2711864406779661,0.755208605884605,1.0,5/24,13.95%,ITPR1;CCL19;FGF2;ANXA6;IBTK
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.5092513831823753,-1.1767920670280232,0.28368794326241137,0.7346732635078773,1.0,3/10,11.86%,CD55;TGFBR2;CD81
prerank,ncRNA metabolic process (GO:0034660),0.44539391222207825,1.1766576729437535,0.25035360678925034,0.7549214398671934,1.0,11/37,18.32%,TDRD1;DDX17;TUT7;PIWIL4;PARN;BCDIN3D;TUT4;PRKRA;TENT4B;DDX4;DICER1
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.438121255459354,-1.1766057206889056,0.2324455205811138,0.7333499061982666,1.0,9/16,30.92%,PPT1;ACSS1;HSD17B8;DIP2A;PPT2;ACACA;CBR4;SCD5;MLYCD
prerank,Golgi localization (GO:0051645),0.554904605376722,1.175826205637147,0.3017543859649123,0.7564666241499658,1.0,5/11,16.80%,ARHGAP21;TBCCD1;CDC42;UVRAG;COPG1
prerank,cellular response to purine-containing compound (GO:0071415),0.5666868503087986,1.1756510480941302,0.30401529636711283,0.756126085283393,1.0,2/10,5.71%,SLC8A1;GSTM2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.49237428685432505,1.1752266735949957,0.28032786885245903,0.7564670856852567,1.0,2/19,3.14%,ENPP1;TPST1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.35265380546709,-1.1751387453961106,0.19047619047619047,0.7360918482284177,1.0,17/36,26.60%,SDCBP;RYBP;RPL11;HSP90AB1;OPHN1;AQP11;PSMF1;GIPC1;N4BP1;FHIT;CAMLG;UBXN1;DDRGK1;PRKCG;USP7;CCAR2;UCHL5
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.45017635003099543,1.1747486048357694,0.27793696275071633,0.7570868518119699,1.0,9/33,13.81%,OGN;TPM1;IGFBP5;VIP;IL12B;IGFBP3;NDRG4;PDCD4;PTEN
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.36477890915416133,-1.1745868144110247,0.23121387283236994,0.7358099875735551,1.0,16/34,27.02%,PDE4D;PDE4B;KCNQ1;ATP1B1;NOS1;CALM1;CALM3;RYR2;CHGA;GJA5;PIK3CG;PLN;RGS2;HCN4;CALM2;SRI
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.4422206716106465,-1.1739621106353277,0.26790450928381965,0.7358948080136397,1.0,8/16,20.21%,THBS1;PPP1R16B;JCAD;GATA2;VEGFA;APLNR;DLL4;PDCD10
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5611887699117171,1.1738387805685595,0.2849056603773585,0.7589919110136126,1.0,7/10,30.80%,SPHK2;KMT2A;SMARCB1;HDAC5;BRCA1;RAPGEF3;SMAD4
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.45409080256220496,-1.1733322663090988,0.27058823529411763,0.7358818821994341,1.0,6/14,21.85%,RPL7;NIFK;NOL9;RPL7L1;RPF2;ZNHIT3
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3621584505122553,1.1728625496139353,0.1995540691192865,0.7610327158933755,1.0,17/152,7.40%,ADRA1B;ADCY1;ADCY2;ABCA1;ADCY7;LGR4;GRK5;ADCY5;GNAS;ADCY9;ADGRL1;INSL3;VIP;LHCGR;ADRB3;MTNR1A;LPAR1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.45329846911121097,1.1721279750132958,0.2596439169139466,0.7624287502163019,1.0,5/28,5.53%,MITF;NOS1AP;FGFR4;PRKAG2;PRKAA2
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4333222478629518,-1.172087004533965,0.2677595628415301,0.7376982425431525,1.0,3/17,2.95%,CAV1;ADIPOR2;PPARD
prerank,metal ion export (GO:0070839),-0.3757221596460241,-1.1719062884566545,0.2537764350453172,0.7363253967508285,1.0,9/31,12.10%,KCNK5;ATP1A1;KCND3;KCNQ1;ATP1B1;ATP2B4;SLC40A1;ATP1A3;ATP7A
prerank,striated muscle tissue development (GO:0014706),0.45595567904832646,1.1717238010586073,0.2602739726027397,0.7627800927440537,1.0,4/29,4.55%,RBP4;SVIL;CFLAR;MSC
prerank,regulation of T cell cytokine production (GO:0002724),-0.45288897833249375,-1.1716072986900106,0.2446043165467626,0.7353606732506346,1.0,7/15,27.34%,B2M;CD55;FZD5;TRAF2;MAP3K7;MALT1;TRAF6
prerank,mesenchymal cell differentiation (GO:0048762),0.4192973450400533,1.1708980210286086,0.2373806275579809,0.7643310236693218,1.0,11/51,8.88%,ROCK2;TGFBR3;FGFR1;FGFR2;WNT4;TGFBR1;FBXL17;ENG;DDX17;RBPJ;BMP2
prerank,cellular protein metabolic process (GO:0044267),0.33691912850679395,1.170701625557866,0.14402451481103168,0.764090138745079,1.0,31/396,6.54%,LTBP1;IGF1;IGFBP2;PAPPA;CP;FBN1;IGF2;MATN3;LOX;AHSG;PRKCSH;IGFBP4;MSRB3;RRBP1;MMP2;LAMC1;CCN1;APOE;GAS6;FSTL1;CSF1;TGM5;APOA1;APLP2;IGFBP5;SERPIND1;CTSH;CST3;TNC;LMCD1;ADPRH
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5270035372838895,1.170605256988979,0.2986577181208054,0.7635271610070024,1.0,5/14,18.71%,IL17D;IL12B;CARD9;IL23A;IL18
prerank,relaxation of cardiac muscle (GO:0055119),0.541923821383966,1.1705198695531365,0.3142361111111111,0.7629394306936622,1.0,4/13,5.71%,SLC8A1;GSN;ATP1A2;GSTM2
prerank,basement membrane organization (GO:0071711),0.5146452720148439,1.1701731201334056,0.293015332197615,0.7630612156463823,1.0,7/14,17.71%,NID1;NID2;FLRT2;NTNG2;COL4A1;HPN;LAMB2
prerank,cellular response to organic substance (GO:0071310),0.3672229016558389,1.170079045072387,0.21728971962616822,0.7624798241829555,1.0,15/116,6.25%,CLEC3B;PID1;GHR;SMAD3;PTPN13;BMPR1A;PTPN20;TGFBR1;DPYSL3;CYP1B1;ACVR1;SFRP1;IGFBP5;NCOA2;LRRK2
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3643324555046153,-1.1695716038811679,0.24822695035460993,0.7393823178978457,1.0,9/33,4.08%,BMPER;SEMA6A;THBS1;PPP1R16B;EPN2;TJP1;CEMIP2;KLF2;FGF1
prerank,synaptic vesicle recycling (GO:0036465),-0.3663910171835552,-1.1694016727776568,0.21835443037974683,0.7380328952203946,1.0,10/31,17.94%,NLGN1;AMPH;CDK5;OPHN1;SYT1;PACSIN1;NLGN3;RAB3A;STX1A;SYNJ1
prerank,myelination (GO:0042552),-0.337318052888956,-1.169000862280312,0.20703125,0.7374299317595955,1.0,15/46,14.33%,ADGRG6;ACER3;MAL;CMTM8;B4GALT5;MYOC;SCN2A;EIF2B5;DEGS1;MAL2;NF1;TNFRSF21;MALL;NFASC;PLP1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5118977503316764,1.1688448321557905,0.2901639344262295,0.7651917079971586,1.0,10/16,25.13%,LRRK2;MIA3;BCAP31;UBAC2;SEC16B;SEC16A;HSPA5;PPP1R15A;ANK2;VAPA
prerank,dicarboxylic acid catabolic process (GO:0043649),0.5356405671207367,1.1684101721902234,0.293015332197615,0.7656471883651715,1.0,3/13,6.44%,GLUL;DDO;ASPA
prerank,response to interleukin-4 (GO:0070670),-0.49858033068743535,-1.1683155740816815,0.311804008908686,0.7376413033139986,1.0,1/10,0.16%,LEF1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.4720902729256749,1.167992787244855,0.27860696517412936,0.766029690371662,1.0,3/22,5.23%,RUNX1;IRF1;BCL6
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5558816271872375,1.1678599684904603,0.2951388888888889,0.7655655293826039,1.0,5/10,19.36%,ATP1A2;ADRA2A;YWHAE;VDAC1;SESTD1
prerank,cellular component disassembly (GO:0022411),0.4100764502513393,1.1677163733781473,0.2635046113306983,0.7651584962398272,1.0,9/53,7.04%,ADAMTS5;GSN;MMP2;LAMC1;MMP19;SH3PXD2B;MMP11;SCUBE1;TIMP2
prerank,positive regulation of secretion by cell (GO:1903532),0.3921020859754615,1.1674359096360512,0.24935064935064935,0.7651199781393055,1.0,6/70,5.48%,IGF1;BMP6;DTNBP1;MYO18A;MYH10;BAIAP3
prerank,negative regulation of secretion by cell (GO:1903531),-0.3460798250990188,-1.167295003263653,0.21639344262295082,0.7388173267817313,1.0,4/38,2.25%,GRM7;STXBP6;IL1RAPL1;NOTCH1
prerank,neuron migration (GO:0001764),0.4095215832407304,1.1672605394829425,0.252400548696845,0.7647949423244047,1.0,7/48,5.26%,NRP1;AUTS2;FGFR1;MARK1;SH3RF1;RAPGEF2;LRP12
prerank,negative regulation of coagulation (GO:0050819),0.5205995880785328,1.1669355540461905,0.28046744574290483,0.7649302476730598,1.0,4/14,5.52%,SERPINE1;APOE;VTN;TFPI
prerank,extracellular matrix disassembly (GO:0022617),0.41067922733584133,1.166769492231204,0.25132275132275134,0.7645960830662043,1.0,14/53,15.02%,ADAMTS5;GSN;MMP2;LAMC1;MMP19;SH3PXD2B;MMP11;SCUBE1;TIMP2;HTRA1;CTSL;NOXO1;HPN;MMP14
prerank,cellular response to pH (GO:0071467),-0.42354566954155926,-1.166681858359971,0.26329113924050634,0.738858317990448,1.0,7/17,26.19%,HYAL1;GPLD1;GPR68;RAB11FIP5;HVCN1;PKD2L1;KCNK4
prerank,stem cell differentiation (GO:0048863),0.4271311894883332,1.1664338327167059,0.27136431784107945,0.7647882176828927,1.0,10/39,11.79%,SP7;FGFR2;KIT;FBXL17;SFRP1;MLLT3;BATF;OSR1;EEF1AKMT4-ECE2;UFL1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.5447047382290957,1.1664063144807693,0.30120481927710846,0.7640481069512725,1.0,5/12,18.71%,IL17D;IL12B;CARD9;IL23A;IL18
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4136127960534887,1.1662336884674607,0.2635228848821082,0.7636814957789779,1.0,11/46,14.57%,TIMP3;LYN;FBLN1;EMILIN1;RANBP9;EPHB2;SPRY2;SPRED3;CNKSR3;PTEN;SPRED1
prerank,negative regulation of protein processing (GO:0010955),0.5418580757264829,1.1662200299379737,0.3127147766323024,0.7628863884270336,1.0,5/12,14.46%,SERPINE1;LRRK2;SNX12;CTSZ;GAS1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3831518067437885,-1.1657666922827965,0.23323615160349853,0.7396094222433809,1.0,8/25,15.23%,SLIT2;ARHGAP44;LIMK2;TBC1D30;CEP97;TESK1;ABI3;PLXNB3
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.48443760627945553,1.1655902244133356,0.28503937007874014,0.7639261041853767,1.0,2/21,4.67%,EPHA7;MT3
prerank,retrograde axonal transport (GO:0008090),-0.4290507263638672,-1.16485176534856,0.2810945273631841,0.740434419492052,1.0,8/16,27.16%,DLG2;TMEM108;PAFAH1B1;KIF1A;KIF5A;HAP1;SOD1;ACTR10
prerank,regulation of sensory perception of pain (GO:0051930),-0.476948329314156,-1.1645033625855792,0.2853828306264501,0.7396577951452882,1.0,5/11,18.76%,MGLL;CCN3;ATPSCKMT;ZFHX2;ACP3
prerank,membrane organization (GO:0061024),-0.2612302477487215,-1.1638221233360977,0.0759493670886076,0.7399860210363569,1.0,36/227,8.93%,DNM3;CERT1;SGCZ;FNBP1L;SGIP1;ACTB;ANK3;RIMS1;EPN2;NUP93;REEP1;REPS2;CCDC88A;TFRC;PPT1;HSPA8;CBL;DYSF;FZD4;SH3GL2;TMEM33;SPTBN1;AMPH;ATP2C1;HIP1R;SUN2;VAMP8;SYP;PLEKHA3;SYT1;ARPC3;GAK;PACSIN2;OSBPL2;SH3KBP1;RTP4
prerank,regulation of protein localization to cell surface (GO:2000008),0.4387492530524909,1.1637816114813182,0.26705370101596515,0.7684991857709003,1.0,7/33,11.78%,ACTN2;LEPROT;SNX33;COMMD1;PICALM;TAX1BP3;EGF
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.5475093870719452,1.1635694723912402,0.2956989247311828,0.768278964263887,1.0,2/10,9.87%,MT3;PRKN
prerank,polyamine metabolic process (GO:0006595),0.5314184468918671,1.1624708741364183,0.3235772357723577,0.770716791331007,1.0,5/13,23.11%,SMOX;SMS;SAT2;SAT1;HDAC6
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5011097619094066,1.1620814501291075,0.3096774193548387,0.7710454757542162,1.0,4/17,8.07%,NRP1;NTF3;CDC42;NTRK3
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3753417912651562,-1.1619265676991442,0.23723723723723725,0.7439132548919549,1.0,5/29,6.84%,SLC4A10;MCTP1;ZDHHC2;GRIK2;SYP
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.440317905176526,1.161646368201447,0.2710144927536232,0.7715557538153912,1.0,10/34,17.10%,LYN;LGR4;PTPRS;NR1D1;TLR6;IRAK3;RAB7B;CD14;SMPDL3B;GPR108
prerank,cellular response to alcohol (GO:0097306),0.4289245293896219,1.1610243584209199,0.29603399433427763,0.7726388480407708,1.0,7/42,7.00%,ADCY1;ADCY2;ADCY7;ADCY5;SMO;SFRP1;SPHK2
prerank,regulation of primary metabolic process (GO:0080090),0.3622772017158265,1.1601148087756534,0.22337962962962962,0.7744428312938243,1.0,35/126,21.18%,ROCK2;TBL1XR1;FGFR4;CHD9;APOE;C1QTNF2;PSME4;MVK;NCOA2;LDLR;SREBF1;NR1D1;NCOR1;IDI1;NCOR2;NR1D2;FASN;HELZ2;CERS2;RXRA;HMGCS1;OAZ3;SP1;PSMB5;CARM1;PSMC2;PSMD4;PSMD1;SCD;NCOA6;ABCA7;PSME3;PSAP;RUBCNL;PSMA3
prerank,"phototransduction, visible light (GO:0007603)",-0.4482503876194732,-1.1597538111256998,0.2879177377892031,0.7487868484758383,1.0,7/14,33.33%,RP1;GNB1;PDE6A;GNA11;SAG;PDE6B;GNAQ
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.4675572324121929,1.1594931142305782,0.2723146747352496,0.775451056374508,1.0,13/25,23.92%,FBXL17;DERL1;RNF185;NGLY1;UGGT2;CLPP;AUP1;LONP1;YME1L1;ZER1;BAG6;HDAC6;ATXN3
prerank,positive regulation of nervous system development (GO:0051962),-0.3417781675510008,-1.1591671608009801,0.22695035460992907,0.7486946699290755,1.0,17/42,16.13%,GRID2;NLGN1;IL1RAPL1;PTPRD;EPHB1;NRXN1;TGM2;SNW1;CLSTN2;CLSTN3;CX3CR1;FAIM;MME;NUMB;LRRC4B;GPER1;NLGN3
prerank,positive regulation of cell development (GO:0010720),0.4426455533295831,1.1583645378300977,0.2594752186588921,0.7779444484166967,1.0,5/31,5.70%,NKX6-1;NUMBL;PDE3A;LIG4;SERPINF1
prerank,negative regulation of mRNA processing (GO:0050686),-0.4331234739733859,-1.1581183226751246,0.2613065326633166,0.7500660271265591,1.0,9/15,32.74%,SRSF12;SRSF7;RBMX;C1QBP;SRSF4;U2AF2;PCBP4;RNPS1;BARD1
prerank,regulation of hydrolase activity (GO:0051336),-0.30175704256179064,-1.1577627037942366,0.19724770642201836,0.7493320369003955,1.0,18/71,7.18%,CHN2;FGD5;EFNA5;CAV1;PLXNA4;ARHGAP44;VAV3;RABGAP1;SIPA1L1;RASIP1;PRKG1;RDX;ARHGAP27;TBC1D15;EPHA5;NOS1;NGEF;CHN1
prerank,male meiosis I (GO:0007141),0.5040387592103115,1.157569743579056,0.2983050847457627,0.7794807711929617,1.0,6/16,17.88%,HSF2BP;ZSCAN21;SYCP3;MYBL1;FOXJ3;DDX4
prerank,icosanoid metabolic process (GO:0006690),0.428700440667806,1.1574903901410134,0.27709190672153633,0.778868798885907,1.0,7/40,7.26%,PTGIS;DAGLA;CYP1B1;PLA2G4A;DPEP2;DPEP1;ALOXE3
prerank,establishment of melanosome localization (GO:0032401),-0.41600189362022766,-1.1574088760740089,0.25984251968503935,0.748546929105149,1.0,8/19,18.89%,RAB27A;RAB11A;RAB27B;ARL6;BLOC1S5;MLPH;BBS7;MREG
prerank,somite development (GO:0061053),0.5363608203559593,1.156876549212425,0.3283333333333333,0.7797998933944504,1.0,6/11,24.78%,SMO;MEOX2;SHH;SOX11;PPP2R3A;LOXL3
prerank,regulation of mast cell activation (GO:0033003),0.5604570801297191,1.1564200960614093,0.3298059964726631,0.7802820692878009,1.0,2/10,6.13%,LYN;TSLP
prerank,cell junction organization (GO:0034330),-0.3009935274411383,-1.1554708716697137,0.1708542713567839,0.7527183638597742,1.0,26/71,19.87%,OCLN;CTNND2;PPFIA2;LIMS2;ACTB;TJP2;TJP1;MYO9A;TGFB2;PPFIA1;GRM5;OPHN1;RAB8B;AGRN;CXADR;TGFB1;APP;NLGN3;CBLN2;MARVELD2;ACTG1;ELFN1;LIMS1;DVL1;PPFIA4;SH3BP1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.38325561840806466,1.155220657939856,0.2592137592137592,0.7828902911460232,1.0,14/80,10.83%,SAMD4A;ROCK2;PLD1;EPHA4;SMPD2;SPHK2;CPEB3;CD28;SLC2A13;METTL14;PICALM;NSMAF;EIF6;DDX3X
prerank,phospholipid biosynthetic process (GO:0008654),-0.3531853510848462,-1.1542965223773867,0.26158940397350994,0.7545423619749372,1.0,5/36,4.52%,SGMS1;SGMS2;MBOAT1;CPNE3;LPCAT1
prerank,positive regulation of GTPase activity (GO:0043547),-0.25886473710743474,-1.153683424922042,0.10843373493975904,0.7545130957507599,1.0,45/188,13.17%,PKP4;DOCK9;RAP1A;ITGA6;F11R;CAV2;RABGAP1;SIPA1L1;RAP1GDS1;BCAR3;SNX13;NET1;RGS6;ARHGEF15;TBC1D1;TBC1D8;SIPA1L2;TBC1D14;ARHGAP27;TBC1D15;TGM2;RAP1GAP2;ERBB2;TBC1D9;EZH2;CCL14;NGEF;TBC1D30;ARAP1;RASGRF1;RGS7;CCDC125;LARS1;BCR;RUNDC1;RALGAPA2;SCRIB;ARHGAP25;AGRN;RANGAP1;EVI5;RGS16;NF1;TBC1D5;CD40
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3546172960819655,-1.1536596775435872,0.23875432525951557,0.7527430051494859,1.0,13/33,17.94%,DNM3;NLGN1;AMPH;CDK5;OPHN1;SYT1;ITSN2;GAK;PACSIN1;NLGN3;STX1A;DNM1;SYNJ1
prerank,neuron projection regeneration (GO:0031102),0.5527972118682971,1.153626259947306,0.32321428571428573,0.786828539181181,1.0,2/10,4.42%,NREP;MTR
prerank,protein mannosylation (GO:0035268),0.4797811241733556,1.1532043008503334,0.31124807395993837,0.7872393581749885,1.0,4/22,6.02%,TMTC1;TMTC4;LARGE1;LARGE2
prerank,monosaccharide transmembrane transport (GO:0015749),0.5063779368840142,1.1531572311550784,0.3101160862354892,0.7865324675132027,1.0,3/16,9.40%,SLC2A10;SLC45A3;SLC5A3
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.500867352250417,1.153071357848395,0.31333333333333335,0.7859120747815757,1.0,4/17,6.32%,AR;ATP1A2;TFPI;SRC
prerank,calcium ion transport (GO:0006816),0.3660821700670908,1.1530637996922843,0.24607961399276237,0.7850982058553857,1.0,15/113,9.62%,ITPR1;SLC24A3;NALCN;SLC8A1;SLC8A3;TRPA1;GAS6;STIM1;SLC24A1;SLC24A5;CACNA1C;PANX1;ORAI2;TRPM4;ITGAV
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.4595882841648838,1.1530016203682925,0.28634361233480177,0.7844263230873819,1.0,10/26,22.22%,LGR4;IRF1;APPL2;IRAK3;SMPDL3B;GPR108;APPL1;TLR5;BIRC3;BIRC2
prerank,negative regulation of locomotion (GO:0040013),-0.46145166383051556,-1.1529339235878486,0.33164556962025316,0.7532258669765942,1.0,3/12,8.27%,FRMD5;PTPN2;CCDC125
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5165947310526093,1.1522652046155932,0.3187919463087248,0.7857204162817939,1.0,4/13,11.34%,PGM3;LARGE1;RENBP;MGAT3
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.4548659242725345,-1.1520481311029387,0.26515151515151514,0.7541448101680491,1.0,4/14,9.95%,YBX3;ANGEL2;ELAVL4;ELAVL1
prerank,organelle organization (GO:0006996),0.33242999311854776,1.151994138640676,0.15768056968463887,0.7856817542437071,1.0,112/388,20.04%,SH3D19;MICAL3;OBSL1;TPM1;NEDD9;PYROXD2;USP6NL;LMAN2L;MARK1;ANK1;SEC31A;OPTN;APOE;PALLD;RAB30;MYO18A;GORASP2;CNN2;WDPCP;FGD1;BRWD1;ARHGAP21;TMED1;GOLGB1;FGD4;PHIP;LIG4;FAF2;DES;LMAN1;CDC42;ARHGAP10;LRRK2;RANBP9;ZW10;EIF2AK3;EPS15;UBXN2B;WTIP;MAST2;PLD2;CSPG5;CAPZB;TRIP11;MIA3;WDR81;PRKN;TJAP1;PDZD8;RHOT1;PLEKHM2;TMED4;ARL1;LONP2;TFAM;POLRMT;PEX6;CFAP410;GOLPH3L;SLC25A36;GORASP1;FGD3;PEX2;GOLGA8B;GOLGA5;SIPA1;RAB3GAP1;MDK;CHMP5;TANGO2;ABCD2;ATP8B2;ABCA3;TBC1D20;TOR1B;CECR2;SEC16B;BAG5;PIKFYVE;PEX11B;AUP1;HACE1;CUL7;HUWE1;TOR1AIP2;GOLPH3;ARFGEF1;VPS13D;VPS13C;RAB32;LONP1;CAMSAP1;RHOU;TMED10;CSNK1A1;PRKCI;DYRK3;YME1L1;ODF2;PHB2;SMPD4;HTT;DPYSL2;ZFYVE16;NUMA1;SIRT5;CDCA8;STX17;PEX7;YTHDF2;STOML2;NSFL1C
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5103681602413488,1.1519766585110804,0.32605042016806723,0.7848759440956447,1.0,5/16,17.50%,AUTS2;BCOR;KMT2A;WDR5;DNMT3B
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.420458059439367,-1.1518233477834932,0.24494949494949494,0.7530736743882421,1.0,4/17,21.09%,NEDD4L;KCNQ1;RYR2;KCNJ8
prerank,neural crest cell differentiation (GO:0014033),-0.42082383772921106,-1.1517513176637426,0.29591836734693877,0.7514967199936872,1.0,3/18,5.75%,MEF2C;CDH2;LRP6
prerank,generation of neurons (GO:0048699),0.34736393203496846,1.1517033857954853,0.21046892039258452,0.7848869784526663,1.0,25/190,7.45%,NRP1;AUTS2;RUNX1;FGFR1;MARK1;RUNX2;SH3RF1;FZD2;WNT8B;YAP1;WNT4;ASCL1;WNT6;RAPGEF2;NEUROD4;FZD1;NEUROD1;LRP12;THOC2;ATOH8;HES7;SMARCA1;WNT5B;MAP2K1;BRSK1
prerank,negative regulation of cellular process (GO:0048523),0.3275945745456385,1.1508544143481525,0.12854251012145748,0.7864497245759089,1.0,131/521,18.05%,PLXNA2;ENPP1;GJA1;COL4A3;CCN2;ANGPT1;TXNIP;TGFBR3;SMAD3;AR;LYN;DLC1;BCL2;PODN;CCN1;SP100;RIPOR2;PDS5B;NUPR1;SEMA5A;FBLN1;UBR2;PDCD5;IRF1;CYP1B1;APOA1;APPL2;RAPGEF2;TSPYL2;SFRP1;MT3;AXIN2;CCN5;RARG;BCL6;PDPN;CASK;ALDH1A2;SKI;EMILIN1;APBB2;PML;PARP16;ING5;SPHK2;P3H3;CEBPA;SIRT2;EIF2AK3;MAP2K1;NMI;RNF139;CCN4;DSCAM;EPHB2;PIWIL4;BMP2;KAT2B;CD200;MIA3;STK11;S100A11;PRKN;FGF2;RBBP7;INCA1;ANXA6;SLIT3;DDX3X;FGFBP1;CGRRF1;IGFBP3;IFNK;GSDME;PLXNC1;RGCC;ST7L;SPOCD1;RAD18;JADE1;NME6;REST;IMPACT;CD33;NR4A1;ACVR1B;NIBAN2;DACT2;CDA;PDCD4;SIPA1;NPAS2;NOX4;MUL1;SFRP4;MDK;TSC2;FRK;SYT11;PTEN;ETS1;PLXNA1;CLMN;PLXNB2;GLMN;BMP5;NR1H3;FER1L5;SHH;TMBIM6;MYBL1;RBM5;ADAMTS1;BMP4;PRKRA;SESN2;SST;SPEG;ZBTB17;CDK10;VPS13C;KANK2;ATF5;TNS2;CDKN2C;DCBLD2;DDX4;CDC73;MYO16;SOX11;BECN1
prerank,regulation of integrin activation (GO:0033623),-0.43877082182919497,-1.1507784959454388,0.2942708333333333,0.7526250097211113,1.0,5/15,10.97%,PIEZO1;RASIP1;RAP1B;SKAP1;PLEK
prerank,response to fatty acid (GO:0070542),0.4965392627972359,1.1507592305431293,0.31437598736176936,0.7858714322228878,1.0,1/17,0.89%,PID1
prerank,B cell differentiation (GO:0030183),-0.3331113358118828,-1.1506887702047202,0.2375886524822695,0.751110080499031,1.0,29/46,36.83%,PTPRJ;TPD52;PLCG2;TCF3;PTPN2;ITGA4;HHEX;BLNK;PTPRC;JAK3;ADGRG3;MSH2;VCAM1;KLF6;DCAF1;CEBPG;IRF2BP2;GPS2;CR2;FLT3;LYL1;IL11;MS4A1;ZBTB7A;CLCF1;IL4;CD79A;HDAC9;SYVN1
prerank,positive regulation of B cell activation (GO:0050871),-0.327782856079875,-1.1502565488382483,0.22014925373134328,0.7505428746235684,1.0,15/50,16.80%,MEF2C;VAV3;CD38;TFRC;NFATC2;SH3KBP1;SHLD1;CD81;CD40;GPR183;NOD2;BTK;PTPRC;CD27;CD320
prerank,cellular response to chemokine (GO:1990869),-0.33087921592488023,-1.1501999882921663,0.2127659574468085,0.748959232942805,1.0,5/46,6.32%,SLC12A2;LRCH1;PTK2B;ACKR3;CCL14
prerank,regulation of cell junction assembly (GO:1901888),-0.37114086427831583,-1.1495454963210963,0.2727272727272727,0.7489623672957633,1.0,7/27,2.58%,PRKCH;MEF2C;OCLN;CLDN5;RAP1A;F11R;TJP1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.48574013907410213,1.1493363921712458,0.3011093502377179,0.7891476503118133,1.0,4/19,8.17%,PHYKPL;DDO;ASPA;ALDH7A1
prerank,AMP metabolic process (GO:0046033),0.5283228963073883,1.1492627474471895,0.3300653594771242,0.7885256818303579,1.0,2/13,3.37%,AMPD3;NUDT2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.45502838919528005,1.148880308304266,0.29721362229102166,0.7888482729407693,1.0,8/26,18.12%,GAL3ST2;LARGE1;GBGT1;ALG11;ALG6;GOLPH3;GK;TNIP1
prerank,positive regulation of apoptotic process (GO:0043065),0.33655429313856794,1.148729429331313,0.1835245046923879,0.7884516689966888,1.0,63/293,17.01%,EPHA7;STK17B;DAPK2;PTGIS;DAPK1;DLC1;OLFM1;PLEKHG2;GADD45B;PHLDA1;TIAM2;TGFBR1;NUPR1;MOAP1;SOS2;PDCD5;FGD1;CYP1B1;SFRP1;FGD4;ING3;NEUROD1;RARG;BCL6;MAP3K20;ARHGEF17;ING5;SIK1;SPHK2;SIRT2;ARHGEF18;TRAF7;STK4;BCL2L11;AIFM1;BMP2;ARHGEF11;FOXA1;DDX3X;IGFBP3;APH1B;SPDEF;REST;FGD3;PLEKHN1;ADAMTSL4;PAWR;SFRP4;IFIT2;AKAP13;MTCH2;MTCH1;ARHGEF19;TRIO;SUDS3;RBM5;NLRC4;BMP4;CASP9;ATM;ZBP1;PTPA;PSEN2
prerank,regulation of cilium assembly (GO:1902017),-0.3115367263490546,-1.1484576188757583,0.1906779661016949,0.7505961976516371,1.0,18/62,16.68%,LIMK2;RABGAP1;CCDC88A;TBC1D1;TBC1D8;TBC1D14;TBC1D15;DCDC2;KCTD17;TBC1D30;CEP97;TESK1;EVI5;TBC1D5;DYNLT2B;SDCCAG8;ATG3;FUZ
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5161945579058766,1.1484274098709286,0.32172470978441126,0.788536195934353,1.0,2/16,3.41%,LRP1;APOE
prerank,regulation of protein ubiquitination (GO:0031396),0.3626361258870731,1.1483859203648301,0.25089605734767023,0.7878219800258245,1.0,23/108,16.32%,MYCBP2;ANGPT1;SASH1;OGT;TGFBR1;CDK5RAP3;PRICKLE1;LRRK2;DERL1;SPRTN;ARRB1;SPRY2;COMMD1;PRKN;UFL1;FBXO4;HDAC8;RIPK2;FANCI;UBE2D1;BAG5;HUWE1;AKT1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.5126327483263392,1.148308314743214,0.3184818481848185,0.7872036280429652,1.0,1/14,2.33%,OSMR
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.3058424386499061,-1.1479394701739005,0.1782178217821782,0.7503958190125029,1.0,30/69,27.56%,COX4I1;NDUFC1;UQCRH;COX6A1;SDHD;COX5B;NDUFA6;NDUFA5;CYCS;NDUFA8;NDUFB7;NDUFA7;NDUFA10;NDUFA3;COX5A;COX6C;NDUFS1;COX8A;NDUFS5;UQCR10;UQCR11;NDUFS7;NDUFB3;UQCRQ;NDUFAB1;UQCRFS1;NDUFV2;AFG1L;UQCRC1;NDUFB4
prerank,aspartate family amino acid metabolic process (GO:0009066),0.49433192877703735,1.147865825010772,0.3258064516129032,0.7876737198832201,1.0,3/18,6.44%,ASPG;MTHFR;ASPA
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.483133240791244,-1.14731759473437,0.3155339805825243,0.75052144715393,1.0,7/10,31.31%,NOTCH1;LRP6;LIN7C;DLL4;ARHGAP12;TBX20;PHACTR4
prerank,regulation of lamellipodium organization (GO:1902743),0.5207256122956879,1.1467691974154304,0.3167808219178082,0.790064435810399,1.0,4/14,8.42%,PDPN;CDC42;CARMIL1;CAPZB
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4151041259264501,1.1461359240197986,0.2851123595505618,0.7910446221962296,1.0,10/40,16.14%,SLC7A11;SLC13A3;SLC7A13;SLC38A6;SLC38A9;ABCC5;SLC38A3;SLC7A6;SLC38A10;SLC38A2
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.4368572121858708,-1.1460748088621242,0.28883495145631066,0.7524643729139306,1.0,8/14,30.99%,SRSF12;SRSF7;RBMX;C1QBP;SRSF4;U2AF2;PCBP4;RNPS1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.4893737536557242,-1.1459679716945363,0.29711751662971175,0.7510489011353303,1.0,3/10,10.07%,ENPP2;PLA2G7;PNPLA8
prerank,protein glycosylation (GO:0006486),0.3595766846188247,1.145594941051548,0.25146886016451236,0.7917782441371894,1.0,26/125,14.17%,GALNT18;GALNTL5;B3GALT1;OGT;ST3GAL5;MAN1C1;PGM3;ST3GAL3;LARGE1;MOGS;LARGE2;FUT10;STT3A;B4GALT1;ALG5;B3GALNT1;TET1;DOLPP1;GFPT1;MGAT3;ALG11;DDOST;POMT1;ALG6;GALNT6;ALG10B
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3897994848878702,-1.1453251643979165,0.2836676217765043,0.75124940200083,1.0,7/24,20.90%,TTLL7;TTLL5;AGBL4;TTLL3;TTLL8;PARP1;TTLL6
prerank,cellular polysaccharide catabolic process (GO:0044247),0.4966249190082795,1.1443126327480957,0.3026315789473684,0.7947799773728312,1.0,7/16,16.58%,PHKB;GAA;AGL;PYGM;PHKA2;PHKA1;PYGB
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3071783640331514,-1.1442133763498683,0.19313304721030042,0.7529275533612849,1.0,17/67,15.14%,PODXL;ATP8B1;CAV1;PPP1R16B;RABGAP1;TBC1D1;TBC1D8;TBC1D14;RDX;TBC1D15;DCDC2;EVI5;TBC1D5;DYNLT2B;SDCCAG8;GAP43;ATG3
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5638880970561218,1.1442124208880322,0.3453887884267631,0.7942381222294054,1.0,6/10,24.44%,IVD;ETFDH;ETFB;ETFA;ACADM;ACADVL
prerank,regulation of myoblast fusion (GO:1901739),0.5413670826454969,1.1440906078552995,0.33211678832116787,0.7937655212639898,1.0,3/11,10.61%,RIPOR2;CFLAR;CD53
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.43341382108509335,1.1440285673896586,0.3058321479374111,0.793104659196013,1.0,4/35,3.17%,PAM;SLC27A5;ACSS3;HMGCLL1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5525283370651306,1.1439297703626223,0.32456140350877194,0.7925577636792234,1.0,1/10,0.25%,BMP6
prerank,regulation of protein localization to membrane (GO:1905475),0.4526755795288492,1.1438869058370797,0.2865761689291101,0.7918528640179281,1.0,3/28,1.45%,GPC6;GSN;AR
prerank,regulation of cell motility (GO:2000145),0.36061617496613696,1.1418013851495157,0.2552204176334107,0.7970593275724766,1.0,24/121,12.04%,PLXNA2;LDB2;ROCK2;AMOTL2;DOCK10;MACF1;ARHGAP18;CCL19;FBLN1;TBCCD1;BEX4;MEMO1;PARD6B;EGFR;NTN1;FGF2;LMO4;AMOTL1;NEXN;MGAT3;PLXNC1;HBEGF;EGF;CCDC25
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3761867389961815,1.1413209862342504,0.25569620253164554,0.7975952594720848,1.0,12/80,9.72%,NRP1;AUTS2;PIK3R1;DOCK11;RIPOR2;DPYSL3;CCL19;CDC42EP4;CDC42;ARHGAP35;CROCC;PLEKHM1
prerank,macromolecule catabolic process (GO:0009057),-0.36748463462972014,-1.1411813717288963,0.2885714285714286,0.7601070344036697,1.0,8/26,12.18%,SMURF1;PPT1;SIAH1;TRIM24;KIF16B;LGMN;TGFB1;MTOR
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.43736412787374135,1.1399581640375205,0.3,0.8006854031208402,1.0,2/32,0.61%,PDPK1;CEMIP
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.5155635576724307,1.1394719848972197,0.3202725724020443,0.8013421728935481,1.0,2/13,5.78%,NRP1;ENG
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.5102661340736165,1.139325799221286,0.3162393162393162,0.8009357747256964,1.0,5/15,16.45%,GLI3;IL12B;EBI3;SHH;IL23A
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.42403449143265926,1.1390538777884087,0.29472140762463345,0.8008781639313722,1.0,8/35,8.19%,AR;PMEPA1;YAP1;RBFOX2;NEDD4;SRC;DDX17;ZMIZ1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4705334347111176,1.1389892479355044,0.30866141732283464,0.8002339979187482,1.0,9/20,23.38%,ROCK2;FMNL1;RHOQ;LLGL1;ARF6;FHOD1;LLGL2;DLG1;NCKAP1L
prerank,sulfate transport (GO:0008272),-0.44976798667043705,-1.1388637962873234,0.3176178660049628,0.765399941334834,1.0,5/14,13.72%,SLC26A7;SLC26A2;SLC25A30;SLC26A6;SLC25A11
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5183018707468341,1.1388412868448434,0.3150242326332795,0.7998436924218032,1.0,3/14,4.39%,GAS6;RFFL;APOA1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.42102015522770275,1.1384503734655542,0.2971830985915493,0.8001636838163686,1.0,8/39,9.95%,NRP1;GDNF;GLI2;SALL1;NKX2-1;ENG;BMP2;FGF2
prerank,protein lipidation (GO:0006497),-0.3049494654097734,-1.1372000506857864,0.24096385542168675,0.7687450901851034,1.0,19/59,18.44%,ZDHHC2;DPM1;PIGP;ZDHHC16;PGAP2;ZDHHC15;GPLD1;ZDHHC14;PIGB;UGCG;WDR45B;ZDHHC5;DPM3;PIGL;PIGU;WIPI2;DPM2;PIGO;PIGV
prerank,regulation of protein phosphorylation (GO:0001932),0.3345039516917526,1.1371933451853573,0.2232905982905983,0.8030586754534047,1.0,53/256,14.26%,EPHA7;IGF2;ROCK2;ANGPT1;PID1;PTPN13;PLPP3;LYN;IL34;LEPR;PELI2;CCN1;GAS6;FBLN1;CDK5RAP3;TSPYL2;MT3;AXIN2;PHIP;MUSK;SLCO3A1;ENG;CDH5;LRRK2;PML;WWTR1;EIF2AK3;NTRK3;STK4;EGFR;EPHB2;ARRB1;DAB2;BMP2;NSD1;ITGB3;MYADM;STAT2;PRKN;FGF2;IGFBP3;CEBPB;TMEM119;RAP2A;F2;PPP2R5D;IMPACT;INSR;PTEN;IBTK;PLXNB2;PDCL3;AKAP8L
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3182683275910568,1.137019381976691,0.037,0.8027421819528227,1.0,335/1646,17.63%,IGF1;TCF7L2;TCF4;ZBTB20;COL1A1;NFIA;IGF2;RORA;RHOH;CDK14;TRPS1;TBL1XR1;ZFHX4;RUNX1T1;TEAD1;ATXN1;PKNOX2;SMAD3;PBX1;ZEB2;ARNT2;AR;SOX5;ZKSCAN2;MITF;NKX6-1;GLIS3;TGFA;RUNX1;IL31RA;NR2F2;GLI2;PRRX1;SALL1;WWC2;SP7;ZIC1;VGLL3;OGT;GLI3;IKZF2;MAF;ZEB1;ARID5B;RUNX2;FZD2;PRDM5;NKX2-1;ARID4A;SP100;YAP1;KIT;WNT4;FOXP2;RBFOX2;ASCL1;NFIB;APOE;MLXIP;NUP107;TGFBR1;JDP2;GAS6;SIX5;ZIC4;NFIX;MIDEAS;LBH;MXI1;TLE1;LBX2;FBXL19;IRF1;RLF;MEOX2;OGG1;SMURF2;IKZF4;BRWD1;PRICKLE1;ZIC2;MSC;ACVR1;SFRP1;RFX5;ZHX2;MT3;NEUROD4;ETV6;FZD1;CREB3L2;CDK16;ZNF83;NEUROD1;NCOA2;PHIP;KLF15;ARID1B;BCL6;MLLT3;DENND4A;TBX3;ATXN7L3;DKK3;SP4;USP47;TCF7;ENG;EPAS1;HLF;ZBTB8B;CUX2;BCOR;CBX3;ATOH8;NAB2;HES7;SMARCA1;BATF;ZNF23;MED14;APBB2;ZNF483;PML;NR5A1;NFE2L2;ING5;DDX17;MBD2;WWTR1;CEBPA;ZBTB38;ZNF697;SIRT2;MAP2K1;SREBF1;SAP30;RNF10;SMARCC2;ZBTB24;TSHZ2;REXO4;NR1D1;BBX;RAI1;MED16;MED8;PPP1R13L;WTIP;RBPJ;OSR1;ZMIZ1;ZMYND15;SAFB2;TULP3;CHD2;HIVEP2;LIN9;MTA3;EGFR;NCOR1;TCF7L1;FOXC2;ARRB1;KDM5B;NONO;PCGF3;STAT5B;BMP2;ARHGEF11;SCML2;PICALM;CBY1;ARNT;CREBL2;MZF1;SMAD1;HOXC5;GTF2IRD1;ZBTB4;GMEB1;NSD1;ZBTB1;BICRAL;CCNK;CREB3L4;CREB3;STAT2;MED13L;HEXIM2;SP140;PAX1;GLIS2;FGF2;PHF2;PHF1;NCOR2;FOXA1;ZSCAN21;ACTR8;NR1D2;BAZ1B;ZKSCAN3;PBXIP1;MBD1;RNF6;TFAM;ZNF177;KDM5C;SETD5;ZBTB8A;KMT2A;CCNL2;KLF9;SP5;L3MBTL1;TEAD3;NKX2-8;IFNK;CEBPB;MED29;ZBTB37;NFE2;CCNL1;BHLHE41;EGF;SPDEF;REST;ZFP30;STAT6;MNAT1;GLI1;NR4A1;ACVR1B;CAMTA1;NIBAN2;BTRC;ZNF318;HMGN5;PDCD4;INSR;NPAS2;KMT2E;TRIP4;SMARCD2;ZNF182;MYCN;GATA6;HIVEP1;TIAL1;L3MBTL2;YAF2;SUFU;EBF1;STAT4;ETS1;TCF12;HOXC8;TAF5L;ZNF383;KDM7A;ZNF25;TADA3;ZNF148;HDAC4;FOXK2;FSTL3;HOXD1;ZNF219;TWIST2;NR1H3;FUBP3;SAP30L;SMARCB1;CAMTA2;MYCBP;DYRK1A;HOXC4;RXRA;SCMH1;PHF8;SUDS3;TFCP2;CDKN1C;GPBP1;SHH;ZNF276;MYBL1;TSHZ1;METTL4;FADS1;BMP4;CBX5;MYT1;MTF1;TGFBRAP1;PSPC1;ZNF585B;ZNF585A;BAZ2B;HDGFL3;RIOX1;ZBTB17;TFDP1;DYRK1B;AKT1;MXD4;MAFA;TIMELESS;NCOA7;CREB3L1;ZNF423;PCBD2;FOXJ3;EBF4;NIPBL;KDM3B;ATF5;PLAG1;ZSCAN20;FOXO6;CCNQ;GON4L;CHD7;NEUROD6;SP1;RHOG;AHRR;CREB5;ZFAT;SPIN4;ZSCAN29;FOXO3;IRF2;ZIC5
prerank,regulation of microglial cell activation (GO:1903978),0.5021286327678365,1.1365573666281836,0.32730263157894735,0.8032530847835754,1.0,5/15,16.92%,LDLR;NR1D1;TTBK1;SYT11;CX3CL1
prerank,positive regulation of neuron death (GO:1901216),0.40716434461527795,1.136343142140985,0.29298486932599727,0.803066841438102,1.0,5/46,9.05%,EPHA7;EFNB2;NUPR1;TLR6;PICALM
prerank,establishment of mitotic spindle localization (GO:0040001),0.44431087240372424,1.136182061881851,0.30428134556574926,0.8027513183648571,1.0,12/28,23.02%,GJA1;ZW10;SPDL1;UBXN2B;KPNB1;CENPA;HTT;NUMA1;NSFL1C;NDE1;FBXW11;ITGB1
prerank,tRNA aminoacylation (GO:0043039),-0.3377072342623956,-1.13593372601697,0.2542372881355932,0.7707648828655634,1.0,13/37,24.80%,WARS1;WARS2;LARS1;YARS2;YARS1;QARS1;KARS1;FARS2;AIMP1;MARS2;AIMP2;TARS1;GATC
prerank,circulatory system development (GO:0072359),0.3567802384141231,1.1350678433912282,0.2630966239813737,0.8052850649506986,1.0,22/118,9.71%,RBP4;FBN1;PDLIM5;HSPG2;GLI2;PDLIM2;SALL1;TGFBR1;SH3PXD2B;ACVR1;CDH5;ADAP2;BCOR;CACNA1C;CRB2;NTRK3;OSR1;FOXC2;BMP2;KAT2B;EEF1AKMT4-ECE2;STK11
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.4911535783866374,1.1350124926036036,0.304552590266876,0.8046120674025595,1.0,4/18,7.90%,DAAM2;IL34;SLC45A3;DRD3
prerank,homocysteine metabolic process (GO:0050667),0.5329792022189076,1.1344392832165642,0.3588850174216028,0.8054884932373453,1.0,4/11,13.22%,MTHFR;DPEP1;MMUT;NOX4
prerank,regulation of DNA repair (GO:0006282),0.406017408097761,1.1343547058666372,0.2700135685210312,0.8048833171349629,1.0,9/44,13.03%,EYA2;EYA1;AXIN2;PML;TRIP12;EGFR;UBE2V2;ERCC8;NPAS2
prerank,granulocyte chemotaxis (GO:0071621),-0.3206736395678456,-1.1343334178792817,0.2277992277992278,0.7737347447852927,1.0,9/55,11.56%,PDE4B;BSG;TGFB2;PPIA;CCL14;FCER1G;CKLF;EDN1;CXADR
prerank,lamellipodium organization (GO:0097581),-0.36302105204892143,-1.134027738864682,0.29573170731707316,0.7729136066150254,1.0,9/29,9.42%,PARVB;CCDC88A;ABLIM1;S1PR1;SPATA13;CDH13;ABLIM3;SNX1;ABLIM2
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.47899643683333326,1.1339603256590034,0.31751227495908346,0.8052104624132812,1.0,1/18,0.44%,FBN1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.42496062627780995,1.1334910747406426,0.2936170212765957,0.8057385512198342,1.0,7/35,6.96%,COL4A3;SPARC;NR2F2;APOE;SULF1;ATOH8;IL12B
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.4562229101522138,1.1333545235112432,0.31634182908545727,0.8052948576595093,1.0,7/23,19.76%,EPHX2;GSTM4;GSTM2;ALOXE3;FADS1;CYP1A1;ALOX12
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.4961208631323396,1.1333200653522824,0.332220367278798,0.8045699743459663,1.0,3/15,3.55%,FGFR2;PDGFRA;TGFBR1
prerank,regulation of JNK cascade (GO:0046328),0.36289857738429704,1.1332716500431672,0.2660891089108911,0.8038880143904165,1.0,19/101,12.77%,CCN2;SH3RF3;TGFBR3;DACT1;SH3RF1;GADD45B;CCL19;EDAR;MTURN;MAP4K4;EGFR;NCOR1;LTBR;PRKN;ITCH;TAOK3;CARD9;RAP2A;DUSP19
prerank,positive regulation of protein import (GO:1904591),0.44028426976793134,1.132693458911684,0.31277533039647576,0.8048117041315799,1.0,10/30,18.77%,PIK3R1;SMAD3;ZIC1;PDCD5;RBM22;FLNA;UBR5;PIK3R2;EFCAB7;TPR
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4628366012631792,1.1325714973629828,0.3172302737520129,0.8043428478656045,1.0,4/20,7.37%,EPHX2;APOE;GNB3;SREBF1
prerank,protein localization to cell junction (GO:1902414),-0.38963946127412885,-1.1324512091200127,0.27393617021276595,0.7759050374284019,1.0,8/22,12.57%,NLGN1;TJP2;TJP1;NECTIN1;HEG1;SHANK1;PCLO;PAK2
prerank,protein heterooligomerization (GO:0051291),-0.42084063029182484,-1.131993788295517,0.28756476683937826,0.7755212420489983,1.0,10/17,27.32%,KCNC2;GRIN2B;CPSF7;MAT2A;HSD17B8;TMEM120A;GRIN1;CBR4;CPSF6;PKD1
prerank,regulation of phosphate metabolic process (GO:0019220),0.4916895392086222,1.1317947830905384,0.334983498349835,0.8057486219672443,1.0,3/16,7.23%,SRPX2;GNB3;SIRT2
prerank,nuclear pore organization (GO:0006999),-0.431182663212786,-1.1317231465583415,0.31725888324873097,0.7745772731129309,1.0,4/14,7.42%,NUP93;NUP35;NUP153;NUP54
prerank,embryonic heart tube development (GO:0035050),-0.4314715418820111,-1.1315102518911757,0.3035294117647059,0.7735445426847302,1.0,6/14,16.35%,SOX17;TBX2;SOX18;HES1;RYR2;CITED2
prerank,synaptic membrane adhesion (GO:0099560),0.5050536850237006,1.1309368773500186,0.33499170812603646,0.8074053701146758,1.0,2/14,5.20%,GPC6;PTPRS
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4759555262710813,1.130702188767629,0.3160453808752026,0.8072517623693557,1.0,4/20,6.40%,SLC8A1;ATP1A2;GSTM2;CACNA1C
prerank,vacuolar acidification (GO:0007035),0.46910637624991686,1.1302620009395767,0.3291731669266771,0.8077173470435635,1.0,1/21,0.21%,ATP6V0A4
prerank,cellular response to glucose stimulus (GO:0071333),0.44251782828490943,1.1299210279437928,0.31314623338257014,0.807891891976059,1.0,3/30,5.53%,ZBTB20;GAS6;PRKAA2
prerank,negative regulation of angiogenesis (GO:0016525),0.36835739998134714,1.1290694032247754,0.2927120669056153,0.8095346160224727,1.0,13/84,6.57%,COL4A3;ROCK2;SPARC;DCN;HSPG2;SERPINE1;THBS2;ISM1;SULF1;SERPINF1;ADAMTS9;EMILIN1;PML
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.541949425816149,1.1290533603588284,0.362962962962963,0.8087552873583072,1.0,4/10,8.94%,HECW2;NEDD4;OSR1;COMMD1
prerank,regulation of cell population proliferation (GO:0042127),0.3218128333074727,1.1287442794742142,0.13440320962888666,0.8088123620759308,1.0,116/691,13.94%,IGF1;TCF7L2;BMP6;IGF2;ESM1;COL4A3;ELN;GDNF;KSR1;PDGFD;AREG;AR;TGFA;RUNX1;IL31RA;LYN;DLC1;BCL2;GRK5;PODN;FGFR1;IL34;IL6R;OSMR;BMPR1A;EPGN;FGFR2;YAP1;FGFR4;PDGFRA;KIT;RBFOX2;PDGFRB;PDS5B;TGFBR1;EFNB2;NUPR1;NPR3;PDCD5;CSF1;IRF1;CYP1B1;RAPGEF2;SFRP1;NTF3;AXIN2;HTR1A;PHIP;CTSH;RARG;BCL6;PDPN;TBX3;VIP;ALDH1A2;ENG;ZFP36L1;NUAK1;SKI;TSLP;PML;BEX4;ING5;P3H3;WWTR1;CEBPA;AGTR1;SIRT2;MAP2K1;IL13RA1;RAB25;NMI;NTRK3;TET1;RNF139;EGFR;STAT5B;BMP2;KAT2B;CD200;TRPM4;ITGAV;STAT2;STK11;S100A11;FGF2;INCA1;CDC123;SETD4;FGFBP1;TSPO;CGRRF1;IGFBP3;IFNK;GSDME;HBEGF;RGCC;EGF;UFL1;ADRA2A;REST;STAT6;CD33;GLI1;NIBAN2;FOLR2;HMGN5;INSR;NOX4;SFRP4;TSC2;FRK;PTEN;STAT4;ETS1;CLMN
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.38232570937096705,1.1284129877946971,0.2838018741633199,0.8089318190732091,1.0,8/60,8.68%,TCF7L2;CDK8;RUNX2;TNRC6B;MED14;MED16;MED8;TNRC6A
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.44729575400948074,1.1282152460768307,0.3107255520504732,0.808655957551638,1.0,8/24,15.14%,VTN;NEDD4;MT3;EMILIN1;ARNT;ITGB3;NIBAN2;GRB10
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.32746051472787907,1.1276437286714645,0.2097107438016529,0.8095053855929388,1.0,77/327,18.52%,NFIA;IGF2;RORA;RHOH;ATXN1;ARNT2;MITF;WWC2;NUP107;TGFBR1;OGG1;MSC;NCOA2;DENND4A;TCF7;ENG;NAB2;APBB2;PML;WWTR1;CEBPA;ZBTB38;SAP30;REXO4;WTIP;ZMIZ1;TULP3;TCF7L1;NONO;BMP2;CREBL2;MZF1;GTF2IRD1;ACTN4;ZBTB4;NSD1;PHF1;ZSCAN21;ACTR8;NR1D2;RNF6;IFNK;CEBPB;REST;ACVR1B;HMGN5;INSR;TRIP4;YAF2;SUFU;TAF5L;FOXK2;ZNF219;SAP30L;MYCBP;GPBP1;MYBL1;FADS1;MYT1;TGFBRAP1;PSPC1;MAFA;ZNF423;COPS2;ATF5;PLAG1;GON4L;CHD7;SP1;ZFAT;SPIN4;IRF2;CARM1;SOX11;NFIL3;SRSF10;PPIE
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.38715934360109844,-1.1273244614106464,0.2821917808219178,0.7846877895620026,1.0,10/20,26.51%,GATM;GCLM;PTDSS1;OPLAH;GAMT;GCLC;GGT1;GGCT;PLSCR1;GSS
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5237190845996811,1.1273153365570994,0.33797909407665505,0.8096401270673877,1.0,3/12,3.91%,DOCK10;DOCK11;NOTCH2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.4427047346830096,1.1272506514422762,0.3143712574850299,0.8089980520387322,1.0,7/29,13.84%,GHR;IL31RA;NMI;STAT5B;STAT2;STAT6;STAT4
prerank,regulation of Rac protein signal transduction (GO:0035020),0.491568142511562,1.127223309161124,0.32148626817447495,0.8082563468120444,1.0,4/16,11.91%,AUTS2;OGT;ALS2;KBTBD7
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.26217196876276744,-1.1270958247155403,0.1346153846153846,0.7836367749165458,1.0,44/149,22.34%,PRKCH;CAV1;RPS6KA5;NOD1;TNFRSF11A;TFRC;TRIM14;PPIA;NFKBIA;RPS3;ARHGEF2;AIM2;TRIM25;RBCK1;ALK;RPS6KA4;TRAF5;PRKCZ;CX3CR1;CARD14;RTKN2;TRAF1;CD40;TRIM68;APP;NOD2;CARD16;EP300;TAB1;BTK;TRIM6;TLR4;CLU;DHX9;NPM1;TRIM62;UBE2V1;AGER;PSMA6;TRAF2;CHUK;DDRGK1;MAP3K7;MALT1
prerank,regulation of inflammatory response (GO:0050727),0.3448799212030499,1.1267741098080495,0.2549234135667396,0.808843078184838,1.0,40/190,17.49%,ADAMTS12;PTGIS;RORA;AHSG;SERPINE1;PTGES;DAGLA;CASP12;APOE;APOA1;MVK;BCL6;CDH5;TSLP;IL12B;CEBPA;AGTR1;NR1D1;NMI;CCN4;CD200;NR1D2;SETD4;UFL1;TNFAIP6;SELENOS;NAPEPLD;PDCD4;MDK;ETS1;TNFRSF1A;NR1H3;LACC1;IL23A;CD47;ZBP1;CASP1;CX3CL1;SMPDL3B;FNDC4
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.35613321567006784,1.126594247184586,0.28421052631578947,0.8085832088200521,1.0,13/116,7.14%,ADCY1;ADCY2;ADCY7;LYN;ADCY5;ADCY9;INSL3;VIP;LHCGR;ADRB3;SRC;CD247;DPEP1
prerank,stress granule assembly (GO:0034063),-0.402234953678986,-1.126519902474719,0.29411764705882354,0.7836843848542412,1.0,6/20,12.99%,BICD1;CSDE1;RPS23;LSM14A;YTHDF3;G3BP1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.43505890193235924,1.1264307269242548,0.32650073206442165,0.8082720270130297,1.0,11/30,16.00%,SP7;KIT;SFRP1;MLLT3;BATF;UFL1;FSTL3;PRRC2C;SHH;BMP4;PLD4
prerank,ERBB signaling pathway (GO:0038127),0.37574108177842436,1.1263322396453326,0.3138780804150454,0.807744189639517,1.0,14/64,11.78%,PDPK1;PIK3R1;AREG;TGFA;EPGN;PIGR;SRC;CUL5;SLC30A10;EGFR;AAMP;BRAF;HBEGF;EGF
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.36532342548768254,-1.1262283318488246,0.27070063694267515,0.7827985039176106,1.0,17/30,26.60%,SDCBP;RYBP;RPL11;HSP90AB1;USP14;GIPC1;N4BP1;SVIP;FHIT;STYX;CAMLG;UBXN1;DDRGK1;USP7;SGTA;CCAR2;UCHL5
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.47708549592742133,-1.1257086443870281,0.2927400468384075,0.7825147614147154,1.0,5/11,33.63%,ITM2A;BACE2;NECAB2;ITM2C;NECAB3
prerank,RNA methylation (GO:0001510),0.3874724873306892,1.1256855238761956,0.3016905071521456,0.8087632087930678,1.0,18/60,19.19%,TRMT44;BUD23;TRMO;NSUN2;METTL14;DIMT1;FTSJ3;BCDIN3D;WTAP;TRMT13;TRMT112;THUMPD3;NSUN5;THUMPD2;NSUN4;THADA;METTL3;METTL1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4597898448642664,-1.1251201143643843,0.3211845102505695,0.7825055533551142,1.0,4/11,15.88%,MEF2C;TGFB2;TGFB1;GPER1
prerank,import into cell (GO:0098657),0.411526769692996,1.1240079301266575,0.31353591160220995,0.8127886550891275,1.0,9/41,9.40%,SLC1A3;GLUL;ATP1A2;SLC6A13;SLC22A2;SLC11A2;SLC22A4;SLC29A1;SLC5A3
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.37923988805613884,1.1237052054529817,0.31402831402831405,0.812866271010813,1.0,17/66,17.48%,PIK3R1;SMAD3;ZIC1;YAP1;CDK5RAP3;WWTR1;EIF2AK3;RBM22;F2;NMD3;FLNA;UBR5;SESN2;PIK3R2;AKT1;LIF;EFCAB7
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.35401265362381834,1.123459508591755,0.2838785046728972,0.8127475455506868,1.0,13/117,7.14%,ADCY1;ADCY2;ADCY7;LYN;ADCY5;ADCY9;INSL3;VIP;LHCGR;ADRB3;SRC;CD247;DPEP1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.3652605802385872,-1.1233655323402247,0.27089337175792505,0.786208683756976,1.0,10/25,22.34%,SLC7A5;PLCG2;B2M;CD55;NOD2;TRIM6;FZD5;TRAF2;MAP3K7;MALT1
prerank,positive regulation of metabolic process (GO:0009893),0.3608293434284616,1.1233142712813244,0.2946859903381642,0.8123330492536157,1.0,22/103,15.26%,GJA1;CAMK1D;LEPR;OGT;ACSL1;GNAS;APPL2;DYNC1H1;EPAS1;ADRB3;ALMS1;MFAP2;CEBPB;STAT6;INSR;DECR1;FASN;DIO2;G0S2;CNOT3;GRB10;IL4R
prerank,nucleic acid-templated transcription (GO:0097659),0.4063819050029043,1.1230354515975423,0.3096590909090909,0.8123240905745519,1.0,6/42,11.26%,POLR2D;THRB;POLR3A;CREBL2;POLR2C;NKX2-8
prerank,positive regulation of tissue remodeling (GO:0034105),0.5415463532229918,1.1226927172743653,0.35638297872340424,0.812504701737779,1.0,2/10,6.96%,ROCK2;IL12B
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.44973144317047453,1.12260625102422,0.3323397913561848,0.8119335425254892,1.0,2/28,1.85%,ITPR1;BCL2
prerank,regulation of protein kinase activity (GO:0045859),0.3538885631721529,1.1226012912371848,0.2826603325415677,0.8111441529796696,1.0,11/106,4.50%,PDPK1;DDR2;PPM1E;CCN1;DTNBP1;PRKAG2;GAS6;CCL19;CSF1;RAPGEF2;TSPYL2
prerank,regulation of transport (GO:0051049),0.41535419367796966,1.1225228071901598,0.3191800878477306,0.8105734637942781,1.0,6/36,9.87%,NRP1;LEPR;SLC30A8;LRRK2;RAB25;PRKN
prerank,positive regulation of immunoglobulin production (GO:0002639),0.43658971828704185,1.1225001212809906,0.3313253012048193,0.8098351886037461,1.0,3/31,8.50%,RBP4;KMT5B;EPHB2
prerank,inorganic cation transmembrane transport (GO:0098662),0.3318862850381425,1.1224462388913723,0.23864836325237593,0.8091987008044127,1.0,30/268,9.62%,SLC1A3;ATP6V0A4;KCNK2;SLC24A3;SCN7A;NALCN;SLC8A1;SLC8A3;TRPA1;ATP1A2;SLC41A1;SCARA5;SLC6A9;SLC30A8;GAS6;SLC6A13;SLC9A9;SLC24A1;SLC30A2;SLC11A2;SLC24A5;KCNK7;CACNA1C;SLC30A10;NNT;KCNQ4;TRPM4;SLC9A5;KCNJ14;ITGAV
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.42038166883826256,1.1214901039123208,0.3163841807909605,0.8111623769335216,1.0,5/38,7.73%,RORA;RHOH;TLE1;MAPKBP1;NR1D1
prerank,regulation of synapse assembly (GO:0051963),0.4037098393144994,1.120989113398878,0.3046979865771812,0.8118044807426262,1.0,10/46,10.87%,GPC6;PDLIM5;SRPX2;MUSK;CUX2;EPHB2;MDGA1;SLIT1;EPHB3;SETD5
prerank,phosphorylation (GO:0016310),0.32347941733586877,1.1209584385731162,0.2147995889003083,0.81109091077823,1.0,65/384,13.78%,EPHA7;STK17B;DAPK2;PDPK1;PDK1;NRK;ROCK2;CDK14;CDK8;DAPK1;GRK3;LYN;GRK5;FGFR1;BMPR1A;DMPK;MARK1;PRKAG2;TGFBR1;GAS6;ACVR1;CDK16;PRKAA2;MAP3K20;NUAK1;LRRK2;AKT3;SIK1;SPHK2;EIF2AK3;MAP2K1;BRSK1;IRAK3;MAST2;OXSR1;MAP4K4;STK4;EPHB2;XYLB;BMP2;CAMK2B;NEK6;STK11;RNASEL;RYK;TAOK3;PI4KA;BRAF;TTBK1;IKBKE;IGFBP3;TBK1;MAP4K5;ACVR1B;WNK1;TLK1;STRADA;MAP3K13;GRK4;INSR;PIK3R4;FRK;MERTK;CDK12;MARK2
prerank,negative regulation of phosphorylation (GO:0042326),0.3705141370033839,1.1209429456348325,0.30223880597014924,0.810331779044309,1.0,23/85,15.79%,PID1;PTPN13;PLPP3;LYN;DYNLL1;NUPR1;FBLN1;CDK5RAP3;LRRK2;WWTR1;NTRK3;NCOR1;EPHB2;MYADM;PRKN;IGFBP3;IMPACT;PTEN;IBTK;HDAC4;NPRL2;CDKN1C;BMP4
prerank,heart contraction (GO:0060047),0.41005607335611083,1.120917245021117,0.3140376266280753,0.809609083274177,1.0,7/41,10.11%,SLC8A1;ATP1A2;TPM1;TNNC1;MYL4;GAA;CSRP3
prerank,regulation of cell communication (GO:0010646),0.4211071315098751,1.1208636457729164,0.31988041853512705,0.8089665993901961,1.0,4/35,4.50%,SLC8A1;GRK3;GRK5;TSPYL2
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.37205446433829403,-1.1208209242971627,0.28851540616246496,0.7905535352856546,1.0,6/24,9.72%,GPI;HK2;PFKL;TPI1;PFKP;ALDOA
prerank,canonical glycolysis (GO:0061621),-0.37205446433829403,-1.1208209242971627,0.28851540616246496,0.7905535352856546,1.0,6/24,9.72%,GPI;HK2;PFKL;TPI1;PFKP;ALDOA
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.37650979975899296,-1.120760281711041,0.29829545454545453,0.7889860612963798,1.0,9/25,13.86%,CAV1;CTNNA3;CAMK2D;CALM1;JUP;CALM3;CXADR;RYR2;DSG2
prerank,negative regulation of nuclear division (GO:0051784),0.5239022007888586,1.1202075994148237,0.3441441441441441,0.8101347863178818,1.0,3/11,15.79%,TOM1L2;NME6;BMP4
prerank,positive regulation of neurogenesis (GO:0050769),0.3779896070790418,1.1201518929203205,0.2972972972972973,0.8095079784300171,1.0,8/68,5.90%,ROBO1;PLXNA2;OBSL1;TIAM2;NUMBL;LIG4;SERPINF1;CUX2
prerank,protein transport (GO:0015031),0.3246153174233452,1.1198675940607206,0.24613800205973224,0.8094989379234492,1.0,51/332,14.16%,ATP6V0A4;WLS;RABGAP1L;TBC1D4;STEAP3;TXNIP;ARRDC4;LRP1;ABCA1;VAMP5;USP6NL;LMAN2L;SEC31A;MACF1;OPTN;APOE;TMED1;GOLGA4;VPS26C;RAB23;TVP23B;STXBP3;TOM1;ARFGAP3;STX16;SNX33;ADPRH;LTBP2;MIA2;IFT27;COPZ2;RAB22A;ARFIP2;MIA3;TBC1D2B;GGA2;TMED4;ATP6V1E1;ARL1;ARRDC2;COPA;STXBP1;RCN3;GOLPH3L;MTTP;TLK1;USO1;TVP23A;ARF4;TANGO2;SNX9
prerank,peptide hormone secretion (GO:0030072),0.45270539830273926,1.1198659000758973,0.3297709923664122,0.80871204947311,1.0,5/26,5.72%,SLC30A8;CDK16;NEUROD1;VIP;FAM3B
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.46312178773332335,-1.1197516937796488,0.31313131313131315,0.7904044016798212,1.0,3/11,2.58%,F11R;TJP2;TJP1
prerank,cellular protein modification process (GO:0006464),0.3152808603466869,1.1197435066026302,0.12212212212212212,0.808283990361846,1.0,154/982,13.83%,LTBP1;STK17B;DAPK2;PDPK1;PDK1;CP;FBN1;SPSB1;NRK;PPM1H;ROCK2;CDK14;LOXL1;PPM1E;CDK8;MATN3;DAPK1;UST;LOX;PTPN13;GRK3;AHSG;PRKCSH;IGFBP4;GALNTL5;LYN;GRK5;OBSL1;FGFR1;ART4;B3GALT1;BMPR1A;DMPK;ST3GAL5;LAMC1;MARK1;CCN1;PPP3CA;APOE;PRKAG2;TGFBR1;ST3GAL3;GAS6;PTPN21;FSTL1;FBXL19;CSF1;LARGE1;TGM5;APOA1;APLP2;ACVR1;MT3;CDK16;PSME4;IGFBP5;SERPIND1;PTPRS;PRKAA2;MAP3K20;NUAK1;EPAS1;CST3;TNC;LRRK2;FUT10;ADPRH;CUL4B;AKT3;CD247;STT3A;PARP16;ATG10;SIK1;SIRT2;EIF2AK3;CUL5;MAP2K1;ALG5;BRSK1;ARAF;B3GALNT1;PTPN9;RCN1;FBXL3;IRAK3;MAST2;OXSR1;MAP4K4;STK4;DNAJC3;UBA7;MTMR3;FN3KRP;BMP2;COMMD1;CAMK2B;NEK6;MIA3;MTMR7;NGLY1;STK11;PARP14;KRT10;CTDSP2;RNASEL;RYK;RBBP7;PTPRM;ASB12;TAOK3;BRAF;BMP15;TTBK1;IKBKE;PDIA6;IGFBP3;FBXO9;WIPI1;COL3A1;DCAF8;FBXL12;FBXO11;ERCC8;UFL1;FBXO4;KBTBD7;TBK1;PTPN3;DDOST;MAP4K5;PPP2R5D;FEM1C;ACVR1B;WNK1;TLK1;STRADA;MAP3K13;ITIH2;GRK4;BTRC;GPS1;INSR;COPS3;TNKS2;PIK3R4;FRK;MERTK;CDK12;P4HB;MARK2;ARF4;PTEN;UBE2E2
prerank,negative regulation of endocytosis (GO:0045806),0.44760560632379,1.1195157649460732,0.3409436834094368,0.8081998272970717,1.0,6/24,15.76%,EPHA3;SNX33;PICALM;SYT11;NR1H3;ARF6
prerank,regulation of protein import into nucleus (GO:0042306),0.4146467877081812,1.1193740526505493,0.3328591749644381,0.8078473943742733,1.0,12/36,18.77%,PIK3R1;SMAD3;ZIC1;RAB23;RBM22;SUFU;FLNA;UBR5;BMP4;PIK3R2;EFCAB7;TPR
prerank,iron ion transmembrane transport (GO:0034755),0.5298545623199546,1.1193685496137453,0.35361216730038025,0.8070770627606221,1.0,4/10,10.91%,SCARA5;SLC25A37;SLC11A2;ABCC5
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.3872237371571665,-1.119215122215042,0.31142857142857144,0.790362685537675,1.0,4/21,4.67%,MTUS1;PTK2B;THBS1;CMKLR1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3169226616973966,1.1190877593795914,0.14156626506024098,0.8071060340858986,1.0,160/807,16.50%,TCF7L2;BMP6;LDB2;IGF2;FHL2;TRPS1;TBL1XR1;RUNX1T1;ATXN1;SMAD3;ZEB2;AR;MITF;NKX6-1;GLIS3;RUNX1;NR2F2;GLI2;DACT1;SALL1;KCNIP3;WWC2;GLI3;CBX7;ZEB1;AEBP1;ARID5B;RUNX2;PRDM5;NKX2-1;FGFR2;MDFI;THRB;ARID4A;SP100;YAP1;WNT4;FOXP2;RBFOX2;ASCL1;DNMT3A;RARB;JDP2;GAS6;NFIX;MIDEAS;LBH;MXI1;TLE1;IRF1;SMURF2;IKZF4;PRICKLE1;ZIC2;SFRP1;ZHX2;MT3;ETV6;RARG;BCL6;TBX3;DKK3;USP47;CUX2;SKI;BCOR;CBX3;ATOH8;NAB2;PML;MBD2;CEBPA;CPEB3;ZBTB38;SIRT2;SAP30;SMARCC2;MTA2;NR1D1;DR1;RBPJ;OSR1;ZMYND15;MTA3;NCOR1;FOXC2;DAB2;NONO;BMP2;BRMS1L;SCML2;JAZF1;CBY1;MZF1;GTF2IRD1;ZBTB4;NSD1;ZBTB1;HEXIM2;PRKN;GLIS2;IFI27;NCOR2;CXXC5;NR1D2;ZKSCAN3;PBXIP1;MBD1;ZNF177;KDM5C;L3MBTL1;CEBPB;BHLHE41;SPDEF;HDAC8;REST;PHF21A;PER3;IMPACT;USP9X;NIBAN2;TCF25;BTRC;ZNF318;PEX2;PAF1;PDCD4;GATA6;FRK;HIVEP1;IGBP1;L3MBTL2;YAF2;SUFU;ZNF25;TCERG1;ZNF148;HDAC4;FOXK2;ZNF219;TWIST2;FLNA;HSBP1;NR1H3;RNF2;UBE2D1;RXRA;SCMH1;SUDS3;CDKN1C;SHH;BMP4;CBX5;PSPC1;FNIP1;RIOX1;MXD4;TIMELESS;CREB3L1;ZNF423
prerank,histone lysine demethylation (GO:0070076),0.4393145959309434,1.1190252784343375,0.31097560975609756,0.8065058230926178,1.0,11/25,23.24%,KDM5B;PHF2;KDM5C;KDM7A;PHF8;RIOX1;KDM3B;KDM4A;KDM5A;KDM4C;KDM3A
prerank,melanosome localization (GO:0032400),-0.38942088609698355,-1.1188342648663838,0.3113456464379947,0.7897766678373543,1.0,8/21,18.89%,RAB27A;RAB11A;RAB27B;ARL6;BLOC1S5;MLPH;BBS7;MREG
prerank,response to laminar fluid shear stress (GO:0034616),0.5276610965963378,1.1188323518647225,0.3670886075949367,0.8062718506983959,1.0,2/10,6.80%,ABCA1;NFE2L2
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.4139390874731429,-1.1185564226910796,0.2789598108747045,0.7889205284880489,1.0,6/15,13.88%,MVB12B;PTPN12;ERBB2;CDH13;LGMN;CEACAM1
prerank,lymphocyte chemotaxis (GO:0048247),0.4246570537790058,1.1183111209676544,0.3386396526772793,0.8070201093497608,1.0,5/34,6.27%,CYP7B1;GAS6;CCL19;CXCL16;CCL4
prerank,secondary alcohol metabolic process (GO:1902652),0.407001897010556,1.1175069965153925,0.32689655172413795,0.8085941152831736,1.0,8/42,15.33%,ABCA1;APOE;APOA1;CYP27A1;IDH2;LCAT;OSBPL5;RXRA
prerank,snRNA transcription (GO:0009301),0.37205947234135484,1.1167912380924796,0.30927835051546393,0.8098945209326892,1.0,22/70,22.03%,POLR2D;PHAX;GTF2E1;SNAPC1;USPL1;RPAP2;CCNK;POLR2C;INTS4;ELL2;SNAPC5;TAF9;GTF2E2;SNAPC4;SP1;CCNT2;POLR2L;GTF2A1;CCNT1;TAF8;NCBP2;CDK7
prerank,aminoglycan catabolic process (GO:0006026),0.4383216327361103,1.1166267659121174,0.32168850072780203,0.8095520235863807,1.0,3/28,6.42%,GPC6;HSPG2;SDC1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.45852106665440084,1.1165147710456074,0.34142640364188165,0.809064867819505,1.0,4/22,6.13%,GHR;KIT;CYP1B1;TSLP
prerank,lamellipodium assembly (GO:0030032),-0.3646857026409268,-1.1164876457627297,0.2926829268292683,0.7936496918177679,1.0,8/26,9.42%,PARVB;CCDC88A;ABLIM1;S1PR1;SPATA13;CDH13;ABLIM3;ABLIM2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4562462083753114,1.1164303058592853,0.3333333333333333,0.8085217590742001,1.0,2/23,1.00%,ERRFI1;CBLB
prerank,regulation of intracellular protein transport (GO:0033157),-0.3494215113414654,-1.116353372086796,0.27710843373493976,0.7922842487890802,1.0,13/32,30.31%,PRR5L;PTPN14;KIF20B;TGFB1;UHMK1;PDCD10;PLK3;TENM1;CEP131;GCC2;RAB29;ZFAND1;LCP1
prerank,positive regulation of exocytosis (GO:0045921),-0.3453322356128498,-1.1163138891318465,0.2911392405063291,0.7906581575807016,1.0,13/35,24.56%,RAB27A;SDCBP;CADPS;RAB27B;PDCD6IP;CFTR;RAB3A;RAB15;CLASP1;VPS4A;SNF8;EXPH5;STXBP5
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.499264761992928,1.1157659885516344,0.3474025974025974,0.8097045083528676,1.0,3/15,3.21%,ADGRV1;COL11A1;KIT
prerank,positive regulation of neuron projection development (GO:0010976),0.3666719324520977,1.1157480049159898,0.31704260651629074,0.8089807047697579,1.0,15/85,9.39%,EPHA3;CAMK1D;LYN;APOE;DPYSL3;RAPGEF2;ROR1;FZD1;PTK7;CUX2;ATP1B2;ARHGAP35;NTRK3;CAMK2B;RAPGEF1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.47603202224165153,-1.1154253305935573,0.33853006681514475,0.7881388052613507,1.0,3/10,23.01%,NBN;SLX4;EXO1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.47603202224165153,-1.1154253305935573,0.33853006681514475,0.7881388052613507,1.0,3/10,23.01%,NBN;SLX4;EXO1
prerank,t-circle formation (GO:0090656),-0.47603202224165153,-1.1154253305935573,0.33853006681514475,0.7881388052613507,1.0,3/10,23.01%,NBN;SLX4;EXO1
prerank,T-helper cell differentiation (GO:0042093),-0.433411575442716,-1.1152078247025534,0.3283582089552239,0.7871406950042701,1.0,5/14,16.70%,LEF1;FOXP1;ATP7A;GPR183;ZFPM1
prerank,glycolipid biosynthetic process (GO:0009247),0.41293517478572545,1.1149383681897547,0.3190883190883191,0.8106126194057482,1.0,4/38,4.54%,ST6GALNAC5;ST3GAL5;LARGE1;GBGT1
prerank,positive regulation of protein metabolic process (GO:0051247),0.3538429918087546,1.1147277218358902,0.28486293206197855,0.8104043054587544,1.0,15/110,7.09%,ROCK2;HECW2;DACT1;NKD1;SLC6A9;IL17D;APOE;CSF1;NEDD4;SMURF2;SLC25A37;VIP;RANBP9;IL12B;AGTR1
prerank,regulation of cell growth (GO:0001558),-0.25072722642554884,-1.1146429490592482,0.13978494623655913,0.7870014800468419,1.0,48/204,13.98%,PLCE1;SLIT2;FHL1;PTPRJ;ADAM10;NRG3;SPOCK1;SH3BP4;CCN3;NET1;ACVRL1;PAK5;TFRC;PPT1;OSGIN2;ADAM15;SDCBP;SOX17;TGFB2;CAMK2D;ERBB2;AKAP6;SOCS2;NPR1;NDRG3;MFSD2A;SERTAD3;EGLN2;HYAL1;WFDC1;SGK1;RPS6KA1;CCDC85B;LTBP4;OGFR;MINAR1;BCAR1;SIRT1;SLC25A33;TGFB1;FAM107A;MTOR;ATAD3A;SUPV3L1;APBB1;SERTAD2;CEACAM1;H3-3A
prerank,RNA destabilization (GO:0050779),0.47810498293497933,1.1145526286963507,0.3312302839116719,0.8101387948145933,1.0,10/18,27.17%,ROCK2;DXO;METTL14;METTL3;FTO;YTHDF2;METTL16;GIGYF2;PUM1;ZC3H18
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.3671557920192102,-1.1145477252698464,0.2880886426592798,0.7855617089854425,1.0,6/25,9.72%,GPI;HK2;PFKL;TPI1;PFKP;ALDOA
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4505323602172403,1.1141796264972803,0.33073322932917315,0.8105126118725258,1.0,3/24,6.01%,AUTS2;PIK3R1;CDC42
prerank,gliogenesis (GO:0042063),-0.42865556536183125,-1.1139213800036312,0.2962085308056872,0.7857122340601319,1.0,3/15,4.12%,CDH2;CDK6;TGFB2
prerank,JNK cascade (GO:0007254),-0.33056408835756135,-1.1135146686275181,0.29577464788732394,0.785174508659961,1.0,20/40,30.60%,NOD1;TNFRSF19;MAPK10;MAPK8;MAP4K3;ARHGEF6;NOD2;TAB1;MAP3K11;UBE2V1;MINK1;MAP3K7;MAP2K4;GPS2;TRAF6;RPS27A;UBC;PTGER4;IKBKG;MAP3K10
prerank,"base-excision repair, AP site formation (GO:0006285)",0.48541529987210463,1.1133588229990004,0.3387358184764992,0.8121231433808086,1.0,7/17,24.28%,OGG1;NEIL1;TERF2;MBD4;MUTYH;MPG;TDG
prerank,chromosome organization (GO:0051276),0.3604766933045211,1.1133525162949292,0.3142857142857143,0.8113583558874663,1.0,17/99,13.00%,TCF7L2;SETD7;BRWD1;AXIN2;LIG4;MTHFR;CUL4B;TOP2B;POLE3;TCF7L1;PHF1;RAE1;CENPH;L3MBTL1;HDAC8;GPS1;COPS3
prerank,blood vessel diameter maintenance (GO:0097746),-0.33849840479002363,-1.113215721661831,0.2875,0.7843127764551459,1.0,14/34,20.41%,EDNRA;NOS3;KLF2;NPR1;NOS1;KCNMB2;GCLM;ACE2;EDN1;EDNRB;GPER1;GCLC;ITGB1BP1;ROCK1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4713370435020932,1.1131092400399587,0.344,0.811299116246798,1.0,8/18,26.03%,DNAAF1;CCDC40;CABYR;SPEF2;CFAP53;ROPN1L;ODAD4;NPHP3
prerank,regulation of cartilage development (GO:0061035),0.48842068404167865,1.1125942601229797,0.3442088091353997,0.8119599134835191,1.0,5/18,15.79%,TRPS1;SOX5;BMP2;MDK;BMP4
prerank,muscle cell development (GO:0055001),0.4309434601483418,1.1125585061585967,0.32697947214076245,0.811306187956447,1.0,4/30,6.42%,IGF1;SLC8A1;ENG;SDC1
prerank,B cell activation (GO:0042113),-0.29575517608462315,-1.1124101968284852,0.22707423580786026,0.7851246112061077,1.0,30/68,29.91%,MEF2C;PTPRJ;TPD52;PLCG2;TCF3;PTPN2;ITGA4;HHEX;CASP8;BLNK;CD40;GPR183;BTK;PTPRC;JAK3;CD86;ADGRG3;MSH2;VCAM1;MALT1;KLF6;DCAF1;CEBPG;LAX1;GPS2;PIK3CD;CR2;FLT3;LYL1;IL11
prerank,regulation of transferase activity (GO:0051338),0.4818456906685014,1.1122890882051388,0.3397129186602871,0.8113014712297756,1.0,1/17,0.36%,LDB2
prerank,epithelium development (GO:0060429),0.35188589311472585,1.1119575931948822,0.3009478672985782,0.8114110786921733,1.0,18/107,13.44%,ERRFI1;DAG1;DACT1;SALL1;FGFR2;WNT4;CNN3;SMO;MEOX2;ALDH1A2;VCL;OSR1;BMP2;RCN3;NDRG4;GSTK1;VDAC1;GATA6
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.3921967525518312,-1.1118333337210502,0.3226600985221675,0.7851914683386925,1.0,3/18,7.60%,OCLN;SLC2A1;INPP5K
prerank,regulation of ruffle assembly (GO:1900027),-0.37726060259353167,-1.1117490339940526,0.31266846361185985,0.7837491305974775,1.0,4/23,6.99%,CAV1;NLGN1;RDX;EPS8L2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3478136541583826,1.1116139932848574,0.28604382929642447,0.8116327473831352,1.0,28/136,17.25%,TCF7L2;PTGIS;MDFI;SP100;GAS6;NUPR1;IRAK2;CDK5RAP3;CYP1B1;SIK1;IRAK3;MTURN;ARRB1;COMMD1;CD200;GLIS2;ITCH;UFL1;BTRC;SFRP4;SUFU;HDAC4;FLNA;RNF2;EGLN1;NWD1;COMMD6;PIM1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.4884883843802946,1.111557385871028,0.3524720893141946,0.8110446766650113,1.0,7/16,19.92%,RUNX1;WNT4;RGCC;F2;BMP4;CREB3L1;LARP6
prerank,positive regulation of histone acetylation (GO:0035066),-0.36028703621317226,-1.1114370035057075,0.3038961038961039,0.7830243199762014,1.0,7/23,13.57%,RPS6KA5;NOS1;PPARGC1A;BRD7;RPS6KA4;TADA2A;MAPK3
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.34500851265190335,-1.1112066142296246,0.29559748427672955,0.7820708136138568,1.0,11/32,12.18%,PPP1R16B;ITGA1;PPIA;HSP90AB1;PPP1R15B;PPP2R5A;SPPL3;CALM1;CALM3;TGFB1;MTOR
prerank,regulation of vasoconstriction (GO:0019229),0.4327896358024972,1.1111895703626635,0.34672619047619047,0.8113696345958913,1.0,5/27,9.70%,ADRA1B;BDKRB2;AGTR1;TRPM4;ADM
prerank,positive regulation of actin nucleation (GO:0051127),0.5232174246242823,1.1111892970022101,0.3784246575342466,0.8105976368465138,1.0,4/11,21.33%,GSN;WASF1;FCHSD2;BRK1
prerank,protein localization to condensed chromosome (GO:1903083),0.5019293108687006,1.1109162903605072,0.34464285714285714,0.810591692212454,1.0,4/12,9.77%,ZW10;SPDL1;CHAMP1;MTBP
prerank,myoblast fusion (GO:0007520),-0.4601037911663077,-1.1107078059545512,0.32558139534883723,0.7819474127786143,1.0,6/12,13.85%,ADGRB3;JAM2;ADAM12;NOS1;CD81;CACNA1H
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5267469001878664,1.1103546636581112,0.35766423357664234,0.8113823687956827,1.0,2/10,7.36%,LYN;MAP2K1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4577320730932293,-1.1102517356153254,0.35732647814910024,0.781612280172734,1.0,4/12,9.76%,ANK3;ATP1B1;NOS1;WNK2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.37442088127236506,-1.1100897283275182,0.3081395348837209,0.7787198221148559,1.0,7/23,12.29%,PPP1R13B;YWHAH;YWHAQ;MAPK8;YWHAG;CASP8;BBC3
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.37442088127236506,-1.1100897283275182,0.3081395348837209,0.7787198221148559,1.0,7/23,12.29%,PPP1R13B;YWHAH;YWHAQ;MAPK8;YWHAG;CASP8;BBC3
prerank,heart process (GO:0003015),-0.43310515643623226,-1.1100733837100727,0.32575757575757575,0.7771097163791717,1.0,1/14,0.35%,SGCZ
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.3767765151812585,-1.1098878141317603,0.2630057803468208,0.7759845414302332,1.0,11/22,32.79%,PTPRJ;PTPN2;PTPN22;CEACAM1;DGKZ;CD300A;DUSP3;GPS2;PRNP;PHPT1;FCGR2B
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3673384879879923,1.1097326904445894,0.3128834355828221,0.8123158958533084,1.0,15/80,15.95%,MYCBP2;ANGPT1;ARRDC4;CDK5RAP3;PRICKLE1;LRRK2;DERL1;SPRTN;COMMD1;FBXO4;RIPK2;FANCI;UBE2D1;DCUN1D2;HUWE1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.4215907805707298,1.1090499599682653,0.332398316970547,0.8134332085175476,1.0,3/34,8.50%,RBP4;SPHK2;EPHB2
prerank,regulation of viral life cycle (GO:1903900),-0.3867844628720034,-1.1087317231040918,0.2988826815642458,0.7776861935696224,1.0,10/21,21.16%,TRIM14;PPIA;HS3ST5;TRIM25;TRIM68;TYRO3;TRIM6;TRIM62;VPS4A;NECTIN2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.49529701025350276,1.1086440704840048,0.34442595673876875,0.813853951905594,1.0,1/14,0.14%,NRP1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.3878624904108228,1.108481508886435,0.31357048748353095,0.813533082272688,1.0,16/59,16.62%,PDPK1;ROCK2;TGFBR1;ACVR1;LRRK2;MAP2K1;OXSR1;TTBK1;TBK1;ACVR1B;WNK1;MARK2;DYRK1A;DYRK1B;AKT1;CDK10
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5061131379285413,1.1084544983286695,0.37104825291181365,0.8128389260433697,1.0,2/13,6.25%,NUPR1;LRRK2
prerank,epithelial cell development (GO:0002064),0.46553814723313136,1.1081108990028823,0.3483670295489891,0.8130713108555462,1.0,5/20,12.67%,BFSP1;WNT5B;RAB25;LRTOMT;DACT2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.4085045088065228,1.1080212670384655,0.33195020746887965,0.8125664507281448,1.0,9/42,16.45%,SERPINE1;IL6R;OPTN;IL12B;CAMP;RNASE7;F2;GSDMD;IL23A
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.5342669641908938,1.107996648882094,0.3466424682395644,0.8118761242870016,1.0,3/10,8.65%,DCN;IL12B;SPRY2
prerank,response to organic cyclic compound (GO:0014070),0.39426152906039086,1.1079641710884445,0.3225371120107962,0.8111976038798656,1.0,11/52,10.21%,WNT8B;FGFR4;CYP1B1;SFRP1;IGFBP5;LRRK2;STRN3;KYNU;DRD3;STAT5B;FOXA1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.48461572412584986,1.1079269586206981,0.3640776699029126,0.8105356271426764,1.0,8/16,22.68%,AMPD3;NUDT2;GART;AMPD2;PPAT;PFAS;ADSS1;ADSL
prerank,regulation of cellular localization (GO:0060341),0.4026634363034026,1.1076837424197439,0.31690140845070425,0.8104564041803081,1.0,11/46,9.87%,GSN;LYN;ADCY5;CDK16;DYNC1H1;LRRK2;BRSK1;NR1D1;PARD6G;PARD6B;PRKN
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.4201844025385166,-1.1074123404804428,0.3358024691358025,0.7797958130341229,1.0,9/15,35.04%,RAD17;HUS1;MDC1;FANCD2;ATF2;HUS1B;NEK11;RAD9A;EME1
prerank,calcium ion transmembrane transport (GO:0070588),0.35907698601800303,1.1070729234215473,0.30049261083743845,0.8114154449916848,1.0,14/86,9.65%,SLC24A3;NALCN;SLC8A1;SLC8A3;TRPA1;GAS6;SLC24A1;MCU;SLC24A5;CACNA1C;PMPCB;TRPM4;ITGAV;MICU2
prerank,regulation of defense response (GO:0031347),0.36514474302491484,1.1070136103201402,0.3379396984924623,0.8108350533491306,1.0,9/76,7.09%,ADAMTS12;AHSG;PTGES;CASP12;APOE;IRF1;APPL2;BCL6;AGTR1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5104336465471365,1.1064314476655221,0.3395585738539898,0.811733003586837,1.0,4/13,14.76%,OGG1;NEIL1;MBD4;UPP2
prerank,protein localization to vacuole (GO:0072665),-0.44022153657241836,-1.1059832670161012,0.3389830508474576,0.782353481065864,1.0,4/13,18.96%,SH3BP4;KPTN;CD81;LMBRD1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.47556401204630194,1.1051209981205143,0.36923076923076925,0.8146483850741751,1.0,5/18,7.82%,DLC1;KANK1;ITGA3;RIPOR2;ARHGAP35
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.48490096284908,1.1049973049038306,0.35206611570247937,0.8142212581213325,1.0,5/16,21.01%,ZFP36L1;CPEB3;PLEKHN1;RC3H1;ZFP36L2
prerank,protein-containing complex assembly (GO:0065003),0.3269583915283926,1.1045283250137836,0.2879746835443038,0.8147836399451465,1.0,75/259,21.74%,TCF7L2;SEC24D;TEAD1;AREG;MITF;TGFA;PLEKHA7;LAMC1;SEC31A;YAP1;SH3PXD2B;TLE1;MCU;AXIN2;LMAN1;TCF7;BCL9;LRRK2;RANBP9;PML;ZW10;CD247;TRAPPC4;AFDN;PARD6B;TCF7L1;GOSR2;PICALM;TSPAN4;CDC123;TRAPPC10;KMT2A;TRAPPC9;TRAPPC6B;GORASP1;FANCC;MNAT1;KLHL12;CTSZ;SEC23A;USO1;NOL3;LLGL1;DLG4;WASF1;SNX9;TBC1D20;TNFRSF1A;COL16A1;SEC16B;GSDMD;PARD3;SEC24A;CX3CL1;TAPBP;TMED10;CSNK1A1;DARS1;CDC73;KAT5;RBBP5;MDM4;HSF1;AFG3L2;STOML2;HGSNAT;TRAPPC1;CAPZA1;SLC9A1;TRAPPC3;SEC16A;TLE3;OPA1;LEO1;TLE4
prerank,calcium ion homeostasis (GO:0055074),0.3611305040519727,1.1039392299316504,0.32546583850931676,0.8157285322917808,1.0,12/95,7.90%,SLC24A3;SLC8A1;SLC8A3;DMPK;CCL19;STIM1;ATP13A3;SLC24A1;CDH5;SLC24A5;TMEM203;DRD3
prerank,response to metal ion (GO:0010038),0.3744024968149078,1.1038789724913625,0.33031088082901555,0.8151454733474662,1.0,10/67,6.56%,PAM;BCL2;PPP3CA;SLC30A8;SEC31A;NEDD4;MT3;SLC30A2;SLC11A2;NDRG1
prerank,spliceosomal complex assembly (GO:0000245),0.3929159361523038,1.1037894559771426,0.3137516688918558,0.8146183284843432,1.0,12/46,18.50%,CELF2;SF1;DDX23;NOL3;SNRPD2;SRSF5;RBM5;SF3B1;PRPF6;KHDC4;DDX1;SRSF10
prerank,positive regulation of signaling (GO:0023056),-0.32906172173329107,-1.1036127133161369,0.2945205479452055,0.787761631329408,1.0,12/37,12.28%,RIMS1;GRIK2;RIMS2;SYT1;INPP5F;CLSTN2;EDN1;SCRIB;CLSTN3;NSF;HOMER1;CD80
prerank,membrane lipid metabolic process (GO:0006643),0.4505351898511284,1.1035804884929807,0.32653061224489793,0.8144746545926488,1.0,4/22,7.26%,AGMO;CYP1B1;SPHK2;ALOXE3
prerank,steroid hormone biosynthetic process (GO:0120178),0.42611136855098747,1.103372602667662,0.33827893175074186,0.8143048288936889,1.0,5/29,11.14%,AKR1B1;STAR;HSD3B2;SRD5A1;TSPO
prerank,negative regulation of epithelial cell migration (GO:0010633),0.4264430017439825,1.103335395928063,0.3274336283185841,0.8136432489478228,1.0,10/33,13.81%,MCC;DCN;NR2F2;SP100;APOE;ADAMTS9;PTPRM;DNAJA4;PTPN23;PTEN
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.444101873152921,1.1032397649382655,0.3459214501510574,0.8131571282301968,1.0,5/24,9.33%,NRP1;PIK3R1;SFRP1;MAP4K4;MAPRE2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.2791452871964737,-1.1027958660677035,0.22842639593908629,0.7884741819357819,1.0,24/86,19.41%,OCLN;BAIAP2L1;PTK2B;NAV3;MET;RPS3;PAK1;CFL2;EDN1;PLEK;WDR1;FES;DCTN1;TRPV4;CDK5RAP2;APP;CDK5R1;CTTN;PRKCE;GPX1;LMOD1;CLASP1;CLU;NCK2
prerank,cell differentiation in hindbrain (GO:0021533),-0.4598773672848395,-1.1025944005693444,0.3412322274881517,0.7874403103283478,1.0,3/11,12.10%,GRID2;OPHN1;ATP7A
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3802531131361384,-1.1024491776441305,0.3256484149855908,0.78459767166075,1.0,13/22,39.61%,ZDHHC2;ZDHHC15;ZDHHC14;ZDHHC18;ZDHHC8;ZDHHC24;ZDHHC22;CLIP3;ZDHHC12;ZDHHC6;ZDHHC21;ZDHHC19;ZDHHC7
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3802531131361384,-1.1024491776441305,0.3256484149855908,0.78459767166075,1.0,13/22,39.61%,ZDHHC2;ZDHHC15;ZDHHC14;ZDHHC18;ZDHHC8;ZDHHC24;ZDHHC22;CLIP3;ZDHHC12;ZDHHC6;ZDHHC21;ZDHHC19;ZDHHC7
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.33569710111482365,-1.1022416995905977,0.31438127090301005,0.7835701961261409,1.0,19/37,26.60%,SDCBP;HIPK2;RYBP;RPS7;RPL11;HSP90AB1;TAF1;RPL5;GIPC1;N4BP1;FHIT;RPL23;CAMLG;UBXN1;DDRGK1;USP7;SGTA;CCAR2;UCHL5
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3742074381867831,1.102077012397509,0.31545338441890164,0.8157628110710997,1.0,10/67,9.62%,NRP1;ROCK2;PIK3R1;SULF1;AXL;CDC42;SRC;AAMP;ITGB3;ITGAV
prerank,lipid modification (GO:0030258),-0.3243635817018232,-1.102012065433908,0.273015873015873,0.7826210038702592,1.0,15/37,19.98%,DGKB;DGKH;MBOAT1;PLA2G7;PLPPR5;DGKK;PLPPR1;DGKG;DGKQ;PLPP4;MBOAT7;LPCAT3;DGKZ;DGKI;PLPP6
prerank,potassium ion export across plasma membrane (GO:0097623),-0.45016927715214794,-1.1016340160800793,0.34382566585956414,0.782119081201197,1.0,3/13,5.35%,KCNK5;KCND3;KCNQ1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.5106983065111652,1.1013943377256559,0.35602094240837695,0.8168699378004395,1.0,2/12,3.64%,GDNF;SMO
prerank,epithelial cell morphogenesis (GO:0003382),0.46632323211980303,1.1008673288586273,0.36538461538461536,0.8176679052747858,1.0,3/17,12.67%,COL22A1;RAB25;DACT2
prerank,regulation of vacuole organization (GO:0044088),0.45933265308305493,1.1005381876752256,0.344391785150079,0.8178319805019156,1.0,8/20,18.09%,NPRL3;ADPRH;ENO2;MTMR3;NPRL2;PIKFYVE;LAPTM4B;ENO3
prerank,positive regulation of angiogenesis (GO:0045766),0.3510365762174593,1.10044481740774,0.3130227001194743,0.8173198615786361,1.0,17/108,9.95%,PTGIS;PDPK1;SASH1;RUNX1;SERPINE1;VASH2;SEMA5A;STIM1;ITGB8;CYP1B1;CTSH;SMOC2;CDH5;FOXC2;ANXA3;SMAD1;FGF2
prerank,mesonephros development (GO:0001823),-0.46360072357461335,-1.100251692170603,0.3688888888888889,0.7845908301563144,1.0,3/11,11.99%,ZBTB16;FGF1;PAX8
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.39551610492057027,-1.1002414244522705,0.3324324324324324,0.7830168741721069,1.0,6/19,12.26%,PLCE1;NFATC2;NFATC3;NFATC1;EDN1;HRH1
prerank,synaptic vesicle cycle (GO:0099504),-0.34187682407163317,-1.100145524677144,0.31470588235294117,0.7816696773480416,1.0,7/30,16.79%,NLGN1;RIMS1;CDK5;PCLO;CPLX1;RAB3A;STX1A
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.44454136298564656,1.0998184396720134,0.35993485342019543,0.8182950245634812,1.0,11/24,23.07%,SEC24D;SEC31A;BCAP31;ABCB9;SEC23A;SEC24A;TAPBP;IDE;TAP1;PDIA3;CANX
prerank,actin polymerization or depolymerization (GO:0008154),0.39203151348803966,1.0994226717184588,0.3356449375866852,0.8185890659880268,1.0,4/50,1.79%,MICAL3;SVIL;GSN;ARHGAP6
prerank,cardiac ventricle morphogenesis (GO:0003208),0.40024285336483884,1.099414804903578,0.3412256267409471,0.8178504983561121,1.0,7/41,7.99%,TGFBR3;TPM1;BMPR1A;FGFR2;ENG;TNNC1;RBPJ
prerank,translational elongation (GO:0006414),-0.2756855125130573,-1.0992350911986082,0.20481927710843373,0.7826772430917576,1.0,40/101,31.54%,EEF2;GTPBP1;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;EEF1A1;EEF1B2;MRPS12;MRPL4;MRPS26;MRPL21;MRPL44;MRPS33;MRPL48;MRPL55;RACK1;MRPL57;MRPL42;MRPS18B;MRPS10;MRPS21;MRPS7;MRPL34;MRPL15;MRPL19;EEF1A2;MRPS22;LTN1;MRPS31;MRPL38;EEF2K;MRPL12;MRPL28;MRPL43;MRPL54;MRPS14;AURKAIP1;MRPL2
prerank,positive regulation of protein import into nucleus (GO:0042307),0.42759020289262323,1.0990157772306377,0.36363636363636365,0.8182088523863865,1.0,9/28,18.77%,PIK3R1;SMAD3;ZIC1;RBM22;FLNA;UBR5;PIK3R2;EFCAB7;TPR
prerank,positive regulation of response to external stimulus (GO:0032103),0.34314294860334543,1.0978990809189257,0.30565167243367936,0.8206054214702696,1.0,30/128,18.86%,BMP6;SASH1;SERPINE1;OPTN;PDGFRB;CCL19;TSLP;IL12B;CEBPA;AGTR1;DDX60;NMI;CCN4;SETD4;IFNK;F2;NAPEPLD;PDCD4;MDK;ETS1;TNFRSF1A;RIOK3;IL23A;CD47;ZBP1;CX3CL1;DHX58;TNIP1;IL18;PRKCA
prerank,histone H2A acetylation (GO:0043968),0.4678759828850673,1.0978224186802235,0.3643926788685524,0.8200534901909785,1.0,3/16,7.00%,ING3;BRD8;SPHK2
prerank,phospholipid translocation (GO:0045332),-0.3502521687898576,-1.0972070690068685,0.2949852507374631,0.7871143980288199,1.0,8/28,7.74%,ATP8A1;ATP8B1;ATP11C;ABCC1;ATP11B;P2RX7;ATP11A;MFSD2A
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.40913833421028606,1.0966991156770771,0.3483606557377049,0.8224076390069099,1.0,8/39,9.03%,ROBO1;YAP1;MAML3;SRC;ENHO;RBPJ;ZMIZ1;KAT2B
prerank,renal filtration (GO:0097205),0.5321093274633981,1.0962830307667129,0.3979591836734694,0.8228637887257916,1.0,3/10,3.74%,SULF2;ITGA3;SULF1
prerank,brain development (GO:0007420),0.33866512811967897,1.0951404782722107,0.32122587968217936,0.8253142430056891,1.0,14/136,4.51%,EPHA7;ATXN1;PBX1;ARNT2;HSPG2;ZIC1;PCDH18;SHROOM2;NKX2-1;NFIB;CDK5RAP3;SYNJ2;RAPGEF2;ZIC2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.4905327839447617,1.0944806796332345,0.3781942078364566,0.826405016026889,1.0,4/14,9.95%,SULF2;SULF1;SPRY2;FGF2
prerank,regulation of coagulation (GO:0050818),-0.4568417013841578,-1.0944018404366713,0.3598130841121495,0.7937528902839227,1.0,2/11,5.36%,CAV1;HS3ST5
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.4549260598771451,1.0943959026079755,0.3671497584541063,0.8258827835011038,1.0,9/20,24.44%,WNT4;SIK1;BMP2;BMP5;ERLIN1;SLC27A1;ERLIN2;BRCA1;ACADVL
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.34941465156888907,1.0942268156777852,0.3361144219308701,0.82562110844423,1.0,16/107,8.40%,SLC24A3;SLC8A1;SLC8A3;SLC41A1;DMPK;SLC30A8;CCL19;STIM1;ATP13A3;SLC24A1;MT3;CDH5;SLC24A5;TMEM203;DRD3;SLC30A10
prerank,positive regulation of catalytic activity (GO:0043085),0.40706063825127314,1.0941325815187206,0.3400286944045911,0.8251598292462908,1.0,6/37,9.40%,IGF2;FGFR4;APOA1;MT3;NHEJ1;SLC5A3
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.36236369712213967,1.093973328899145,0.33417402269861285,0.8248650492793659,1.0,18/76,18.12%,MYCBP2;ANGPT1;CDK5RAP3;PRICKLE1;LRRK2;DERL1;SPRTN;COMMD1;FBXO4;RIPK2;MUL1;HDAC4;FANCI;UBE2D1;DCUN1D2;HUWE1;UBE3A;TNIP1
prerank,regulation of adaptive immune response (GO:0002819),0.46888518812421026,1.0938838190177533,0.36801242236024845,0.8243775617559248,1.0,2/18,4.15%,ADCY7;IRF1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5094744689864893,1.0936064294000185,0.3620689655172414,0.8244359894761615,1.0,2/12,2.00%,CYP26B1;DHRS3
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4533074479728602,1.093440687866083,0.3518225039619651,0.8241962030223401,1.0,6/21,10.40%,SLC8A3;MCU;BCAP31;MICU2;PDZD8;ANXA6
prerank,central nervous system neuron axonogenesis (GO:0021955),0.4960472776286353,1.0929438066794777,0.36649214659685864,0.8247452441740077,1.0,3/12,8.50%,MYCBP2;ARHGAP35;EPHB2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.38191428828980967,-1.0927820076088155,0.3261455525606469,0.796905312479834,1.0,7/20,12.36%,SEMA6D;SEMA6A;SEMA7A;SEMA5B;SEMA3G;SEMA3C;SEMA4B
prerank,stabilization of membrane potential (GO:0030322),0.4792211337446822,1.0926801383836804,0.36258278145695366,0.8247276355842375,1.0,2/16,6.36%,KCNK2;KCNK7
prerank,neuron apoptotic process (GO:0051402),-0.3954548971357582,-1.0926035753060677,0.35945945945945945,0.795777447062356,1.0,8/19,14.78%,TRPC5;SIAH1;CIT;CDK5;SCN2A;ERBB3;TNFRSF21;APP
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.4639352523923876,1.0925455302498497,0.3639240506329114,0.8243593781778613,1.0,8/20,21.82%,NR2F2;CEBPA;HEXIM2;INCA1;PTEN;CDKN1C;CDKN1B;HEXIM1
prerank,negative regulation of histone methylation (GO:0031061),0.5224296117596055,1.0923537594411838,0.37785588752196836,0.8241232895229315,1.0,7/10,23.49%,BCOR;PHF1;WDR5;DNMT3B;JARID2;DNMT1;BRCA1
prerank,positive regulation of neuron differentiation (GO:0045666),0.4012638270130515,1.0923442777220975,0.3472803347280335,0.8233970136361047,1.0,6/40,5.95%,TCF4;FGFR1;ZEB1;ASCL1;NEUROD1;ADRA2C
prerank,sphingolipid biosynthetic process (GO:0030148),-0.2894493407021203,-1.092321983071941,0.25,0.7949815958066518,1.0,9/71,5.16%,SGMS1;CERT1;ACER3;SGMS2;ELOVL7;ACER2;DEGS2;SPNS2;ELOVL5
prerank,regulation of proteolysis (GO:0030162),0.38995658990745646,1.0918528067640643,0.3512396694214876,0.8239947794572696,1.0,14/48,16.32%,DNAJC1;OGT;ASPH;FGFR4;CST3;RNF139;ITCH;CLN3;F2;BTRC;TM4SF20;SHH;SPOP;AKT1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4891338859826645,1.0917413503602558,0.3587140439932318,0.82354597813936,1.0,3/13,10.12%,MOAP1;BCL2L11;RHOT1
prerank,regulation of cellular component organization (GO:0051128),-0.25848628840990207,-1.091097738572094,0.22608695652173913,0.7970381532444155,1.0,29/135,12.50%,PLCE1;RAP1A;NRG3;RIT2;SPOCK1;TJP1;NET1;PAK5;TFRC;HSPA8;CAMK2D;SOCS2;HIP1R;RAP1B;OPHN1;CDH13;RAB5B;PACSIN2;EGLN2;WFDC1;SGK1;LTBP4;SSRP1;OGFR;BCAR1;FAM107A;MTOR;ATAD3A;PACSIN1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4224146425417118,1.0910504780973576,0.36082474226804123,0.8246968695627682,1.0,10/29,20.47%,SMAD3;ZC3H7B;TUT7;SMAD1;TUT4;PRKRA;DICER1;METTL3;SMAD2;AGO4
prerank,regulation of protein modification process (GO:0031399),0.3815144556459664,1.090336220755661,0.35278154681139756,0.8259299038373533,1.0,15/50,16.08%,IGF2;LYN;MT3;HPF1;PHIP;CDH5;PML;ATG10;KAT2B;STAT2;SPRED3;PLXNB2;SPRED1;SESN2;FNIP1
prerank,cellular glucose homeostasis (GO:0001678),0.3980755053738706,1.0902480117721352,0.34281650071123754,0.8254412433342877,1.0,5/41,7.73%,ZBTB20;PIK3R1;GAS6;PRKAA2;NR1D1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4888909631948763,1.0900963356684616,0.37860780984719866,0.8250987556414721,1.0,3/13,7.90%,ADGRV1;GRM2;DRD3
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.4306703154189647,-1.0899789512375926,0.3488943488943489,0.7987954481514086,1.0,6/14,20.21%,THBS1;NOTCH1;KLF4;DLL4;ITGB1BP1;PDCD10
prerank,intracellular pH reduction (GO:0051452),0.40624383319965224,1.0894660073152715,0.34411764705882353,0.8260596867071132,1.0,4/33,10.36%,ATP6V0A4;GPR89A;GPR89B;ATP6V1E1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.38416085947153417,1.0893848501990528,0.3257372654155496,0.8255348298845961,1.0,9/49,11.40%,DAPK2;BCL2;NUPR1;SRC;EIF2AK3;BCL2L11;BCAP31;DDX3X;GSDME
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4187773557498947,1.0892802702586035,0.3724035608308605,0.8250801769212492,1.0,5/32,7.18%,AUTS2;PIK3R1;CDC42;SRC;CARMIL1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.47521455275681623,1.0892462006167534,0.3685950413223141,0.8244260286268984,1.0,6/16,18.67%,PDS5B;POGZ;SGO1;NIPBL;NAA50;BOD1
prerank,skeletal muscle organ development (GO:0060538),0.4248247386931842,1.0881560302331128,0.3834355828220859,0.826669508569414,1.0,4/26,4.55%,SVIL;CFLAR;LARGE1;MSC
prerank,cellular response to drug (GO:0035690),-0.36485589030260357,-1.0880387820558834,0.3681159420289855,0.8029722018054699,1.0,7/25,10.51%,MEF2C;PDE4B;ACER2;TFRC;KCNQ1;AIM2;GPLD1
prerank,nervous system development (GO:0007399),0.31473736345611975,1.087733589626069,0.26149131767109296,0.8270948525063645,1.0,66/429,10.78%,NELL1;ROBO1;LDB2;TEAD1;FARP1;ATXN1;GDNF;ADGRV1;GSN;ZEB2;ARNT2;DACT1;RBFOX1;OBSL1;ZIC1;DAGLA;GFRA2;WNT8B;YAP1;RBFOX2;ASCL1;NUMBL;TGFBR1;SMO;ZIC4;SEMA5A;NOTCH2;WDPCP;FBXL17;IGF2BP2;MTR;ZIC2;NTF3;AXL;NEUROD1;LIG4;NAV2;TBX3;ALDH1A2;ATXN10;NAB2;FUT10;ADGRA2;DCHS1;WWTR1;PMP22;FGF11;LPAR1;APBA1;SH3GL1;CSPG5;DSCAM;CBLN1;EPHB2;NHEJ1;CNTFR;MARCKSL1;PRKN;GLIS2;FGF13;FGF2;RYK;GFRA4;P2RX5;NRSN1;PCDHB3
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.2690023608802426,-1.087693441183625,0.25,0.8023881084266113,1.0,33/114,24.68%,TMSB4X;PTK2B;TNFRSF11A;ST18;NFKBIA;TNFRSF11B;AIM2;BAG4;JAK2;EIF5A;TRAF5;CARD14;PSMF1;TRAF1;TXNDC17;CD40;PSMB8;PSMB2;PSMA4;PSMB10;CD27;LIMS1;PSMC4;PSMD9;PSMD5;PSMA6;TRAF2;COMMD7;CHUK;PSMD11;TNFRSF12A;PSMA8;PSMB1
prerank,negative regulation of cyclase activity (GO:0031280),0.4822133324651664,1.0874286305110556,0.37891268533772654,0.8272361195816409,1.0,3/14,7.90%,ADGRV1;GRM2;DRD3
prerank,cobalamin metabolic process (GO:0009235),0.46432393891746027,1.0870274533105595,0.3778135048231511,0.8276003173376563,1.0,3/17,8.07%,MMAB;MTR;MMUT
prerank,regulation of protein kinase C signaling (GO:0090036),0.4848701389605498,1.086600962508792,0.3604060913705584,0.8280581337949166,1.0,3/14,9.57%,ADGRV1;SPHK2;MYADM
prerank,rRNA 3'-end processing (GO:0031125),0.5229665191096158,1.0861331993424683,0.37264957264957266,0.8286446377388893,1.0,7/10,27.54%,ERI3;ERI1;EXOSC7;EXOSC2;ERI2;EXOSC8;EXOSC9
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4212973180385997,1.0860119863031914,0.362043795620438,0.8282356963428151,1.0,8/30,10.71%,AR;SFRP1;NCOA2;SAFB2;NCOR1;DAB2;NCOR2;RNF6
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.401712413378079,-1.0859798669352159,0.3393316195372751,0.8058906634156089,1.0,3/15,9.63%,PRKCH;MED1;TRIM16
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3616094530486193,1.0857225493333718,0.35301668806161746,0.8282939557254702,1.0,21/69,22.03%,POLR2D;PHAX;GTF2E1;SNAPC1;RPAP2;CCNK;POLR2C;INTS4;ELL2;SNAPC5;TAF9;GTF2E2;SNAPC4;SP1;CCNT2;POLR2L;GTF2A1;CCNT1;TAF8;NCBP2;CDK7
prerank,regulation of adenylate cyclase activity (GO:0045761),0.44682242588863436,1.0854718418552074,0.375609756097561,0.8282500486021933,1.0,5/22,7.90%,ADGRV1;STIM1;CACNA1C;GRM2;DRD3
prerank,negative regulation of cellular metabolic process (GO:0031324),0.3987973992867445,1.0854228206867527,0.35640648011782033,0.8276404106657055,1.0,8/37,9.87%,OPTN;APOE;MT3;SIRT2;NCOR1;ITGB3;ITGAV;PRKN
prerank,cell part morphogenesis (GO:0032990),0.4913879321984796,1.0852990982600705,0.38,0.8272689785038398,1.0,4/13,13.47%,PID1;CSPG5;NUBPL;WASF1
prerank,covalent chromatin modification (GO:0016569),0.4897211425084038,1.0848824571520936,0.37435008665511266,0.8276846077521305,1.0,4/14,11.79%,MT3;MBD2;SETD5;UFL1
prerank,regulation of Golgi organization (GO:1903358),0.462121762619368,1.0848669452072561,0.39171974522292996,0.8269960939529549,1.0,3/17,7.36%,USP6NL;RBSN;MAP2K1
prerank,heart development (GO:0007507),0.33124361299067967,1.084565215785402,0.3129943502824859,0.8271063971585734,1.0,31/150,14.11%,RBP4;FBN1;PDLIM5;TGFBR3;DLC1;GLI2;PDLIM2;SALL1;TGFBR1;SH3PXD2B;ACVR1;SCUBE1;ADAP2;BCOR;CACNA1C;FLRT2;NTRK3;OSR1;FOXC2;BMP2;KAT2B;EEF1AKMT4-ECE2;CSRP3;SYNPO2L;COL3A1;TCF25;NDRG4;INSR;TSC2;PTEN;AKAP13
prerank,sphingoid metabolic process (GO:0046519),0.5132152073057953,1.0844352507053399,0.3745819397993311,0.82672507463079,1.0,3/12,11.00%,PLPP3;SPHK2;KDSR
prerank,cellular response to hormone stimulus (GO:0032870),0.3628889534528832,1.0843989623123664,0.3607843137254902,0.826106559018437,1.0,19/69,13.92%,GHR;AR;ATP1A2;THRB;SFRP1;NCOA2;CTSH;BRD8;TFPI;ZFP36L1;LHCGR;SRC;STAT5B;SLIT3;KLF9;ADRA2A;SLC5A5;CTSL;NCOA3
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.40246425017588294,-1.083933368673548,0.35674157303370785,0.8104467095241229,1.0,3/17,6.09%,ANK3;KCNAB1;AKAP6
prerank,chromatin remodeling (GO:0006338),0.34765259835893114,1.0838778218966487,0.33575757575757575,0.8268451311366648,1.0,37/100,24.02%,ARID1B;NPM3;INO80;CBX3;SMARCA1;MBD2;NPM2;SMARCC2;MTA2;DR1;POLE3;KDM5B;KAT2B;ZBTB1;FOXA1;ACTR8;BAZ1B;KDM5C;SMARCD2;HDAC4;CECR2;SMARCB1;BAZ2B;HNRNPC;SRCAP;ATRX;KDM4A;JARID2;KDM5A;KDM4C;NUDT5;TAF6L;HDAC5;PBRM1;SMARCAD1;SMARCE1;HDAC1
prerank,mesenchymal to epithelial transition (GO:0060231),0.5176683598201975,1.083826619743729,0.3774597495527728,0.8262697156221169,1.0,1/10,2.13%,SALL1
prerank,chromatin assembly or disassembly (GO:0006333),0.5069747204804419,1.0837890151318723,0.39233576642335766,0.8256451824993092,1.0,3/11,11.90%,CHAF1B;MTA2;HDAC8
prerank,macrophage chemotaxis (GO:0048246),-0.4625564347961181,-1.0832941455213967,0.35526315789473684,0.810850825933208,1.0,3/10,23.76%,CKLF;EDNRB;CCL2
prerank,axonal transport of mitochondrion (GO:0019896),-0.4610825258949778,-1.083197638120373,0.3616504854368932,0.8095745529680939,1.0,5/11,27.16%,SYBU;TRAK2;HIF1A;HAP1;ACTR10
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.4034635553839758,-1.0831884727132006,0.3194444444444444,0.80799328973604,1.0,5/17,16.94%,PTPRJ;PTPN2;PTPN22;CEACAM1;DGKZ
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.4281667063586907,1.083023260270647,0.38130563798219586,0.8269940106093082,1.0,2/26,3.88%,ITPR1;CCL19
prerank,negative regulation of type I interferon production (GO:0032480),-0.32474336059194653,-1.0829243466805611,0.30132450331125826,0.807098674452899,1.0,12/40,18.96%,IFIH1;RNF125;SIRPA;TRIM25;NLRC5;YY1;REL;TNFAIP3;RELB;PCBP2;UFD1;TAX1BP1
prerank,aminoglycan biosynthetic process (GO:0006023),0.38876165024612164,1.0828489144812294,0.35006784260515605,0.8267533203282236,1.0,12/49,15.09%,GPC6;HSPG2;B3GALT1;PXYLP1;HS6ST1;SDC1;B3GALNT1;EXT1;NDST1;GALNT5;SDC4;EXT2
prerank,negative regulation of axon extension (GO:0030517),-0.3359935265798134,-1.0822374601518792,0.3274336283185841,0.8075771861357954,1.0,9/30,12.36%,SEMA6D;SEMA6A;MAP2;SEMA7A;DIP2B;SEMA5B;SEMA3G;SEMA3C;SEMA4B
prerank,negative regulation of programmed cell death (GO:0043069),0.31202284015327586,1.0821931369911735,0.2925311203319502,0.8277907566896623,1.0,72/355,17.25%,IGF1;FHL2;ANGPT1;PIK3R1;GDNF;IL31RA;BCL2;GRK5;SON;SH3RF1;ASCL1;CFLAR;GAS6;NUPR1;MYO18A;NOTCH2;FSTL1;TXNDC5;SFRP1;MT3;AXL;PHIP;CTSH;PDPN;TBX3;PRKAA2;VIP;USP47;BFAR;TSLP;ARHGAP10;SRC;DPEP1;CD28;ARAF;OSR1;MAP4K4;EGFR;DNAJC3;DAB2;SPRY2;ITCH;BRAF;DDX3X;CLN3;ANXA5;NIBAN2;HMGN5;RIPK2;NOL3;VDAC1;GATA6;ARF4;DSTYK;TM7SF3;HSPA9;TAF9;HYPK;PLK2;HPN;FLNA;SHH;TMBIM6;BMP4;AKT1;GOLPH3;KANK2;CX3CL1;ATF5;PSEN2;GLO1;PIM1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.34257056307065487,-1.0821424649676343,0.3433333333333333,0.8062982951569388,1.0,17/33,34.07%,PTPRJ;RPS3;PTPN2;CD81;PTPN22;CEACAM1;DGKZ;NECTIN2;CD300A;CARD11;DUSP3;RAB29;PRNP;IKBKG;PHPT1;TRAT1;CD226
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.37200827034074474,-1.081977944030777,0.34269662921348315,0.8052097715182858,1.0,3/25,1.80%,TMTC2;CAV1;ANK3
prerank,regulation of ion transport (GO:0043269),-0.2884901787808662,-1.0818619068278952,0.28708133971291866,0.8040244598732734,1.0,14/76,6.94%,NKAIN2;KCNJ2;ATP1A1;ANK3;NEDD4L;B2M;KCNJ3;YWHAH;PXK;NKAIN1;P2RX7;NKAIN3;NOS1;SYT1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.39442740436973567,1.0812039727104144,0.350210970464135,0.8297559247655888,1.0,11/40,13.37%,ANGPT1;SERPINE1;VTN;CCL19;NTF3;CD63;ARRB1;DAB2;EGF;INSR;SFRP4
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.41750717646700325,-1.0806175201669488,0.3911917098445596,0.8061590836812474,1.0,4/15,16.02%,ARPC1B;ARPC5L;ARPC3;ARPC4
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.4747056117147219,1.0805480227077582,0.37925445705024313,0.8308200950449379,1.0,2/15,3.64%,GDNF;SMO
prerank,protein localization to cell surface (GO:0034394),0.4265009996657596,1.0804972368693793,0.37575757575757573,0.8302144482520516,1.0,4/26,10.05%,FBLN5;ANGPT1;VCL;GGA2
prerank,regulation of acrosome reaction (GO:0060046),-0.4584235265100529,-1.0804560503604979,0.3708609271523179,0.8050829212985224,1.0,2/10,13.85%,GLRA1;CACNA1H
prerank,negative regulation of immune response (GO:0050777),0.3329455283155811,1.0802662323969907,0.3424036281179138,0.8301383702979213,1.0,19/154,9.99%,ADCY1;ADCY2;ADCY7;LYN;ADCY5;ADCY9;INSL3;VIP;LHCGR;ADRB3;SRC;CD247;MAPKBP1;DPEP1;SIRT2;IRAK3;NMI;ADM;ITCH
prerank,steroid metabolic process (GO:0008202),0.36107796179108076,1.0801911605170211,0.34375,0.8295983878169189,1.0,7/72,7.50%,CYP7B1;CYP26B1;CYP1B1;STAR;HSD3B2;CYP27A1;SRD5A1
prerank,heterocycle biosynthetic process (GO:0018130),0.4854635200071651,1.080187535264173,0.36046511627906974,0.8288817144083518,1.0,4/14,12.34%,PYCR1;PYCR3;LIAS;MOCS1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5253955298011714,1.0798641393527633,0.4214162348877375,0.8283662421692891,1.0,3/10,12.52%,APOA1;MYADM;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5253955298011714,1.0798641393527633,0.4214162348877375,0.8283662421692891,1.0,3/10,12.52%,APOA1;MYADM;WNK1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5077463220277054,1.0793754182319477,0.4007155635062612,0.8289432146836645,1.0,4/11,19.46%,LYN;TLR6;PJA2;TIRAP
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.32755677194513144,1.079337397389312,0.31938325991189426,0.828315467500075,1.0,22/190,8.00%,ITPR1;RORA;RHOH;UACA;CGNL1;DAG1;LYN;BCL2;WWC2;MGRN1;NPRL3;TLE1;UBR2;RFFL;PDE3A;PRKAA2;SRC;MAPKBP1;NR1D1;DRD3;WTIP;NMI
prerank,regulation of humoral immune response (GO:0002920),0.3887888586008096,1.0793257066049748,0.3587570621468927,0.8276207229387476,1.0,10/44,16.26%,SERPING1;CFH;VTN;C4B;C8G;F2;GATA6;CFHR2;CXCL13;PROS1
prerank,regulation of endocytosis (GO:0030100),0.374999497268391,1.0792840140976783,0.34342105263157896,0.8270128922068447,1.0,10/61,9.33%,EPHA3;LRP1;APOE;CCL19;SRC;SNX33;STON1;DAB2;PICALM;SNX12
prerank,mitochondrion morphogenesis (GO:0070584),0.5061767972079138,1.0791646093758391,0.390625,0.8266073915065332,1.0,3/11,13.47%,PID1;NUBPL;WASF1
prerank,regulation of epithelial cell migration (GO:0010632),0.3796558938563246,1.0791060093133817,0.36436170212765956,0.8260473632563684,1.0,9/51,7.49%,GLUL;SASH1;MCC;MACF1;INSL3;CTSH;SRC;DOCK5;RAB25
prerank,cellular response to alkaloid (GO:0071312),0.4555917281411469,1.078984137084372,0.3790849673202614,0.8256671994508646,1.0,3/17,10.50%,SLC8A1;GSTM2;CASP7
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.31724088304003945,1.0789474404533879,0.3115100316789863,0.8250420436546445,1.0,33/259,9.46%,NRP1;ASAP1;MTSS1;ACTN2;GSN;DYNLL1;RHOD;PARVA;KIT;MYLK;WDPCP;FGD1;DZIP1L;RAPGEF2;FGD4;RAB23;CYS1;CPLANE1;PIBF1;WDR35;TTC39C;B9D1;VCL;IFT43;CARMIL1;PMP22;DNAAF1;FBF1;MAP4K4;EMP3;ARFIP2;IFT81;NTN1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3531758580762233,1.078888004535337,0.34688995215311,0.8244848301769016,1.0,13/94,11.39%,ITPR1;PDK1;BCL2;MOAP1;CYP1B1;PML;CUL5;BCL2L11;AIFM1;STK11;DDX3X;IKBKE;CEBPB
prerank,negative regulation of protein modification process (GO:0031400),0.3547240918977445,1.0786008322040508,0.36742424242424243,0.8245552717312856,1.0,18/79,13.95%,PID1;PTPN13;PLPP3;LYN;FBLN1;CDK5RAP3;PRKAA2;LRRK2;BEX4;WWTR1;NTRK3;EPHB2;MYADM;PRKN;IGFBP3;IMPACT;PTEN;IBTK
prerank,positive regulation of cell communication (GO:0010647),-0.34311768900015005,-1.0778621037683123,0.32247557003257327,0.8111919339252545,1.0,10/28,12.28%,ANK3;RIMS1;GRIK2;RIMS2;SYT1;CLSTN2;EDN1;CLSTN3;HOMER1;CD80
prerank,positive regulation of collagen metabolic process (GO:0010714),0.4641787953474424,1.077079190765596,0.3934169278996865,0.827926693105238,1.0,7/17,19.92%,RUNX1;WNT4;RGCC;F2;BMP4;CREB3L1;LARP6
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4407567067406818,-1.0770439294236998,0.36764705882352944,0.812011636979893,1.0,6/12,20.68%,PLCG2;RAB27A;ZNF205;TLR4;GRIN1;ADGRB1
prerank,hexose biosynthetic process (GO:0019319),0.38714002187140056,1.0767699917388673,0.37186629526462395,0.8280370292963022,1.0,4/42,7.87%,RBP4;AKR1B1;MDH2;ENO2
prerank,intraciliary retrograde transport (GO:0035721),0.5003379320970343,1.076741447295355,0.38956521739130434,0.827392363503235,1.0,3/12,11.08%,WDR35;IFT43;DYNC2I1
prerank,cellular glucan metabolic process (GO:0006073),0.5053244127167891,1.07671553834545,0.41235392320534225,0.8267339206343695,1.0,5/11,16.44%,PHKB;PRKAG2;PYGM;PPP1R3C;PHKA1
prerank,phosphatidylserine metabolic process (GO:0006658),-0.3307303256121551,-1.0765197648699303,0.34579439252336447,0.8119595143946976,1.0,13/32,28.25%,SERINC5;MBOAT1;PLA1A;PLAAT3;PTDSS1;LPCAT3;PLA2G4F;PLA2G4E;PLSCR1;PLA2G4B;LPCAT4;MBOAT2;PLA2G5
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.44081510249112144,-1.0762646320860698,0.3853658536585366,0.8111028389661404,1.0,6/12,30.04%,RAD17;TOPBP1;HUS1;HUS1B;CDC6;TICRR
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5038273610816574,1.076126791851027,0.38137082601054484,0.8276186376732705,1.0,2/12,7.70%,B3GALT1;B3GALNT1
prerank,ceramide biosynthetic process (GO:0046513),-0.31563209293219624,-1.0758165981795575,0.3359683794466403,0.8109529855682899,1.0,5/40,2.80%,ST6GALNAC3;SGMS1;ST8SIA4;SGMS2;DEGS2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.47617636329267893,1.075532930743552,0.4090909090909091,0.8284659789018722,1.0,6/16,24.44%,APPL2;NCOR1;ERLIN1;ERLIN2;BRCA1;ACADVL
prerank,negative regulation of complement activation (GO:0045916),0.5137682785608517,1.0754949414882302,0.40142095914742454,0.8278546160324312,1.0,1/10,2.10%,SERPING1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.4016433148700615,1.075478285913796,0.3551673944687045,0.8271849485023164,1.0,4/40,6.25%,PID1;BCL2;PYCR1;LRRK2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.44196781493528203,1.0754505094840856,0.37668161434977576,0.8265504462610128,1.0,4/23,13.13%,CEMIP;PRKAG2;EGF;RIPK2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.37893915294430536,1.0748473808349592,0.3729508196721312,0.8274358775733542,1.0,5/51,4.13%,SERPINE1;IL34;IL6R;GAS6;CSF1
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.347733249567558,-1.0746163364675054,0.32710280373831774,0.8128838510626689,1.0,9/27,22.83%,RIMS1;ARHGAP17;RIMS2;SYT1;SYT6;SYT4;SYT15;RIMS3;SYT5
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.36844194346663606,-1.0742358380480344,0.34972677595628415,0.8124969182958655,1.0,6/21,5.36%,EXTL3;NDST3;HS3ST4;XYLT1;HS6ST3;HS3ST5
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.43715667200534764,1.0741033831271125,0.3677621283255086,0.8286558589934732,1.0,3/24,3.86%,NRP1;SEMA3D;SEMA5A
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3767175431233875,-1.0738760357991097,0.3860103626943005,0.8120011379071819,1.0,12/23,25.35%,PDE4B;TGM2;KCNQ1;ATP2B4;GNB1;RYR2;MAPK3;GNG2;GABPA;ATF4;MAPK1;ADCY6
prerank,muscle tissue development (GO:0060537),0.49207018580999473,1.073637443318171,0.3942470389170897,0.8292056635532783,1.0,6/13,15.79%,SMO;CSRP2;ENG;CSRP3;SHH;BMP4
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.4175790373877933,-1.0730368839213251,0.38235294117647056,0.8129277095930469,1.0,2/14,1.69%,ADAM10;PTK2B
prerank,sulfation (GO:0051923),0.5095827869096208,1.0725770961047747,0.39042357274401474,0.8313798475308504,1.0,1/11,1.38%,UST
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.304445142817582,-1.0724768485979086,0.35687732342007433,0.8130962222372656,1.0,13/44,14.37%,KCNJ2;KCNJ3;KCNMA1;KCNN2;KCNQ1;AKAP6;ATP1B1;KCNMB2;WNK2;KCNJ15;GNB1;KCNJ10;GNG2
prerank,positive regulation of response to wounding (GO:1903036),0.4303254578186471,1.072097110939307,0.3814756671899529,0.831982825231684,1.0,8/24,16.39%,KANK1;MYLK;VTN;INSL3;HBEGF;ADRA2A;MDK;ARFGEF1
prerank,vesicle organization (GO:0016050),-0.3126832718048267,-1.0720659344496501,0.3447098976109215,0.8126690814460453,1.0,10/46,15.04%,CAV1;FNBP1L;CD34;CAV2;DNAJC13;ALS2CL;WASHC5;EXOC8;SRGN;AKTIP
prerank,response to gamma radiation (GO:0010332),0.425745443554281,1.0718277286490991,0.38461538461538464,0.8319860797331736,1.0,3/24,5.58%,YAP1;LIG4;MAP3K20
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.49819908928702294,1.0714331324803612,0.387719298245614,0.832319627998831,1.0,1/11,1.25%,GSN
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.34472807687641455,1.070967755572063,0.3704600484261501,0.832834505861347,1.0,13/93,10.78%,CCN2;SH3RF3;SASH1;SH3RF1;GADD45B;CCL19;EDAR;RELL1;MTURN;BMP2;LTBR;TAOK3;CARD9
prerank,polyol metabolic process (GO:0019751),-0.3026650559705246,-1.069799047373327,0.35135135135135137,0.8178816284459509,1.0,17/46,22.14%,PLCE1;PLCG2;INPP5D;INPP4B;NUDT4;MINPP1;CALM1;IP6K1;ISYNA1;IPMK;PLCD4;INPP5B;SYNJ1;PPIP5K1;PLCH1;NUDT11;ITPKB
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3887239819617117,1.0694595195378296,0.36712328767123287,0.8362555448249751,1.0,5/44,7.26%,CYP7B1;SLC27A5;PRKAG2;INSIG2;CYP27A1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.29699393384904527,-1.0693382913954421,0.29535864978902954,0.8177118647530436,1.0,6/49,6.50%,LRCH1;MAP2;F11R;SH3BP4;RDX;NOS1
prerank,inositol phosphate metabolic process (GO:0043647),-0.3033781971003024,-1.0693079077148706,0.3552123552123552,0.8162264205383499,1.0,17/46,22.14%,PLCE1;PLCG2;INPP5D;INPP4B;NUDT4;MINPP1;CALM1;IP6K1;ISYNA1;IPMK;PLCD4;INPP5B;SYNJ1;PPIP5K1;PLCH1;NUDT11;ITPKB
prerank,vasculogenesis (GO:0001570),-0.3392459326768195,-1.0692797660602706,0.3449367088607595,0.8147521601788215,1.0,12/32,13.29%,CAV1;KDR;NOTCH1;SOX17;RAMP2;RASIP1;HEY2;SOX18;VEGFA;TGFBR2;TGFB1;APLNR
prerank,embryonic hemopoiesis (GO:0035162),-0.4386678858257941,-1.0690817206234011,0.39215686274509803,0.813791819941453,1.0,4/12,9.66%,KITLG;KDR;TAL1;TGFBR2
prerank,neuron projection organization (GO:0106027),-0.4140948024734703,-1.0685180277794117,0.40298507462686567,0.8138480040247864,1.0,9/15,27.09%,PLS1;LGMN;ATP1A3;ARF1;DCTN1;APP;GSK3B;PICK1;PRNP
prerank,cell differentiation in spinal cord (GO:0021515),-0.4594237217794366,-1.0680736903036365,0.3798076923076923,0.8136360956474459,1.0,2/10,9.28%,MDGA2;ZC4H2
prerank,regulation of immune response (GO:0050776),0.326527998827312,1.067993747580744,0.352046783625731,0.8394303613897777,1.0,10/135,7.11%,COL1A2;COL1A1;COLEC12;ADCY7;LYN;IRF1;APPL2;BCL6;CD247;KLRD1
prerank,negative regulation of histone acetylation (GO:0035067),-0.43839451563577114,-1.0669347829739673,0.38963963963963966,0.8155346824806584,1.0,4/11,28.34%,CTBP1;SIRT1;THAP7;SET
prerank,negative regulation of chemokine production (GO:0032682),-0.4296335439590693,-1.0666315695447235,0.37593984962406013,0.8148506296163643,1.0,4/14,13.98%,APOD;SIRPA;KLF4;SIGIRR
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5126470811760041,1.0662556944963948,0.39285714285714285,0.8434119046043272,1.0,3/10,6.80%,PYCR1;LRRK2;NFE2L2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.4673026685358854,-1.0658322641792979,0.4195121951219512,0.8157509450015911,1.0,5/10,13.29%,PDE4D;PDE3B;PDE2A;UBE2B;APLNR
prerank,proteasomal protein catabolic process (GO:0010498),0.3185489259026185,1.0656135287949917,0.3406113537117904,0.8444205838705451,1.0,61/201,22.65%,SPSB1;TBL1XR1;HECW2;FBXL17;FBXL19;NEDD4;SMURF2;RFFL;ERLEC1;PSME4;BFAR;DERL1;CUL4B;PML;NFE2L2;SIRT2;UBE4B;UBE2U;UBXN2B;NR1D1;RNF185;RNF139;ARRB1;UBXN11;PRKN;ITCH;IFI27;RCN3;ERCC8;KBTBD7;FEM1C;BTRC;TNFAIP1;APPBP2;ENC1;HACE1;SPOP;DDI1;HUWE1;NHLRC3;PSMB5;PSMC2;PSMD4;KAT5;RNF34;PSMD1;DCAF11;NSFL1C;PSME3;ZSWIM8;CCDC47;FEM1B;UCHL1;KCTD13;PSMA3;BAG6;DDIT3;BIRC2;FBXW11;RNF216;KLHL20
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.41143657385387994,1.065405738171693,0.39436619718309857,0.8435467277966824,1.0,6/29,17.80%,ACOT11;ACOT6;ACOT2;ACSF2;ACOT9;OXSM
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.41143657385387994,1.065405738171693,0.39436619718309857,0.8435467277966824,1.0,6/29,17.80%,ACOT11;ACOT6;ACOT2;ACSF2;ACOT9;OXSM
prerank,"transcription, DNA-templated (GO:0006351)",0.3181917048332802,1.0652412654672256,0.3464052287581699,0.8432620249849905,1.0,65/207,23.89%,POLR2D;SOX5;GLIS3;MAF;THRB;HSF2BP;NFIX;MLLT3;BRF1;GTF2E1;GTF3C1;GTF2H5;PMF1;MED16;TRIP11;POLR3A;CREBL2;CCNK;POLR2C;PAX1;MBD1;TFAM;POLRMT;NKX2-8;TTF2;MNAT1;PAF1;TEFM;TAF5L;TAF9;NELFE;GTF2E2;AFF4;FUBP3;TTF1;TFDP1;COPS2;FOXO3;CCNT2;TSC22D1;CDC73;POLR2L;TAF2;NCOA6;HSF1;GTF2A1;NFE2L3;DEAF1;IRF9;MLLT1;BRF2;CCNT1;LEO1;GTF3C3;NCBP2;NOCT;CDK7;RPAP1;ERCC3;ERCC2;SETX;POLR1C;TAF4B;NAT14;KLF13
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3683378682467765,1.0650836801983383,0.3797634691195795,0.8429924303929628,1.0,9/64,7.26%,DAGLA;ACSL1;EPHX2;CYP1B1;ACOT2;PLA2G4A;GSTM4;GSTM2;ALOXE3
prerank,long-chain fatty acid import into cell (GO:0044539),0.5260517770512881,1.0649780126179789,0.4058721934369603,0.8425591128603706,1.0,2/10,2.43%,SLC27A5;ACSL1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.37218534642604517,-1.0648562472209009,0.3638676844783715,0.8171559481396816,1.0,9/20,30.67%,ADAM10;MBTPS2;TGFB1;ADAM9;RHBDD1;APH1A;MBTPS1;TRAF6;NCSTN
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.37848524805285705,1.064622685740434,0.3795918367346939,0.8428144701432316,1.0,4/48,2.07%,PDPK1;ANGPT1;SRPX2;FGFR1
prerank,microglial cell activation (GO:0001774),-0.37448269323338035,-1.063932903064331,0.37567567567567567,0.8184975254105862,1.0,13/21,41.73%,JAK2;CX3CR1;APP;CLU;AGER;AIF1;IFNGR1;TREM2;IL4;MAPT;C5AR1;ITGB2;TNF
prerank,cellular response to oxidative stress (GO:0034599),0.3395195143708057,1.0639150669886162,0.3752969121140142,0.8439429676943002,1.0,21/118,13.22%,DAPK1;PLA2R1;TPM1;PDGFRA;PYCR1;NUDT2;MT3;SLC25A24;PRKAA2;GPX8;LRRK2;NFE2L2;SIRT2;ERCC6L2;EGFR;ARNT;MGAT3;FANCC;SELENOS;GPX3;NOX4
prerank,ruffle organization (GO:0031529),0.45453995389366797,1.063872725268574,0.3862520458265139,0.8433496115956312,1.0,4/16,9.01%,TPM1;LIMA1;CARMIL1;ARFIP2
prerank,glycolipid metabolic process (GO:0006664),-0.30007618471915987,-1.062986397959517,0.3284671532846715,0.8197125348543289,1.0,3/47,0.80%,ST6GALNAC3;ST3GAL6;ESYT2
prerank,electron transport chain (GO:0022900),-0.40391034164130074,-1.0627702253113411,0.3790523690773067,0.8187572544695692,1.0,7/15,25.23%,PDIA5;PPARGC1A;CYB561;NDUFA5;SDHB;ETFRF1;UQCRFS1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4560339715015874,-1.0624911094087772,0.3933649289099526,0.8180730361280579,1.0,4/10,5.90%,PTPRJ;APOD;PTPN12;PTPN2
prerank,cellular response to interleukin-4 (GO:0071353),-0.4554416149025179,-1.0622700582521936,0.40401785714285715,0.8172199717321643,1.0,1/10,0.16%,LEF1
prerank,regulation of leukocyte migration (GO:0002685),0.463242622895072,1.0622649289915813,0.40229885057471265,0.8469995200047366,1.0,2/16,9.14%,RHOH;MIA3
prerank,protein ubiquitination (GO:0016567),0.30355427159668674,1.0622310974493305,0.3319796954314721,0.8463712037913501,1.0,111/471,19.41%,MYCBP2;SPSB1;RNF220;PDZRN3;HECW2;SH3RF3;ARRDC4;SASH1;BCL2;PELI2;SH3RF1;MGRN1;FBXL17;FBXL19;UBR2;NEDD4;SMURF2;RNF213;PSME4;EPAS1;BFAR;DERL1;ZNRF3;CUL4B;DTX4;NFE2L2;RNF31;TRIP12;UBE4B;CUL5;RNF10;UBE2U;TRAF7;FBXL3;RNF185;RNF139;ARRB1;UBE2V2;COMMD1;UBOX5;FBXO28;PRKN;ITCH;RNF181;ASB12;MIB1;RNF6;RNF38;RNF152;FBXO9;FBXL12;FBXO11;ERCC8;FBXO4;RAD18;SELENOS;USP9X;KLHL12;RNF217;BTRC;PEX2;PAF1;RNFT1;TNFAIP1;TNKS2;MUL1;RC3H2;UBE2E2;RNF19A;ENC1;THOP1;UBA6;AMFR;UBE2D1;HLTF;UBR5;ASB1;DZIP3;HACE1;CUL7;SPOP;RNF13;HUWE1;UBE2R2;NHLRC3;MSL2;RNF138;UBE3B;PJA2;DTX3;UBR3;PSMB5;RNF135;UNKL;UBE3A;PSMC2;CDC73;KLHL18;HERC6;PSMD4;RNF34;WAC;RC3H1;TRIM21;PSMD1;TRIM41;TRIM47;TRIM26;FBXL18;TRIM32;RNF11
prerank,acute inflammatory response (GO:0002526),0.4296927403645439,1.0620425430943594,0.41131498470948014,0.84616643168665,1.0,2/23,2.23%,AHSG;IL6R
prerank,response to organonitrogen compound (GO:0010243),0.39050788203474684,1.0619610421104817,0.3627450980392157,0.8456842884044585,1.0,9/38,11.56%,ERLEC1;DERL1;KYNU;DRD3;IRAK3;RNF185;RNF139;PRKN;RCN3
prerank,cell-cell junction assembly (GO:0007043),0.3632030484672578,1.0611319846623264,0.374167776298269,0.8472554730326555,1.0,12/63,8.25%,GJA1;CDH11;GJB6;GJB2;TLN2;ARVCF;TLN1;CDH5;VCL;DCHS1;FBF1;PARD6B
prerank,gastrulation (GO:0007369),-0.39952064277781163,-1.0609743563707337,0.375609756097561,0.8196474451667022,1.0,4/15,13.17%,GPC3;LRP5;TASOR;UGDH
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3064027217800512,1.0609586941456335,0.3425641025641026,0.8470462085158165,1.0,79/366,18.52%,NFIA;IGF2;RORA;RHOH;ATXN1;ARNT2;MITF;WWC2;CCNA2;NUP107;TGFBR1;OGG1;MSC;NCOA2;DENND4A;TCF7;ENG;NAB2;APBB2;PML;WWTR1;CEBPA;ZBTB38;SAP30;REXO4;WTIP;TULP3;TCF7L1;NONO;BMP2;CREBL2;MZF1;GTF2IRD1;ZBTB4;NSD1;PHF1;ZSCAN21;ACTR8;NR1D2;RNF6;EIF2B4;IFNK;CEBPB;REST;ACVR1B;HMGN5;INSR;TRIP4;MTPN;YAF2;SUFU;TAF5L;FOXK2;ZNF219;RBM4B;SAP30L;MYCBP;GPBP1;MYBL1;FADS1;MYT1;TGFBRAP1;PSPC1;MAFA;ZNF423;ATF5;PLAG1;GON4L;CHD7;SP1;ZFAT;SPIN4;FOXO3;IRF2;CARM1;SOX11;NFIL3;SRSF10;PPIE
prerank,mRNA splice site selection (GO:0006376),0.41557708671486077,1.0609523159637142,0.38288288288288286,0.8463505997653015,1.0,6/30,18.50%,CELF2;SF1;NOL3;SRSF5;KHDC4;SRSF10
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.28416021331916186,-1.0609007212290218,0.29918032786885246,0.8183201059812611,1.0,7/62,2.27%,MEF2C;ZBTB16;CDK6;PTK2B;TNRC6C;THBS1;HOXA5
prerank,negative regulation of neuron projection development (GO:0010977),0.3664389733867255,1.0608915096115155,0.38896189224704336,0.8458043447437459,1.0,10/56,7.82%,EPHA4;KANK1;APOE;EFNB2;DPYSL3;MT3;PTPRS;DENND5A;LPAR1;PTPN9
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.48982980493340106,1.060700216785416,0.4263157894736842,0.8456078863402584,1.0,5/12,22.66%,MIA3;WNK1;MDK;AKT1;LCK
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.35966218286101853,-1.0592452181397296,0.41002949852507375,0.8215475037040557,1.0,15/23,42.52%,CADM1;PIK3R6;PVR;RAET1E;NECTIN2;LILRB1;SLAMF6;CD226;CRTAM;ARRB2;NCR1;LAMP1;CD160;KLRK1;AP1G1
prerank,cardiac muscle cell contraction (GO:0086003),-0.3915797374854877,-1.0591585704819582,0.3884514435695538,0.820277071197899,1.0,5/19,4.80%,KCNJ2;ATP1A1;SCN1A;CAMK2D;FGF12
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.35458306539288015,1.0590566445630596,0.3838120104438642,0.849463025877131,1.0,14/71,13.05%,ADAMTS12;FBXL17;CTSH;CTSF;CUL4B;NR1D1;CLPX;NGLY1;PRKN;CLPP;RSPRY1;USP9X;CTSZ;CTSL
prerank,mitotic cytokinesis (GO:0000281),0.3747309846459418,1.0584225945401113,0.383989145183175,0.8504531346975637,1.0,8/47,9.35%,ROCK2;SON;MYH10;KIF20A;EFHC1;SNX33;SNX18;KLHDC8B
prerank,inner mitochondrial membrane organization (GO:0007007),-0.3048553464404204,-1.0583342429074862,0.35447761194029853,0.8212546165471597,1.0,15/47,25.79%,TOMM70;LETM1;ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;MTX3;ATP5PD;MTX2;MTX1;TIMM10;IMMT;ATP5MC2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3434431613352652,-1.05811488243732,0.35443037974683544,0.8202855708515723,1.0,8/29,17.38%,CAV1;THBS1;TNFSF10;RET;PAK2;DEDD2;GPER1;INHBA
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3615021212388499,-1.0577607790010903,0.3463855421686747,0.8198650456494277,1.0,7/21,11.27%,PDE4D;NT5E;NT5C2;PDE2A;NUDT4;PDE9A;NT5C1A
prerank,glutathione derivative metabolic process (GO:1901685),0.4411097283915887,1.0573580322461504,0.401305057096248,0.8519135999966283,1.0,5/20,13.34%,GSTM4;GSTM2;MGST1;GSTT1;GSTK1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.4411097283915887,1.0573580322461504,0.401305057096248,0.8519135999966283,1.0,5/20,13.34%,GSTM4;GSTM2;MGST1;GSTT1;GSTK1
prerank,macrophage differentiation (GO:0030225),0.48120131543559325,1.0571776395306072,0.4311774461028192,0.8516730319028885,1.0,3/13,6.01%,IL31RA;CSF1;CDC42
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3995193892362544,1.0569184666235658,0.39730134932533734,0.8516606183891917,1.0,5/33,7.61%,GLUL;ART4;PYCR1;PYCR3;ALDH18A1
prerank,long-chain fatty acid transport (GO:0015909),0.40843172045579,1.0569002680003061,0.3991291727140784,0.8510027587502639,1.0,4/30,5.53%,ACSL1;APOE;PRKAG2;PRKAA2
prerank,triglyceride metabolic process (GO:0006641),0.36934812625012287,1.0568545849041646,0.37327823691460055,0.8504127706246304,1.0,3/48,3.41%,AGMO;SLC27A5;APOE
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.4180084410345116,1.0568296233948662,0.4088145896656535,0.8497747810710378,1.0,3/28,3.41%,ADCY1;EPHA4;APOE
prerank,regulation of mRNA polyadenylation (GO:1900363),0.4467900397461969,1.056479434751691,0.3896940418679549,0.8500179862896784,1.0,10/17,27.15%,CPEB1;CPEB3;ZC3H3;NELFE;HSF1;CCNT1;NCBP2;RNF20;RNF40;NCBP1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.304319059211648,-1.0552516411347936,0.3392857142857143,0.825826109539658,1.0,12/47,12.79%,STXBP6;EXOC4;EXOC6;ANK3;EXOC5;SPTBN1;KIF13A;STEAP2;ARL3;NSF;EXOC8;EXOC2
prerank,response to estrogen (GO:0043627),-0.3179967372748025,-1.055140817840859,0.3709677419354839,0.8246464142791307,1.0,10/31,17.60%,CAV1;ESR1;TRIM24;TRIM25;NCOA4;EP300;CITED2;SERPINB9;ARID5A;KRT19
prerank,photoreceptor cell development (GO:0042461),-0.40707504779872683,-1.0550191908748354,0.4131578947368421,0.823476338014787,1.0,5/14,9.63%,RORB;RP1;MFSD2A;ARL3;VEGFA
prerank,membrane fusion (GO:0061025),-0.3256798176669196,-1.0550166108094072,0.3935483870967742,0.8219852208823605,1.0,5/33,11.28%,DNM3;RIMS1;DYSF;GCA;NSF
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.37852154296284735,1.0549677728639268,0.3875338753387534,0.8533188788744651,1.0,17/45,21.01%,SMAD3;TOM1L2;BCL6;ZFP36L1;ZW10;ZWINT;RGCC;NME6;PTPN3;GAS1;PLK2;CDKN1C;BMP4;CDKN1B;FOXC1;PRCC;ZFP36L2
prerank,regulation of neuron projection development (GO:0010975),0.3233506790366243,1.0543414277533978,0.3811659192825112,0.854310198354463,1.0,27/163,9.39%,EPHA3;PDLIM5;CAMK1D;LYN;KIF13B;EPHA4;KANK1;MARK1;APOE;EFNB2;DPYSL3;RAPGEF2;ROR1;MT3;FZD1;PTK7;PTPRS;LRRK2;DENND5A;ATP1B2;LPAR1;BRSK1;ARHGAP35;PTPN9;NTRK3;CAMK2B;RAPGEF1
prerank,epiboly involved in wound healing (GO:0090505),0.4551432026730809,1.0539578443995061,0.43471074380165287,0.8546752962869968,1.0,4/16,14.66%,CCN1;PDPN;ARHGAP35;FLNA
prerank,modulation by host of viral genome replication (GO:0044827),0.4799677446333934,1.053459976438538,0.3969849246231156,0.8552736003555422,1.0,4/13,14.43%,CCNK;PRKN;IFI27;TBC1D20
prerank,neuron projection morphogenesis (GO:0048812),-0.2502897227787647,-1.0527280981796239,0.3089430894308943,0.8271967105855323,1.0,36/137,16.75%,CNTNAP2;SHANK3;CTNND2;GPM6A;MAP2;NLGN1;ACTB;ANK3;NGF;NRCAM;IQGAP1;SLC9A6;KLF7;EPHB1;CNTN4;NTNG1;BTBD3;CDK5;DCDC2;PAK1;SGK1;SHANK1;DCC;KIF20B;NEFH;ATP7A;PACSIN1;NYAP2;APBB1;DIP2A;LMTK2;APP;MAP1B;SHTN1;CTTN;RAB3A
prerank,regulation of macrophage migration (GO:1905521),-0.45672307776778903,-1.0520207450486099,0.3847980997624703,0.827722974338328,1.0,4/10,11.86%,MTUS1;PTK2B;CX3CR1;CD81
prerank,regulation of autophagosome assembly (GO:2000785),0.406740734070505,1.0513478850949636,0.40088757396449703,0.8601525071373464,1.0,9/33,16.55%,NUPR1;NPRL3;LRRK2;ADPRH;MTMR3;RAB3GAP1;NPRL2;PIKFYVE;PIP4K2C
prerank,regulation of microtubule polymerization (GO:0031113),-0.3104209343297676,-1.0512647167284244,0.3649122807017544,0.8285796585511112,1.0,11/40,18.64%,OCLN;MAP2;NAV3;MET;RPS3;PAK1;FES;DCTN1;CDK5RAP2;CDK5R1;CLASP1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4316824115159428,1.0509931950174565,0.4110429447852761,0.86042873603041,1.0,9/22,26.40%,ROCK2;PPP4R4;BOD1L1;PTPA;BOD1;NCKAP1L;PPP1R15A;MASTL;STYXL1
prerank,motor neuron axon guidance (GO:0008045),0.46300696698304317,1.0508268219923595,0.41567291311754684,0.8601675723086208,1.0,4/15,10.48%,RHOH;EPHA4;NTN1;SLIT1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.40803530392089143,1.0505857130554879,0.4122681883024251,0.8600795235965933,1.0,6/30,11.46%,ROBO1;APOA1;LPAR1;ARRB1;SYNPO2L;COL3A1
prerank,mitochondrial translational termination (GO:0070126),-0.2656131653545517,-1.0502516822751278,0.3409090909090909,0.8300738798170574,1.0,34/88,31.54%,MRRF;MTRF1L;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS12;MRPL4;MRPS26;MRPL21;MRPL44;MRPS33;MRPL48;MRPL55;MRPL57;MRPL42;MRPS18B;MRPS10;MRPS21;MRPS7;MRPL34;MRPL15;MRPL19;MRPS22;MRPS31;MRPL38;MRPL12;MRPL28;MRPL43;MRPL54;MRPS14;AURKAIP1;MRPL2
prerank,cell-substrate junction assembly (GO:0007044),0.40067049772891394,1.0498970616339913,0.4185714285714286,0.8611558514963737,1.0,5/33,6.32%,ACTN2;DLC1;RHOD;LAMC1;SRC
prerank,negative regulation of axonogenesis (GO:0050771),-0.33475939151681794,-1.0498953453893782,0.3592814371257485,0.8296512778101595,1.0,11/27,18.31%,MAP2;DIP2B;GDI1;ARHGDIA;ULK1;SEMA3G;DCC;LINGO1;MAG;RTN4R;MCF2
prerank,negative regulation of protein polymerization (GO:0032272),-0.3378475106559615,-1.0497175769238662,0.3567073170731707,0.8287160395943044,1.0,5/27,6.31%,SLIT2;MAP2;KANK3;CYRIB;HIP1R
prerank,regulation of fibrinolysis (GO:0051917),-0.41703608882694626,-1.0494276115565166,0.40404040404040403,0.8280983906584634,1.0,3/13,2.71%,THBS1;THBD;FAP
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.40941528543478123,-1.049327473010848,0.37813211845102507,0.8268817759565499,1.0,6/14,34.34%,ECI2;AMACR;ACOX1;ACOX2;ACOXL;ACOT8
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3917321515357856,1.049166677951765,0.4172461752433936,0.8624011278850371,1.0,9/37,15.81%,CEMIP;PRKAG2;SIRT2;SPRY2;SPRED3;EGF;RIPK2;SPRED1;PARD3
prerank,tetrapyrrole metabolic process (GO:0033013),0.4426565279954475,1.0488383800123346,0.42857142857142855,0.8625832190925904,1.0,3/18,8.07%,MMAB;MTR;MMUT
prerank,actin filament organization (GO:0007015),0.32113869353768776,1.048741675793341,0.38212290502793295,0.8621191637072222,1.0,23/151,10.56%,RHOH;SVIL;GSN;CGNL1;RHOD;TPM1;NEDD9;TMOD4;SHROOM2;RHOBTB1;DPYSL3;MYO1B;MCU;RHOBTB3;CDC42;RHOBTB2;CARMIL1;MYO1C;FAT1;MARCKSL1;MPRIP;EFS;SHROOM3
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.41459594159579477,1.0484988437693628,0.42485549132947975,0.8620716120348834,1.0,7/25,7.99%,BMPR1A;CCN1;SULF1;ENG;CDH5;CRB2;RBPJ
prerank,bile acid biosynthetic process (GO:0006699),0.4272429058709952,1.0484409244627362,0.40307692307692305,0.8615094788701607,1.0,3/24,7.26%,CYP7B1;SLC27A5;CYP27A1
prerank,regulation of B cell apoptotic process (GO:0002902),0.48298652767652417,1.0482742635945783,0.4199655765920826,0.8612674797148473,1.0,2/12,5.23%,LYN;BCL6
prerank,phagosome maturation (GO:0090382),0.38606042576043115,1.0475278435018707,0.4037626628075253,0.8624773833922686,1.0,1/35,0.21%,ATP6V0A4
prerank,glycogen metabolic process (GO:0005977),0.40827004605662776,1.047397984441116,0.4108983799705449,0.8621168319652386,1.0,10/27,16.58%,PHKB;PRKAG2;NR1D1;GAA;AGL;PYGM;PPP1R3C;PHKA2;PHKA1;PYGB
prerank,regulation of osteoclast differentiation (GO:0045670),0.3932273496820856,1.0472097127596296,0.4048991354466859,0.8618874010227849,1.0,10/33,21.08%,FBN1;CSF1;IL12B;TCTA;CEBPB;FSTL3;IL23A;CARTPT;GPR137B;PRXL2A
prerank,histone H2B ubiquitination (GO:0033523),0.5071664754518576,1.0468000029206994,0.4176991150442478,0.8623046434369098,1.0,7/10,26.41%,PAF1;CDC73;WAC;LEO1;RNF20;UBE2E1;RNF40
prerank,endothelial cell differentiation (GO:0045446),-0.430244111854153,-1.0464018111736717,0.4095022624434389,0.8339335923171811,1.0,6/12,19.21%,TIE1;KDR;ACVRL1;SOX18;BMPR2;ACVR2B
prerank,carbohydrate catabolic process (GO:0016052),-0.3060819951763787,-1.046204238711874,0.39057239057239057,0.8330390574885483,1.0,13/38,24.73%,GPI;HK2;PFKL;TPI1;ALDOA;PFKFB1;MAN2B1;NEU1;ALDOC;PKM;PGAM1;PGAM4;NEU2
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.2727978022144621,-1.0461782065929206,0.38,0.8316277496793749,1.0,28/70,28.25%,ENPP2;MBOAT1;LPCAT1;SLC44A5;PLA2G7;MFSD2A;PLAAT3;PNPLA8;GPLD1;PLA2G4C;PCTP;MBOAT7;LPCAT3;STARD7;LPCAT2;PCYT1B;PLA2G4F;CHKA;PLA2G4E;DBI;CHPT1;ABHD4;PLAAT1;LIPC;PLA2G4B;LPCAT4;MBOAT2;PLA2G5
prerank,positive regulation of innate immune response (GO:0045089),-0.33592007410369,-1.0460586467183144,0.382183908045977,0.8304809937151184,1.0,12/30,25.39%,RPS19;GBP5;LBP;NLRC5;IFI35;UBE2K;TRIM6;DHX9;TRIM62;PLSCR1;POLR3C;SLC15A4
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4429155099023805,-1.0459955316975675,0.39732142857142855,0.8292036082274651,1.0,6/10,28.75%,DGKH;GAP43;CHRM1;PICK1;F2R;PLPP1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.34509214255207915,1.0459565425416015,0.3854818523153942,0.8638176816351458,1.0,13/72,9.95%,PLEKHH2;EML2;KANK1;APOE;CHADL;LDLR;LIMA1;CDH5;EMILIN1;MYADM;KATNB1;PRKN;FGF13
prerank,primary miRNA processing (GO:0031053),0.5048703905953911,1.0452642480080463,0.4423407917383821,0.8649757683121974,1.0,5/10,22.96%,SMAD3;SMAD1;METTL3;SMAD2;DROSHA
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.3634063824220558,-1.0449915818622793,0.3854748603351955,0.8306736288727883,1.0,9/20,18.67%,ENTPD1;NT5E;P2RX7;HSP90AB1;APP;TXN;ANO6;C3AR1;PSTPIP1
prerank,icosanoid biosynthetic process (GO:0046456),0.5030691512457762,1.0448837360366845,0.4185639229422067,0.8652659914920975,1.0,6/10,27.36%,PLA2G4A;FADS1;ALOX5AP;LTA4H;MGST3;MGST2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2995962798489168,1.0444504511599526,0.3708206686930091,0.8657221696621218,1.0,103/497,16.95%,TCF7L2;SAMD4A;ENPP1;RUNX1T1;ATXN1;DAPK1;NR2F2;SALL1;GLI3;ZEB1;ARID5B;RUNX2;PRDM5;NKX2-1;ARID4A;WNT4;FOXP2;RBFOX2;ASCL1;GAS6;MIDEAS;LBH;TLE1;IGF2BP2;IRF1;SMURF2;IKZF4;PRICKLE1;TSPYL2;ZIC2;SFRP1;ZHX2;MT3;IGFBP5;BCL6;TBX3;DKK3;USP47;BCOR;CBX3;ATOH8;PML;MBD2;CEBPA;CPEB3;ZBTB38;SIRT2;EIF2AK3;SMARCC2;NR1D1;RBPJ;RNF139;ZMYND15;MTA3;NCOR1;NONO;BMP2;SCML2;CBY1;ZBTB4;HEXIM2;S100A11;GLIS2;NCOR2;NR1D2;ZKSCAN3;PBXIP1;MBD1;DDX3X;KDM5C;L3MBTL1;BHLHE41;SELENOS;REST;NIBAN2;LARP1;BTRC;ZNF318;PDCD4;GATA6;L3MBTL2;YAF2;ENC1;ZNF148;HDAC4;FOXK2;ZNF219;TWIST2;SCMH1;WAPL;SYNCRIP;SUDS3;CDKN1C;BMP4;CBX5;PSPC1;RIOX1;TIMELESS;CREB3L1;ZNF423;IGF2BP1;NIPBL;ATF5
prerank,negative regulation of potassium ion transport (GO:0043267),-0.40923008759112856,-1.0440782925365575,0.4149184149184149,0.8319353665325272,1.0,4/13,6.50%,CAV1;PTK2B;NEDD4L;NOS1
prerank,cognition (GO:0050890),-0.30410515564083407,-1.0440624766316242,0.3602941176470588,0.8305230406204142,1.0,15/42,21.97%,SHROOM4;GRM5;MFSD2A;DOP1B;GPR155;STRA6;FAM107A;NF1;SLC1A4;CBR3;APP;CHMP2B;PTCHD1;ST3GAL4;JAKMIP1
prerank,nitrogen compound transport (GO:0071705),0.3211731807759519,1.043939034412596,0.39359267734553777,0.8664324209073428,1.0,12/141,5.62%,SLC7A11;SLC7A2;TXNIP;SLC1A5;ARRDC4;LMAN2L;SLC6A13;SLC44A1;SLC22A2;SLC35F3;PDPN;TOM1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.44252981677421743,1.043900845364805,0.43094841930116473,0.8658238272411611,1.0,8/17,22.50%,ZW10;SPDL1;CHAMP1;MTBP;BOD1;CENPA;CTCF;IK
prerank,histone H4-K16 acetylation (GO:0043984),0.4452988972348372,1.043685931425648,0.44145569620253167,0.8657192473740396,1.0,8/19,22.46%,OGT;KMT2A;JADE1;WDR5;MSL2;KANSL1;MEAF6;KANSL3
prerank,telomere maintenance via recombination (GO:0000722),0.49798277636666344,1.043371900513365,0.4233576642335766,0.8658269421612584,1.0,5/11,19.90%,SMC5;SMC6;TEP1;RAD51D;NSMCE2
prerank,prostanoid metabolic process (GO:0006692),0.47747944634433087,1.0432222910668631,0.43844856661045534,0.8655221427206911,1.0,1/13,1.81%,PTGES
prerank,ameboidal-type cell migration (GO:0001667),-0.2911581792707364,-1.0431778762447628,0.38113207547169814,0.8315507956775972,1.0,18/51,15.90%,GPC3;SEMA6D;SEMA6A;SEMA7A;CCN3;ERBB4;TBX1;ITGA4;PKN1;SEMA5B;SEMA3G;FAT2;SEMA3C;PKN3;SEMA4B;PDLIM1;CORO1C;SOX8
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.4171958705771135,1.0431537367866826,0.4171686746987952,0.8649871273523767,1.0,13/26,25.49%,PRKAG2;APOA1;SLC45A3;PRKAA2;LPGAT1;EIF6;NR1H3;ERLIN1;ERLIN2;BRCA1;PRKAB2;ACADVL;PDK4
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.41431121986848823,1.0430870111413117,0.427536231884058,0.864438161123961,1.0,4/28,7.82%,ARHGAP28;PLEKHG2;ARHGAP18;ARHGAP35
prerank,granulocyte differentiation (GO:0030851),-0.3763736160975307,-1.0429534790222117,0.3837837837837838,0.8307415577339204,1.0,3/18,8.17%,LEF1;CBFA2T3;TAL1
prerank,calcium ion import (GO:0070509),0.39782447763637246,1.0424156150309267,0.40120663650075417,0.8655065568575281,1.0,5/28,11.52%,SLC8A1;MCU;CACNA1C;MICU2;CACNA1G
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.44894451747008834,-1.0423071814522227,0.42105263157894735,0.8312458297068817,1.0,6/10,19.51%,PDE4B;NIPSNAP2;CALM1;CALM3;CACNA2D1;CACNB3
prerank,histone ubiquitination (GO:0016574),0.42690335531909057,1.0422766136710941,0.42727272727272725,0.8651709484114818,1.0,11/21,26.41%,UBR2;ATXN7L3;UBE2U;PAF1;HUWE1;CDC73;WAC;LEO1;RNF20;UBE2E1;RNF40
prerank,regulation of interleukin-1 beta production (GO:0032651),0.35505372234357774,1.0422648682549405,0.4193954659949622,0.8645007932190713,1.0,5/66,7.95%,IGF1;CCL19;APOA1;PANX1;TLR6
prerank,amino acid import (GO:0043090),0.4325870553296628,1.0418467857535796,0.43859649122807015,0.8648944449140762,1.0,5/21,7.71%,SLC1A3;SLC6A13;SLC22A2;SFXN2;SLC22A4
prerank,negative regulation of lyase activity (GO:0051350),0.4466481247241217,1.0415802862505186,0.43890675241157556,0.8649045333525796,1.0,3/16,7.90%,ADGRV1;GRM2;DRD3
prerank,ncRNA 3'-end processing (GO:0043628),-0.3963767020638982,-1.041398534986301,0.4114713216957606,0.8324170071093107,1.0,4/14,17.96%,INTS6;PTCD1;INTS8;ELAC2
prerank,positive regulation of cation channel activity (GO:2001259),-0.3202542050601168,-1.0411432075008975,0.3732876712328767,0.8316718101043189,1.0,17/40,23.76%,SHANK3;TMSB4X;ANK3;AKAP6;STAC;CALM1;ADRB2;CALM3;ATPSCKMT;P2RY6;NLGN3;KCNIP2;CTSS;RELN;HAP1;CASQ1;CCL2
prerank,lytic vacuole organization (GO:0080171),0.39689429137921917,1.0410376055366863,0.42035398230088494,0.8656642735822988,1.0,11/32,21.88%,ABCA1;LRRK2;GAA;ZKSCAN3;CLN3;HOOK2;TPCN2;TMEM106B;HPS4;SNAPIN;MYO7A
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3498951610937086,1.0409008790800174,0.4263959390862944,0.8653192497692062,1.0,13/70,15.94%,PDPK1;SMAD3;BCL2;IL6R;MOAP1;ITGAV;IFI27;DDX3X;ACVR1B;CASP8AP2;G0S2;TNFRSF1A;CASP9
prerank,response to nitric oxide (GO:0071731),0.4716147048979461,1.0404190598878447,0.43676222596964587,0.8659702737451724,1.0,4/13,7.14%,CCL19;MTR;MT3;DPEP1
prerank,natural killer cell activation (GO:0030101),0.41977794795282236,1.0402017843246494,0.40625,0.8658045544019487,1.0,4/23,11.30%,PBX1;AXL;IL12B;IFNK
prerank,cardiac muscle cell differentiation (GO:0055007),0.42461247694473847,1.0399496353059665,0.428125,0.8657550691583205,1.0,5/21,9.13%,SLC8A1;ACVR1;SIK1;BMP2;CBY1
prerank,regulation of peptide hormone secretion (GO:0090276),0.3490272417144081,1.03990842725686,0.4028683181225554,0.8651719905813207,1.0,5/67,6.40%,ITPR1;RAPGEF4;NEUROD1;ADRA2C;CACNA1C
prerank,alpha-amino acid catabolic process (GO:1901606),0.4008228381490379,1.039532942309666,0.4094955489614243,0.8654867429371822,1.0,10/29,22.87%,TDO2;DDO;HOGA1;KYNU;SARDH;ACADSB;KYAT1;CBS;PRODH;FAH
prerank,protein localization to kinetochore (GO:0034501),0.4550652969804394,1.039179651253883,0.41216216216216217,0.8657855103130321,1.0,4/14,9.77%,ZW10;SPDL1;CHAMP1;MTBP
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.43734121977509743,-1.039161453189111,0.423728813559322,0.836004934099563,1.0,6/11,29.38%,ATL2;ARL6IP1;BNIP1;LPCAT3;ATL1;STX18
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.34557557545619855,-1.0390977225946043,0.3870967741935484,0.834736829558705,1.0,6/23,17.54%,PTPN2;HSP90AB1;NLRC5;JAK2;CDC37;TXK
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.4449341776184189,1.0388048374832293,0.3979763912310287,0.8660333270901128,1.0,5/16,14.19%,AR;RBFOX2;DDX17;TRIP4;TADA3
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.3901972716429606,-1.0383407903879445,0.39097744360902253,0.8354838141628886,1.0,6/16,24.51%,CELF4;SNW1;THRAP3;RBMX;SF3B4;DAZAP1
prerank,rRNA methylation (GO:0031167),0.4204728150298166,1.0380078447609549,0.42105263157894735,0.8674390225493441,1.0,6/22,15.12%,BUD23;DIMT1;FTSJ3;TRMT112;NSUN5;NSUN4
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.40388681256738374,-1.0376584475950241,0.43112244897959184,0.835991462749715,1.0,3/14,9.80%,NOS3;ACE2;EDN1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4293676738599026,1.0373421959708857,0.4367283950617284,0.8684978616624943,1.0,3/19,4.39%,RUNX1;IRAK2;APOA1
prerank,glycolytic process (GO:0006096),-0.33068054635993505,-1.0373200740975526,0.37735849056603776,0.835552059308381,1.0,10/28,23.78%,GPI;HK2;PFKL;TPI1;ALDOA;PFKFB1;ALDOC;PKM;PGAM1;PGAM4
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3395022499739092,-1.037265382005093,0.4012158054711246,0.8342261440634486,1.0,8/26,12.92%,EFNA5;ANO1;LRP5;KLF7;EPHA5;GPLD1;ADCY8;CFTR
prerank,organic acid transport (GO:0015849),0.33690222587351026,1.037096761718602,0.4296028880866426,0.8684497457619643,1.0,9/94,5.32%,SLC7A11;SLC7A2;SLC1A5;SLC13A3;SLC27A5;ACSL1;SLC6A13;NCOA2;PDPN
prerank,response to X-ray (GO:0010165),0.4702320613578628,1.0362479266730227,0.4517857142857143,0.8699734739077346,1.0,5/14,20.56%,LIG4;IKBIP;ATM;NIPBL;BRCC3
prerank,mitochondrial fission (GO:0000266),-0.38883769230534815,-1.0357651550621938,0.43967828418230565,0.8369992027531717,1.0,6/16,25.12%,DNM3;MTFR1;MTFR2;DNM1;FIS1;SLC25A46
prerank,positive regulation of cell growth (GO:0030307),0.3341366059016435,1.0357622880604478,0.4166666666666667,0.8705193791943512,1.0,10/96,6.07%,IGF1;BCL2;MACF1;TGFBR1;SFRP1;GOLGA4;CXCL16;USP47;CDC42;INO80
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.36593287860063545,1.0355211272254945,0.4113756613756614,0.8705224235626295,1.0,16/53,24.51%,EYA2;EYA1;PLA2R1;EGFR;SPRED3;ERCC8;NPAS2;SPRED1;ATM;SMCHD1;UIMC1;BRCC3;NSMCE4A;BRCA1;TMEM161A;PMAIP1
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3709216684927781,-1.0353668840482582,0.40153452685422,0.8367416954507202,1.0,4/18,8.47%,CAV1;NEDD4L;CAMK2D;SLC43A2
prerank,cholesterol transport (GO:0030301),0.37698654715584445,1.0353112396729136,0.4173669467787115,0.8703635628287709,1.0,6/45,5.64%,ABCA1;APOE;APOA1;LDLR;STAR;LIMA1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3427662225506381,1.0349480065271415,0.4344569288389513,0.8706004858882432,1.0,11/85,9.39%,IGF1;LYN;DLC1;OGT;KANK1;NOTCH2;DENND4A;ARHGEF18;EPHB2;SPRY2;RAPGEF1
prerank,long-term synaptic potentiation (GO:0060291),-0.3611869021135592,-1.034352011788617,0.41333333333333333,0.8381916016084827,1.0,6/21,10.77%,SLC24A2;PTK2B;GRIN2A;TSHZ3;GRIN2B;PRKCZ
prerank,regulation of cholesterol transport (GO:0032374),0.4330002673139733,1.0343170128321213,0.4301948051948052,0.8715223944551761,1.0,5/20,18.57%,LRP1;APOA1;TSPO;NR1H3;YJEFN3
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.40606178075514576,-1.0342905659658728,0.3994708994708995,0.8369355445889272,1.0,5/14,11.17%,MYO9A;OPHN1;SCRIB;MSN;PATJ
prerank,negative regulation of TORC1 signaling (GO:1904262),0.47466391001198976,1.034160413986269,0.43986254295532645,0.8712314834767736,1.0,7/13,20.41%,STK11;CASTOR2;RNF152;ITFG2;SESN2;ATM;SZT2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3510273505978887,1.0335885904522235,0.42317380352644834,0.8720771860956769,1.0,14/67,9.57%,NRP1;NEDD9;CSF1;APOA1;SFRP1;ECM2;CDC42;PLEKHA2;CARMIL1;DOCK5;CSPG5;RSU1;ARL2;MYADM
prerank,maturation of 5.8S rRNA (GO:0000460),0.4492190944450399,1.0335732691859665,0.42671009771986973,0.8714242751775246,1.0,5/17,12.61%,C1D;MPHOSPH6;FTSJ3;EIF6;MTREX
prerank,regulation of fibroblast migration (GO:0010762),0.4313369040363631,1.0329818472190038,0.4174603174603175,0.8722249764715004,1.0,5/20,11.57%,DDR2;RFFL;APPL2;FGF2;CLN3
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.33673848906939513,1.0328695060431348,0.4098159509202454,0.871813680817476,1.0,19/90,15.26%,GJA1;LEPR;OGT;ACSL1;GNAS;APPL2;DYNC1H1;EPAS1;ADRB3;ALMS1;MFAP2;CEBPB;STAT6;DECR1;DIO2;G0S2;CNOT3;GRB10;IL4R
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.29175395148672945,-1.0327839616025718,0.3715415019762846,0.8398585885399568,1.0,18/54,22.05%,CAV1;IVNS1ABP;NXN;RPS3;CRY1;RPL11;MINAR1;COPS9;TNFAIP3;RPL5;N4BP1;VPS28;USP4;PRMT3;PRR7;ADGRB1;CAMLG;UBXN1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3474008451260323,1.031964395699748,0.4167741935483871,0.8735724115183273,1.0,17/72,22.78%,POLR2D;CUL4B;GTF2H5;POLR2C;ERCC8;MNAT1;GPS1;COPS3;COPS2;XPA;PPIE;POLR2L;RFC5;LIG1;CDK7;ERCC3;ERCC2
prerank,ether lipid metabolic process (GO:0046485),0.4658038395589203,1.0317532822029012,0.4510135135135135,0.8734596868818538,1.0,1/14,0.63%,AGMO
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.36042235448274285,1.031750777688898,0.4096858638743455,0.8727761424347676,1.0,21/52,24.44%,SEC31A;TSPYL2;TLN1;PARP16;GFPT1;DNAJC3;GOSR2;KDELR3;CTDSP2;PDIA6;WIPI1;CUL7;ZBTB17;YIF1A;SRPRB;CXXC1;HSPA5;WFS1;ATP6V0D1;EXTL2;ACADVL
prerank,zinc ion transport (GO:0006829),0.42559022315166184,1.0317020379721495,0.44709388971684055,0.8722092332819439,1.0,5/21,11.00%,SLC30A8;MT3;SLC30A2;SLC30A10;SLC39A13
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.32174472041748375,1.0316707453155187,0.413516609392898,0.8716007238541651,1.0,29/140,10.12%,RHOH;CGNL1;ARHGAP6;DLC1;SYDE2;RHOD;ARHGAP28;PLEKHG2;ARHGAP18;TIAM2;SOS2;ARHGAP29;FGD1;ARHGAP21;FGD4;ARHGAP19;ARHGAP32;CDC42;ARHGAP10;SRC;ARHGEF17;FAM13A;ARHGEF18;ARHGAP35;SYDE1;ARHGAP9;ARHGEF11;ITGAV;RHOT1
prerank,cell cycle G2/M phase transition (GO:0044839),0.321759900626237,1.0315847551583261,0.41879350348027844,0.8711349861543554,1.0,23/129,14.87%,CDK14;DYNLL1;NINL;CCNA2;OPTN;CEP152;PHLDA1;FBXL17;DYNC1H1;ALMS1;BRSK1;FBXL3;FBXL12;YWHAE;MNAT1;BTRC;DYNC1I2;HAUS1;HAUS3;AKAP8L;HAUS7;CEP192;CEP164
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4421347116530119,-1.0314927571349088,0.4507042253521127,0.8422962906873368,1.0,3/10,5.24%,ZBTB16;ACVRL1;PKDCC
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.4660784302713934,1.0313822324916007,0.432475884244373,0.8710038156757313,1.0,3/14,16.45%,CSF1;IL12B;IL23A
prerank,response to ketone (GO:1901654),-0.34209521563195966,-1.0311329989349185,0.39106145251396646,0.8419503283795918,1.0,5/24,4.12%,SLIT2;CAV1;THBS1;ABHD2;TGFB2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.3905088094686102,-1.0311187505331232,0.39641943734015345,0.8405601545302065,1.0,3/14,5.26%,TMSB4X;FAF1;NFKBIA
prerank,regulation of microtubule-based movement (GO:0060632),-0.43311484112371273,-1.0307433234026957,0.42691415313225056,0.8402000920338885,1.0,5/11,25.10%,MAP2;NEFH;DYNLT2B;HAP1;CCDC65
prerank,receptor metabolic process (GO:0043112),-0.2888748866197911,-1.030600836960208,0.375886524822695,0.8391671341361054,1.0,12/53,11.86%,DNM3;CAV1;SMURF1;ACKR3;TFRC;RAMP2;SNX1;FCER1G;KIF16B;LGMN;TGFB1;CD81
prerank,aminoglycan metabolic process (GO:0006022),0.4908429849395714,1.0305203345211067,0.42517006802721086,0.8725342965141419,1.0,1/10,1.41%,GAL3ST3
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3136088417987682,1.0303884390344438,0.4217002237136465,0.872190416973247,1.0,8/144,3.61%,TCF7L2;CEMIP;PIK3R1;SMAD3;BCL2;ZIC1;LEPROT;GAS6
prerank,cellular response to estrogen stimulus (GO:0071391),0.46239442927960683,1.030265439633756,0.436241610738255,0.871820723017692,1.0,2/14,4.62%,AR;SFRP1
prerank,cellular response to light stimulus (GO:0071482),-0.26805833792520056,-1.0297378050921895,0.4027777777777778,0.8402955175490578,1.0,30/66,34.01%,PTPRK;KDM1A;TAF1;YY1;RPL26;COPS9;GNB1;BAK1;PDE6A;EP300;N4BP1;RHBDD1;NPM1;PARP1;POLK;TRIAP1;ATF4;SDE2;EIF2AK4;RUVBL2;RHNO1;FMR1;AQP1;RRH;OPN1MW3;OPN1MW;OPN3;SAG;PDE6B;NSMCE3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.34302009464720706,-1.0297326079877334,0.4301994301994302,0.8388846011435117,1.0,12/25,24.81%,HIPK2;RPS7;RPL11;HSP90AB1;OPHN1;TAF1;PSMF1;RPL5;RPL23;EFNA1;PRKCG;SGTA
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3958718476310811,1.0296647896041113,0.4287812041116006,0.8720343886081787,1.0,10/31,22.78%,POLR2D;GTF2H5;POLR2C;MNAT1;CMTR2;POLR2L;NCBP2;CDK7;ERCC3;ERCC2
prerank,7-methylguanosine RNA capping (GO:0009452),0.3958718476310811,1.0296647896041113,0.4287812041116006,0.8720343886081787,1.0,10/31,22.78%,POLR2D;GTF2H5;POLR2C;MNAT1;CMTR2;POLR2L;NCBP2;CDK7;ERCC3;ERCC2
prerank,cellular response to organic cyclic compound (GO:0071407),0.3204558622493496,1.0296060731969203,0.42303306727480045,0.8714943800655638,1.0,15/141,6.25%,RORA;ADCY1;ROCK2;ADCY2;AR;ATP1A2;ADCY5;CYP1B1;RAPGEF2;SFRP1;PDE3A;IGFBP5;TFPI;ZFP36L1;LRRK2
prerank,isotype switching (GO:0045190),0.48435884459986633,1.0292661673681498,0.4326750448833034,0.8716653920064655,1.0,2/10,6.30%,LIG4;BATF
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.39871932845004876,1.0289123898909946,0.42073170731707316,0.8718814810942902,1.0,6/30,11.79%,VAMP5;MACF1;OPTN;GOLGA4;GGA2;GOLPH3L
prerank,positive regulation of ATPase activity (GO:0032781),0.3706555941782213,1.0288758983261979,0.4311797752808989,0.8712959623141288,1.0,6/41,11.42%,DYNLL1;TPM1;ATP1B2;MYL4;TNNT3;TOR1AIP1
prerank,metal ion transport (GO:0030001),0.3369450345711704,1.0285957071666645,0.43828715365239296,0.8713499676331131,1.0,9/86,6.85%,ITPR1;SLC8A1;SLC8A3;SLC41A1;SLC30A8;SLC24A1;MT3;CACNA1C;PANX1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.3871377854189596,1.0282647150455644,0.4273255813953488,0.8714816676950083,1.0,7/35,8.07%,NRP1;PDGFRA;NOTCH2;NTF3;IQGAP2;CDC42;NTRK3
prerank,regulation of neuron differentiation (GO:0045664),0.34428025652178645,1.028166062682948,0.4245398773006135,0.8710453413336772,1.0,10/76,6.25%,TCF4;NREP;FGFR1;ZEB1;ASCL1;CDK5RAP3;NTF3;NEUROD1;ADRA2C;LRRK2
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3636709786237017,-1.0273758828702422,0.3926553672316384,0.8443238054139836,1.0,10/22,24.82%,B2M;CNTN4;MED1;HES1;HEY1;DLL1;DTX1;GSK3B;EIF2AK4;NEPRO
prerank,neural crest cell migration (GO:0001755),0.3868597810713166,1.027284637761928,0.43567251461988304,0.8726810977677779,1.0,4/36,3.86%,NRP1;GDNF;SEMA3D;SEMA5A
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.30325310686789075,-1.027196233175765,0.4080267558528428,0.843422468931817,1.0,12/43,13.99%,MEF2C;NOTCH1;SOX17;TBX2;ZIC3;SOX18;TGFBR2;HES1;STIL;APLNR;RYR2;MICAL2
prerank,anterograde axonal transport (GO:0008089),-0.314642671428953,-1.0269521436908466,0.38782051282051283,0.8426933408060047,1.0,15/37,28.52%,DLG2;RAB21;AP3B1;RAB27B;KIF1A;TRAK2;BLOC1S5;AP3S1;KIF5A;KIF4A;HAP1;KIF1B;SOD1;AP3B2;HSPB1
prerank,lipoprotein catabolic process (GO:0042159),0.4837465379261909,1.0269488836750054,0.4369449378330373,0.872878753876888,1.0,3/11,5.75%,APOE;ABHD17C;LYPLAL1
prerank,mesenchyme development (GO:0060485),0.4509932082587499,1.0269113422222929,0.4249146757679181,0.8723094389424987,1.0,3/15,8.88%,FGFR2;TGFBR1;BMP2
prerank,neuromuscular synaptic transmission (GO:0007274),0.43629832932835916,1.0261668645724267,0.44390243902439025,0.873545098823588,1.0,5/18,20.47%,ERC2;DTNA;STAC3;FCHSD2;CHRNB2
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4536437149673034,1.0249569679754287,0.44655172413793104,0.8760593545922251,1.0,5/13,18.27%,CBLB;KPNA6;KPNA2;KPNA1;KPNB1
prerank,xenobiotic transport (GO:0042908),-0.381871922028862,-1.0248005773046944,0.4211822660098522,0.8473902674678815,1.0,5/17,5.19%,SLC47A1;ABCG2;SLC7A5;ABCC1;SLC15A2
prerank,pentose-phosphate shunt (GO:0006098),0.4819448734711511,1.0243931021570574,0.44665461121157324,0.8768876084062122,1.0,6/11,31.93%,H6PD;PGD;TALDO1;TKT;PGLS;DERA
prerank,cellular component assembly (GO:0022607),0.30276206753214147,1.0240685937967944,0.41983122362869196,0.8770473096886535,1.0,45/253,14.66%,RHOH;TEAD1;CALD1;GSN;MITF;RHOD;NEDD9;PARVA;LAMC1;SHROOM2;YAP1;GAS6;DPYSL3;MYO1B;GORASP2;FZD1;FSCN3;LIMA1;CHAF1B;CDC42;RANBP9;PML;ZW10;CD247;PARD6B;SYCE2;TLCD1;CFAP46;PICALM;TSPAN4;TEX12;FLNC;KMT2A;STAG3;FANCC;RHOQ;MNAT1;CCDC40;PAWR;LLGL1;DLG4;WASF1;SNX9;ABCA3;FLNA
prerank,positive regulation of phospholipid transport (GO:2001140),0.49478556370863147,1.0235307725918215,0.46139705882352944,0.8777481983425035,1.0,5/10,22.23%,APOE;APOA1;ABCA3;ABCA7;PRELID1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4459922257514876,1.0229130572220024,0.45516074450084604,0.8786866123411654,1.0,3/16,3.79%,NOS1AP;APOE;NPR3
prerank,amyloid fibril formation (GO:1990000),0.3547220771039377,1.022557423802086,0.4375838926174497,0.8788768088897722,1.0,9/51,12.44%,GSN;HSPG2;APOA1;CST3;SNCAIP;PRKN;GGA2;APH1B;USP9X
prerank,regulation of metal ion transport (GO:0010959),0.43302297564174197,1.0224413277064084,0.43322475570032576,0.8784707080746808,1.0,4/16,9.11%,BCL2;STIM1;SLC30A10;CAMK2B
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.2715300731046231,-1.0222484272364067,0.4009216589861751,0.8534069597623105,1.0,22/71,19.21%,ELMO1;YES1;ACTB;PLCG2;VAV3;ARPC1B;HSP90AB1;PAK1;DOCK1;ARPC3;WIPF3;WASF2;FCER1G;CYFIP2;PLPP4;MAPK3;PIK3CA;ARPC4;PRKCE;ACTG1;FCGR1A;FGR
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.42240169918217796,1.0219864609667355,0.4198717948717949,0.8789750467763869,1.0,4/19,10.77%,PGM3;GFPT1;UAP1;RENBP
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3420452713314756,1.02189083498229,0.4336734693877551,0.8785357407351592,1.0,12/75,10.29%,SLC8A1;SLC8A3;LYN;NR2F2;APOE;CDK5RAP3;PKIA;CEBPA;IRAK3;SPRY2;HEXIM2;INCA1
prerank,regulation of complement activation (GO:0030449),0.37393458002686775,1.0218447531109247,0.4294032023289665,0.8779841521641779,1.0,5/40,6.29%,SERPING1;CFH;VTN;C4B;C8G
prerank,postsynaptic membrane organization (GO:0001941),-0.37556898007798645,-1.0218365317766067,0.4393203883495146,0.8531696166372889,1.0,3/17,4.38%,SHANK3;NLGN1;NRXN1
prerank,regulation of cellular metabolic process (GO:0031323),0.3662903074517049,1.021684643248629,0.4340974212034384,0.8777281446326982,1.0,9/45,15.01%,PID1;CYP1B1;GNB3;PRKN;NCOR2;EIF6;FASN;ARF4;RSPO1
prerank,positive regulation of DNA replication (GO:0045740),0.45202055329143165,1.0215432780264182,0.44867549668874174,0.877413788945599,1.0,5/16,12.43%,GLI2;NPM2;EGFR;EGF;GLI1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.39922855238970073,1.0215353308564306,0.4281298299845441,0.8767586861305127,1.0,5/27,3.88%,EPHA8;PDGFRA;KIT;PDGFRB;CCL19
prerank,regulation of mitochondrial fission (GO:0090140),0.413543134041614,1.0215099325504653,0.4326465927099842,0.8761546440147228,1.0,6/24,13.34%,DCN;MCU;LRRK2;STAT2;PRKN;MUL1
prerank,protein localization to lysosome (GO:0061462),-0.3305084907578025,-1.0214806992110677,0.3955431754874652,0.8527976757809392,1.0,9/28,20.23%,SH3BP4;SORL1;KPTN;CD81;NCOA4;SCARB2;LMBRD1;GGA3;VPS4A
prerank,myeloid leukocyte differentiation (GO:0002573),0.347276394068205,1.0211467619482921,0.4302030456852792,0.87638688861072,1.0,10/65,7.08%,RUNX1;IL31RA;KIT;CCL19;CSF1;CDC42;BATF;PML;EFNA2;CEBPA
prerank,glycine metabolic process (GO:0006544),-0.4167931729486407,-1.0208739995275307,0.4625,0.8531174816055072,1.0,6/12,35.07%,GCSH;GCAT;SHMT1;AMT;GLYAT;GLDC
prerank,regulation of protein neddylation (GO:2000434),-0.44773674668315144,-1.0204164808154557,0.44772727272727275,0.8530037515327835,1.0,5/10,15.43%,RPL11;DCUN1D4;COPS9;RPL5;HIF1A
prerank,negative regulation of developmental growth (GO:0048640),0.39857531747056896,1.0203042660319677,0.4452662721893491,0.8778946604703487,1.0,7/30,10.71%,WWC2;NKD1;MT3;PTPRS;ULK2;FGF13;RNF6
prerank,regulation of blood coagulation (GO:0030193),-0.3366918583400844,-1.0201857927670983,0.4597014925373134,0.8523012209822102,1.0,5/27,2.71%,CAV1;CD34;THBS1;THBD;FAP
prerank,cellular response to interferon-beta (GO:0035458),-0.39818279160163206,-1.0201269883226503,0.4329411764705882,0.8510371445420533,1.0,5/14,16.42%,AIM2;PNPT1;UBE2K;UBE2G2;TRIM6
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.35446882684656256,1.019613782797234,0.440745672436751,0.8790193581806947,1.0,8/52,12.24%,CELF2;RBFOX1;RBFOX2;DDX17;HNRNPA1;SMU1;REST;WTAP
prerank,B cell proliferation (GO:0042100),0.43130148614784436,1.0190705918473564,0.46324786324786327,0.8797712206984856,1.0,2/17,3.00%,BCL2;GAPT
prerank,positive regulation of JNK cascade (GO:0046330),0.3440146025612763,1.0190390720498388,0.4448818897637795,0.8791835442366559,1.0,10/70,10.78%,CCN2;SH3RF3;SH3RF1;GADD45B;CCL19;EDAR;MTURN;LTBR;TAOK3;CARD9
prerank,protein modification by small protein conjugation (GO:0032446),0.2958204296262592,1.0188178356237825,0.4365904365904366,0.879076287764071,1.0,92/361,20.59%,MYCBP2;SPSB1;RNF220;PDZRN3;HECW2;ARRDC4;EYA1;MGRN1;NUP107;FBXL17;UBR2;NEDD4;CDK5RAP3;SMURF2;RNF213;EPAS1;DERL1;ZNRF3;CUL4B;DTX4;NFE2L2;ATG10;CUL5;NUP42;TRAF7;FBXL3;RNF139;UBA7;ARRB1;UBE2V2;COMMD1;TRPM4;PRKN;ITCH;RNF181;ASB12;MIB1;RAE1;RNF6;RNF38;NUP98;RNF152;FBXO9;FBXO11;UFL1;FBXO4;RAD18;SELENOS;USP9X;URM1;BTRC;PEX2;PAF1;TNFAIP1;MUL1;NUP214;ENC1;UBA6;AMFR;UFC1;UBE2D1;HLTF;DCUN1D2;ASB1;HACE1;CUL7;HUWE1;UBE2R2;MSL2;RNF138;PJA2;DTX3;UBR3;RNF135;CDC73;KLHL18;SEH1L;TPR;RNF34;WAC;TRIM21;TRIM41;TRIM47;TRIM26;TRIM32;SUMO1;ARIH2;NSMCE2;ZSWIM8;CDC23;AAAS;HIF3A
prerank,regulation of apoptotic process (GO:0042981),0.2890874931513184,1.0185414843203617,0.43743743743743746,0.8790796492561765,1.0,130/676,17.25%,IGF1;STK17B;DAPK2;FHL2;ANGPT1;STEAP3;ACTN2;PIK3R1;GDNF;DAPK1;IL31RA;BCL2;GRK5;OLFM1;SON;SH3RF1;PLEKHG2;ASCL1;GADD45B;PHLDA1;TIAM2;CFLAR;GAS6;NUPR1;MYO18A;NOTCH2;MOAP1;FSTL1;SOS2;TXNDC5;PDCD5;FGD1;CYP1B1;SFRP1;MT3;NTF3;AXL;FGD4;ING3;NEUROD1;PHIP;CTSH;RARG;BCL6;PDPN;TBX3;PRKAA2;MAP3K20;VIP;USP47;BFAR;TSLP;ARHGAP10;SRC;NDRG1;ARHGEF17;ING5;SPHK2;DPEP1;CD28;ARHGEF18;ARAF;OSR1;MAP4K4;STK4;EGFR;DNAJC3;DAB2;BCL2L11;SPRY2;AIFM1;BMP2;ARHGEF11;ACTN4;PRKN;ITCH;FOXA1;BRAF;DDX3X;IGFBP3;APH1B;CLN3;FBXO11;SPDEF;ANXA5;REST;FGD3;PLEKHN1;ADAMTSL4;NIBAN2;PAWR;HMGN5;RIPK2;NOL3;SFRP4;VDAC1;GATA6;IFIT2;ARF4;AKAP13;DSTYK;HSPA9;TAF9;HYPK;GAS1;PLK2;HPN;FLNA;MTCH2;MTCH1;ARHGEF19;TRIO;SUDS3;SHH;TMBIM6;RBM5;NLRC4;BMP4;CASP9;AKT1;GOLPH3;ATM;ZBP1;CASP1;PTPA;CX3CL1;ATF5;PSEN2;GLO1;PIM1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.4276765196012258,1.0183958232745267,0.45024469820554647,0.8787837661841839,1.0,4/18,13.34%,DCN;MCU;PRKN;MUL1
prerank,mitochondrial translation (GO:0032543),-0.2500948888356892,-1.0183611353361752,0.4342105263157895,0.854740316068451,1.0,39/104,31.54%,MRRF;NOA1;MTRF1L;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS12;MRPL4;MRPS26;FASTKD2;MRPL21;MRPL44;NDUFA7;MRPS33;MRPL48;MRPL55;MRPL57;MRPL42;MRPS18B;MRPS10;MRPS21;MRPS7;MRPL34;MRPL15;MRPL19;MRPS22;GATC;MRPS31;MRPL38;MRPL12;MRPL28;MRPL43;MTIF3;MRPL54;MRPS14;AURKAIP1;MRPL2
prerank,regulation of presynapse organization (GO:0099174),0.43293371378418843,1.0182341968147977,0.45800316957210774,0.8778666388194672,1.0,1/18,0.24%,GPC6
prerank,regulation of presynapse assembly (GO:1905606),0.43293371378418843,1.0182341968147977,0.45800316957210774,0.8778666388194672,1.0,1/18,0.24%,GPC6
prerank,protein processing (GO:0016485),0.32326992194988363,1.0180399357355392,0.4346246973365617,0.877659989025035,1.0,18/102,17.01%,CPXM2;OGT;AEBP1;CPXM1;CTSH;MMEL1;SPRTN;SEC11C;ECE2;EEF1AKMT4-ECE2;LONP2;APH1B;CLN3;CTSL;MMP14;SEC11A;CASP1;PSEN2
prerank,mRNA stabilization (GO:0048255),0.37599815587614166,1.01799226691638,0.4351464435146444,0.877115811583806,1.0,14/40,21.99%,GDNF;TENT5A;AXIN2;VIP;TENT5D;LARP1;SYNCRIP;MAPKAPK2;IGF2BP1;HNRNPC;TIRAP;HNRNPU;MYD88;NOCT
prerank,copper ion transport (GO:0006825),0.4785372967254502,1.017717397053621,0.4670138888888889,0.8771539482080791,1.0,2/11,5.92%,STEAP3;SLC11A2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.43260483521077225,1.017667347216408,0.464,0.8766001553018636,1.0,4/19,11.55%,BMP6;AFDN;FOXA1;RGCC
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.4639094773099345,1.0174901348232213,0.43993506493506496,0.8763865967631189,1.0,2/13,5.23%,ABCA1;LDLR
prerank,axonemal dynein complex assembly (GO:0070286),0.3956687129925486,1.017446188112118,0.4372163388804841,0.8758342318365359,1.0,9/27,19.16%,SPAG1;CFAP73;DNAAF1;DNAI3;CCDC40;DNAAF5;DNAL1;TTC12;DNAH8
prerank,rRNA pseudouridine synthesis (GO:0031118),0.4863879791637351,1.0174378920228682,0.43127147766323026,0.8751862174443533,1.0,3/10,18.13%,RPUSD4;RPUSD2;NAF1
prerank,carnitine shuttle (GO:0006853),0.4760446851197597,1.0174204850412236,0.458477508650519,0.8745677280062158,1.0,2/11,5.53%,PRKAG2;PRKAA2
prerank,regulation of translational initiation (GO:0006446),0.3512228831634107,1.0172686089518648,0.4387755102040816,0.8742831418720578,1.0,19/63,22.22%,POLR2D;EIF2AK3;DNAJC3;EIF4A2;CDC123;DDX3X;EIF5B;CEBPB;IMPACT;LARP1;ALKBH1;DDX1;CTIF;TPR;YTHDF2;MIF4GD;EIF4G2;NCBP2;RBM4
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.3683698406465511,-1.0167826376245814,0.4075067024128686,0.8579272886608,1.0,7/18,24.87%,SEC14L1;RNF125;USP15;UFD1;C1QBP;OASL;PUM2
prerank,negative regulation of viral entry into host cell (GO:0046597),0.46517348340368386,1.0166818791846846,0.453781512605042,0.8751534626468251,1.0,1/12,1.25%,GSN
prerank,nucleoside phosphate catabolic process (GO:1901292),0.4651831290993082,1.0164253123061553,0.4527027027027027,0.8751605343583913,1.0,1/13,0.56%,ENPP1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.4780842199297376,1.0162408854606484,0.4444444444444444,0.8749730394939239,1.0,4/11,15.79%,MAP2K1;EGFR;MYCN;BMP4
prerank,histone H3 acetylation (GO:0043966),-0.3028045477136145,-1.0160316600263737,0.41454545454545455,0.8586287880551865,1.0,15/40,22.21%,LEF1;JADE3;TRIM16;KAT2A;TAF10;TADA2A;LDB1;PER1;KAT6A;NAA60;BRCA2;SGF29;YEATS2;TAF5;MAP3K7
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.4446283591877507,1.0157876084477042,0.4468802698145025,0.8754781687308464,1.0,2/15,2.07%,RAI2;FGFR1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.38375686937686104,1.0156549632807004,0.43988684582743987,0.8751563468237187,1.0,5/33,6.96%,RUNX1;IL34;CSF1;ZFP36L1;IL12B
prerank,purine-containing compound biosynthetic process (GO:0072522),0.4052122241947145,1.0152023916183126,0.4537313432835821,0.8756268141947285,1.0,7/25,19.06%,AMPD3;ADK;GART;AMPD2;DCK;PPAT;PRPSAP2
prerank,positive regulation of cellular metabolic process (GO:0031325),0.32706409609657044,1.0150389943228417,0.4469078179696616,0.8753298998907973,1.0,19/98,14.87%,ANGPT1;PID1;APOE;PDGFRB;CSF1;APOA1;MT3;NTF3;AGTR1;CD63;ARRB1;DCXR;EGF;F2;INSR;FASN;SFRP4;HPN;NR1H3
prerank,regulation of lipid catabolic process (GO:0050994),-0.3572370168810422,-1.014916984717249,0.4189189189189189,0.8604627494019732,1.0,2/19,8.17%,PDE3B;ALK
prerank,endothelial cell migration (GO:0043542),0.3766902222008032,1.014905731816469,0.4254062038404727,0.8749943634362063,1.0,5/37,6.47%,NRP1;FSTL1;CYP1B1;CDH5;ADGRA2
prerank,regulation of autophagy (GO:0010506),0.3037815388167535,1.0146746823740693,0.44790547798066593,0.8749249665403076,1.0,50/216,21.25%,DAPK2;ITPR1;DAPK1;DCN;BCL2;LEPR;OPTN;PRKAG2;NUPR1;NEDD4;MT3;PRKAA2;LRRK2;SIRT2;SREBF1;MTMR3;STK11;PRKN;SLC38A9;ZKSCAN3;ATP6V1E1;RNF152;LAMTOR2;UFL1;RRAGD;USP10;VDAC1;FOXK2;PLK2;NPRL2;TPCN2;PIK3R2;AKT1;ATM;PIP4K2C;FOXO3;KAT5;PRKACA;TRIM21;PRKAG1;KDM4A;RHEB;PSAP;SNX6;GPR137B;WDR41;UCHL1;MLST8;ATP13A2;EIF4G2
prerank,regulation of phagocytosis (GO:0050764),0.3531591017435759,1.0142527741801508,0.4386422976501306,0.8753383488768163,1.0,11/53,16.63%,CAMK1D;AHSG;TULP1;GAS6;APOA1;IL15RA;ITGAV;MERTK;SYT11;FER1L5;CD47
prerank,protein targeting to lysosome (GO:0006622),-0.3578419734258536,-1.0142498367457617,0.4255874673629243,0.8610018526268305,1.0,12/20,31.69%,HSPA8;SORL1;NCOA4;SCARB2;CLU;GGA3;VPS4A;GNPTAB;GCC2;HGS;SNX16;AP3M1
prerank,bile acid metabolic process (GO:0008206),0.4020497340178975,1.0138647159803895,0.4505988023952096,0.875666264278866,1.0,3/27,7.26%,CYP7B1;SLC27A5;CYP27A1
prerank,cellular protein-containing complex assembly (GO:0034622),0.3103544540549186,1.0138594467236217,0.4634420697412823,0.8750206251418953,1.0,23/159,14.48%,TCF4;FMOD;ANGPT1;SMAD3;NUP107;COX7A2;SPAG1;SRC;EPS15;DNAAF1;AIFM1;ARL2;PICALM;SMAD1;CENPC;NUP98;STXBP1;UVRAG;CCDC40;RAB5IF;NSG2;SNX9;ADRM1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.471936339116236,1.0137479440107544,0.4656616415410385,0.8746835309272869,1.0,4/12,10.17%,SFRP1;NCOR1;DAB2;NCOR2
prerank,heart looping (GO:0001947),-0.30813419202458325,-1.013331513356012,0.41776315789473684,0.8622386520685718,1.0,10/39,13.99%,MEF2C;NOTCH1;SOX17;TBX2;ZIC3;SOX18;TGFBR2;STIL;APLNR;MICAL2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3216587827056753,1.0133012704553641,0.4520048602673147,0.8751652513564248,1.0,30/104,22.49%,SLC8A1;KSR1;SLC8A3;CCNA2;CDK5RAP3;SRC;PARP16;MAP2K1;CCNK;TELO2;DDX3X;UVRAG;MNAT1;DUSP19;CDK12;CNPPD1;AKT1;CDKN2C;CCNT2;CDKN1B;HTT;SERTAD1;ETAA1;TRIB1;CCND2;CCNT1;CDK7;TSG101;CCNG2;CCNE2
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2627986722823887,-1.0120301709137698,0.4186046511627907,0.8645701089928453,1.0,20/75,18.44%,GPCPD1;SERINC5;DGKH;CPNE3;PLA2G7;PIGP;PLA1A;PAFAH1B1;GPLD1;PLEK;PIGB;PNPLA3;PLA2G4C;CRLS1;PIGL;ABHD6;DPM2;SYNJ1;PNPLA6;PIGV
prerank,negative regulation of cell death (GO:0060548),0.3284374622000809,1.0120292108824067,0.4449877750611247,0.8777129610993492,1.0,21/88,18.05%,CCN2;CCN1;CSF1;INPP5A;MT3;CCN5;LRRK2;PARP16;CCN4;CD200;PRKN;FGF2;RAD18;IMPACT;NPAS2;TM7SF3;BMP4;AKT1;KANK2;SOX11;BECN1
prerank,urogenital system development (GO:0001655),0.4780874495960967,1.012013602090597,0.4633699633699634,0.8770989453599736,1.0,4/11,15.58%,OSR1;EPHB2;EPHB3;SHH
prerank,Golgi inheritance (GO:0048313),-0.419221613875356,-1.0118838266599959,0.46987951807228917,0.8635679178843048,1.0,4/11,29.06%,VRK1;PDCD10;PLK3;CDK1
prerank,protein localization to mitochondrion (GO:0070585),0.4673341900557529,1.0117131437993783,0.4337568058076225,0.8772033974874212,1.0,4/11,16.32%,LRRK2;COX18;MTCH2;AKT1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.3871708411611795,-1.0115965134811398,0.42597402597402595,0.8629808926467359,1.0,3/14,9.76%,ANK3;ATP1B1;WNK2
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4145683491736013,1.0113563165055903,0.4542635658914729,0.87744607645865,1.0,5/23,13.87%,MOAP1;COX18;BCL2L11;TIMM9;TOMM22
prerank,positive regulation of macrophage differentiation (GO:0045651),0.4762038019376153,1.0111380751962236,0.4598290598290598,0.8773077425657845,1.0,5/11,19.82%,IL34;CSF1;LIF;PRKCA;HSF1
prerank,organelle fission (GO:0048285),-0.34568593795396846,-1.011080111107056,0.4294117647058823,0.8630667727805983,1.0,6/24,17.31%,DNM3;WASHC5;MTFR1;CORO1C;MTFR2;DNM1
prerank,negative regulation of transport (GO:0051051),0.3569550811657697,1.0109931756801411,0.4684931506849315,0.8769987934319118,1.0,11/51,15.10%,EPHA3;SNX33;SNX12;ITGB3;ITGAV;PRKN;EGF;SYT11;PTEN;NR1H3;FER1L5
prerank,nuclear migration (GO:0007097),0.47212761213062154,1.0109200383262484,0.4384057971014493,0.8765074736085533,1.0,6/13,24.06%,SYNE2;DYNC1H1;CLMN;CEP120;FBXW11;TMEM201
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4188147507268532,1.010911904717118,0.444794952681388,0.8758720957736825,1.0,4/23,6.32%,GHR;KIT;CYP1B1;PIBF1
prerank,cardiac muscle cell action potential (GO:0086001),-0.32116457009464744,-1.0107844334188743,0.41455696202531644,0.8625206815605371,1.0,7/30,6.40%,KCNJ2;ATP1A1;SCN1A;KCND3;FGF12;KCNQ1;ATP1B1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.4738653901077742,1.0105544129225315,0.47192982456140353,0.8761307704971915,1.0,2/12,12.03%,AR;SELENOS
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.4270730289636248,-1.010354569110751,0.4755244755244755,0.862338568173369,1.0,6/11,41.64%,JAK2;SIRT1;TMEM106A;XBP1;IL4;CIITA
prerank,intracellular cholesterol transport (GO:0032367),0.437166363136242,1.0102649799358834,0.4318555008210181,0.8762346425537059,1.0,3/15,5.38%,ABCA1;LDLR;STAR
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.316731646891772,1.0101897799253392,0.460093896713615,0.8757809079400177,1.0,22/128,14.87%,CDK14;DYNLL1;NINL;CCNA2;OPTN;CEP152;PHLDA1;FBXL17;DYNC1H1;ALMS1;BRSK1;FBXL3;FBXL12;YWHAE;MNAT1;BTRC;DYNC1I2;HAUS1;HAUS3;HAUS7;CEP192;CEP164
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3815079012873801,1.010060947202175,0.46348314606741575,0.8754434893751165,1.0,7/35,8.65%,DLC1;KANK1;ITGA3;RIPOR2;ARHGAP35;EPHB2;SPRY2
prerank,protein complex oligomerization (GO:0051259),-0.2560147649896549,-1.0099729500054229,0.40782122905027934,0.8620492047654852,1.0,26/85,21.91%,LRRC8C;LRRC8D;LETM1;KCNC2;EHD4;CPSF7;MAT2A;ELAVL1;ATL2;AQP11;PNPT1;ADCY8;PDCD6IP;HOMER1;TMEM120A;UGDH;UPB1;CUTC;RBMX;VSTM5;ECT2;MPP2;POLQ;EHD3;GLRA3;KCNC1
prerank,cGMP biosynthetic process (GO:0006182),-0.44191687301091664,-1.009743662250191,0.45584725536992843,0.8613348586306755,1.0,3/10,6.27%,GUCY1B1;GUCY1A1;NPR1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.44038057367348604,1.0094616065761362,0.4779050736497545,0.876367846106226,1.0,3/17,8.44%,PID1;NUPR1;NCOR1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3765365924202104,1.0092388795299252,0.454014598540146,0.8762584096956161,1.0,5/36,7.79%,DAPK2;BCL2;TGFBR1;ING5;TRAF7
prerank,methylguanosine-cap decapping (GO:0110156),-0.4240054042808089,-1.008987293874709,0.4358407079646018,0.862050294788923,1.0,4/10,20.67%,EDC3;PNRC2;DCP2;DCPS
prerank,regulation of mast cell degranulation (GO:0043304),0.4535855681292821,1.0089050967343216,0.4413793103448276,0.8764621000185537,1.0,2/14,7.00%,LYN;SPHK2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.25183075420005313,-1.0088955936119102,0.4444444444444444,0.8608868984979535,1.0,39/100,25.08%,RNF144B;CBFA2T3;RNF144A;SDCBP;RBX1;TRIB2;RYBP;RPL11;HSP90AB1;TAF1;GSK3A;FOXF2;HSPBP1;ZYG11B;GIPC1;COP1;RAD23A;GNA12;N4BP1;FHIT;RACK1;BBS7;CLU;DVL1;RNF14;RCHY1;GABARAP;CAMLG;UBXN1;DDRGK1;USP5;NUB1;GSK3B;DDA1;DESI1;VCP;USP7;CSNK1D;CCAR2
prerank,regulation of immune effector process (GO:0002697),0.36790387744414654,1.0088221977327971,0.44379562043795623,0.8760302282957841,1.0,5/41,6.29%,SERPING1;CFH;VTN;C4B;C8G
prerank,cellular response to radiation (GO:0071478),-0.30409689737581513,-1.0087286602997556,0.4368231046931408,0.8599368422266248,1.0,22/40,35.93%,NET1;RHOB;RAD1;SIRT1;HUS1;KDM4D;RAD51;ECT2;CDKN1A;TANK;RAD51AP1;RHNO1;RRH;FIGNL1;OPN1MW3;OPN1MW;OPN3;MAPK14;NSMCE3;EEF1D;RAD9A;GRB2
prerank,sphingosine metabolic process (GO:0006670),-0.36850093607493906,-1.0085305133705662,0.4368421052631579,0.859109421617687,1.0,4/17,9.90%,ACER3;ACER2;NAAA;SPTLC2
prerank,cellular response to interleukin-12 (GO:0071349),-0.2860462529542807,-1.0080401360607554,0.41754385964912283,0.859150057646409,1.0,14/48,15.02%,PITPNA;PPIA;RAP1B;SIRPA;JAK2;MSN;LMNB1;ARF1;PAK2;TYK2;BOLA2;SNRPA1;HNRNPA2B1;RPLP0
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.47287026681537775,1.0079717683109943,0.46245733788395904,0.8774363432064116,1.0,3/11,6.32%,KANK1;PDPN;SRC
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.4157861397520983,1.007166748960524,0.45271317829457364,0.8789065876511972,1.0,8/22,21.82%,NR2F2;CEBPA;HEXIM2;INCA1;PTEN;CDKN1C;CDKN1B;HEXIM1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.32290096068826835,-1.0071552066378937,0.44761904761904764,0.8603979403699504,1.0,9/32,13.57%,TAF1B;RRN3;TAF1;TBP;CAVIN1;GTF2H1;TAF1C;UBTF;MAPK3
prerank,positive regulation of telomere capping (GO:1904355),-0.36451661654179657,-1.0070144981712637,0.43609022556390975,0.8594172302729968,1.0,5/17,16.96%,NEK7;PKIB;HNRNPD;MAPK3;PNKP
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.27943391310818794,-1.0060846511542705,0.449438202247191,0.8605496927116533,1.0,17/55,24.68%,FHL1;CUL1;RBX1;FBXL7;AVEN;PSMF1;PSMB8;PSMB2;PSMA4;PSMB10;PSMC4;PSMD9;PSMD5;PSMA6;PSMD11;PSMA8;PSMB1
prerank,integrated stress response signaling (GO:0140467),0.446676947232656,1.0058658757378862,0.46815834767641995,0.8814235444871551,1.0,5/14,22.82%,NFE2L2;EIF2AK3;IMPACT;DDIT3;HSPA5
prerank,positive regulation of transport (GO:0051050),0.3286237811842557,1.0053481842328633,0.47530864197530864,0.8821192881675819,1.0,11/85,8.55%,CAMK1D;LRP1;AHSG;TULP1;APOE;GAS6;CCL19;APOA1;DYNC1H1;IL15RA;DAB2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.42146570179048476,1.0036785604533807,0.4804560260586319,0.8856542060951279,1.0,4/18,5.87%,ROCK2;KANK1;RIPOR2;CDH5
prerank,camera-type eye morphogenesis (GO:0048593),-0.43373551962307455,-1.003158303951398,0.46444444444444444,0.8674662619745204,1.0,5/10,12.39%,TENM3;LRP6;TBX2;VEGFA;NF1
prerank,positive regulation of cyclase activity (GO:0031281),-0.38505228154598686,-1.0025304109994593,0.46153846153846156,0.8678935526426819,1.0,6/14,14.40%,NOS3;NOS1;MAPK8;NF1;MAPK3;CACNA1D
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3979788039313726,1.0024599982145634,0.4591194968553459,0.8881118224611672,1.0,9/26,20.96%,MAPKBP1;SIRT2;IRAK3;NMI;ITCH;MUL1;DHX58;TRIM21;TRIB1
prerank,striated muscle cell differentiation (GO:0051146),0.4296565648701942,1.0017347509761096,0.4525043177892919,0.8893273493018826,1.0,6/16,14.11%,SKI;SDC1;SIK1;BMP2;CBY1;AKAP13
prerank,O-glycan processing (GO:0016266),0.3514640291167123,1.0017270852739424,0.4718954248366013,0.8886810220648035,1.0,4/54,3.60%,GXYLT2;GALNT14;GALNT15;ST3GAL3
prerank,regulation of feeding behavior (GO:0060259),0.4709477744601791,1.0016222017220817,0.44387755102040816,0.8882886636481241,1.0,2/11,5.63%,LEPR;GNB3
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4265909401079543,-1.0015972061764784,0.47912087912087914,0.8690863151132351,1.0,4/10,23.22%,ESR1;ATF7IP;PSMC4;THRA
prerank,lipoprotein biosynthetic process (GO:0042158),0.4658173239060344,1.0012983150348245,0.4740740740740741,0.8884444291196125,1.0,3/11,11.28%,APOE;ATG10;WIPI1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.4781820999675595,1.0010069186680406,0.47794117647058826,0.8885080272745562,1.0,4/10,22.82%,NFE2L2;EIF2AK3;DDIT3;HSPA5
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.4034667643735436,1.0009506432627568,0.46984126984126984,0.8880180707777894,1.0,7/22,19.46%,LYN;APPL2;NR1D1;RAB7B;NR1H3;APPL1;TIRAP
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.4023748630709989,-1.0007577728954973,0.455470737913486,0.8702659429218423,1.0,7/12,36.85%,PRKDC;CCND1;FBXO31;PLK3;SDE2;RPA2;RFWD3
prerank,mRNA modification (GO:0016556),0.41395326904982804,1.000748471760141,0.4648318042813456,0.8878885814872142,1.0,10/22,24.80%,PUS3;NSUN2;METTL14;RPUSD2;WTAP;TRUB2;METTL3;TRUB1;METTL16;PCIF1
prerank,neuron differentiation (GO:0030182),0.3058402566357892,1.0006263383095164,0.48272017837235226,0.8875444886175757,1.0,21/165,7.45%,PBX1;RUNX1;GLI2;RUNX2;FZD2;WNT8B;WNT4;ASCL1;TGFBR1;WNT6;NEUROD4;FZD1;HS6ST1;NEUROD1;THOC2;ATOH8;SMARCA1;WNT5B;MAP2K1;USH2A;BRSK1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3632563789538707,-1.0003166676602697,0.45308310991957107,0.8701548956193952,1.0,10/19,27.09%,PTPRJ;KDR;GRM5;RYR2;PTPRC;VCAM1;FIS1;SELP;DMTN;PRNP
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.441635521970422,1.0002954628445493,0.4701130856219709,0.8877360013254276,1.0,3/16,4.21%,ST6GALNAC5;ST3GAL5;LARGE1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3686133427623456,-0.9992913942954024,0.4473007712082262,0.8717377327900206,1.0,7/17,16.35%,ITGA1;HSP90AB1;PPP1R15B;CALM1;CALM3;MTOR;PTPRC
prerank,receptor-mediated endocytosis (GO:0006898),0.30945919994990745,0.9992125058558624,0.4845238095238095,0.8897450878448406,1.0,26/132,13.47%,DNAJC6;COLEC12;SPARC;LRP1;GRK3;HSPG2;APOE;NEDD4;APOA1;LDLR;CXCL16;COLEC11;ADRB3;EPS15;DAB2;MASP1;PICALM;AP1G2;IGF2R;ADM;CLN3;LRP3;GRK4;INSR;CTSL;WASF1
prerank,cellular response to hydroxyurea (GO:0072711),0.4784092619063722,0.9991492468218074,0.4714038128249567,0.8892433701863373,1.0,4/10,19.09%,DDI1;RTF2;TIMELESS;ATRX
prerank,positive regulation of sodium ion transport (GO:0010765),-0.4136225069704996,-0.9988474650779046,0.49624060150375937,0.8716849720429486,1.0,2/12,6.50%,ANK3;NOS1
prerank,cellular calcium ion homeostasis (GO:0006874),0.31095707982281057,0.9986151229931376,0.4676674364896074,0.8899061619072349,1.0,22/133,12.09%,SLC24A3;SLC8A1;SLC8A3;BCL2;DMPK;CCL19;STIM1;ATP13A3;SLC24A1;MCU;CDH5;SLC24A5;PML;TMEM203;DRD3;MICU2;PDZD8;CSRP3;ANXA6;CLN3;F2;YWHAE
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.4651742864454048,0.9981509577068662,0.47643979057591623,0.8904245679486202,1.0,4/13,16.40%,PLA2R1;SPRED3;SPRED1;ATM
prerank,positive regulation of leukocyte migration (GO:0002687),0.39075892598935613,0.9977550962305923,0.46244477172312226,0.8907424726263254,1.0,4/27,13.38%,IL6R;CSF1;MIA3;MDK
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3288439843529008,-0.9976765395898766,0.45808383233532934,0.8738035130673848,1.0,11/27,26.90%,PDE4D;CAMK2D;NOS1;CALM1;AHNAK;HPCA;CACNB3;FKBP1A;PLN;CALM2;DMD
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.36984845278758754,0.9976684975784146,0.48194444444444445,0.8903060468644548,1.0,17/42,25.25%,ARID1B;INO80;SMARCA1;MBD2;SMARCC2;MTA2;ACTR8;SMARCD2;CECR2;SMARCB1;HNRNPC;SRCAP;PBRM1;SMARCAD1;SMARCE1;HDAC1;DMAP1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.26622884195180163,-0.9971041451839465,0.4604651162790698,0.8740095504788008,1.0,22/73,19.21%,ELMO1;YES1;ACTB;PLCG2;VAV3;ARPC1B;HSP90AB1;PAK1;DOCK1;ARPC3;WIPF3;WASF2;FCER1G;CYFIP2;PLPP4;MAPK3;PIK3CA;ARPC4;PRKCE;ACTG1;FCGR1A;FGR
prerank,regulation of response to oxidative stress (GO:1902882),-0.4114244479170246,-0.9968136014047293,0.4721549636803874,0.8735227432262506,1.0,1/11,0.90%,MCTP1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.48130139113330667,0.996638070862993,0.48576512455516013,0.8921991568651056,1.0,2/10,11.02%,SETD7;SETD4
prerank,positive regulation of endocytosis (GO:0045807),0.3524658452347579,0.9965595678984568,0.47297297297297297,0.8917474864479109,1.0,8/45,6.01%,LRP1;SERPINE1;APOE;VTN;CCL19;APPL2;AXL;CDC42
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.46596679828015164,0.996076657131961,0.45342706502636204,0.892341875907195,1.0,2/11,5.12%,NOS1AP;CACNB1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.36071883868662236,0.9960179292821277,0.47404371584699456,0.8918345333092421,1.0,12/44,16.32%,SH3RF1;GAS6;CAST;MT3;USP47;SRC;DPEP1;DDX3X;YWHAE;IGBP1;FNIP1;AKT1
prerank,lipid catabolic process (GO:0016042),-0.35448697799709283,-0.9958768854319738,0.4719387755102041,0.8748051474497778,1.0,9/18,30.32%,PPT1;LIPE;PLA1A;PLAAT3;HSD11B1;LIPH;LIPC;HSD17B14;LPL
prerank,regulation of calcium-mediated signaling (GO:0050848),0.4036378865407827,0.9954886588604226,0.4625748502994012,0.8925204040381114,1.0,4/25,10.43%,ITPR1;LRRK2;CCL4;P2RX5
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.47553408556283744,0.995471363396135,0.47692307692307695,0.891912461563363,1.0,6/11,28.95%,SLC30A10;SLC18A2;ABCD2;ABCD1;FYN;PPARA
prerank,copper ion homeostasis (GO:0055070),-0.3695887703218575,-0.9948469646662733,0.47174447174447176,0.8762506342893697,1.0,9/17,27.09%,ATOX1;ARF1;ATP7A;APP;SLC31A1;CUTC;MT2A;SLC31A2;PRNP
prerank,regulation of striated muscle contraction (GO:0006942),0.38644954742143295,0.9946522790453475,0.4597156398104265,0.893243213823413,1.0,2/27,1.88%,SLC8A3;ATP1A2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.34177099960041535,0.9945350356737099,0.4796854521625164,0.892911520914552,1.0,11/60,13.24%,FGFR4;PDGFRB;CHTF8;SMOC2;PARM1;HNRNPA1;FGF2;PARN;RGCC;FBXO4;TNKS2
prerank,regulation of neuron death (GO:1901214),-0.25517749947622215,-0.9943413346783073,0.43005181347150256,0.876266270040164,1.0,12/82,9.85%,GRID2;MEF2C;CD34;EGLN3;EPHB1;SORL1;CDK5;GRIN2B;PPARGC1A;EGLN2;DCC;DDIT4
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.30474327257660133,0.9942215521965396,0.4943310657596372,0.8930579770169981,1.0,27/158,14.70%,WLS;GJA1;PELI2;CFLAR;CCL19;EDAR;ROR1;RNF31;LPAR1;TLR6;NEK6;SLC20A1;LTBR;PRKN;GPR89A;CXXC5;TMED4;CARD9;IKBKE;TNIP2;TBK1;RIPK2;MUL1;AKAP13;PLK2;FLNA;TNFRSF1A
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.36282897911865997,-0.9941041986434953,0.4548022598870056,0.8755038428603582,1.0,5/18,6.64%,ACTB;ZDHHC2;SPTBN1;CDK5;VAMP8
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.32699585559210975,-0.9936502473867236,0.44692737430167595,0.8754259847734959,1.0,12/29,30.77%,RPS14;RPS19;UTP4;RRP36;RPS21;WDR46;HELB;RRS1;RPS16;RPS8;RPP40;TSR1
prerank,error-prone translesion synthesis (GO:0042276),-0.3476517465586647,-0.9934357632044227,0.46115288220551376,0.874641367373538,1.0,2/21,8.41%,REV3L;POLH
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.44803011448046776,0.9933809587322086,0.47761194029850745,0.894491069255857,1.0,2/13,6.40%,GJA1;CACNA1C
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.423724319905769,0.9932990118791862,0.476038338658147,0.8940605594750457,1.0,5/20,13.37%,GSN;PLA2R1;RGCC;PDCD4;SFRP4
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.35816486351705595,-0.9932583661584901,0.461734693877551,0.8737922712125277,1.0,5/18,11.72%,ESR1;RPS13;PTBP2;PTBP3;TGFB1
prerank,regulation of p38MAPK cascade (GO:1900744),0.37513530902379594,0.9922448128158737,0.4670487106017192,0.8961013416346186,1.0,4/35,8.88%,SASH1;GADD45B;RELL1;BMP2
prerank,linoleic acid metabolic process (GO:0043651),0.4340968218961855,0.9918019072829172,0.4766666666666667,0.8965530282868872,1.0,3/17,7.26%,ACSL1;GSTM2;ALOXE3
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.42219394396687593,0.9913934625948329,0.502454991816694,0.896891686668664,1.0,6/18,21.01%,ZFP36L1;BCL2L11;KLF9;REST;HNRNPU;ZFP36L2
prerank,positive regulation of rRNA processing (GO:2000234),0.463772658325014,0.9913793772337294,0.47810858143607704,0.8962720633069995,1.0,4/10,13.64%,BUD23;DIMT1;WDR43;TRMT112
prerank,cranial nerve development (GO:0021545),0.46262198858325654,0.9911141458432725,0.4664246823956443,0.8962473975114228,1.0,4/11,21.43%,SALL1;CHD7;CHRNB2;TIFAB
prerank,cellular response to hypoxia (GO:0071456),0.30601209960004305,0.9904869306717914,0.4769585253456221,0.8971974968963331,1.0,11/126,7.23%,PTGIS;RORA;SLC8A3;SFRP1;MT3;PSME4;CPEB1;ZFP36L1;EPAS1;NDRG1;SIRT2
prerank,histone H4 deacetylation (GO:0070933),0.478998460127694,0.9904065870734566,0.4691780821917808,0.8967408442708011,1.0,6/10,24.02%,SIRT2;HDAC8;REST;HDAC4;SMARCAD1;HDAC1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3046046823695584,0.990117816364326,0.4801362088535755,0.8968154214040173,1.0,37/153,18.86%,PDPK1;ROCK2;CAMK1D;DMPK;MARK1;TGFBR1;GAS6;LRRK2;AKT3;ULK2;EIF2AK3;BRSK1;MAST2;STK4;NEK6;VRK3;TTBK1;IKBKE;TBK1;WNK1;TLK1;MAP3K13;MARK2;PLK2;DYRK1A;PIKFYVE;MAPKAPK2;DYRK1B;AKT1;ATM;CDC7;CSNK1A1;PRKCI;DYRK3;RICTOR;PRKCA;PRKACA
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.32889523098561957,0.9900409623283308,0.5074074074074074,0.8963618966053107,1.0,14/79,9.95%,ADAMTS12;SULF2;BMPR1A;SULF1;NEDD4;SMURF2;CASK;SKI;EMILIN1;SPRY2;BMP2;LEMD3;SMAD1;FGF2
prerank,negative regulation of apoptotic process (GO:0043066),0.28298648552762595,0.9899437070392203,0.5229357798165137,0.895944102131255,1.0,72/444,14.66%,IGF1;FHL2;ANGPT1;PIK3R1;GDNF;IL31RA;BCL2;GRK5;SON;SH3RF1;YAP1;ASCL1;APOE;CFLAR;GAS6;NUPR1;MYO18A;NOTCH2;FSTL1;TXNDC5;TLE1;SFRP1;MT3;NTF3;AXL;RNF213;PHIP;CTSH;LIG4;PDPN;TBX3;PRKAA2;VIP;USP47;BFAR;TSLP;ARHGAP10;SRC;DPEP1;CD28;ARAF;OSR1;MAP4K4;SLC30A10;EGFR;DNAJC3;DAB2;SPRY2;PRKN;ITCH;BRAF;DDX3X;CLN3;ANXA5;YWHAE;NIBAN2;HMGN5;RIPK2;NOL3;MDK;VDAC1;GATA6;IGBP1;MERTK;ARF4;DSTYK;HSPA9;TAF9;HYPK;PLK2;HPN;FLNA
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3713754142492288,-0.9898549060953364,0.4580335731414868,0.8822159597669528,1.0,6/15,27.08%,HIP1R;SCYL2;UBQLN2;SNAP91;UNC119;BMP2K
prerank,neuron projection development (GO:0031175),0.303335476489283,0.9896757895872977,0.503954802259887,0.8959599422623272,1.0,29/168,11.03%,NRK;GDNF;ADGRV1;LYN;GRXCR1;DOCK10;EPHA4;EPHA8;DTNBP1;VASH2;APOE;NEDD4;RAPGEF2;NTF3;CDK16;LRP12;ATXN10;CDC42;LRRK2;ALS2;MAP4K4;EPHB2;BLOC1S1;RYK;PTPRM;TAOK3;EPHB3;GAS7;MANF
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.34798221564247855,0.9893722761196391,0.46802721088435373,0.8960735415247516,1.0,13/49,15.24%,RUNX1;TNRC6B;MTURN;TNRC6A;SETD1A;KAT2B;RAB7B;EIF6;KMT2A;L3MBTL1;NFE2;KMT2E;WDR5
prerank,cellular response to cAMP (GO:0071320),-0.3075071755716621,-0.9893504736387563,0.47151898734177217,0.882252459563479,1.0,8/30,12.92%,RAP1A;PDE2A;KCNQ1;AKAP6;RAP1B;INPP5K;SLC26A6;CFTR
prerank,regulation of neuron migration (GO:2001222),0.39879685077620686,0.989008213465588,0.48847926267281105,0.8963072940078618,1.0,9/26,16.92%,PHACTR1;RAPGEF2;CAMK2B;COL3A1;NTNG2;MDK;PLXNB2;NIPBL;CX3CL1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4760434249646174,0.9879779887299016,0.49206349206349204,0.8982341336779796,1.0,4/10,15.00%,DCLRE1C;DCLRE1A;TERF2;RTEL1
prerank,regulation of fatty acid oxidation (GO:0046320),0.4348155151168923,0.9879423255717056,0.48494983277591974,0.89767159407548,1.0,3/16,10.49%,PRKAG2;APPL2;LONP2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3715560471394626,0.9878586763362732,0.48575498575498577,0.8972277363184898,1.0,5/36,8.68%,TCF7L2;PPP3CA;FZD2;TNRC6B;TNRC6A
prerank,rRNA modification (GO:0000154),0.3970436829013075,0.9876683825499645,0.4893292682926829,0.8971000764788598,1.0,5/21,15.12%,BUD23;DIMT1;FTSJ3;TRMT112;NSUN4
prerank,positive regulation of immune system process (GO:0002684),-0.3712781945940625,-0.9874226598170318,0.47680412371134023,0.8863666039840445,1.0,3/16,9.63%,IL15;TGFB2;VEGFA
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.3469629562685124,-0.9873731960696531,0.4588859416445623,0.8851069184903041,1.0,13/22,32.33%,AKAP6;ATP1B1;STAC;CALM1;CALM3;RYR2;P2RY6;HAP1;CASQ1;CALM2;VMP1;GSTO1;JPH2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.39200959568505434,-0.9872729628529001,0.46534653465346537,0.8840187052956751,1.0,6/13,14.53%,GRIN2A;PERP;CYFIP2;CASP8;LGMN;BAK1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.4497765153764132,0.9872464608127428,0.47571189279731996,0.8974891975774504,1.0,5/13,21.79%,IRAK2;TNIP2;PIK3R4;EPG5;MYD88
prerank,positive regulation of chromosome organization (GO:2001252),0.43053516311366213,0.9868978388477171,0.48148148148148145,0.8977514272545042,1.0,7/15,26.14%,LIG4;PML;PPP1R10;RTEL1;ATRX;MRE11;RAD50
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.3628879008532499,-0.9868617843591322,0.4833759590792839,0.8838426848390847,1.0,11/16,42.52%,CADM1;PVR;RAET1E;NECTIN2;SLAMF6;CD226;CRTAM;LAMP1;CD160;KLRK1;AP1G1
prerank,antibacterial humoral response (GO:0019731),0.4267508402565512,0.9861708951199875,0.47884940778341795,0.8989593860362056,1.0,3/16,10.59%,WFDC3;CAMP;RNASE7
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4019144567224208,0.9860018396182461,0.48562300319488816,0.8987576262555456,1.0,3/22,5.98%,RBP1;ALDH1A2;UBIAD1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.4047961128561913,0.9856935449840237,0.48982785602503914,0.8988510276628797,1.0,9/23,24.53%,FAF2;LMAN1;DERL1;SELENOS;AUP1;TECPR2;SEC16A;RANGRF;OS9
prerank,protein import into nucleus (GO:0006606),0.3311673087199649,0.9856180024334568,0.47503201024327785,0.8983911700844781,1.0,19/66,19.09%,CBLB;RANBP17;NUP107;APPL2;PRICKLE1;FAM53C;KPNA6;HEATR3;CSE1L;PPP1R10;TSC2;NUP214;AKT1;KPNA2;KPNA1;KPNB1;TPR;PHB2;APPL1
prerank,neuron maturation (GO:0042551),-0.3601435157288651,-0.9855447371098861,0.4585492227979275,0.8863578215854755,1.0,8/18,22.16%,ADGRB3;B4GALT5;SCARF1;APP;ANKS1A;SRRM4;LGI4;RND1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3834989434441442,0.9854602731121859,0.4828101644245142,0.8981511799358785,1.0,7/27,16.92%,GAS6;IRAK3;ARRB1;CD200;SELENOS;SYT11;CX3CL1
prerank,negative regulation of cilium assembly (GO:1902018),-0.3976867726575004,-0.9854221964587004,0.4756380510440835,0.8853523574295509,1.0,4/12,10.81%,LIMK2;TBC1D30;CEP97;TESK1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.41979720280769917,0.9851228674052225,0.49065420560747663,0.8983127715884662,1.0,3/17,6.99%,ROCK2;CDH5;VCL
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.39218908609094727,-0.9848824040812155,0.5085158150851582,0.8855111287146039,1.0,4/13,6.68%,TMSB4X;NOS3;NOS1;PPARGC1A
prerank,I-kappaB phosphorylation (GO:0007252),-0.4222790667085354,-0.9848791217896953,0.4713375796178344,0.8841490927434205,1.0,7/10,39.91%,TLR4;DAB2IP;CHUK;MAP3K7;ERC1;TLR2;TLR3
prerank,negative regulation of hippo signaling (GO:0035331),0.44819298858862233,0.9847183748568081,0.48293515358361777,0.8986836405009146,1.0,2/12,7.97%,WWC2;WTIP
prerank,polarized epithelial cell differentiation (GO:0030859),-0.3816494974409612,-0.9846870148151055,0.4806763285024155,0.8833550732719555,1.0,4/13,11.01%,MYO9A;OPHN1;SCRIB;MSN
prerank,adipose tissue development (GO:0060612),0.45746979056573234,0.984572511595368,0.4686971235194585,0.8984129118356725,1.0,5/11,16.30%,ARID5B;SH3PXD2B;PGRMC2;DGAT2;DYRK1B
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.3847474870649643,-0.9845219842318226,0.458128078817734,0.8824649430503608,1.0,5/14,16.48%,PPP2R2B;PPP1R15B;PPP2R2A;PPP2R2C;PPP1CA
prerank,nuclear export (GO:0051168),0.3236197559855739,0.9835068522898476,0.5006242197253433,0.9003775020986126,1.0,15/80,14.86%,ATXN1;RANBP17;U2AF1L4;PHAX;THOC2;NUP42;XPO7;HNRNPA1;DDX39A;RAE1;CSE1L;MAGOHB;STRADA;NUP214;SRSF5
prerank,regulation of viral transcription (GO:0046782),0.35954233246743406,0.9834422592375798,0.48159057437407954,0.8998896846553829,1.0,1/39,0.16%,POLR2D
prerank,body fluid secretion (GO:0007589),0.43449558553004375,0.9832430339301362,0.49056603773584906,0.8997505070986078,1.0,3/15,7.71%,SLC22A2;VIP;SLC22A4
prerank,protein localization to nucleus (GO:0034504),0.31583637919805924,0.983043250406964,0.4884004884004884,0.8996136867243576,1.0,28/102,19.81%,COL1A1;RANBP17;NUP107;APPL2;PRICKLE1;FAM53C;PML;ARL2;HEATR3;CSE1L;TOR1AIP1;PPP1R10;YWHAE;PAF1;BANP;TSC2;NUP214;TOR1B;PIKFYVE;BMP4;TOR1AIP2;AKT1;KPNB1;XPA;TPR;PHB2;APPL1;ABCA7
prerank,positive regulation of ion transport (GO:0043270),0.3530174738510783,0.9827370638412677,0.49216710182767626,0.8997122928626482,1.0,4/48,6.27%,ACTN2;GDNF;MYLK;CCL4
prerank,melanosome organization (GO:0032438),0.3943103797220516,0.9824604947383236,0.49321266968325794,0.8997417491112775,1.0,9/26,20.02%,SHROOM2;DTNBP1;BLOC1S1;AP1M1;PIKFYVE;RAB32;ABCB6;HPS4;SNAPIN
prerank,central nervous system neuron development (GO:0021954),-0.3799181897956425,-0.9823386953248578,0.5052356020942408,0.8872148178906433,1.0,5/15,12.10%,MAP2;LHX6;B4GALT5;HSP90AB1;ATP7A
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.2807860803925214,-0.9820617711305721,0.5072992700729927,0.8866326282618309,1.0,16/50,22.05%,CAV1;IVNS1ABP;NXN;RPS3;CRY1;TAF1;MINAR1;TNFAIP3;N4BP1;VPS28;USP4;PRMT3;PRR7;ADGRB1;CAMLG;UBXN1
prerank,response to lipopolysaccharide (GO:0032496),-0.23906101107858763,-0.9819807595451513,0.5245901639344263,0.8855423932465079,1.0,30/138,19.17%,MEF2C;PDE4B;NOS3;TNFRSF11A;GGT5;GCH1;VIM;NOS1;LBP;SIRPA;FOXP1;MAPK8;JAK2;SCARB1;CX3CR1;CD80;GIT1;TNFAIP3;PTPN22;NOD2;SBNO2;CARD16;TRIM6;TLR4;ERBIN;ADAM9;HMGB2;CD86;IFNAR1;GGT1
prerank,positive regulation of programmed cell death (GO:0043068),0.2904345860613597,0.9818963629810413,0.5332629355860612,0.9004579027308519,1.0,56/272,17.01%,STK17B;DAPK2;DAPK1;OLFM1;PLEKHG2;GADD45B;PHLDA1;TIAM2;MOAP1;SOS2;PDCD5;FGD1;CYP1B1;SFRP1;FGD4;ING3;NEUROD1;RARG;BCL6;MAP3K20;LRRK2;ARHGEF17;ING5;SPHK2;ARHGEF18;STK4;BCL2L11;AIFM1;BMP2;ARHGEF11;FOXA1;DDX3X;IGFBP3;APH1B;SPDEF;REST;FGD3;PLEKHN1;ADAMTSL4;PAWR;SFRP4;IFIT2;AKAP13;MTCH2;MTCH1;ARHGEF19;TRIO;SUDS3;RBM5;NLRC4;BMP4;CASP9;ATM;ZBP1;PTPA;PSEN2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.42079839537229197,0.981722073493354,0.48881789137380194,0.9002384176774977,1.0,2/18,7.09%,GDNF;AGTR1
prerank,positive regulation of vasculogenesis (GO:2001214),0.46532243340022345,0.9816960395341021,0.5017182130584192,0.8996641645793133,1.0,2/10,4.45%,RIN2;RAPGEF2
prerank,peptide cross-linking (GO:0018149),-0.3293931019181472,-0.9815893503926487,0.504424778761062,0.8853147906651874,1.0,3/25,4.98%,FN1;THBS1;TGM2
prerank,positive regulation of viral process (GO:0048524),0.3369096721011367,0.9809590770647805,0.4946949602122016,0.9008397720874447,1.0,13/60,18.55%,POLR2D;AXL;KPNA6;CD28;POLR2C;DDX3X;LARP1;STAU1;TBC1D20;NELFE;KPNA2;PPIE;POLR2L
prerank,protein heterotetramerization (GO:0051290),-0.38697242563245526,-0.9807219314883266,0.48661800486618007,0.8864082042110115,1.0,7/13,27.32%,GRIN2B;CPSF7;HSD17B8;GRIN1;CBR4;CPSF6;PKD1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.40074083124814275,0.9805553288794362,0.5015873015873016,0.9011777770710264,1.0,4/21,6.40%,SLC8A1;ATP1A2;GSTM2;CACNA1C
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.32713356214935013,0.9804864088202184,0.49558638083228246,0.9007128801924075,1.0,9/76,8.07%,NRP1;SEMA5A;CDC42EP4;NTF3;SYNPO2;DYNC1H1;CDC42;CARMIL1;NTRK3
prerank,negative regulation of chemotaxis (GO:0050922),0.3793923509843797,0.9804358035294714,0.5103857566765578,0.900194991012778,1.0,4/31,3.86%,ROBO1;SEMA3D;ANGPT2;SEMA5A
prerank,regulation of intracellular pH (GO:0051453),-0.30319383988144366,-0.9800522294384428,0.5062893081761006,0.8868812980587139,1.0,6/34,9.81%,SLC4A10;SLC9A2;SLC9A6;SLC4A8;SLC9A7;SLC26A6
prerank,indolalkylamine catabolic process (GO:0046218),0.46933858431972975,0.9798126416302425,0.49122807017543857,0.9010795598493165,1.0,2/10,6.98%,TDO2;KYNU
prerank,chondroitin sulfate catabolic process (GO:0030207),0.4485579026777708,0.979753566511895,0.5176470588235295,0.9005914281376952,1.0,3/13,8.32%,DCN;BGN;CSPG5
prerank,cellular response to interleukin-2 (GO:0071352),-0.41165682445162777,-0.979229256583133,0.47706422018348627,0.8864675679696891,1.0,5/11,28.45%,PTK2B;STAT5A;JAK3;IL2RG;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.41165682445162777,-0.979229256583133,0.47706422018348627,0.8864675679696891,1.0,5/11,28.45%,PTK2B;STAT5A;JAK3;IL2RG;SHC1
prerank,regulation of vasculature development (GO:1901342),-0.3193946430944572,-0.9788488221071472,0.4873417721518987,0.8861651731404082,1.0,9/26,12.39%,BMPER;WARS1;ERBB2;EMP2;HTATIP2;TSPAN12;VASH1;PLXND1;NF1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.2567919648485303,-0.9784885578959793,0.5051546391752577,0.8858886951285844,1.0,29/78,24.81%,CAV1;RNF144B;CBFA2T3;RNF144A;RBX1;TRIB2;TAF1;GSK3A;HSPBP1;ZYG11B;COP1;RAD23A;RACK1;BBS7;UBQLN2;CLU;DVL1;RNF14;PLK3;RCHY1;GABARAP;DDRGK1;USP5;NUB1;GSK3B;DDA1;VCP;CSNK1D;SGTA
prerank,eye photoreceptor cell differentiation (GO:0001754),0.4569849660430475,0.9776667551618575,0.5044404973357016,0.9051027013007555,1.0,3/12,8.32%,NKD1;TULP1;DSCAM
prerank,regulation of cytokinesis (GO:0032465),-0.2605627931245585,-0.977617587865901,0.5309734513274337,0.8869625050064607,1.0,25/78,22.48%,PKP4;KIF13A;CIT;RAB11A;RAB11FIP3;CALM1;KIF20B;CALM3;CDC14A;BCL2L1;GIT1;CSPP1;CETN2;GIPC1;PRPF40A;PRC1;PRKCE;KIF23;ECT2;CUL3;E2F7;VPS4A;PLK3;FLCN;KIF14
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4607942370214869,0.9775672291290952,0.49734513274336284,0.9047144280560852,1.0,3/11,13.74%,PRKN;REST;P4HB
prerank,negative regulation of protein kinase activity (GO:0006469),0.31719313656133147,0.9771776066099093,0.5018359853121175,0.9049846088388651,1.0,7/88,4.27%,PDPK1;PPM1E;SLC8A1;SLC8A3;DTNBP1;PRKAG2;CDK5RAP3
prerank,transepithelial transport (GO:0070633),0.4356780487241913,0.9768869022091329,0.504950495049505,0.9050400100058102,1.0,1/15,0.14%,SLC1A3
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.28115876982950516,0.9767708066058028,0.563265306122449,0.9046725283763137,1.0,88/417,16.95%,TCF7L2;RUNX1T1;ATXN1;NR2F2;SALL1;GLI3;ZEB1;ARID5B;RUNX2;PRDM5;NKX2-1;ARID4A;WNT4;FOXP2;RBFOX2;ASCL1;GAS6;MIDEAS;LBH;TLE1;IRF1;SMURF2;IKZF4;PRICKLE1;ZIC2;SFRP1;ZHX2;MT3;BCL6;TBX3;DKK3;USP47;BCOR;CBX3;ATOH8;PML;MBD2;CEBPA;ZBTB38;SIRT2;SMARCC2;NR1D1;RBPJ;ZMYND15;MTA3;NCOR1;NONO;BMP2;SCML2;CBY1;ZBTB4;HEXIM2;EIF4A2;GLIS2;NCOR2;NR1D2;ZKSCAN3;PBXIP1;MBD1;KDM5C;L3MBTL1;BHLHE41;REST;NIBAN2;BTRC;ZNF318;PDCD4;GATA6;L3MBTL2;YAF2;ZNF148;HDAC4;FOXK2;ZNF219;TWIST2;SCMH1;SUDS3;CDKN1C;BMP4;CBX5;PSPC1;RIOX1;TIMELESS;CREB3L1;ZNF423;COPS2;NIPBL;ATF5
prerank,regulation of monocyte differentiation (GO:0045655),0.44187048627502956,0.976701647936327,0.4858569051580699,0.9042138052429767,1.0,3/14,5.80%,IL34;CSF1;ZFP36L1
prerank,regulation of protein localization to nucleus (GO:1900180),0.3616443985044891,0.9766519618813974,0.4929378531073446,0.9036789591271426,1.0,13/43,18.77%,GLUL;YAP1;CDK5RAP3;WWTR1;EIF2AK3;BYSL;F2;SHH;BMP4;SESN2;AKT1;LIF;TPR
prerank,hyaluronan metabolic process (GO:0030212),0.39620083297061304,0.976254840293367,0.47685185185185186,0.9040156869946618,1.0,4/23,10.91%,CEMIP;LYVE1;FGF2;ABCC5
prerank,nucleus organization (GO:0006997),-0.2901457238899236,-0.9761733915519101,0.46830985915492956,0.8898071399597293,1.0,12/47,20.24%,SYNE1;NUP93;RPS19;NUP35;SUN2;NUP54;PDCD6IP;NUP155;PITPNB;IRAG2;VPS4A;CHMP2B
prerank,hemidesmosome assembly (GO:0031581),-0.407311075807401,-0.9758774513241129,0.5146067415730337,0.8893331769013922,1.0,2/11,3.21%,ITGA6;ITGB4
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.41563463182654486,-0.97585559980142,0.5168539325842697,0.8880610605164151,1.0,5/11,16.50%,NOVA2;PCBP3;PCBP1;PCBP2;RASA1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.28898600354771237,0.9758116582855214,0.5370762711864406,0.9044101472316732,1.0,29/234,10.91%,ADCY1;DDR2;CAMK1D;SMAD3;AR;NKX6-1;PLPP3;ARID5B;FZD2;KIT;CFLAR;SMO;IRAK2;CRTC3;ZIC2;ROR1;FZD1;NEUROD1;SLCO3A1;RNF31;TLR6;IRAK3;CD200;ANXA3;RAB7B;FOXA1;NFAM1;CARD9;IKBKE
prerank,protein localization to organelle (GO:0033365),0.3027829295619004,0.9754505758534594,0.5138568129330254,0.9046480088497061,1.0,34/133,20.24%,COL1A1;OBSL1;TULP1;OPTN;TRAM2;LRRK2;WDR35;TULP3;CYB5A;CROCC;CSRP3;ARL1;DDX3X;TOR1AIP1;TRAM1;YWHAE;PAF1;UBAC2;BANP;TOR1B;MTCH2;LAMP2;PIKFYVE;AUP1;ARF6;BMP4;ZNF423;DCP1A;MICALL1;DDX1;XPA;EHD1;ABCA7;CCDC47
prerank,response to tumor necrosis factor (GO:0034612),0.31766006196820334,0.9753214860065719,0.49753086419753084,0.9043213264285249,1.0,10/91,8.39%,ADAMTS12;PID1;CCL19;SFRP1;CXCL16;ZFP36L1;CCL4;NFE2L2;NR1D1;AFF3
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.4051410280337283,-0.975123885898461,0.48370927318295737,0.8888069608999583,1.0,2/11,1.66%,MECOM;CD34
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.37880526529786496,0.9745343863176862,0.5,0.9055965972320555,1.0,4/33,9.95%,TEAD1;SMAD3;ATOH8;FGF2
prerank,presynapse organization (GO:0099172),-0.4171196817559069,-0.9743450886694379,0.4880952380952381,0.8895710244812617,1.0,4/10,18.92%,NLGN1;LRRTM3;NLGN3;DVL1
prerank,cholesterol metabolic process (GO:0008203),0.33205300557437994,0.9741165187386335,0.5109114249037228,0.905982482803068,1.0,12/68,16.20%,ABCA1;APOE;INSIG2;APOA1;MT3;MVK;CYP27A1;IDI1;LCAT;OSBPL5;RXRA;HMGCS1
prerank,mesoderm development (GO:0007498),-0.35602169787463556,-0.9739710036847269,0.4830287206266319,0.8893374524590638,1.0,12/18,30.39%,TIE1;TBX1;BMX;JAK2;VEGFA;BTK;HCK;MESD;MEST;TCF15;IKZF1;IKZF3
prerank,protein modification process (GO:0036211),-0.25871612166597574,-0.973893625756276,0.4973544973544973,0.8881979054539669,1.0,15/76,16.29%,ST3GAL6;ST8SIA4;YES1;STK38;UBA3;CHRM3;B4GALT7;MMP15;MAN2B1;UBE2D3;ATG3;UBE2S;RPN1;PRKDC;QPCT
prerank,extracellular transport (GO:0006858),0.45816932899158636,0.9737635331447465,0.51138353765324,0.9061747302695262,1.0,5/12,22.15%,CCDC40;CABYR;SPEF2;ROPN1L;TSG101
prerank,muscle tissue morphogenesis (GO:0060415),0.42531321533491906,0.9737126042352364,0.49917898193760263,0.9056874435058022,1.0,3/16,8.88%,TGFBR3;MYLK;BMP2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.31514250664341786,0.9736526348713066,0.5071942446043165,0.9052008354144513,1.0,14/101,10.83%,SAMD4A;PLD1;DACT1;OGT;ASPH;FGFR4;CSF1;ATG10;AGTR1;CPEB3;CD28;METTL14;EIF6;DDX3X
prerank,regulation of BMP signaling pathway (GO:0030510),0.3263314835182633,0.9735821653548685,0.49133663366336633,0.9047290215587349,1.0,15/73,9.27%,BMPR1A;ITGA3;CCN1;SULF1;FSTL1;TWSG1;SMURF2;ENG;CDH5;SKI;CRB2;RBPJ;BMP2;LEMD3;SMAD1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.4476966614423926,0.9733769328675674,0.5017182130584192,0.9046063108380579,1.0,1/11,0.91%,ACTN2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3325267011085902,-0.9731448734171898,0.4987012987012987,0.8890334455588746,1.0,4/22,8.69%,ESR1;MED1;MED4;SUB1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4288578963751709,0.973004996369366,0.5032258064516129,0.9048770869994337,1.0,3/15,8.88%,GLI2;WNT6;BMP2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4514276523320424,0.9729799135057704,0.5114638447971781,0.9043219554961045,1.0,2/12,8.61%,PIK3R1;BCL2L11
prerank,synaptonemal complex assembly (GO:0007130),0.430740347568941,0.9728239599594269,0.5112262521588946,0.9034313534052381,1.0,3/15,11.77%,SYCE2;TEX12;STAG3
prerank,synaptonemal complex organization (GO:0070193),0.430740347568941,0.9728239599594269,0.5112262521588946,0.9034313534052381,1.0,3/15,11.77%,SYCE2;TEX12;STAG3
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.30717625201963417,-0.9727668680335828,0.4755700325732899,0.8887597104136551,1.0,10/31,11.70%,DLG2;LIN7A;MYO9A;LRRC7;LIN7C;OPHN1;SCRIB;MSN;PDCD6IP;WDR1
prerank,dendrite morphogenesis (GO:0048813),0.3648889964468028,0.9726981354388965,0.5140845070422535,0.9031103395631022,1.0,8/35,13.81%,PHACTR1;FARP1;DOCK10;CDC42;EPHB2;EPHB3;DLG4;PTEN
prerank,insulin secretion (GO:0030073),0.4114033711353471,0.9722612451402491,0.48536209553158705,0.9035273190034798,1.0,5/19,16.42%,SLC30A8;NEUROD1;FAM3B;CYB5R4;MAFA
prerank,diol metabolic process (GO:0034311),-0.35108295126246947,-0.9719498480015282,0.5070422535211268,0.8897148759494805,1.0,6/19,10.91%,NOS3;DEGS2;GCH1;NAAA;CALM1;SPR
prerank,oligosaccharide metabolic process (GO:0009311),0.34656617322633476,0.9718884225157585,0.5083102493074793,0.9037822748357207,1.0,4/46,3.60%,ST6GALNAC5;GAL3ST3;B3GALT1;ST3GAL3
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.27506668573855964,-0.9714639198117533,0.4827586206896552,0.889725479365301,1.0,13/46,15.02%,PITPNA;PPIA;RAP1B;JAK2;MSN;LMNB1;ARF1;PAK2;TYK2;BOLA2;SNRPA1;HNRNPA2B1;RPLP0
prerank,retina homeostasis (GO:0001895),0.4014581755167525,0.9714336578931831,0.5073409461663948,0.9042171521608972,1.0,4/23,6.90%,TULP1;PIGR;CRB2;ATP1B2
prerank,positive regulation of translation (GO:0045727),0.3149274604201083,0.9710616709786558,0.5122850122850123,0.904434828376051,1.0,10/94,10.83%,POLR2D;SAMD4A;PLD1;RPUSD4;CPEB3;CD28;METTL14;CDC123;EIF6;DDX3X
prerank,negative regulation of cell growth (GO:0030308),0.30458324200011094,0.9710084984307773,0.5337995337995338,0.9039356058418103,1.0,26/121,13.34%,ENPP1;GJA1;SMAD3;TSPYL2;SFRP1;MT3;PTPRS;BCL6;APBB2;PML;ULK2;SPHK2;STK11;FGF13;RBBP7;SLIT3;RNF6;DDX3X;CGRRF1;ST7L;JADE1;NME6;ACVR1B;CDA;SIPA1;MUL1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.31593785479179654,0.9707514951077756,0.5106117353308365,0.9039144747289158,1.0,26/78,23.56%,NR2F2;CCNA2;CDK5RAP3;CEBPA;EGFR;CCNK;HEXIM2;INCA1;RGCC;MNAT1;PTEN;CNPPD1;CDKN1C;AKT1;CDKN2C;CCNT2;CDKN1B;SERTAD1;CCND2;CCNT1;HEXIM1;CDK7;CCNG2;CCNE2;PKD2;CCNY
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.2821787522999137,-0.9704688154027892,0.5252918287937743,0.8912171996164711,1.0,4/41,2.58%,PODXL;PIEZO1;ANK3;TJP1
prerank,peptidyl-threonine modification (GO:0018210),0.3325079400747001,0.9701860576494044,0.5211267605633803,0.9046586484128656,1.0,16/66,16.62%,PDPK1;ROCK2;TGFBR1;ACVR1;LRRK2;MAP2K1;OXSR1;TTBK1;TBK1;ACVR1B;WNK1;MARK2;DYRK1A;DYRK1B;AKT1;CDK10
prerank,DNA catabolic process (GO:0006308),0.4536283896149754,0.9701657224743387,0.5160202360876898,0.904087603773429,1.0,2/11,10.65%,REXO4;DNASE1L1
prerank,negative regulation of ion transport (GO:0043271),0.385251005775718,0.9699896915420637,0.49847560975609756,0.9039015521442828,1.0,7/24,13.72%,ACTN2;NEDD4;VIP;ADRA2A;CD33;WNK1;SYT11
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.4079476736609106,0.9696962014856557,0.49293563579277866,0.9039789314141408,1.0,3/19,8.12%,NRP1;SFRP1;MAP4K4
prerank,positive regulation of protein catabolic process (GO:0045732),0.31696729148903935,0.9695253869410856,0.5257214554579673,0.9037192652343549,1.0,9/84,6.51%,SH3D19;HECW2;DACT1;NKD1;APOE;NEDD4;SMURF2;VIP;SNX33
prerank,cellular response to fluid shear stress (GO:0071498),0.4498901322919505,0.9693711439530361,0.5428051001821493,0.9034264943750786,1.0,2/12,6.80%,MTSS1;NFE2L2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.42471539706802275,0.9691384049718443,0.5152,0.903366106148893,1.0,5/17,8.88%,BMPR1A;NOTCH2;ACVR1;RBPJ;BMP2
prerank,potassium ion transport (GO:0006813),0.30464576814858385,0.9686799640093192,0.5405092592592593,0.9038223514863222,1.0,7/120,4.61%,SLC1A3;KCNK2;SLC24A3;NALCN;ATP1A2;SLC9A9;SLC24A1
prerank,response to cAMP (GO:0051591),-0.2935715240232332,-0.9686640397682232,0.5051903114186851,0.8950374050735782,1.0,9/37,12.92%,RAP1A;PDE2A;KCNQ1;AKAP6;RAP1B;INPP5K;SLC26A6;DGKQ;CFTR
prerank,detection of calcium ion (GO:0005513),-0.3980358913746911,-0.9685216268228755,0.5081585081585082,0.8941543078667437,1.0,6/13,13.72%,SYT1;KCNMB2;CALM1;CALM3;RYR2;CASQ2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4045824207767229,-0.9683148468303746,0.5192307692307693,0.8933872522352846,1.0,8/12,32.25%,SGTB;SGTA;CHMP4B;CHMP4A;GET3;SEC61G;SEC63;SEC61A2
prerank,insulin receptor signaling pathway (GO:0008286),0.3246456862165927,0.9677941284854324,0.5089058524173028,0.9053319298940196,1.0,3/69,1.19%,ATP6V0A4;IGF2;PIK3R1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.416187943004178,-0.9674769503362238,0.49019607843137253,0.8944375110688626,1.0,4/10,14.84%,SIRPA;YY1;REL;RELB
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3396419399964229,0.9673320340947036,0.5006747638326585,0.9051977584789308,1.0,7/50,11.13%,POLR2D;NUP107;NUP42;TNRC6A;POLR2C;RAE1;NUP98
prerank,regulation of gene silencing by RNA (GO:0060966),0.3396419399964229,0.9673320340947036,0.5006747638326585,0.9051977584789308,1.0,7/50,11.13%,POLR2D;NUP107;NUP42;TNRC6A;POLR2C;RAE1;NUP98
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.405850257929921,-0.9672787730566692,0.5089686098654709,0.8936694372886361,1.0,3/11,6.37%,ZFPM2;TGFB2;HEY2
prerank,central nervous system myelination (GO:0022010),-0.4132717515153606,-0.9672783742398204,0.53,0.8923561409346397,1.0,4/11,18.74%,TENM4;B4GALT5;PLP1;CLU
prerank,erythrocyte development (GO:0048821),-0.4173352609431884,-0.9671787317671128,0.4915254237288136,0.8913364617932937,1.0,4/10,24.38%,MED1;ALAS1;ALAS2;DMTN
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.36873933082229543,0.9670495299587795,0.49701492537313435,0.905268272806514,1.0,4/33,4.30%,SERPINE1;LYN;EPHA8;CYP1B1
prerank,acylglycerol biosynthetic process (GO:0046463),0.38908188200345795,0.9669065655164022,0.5055118110236221,0.904979313105616,1.0,7/23,19.36%,AGMO;PLA2G4A;LPGAT1;MOGAT3;DGAT2;GK;LPIN3
prerank,mitochondrial protein processing (GO:0034982),0.44651021926495527,0.966863028990357,0.493006993006993,0.904467504260886,1.0,6/11,25.41%,PMPCB;IMMP1L;YME1L1;AFG3L2;STOML2;MIPEP
prerank,defense response to protozoan (GO:0042832),-0.39212253402169767,-0.9666647174850745,0.5128805620608899,0.8914386114792184,1.0,5/12,21.15%,GBP4;GBP7;CD40;LYST;GBP6
prerank,protein tetramerization (GO:0051262),-0.25493397474209073,-0.9665996443920766,0.5344827586206896,0.8903008747601017,1.0,27/67,27.32%,KCNJ2;B2M;GBP5;GRIN2B;CPSF7;OSBPL2;ACOT13;ALDOA;HSD17B8;HOMER1;APIP;AQP4;ALDH9A1;UPB1;CUTC;ACACB;HCN1;GRIN1;KCNC1;SOD2;ALDH1A3;ACACA;SHMT1;CBR4;PKD2L1;CPSF6;PKD1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.36271058720437876,0.9664517883777953,0.5112676056338028,0.9048889455365325,1.0,10/36,12.32%,DCN;NR2F2;SP100;APOE;ANGPT2;ADAMTS9;FGF2;PTPRM;RGCC;DNAJA4
prerank,positive regulation of developmental growth (GO:0048639),-0.27493319225974,-0.9655305646816058,0.5291970802919708,0.8919916023469212,1.0,8/49,7.38%,SMURF1;SEMA7A;RIMS1;NEDD4L;NGF;RIMS2;SYT1;ITSN2
prerank,regulation of cell cycle (GO:0051726),0.2812763952472821,0.9653916459472837,0.5733752620545073,0.9067658411309802,1.0,43/271,13.44%,TCF7L2;SMAD3;GRK5;SON;FGFR2;GADD45B;TGFBR1;SND1;NUPR1;NOTCH2;FBXL17;IRF1;CDK5RAP3;TSPYL2;LIN52;SFRP1;PCLAF;TBX3;MAP3K20;APBB2;PML;SIK1;IL12B;CKS1B;SIRT2;MAP2K1;FBXL3;TTC28;LIN9;BMP2;KAT2B;NEK6;STK11;CDC123;L3MBTL1;RGCC;FBXL12;NR4A1;PDCD4;MAP2K6;SIPA1;TSC2;GATA6
prerank,ureteric bud development (GO:0001657),-0.35715229566431916,-0.9652620691527058,0.48737373737373735,0.8914197329497284,1.0,3/17,2.75%,SLIT2;GPC3;SIX1
prerank,transition metal ion transport (GO:0000041),0.36546827928820336,0.9650068833406525,0.511921458625526,0.9070412273835492,1.0,6/35,8.40%,CP;SLC30A8;MT3;HEPH;SLC11A2;SLC30A10
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3943305037493932,-0.9649145393992073,0.5345622119815668,0.8910181495493767,1.0,4/12,12.92%,ANO1;GPLD1;ADCY8;CFTR
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.33264449523990064,-0.9646675123458859,0.5210526315789473,0.8904154093598972,1.0,8/20,26.42%,FAR2;PPT1;HSD17B8;PPT2;ACSL3;ACACA;CBR4;SCD5
prerank,regulation of dendrite morphogenesis (GO:0048814),0.36817835343336147,0.9643488752266525,0.5074850299401198,0.9079592536478533,1.0,5/32,5.90%,HECW2;OBSL1;NEDD4;RAPGEF2;CUX2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3610715176977141,0.9637633456465081,0.5100286532951289,0.9086431812441229,1.0,4/35,4.30%,GHR;LEPROT;KIT;CYP1B1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.28910769373136647,-0.9635393234333345,0.5050505050505051,0.8922882694561161,1.0,10/42,13.99%,MEF2C;NOTCH1;SOX17;TBX2;ZIC3;SOX18;TGFBR2;STIL;APLNR;MICAL2
prerank,regulation of macrophage activation (GO:0043030),0.368762461294507,0.9633875927008132,0.523598820058997,0.9089277746998697,1.0,8/30,16.84%,IL31RA;MYO18A;CEBPA;TLR6;CD200;TNIP2;NR1H3;PJA2
prerank,regulation of Notch signaling pathway (GO:0008593),-0.25427590451248777,-0.9633710216025131,0.5384615384615384,0.8914131576288506,1.0,25/76,21.89%,NOTCH3;EPN2;NOTCH1;NOS3;CCN3;BEND6;TGFB2;JAG2;GATA2;NOTCH4;SNW1;MFNG;LFNG;GALNT11;HEY1;NOD2;EP300;SYNJ2BP;DLL4;DLL1;ITGB1BP1;EGFL7;PDCD10;DTX1;POFUT1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.3617877108784131,0.9631662776198378,0.5295815295815296,0.9088221290237172,1.0,6/36,9.87%,GAS6;CSF1;AXL;TSLP;PARP14;PRKN
prerank,regulation of cell development (GO:0060284),0.3584549416298361,0.9628970193290629,0.5239398084815321,0.908844190839254,1.0,11/36,19.78%,YAP1;ASCL1;NOTCH2;HES7;ADGRA2;BHLHE41;AKT1;CX3CL1;YTHDF2;WNT3;RHEB
prerank,positive regulation of macroautophagy (GO:0016239),0.3423652266289763,0.9628755114198074,0.5300546448087432,0.9082867182482253,1.0,15/48,19.73%,DCN;OPTN;PRKAA2;TBK1;UVRAG;LARP1;RAB3GAP1;VDAC1;TSC2;SESN2;VPS13D;PIP4K2C;WAC;HTT;GPSM1
prerank,neural tube development (GO:0021915),0.42321861815816575,0.962601819945805,0.5292153589315526,0.9083008504146718,1.0,2/15,5.73%,DACT1;ALDH1A2
prerank,neurotransmitter transport (GO:0006836),0.3233786905804273,0.9625990112410908,0.5127877237851662,0.9076935811574539,1.0,11/73,11.50%,SLC1A3;GLUL;ATP1A2;SLC22A2;STXBP3;CASK;BRSK1;APBA1;SLC29A1;PPFIA3;STXBP1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.32002052459921687,0.9625632169593574,0.5,0.9071696550467169,1.0,11/76,11.79%,PTGIS;IRAK2;CDK5RAP3;CYP1B1;IRAK3;MTURN;ARRB1;COMMD1;CD200;ITCH;UFL1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.40703448820634325,0.9624483017005441,0.5064935064935064,0.9068237360821129,1.0,5/19,10.48%,OLFM1;BMPR1A;ACVR1;BMP2;SLIT3
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4353382034172647,0.9619561099452942,0.5126050420168067,0.9073449428959043,1.0,3/13,6.13%,GAS6;AXL;TSLP
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.39157651153698386,-0.9619504487993992,0.5178997613365155,0.8940060314641202,1.0,3/12,11.72%,ESR1;ELAVL1;TGFB1
prerank,negative regulation of DNA binding (GO:0043392),-0.3081238228178999,-0.9619247722830216,0.5213414634146342,0.892775077646457,1.0,10/28,20.30%,LEF1;NFKBIA;KDM1A;HEY2;JAK2;JUN;HEY1;TFAP4;RSF1;HMGA2
prerank,tRNA wobble uridine modification (GO:0002098),0.4382394927886476,0.961811072019303,0.5057660626029654,0.9070734904349338,1.0,5/14,21.54%,URM1;TRMT9B;DPH3;ELP4;TRMU
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3590408380788182,0.9618046641814061,0.5129682997118156,0.9064732188358586,1.0,10/37,16.00%,ADCY7;IL17D;APPL2;TLR6;CARD9;F2;PDCD4;CHID1;ABCD2;PLD4
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4504179464705472,0.9615632653422378,0.5105633802816901,0.9064439623184328,1.0,2/10,4.49%,PXYLP1;DSE
prerank,transcription by RNA polymerase I (GO:0006360),-0.302918627954909,-0.9614403398205152,0.517799352750809,0.8928413603839727,1.0,9/34,13.57%,TAF1B;RRN3;TAF1;TBP;CAVIN1;GTF2H1;TAF1C;UBTF;MAPK3
prerank,inner ear morphogenesis (GO:0042472),0.3947806060777271,0.9613336649086774,0.5056910569105691,0.9063606399106354,1.0,4/22,8.50%,ZIC1;FGFR2;TTC39C;EPHB2
prerank,negative regulation of autophagy (GO:0010507),0.33461205258420434,0.9613230300903715,0.5206611570247934,0.9057750683525349,1.0,7/54,7.23%,BCL2;LEPR;NUPR1;MT3;SNRNP70;LRRK2;SIRT2
prerank,negative regulation of B cell proliferation (GO:0030889),0.46037930099460345,0.9612124849148569,0.5368421052631579,0.9054159916023332,1.0,1/11,1.80%,LYN
prerank,negative regulation of DNA recombination (GO:0045910),0.3446444891469116,0.9608548680437949,0.5218002812939522,0.905686213216693,1.0,1/43,0.16%,POLR2D
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.3282370568557314,-0.9605909456723489,0.48476454293628807,0.8938654345209612,1.0,6/23,15.77%,NMT2;FNTA;FNTB;CALM1;PDE6A;METAP2
prerank,membrane depolarization (GO:0051899),-0.31206266176279834,-0.9604845563471744,0.5186335403726708,0.8928472991951467,1.0,11/32,19.72%,CAV1;YWHAH;SCN1A;P2RX7;SCN3A;SCN2A;CACNA1H;CACNG4;CACNA1A;CACNB3;SCN8A
prerank,positive regulation of lipid kinase activity (GO:0090218),0.36852234964422614,0.9602414462327327,0.5251908396946565,0.9064970335741946,1.0,5/29,3.88%,EPHA8;PDGFRA;KIT;PDGFRB;CCL19
prerank,regulation of DNA replication (GO:0006275),0.34229654029223905,0.9599683799145657,0.5006711409395973,0.9065347714150759,1.0,9/49,12.43%,GLI2;CCNA2;TSPYL2;ZBTB38;NPM2;EGFR;S100A11;EGF;GLI1
prerank,genitalia development (GO:0048806),0.4338297612758529,0.959930958358318,0.5017123287671232,0.9060294949502672,1.0,5/12,21.43%,TBX3;LHCGR;SHH;CHD7;TIFAB
prerank,positive regulation of hormone secretion (GO:0046887),-0.35314094139994434,-0.9598551153098424,0.5175202156334232,0.8933089861965465,1.0,10/17,45.75%,VAMP8;EDN1;SPP1;GRP;C1QTNF3;PLA2G3;RASL10B;TFR2;CYP19A1;HCAR2
prerank,maturation of SSU-rRNA (GO:0030490),-0.301644024574913,-0.959474153901331,0.5090361445783133,0.8930557044549864,1.0,9/34,21.37%,RPS14;RPS19;RIOK1;UTP4;LSM6;SNU13;RRP36;WDR46;HELB
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.4090234596190634,-0.9589514182974905,0.5170068027210885,0.8931448151657304,1.0,3/10,13.25%,LBP;IFI35;PTPN22
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4556747944999863,0.9587954274341994,0.523728813559322,0.9080831548413134,1.0,3/12,18.71%,IL12B;IL23A;IL18
prerank,regulation of stem cell differentiation (GO:2000736),0.30806852137837687,0.9584645456749675,0.5252774352651048,0.9082307868283777,1.0,22/89,21.18%,GDNF;RUNX1;SP7;BMPR1A;YAP1;PDGFRA;PSME4;SETD1A;NSUN2;ITCH;KMT2A;TCF12;PSMB5;PSMC2;PSMD4;METTL3;PSMD1;YTHDF2;PSME3;HNRNPU;ZFP36L2;PSMA3
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3777476820742955,0.9582224431134861,0.5243161094224924,0.9081876129967095,1.0,13/26,21.27%,EGFR;MTBP;DDX3X;RGCC;KMT2E;UBE2E2;ADAMTS1;TFDP1;AKT1;CDK10;LSM10;CCND2;PLCB1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.29288237903552305,-0.9581220664193872,0.5210843373493976,0.894073377060816,1.0,18/34,21.11%,SEMA6A;KDR;NOTCH1;RAMP2;MT1G;FLT4;GAB1;VEGFA;PIK3CA;ERN1;FLT1;DLL4;VEGFC;ITGB1BP1;DAB2IP;MAP2K3;VEGFD;ANXA1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.31139600124386285,0.9578514128064447,0.5525339925834364,0.9084445027881229,1.0,13/91,9.62%,NRP1;PLD1;SLC30A8;ATP9A;LRRK2;SRC;MAP2K1;RAB25;STON1;RNF139;PICALM;SNX12;ITGAV
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.22057977261795497,-0.9577673652210156,0.6071428571428571,0.8937227500498907,1.0,48/172,18.12%,PIP5K1B;PLCG2;DGKB;INPP5D;BMX;PIK3R6;DGKH;CPNE3;LPCAT1;SLC44A5;MTMR2;INPP4B;PLEKHA3;INPP5F;INPP5K;MFSD2A;PLEKHA1;AGPAT1;PGS1;PIK3R3;MTMR9;PNPLA3;PLA2G4C;DGKG;ETNK1;ARF1;DGKQ;PCTP;SACM1L;MTMR6;CRLS1;ARF3;MBOAT7;PIK3C2B;PIK3CA;RAB4A;PIK3R5;PTDSS1;LPCAT3;AGPAT5;STARD7;LPCAT2;PITPNM3;DGKZ;PCYT1B;SYNJ1;INPP5E;SELENOI
prerank,lysosome organization (GO:0007040),0.356106091063946,0.9576446117513272,0.5445544554455446,0.908312865805615,1.0,11/36,21.88%,ABCA1;LRRK2;GAA;ZKSCAN3;CLN3;HOOK2;TPCN2;TMEM106B;HPS4;SNAPIN;MYO7A
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.41625774289454653,-0.9574236880932592,0.5131004366812227,0.8933995089857606,1.0,3/10,14.78%,SHANK3;SYP;APP
prerank,pulmonary valve morphogenesis (GO:0003184),0.4062963596807835,0.9569391295232111,0.5283018867924528,0.9092935400044049,1.0,2/17,3.91%,ROBO1;NOTCH2
prerank,histone monoubiquitination (GO:0010390),0.3899670592007782,0.9568570005317633,0.5117994100294986,0.9088688968455978,1.0,11/24,26.41%,ATXN7L3;BCOR;CUL4B;PAF1;RNF2;CDC73;WAC;LEO1;RNF20;UBE2E1;RNF40
prerank,neural crest cell development (GO:0014032),-0.2773822900879804,-0.9562177434971988,0.554006968641115,0.8954759760106461,1.0,6/44,3.26%,SEMA6D;CDH2;SEMA6A;SEMA7A;ERBB4;TBX1
prerank,regulation of axon extension (GO:0030516),0.36361706639905567,0.9557363943471168,0.5315712187958884,0.9109171478564152,1.0,9/37,12.68%,OLFM1;MACF1;APOE;MT3;GOLGA4;PTPRS;NTN1;RNF6;MAP3K13
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4357008025266054,0.955573780432037,0.53184165232358,0.9106703040953639,1.0,6/13,12.43%,TGFBR3;BMPR1A;FGFR2;RBPJ;FGF2;GLI1
prerank,early endosome to Golgi transport (GO:0034498),0.4453631435160321,0.9551514070517337,0.5156794425087108,0.911036302970713,1.0,3/11,10.76%,LMAN1;RBSN;TRAPPC10
prerank,regulation of DNA biosynthetic process (GO:2000278),0.37997266883215514,0.9545409431264579,0.5181268882175226,0.9117864094924533,1.0,7/27,12.54%,FGFR4;PDGFRB;SMOC2;FGF2;RGCC;TERF2;NIBAN2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3181862723120374,0.9543963823746312,0.5349693251533743,0.9114894074245826,1.0,26/73,24.28%,IGF2;DNMT3A;POLR1G;SPHK2;MYO1C;KAT2B;PHF2;PHF1;RBBP7;BAZ1B;PPHLN1;HDAC4;GLMN;SF3B1;DNMT3B;POLR2L;POLR1F;JARID2;DNMT1;HDAC5;CTCF;POLR1H;HDAC6;POLR1C;PPM1D;TDG
prerank,regulation of T cell migration (GO:2000404),-0.34087635559181617,-0.9541645622594461,0.538083538083538,0.8998172670933136,1.0,2/18,3.88%,LRCH1;APOD
prerank,regulation of necroptotic process (GO:0060544),0.37978683742074604,0.9534182268637256,0.524031007751938,0.9132315544520915,1.0,3/23,3.46%,OGT;MLKL;CFLAR
prerank,regulation of anoikis (GO:2000209),0.39632861591877716,0.953236711442345,0.517799352750809,0.9130306179919547,1.0,4/19,6.93%,BCL2;TLE1;SRC;SIK1
prerank,response to alcohol (GO:0097305),0.3769511830736509,0.9531833796749534,0.5458646616541354,0.9125341664010804,1.0,6/27,10.48%,TGFBR3;TGFBR1;CCL19;HSD3B2;DRD3;SLIT3
prerank,protein N-linked glycosylation (GO:0006487),0.32193203103090284,0.9530087883123902,0.5284237726098191,0.912329912196994,1.0,16/66,14.17%,MAN1C1;PGM3;MOGS;LMAN1;STT3A;B4GALT1;DERL3;ALG5;DOLPP1;GFPT1;UGGT2;MGAT3;ALG11;DDOST;ALG6;ALG10B
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.3048907102333571,-0.9525423494380806,0.5222929936305732,0.9028423694632539,1.0,4/31,3.91%,CDK6;NOTCH1;RORB;LRP5
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.41411492330567734,-0.9521883527060209,0.5480093676814989,0.9025204211487765,1.0,4/10,10.14%,TBX1;LRP5;TGFBR2;PDGFA
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3476521393204454,0.951553722962811,0.53737658674189,0.915035986899097,1.0,6/41,7.26%,DAGLA;ACSL1;CYP1B1;PLA2G4A;GSTM2;ALOXE3
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.37199272993813015,-0.9515198136244372,0.5278450363196125,0.9031038162093716,1.0,4/13,18.80%,SYT1;CACNA1H;STX1A;SYT4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.33908697957853673,0.9515157719756955,0.5361527967257844,0.9145196476937714,1.0,13/50,16.32%,SH3RF1;GAS6;RFFL;MT3;USP47;SRC;DPEP1;DDX3X;YWHAE;NOL3;IGBP1;FNIP1;AKT1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.3745972814904044,0.9511698756569087,0.5289017341040463,0.9147441809298235,1.0,5/27,9.62%,ABCA1;CSF1;AGTR1;ITGB3;ITGAV
prerank,nucleosome disassembly (GO:0006337),0.42545938490180646,0.9506714527252036,0.5223880597014925,0.9147020169245573,1.0,6/14,23.60%,SMARCC2;NFE2;SMARCD2;SMARCB1;ARID2;SMARCE1
prerank,chromatin disassembly (GO:0031498),0.42545938490180646,0.9506714527252036,0.5223880597014925,0.9147020169245573,1.0,6/14,23.60%,SMARCC2;NFE2;SMARCD2;SMARCB1;ARID2;SMARCE1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.3809206542395894,0.9501503033756209,0.5362318840579711,0.9152661011028167,1.0,1/23,0.21%,ATP6V0A4
prerank,homotypic cell-cell adhesion (GO:0034109),0.3522519108653974,0.9499758172418249,0.5317577548005908,0.9150603128190654,1.0,9/39,11.50%,PLPP3;PDGFRA;GNAS;MYL12A;STXBP3;TLN1;VCL;ITGB3;STXBP1
prerank,brain morphogenesis (GO:0048854),-0.38521581196984844,-0.9498756770472652,0.522248243559719,0.9062504354537658,1.0,2/12,8.79%,SHANK3;PAFAH1B1
prerank,negative regulation of protein secretion (GO:0050709),0.3561051924195116,0.949811532297361,0.532561505065123,0.9148474128353367,1.0,12/38,18.16%,APOE;SFRP1;IL12B;DRD3;CD200;PRKN;ADRA2A;REST;SERGEF;NR1H3;RHBDF2;DPH3
prerank,regulation of rRNA processing (GO:2000232),0.4118899362952948,0.9497777664825108,0.5281456953642384,0.9143181595645437,1.0,5/16,13.64%,BUD23;KAT2B;DIMT1;WDR43;TRMT112
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.3303016374959348,-0.9495984944779972,0.5260416666666666,0.9057628018933593,1.0,8/20,23.60%,PPIA;FKBP5;PPIG;FKBP1A;PPIL1;PPIB;PPID;PPIL6
prerank,negative regulation of lipid storage (GO:0010888),0.4001848915695355,0.949483046574261,0.5334346504559271,0.9143996637794334,1.0,4/19,9.62%,ABCA1;OSBPL8;ITGB3;ITGAV
prerank,digestive tract morphogenesis (GO:0048546),0.433022890559527,0.9493581080443021,0.5474209650582362,0.9140804299420706,1.0,6/14,17.97%,FGFR2;PDGFRA;EPHB3;GLI1;NIPBL;SOX11
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3697166475346019,0.9493078218450896,0.5305810397553516,0.9135995965354293,1.0,3/27,2.18%,DCN;BGN;PXYLP1
prerank,plasma membrane repair (GO:0001778),-0.3792751394755374,-0.9489301548002388,0.5106888361045131,0.9062320528662544,1.0,2/13,4.03%,AHNAK2;DYSF
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3342783453550737,0.9488050741125901,0.5483870967741935,0.9140989110297494,1.0,12/54,16.64%,GPC6;HSPG2;PXYLP1;HS6ST1;SDC1;EXT1;NDST1;GALNT5;SDC4;EXT2;GNS;HS2ST1
prerank,mammary gland development (GO:0030879),0.387363140524622,0.9483191133170076,0.5337423312883436,0.9145935554785088,1.0,4/21,7.82%,GLI2;WNT4;TBX3;ARHGAP35
prerank,peptidyl-lysine modification (GO:0018205),0.30038742117002676,0.9482559160289296,0.5476477683956574,0.9141333798619332,1.0,24/99,20.39%,LOXL1;LOX;EYA1;NUP107;P3H3;SIRT2;NUP42;USPL1;KAT2B;TRPM4;BLOC1S1;RAE1;NUP98;SENP6;NUP214;HDAC4;SENP7;SEH1L;KAT5;TPR;SIRT5;SUMO1;NSMCE2;AAAS
prerank,cellular sodium ion homeostasis (GO:0006883),0.4224786841732604,0.9481844955694846,0.5314569536423841,0.913699184457365,1.0,3/15,6.90%,SLC8A1;ATP1A2;ATP1B2
prerank,negative regulation of cholesterol transport (GO:0032375),0.45926437358774813,0.947825846154995,0.5441176470588235,0.9139442104984377,1.0,10/10,54.10%,SHH;SREBF2;NFKB1;APOC1;APOC3;ABCG8;PLA2G10;APOA2;ABCA2;ABCG5
prerank,response to ethanol (GO:0045471),-0.3759635189378671,-0.9476720538197243,0.5402010050251256,0.9082957210996621,1.0,5/14,7.24%,GRIN2A;GLRA1;GLRA2;GRIN2B;GRIN3A
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.2401314262251393,-0.9475193877725553,0.5823529411764706,0.9074307967604666,1.0,23/93,20.21%,PDE4D;CAV1;FNIP2;NGF;BCAR3;TFRC;NOS1;HSP90AB1;PAK1;ATP2B4;INPP5K;VEGFA;DDIT4;TGFB1;NLRP2B;APP;TXN;TRIM6;RACK1;CD44;NCK2;HCLS1;PDCD10
prerank,ear morphogenesis (GO:0042471),0.3989342725680057,0.9469136626020377,0.5510204081632653,0.9153339253424869,1.0,4/20,8.50%,ZIC1;FGFR2;OSR1;EPHB2
prerank,organic hydroxy compound transport (GO:0015850),0.35936386713370755,0.9468571120692435,0.5102639296187683,0.9148704741033588,1.0,3/36,5.04%,RBP4;SLC27A5;NCOA2
prerank,regulation of TOR signaling (GO:0032006),0.3195148315966937,0.9462156628636326,0.5634517766497462,0.9157722480060085,1.0,19/67,18.34%,GAS6;NPRL3;UBR2;RFFL;PRKAA2;ARAF;TELO2;SLC38A9;FBXO9;LAMTOR2;RRAGD;TSC2;ITFG2;NPRL2;FNIP1;GOLPH3;DYRK3;SEH1L;RICTOR
prerank,negative regulation of nervous system development (GO:0051961),-0.3487662874109832,-0.9461158695368076,0.5298701298701298,0.9100269487577329,1.0,3/17,5.52%,NOTCH1;B2M;SORL1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.43613752679238005,0.9460568791060547,0.5449915110356537,0.9155167703537772,1.0,4/12,18.67%,CHAMP1;CENPC;SEH1L;BOD1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.386912473853244,0.9457867967062493,0.5317829457364341,0.915554279694749,1.0,7/21,23.30%,CYP26B1;HOGA1;NUDT19;LPIN3;LPIN2;FAH;LDHD
prerank,metanephric mesenchyme development (GO:0072075),0.44544568089217856,0.9452504200694375,0.5387523629489603,0.9161620371939855,1.0,5/10,22.95%,WNT4;OSR1;SHH;STAT1;PKD2
prerank,response to hydrogen peroxide (GO:0042542),-0.2688812468832637,-0.9450210634080719,0.5340501792114696,0.9117366550927405,1.0,14/45,21.11%,NET1;RPS3;SIRPA;RHOB;PLEKHA1;SIRT1;TNFAIP3;APTX;ECT2;ADAM9;CAT;GPX1;PDCD10;ANXA1
prerank,sodium ion homeostasis (GO:0055078),0.39289645360014247,0.9447519811353163,0.5290322580645161,0.916697260012614,1.0,3/21,6.90%,SLC8A1;ATP1A2;ATP1B2
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.2924044619973799,0.9445920453616334,0.5670945157526255,0.9164610963291112,1.0,11/124,6.01%,TCF7L2;PPP3CA;FZD2;WNT4;SMURF2;PRICKLE1;SFRP1;FZD1;PSME4;TNRC6B;CDC42
prerank,histone lysine methylation (GO:0034968),0.3570960388250779,0.9445267826909624,0.5533428165007113,0.9160195943662057,1.0,11/33,20.74%,PRDM5;WDR82;KMT2A;SMYD3;TRMT112;SETDB1;WDR5;SETD1B;RBBP5;N6AMT1;CXXC1
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.28517535448946635,-0.9433885752554466,0.5541795665634675,0.9149056478436058,1.0,11/39,21.87%,FNBP1L;PPFIA2;MYO1D;TANC2;PAFAH1B1;KIF1A;TRAK2;BICDL1;SYT4;MYO15A;HAP1
prerank,negative regulation of binding (GO:0051100),-0.24616168358981314,-0.9432431797088673,0.5701357466063348,0.9139872984524633,1.0,26/81,20.41%,LEF1;CAV1;ACTB;NFKBIA;BTAF1;SORL1;KDM1A;CTNNBIP1;MAPK8;GTF2F1;JAK2;DISC1;JUN;RALB;CARD16;TFAP4;PPP1CA;ZFPM1;RACK1;RSF1;CDKN1A;DVL1;ITGB1BP1;EFHB;HMGA2;ROCK1
prerank,regulation of interferon-gamma production (GO:0032649),-0.2468894259854909,-0.9431954216956996,0.5674418604651162,0.9128322683349571,1.0,17/71,23.21%,PDE4D;PDE4B;SLC7A5;CYRIB;SIRPA;SCRIB;PTPN22;INHA;ZFPM1;TLR4;INHBA;TXK;FZD5;C1QBP;CD276;VSIR;CEBPG
prerank,regulation of actin filament polymerization (GO:0030833),-0.2490018470022255,-0.9429651598813984,0.5769230769230769,0.9121678085395274,1.0,6/69,2.99%,SLIT2;BAIAP2L1;KANK3;ESAM;PTK2B;CYRIB
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3753517816689756,0.9428180230449642,0.5465648854961832,0.9192851919964271,1.0,2/24,8.00%,CEMIP;MYO1C
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.429131074586013,0.9427890761874088,0.5238095238095238,0.918748345549686,1.0,1/11,2.97%,PIGR
prerank,glucan biosynthetic process (GO:0009250),-0.37156141965256706,-0.9423347909792924,0.5476190476190477,0.9113263682505285,1.0,3/12,6.81%,GBE1;GYS1;UGP2
prerank,glycogen biosynthetic process (GO:0005978),-0.37156141965256706,-0.9423347909792924,0.5476190476190477,0.9113263682505285,1.0,3/12,6.81%,GBE1;GYS1;UGP2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3862208039638162,0.9421356208881794,0.5334370139968896,0.9196204419704361,1.0,2/20,3.31%,GRK3;MGRN1
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.4031729307191538,-0.9420198834832637,0.5518867924528302,0.9109763487885121,1.0,1/10,1.03%,ST6GAL1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.35981854873891783,-0.9417931577801665,0.5280898876404494,0.9103330161555523,1.0,4/15,20.36%,RPS7;RPL11;RPL5;RPL23
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3490582044503851,0.9415334485674961,0.5461956521739131,0.9204040632081202,1.0,9/43,17.59%,TEAD1;SMAD3;NFIB;ATOH8;FGF2;REST;ETS1;BMP4;FOXO3
prerank,hyaluronan catabolic process (GO:0030214),0.4035362820222719,0.941233040083236,0.5260663507109005,0.9204897413331407,1.0,3/18,9.95%,CEMIP;LYVE1;FGF2
prerank,carnitine metabolic process (GO:0009437),0.44093607752642294,0.9400981520198479,0.5346020761245674,0.9224948883378686,1.0,5/12,24.17%,CPT1C;BBOX1;CPT1A;ACADM;CPT2
prerank,male gonad development (GO:0008584),0.3650407570866616,0.9399159804302991,0.5552325581395349,0.9223076878528014,1.0,5/34,6.67%,AR;KIT;WNT4;LHCGR;NR5A1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.25451269200931836,-0.9396751906232066,0.6033755274261603,0.9147264915820759,1.0,20/65,24.68%,FHL1;CUL1;RBX1;FBXL7;AVEN;PSMF1;PSMB8;PSMB2;PSMA4;PSMB10;PSMC4;CHFR;VPS4A;PSMD9;PSMD5;PSMA6;PSMD11;NABP1;PSMA8;PSMB1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3278207511891501,0.9396691682660697,0.5462068965517242,0.9222784530808362,1.0,5/49,6.32%,LDLRAD4;DACT1;PMEPA1;CDC42;SRC
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.383562276071862,0.9396324988377173,0.5696400625978091,0.9217592507138053,1.0,9/22,23.03%,CCNK;CDK12;TCERG1;CCNT2;CDC73;CCNT1;LEO1;SCAF8;CDK13
prerank,cytosolic calcium ion transport (GO:0060401),0.3675371245054875,0.9395626455333614,0.54858934169279,0.9213231065224627,1.0,4/28,9.65%,SLC8A1;MCU;CACNA1C;MICU2
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3372403298068468,0.9392389119473117,0.5288461538461539,0.9214717420987771,1.0,6/46,8.31%,PLD1;GPD1;PLA2G4A;AGPAT3;DDHD2;PLD2
prerank,regulation of oxidative phosphorylation (GO:0002082),0.41045973200329805,0.9390897230684262,0.541871921182266,0.9212048528603395,1.0,2/16,5.43%,NUPR1;COX7A2
prerank,oligodendrocyte differentiation (GO:0048709),0.3951682308595367,0.9387662874747782,0.561014263074485,0.9213277187133607,1.0,5/19,15.58%,SLC8A3;EIF2B4;NSUN5;EIF2B3;SHH
prerank,protein localization to chromatin (GO:0071168),-0.3395730647040427,-0.9386253839427658,0.5406824146981627,0.9163682733857029,1.0,10/18,29.64%,ESR1;TASOR;MCM8;LRWD1;SGF29;MSH2;RAD21;RUVBL2;PIH1D1;PLK1
prerank,regulation of neuron apoptotic process (GO:0043523),0.29868681682671677,0.9382658191039509,0.5824175824175825,0.9218612747196858,1.0,8/96,5.16%,EPHA7;GDNF;BCL2;APOE;NUPR1;MT3;NTF3;LIG4
prerank,DNA double-strand break processing (GO:0000729),0.4030173659086311,0.9382463248910788,0.55,0.9213226813726443,1.0,12/18,29.31%,UBE2V2;ATM;RNF138;KAT5;EXD2;SMARCAD1;BRCA1;MRE11;RAD50;DNA2;UBE2N;RBBP8
prerank,regulation of response to external stimulus (GO:0032101),0.28977992332546443,0.9381378251785244,0.5757918552036199,0.9209784551245989,1.0,25/121,17.67%,ADAMTS12;AHSG;PTGES;CASP12;PDGFRA;EFNB2;IRF1;APPL2;BCL6;ADGRA2;AGTR1;GUCY2D;EPHB2;NR1D2;UFL1;F2;GRK4;GATA6;PDE6G;LACC1;ZBP1;CASP1;CX3CL1;RNF135;DHX58
prerank,regulation of T cell mediated immunity (GO:0002709),0.4464303859488853,0.9372140309402244,0.5486725663716814,0.9224999194507985,1.0,2/10,9.50%,TRPM4;ZBTB1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3138102825456506,-0.9366443115606699,0.5542857142857143,0.9203473306659585,1.0,11/26,22.11%,FNBP1L;SGIP1;ITSN2;INPP5F;GAK;AP2A1;CLTB;LMBRD1;DLL1;SNAP91;AP2M1
prerank,dendrite self-avoidance (GO:0070593),-0.3497917433403426,-0.9364418391270046,0.5392670157068062,0.9195992805915252,1.0,5/16,10.43%,BSG;CNTN4;CNTN6;ROBO4;EMB
prerank,phosphate ion transmembrane transport (GO:0035435),-0.37240765813036725,-0.9360961999953,0.5401785714285714,0.9191763855690521,1.0,4/12,15.37%,SLC37A3;SLC25A30;SLC25A11;XPR1
prerank,Notch signaling pathway (GO:0007219),0.3278548570279008,0.9355763348458941,0.5590551181102362,0.9256651217696111,1.0,13/59,11.36%,PBX1;GMDS;ASCL1;MAML3;NOTCH2;DTX4;TRAF7;RBPJ;BMP2;KAT2B;ITCH;MIB1;APH1B
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3592753697548936,0.9352659905412207,0.5370101596516691,0.9257197617433519,1.0,9/31,13.73%,STXBP3;SYT9;STXBP1;CACNA1G;ADRA2A;REST;RAB3GAP1;SYT11;SYT12
prerank,negative regulation of synaptic transmission (GO:0050805),0.39079356031124074,0.9352567524997444,0.5527156549520766,0.925147675322489,1.0,8/23,14.58%,SLC24A1;LRRK2;DRD3;CBLN1;STXBP1;SYT11;PTEN;PLK2
prerank,negative regulation of viral transcription (GO:0032897),-0.38450608623074556,-0.9348862680497699,0.5535714285714286,0.9211523898078787,1.0,7/13,30.72%,TRIM14;TRIM11;TRIM62;IFITM3;MID2;TRIM13;UBP1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.3349764943699809,0.9348121763895131,0.5505464480874317,0.9255225755038872,1.0,6/42,8.12%,NRP1;RIN2;CSF1;SFRP1;PLEKHA2;MAP4K4
prerank,RNA processing (GO:0006396),0.2823474800873797,0.9346132686466906,0.6114221724524076,0.9253568143391356,1.0,37/176,18.86%,CELF2;RBMS1;ATXN1;SON;DDX17;TUT7;RBMS2;NONO;RBPMS;HNRNPR;RNASEL;TENT4A;SMU1;DDX23;PRMT9;MAGOHB;TUT4;NOL3;CDK12;SNRPD2;RBM39;TCERG1;AKAP8L;SRSF5;RNPC3;RBM6;SYNCRIP;RBM5;GEMIN2;TENT4B;HNRNPC;SF3B1;SF3B2;PRPF6;DICER1;METTL3;PRKACA
prerank,synapse organization (GO:0050808),0.29539991378116204,0.9345520984848967,0.5904317386231038,0.9248997847999461,1.0,17/125,8.34%,GPC6;PDZRN3;FARP1;PPFIBP2;SLC8A3;OBSL1;UNC13C;CAST;NEDD4;CACNB1;PTPRS;MUSK;CDC42;LRRK2;APBB2;DSCAM;CBLN1
prerank,positive regulation of growth (GO:0045927),0.31933476466103866,0.9340279942395182,0.5481770833333334,0.9255360240048353,1.0,23/64,23.48%,BCL2;RFTN1;TGFBR1;SFRP1;CXCL16;USP47;CDC42;INO80;EGFR;DDX3X;INSR;MTPN;HPN;MMP14;AKT1;TRIM32;N6AMT1;DDX49;EIF4G2;PLCB1;EXOSC2;BRAT1;WFS1
prerank,neuromuscular process (GO:0050905),0.3997535403143008,0.9339998189757368,0.5486443381180224,0.9250076696889918,1.0,1/16,0.50%,MYCBP2
prerank,regulation of dendrite development (GO:0050773),0.34493356735633046,0.933986165174245,0.5541490857946554,0.9244460760468005,1.0,4/37,4.26%,CAMK1D;HECW2;MARK1;NEDD4
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.36441369869365425,-0.9338741356786339,0.5388349514563107,0.9225908549550167,1.0,5/13,21.78%,SRSF12;LSM2;PRPF31;USP4;CD2BP2
prerank,cytoplasmic sequestering of protein (GO:0051220),0.4225507866833247,0.9333014447387187,0.5537190082644629,0.925442514463056,1.0,3/13,14.66%,MDFI;SUFU;FLNA
prerank,coenzyme A metabolic process (GO:0015936),0.41612109351585913,0.9332284982133088,0.5366269165247018,0.9250324989245448,1.0,7/14,27.54%,NUDT7;PANK1;COASY;SLC25A16;DCAKD;PANK2;ACOT7
prerank,regulation of interleukin-13 production (GO:0032656),-0.3664176817435161,-0.9331844553138918,0.5239234449760766,0.9232763804105792,1.0,3/13,12.83%,LEF1;PRKCZ;TNFRSF21
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.38038579224533986,-0.9331264625999166,0.5213032581453634,0.922154801194189,1.0,3/12,3.88%,PTPRJ;CBL;APOD
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.3897491728321365,-0.9330440685476126,0.56,0.921130829957597,1.0,2/11,5.53%,CAV1;PTPRT
prerank,negative regulation of microtubule polymerization (GO:0031115),0.4307294720731386,0.9329987035878005,0.5337726523887973,0.9249862845624838,1.0,2/12,5.87%,EML2;CDH5
prerank,Rac protein signal transduction (GO:0016601),0.39425375985049144,0.932698523965696,0.5158597662771286,0.9250617940411473,1.0,1/18,0.73%,RHOH
prerank,pulmonary valve development (GO:0003177),0.3945513234954644,0.9324676240762316,0.5566188197767146,0.9249740076356571,1.0,2/18,3.91%,ROBO1;NOTCH2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3407813105660289,0.932102271793683,0.5517241379310345,0.9252294170174874,1.0,4/38,3.61%,NEDD9;IL34;EPHA4;GAS6
prerank,positive regulation of autophagy (GO:0010508),0.30703953570620335,0.9319594942883926,0.585820895522388,0.9249513723396676,1.0,22/81,19.73%,DAPK1;DCN;OPTN;PRKAA2;LRRK2;STK11;PRKN;RNF152;UFL1;TBK1;LARP1;TSC2;PLK2;NPRL2;SESN2;FOXO3;KAT5;WAC;TRIM21;PHB2;HTT;GPSM1
prerank,peptidyl-serine modification (GO:0018209),0.2848692691732918,0.9318365895112618,0.5990939977349944,0.9246308529068616,1.0,37/166,18.86%,PDPK1;ROCK2;CAMK1D;DMPK;MARK1;TGFBR1;GAS6;HPF1;LRRK2;AKT3;ULK2;EIF2AK3;BRSK1;MAST2;STK4;NEK6;VRK3;TTBK1;IKBKE;TBK1;WNK1;TLK1;MAP3K13;MARK2;PLK2;DYRK1A;MAPKAPK2;DYRK1B;AKT1;ATM;CDC7;CSNK1A1;PRKCI;DYRK3;RICTOR;PRKCA;PRKACA
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.36465670997181654,0.9318329998740247,0.5491679273827534,0.9240519788291736,1.0,4/26,8.78%,PDPK1;ZFP36L1;EGFR;STAT5B
prerank,gluconeogenesis (GO:0006094),0.3378717410968653,0.9317096869060493,0.5427769985974754,0.923746054180918,1.0,3/39,7.87%,RBP4;MDH2;ENO2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.36394540544181186,0.9315117955188935,0.5557228915662651,0.923588196834151,1.0,3/26,9.15%,HECW2;NEK6;ANAPC5
prerank,fatty acid oxidation (GO:0019395),-0.25832148057536675,-0.9309583649695562,0.5732758620689655,0.9255065019729173,1.0,14/57,26.20%,ADIPOR2;PPARD;ECI2;ECHDC1;PPARGC1A;ACAD11;ABCD3;ACOX1;ABCD4;MTLN;ACAA2;ACAD10;HACL1;ACADS
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.396619341825366,0.9306343878841962,0.5508196721311476,0.9249646206711427,1.0,5/18,11.11%,SRPX2;AKT3;FOXC2;FGF2;FGFBP1
prerank,regulation of intracellular signal transduction (GO:1902531),0.26887684353333346,0.9306260588878755,0.6842639593908629,0.9243954198675761,1.0,67/420,12.98%,DAPK2;PDPK1;NRK;RHOH;PTPN13;ARHGAP6;LYN;DLC1;SYDE2;RHOD;WWC2;ARHGAP28;PLEKHG2;OPTN;ARHGAP18;TIAM2;PRKAG2;LBH;AKAP7;SOS2;ARHGAP29;FGD1;RFFL;ARHGAP21;FGD4;ARHGAP19;PRKAA2;ARHGAP32;NUAK1;CDC42;ARHGAP10;LRRK2;PML;ARHGEF17;ING5;FAM13A;SPHK2;ARHGEF18;GRM2;ARAF;MTA2;ARHGAP35;PPP1R13L;NTRK3;MAP4K4;SYDE1;STK4;EGFR;ARHGAP9;ARHGEF11;TELO2;ITGAV;STK11;RHOT1;RBBP7;TAOK3;CASTOR2;L3MBTL1;FBXO9;RCN3;UFL1;FGD3;FAM13B;RHOQ;ARHGAP5;BANP;MAP2K6
prerank,negative regulation of developmental process (GO:0051093),0.3102892245871601,0.9304885785082815,0.5439698492462312,0.9241172078187118,1.0,10/69,9.87%,ROCK2;KANK1;IL17D;NFIB;GAS6;SFRP1;PTPRS;CST3;BMP2;PRKN
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.3260620305040793,-0.9298106436482713,0.5564516129032258,0.9272199553244248,1.0,9/21,21.01%,SLIT2;CYRIB;TGFB2;ARHGAP25;SPRY4;CD2AP;SH3BP1;DAB2IP;ARHGAP12
prerank,negative regulation of catalytic activity (GO:0043086),-0.3148562102750026,-0.9296858054221141,0.58311345646438,0.9262767968838972,1.0,5/24,11.42%,NOTCH1;NOSIP;NOS1;TMBIM1;SIRT1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.3386278318887739,-0.9292145684995772,0.5642458100558659,0.9263147632628692,1.0,6/18,27.83%,PPP1R16B;INPP5K;URI1;PPP1R35;MFHAS1;GPATCH2
prerank,activation of GTPase activity (GO:0090630),0.3040374568555379,0.9290801383432857,0.5817958179581796,0.9266509778567154,1.0,12/89,9.90%,RABGAP1L;TBC1D4;SYDE2;USP6NL;TIAM2;ARHGAP29;NTF3;ADPRH;NTRK3;SYDE1;TBC1D2B;TAX1BP3
prerank,amino acid transmembrane transport (GO:0003333),0.33504150672320143,0.9287817047073464,0.5698324022346368,0.9267487397088648,1.0,13/45,16.55%,SLC7A11;SLC6A13;SLC22A2;SLC7A13;SFXN2;SLC38A6;SLC22A4;SLC38A9;SLC38A3;SLC7A6;SLC38A10;SLC38A2;SLC16A2
prerank,fatty acid transport (GO:0015908),0.40078484655989755,0.9285002630644948,0.5665584415584416,0.9267412043331767,1.0,2/17,3.41%,ACSL1;APOE
prerank,positive regulation of cytokine production (GO:0001819),0.2737871979301879,0.9283491427949032,0.660455486542443,0.9264770393785386,1.0,36/292,12.50%,CCBE1;RORA;ROCK2;RUNX1;SERPINE1;SULF2;PLA2R1;IL6R;IL17D;RFTN1;SULF1;CCL19;IRF1;CYP1B1;TSLP;BATF;PIBF1;IL12B;SPHK2;EIF2AK3;CD28;TLR6;POLR3A;CD200;ARNT;RAB7B;NFAM1;CARD9;SETD4;CEBPB;RGCC;ADRA2A;TBK1;STAT6;CD14;EBI3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.39536743872038743,0.9283308232957604,0.536115569823435,0.9259303130678651,1.0,6/18,15.79%,MAP2K1;EGFR;NCOR1;NCOR2;MYCN;BMP4
prerank,positive regulation of inflammatory response (GO:0050729),0.30379466268292693,0.928230879158468,0.553012048192771,0.9255433498002766,1.0,21/86,18.71%,SERPINE1;OSMR;NUPR1;TSLP;IL12B;CEBPA;AGTR1;NMI;CCN4;SETD4;NAPEPLD;PDCD4;MDK;ETS1;TNFRSF1A;IL23A;CD47;ZBP1;CX3CL1;TNIP1;IL18
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3825639260244263,0.9282152529890686,0.5709459459459459,0.9249901866126646,1.0,4/20,12.28%,PID1;DAB2;PICALM;RHOQ
prerank,regulation of muscle contraction (GO:0006937),0.3684005997770634,0.9280102579171213,0.5737951807228916,0.9248725189993773,1.0,6/26,10.44%,ATP1A2;TPM1;TNNT1;TNNC1;ANXA6;TNNT3
prerank,negative regulation of innate immune response (GO:0045824),0.35062563868219754,0.9274202476091106,0.5505124450951684,0.9255777574458929,1.0,11/34,20.42%,SERPING1;DCST1;IRAK3;NMI;STAT2;MUL1;DHX58;METTL3;TRIM21;YTHDF2;SUSD4
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.3825477005136212,0.9273305058441879,0.5557324840764332,0.925172084205559,1.0,6/22,16.69%,MAN1C1;RNF185;RNF139;UGGT2;AMFR;MAN1A2
prerank,aggrephagy (GO:0035973),0.3599485472571816,0.9271171629363963,0.5718608169440242,0.9250558088171386,1.0,5/27,13.07%,DYNLL1;DYNC1H1;WDR81;PRKN;DYNC1I2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.3933672494758621,-0.9270608882545178,0.5365853658536586,0.9310271409664971,1.0,3/10,13.88%,PRKG1;RDX;CEACAM1
prerank,protein import (GO:0017038),0.3051352179769883,0.9270493546923073,0.5893300248138957,0.9246189009430595,1.0,23/84,19.09%,RANBP17;APOE;NUP107;APPL2;PRICKLE1;FAM53C;SNX33;PXMP2;HEATR3;CSE1L;PPP1R10;PEX2;TSC2;TOMM22;ABCD2;NUP214;LAMP2;PEX11B;AKT1;KPNB1;TPR;PHB2;APPL1
prerank,sensory perception of chemical stimulus (GO:0007606),0.4084097158611464,0.9268509898428737,0.5352112676056338,0.9244710645451438,1.0,1/15,3.26%,GNAS
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.363134455664728,0.9264905800446307,0.5547112462006079,0.9246867193789523,1.0,5/26,12.09%,ATP1A2;GSTM2;DRD3;ADRA2A;YWHAE
prerank,amyloid-beta metabolic process (GO:0050435),0.4034438256838548,0.926393395569024,0.567062818336163,0.9243360377554296,1.0,8/16,23.32%,APEH;MGAT3;APH1B;DYRK1A;PSEN2;ABCA7;IDE;PSEN1
prerank,monocyte differentiation (GO:0030224),0.4304437302359174,0.9263323492262983,0.5565217391304348,0.9239019664823604,1.0,1/10,1.76%,IL31RA
prerank,histone methylation (GO:0016571),-0.3017606743362625,-0.9261983294714469,0.5580736543909348,0.9321097011785792,1.0,6/26,14.71%,EZH2;PRMT7;SMYD2;SUV39H1;SMYD1;PRMT6
prerank,regulation of protein kinase A signaling (GO:0010738),0.388961941445985,0.9260179077788196,0.5741324921135647,0.9240216417325501,1.0,3/20,6.25%,ADGRV1;AKAP7;LRRK2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.2877809633381198,0.9259714701162153,0.6258581235697941,0.9235448545156417,1.0,23/142,13.89%,ADRA1B;SLC8A1;SMAD3;ATP1A2;ADCY5;XCR1;PDGFRA;ACKR2;CCR9;CACNA1C;BDKRB2;AGTR1;LPAR1;DRD3;TRPM4;BCAP31;CLN3;C1QTNF1;F2;YWHAE;CXCR6;DLG4;CXCL13
prerank,regulation of actin nucleation (GO:0051125),0.42793382540388525,0.9256787357429223,0.5699831365935919,0.9236020082730029,1.0,2/12,9.01%,GSN;ARFIP2
prerank,negative regulation of viral life cycle (GO:1903901),0.406288792789321,0.9255606126233249,0.5614617940199336,0.9232907741733782,1.0,1/15,1.25%,GSN
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.27413442131515225,-0.9252142489799062,0.5625,0.9334332900253685,1.0,12/40,27.86%,PGLYRP1;RPL39;GBP4;GBP7;LBP;HMGB2;FGR;CHGA;GBP6;PPP1R11;STAB2;MPEG1
prerank,regulation of cell projection organization (GO:0031344),0.42809456160573767,0.925211544919783,0.5553691275167785,0.9234979288444569,1.0,4/13,13.32%,MACF1;CCL19;SPRY2;NTNG2
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.43847011266818403,0.9249862350342636,0.5555555555555556,0.923414110920305,1.0,2/11,4.45%,LYN;RAPGEF2
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.44357380860381757,0.9247463905362564,0.543010752688172,0.9233558833458368,1.0,4/10,15.33%,RARB;RARG;ACTN4;RXRA
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.2774349654195678,-0.9246838600744749,0.5981012658227848,0.933569331534965,1.0,19/37,34.26%,ENTPD1;HNRNPD;PNPT1;ENTPD2;SUPV3L1;ENTPD6;ENTPD3;ADPRM;RNASEH1;DNASE1L2;NUDT16;PABPC4;NUDT9;ISG20;ENTPD5;NUDT1;RNASEH2B;RNASE3;NUDT15
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.25608805640243787,-0.9245317222536186,0.6244725738396625,0.9314223309999208,1.0,23/56,29.12%,NDUFC1;NDUFAF2;NDUFA6;DMAC2;NDUFA5;TMEM126B;NDUFA8;NDUFB7;NDUFA7;NDUFA10;NDUFA3;NDUFAF8;NDUFS1;NDUFS5;NDUFS7;NDUFB3;NDUFAF3;NDUFAB1;NDUFV2;DMAC1;NDUFB4;NDUFAF7;NDUFV3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.25608805640243787,-0.9245317222536186,0.6244725738396625,0.9314223309999208,1.0,23/56,29.12%,NDUFC1;NDUFAF2;NDUFA6;DMAC2;NDUFA5;TMEM126B;NDUFA8;NDUFB7;NDUFA7;NDUFA10;NDUFA3;NDUFAF8;NDUFS1;NDUFS5;NDUFS7;NDUFB3;NDUFAF3;NDUFAB1;NDUFV2;DMAC1;NDUFB4;NDUFAF7;NDUFV3
prerank,vesicle transport along microtubule (GO:0047496),-0.31671777908573717,-0.9244431054579609,0.5614525139664804,0.9303813828131379,1.0,8/23,21.87%,KIFAP3;KIF13A;PAFAH1B1;KIF1A;TRAK2;BICDL1;KIF5A;HAP1
prerank,apoptotic mitochondrial changes (GO:0008637),-0.29301559985152076,-0.9241842698172722,0.5921450151057401,0.9297440614467447,1.0,14/32,27.06%,ERBB4;HK2;BCL2L1;BBC3;BAK1;ATG3;CLU;BIK;NDUFS1;GGCT;FIS1;SOD2;CCAR2;FZD9
prerank,positive regulation of interleukin-13 production (GO:0032736),0.4461821246251679,0.924132372888343,0.5630712979890311,0.924175137738958,1.0,4/10,20.69%,TSLP;SPHK2;IL18;LGALS9
prerank,cellular transition metal ion homeostasis (GO:0046916),0.3034141707477758,0.9239067865148872,0.5973397823458283,0.9240490551432117,1.0,9/91,6.43%,BMP6;CP;SCARA5;SLC30A8;MT3;HEPH;SLC11A2;CYBRD1;ACO1
prerank,negative regulation of protein transport (GO:0051224),0.36710137422425976,0.9236530568563642,0.5646879756468798,0.9240159761200594,1.0,9/25,22.85%,APOE;IL12B;DRD3;SNX12;SERGEF;RHBDF2;DPH3;RSAD2;CYP51A1
prerank,cellular response to gamma radiation (GO:0071480),0.3994610350627903,0.92356989708473,0.5422885572139303,0.9236206867560293,1.0,2/17,5.58%,YAP1;MAP3K20
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.39277189861515865,-0.9232414120371116,0.5242494226327945,0.9309489475406172,1.0,7/10,39.00%,SORL1;SACS;DNAJB6;DNAJB1;DNAJB2;HSPA1A;DNAJB8
prerank,plasma membrane invagination (GO:0099024),0.35990096389029025,0.9228796923891756,0.5665680473372781,0.9245666550491641,1.0,5/29,8.70%,GSN;CDC42;SNX33;GULP1;SNX18
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.31991176864968696,0.9224215525623619,0.5712418300653594,0.9250480835412564,1.0,5/54,3.74%,PDPK1;ANGPT1;FGFR1;APOE;ANGPT2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4095266339521811,0.9224174942927741,0.5640599001663894,0.9244790819726366,1.0,6/16,15.79%,GDNF;SALL1;BMP2;FGF2;SHH;BMP4
prerank,nuclear body organization (GO:0030575),0.4314424212241938,0.9224071384056217,0.549469964664311,0.923922202587466,1.0,5/12,18.30%,PML;USPL1;SERBP1;ETS1;DYRK3
prerank,endodermal cell differentiation (GO:0035987),0.3540166831975214,0.9223319340380246,0.5568862275449101,0.9235066657841057,1.0,8/31,15.02%,COL11A1;MMP2;VTN;ITGB5;ITGAV;COL4A2;PAF1;MMP14
prerank,aromatic amino acid family catabolic process (GO:0009074),0.4071672637814304,0.9221380441858632,0.5500821018062397,0.9233613693132297,1.0,2/15,6.98%,TDO2;KYNU
prerank,negative regulation of cell adhesion (GO:0007162),0.3081921381137544,0.9219002814347252,0.5862068965517241,0.923340273950961,1.0,16/72,14.18%,PLXNA2;ANGPT1;SERPINE1;RIPOR2;SEMA5A;FBLN1;CYP1B1;DSCAM;EPHB2;MIA3;PLXNC1;DACT2;SIPA1;MDK;PLXNA1;PLXNB2
prerank,fatty acid transmembrane transport (GO:1902001),0.38601580049549766,0.9218128754189345,0.56120826709062,0.9229524362435714,1.0,3/19,5.53%,SLC27A5;PRKAG2;PRKAA2
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2640556126622847,0.9215453447320047,0.7053481331987891,0.9229461571674599,1.0,55/532,10.09%,GREM2;COL1A2;RORA;GHR;PIK3R1;IL31RA;BCL2;IL34;IL6R;LEPR;OSMR;MMP2;PELI2;ZEB1;SP100;YAP1;KIT;NUMBL;IRAK2;CCL19;CNN2;CSF1;IRF1;BRWD1;EDAR;APPL2;NCAM1;MT3;PSME4;BCL6;OAS2;CDC42;TSLP;CCL4;BATF;SRC;SDC1;PML;IL12B;CEBPA;IL13RA1;IL15RA;IRAK3;BCL2L11;STAT5B;MAP3K8;CNTFR;CAMK2B;ACTN4;RAPGEF1;STAT2;LTBR;FGF2;RNASEL;IFI27
prerank,phosphatidic acid metabolic process (GO:0046473),0.32782532420604976,0.9211588128633261,0.5626702997275205,0.9232480931651345,1.0,6/48,8.31%,PLD1;GPD1;PLA2G4A;AGPAT3;DDHD2;PLD2
prerank,defense response to bacterium (GO:0042742),0.29370846160133074,0.9209759113726967,0.6075205640423031,0.9230882613703408,1.0,12/105,11.39%,COLEC12;SERPINE1;IL6R;OPTN;OAS2;WFDC3;IL12B;TLR6;CAMP;ANXA3;RNASE7;CEBPB
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.37762253606832036,0.9209419705416836,0.565359477124183,0.9225936806311004,1.0,1/22,1.12%,PPM1E
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3472541280603063,-0.9207817357832849,0.5681233933161953,0.9362041459912236,1.0,6/17,11.72%,NOTCH1;TENM4;PTN;ID2;HES1;TGFB1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.34486490509032,-0.9206153922476912,0.5813333333333334,0.9354337194737455,1.0,5/16,18.44%,PIGP;PIGB;PIGL;DPM2;PIGV
prerank,vascular process in circulatory system (GO:0003018),0.4199161397276552,0.9205867205804484,0.5625,0.9222212453545647,1.0,2/13,7.09%,ROCK2;AGTR1
prerank,regulation of tube diameter (GO:0035296),0.4199161397276552,0.9205867205804484,0.5625,0.9222212453545647,1.0,2/13,7.09%,ROCK2;AGTR1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.2895643845478497,-0.920563470124998,0.5806451612903226,0.9343070836620906,1.0,4/32,7.03%,RPS19;PGLYRP1;RPL39;RPL30
prerank,histone mRNA catabolic process (GO:0071044),0.4039586117922314,0.9201644746741511,0.5568760611205433,0.9225793593061393,1.0,5/15,16.70%,TUT7;ERI1;TUT4;ATM;TENT4B
prerank,nucleotide-excision repair (GO:0006289),0.2963669310003506,0.920052052883702,0.6107142857142858,0.9222436268797541,1.0,13/101,13.00%,POLR2D;OGG1;LIG4;CUL4B;GTF2H5;POLL;COMMD1;POLR2C;ERCC8;FANCC;MNAT1;GPS1;COPS3
prerank,ERAD pathway (GO:0036503),0.30121790590129915,0.919832716162874,0.5754950495049505,0.9221466378308578,1.0,32/83,27.29%,ERLEC1;FAF2;DERL1;UBXN4;DERL3;UBE4B;RNF185;RNF139;ECPAS;UGGT2;PRKN;FOXRED2;RCN3;SELENOS;AMFR;AUP1;TMUB1;TMEM67;ERLIN1;CCDC47;BAG6;JKAMP;HSPA5;ERLIN2;WFS1;ATXN3;OS9;FBXO2;UBE2J2;FBXO17;DNAJB12;TMUB2
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.3820003630164614,0.9194722973392098,0.5534883720930233,0.9223727880378457,1.0,5/20,16.88%,WNT4;SIK1;NCOR1;CDA;GCK
prerank,positive regulation of cell death (GO:0010942),0.3216483201203371,0.919137952166961,0.59765625,0.9225490420237258,1.0,8/59,9.05%,LRP1;EFNB2;SLC6A13;MT3;AXIN2;RARG;LRRK2;PICALM
prerank,peptidyl-arginine modification (GO:0018195),0.4024552861299261,0.9191310876594626,0.5544554455445545,0.9219932216515011,1.0,1/15,2.15%,ART4
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.2978806957960709,0.918671539404749,0.6060240963855422,0.9224592938057247,1.0,15/88,10.41%,SH3D19;DNAJC6;DTNBP1;MYO1B;TXNDC5;GOLGB1;ARFGEF2;MON2;EPS15;ARRB1;COMMD1;AP1G2;BLOC1S1;VPS35L;AP1M1
prerank,potassium ion transmembrane transport (GO:0071805),0.2876804123874963,0.918377682111468,0.6222479721900348,0.9225398805289665,1.0,13/135,9.52%,SLC1A3;KCNK2;SLC24A3;NALCN;ATP1A2;KCNT2;SLC9A9;SLC24A1;KCNK7;ATP1B2;KCNQ4;SLC9A5;KCNJ14
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.3002374185360473,-0.9183735672347451,0.5858310626702997,0.9389381498013852,1.0,4/25,6.44%,ANKRD13A;SDCBP;MTMR2;RIN3
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3188474363742875,0.9183582437827813,0.5857519788918206,0.9220114087876883,1.0,7/56,8.70%,ROCK2;SON;MYH10;KIF20A;EFHC1;SNX33;SNX18
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.3158176323426842,-0.91825164219665,0.590027700831025,0.9379917465814978,1.0,5/23,6.50%,UBASH3B;PTK2B;DIAPH1;CAMK2D;NOS1
prerank,carboxylic acid transport (GO:0046942),0.3227833984517283,0.9181105986092594,0.5933333333333334,0.9219926203338931,1.0,6/55,6.45%,SLC1A5;SLC16A12;SLC13A3;SLC6A9;SLC6A13;SLC38A6
prerank,regulation of gene silencing by miRNA (GO:0060964),0.31325782287814347,0.9180858576070747,0.5835509138381201,0.9214770270621279,1.0,8/62,11.13%,POLR2D;NUP107;NUP42;WTIP;TNRC6A;POLR2C;RAE1;NUP98
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.35088119272645374,-0.9180760529318972,0.5771144278606966,0.9371542772337595,1.0,7/15,25.96%,FAM98B;ERN1;CLP1;CSTF2;TSEN54;TSEN34;CPSF1
prerank,icosanoid secretion (GO:0032309),-0.36767052384120846,-0.9180525130225439,0.5573770491803278,0.9359924849356034,1.0,7/12,29.94%,ABCC4;PNPLA8;ANXA1;NMUR2;PLA2G5;NOS2;ACE
prerank,regulation of hippo signaling (GO:0035330),-0.32840497801542934,-0.9175128428989513,0.5699481865284974,0.9361305209841869,1.0,3/17,5.02%,MOB3B;SCHIP1;CIT
prerank,cellular response to DNA damage stimulus (GO:0006974),0.26615057182700375,0.917112507621326,0.6976264189886481,0.9229481563143398,1.0,100/336,23.49%,LYN;BCL2;SETD7;YAP1;PDS5B;MOAP1;OGG1;PSME4;HPF1;RAD51B;BCL6;PCLAF;USP47;INO80;CBX3;BATF;CUL4B;PML;SMC5;SPRTN;ZBTB38;TRIP12;BRSK1;UBE2U;REXO4;RECQL5;POLE3;KMT5B;UBA7;BCL2L11;ZBTB4;ZBTB1;CCNK;STK11;PHF1;SMC6;BAZ1B;TAOK3;MRNIP;IKBKE;ERCC8;UFL1;FANCC;RAD18;UVRAG;MNAT1;MBD4;MTREX;BOD1L1;MAP2K6;USP10;HMCES;UBE2E2;TAF9;RAD51D;UBA6;RTEL1;UBR5;CBX5;MAPKAPK2;CASP9;XRCC2;ATM;TIMELESS;NIPBL;ALKBH1;ZBTB40;ENDOV;XPA;METTL3;WAC;TAOK1;RAD54L;SUMO1;NRDE2;NCOA6;RBBP5;RFC5;USP3;AATF;ETAA1;STK33;LIG1;FAN1;UBE2T;MUTYH;DDIT3;RMI2;NSMCE4A;APLF;ERCC3;MACROD1;XIAP;VCPIP1;FANCA;SETX;PSEN1;POLI;BRAT1;BRCA1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.3496153658295582,-0.9168903982771562,0.5632754342431762,0.9365124565658218,1.0,7/16,26.02%,SHLD1;CGAS;PARPBP;POLQ;SHLD2;HELB;KLHL15
prerank,neuronal action potential (GO:0019228),-0.31973377212926035,-0.9163680831587112,0.5702247191011236,0.9366197479437063,1.0,10/22,19.72%,ANK3;SCN1A;SCN3A;SCN2A;KCNMB2;KCNA2;CACNA1H;GPER1;MYH14;SCN8A
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.2759304721212328,-0.9163426827309346,0.6279863481228669,0.9354429242891352,1.0,16/38,28.47%,HIRA;H3-3A;KNL1;MIS18BP1;RUVBL1;RSF1;NPM1;CENPI;CENPN;CABIN1;NASP;ASF1A;HAT1;ASF1B;ITGB3BP;HJURP
prerank,regulation of platelet activation (GO:0010543),0.37876872465057077,0.9162953479603864,0.5434439178515008,0.9241218681090443,1.0,6/21,12.01%,LYN;PDGFRA;APOE;PLA2G4A;C1QTNF1;F2
prerank,intermediate filament organization (GO:0045109),0.39599503025478905,0.916114445321728,0.5642633228840125,0.9239238233519549,1.0,4/17,16.18%,BFSP1;DES;KRT9;EPPK1
prerank,negative regulation of kinase activity (GO:0033673),0.3131083904085017,0.9161108688350752,0.5874840357598978,0.9233671144116786,1.0,4/62,3.48%,PDPK1;PPM1E;DTNBP1;PRKAG2
prerank,regulation of receptor internalization (GO:0002090),0.3465304645916074,0.9158535470557745,0.5689900426742532,0.9233519281474573,1.0,9/35,15.01%,ANGPT1;NTF3;CD63;ARRB1;EGF;INSR;SFRP4;DLG4;RSPO1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.2690095837332727,0.9158294467179566,0.6836628511966701,0.9228398944773527,1.0,41/291,13.92%,EPHA3;RORA;ROCK2;PID1;DAPK1;SERPINE1;LYN;TPM1;WNT8B;PDGFRA;WNT6;MTR;RAPGEF2;SFRP1;MT3;PDE3A;AXL;IGFBP5;PTK7;CPEB1;ZFP36L1;WNT5B;CPEB3;DPEP1;ERCC6L2;NR1D1;EGFR;RAPGEF1;SLC38A9;TNIP2;LAMTOR2;SELENOS;RRAGD;SLC5A5;IMPACT;CD14;PAF1;PDCD4;CHMP5;CXCL13;NCOA3
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.28609637989038056,0.9155478525410607,0.6111111111111112,0.9228680403009237,1.0,21/124,11.03%,GDNF;LYN;TPM1;EPHA8;DTNBP1;APOE;WDPCP;NEDD4;RAPGEF2;CDK16;LRP12;LIMA1;ATXN10;ATP1B2;CARMIL1;RAB25;ARFIP2;BLOC1S1;RYK;PTPRM;MANF
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3275702025896239,-0.9152261180832185,0.5818181818181818,0.9369737900577628,1.0,6/18,9.66%,NOTCH1;NOS3;ACVRL1;TGFB2;TBX2;TGFBR2
prerank,neutral amino acid transport (GO:0015804),-0.3018409290807568,-0.9151627401810452,0.5697674418604651,0.9358767491753072,1.0,8/28,13.78%,SLC6A6;SLC7A5;SLC38A5;SLC1A1;SLC43A2;SLC36A4;SLC3A2;SLC1A4
prerank,regulation of lamellipodium assembly (GO:0010591),0.3450548158503553,0.9151330699778547,0.5660377358490566,0.923193780666231,1.0,4/34,8.42%,AUTS2;PIK3R1;CDC42;CAPZB
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.36256876142579386,0.9150864370831802,0.5781487101669196,0.9227045659680491,1.0,8/31,18.90%,LYN;CEBPB;SDC4;GLMN;ATM;SOX11;RC3H1;VTCN1
prerank,macrophage migration (GO:1905517),-0.3642036812342091,-0.914521855354024,0.5744186046511628,0.9362693331147808,1.0,3/13,23.76%,CKLF;EDNRB;CCL2
prerank,negative regulation of MAPK cascade (GO:0043409),0.2984736745402623,0.9144689134919695,0.6002490660024906,0.9234423211847737,1.0,18/87,15.97%,TIMP3;DAG1;LYN;APOE;FBLN1;CDK5RAP3;EMILIN1;RANBP9;IRAK3;EPHB2;SPRY2;SPRED3;CNKSR3;IGBP1;PTEN;SPRED1;BMP4;PIK3R2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.34605086405970764,0.9140748742242457,0.5787172011661808,0.9237329278012173,1.0,6/33,11.79%,AR;RUNX1;NCOA2;SAFB2;RNF6;UFL1
prerank,response to hydroxyurea (GO:0072710),0.4289639814426548,0.9133298889550618,0.5711864406779661,0.9247169805263279,1.0,4/11,19.09%,DDI1;RTF2;TIMELESS;ATRX
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.22848763287591795,-0.9132896747976449,0.6645569620253164,0.9382289798492339,1.0,33/113,20.63%,MPP7;UNC13B;FNIP2;ESR1;PIEZO1;TFRC;WARS1;RASIP1;FAF1;RBX1;GBP5;RPS3;MMP1;RAP1B;TAL1;DDB2;VEGFA;SKAP1;GTF2H1;PLEK;TGFB1;TPPP3;BAK1;SLF1;TLR4;RACK1;PSMC4;CLU;BIK;PARP1;CAPG;DAB2IP;MTLN
prerank,response to zinc ion (GO:0010043),0.36349753115042166,0.9132643251817557,0.576036866359447,0.9242838986989177,1.0,4/25,5.30%,PAM;SLC30A8;MT3;SLC30A2
prerank,cellular protein catabolic process (GO:0044257),0.3138023233466199,0.9132113781694825,0.5936675461741425,0.9238296336836864,1.0,10/59,13.05%,ADAMTS12;CTSH;CTSF;CLPX;PRKN;CLPP;RSPRY1;CPA2;CTSZ;CTSL
prerank,cellular protein localization (GO:0034613),0.26805913257457276,0.9128005170651552,0.6778593913955928,0.9241292128804321,1.0,42/285,12.88%,WLS;GJA1;FBLN5;RABGAP1L;TBC1D4;ANGPT1;USP6NL;SEC31A;SH3PXD2B;TMED1;AXIN2;VPS26C;RAB23;STXBP3;ARFGAP3;LRRK2;STX16;NPHP1;ADPRH;COX18;VCL;CD63;IFT27;COPZ2;RAB22A;EGFR;CROCC;ARFIP2;TBC1D2B;GGA2;CSRP3;TMED4;ARL1;WIPI1;COPA;TM9SF2;STXBP1;LAMTOR2;RAP2A;RRAGD;TLK1;USO1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.36157749177419385,-0.9125764656962171,0.5807228915662651,0.9388850457835843,1.0,3/12,13.08%,MAOA;ATP7A;DDC
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.29696769902099696,0.9121178862667637,0.6144430844553244,0.9250300694242745,1.0,11/84,12.24%,CELF2;RBFOX1;SON;RBFOX2;SF1;DDX17;HNRNPA1;NUP98;SMU1;REST;WTAP
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.3657816287823779,-0.9120675172619949,0.5818639798488665,0.9389869429120281,1.0,7/14,27.58%,CPSF7;ERN1;CSTF2;CPSF1;CPSF4L;CPSF6;TUT1
prerank,glycerol metabolic process (GO:0006071),-0.3879820986389644,-0.9120320153871554,0.575,0.9378280606026071,1.0,4/10,25.34%,TPI1;TKFC;GOT1;COQ2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.35335770519560145,0.912020223163071,0.6006191950464397,0.9246585389585795,1.0,7/27,14.72%,FBXL17;PML;SIK1;FBXL3;FBXL12;PER3;RBM4B
prerank,Fc receptor signaling pathway (GO:0038093),0.28484116520516045,0.9117017441467865,0.6068883610451307,0.9247577924325109,1.0,7/110,4.86%,PDPK1;PIK3R1;LYN;PPP3CA;PIGR;KIT;PSME4
prerank,inflammatory response (GO:0006954),0.2736815249940528,0.9114727979409678,0.6626506024096386,0.9246880801883098,1.0,36/195,16.92%,ADCY1;HSPG2;IL17D;XCR1;TPST1;KIT;CCL19;LTB4R;SCUBE1;CCL4;BDKRB2;AGTR1;TLR6;BMP2;ADM;ITCH;CDO1;NFAM1;LIAS;CEBPB;TNFAIP6;TBK1;CD14;FOLR2;RIPK2;NOX4;CXCL13;HDAC4;ADORA2A;TNFRSF1A;VNN1;NLRC4;MAPKAPK2;KLRG1;PJA2;CX3CL1
prerank,establishment of epithelial cell polarity (GO:0090162),-0.31845682152710825,-0.9114585250557358,0.5752688172043011,0.9380127067514533,1.0,7/19,19.87%,CYTH3;MYO9A;OPHN1;MSN;CYTH1;CLASP1;SH3BP1
prerank,heterochromatin organization (GO:0070828),-0.35411940540861797,-0.9114023500403298,0.5794621026894865,0.9369167376940741,1.0,2/14,3.90%,MECOM;PRDM16
prerank,response to thyroid hormone (GO:0097066),0.41174195861545765,0.9113479579475798,0.5754385964912281,0.924379247518321,1.0,6/13,14.61%,THRB;CTSH;BRD8;KLF9;CTSL;HPN
prerank,response to reactive oxygen species (GO:0000302),-0.2510749132626077,-0.9107976332629861,0.6394849785407726,0.9371542500232279,1.0,21/54,22.95%,PTPRK;APOD;PXN;RPS3;HYAL1;MAPK8;SIRT1;JUN;APTX;MAPK3;HIF1A;PTPRN;ADAM9;CAT;GPX1;PDCD10;PLK3;CHUK;SOD2;PRDX5;MAPK1
prerank,cellular senescence (GO:0090398),0.35884412917255015,0.9106786552685254,0.5780346820809249,0.9252290260420589,1.0,6/27,12.19%,TBX3;PML;SMC5;MAP2K1;SMC6;TERF2
prerank,mesenchyme morphogenesis (GO:0072132),-0.333801617726665,-0.9097500901336107,0.6119791666666666,0.9386564861901107,1.0,5/17,6.64%,NOTCH1;NOS3;ACVRL1;TGFB2;TBX2
prerank,regulation of monocyte chemotaxis (GO:0090025),0.36344037416288405,0.9096496606901483,0.5758998435054773,0.9269136611949292,1.0,2/24,1.80%,SERPINE1;LYN
prerank,neuron remodeling (GO:0016322),-0.38461985948133737,-0.9094790306206589,0.5623678646934461,0.9381323809535793,1.0,5/10,22.16%,ADGRB3;SCARF1;APP;ANKS1A;RND1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.37671186051103944,-0.9091686148117227,0.5852534562211982,0.9376679312101934,1.0,5/11,29.83%,PWP1;MTOR;SMARCA4;PIH1D1;IPPK
prerank,central nervous system development (GO:0007417),0.2683604139915633,0.9084894708050838,0.6743697478991597,0.9287930615737475,1.0,29/250,10.04%,EPHA7;ATXN1;GSN;PBX1;ARNT2;SLC8A3;HSPG2;ZIC1;PCDH18;SHROOM2;NKX2-1;NFIB;SMO;ZIC4;CDK5RAP3;SYNJ2;ZIC2;LIG4;TBX3;SMARCA1;ADGRA2;SH3GL1;SETD1A;NHEJ1;EEF1AKMT4-ECE2;MARCKSL1;PRKN;GLIS2;MDGA1
prerank,cellular response to inorganic substance (GO:0071241),0.37591622665274,0.9082464429031675,0.5681114551083591,0.9287488551155855,1.0,7/21,19.09%,MTR;MT3;DPEP1;DDI1;RTF2;TIMELESS;ATRX
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3606437784668869,0.9080084502245656,0.58125,0.9286763560583596,1.0,9/26,16.32%,PYCR1;LRRK2;NFE2L2;PRKN;REST;NOL3;VNN1;BAG5;AKT1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3066623645218427,0.9077621041787894,0.5976714100905562,0.9286489020920033,1.0,9/64,8.12%,EPHA3;ROCK2;MACF1;CSF1;SFRP1;CASK;PLEKHA2;VCL;MAP4K4
prerank,regulation of cellular component biogenesis (GO:0044087),0.3357159147721612,0.9075676449625517,0.5878378378378378,0.9284842302180041,1.0,6/39,9.39%,ROCK2;APOE;CCL19;RAPGEF2;SNCAIP;RAPGEF1
prerank,cellular response to heat (GO:0034605),0.3406603060109483,0.9075222565757917,0.5760111576011158,0.9280134367207105,1.0,1/35,0.16%,POLR2D
prerank,cellular response to ATP (GO:0071318),-0.3511995488897789,-0.9074986346166319,0.5727923627684964,0.9406986227217508,1.0,2/14,6.92%,P2RX7;TAF1
prerank,acetyl-CoA metabolic process (GO:0006084),0.4020403305291541,0.9071937123825148,0.5617792421746294,0.9281315107945003,1.0,3/15,5.18%,TDO2;MVK;NUDT7
prerank,negative regulation of TOR signaling (GO:0032007),0.33936068492331867,0.9070057516969063,0.5875706214689266,0.9279674515231171,1.0,12/36,16.40%,NPRL3;UBR2;PRKAA2;STK11;CASTOR2;RNF152;TSC2;ITFG2;NPRL2;SESN2;FNIP1;ATM
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.40332672372060824,0.9068815907916072,0.564625850340136,0.9276611460977529,1.0,9/14,26.36%,CHKB;ETNK2;LPIN3;CEPT1;LPIN2;PCYT2;PISD;SLC27A1;LPIN1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.3589720718778452,-0.9068393610381403,0.5863636363636363,0.9411622055488638,1.0,2/13,6.99%,NLGN1;EPS8L2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.350687161545183,-0.906638824067994,0.5816831683168316,0.9404621268445756,1.0,6/15,21.87%,NGF;DDIT4;BCAR1;ZFYVE27;NTRK2;HAP1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.23695935398692003,-0.9062472700845492,0.6580310880829016,0.9402403460626854,1.0,26/76,24.75%,SMURF1;RNF144B;CBFA2T3;RNF144A;RBX1;TRIB2;TAF1;GSK3A;HSPBP1;ZYG11B;COP1;RAD23A;RACK1;BBS7;CLU;DVL1;RNF14;RCHY1;GABARAP;DDRGK1;USP5;NUB1;GSK3B;DDA1;VCP;CSNK1D
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.37301128880613477,-0.9059326520656672,0.5754716981132075,0.9397862453923319,1.0,4/11,18.45%,EGLN3;EGLN2;P4HA3;P3H2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.3605646133173835,0.9055392074909212,0.5808936825885979,0.9298833036477158,1.0,5/25,13.96%,ACTN2;SLC6A9;ATP1B2;WNK1;PIRT
prerank,vesicle transport along actin filament (GO:0030050),-0.3238163172666984,-0.9053494366393624,0.5799457994579946,0.9400399025371139,1.0,2/19,1.54%,FNBP1L;MYO1D
prerank,nitric oxide biosynthetic process (GO:0006809),-0.35939312658343925,-0.9051788898979707,0.5677570093457944,0.9392632820446813,1.0,5/13,10.91%,NOS3;GCH1;NOS1;DDAH2;SPR
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3203020413055919,0.9050383587144883,0.5893854748603352,0.9303924376068438,1.0,2/48,0.61%,PDPK1;CEMIP
prerank,response to UV (GO:0009411),0.29177528054698126,0.9045968350381505,0.6343825665859564,0.9307875747702974,1.0,11/95,9.50%,MFAP4;NEDD4;PCLAF;USP47;INO80;SPRTN;IL12B;UBE4B;BRSK1;EGFR;ZBTB1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.3748799875569643,0.9042388040174388,0.5919354838709677,0.9309678586537092,1.0,3/21,4.72%,FZD2;WNT8B;FZD1
prerank,neutrophil activation (GO:0042119),-0.3747524008225756,-0.9041161637374037,0.5660377358490566,0.9406994941548731,1.0,2/12,9.56%,IL15;FCER1G
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.37853364416553986,-0.9036193500996987,0.5916114790286976,0.9407806652362983,1.0,1/10,1.02%,ADAM10
prerank,hemopoiesis (GO:0030097),0.29620099566752,0.9033389517584081,0.6237980769230769,0.9322901658333204,1.0,12/87,7.08%,TGFBR3;RUNX1;RUNX2;PGM3;MFAP5;FGFR2;KIT;NOTCH2;SFRP1;ETV6;FUT10;CEBPA
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3432149414491465,0.9032883735359848,0.5878962536023055,0.9318477735645163,1.0,11/33,20.11%,MN1;APPL2;INO80;GLI1;PAF1;PTEN;CDC73;CDKN1B;PHB2;APPL1;PSME3
prerank,positive regulation of neuron migration (GO:2001224),-0.3791003757832275,-0.9030488378857194,0.5880952380952381,0.9410317334011538,1.0,5/11,20.45%,SEMA6A;ARHGEF2;KIF20B;SHTN1;DAB2IP
prerank,response to interferon-alpha (GO:0035455),0.39412632462164743,0.9030401250332649,0.581081081081081,0.9317843683919532,1.0,2/16,4.80%,GAS6;AXL
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.42694007331576556,0.9019399587289286,0.5897858319604613,0.9335681745985758,1.0,5/11,21.35%,DERL1;RNF185;UGGT2;AUP1;BAG6
prerank,cardiac myofibril assembly (GO:0055003),0.4095390563682134,0.9015041187281969,0.6097972972972973,0.9339050131395845,1.0,3/15,3.47%,OBSL1;PDGFRA;PDGFRB
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3682746103602488,-0.9011826607088566,0.5720720720720721,0.9444075830755698,1.0,2/12,2.61%,NOTCH1;CCN3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.2473323703204651,-0.9008146720980245,0.6583333333333333,0.9441380991540559,1.0,15/52,19.61%,PPP1R13B;YWHAH;YWHAQ;SAE1;GSK3A;ABLIM3;MAPK8;YWHAG;CASP8;UBE2D3;BBC3;TOMM7;PPP3R1;ATG13;FZD5
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2623757349401233,0.9008087483208883,0.7287784679089027,0.9348383117489787,1.0,88/314,23.48%,SPSB1;TBL1XR1;HECW2;FBXO48;FBXL17;FBXL19;UBR2;NEDD4;SMURF2;RFFL;CDC20B;PSME4;FAF2;BFAR;DERL1;CUL4B;PML;UBXN4;NFE2L2;DERL3;SIRT2;UBE4B;CUL5;UBE2U;UBXN2B;FBXL3;RNF185;ARRB1;UBXN11;ECPAS;ANAPC5;PRKN;ITCH;IFI27;FOXRED2;FBXO9;FBXL12;ERCC8;FBXO4;KBTBD7;SELENOS;FEM1C;BTRC;TNFAIP1;APPBP2;FBXO38;AMFR;UBE2D1;AUP1;HACE1;SPOP;HUWE1;TMUB1;NHLRC3;AMN1;UBR3;PSMB5;PSMC2;TMEM67;PSMD4;KAT5;RNF34;PSMD1;FBXL18;ERLIN1;DCAF11;NSFL1C;PSME3;ZSWIM8;CDC23;FEM1B;UCHL1;KCTD13;PSMA3;BAG6;AURKA;DDIT3;JKAMP;BIRC2;FBXW11;RNF216;KLHL20;ANAPC4;HSPA5;PSMC5;PSMA2;ERLIN2;WFS1
prerank,DNA modification (GO:0006304),0.3701839109745914,0.8999790897874274,0.5851063829787234,0.9359973799739285,1.0,4/22,12.56%,OGG1;NEIL1;TERF2;MBD4
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.2732207346919079,-0.8999739577426323,0.6273291925465838,0.9450417598398423,1.0,12/35,18.09%,CDK6;HOXA5;MED1;TAL1;LDB1;ACVR2A;HIF1A;PRKDC;ZFPM1;FAM210B;INHBA;HMGB2
prerank,nitric oxide metabolic process (GO:0046209),-0.35396062349282975,-0.899909456230987,0.5929411764705882,0.9439670482386101,1.0,5/14,10.91%,NOS3;GCH1;NOS1;DDAH2;SPR
prerank,regulation of cellular senescence (GO:2000772),-0.28777739983695005,-0.899871167227254,0.635593220338983,0.9428478633692935,1.0,7/28,12.08%,CDK6;B2M;VASH1;PNPT1;SIRT1;CGAS;ABI3
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.39412750562454446,0.8995740148861975,0.574750830564784,0.9363083786009796,1.0,4/15,14.70%,SMPD2;SPHK2;NSMAF;TNFRSF1A
prerank,chromatin assembly (GO:0031497),-0.26948353493708327,-0.8995580499404392,0.6585365853658537,0.9423670274495369,1.0,18/38,34.25%,NAP1L4;SIRT1;NAP1L2;H3-3A;NAA60;CHAF1A;RSF1;HMGB2;CDAN1;NPM1;HMGA2;LIN54;ASF1A;H1-0;GRWD1;NAP1L3;NAP1L1;EZH1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.2905022073961967,-0.899333539643222,0.6277602523659306,0.9417064381815166,1.0,9/30,17.11%,ST6GAL1;FUT8;DPM1;UBE2J1;UGGT1;MGAT5;DPM3;RPN1;DPM2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.38658371480212167,0.8992580996285191,0.5806988352745425,0.9364051771921766,1.0,3/19,14.35%,APOE;COLQ;RAPSN
prerank,protein homooligomerization (GO:0051260),0.28453541270198746,0.8991406671667992,0.6556213017751479,0.9360896840087408,1.0,15/114,10.78%,SLC1A5;TRPA1;SCARA5;MLKL;IKZF4;TDO2;APPL2;RNF213;ALDH1A2;ALS2;CBY1;TRPM4;CLYBL;ZBTB1;CARD9
prerank,determination of left/right symmetry (GO:0007368),-0.2771137512905984,-0.899063484369794,0.6340694006309149,0.9411403854737335,1.0,10/36,19.26%,NOTCH1;TBX1;ZIC3;GALNT11;DNAH11;STIL;ARL6;CITED2;BBS7;DLL1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.3535689225564013,-0.898978648332075,0.6084905660377359,0.940171458615845,1.0,8/14,34.07%,RPS3;CD81;NECTIN2;CARD11;RAB29;IKBKG;TRAT1;CD226
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.283125102232216,-0.8989441048080563,0.6253869969040248,0.9378796352274185,1.0,11/32,21.43%,NUP93;NUP35;NUP160;NUP153;NUP54;SEC13;NUP155;RANBP2;NUP88;NUP62;NUP85
prerank,tRNA export from nucleus (GO:0006409),-0.283125102232216,-0.8989441048080563,0.6253869969040248,0.9378796352274185,1.0,11/32,21.43%,NUP93;NUP35;NUP160;NUP153;NUP54;SEC13;NUP155;RANBP2;NUP88;NUP62;NUP85
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.3833883380633783,0.8986455169514473,0.5868852459016394,0.9365862567429143,1.0,2/17,9.64%,SERPINE1;CREB3
prerank,protein methylation (GO:0006479),-0.26951372927145667,-0.8985442333508242,0.6073825503355704,0.9376612708412654,1.0,9/40,19.18%,RAB6A;EZH2;SNRPB;PRMT7;ATPSCKMT;FAM98B;PRMT6;SNRPD3;PRMT3
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.35266789116509195,0.8982376107290195,0.593519882179676,0.9368766974371382,1.0,5/31,15.46%,ARRDC4;GORASP1;BTRC;PTEN;DCUN1D2
prerank,negative regulation of growth (GO:0045926),0.27979352277987773,0.8981246742603005,0.6562137049941928,0.936551765115875,1.0,24/121,13.34%,ENPP1;GJA1;SMAD3;NOTCH2;TSPYL2;SFRP1;MT3;BCL6;APBB2;PML;ING5;SPHK2;STK11;RBBP7;SLIT3;DDX3X;CGRRF1;ST7L;JADE1;NME6;ACVR1B;CDA;SIPA1;MUL1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.32084330332265076,-0.8981227432474591,0.6109589041095891,0.937565247099679,1.0,8/19,18.55%,DLG2;CLIC4;LRRC7;SCRIB;PATJ;SYNJ2BP;ERBIN;MTCL1
prerank,dendritic cell chemotaxis (GO:0002407),0.40108190894022955,0.8980875114762267,0.5931623931623932,0.9360626251322738,1.0,2/14,9.31%,CCL19;TRPM4
prerank,photoperiodism (GO:0009648),0.3458255024590466,0.8980536443709257,0.6070878274268104,0.9355728565848936,1.0,7/28,14.72%,FBXL17;PML;SIK1;FBXL3;FBXL12;PER3;RBM4B
prerank,regulation of tumor necrosis factor production (GO:0032680),0.28496717353341156,0.8969251024432677,0.6381733021077284,0.9373209686925966,1.0,13/112,12.46%,IGF1;GAS6;CCL19;OAS2;ARFGEF2;IL12B;SPHK2;IRAK3;EPHB2;SETD4;SELENOS;CD33;CD14
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.3996382081311733,0.8968900396518867,0.6177474402730375,0.9368437653568001,1.0,4/15,15.65%,FAF2;DERL1;SELENOS;AUP1
prerank,organic substance transport (GO:0071702),0.27933371070218355,0.8965296604515587,0.6567695961995249,0.9370306112473425,1.0,20/121,14.40%,TXNIP;ARRDC4;ABCA1;ABCA9;LMAN2L;SLC22A2;APOA1;SLC35F3;TOM1;PLEKHA8;SLC22A4;MIA3;ABCB9;ARRDC2;SLC22A18;RCN3;SLC48A1;SLC18A2;ABCD2;ABCA3
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.27864623008310374,-0.8963493104856264,0.6464968152866242,0.9408162158282499,1.0,8/35,9.67%,NLGN1;CDH12;ATP2C1;CDH6;CDH8;CDH9;CDH13;CDH10
prerank,protein maturation (GO:0051604),0.28891267568160633,0.8962410177690814,0.6297198538367844,0.9370652396739426,1.0,10/95,11.57%,CPXM2;OGT;AEBP1;CPXM1;MMEL1;ECE2;EEF1AKMT4-ECE2;LONP2;APH1B;CLN3
prerank,lymphocyte differentiation (GO:0030098),0.3037104578673491,0.8961524995813419,0.6149870801033591,0.9366937416529996,1.0,10/68,11.30%,RHOH;PBX1;LEPR;KIT;AXL;NHEJ1;GPR89A;GPR89B;NFAM1;IFNK
prerank,positive regulation of defense response (GO:0031349),0.2919371606021996,0.8960924571728657,0.6227327690447401,0.9362537357153151,1.0,23/89,18.71%,SERPINE1;OPTN;TSLP;IL12B;CEBPA;AGTR1;NMI;CCN4;SETD4;IFNK;NAPEPLD;PDCD4;NPAS2;MDK;ETS1;TNFRSF1A;RIOK3;IL23A;CD47;ZBP1;CX3CL1;TNIP1;IL18
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.41271516511668976,0.8960085330709665,0.6091370558375635,0.9358686567524721,1.0,7/12,22.22%,NEDD4;IFI27;NUP214;BMP4;TPR;AAAS;RBM4
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3885375462803469,0.8951838793303494,0.6056782334384858,0.9370045878529399,1.0,2/16,7.00%,PID1;SPHK2
prerank,positive regulation of telomerase activity (GO:0051973),-0.2817803588012683,-0.8949274951527372,0.6077170418006431,0.943122715949526,1.0,9/33,23.58%,NEK7;HSP90AB1;PKIB;KLF4;NVL;MAPK3;PNKP;MAPK1;HMBOX1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.37436639390200405,0.8946500595356388,0.6028257456828885,0.9375704313390172,1.0,3/21,7.93%,MITF;MED14;MED16
prerank,negative regulation by host of viral process (GO:0044793),0.4317150624554251,0.8946217782955446,0.6049382716049383,0.937065180955618,1.0,2/10,9.87%,CCNK;PRKN
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.417531457826531,0.8937702072348663,0.5873015873015873,0.9382616933341608,1.0,3/11,8.88%,EFNB2;FRS2;BMP2
prerank,skeletal muscle tissue development (GO:0007519),0.34353978482355396,0.893501782748086,0.6193447737909517,0.9382448008271416,1.0,4/32,5.96%,SVIL;CFLAR;MSC;SKI
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.39922604264379163,0.8932233395493885,0.5800653594771242,0.9382604536028774,1.0,3/15,9.95%,PDPK1;SMAD1;FGF2
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3803761946818299,0.8928266553676381,0.5841584158415841,0.9385361351403988,1.0,7/18,16.32%,NFE2L2;NONO;PRKN;NOL3;VNN1;BAG5;AKT1
prerank,negative regulation of protein metabolic process (GO:0051248),0.3218207706688531,0.8926110551139192,0.6174033149171271,0.9384655671226014,1.0,12/48,16.94%,APOE;LDLR;SIRT2;IRAK3;EGFR;SNX12;ITGB3;ITGAV;BANP;FLNA;AGAP2;VBP1
prerank,regulation of establishment of protein localization (GO:0070201),-0.35607705766846476,-0.8925185000263578,0.6095717884130982,0.9479369191698087,1.0,5/13,28.22%,CEP135;GAPVD1;CORO2B;TREM2;PTP4A3
prerank,glycosphingolipid metabolic process (GO:0006687),0.3280062697910431,0.8918253298997162,0.6184573002754821,0.9395067899288962,1.0,6/42,10.22%,ST6GALNAC5;ST3GAL5;LARGE1;SMPD2;B3GALNT1;ST6GALNAC6
prerank,positive regulation of transporter activity (GO:0032411),0.41203360641295494,0.8917298564096874,0.6027164685908319,0.9391605221371266,1.0,6/13,20.73%,KMT2A;SYNGR3;NR1H3;RXRA;KCTD7;SGK2
prerank,negative regulation of catabolic process (GO:0009895),0.3203302310086564,0.8914906223589941,0.5994513031550068,0.9390909108553261,1.0,12/47,16.74%,NUPR1;CST3;SIRT2;IRAK3;EGFR;NCOR1;SNX12;ADRA2A;BANP;HDAC4;FLNA;AGAP2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.32441797933667954,0.8910323983244259,0.6083916083916084,0.9394805200254698,1.0,7/39,12.52%,BMP6;APOA1;BMP2;MIA3;MYADM;RGCC;WNK1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.30620136890711186,-0.8904803666256784,0.6388140161725068,0.9517218634029467,1.0,12/22,30.92%,MVB12B;VPS37B;RNF126;VPS37A;VPS28;VPS36;VPS4A;VPS37C;SNF8;UBAP1;MVB12A;RNF115
prerank,regulation of B cell proliferation (GO:0030888),-0.2593876613111926,-0.8897615229486099,0.6845878136200717,0.9522627338472567,1.0,11/44,16.80%,MEF2C;VAV3;CD38;TFRC;NFATC2;CD81;TNFRSF21;CD40;GPR183;PTPRC;CD320
prerank,piRNA metabolic process (GO:0034587),0.379858709664484,0.8897429661684414,0.6217948717948718,0.9416565487342472,1.0,4/19,17.88%,TDRD1;PIWIL4;MYBL1;DDX4
prerank,regulation of T cell chemotaxis (GO:0010819),-0.3639992438096352,-0.8893366868191832,0.6247191011235955,0.9521295339749067,1.0,1/11,1.02%,ADAM10
prerank,cellular response to interleukin-1 (GO:0071347),0.274058272634704,0.8893085761205759,0.6555299539170507,0.9419974222969009,1.0,11/143,8.86%,ADAMTS12;PTGIS;PELI2;IRAK2;CCL19;SFRP1;PSME4;CCL4;NR1D1;IRAK3;MAP3K8
prerank,response to unfolded protein (GO:0006986),0.31185189894731036,0.8888682853108059,0.6141078838174274,0.9423708446067729,1.0,18/48,24.95%,OPTN;SERPINH1;DERL1;PRKN;HSPB7;TM7SF3;HSPA9;TOR1B;TMBIM6;ERP44;HSPB2;HSF1;DDIT3;HSPA14;HSPA5;BAG3;HSPA4;DNAJA1
prerank,mitotic chromosome condensation (GO:0007076),-0.29042292022298904,-0.8888515739710243,0.6358208955223881,0.9521247010351079,1.0,17/26,41.33%,MCPH1;NCAPD3;SMC4;KMT5A;NCAPH;NCAPG;TTN;SET;CDK1;PLK1;NCAPG2;NUSAP1;RB1;SMC2;NCAPD2;CSNK2A1;CSNK2A2
prerank,regulation of cellular component size (GO:0032535),-0.28069088153475746,-0.8888237280086566,0.6571428571428571,0.9510116595444613,1.0,7/30,12.18%,VAV3;RDX;RAP1GAP2;RIN3;LARS1;MSN;MTOR
prerank,protein autoprocessing (GO:0016540),0.37553296046886386,0.8887368983257558,0.5786061588330632,0.9420756062033719,1.0,5/17,23.41%,SPRTN;CTSL;CASP1;AFG3L2;CASP4
prerank,muscle cell migration (GO:0014812),-0.3793678466440708,-0.8884443094688832,0.6269315673289183,0.9507406538208939,1.0,5/10,22.01%,CCN3;SIX1;ITGB1BP1;ROCK1;MEGF10
prerank,positive regulation of dendritic spine development (GO:0060999),-0.30352125086826787,-0.888443252484328,0.6253521126760564,0.9495543849417536,1.0,4/20,9.69%,SHANK3;NLGN1;LRP8;SHANK1
prerank,regulation of neuron projection arborization (GO:0150011),-0.33813911184619344,-0.8884323790101096,0.6039119804400978,0.9483832143155925,1.0,4/15,7.74%,FZD4;MYO9A;NTNG1;MFSD2A
prerank,microtubule anchoring (GO:0034453),0.41367105780163155,0.8883822395310983,0.5983193277310924,0.942259444197476,1.0,2/12,9.79%,DAG1;SAXO2
prerank,histone H4-K8 acetylation (GO:0043982),0.3985263333530773,0.8866123808499796,0.5888157894736842,0.9447997247992002,1.0,7/15,25.66%,OGT;JADE1;WDR5;KANSL1;MEAF6;KANSL3;JADE2
prerank,histone H4-K5 acetylation (GO:0043981),0.3985263333530773,0.8866123808499796,0.5888157894736842,0.9447997247992002,1.0,7/15,25.66%,OGT;JADE1;WDR5;KANSL1;MEAF6;KANSL3;JADE2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3297833641750888,0.8861202621520173,0.6296296296296297,0.9452241589099302,1.0,5/38,4.62%,SERPINE1;SP100;CFLAR;RFFL;SFRP1
prerank,carbohydrate transport (GO:0008643),-0.3646249173310888,-0.886019988125047,0.601010101010101,0.9529259145997587,1.0,2/11,10.32%,SLC26A6;AQP11
prerank,neuron fate commitment (GO:0048663),0.3952590724592817,0.8860181976823287,0.6164383561643836,0.944872588847166,1.0,2/14,3.55%,ASCL1;TGFBR1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4043026192029616,0.8859222041834486,0.6042402826855123,0.9444981630457537,1.0,5/12,13.05%,THRB;CTSH;BRD8;KLF9;CTSL
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3093533190527078,0.8852227997127304,0.6095890410958904,0.9453990652789913,1.0,10/50,12.94%,SASH1;CCL19;IL12B;NMI;EGFR;ACTN4;DDX3X;TRIP6;CD14;PDCD4
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3885159044831709,0.8850729436407946,0.6228668941979523,0.9451415761164319,1.0,5/15,21.01%,ZFP36L1;BCL2L11;REST;HNRNPU;ZFP36L2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.30065833236756745,0.8850701439567294,0.6573248407643312,0.9445919502615134,1.0,10/72,10.81%,RUNX1;CFLAR;GAS6;IRAK2;AXL;TSLP;RNF31;IRAK3;RNASEL;ABCE1
prerank,primary neural tube formation (GO:0014020),0.33987130478275396,0.8847472359075567,0.5942249240121581,0.9446959581272363,1.0,7/30,14.18%,DLC1;PRICKLE1;MTHFR;SKI;LMO4;TSC2;PLXNB2
prerank,base conversion or substitution editing (GO:0016553),0.40869911189348956,0.8847177146097961,0.6075268817204301,0.9441983997805425,1.0,1/11,1.93%,A1CF
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.4089685690209952,0.8844899072282059,0.6064400715563506,0.9441158271996597,1.0,2/12,5.23%,APOE;LDLR
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.35276728923393824,-0.8844141838579328,0.6157517899761337,0.955723023286196,1.0,3/12,20.37%,SKAP1;CD44;AGER
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.30481994876689245,0.8841432707924207,0.6388526727509778,0.9442555833962184,1.0,13/65,13.08%,ERRFI1;AREG;TGFA;EPGN;CDC42;EPS15;EGFR;SPRY2;HBEGF;EGF;EPS15L1;PTPN3;MVP
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.3425934330296647,0.8841408836488622,0.6116788321167883,0.943708679102785,1.0,6/27,15.79%,TNRC6B;MAP2K1;WTIP;EGFR;MYCN;BMP4
prerank,chromosome condensation (GO:0030261),-0.26896234814936726,-0.8840700007988244,0.6363636363636364,0.9553728968455664,1.0,23/36,41.33%,MCPH1;NCAPD3;SMC4;TOP2A;GPER1;KMT5A;NCAPH;NCAPG;TTN;SET;H1-0;CDK1;PLK1;BANF2;NCAPG2;NUSAP1;RB1;DFFB;ERN2;SMC2;NCAPD2;CSNK2A1;CSNK2A2
prerank,acyl-CoA metabolic process (GO:0006637),0.3323069924960218,0.8839151139893207,0.6347569955817378,0.9435885535184285,1.0,8/35,17.80%,ACOT11;ACOT6;ACOT2;SUCLG2;ACSF2;ACOT9;HMGCS1;OXSM
prerank,oogenesis (GO:0048477),-0.32928589029296595,-0.8837603012000641,0.6217616580310881,0.9548860180618428,1.0,7/15,33.77%,FMN2;PTN;MEI4;TRIP13;KMT2D;PIWIL2;IHO1
prerank,mitotic nuclear membrane organization (GO:0101024),-0.25423116117731887,-0.8834643181266233,0.6846153846153846,0.9532090040169706,1.0,19/51,29.36%,NUP93;NUP35;NUP160;VRK1;PPP2R2A;RANGAP1;EMD;SEC13;NUP155;CCNB2;VPS4A;CHMP2B;NUP85;NUP43;CHMP4B;CHMP4A;CHMP4C;CDK1;LBR
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.25423116117731887,-0.8834643181266233,0.6846153846153846,0.9532090040169706,1.0,19/51,29.36%,NUP93;NUP35;NUP160;VRK1;PPP2R2A;RANGAP1;EMD;SEC13;NUP155;CCNB2;VPS4A;CHMP2B;NUP85;NUP43;CHMP4B;CHMP4A;CHMP4C;CDK1;LBR
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.3916736709647037,0.8833614349571791,0.6016666666666667,0.9441501102267813,1.0,5/14,14.57%,ZEB1;OSR1;SPRY2;SPRED3;SPRED1
prerank,peptidyl-asparagine modification (GO:0018196),-0.28390177683225526,-0.8829265097422704,0.6784565916398714,0.9533147535967647,1.0,9/31,17.11%,ST6GAL1;FUT8;DPM1;UBE2J1;UGGT1;MGAT5;DPM3;RPN1;DPM2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.2907862037810835,0.8827415940639891,0.6392405063291139,0.9448277949162919,1.0,16/80,15.43%,DENND2A;BAIAP3;RHOBTB3;LMAN1;STX16;RBSN;DENND5A;HEATR5A;GOSR2;SNX12;RAB7B;ARL1;TRAPPC10;TMEM87B;BET1L;PIKFYVE
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3742782105604332,0.8826286854517154,0.5730337078651685,0.9445069719976902,1.0,8/19,24.59%,SREBF1;PRKN;VDAC1;HTT;ATP13A2;HAX1;HDAC6;SREBF2
prerank,vasoconstriction (GO:0042310),0.4187621406398813,0.881643093040266,0.6133093525179856,0.9459338757360723,1.0,1/11,1.15%,SLC8A1
prerank,negative regulation of anoikis (GO:2000811),0.3946262293989657,0.8815716591014374,0.5951134380453752,0.9455068538479383,1.0,3/14,6.32%,BCL2;TLE1;SRC
prerank,modulation by host of symbiont process (GO:0051851),-0.2768252965916266,-0.8814648066123066,0.6465256797583081,0.955653357031373,1.0,8/31,16.46%,LEF1;CHD1;SNW1;INPP5K;CX3CR1;JUN;EP300;TFAP4
prerank,negative regulation of biosynthetic process (GO:0009890),0.3867049131876516,0.8812026688328652,0.6146341463414634,0.94570961305971,1.0,4/16,14.08%,EMILIN1;SLC30A10;SLC18A2;ABCD2
prerank,sodium ion export across plasma membrane (GO:0036376),0.4006630930656191,0.8805983519548793,0.6057046979865772,0.9464559358502028,1.0,2/13,6.90%,ATP1A2;ATP1B2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.3858930345415736,0.880186992575891,0.6123778501628665,0.9467760546448606,1.0,4/17,9.03%,PBX1;MAML3;RBPJ;KAT2B
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.3480183856874409,-0.8800073753931509,0.6153846153846154,0.958006574931981,1.0,8/12,44.16%,FOXP1;KLF4;TLR4;LPL;OAS3;MBP;TNF;F2RL1
prerank,histone H2A ubiquitination (GO:0033522),0.37443607537427653,0.8798279089180211,0.5937984496124031,0.9469186811554957,1.0,3/17,6.56%,UBR2;BCOR;CUL4B
prerank,tryptophan catabolic process (GO:0006569),0.4118101794942586,0.8797560420668856,0.6115992970123023,0.9465100300961328,1.0,2/11,6.98%,TDO2;KYNU
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3449413912172529,0.8797185340331578,0.6142649199417758,0.9460428829902571,1.0,1/29,1.21%,ARRDC4
prerank,fatty acid catabolic process (GO:0009062),0.29338121636669806,0.8796304560082489,0.6402048655569782,0.9456652735673644,1.0,11/67,14.08%,PCCA;PCCB;NUDT7;ECHDC2;MMUT;ECI1;ECHS1;ABHD3;PEX2;DECR1;ABCD2
prerank,regulation of protein polymerization (GO:0032271),0.3360198912133423,0.8796294808638643,0.6318051575931232,0.945117284796444,1.0,5/35,10.81%,ARHGAP28;PLEKHG2;ARHGAP18;ARL2;TTBK1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.31846733992782167,0.8793065163102959,0.6501950585175552,0.9452392674629302,1.0,6/44,8.93%,ROCK2;TNRC6B;ZFP36L1;CPEB3;TNRC6A;METTL14
prerank,membrane lipid catabolic process (GO:0046466),-0.37084664118695443,-0.8792227938738301,0.6459770114942529,0.9586536236892111,1.0,2/10,3.34%,ENPP2;PPT1
prerank,actin filament-based transport (GO:0099515),0.362819588761227,0.8789801441397219,0.6214953271028038,0.9453746405297386,1.0,4/21,9.37%,SYNE2;MYO1B;MYO1C;ACTN4
prerank,positive regulation of lyase activity (GO:0051349),-0.3454494898615998,-0.8789246512133171,0.651219512195122,0.9582051996914847,1.0,5/14,14.40%,NOS3;NOS1;ISCU;NF1;CACNA1D
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.2926803716729294,0.8786295967236775,0.6469849246231156,0.9454957445724063,1.0,20/72,26.21%,ENPP1;OGG1;CUL4B;GTF2H5;REXO4;DXO;DNASE1L1;DCP1A;DDX1;DICER1;XPA;RFC5;EXD2;FAN1;ERCC3;ERCC2;SPO11;MRE11;RAD50;RNASE4
prerank,sterol biosynthetic process (GO:0016126),0.33817412816280923,0.8783196383110604,0.6375545851528385,0.9455691076447362,1.0,5/33,9.75%,PRKAG2;INSIG2;APOA1;MVK;IDI1
prerank,mesoderm formation (GO:0001707),0.3856492600052047,0.8780664106969935,0.6409017713365539,0.9455519381754274,1.0,3/17,9.55%,ITGA3;CRB2;ITGB3
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.3045210672686521,-0.8780377068200855,0.6330532212885154,0.9590799131267106,1.0,10/21,28.25%,MBOAT1;PLA1A;PLAAT3;LPCAT3;PLA2G4F;PLA2G4E;PLA2G4B;LPCAT4;MBOAT2;PLA2G5
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.36691002001577055,0.878014678904122,0.6174603174603175,0.9451121614860206,1.0,5/20,10.51%,TNRC6B;WTIP;HELZ;TNRC6A;EIF6
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3127528295747676,0.8780039231069645,0.6593406593406593,0.9445860704011485,1.0,16/51,19.42%,NRK;DTNBP1;NTF3;LRRK2;ALS2;MAP4K4;TAOK3;GAS7;WASF1;EPB41L3;TRIO;MYO16;DICER1;NYAP1;TAOK1;BDNF
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4211557049046511,0.8779809619605997,0.6141592920353982,0.9435445012422807,1.0,2/11,4.30%,INPP5A;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4211557049046511,0.8779809619605997,0.6141592920353982,0.9435445012422807,1.0,2/11,4.30%,INPP5A;SYNJ2
prerank,response to exogenous dsRNA (GO:0043330),0.3710247246587627,0.8778812175381209,0.6261682242990654,0.9432035275968633,1.0,5/18,13.34%,COLEC12;RFTN1;IRAK3;IFNK;MUL1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.369427334536385,-0.8777877224497859,0.6274944567627494,0.9584947742647362,1.0,6/10,37.62%,CRY1;WDR76;CCAR2;RPA2;RFWD3;THOC5
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.2932162862066245,0.8777801682532164,0.6841448189762797,0.9428617768811912,1.0,8/76,7.90%,ADRA1B;ACTN2;LTB4R;VIP;LHCGR;AGTR1;LPAR1;DRD3
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.38014702683541746,-0.8769834788778899,0.6107226107226107,0.9592537056171802,1.0,5/10,26.78%,CALM1;CALM3;CBARP;CRHR1;FMR1
prerank,embryonic appendage morphogenesis (GO:0035113),0.4008664176983688,0.8769004100844944,0.6083032490974729,0.9440962783157832,1.0,2/12,5.96%,CYP26B1;SKI
prerank,intracellular sterol transport (GO:0032366),0.3929516225224755,0.8767120905941699,0.5966666666666667,0.9439256988519414,1.0,2/13,5.38%,ABCA1;STAR
prerank,glucose transmembrane transport (GO:1904659),-0.32205904731077906,-0.87617498278975,0.6297297297297297,0.9599369370145545,1.0,2/18,2.95%,SLC2A1;PPARD
prerank,negative regulation of calcium ion transport (GO:0051926),0.38717898575908904,0.8761168123418682,0.6134868421052632,0.9445645396722567,1.0,4/15,15.62%,ATP1A2;ADRA2A;CD33;TMBIM6
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3835851455135526,-0.8757067931011091,0.5688073394495413,0.9598322550117702,1.0,8/10,56.13%,CCT8;CCT6A;CCT7;CCT2;TCP1;DKC1;WRAP53;CCT4
prerank,toll-like receptor signaling pathway (GO:0002224),0.28625311351780414,0.8755307365368203,0.6605392156862745,0.9452160755609927,1.0,32/84,26.79%,COLEC12;RFTN1;IRAK2;TLR6;IRAK3;NMI;TNIP2;CD14;CTSL;RIPK2;PIK3R4;UBE2D1;MAPKAPK2;TNIP1;EPG5;TLR5;TIRAP;SFTPA1;SFTPA2;BIRC3;LGALS9;MYD88;BIRC2;CNPY3;ITGAM;FADD;TICAM1;NR1H4;HMGB1;IRAK4;CTSK;RIPK1
prerank,ovarian follicle development (GO:0001541),0.40027168534915303,0.8754856716823071,0.6142857142857143,0.944765599570102,1.0,4/13,11.39%,KIT;LHCGR;EIF2B4;CEBPB
prerank,cardiac ventricle development (GO:0003231),-0.3120524233149369,-0.8747366772235348,0.6472222222222223,0.9609776187404311,1.0,9/20,21.45%,NOTCH1;PDE2A;HEY2;HES1;STRA6;HEY1;DLL4;HEYL;GJA5
prerank,cellular response to UV (GO:0034644),0.2911340192529946,0.8746949074234263,0.6765067650676507,0.9458379741009634,1.0,8/76,9.71%,MFAP4;MMP2;NEDD4;USP47;INO80;CUL4B;ZBTB1;STK11
prerank,embryonic axis specification (GO:0000578),-0.33269576756389796,-0.8742771586373206,0.6498740554156172,0.9608897188638298,1.0,5/15,19.61%,COBL;TASOR;STIL;PTCH1;FZD5
prerank,platelet aggregation (GO:0070527),0.33368474347016863,0.8741893985381626,0.6338880484114977,0.9462836279210118,1.0,10/33,15.81%,PDGFRA;GNAS;MYL12A;STXBP3;TLN1;VCL;ITGB3;STXBP1;FLNA;FIBP
prerank,tube closure (GO:0060606),0.3348955573414798,0.8740638571037171,0.6042296072507553,0.9459877037430057,1.0,7/31,14.18%,DLC1;PRICKLE1;MTHFR;SKI;LMO4;TSC2;PLXNB2
prerank,regulation of muscle cell differentiation (GO:0051147),0.3389855081662558,0.8737547496479856,0.6289592760180995,0.946049629812632,1.0,3/31,6.01%,IGF2;FGFR2;CDC42
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.28952627847184,0.8737540855607203,0.6604244694132334,0.9449664553031355,1.0,11/78,13.07%,SEC24D;DYNLL1;SEC31A;DYNC1H1;CTSF;DCTN6;CAPZB;AP1M1;SEC23A;CTSL;DYNC1I2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.28952627847184,0.8737540855607203,0.6604244694132334,0.9449664553031355,1.0,11/78,13.07%,SEC24D;DYNLL1;SEC31A;DYNC1H1;CTSF;DCTN6;CAPZB;AP1M1;SEC23A;CTSL;DYNC1I2
prerank,protein polymerization (GO:0051258),-0.246674687797759,-0.8733274433651306,0.7265917602996255,0.9618200445685097,1.0,25/55,26.01%,COBL;DIAPH1;SPIRE1;DIAPH3;GPX4;WASHC5;JAK2;MSRB2;FAM107A;UBE2K;TRPV4;TPPP3;CASQ2;ARL6;TTC17;UBE2S;TRIM6;CORO7;PSTPIP1;PREX1;CASQ1;AIF1;MID1IP1;CHMP4B;CHMP4A
prerank,calcium import into the mitochondrion (GO:0036444),0.41563340018425343,0.873176370721641,0.6283185840707964,0.9455787355391179,1.0,2/10,9.65%,MCU;MICU2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3344729709226286,0.8727410846790397,0.636231884057971,0.9458795164928454,1.0,8/33,16.32%,AREG;TGFA;EPGN;HBEGF;EGF;ADRA2A;PDE6G;AKT1
prerank,regulation of TORC1 signaling (GO:1903432),0.3288666534991965,0.8727125852726048,0.6260869565217392,0.9453961455630387,1.0,12/33,20.46%,TELO2;STK11;CASTOR2;RNF152;RRAGD;ITFG2;SESN2;ATM;DYRK3;SEH1L;SZT2;GPR137B
prerank,ganglioside biosynthetic process (GO:0001574),0.3888421730647872,0.8718488287566009,0.6341463414634146,0.9465775306645111,1.0,2/15,2.49%,ST6GALNAC5;ST3GAL5
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.30639724321521883,0.8714149001545918,0.6555697823303457,0.9469033216742523,1.0,10/57,13.13%,UACA;DAPK1;ASPH;PDCD5;BCAP31;CARD9;TTBK1;DDX3X;REST;RIPK2
prerank,protein polyubiquitination (GO:0000209),0.2541973590806315,0.8713903351848598,0.7697916666666667,0.9464103411000154,1.0,66/297,19.31%,SPSB1;HECW2;SASH1;BCL2;PELI2;FBXL17;FBXL19;UBR2;NEDD4;SMURF2;RFFL;RNF213;PSME4;BFAR;RNF31;TRIP12;UBE4B;UBE2U;FBXL3;UBE2V2;ANAPC5;UBOX5;FBXO28;PRKN;ITCH;IFI27;RNF6;RNF152;FBXO9;FBXL12;FBXO11;ERCC8;FBXO4;KBTBD7;RNF217;BTRC;TNKS2;MUL1;RC3H2;UBE2E2;FBXO38;RNF19A;THOP1;AMFR;UBE2D1;UBR5;DZIP3;HACE1;SPOP;HUWE1;UBE2R2;NHLRC3;UBE3B;PSMB5;RNF135;UNKL;UBE3A;PSMC2;HERC6;PSMD4;RNF34;RC3H1;TRIM21;PSMD1;FBXL18;TRIM32
prerank,polyol biosynthetic process (GO:0046173),-0.3243980114909642,-0.8709540235683364,0.6428571428571429,0.9661428564721365,1.0,4/16,11.37%,ACER3;IP6K1;ISYNA1;IPMK
prerank,mitochondrial translational elongation (GO:0070125),-0.22158946931532292,-0.870393745222507,0.772972972972973,0.966261786833238,1.0,32/88,31.54%,GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS12;MRPL4;MRPS26;MRPL21;MRPL44;MRPS33;MRPL48;MRPL55;MRPL57;MRPL42;MRPS18B;MRPS10;MRPS21;MRPS7;MRPL34;MRPL15;MRPL19;MRPS22;MRPS31;MRPL38;MRPL12;MRPL28;MRPL43;MRPL54;MRPS14;AURKAIP1;MRPL2
prerank,Notch signaling involved in heart development (GO:0061314),-0.3542949257097505,-0.8701720341228182,0.6458333333333334,0.9655680467479343,1.0,7/11,24.44%,NOTCH1;HEY2;GALNT11;HEY1;DLL4;HEYL;SNAI2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.31104123587281696,-0.8700222070882216,0.6457286432160804,0.9647486225583984,1.0,8/17,31.03%,EMC3;EMC9;CAMLG;MMGT1;SGTA;EMC4;GET3;GET1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.22395888536831424,-0.8698929081723539,0.7640449438202247,0.9638982054895281,1.0,28/96,21.90%,NUP93;NUP35;NUP160;NUP153;EIF4E;NUP54;RBM8A;ALYREF;HHEX;CHTOP;YTHDC1;SRSF7;HNRNPA2B1;SEC13;NUP155;DDX19B;RANBP2;SMG7;DHX38;GLE1;NUP88;MCM3AP;THOC6;SRSF4;NUP62;DDX25;NUP85;SLBP
prerank,anterior/posterior pattern specification (GO:0009952),0.3060779529477736,0.8696509598523677,0.6418918918918919,0.949309560331778,1.0,8/53,13.32%,WLS;TGFBR1;SKI;HES7;BMP2;HOXC5;BHLHE41;ATP6AP2
prerank,mRNA 3'-end processing (GO:0031124),0.28713337854429155,0.8696233495370952,0.6897856242118537,0.9488163480380847,1.0,25/78,26.15%,POLR2D;U2AF1L4;THOC2;DDX39A;WDR33;MAGOHB;PAF1;SRSF5;PCF11;TENT4B;PAPOLG;CDC73;FIP1L1;CPSF2;SRSF3;LEO1;SCAF8;NCBP2;PAPOLA;CASC3;PAPOLB;SLU7;GRSF1;SSU72;AHCYL1
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.26629777513956115,-0.8695518133512289,0.7107142857142857,0.9635145646471284,1.0,14/42,24.38%,SPOCK1;NOTCH1;FZD4;VIT;EMP2;JAK2;NF1;CORO1C;NDNF;LIMS1;CORO2B;MINK1;TBCD;DMTN
prerank,immunoglobulin mediated immune response (GO:0016064),0.41530659524322056,0.8694737734403505,0.6198501872659176,0.9485539856149147,1.0,2/10,10.78%,GAPT;CARD9
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.29471975440389836,0.869278385113018,0.6547770700636942,0.9484307098108641,1.0,26/66,22.95%,DACT1;APPL2;INO80;EGFR;RBL2;DDX3X;RGCC;JADE1;KMT2E;PTEN;UBE2E2;ADAMTS1;TFDP1;AKT1;KANK2;CDK2AP2;CDKN2C;CDC73;MYO16;LSM10;APPL1;PSME3;CCND2;PLCB1;DLG1;PKD2
prerank,tRNA transport (GO:0051031),-0.27032209258180884,-0.8688793475461007,0.6818181818181818,0.9640002282326912,1.0,11/35,21.43%,NUP93;NUP35;NUP160;NUP153;NUP54;SEC13;NUP155;RANBP2;NUP88;NUP62;NUP85
prerank,DNA metabolic process (GO:0006259),0.25451954108931585,0.8687584851630705,0.7608465608465609,0.9489213590689947,1.0,75/270,25.45%,TCF7L2;SP100;PDS5B;OGG1;PSME4;AXIN2;LIG4;RAD51B;NEIL1;INO80;DMC1;POLG;TOP3B;TOP2B;UBE2U;REXO4;POLL;RECQL5;POLE3;KMT5B;UBE2V2;ZBTB1;DNASE1L1;DNASE2;DDX23;MCM2;FANCC;RAD18;UVRAG;TERF2;MNAT1;MBD4;RAD51D;RTEL1;SMARCB1;XRCC2;ATM;TIMELESS;KPNA2;ALKBH1;LONP1;PRIMPOL;CDC7;ENDOV;KAT5;XPA;RAD54L;SUMO1;RFC5;USP3;EXD2;LIG1;FAN1;UBE2T;MUTYH;RMI2;CBS;DNMT1;NSMCE4A;ERCC3;FANCA;NOC3L;SMARCAD1;POLI;BRCA1;MSH6;MPG;TDG;NABP2;HMGB3;MRE11;POLE2;ATRIP;MCM6;MMS19
prerank,inorganic ion transmembrane transport (GO:0098660),-0.35558383061475995,-0.8686712991282411,0.6244019138755981,0.9633427583052959,1.0,8/12,39.33%,ABCC9;CACNA1H;KCNJ8;ABCC8;PKD2L1;P2RX3;KCNJ11;RHAG
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.33773642419664834,0.867860289051668,0.6238805970149254,0.9501635139302532,1.0,5/29,11.79%,RUNX1;YAP1;STRN3;FOXA1;UFL1
prerank,tryptophan metabolic process (GO:0006568),0.4072881312607248,0.8677893258584481,0.6135593220338983,0.9497820595602602,1.0,2/11,6.98%,TDO2;KYNU
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.23208891918693478,-0.867773846428575,0.7621621621621621,0.9642940038368236,1.0,17/73,20.37%,PTPRJ;IFIH1;THBS1;PLCG2;IL33;ARHGEF2;LBP;JAK2;APP;NOD2;PTPRC;TLR4;CD86;CLU;DHX9;FZD5;AGER
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.3306460770028853,-0.8676794341608075,0.6317073170731707,0.9633661364003127,1.0,9/15,45.61%,CCT8;RUVBL1;RUVBL2;SHQ1;CCT6A;NHP2;NOP10;CCT7;CCT2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3601787802882043,-0.8676702172682159,0.6416861826697893,0.9622346894426776,1.0,2/11,11.55%,MSH3;ZRANB3
prerank,mitotic recombination (GO:0006312),0.37736005239367054,0.8671636892510638,0.6193656093489148,0.9504811182212319,1.0,5/15,14.51%,DMC1;SMC5;SMC6;TEP1;RAD51D
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.26760059362624755,-0.8666099117846208,0.65625,0.9634886818081275,1.0,12/33,23.67%,NET1;RPS3;SIRPA;RHOB;PLEKHA1;SIRT1;TNFAIP3;ECT2;SIGMAR1;ANXA1;RNF112;MAPK7
prerank,carboxylic acid metabolic process (GO:0019752),0.3259218125168465,0.8665949234379413,0.6488888888888888,0.9510703975949214,1.0,5/33,11.25%,PTGIS;PLA2G4A;DDO;CYB5A;LIAS
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.40266820932564074,0.8663801647525322,0.6335078534031413,0.9509518753664711,1.0,3/13,6.80%,PYCR1;LRRK2;NFE2L2
prerank,kinetochore organization (GO:0051383),0.39078161111566295,0.8662274657804324,0.6149825783972126,0.9507188672466164,1.0,4/13,18.69%,CENPC;CENPH;POGZ;CENPA
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.2911757838370664,-0.8658595010004619,0.6666666666666666,0.9640467027511305,1.0,11/24,25.08%,ACKR3;KDM1A;TPT1;SIRT1;BCL2L1;CD44;CLU;TRIAP1;MIF;SNAI2;CCAR2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3153114662082894,0.8657530457667023,0.6657142857142857,0.9511210716435772,1.0,14/41,20.39%,OGT;PRKAG2;NUP107;NUP42;EIF6;RAE1;NUP98;NUP214;LACC1;GCK;SEH1L;TPR;PRKAG1;AAAS
prerank,morphogenesis of an epithelium (GO:0002009),0.3458599201615544,0.8655354617361128,0.6381987577639752,0.9510079003157662,1.0,3/25,6.99%,DAG1;FGFR2;VCL
prerank,RNA transport (GO:0050658),0.2924706842571009,0.8653924588206456,0.674775928297055,0.950741331540106,1.0,12/71,14.86%,RBFOX1;RFTN1;U2AF1L4;SIDT1;ZFP36L1;THOC2;HNRNPA1;DDX39A;RAE1;MAGOHB;NUP214;SRSF5
prerank,cell proliferation in forebrain (GO:0021846),0.41174430918991023,0.8651037255587695,0.6062271062271062,0.9507773449620125,1.0,3/10,20.26%,NUMBL;CEP120;AKNA
prerank,cytoplasmic translational initiation (GO:0002183),0.3713197124516452,0.8649751415648252,0.644122383252818,0.9505060394636538,1.0,8/17,24.18%,EIF4A2;EIF3A;EIF2S2;EIF2B3;EIF3I;RBM4;MCTS1;EIF2D
prerank,mesonephric tubule development (GO:0072164),0.380387947789831,0.86488173716393,0.6013179571663921,0.9501431967879345,1.0,3/15,8.10%,SALL1;FGFR2;OSR1
prerank,regulation of type I interferon production (GO:0032479),-0.21969949926214788,-0.8648583780246577,0.8022598870056498,0.9652885178815088,1.0,20/84,18.96%,IFIH1;RNF125;LRRFIP1;POLR3H;TRIM25;NLRC5;CGAS;G3BP1;TNFAIP3;PTPN22;EP300;IRF5;PRKDC;PCBP2;DDX41;IRF8;POLR2E;UFD1;DHX9;TAX1BP1
prerank,intracellular protein transport (GO:0006886),0.252725354231724,0.8648348644296135,0.7792746113989637,0.9496964303832752,1.0,56/304,16.60%,WLS;RABGAP1L;TBC1D4;KIF13B;USP6NL;RANBP17;SEC31A;NUP107;APPL2;PRICKLE1;TMED1;FAM53C;VPS26C;RAB23;STXBP3;LMAN1;ARFGAP3;FUT10;STX16;ADPRH;COX18;TRARG1;LTBP2;NUP42;IFT27;COPZ2;RAB22A;MYO1C;XPO7;ARFIP2;TBC1D2B;HEATR3;KATNB1;GGA2;TMED4;ARL1;CSE1L;COPA;PPP1R10;STXBP1;TLK1;STRADA;USO1;TSC2;ARF4;NUP214;SNX9;IFT22;LAMP2;ARF6;STX1B;ARL5A;AKT1;SNX31;TECPR2;RAB19
prerank,response to interferon-gamma (GO:0034341),0.2938401597942036,0.8645659368024414,0.6657997399219766,0.9497088711859499,1.0,6/67,6.98%,DAPK1;SP100;CCL19;CXCL16;CCL4;KYNU
prerank,organelle disassembly (GO:1903008),-0.27223095142657805,-0.864510985725894,0.6923076923076923,0.9649015310233738,1.0,6/33,11.40%,VRK1;MRRF;TEX264;ULK1;GFM2;UBA5
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.29147463008567875,-0.8634189313641516,0.6555555555555556,0.9662672123242261,1.0,5/23,14.68%,ELOVL7;FAR2;ELOVL5;TECR;HACD2
prerank,negative regulation of cell cycle (GO:0045786),0.2883925307163901,0.8630718609128224,0.6776232616940582,0.9522060587063307,1.0,17/73,16.25%,SMAD3;NR2F2;NUPR1;TSPYL2;CEBPA;BMP2;HEXIM2;INCA1;PTPN3;NR4A1;PDCD4;SIPA1;PTEN;GAS1;CDKN1C;BMP4;ZBTB17
prerank,regulation of aerobic respiration (GO:1903715),-0.3319589396140649,-0.8629571050503185,0.6708860759493671,0.9662840129400566,1.0,3/15,12.10%,CBFA2T3;SLC25A33;ATP7A
prerank,protein monoubiquitination (GO:0006513),0.3230235624919115,0.8629308097286376,0.6557142857142857,0.9519347124478066,1.0,17/36,26.41%,MGRN1;ATXN7L3;PRKN;RAD18;KLHL12;PAF1;HUWE1;UBE2R2;CDC73;WAC;TRIM21;UBE2T;LEO1;RNF20;UBE2E1;KBTBD8;RNF40
prerank,renal absorption (GO:0070293),0.4099948789177145,0.8623377347997858,0.624561403508772,0.9525886819944658,1.0,1/10,1.25%,GSN
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.34955773736220835,-0.862110727583416,0.6473429951690821,0.9670174219102649,1.0,3/12,11.72%,ESR1;LIN28B;TGFB1
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.34798139048948107,-0.8620571761642692,0.6359223300970874,0.9659943444739355,1.0,4/12,11.84%,CAV1;IFIH1;RALB;CGAS
prerank,glycoprotein metabolic process (GO:0009100),0.3031787248288022,0.8619660792940812,0.6622516556291391,0.9527750932577654,1.0,14/53,16.69%,GAL3ST2;PRKCSH;MAN1C1;LARGE1;ADAMTS9;NGLY1;ST6GALNAC6;GANAB;ENGASE;AGA;ERP44;GOLPH3;NEU4;MAN1A2
prerank,negative regulation of JNK cascade (GO:0046329),0.33078526254238794,0.8612054272866527,0.649923896499239,0.9537554711794229,1.0,7/31,12.94%,DACT1;NCOR1;PRKN;ITCH;TAOK3;DUSP19;PDCD4
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.3099153407552046,-0.8611393492363368,0.6517150395778364,0.9668964089870736,1.0,8/18,41.73%,CCT8;CEP135;CORO2B;TREM2;PTP4A3;CCT6A;CCT7;TNF
prerank,lysine catabolic process (GO:0006554),0.39815631729881196,0.8610478499323282,0.6144578313253012,0.9529732633660655,1.0,2/12,8.17%,PHYKPL;ALDH7A1
prerank,lysine metabolic process (GO:0006553),0.39815631729881196,0.8610478499323282,0.6144578313253012,0.9529732633660655,1.0,2/12,8.17%,PHYKPL;ALDH7A1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.354685175613696,-0.8609798314168392,0.6134259259259259,0.9649397827104962,1.0,8/11,32.53%,CALM1;CALM3;CASQ2;FKBP1A;CALM2;SRI;GSTO1;FKBP1B
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.354685175613696,-0.8609798314168392,0.6134259259259259,0.9649397827104962,1.0,8/11,32.53%,CALM1;CALM3;CASQ2;FKBP1A;CALM2;SRI;GSTO1;FKBP1B
prerank,cellular response to UV-A (GO:0071492),0.40124676258780306,0.860960066598998,0.6354344122657581,0.952595091856503,1.0,1/11,2.40%,MMP2
prerank,cellular response to type I interferon (GO:0071357),0.3166947997011991,0.8607005598378596,0.6461988304093568,0.9520105005127004,1.0,12/41,22.93%,SP100;IRF1;OAS2;STAT2;RNASEL;IFI27;IFIT2;IRF2;IRF9;RSAD2;MYD88;STAT1
prerank,type I interferon signaling pathway (GO:0060337),0.3166947997011991,0.8607005598378596,0.6461988304093568,0.9520105005127004,1.0,12/41,22.93%,SP100;IRF1;OAS2;STAT2;RNASEL;IFI27;IFIT2;IRF2;IRF9;RSAD2;MYD88;STAT1
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.3549963771117357,-0.8603356085569221,0.6334106728538283,0.964035583432924,1.0,2/11,5.51%,TNRC6C;NOTCH4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3549963771117357,-0.8603356085569221,0.6334106728538283,0.964035583432924,1.0,2/11,5.51%,TNRC6C;NOTCH4
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.3260564604465831,-0.8601243962746674,0.6683417085427136,0.9633717643629961,1.0,7/16,26.29%,TRIB2;TNFRSF21;JAK3;DLL1;AGER;VSIR;LILRB1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.33447024460387303,-0.8598785768804538,0.6720183486238532,0.9627635028574221,1.0,11/14,35.38%,PRKCZ;CD80;NFKBIZ;CD86;ANXA1;MALT1;RARA;NFKBID;NLRP3;SOCS5;MYB
prerank,positive regulation of protein deacetylation (GO:0090312),0.3884876023881418,0.8593027636598222,0.652991452991453,0.9542849461610311,1.0,6/14,21.30%,NNMT;AKAP8L;DYRK1A;NIPBL;SAP30BP;BRMS1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2714682402134349,-0.8589910185085146,0.6848484848484848,0.9635701393244867,1.0,10/31,27.93%,OTUD7B;OTUD7A;OTUD4;YOD1;TNFAIP3;BABAM1;BABAM2;USP7;OTUB2;USP33
prerank,negative regulation of leukocyte activation (GO:0002695),0.37957775190670895,0.8583656377225113,0.6293823038397329,0.955576134011601,1.0,3/15,14.87%,IL31RA;CD200;NR1H3
prerank,regulation of protein binding (GO:0043393),0.27139725477620075,0.858162878856749,0.7082833133253301,0.9554229640594459,1.0,23/114,16.32%,TCF7L2;LRP1;DACT1;VTN;RAPGEF2;LRRK2;DERL1;STK4;DAB2;BMP2;PRKN;TTBK1;NMD3;CTSZ;RIPK2;IFIT2;CFHR2;MARK2;HDAC4;AMFR;TMBIM6;BMP4;AKT1
prerank,axonal transport (GO:0098930),-0.266121285182273,-0.8578258484150451,0.7051282051282052,0.9649845082179191,1.0,13/36,22.95%,RAB21;SYBU;TMEM108;AP3B1;PAFAH1B1;KIF1A;DCTN1;HIF1A;BLOC1S5;AP3S1;KIF4A;HAP1;KIF1B
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.40470316610156476,0.8571789382488467,0.6419753086419753,0.9568030853984024,1.0,4/11,20.09%,ARID1B;ZMIZ1;ELOF1;SERTAD1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3850835176698133,0.856771957900015,0.6506024096385542,0.9570900307937537,1.0,4/13,15.79%,GLI2;VNN1;SHH;BMP4
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.3019878776968719,-0.8566484850525902,0.6705539358600583,0.9663440350964921,1.0,7/22,22.34%,B2M;CYRIB;CD55;FZD5;TRAF2;MAP3K7;MALT1
prerank,positive regulation of cytokinesis (GO:0032467),-0.2783907912658763,-0.8560821329159033,0.6850152905198776,0.9665068220449804,1.0,10/32,18.73%,PKP4;CIT;KIF20B;CDC14A;CSPP1;GIPC1;PRKCE;KIF23;ECT2;CUL3
prerank,skeletal muscle contraction (GO:0003009),0.3632816601698845,0.855982221649775,0.686046511627907,0.9580295602667374,1.0,3/19,10.44%,TNNT1;TNNC1;TNNT3
prerank,dephosphorylation (GO:0016311),0.25891187874173954,0.8559101096513693,0.7380952380952381,0.9576498954434371,1.0,28/147,17.91%,PPM1H;PPM1E;PTPN13;PLPP3;PXYLP1;PPP3CA;EPHX2;PTPN21;PTPRS;PTPN9;MTMR3;MTMR7;STK11;CTDSP2;PTPRM;PLPP5;PTPN3;PPP2R5D;BTRC;PTEN;PSPH;SDHAF2;PTPRA;DUSP12;UBLCP1;PPM1G;DUSP4;ACP6
prerank,endoderm formation (GO:0001706),0.31825429954423123,0.8558412375075393,0.660377358490566,0.9572485190554026,1.0,4/35,5.11%,COL11A1;MMP2;VTN;ITGB5
prerank,eye photoreceptor cell development (GO:0042462),0.37824613334415547,0.8556825463386942,0.6666666666666666,0.957007565916113,1.0,2/15,6.70%,TULP1;CRB2
prerank,detection of visible light (GO:0009584),0.37466808091758824,0.8547041746837071,0.6391231028667791,0.9583407841827172,1.0,1/16,2.71%,TULP1
prerank,negative regulation of B cell activation (GO:0050869),0.3577187886507067,0.8546345460508303,0.6488188976377953,0.9579413944737264,1.0,2/21,4.62%,LYN;SFRP1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2822047554409129,0.8543654235847533,0.6927860696517413,0.9579281245295924,1.0,11/79,13.07%,SEC24D;DYNLL1;SEC31A;DYNC1H1;CTSF;DCTN6;CAPZB;AP1M1;SEC23A;CTSL;DYNC1I2
prerank,neural tube closure (GO:0001843),0.32053776935032163,0.8540956949956382,0.6343612334801763,0.9579018509718427,1.0,7/34,14.18%,DLC1;PRICKLE1;MTHFR;SKI;LMO4;TSC2;PLXNB2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.35406531038241185,0.8540597210436324,0.6770491803278689,0.9574479354459304,1.0,8/20,26.72%,ZC3H7B;PRKRA;TSNAX;DICER1;AGO4;DROSHA;AGO3;PUM1
prerank,mitochondrial gene expression (GO:0140053),-0.2537012537694582,-0.8540116409340753,0.7237762237762237,0.9700606391344417,1.0,12/42,19.67%,TFB2M;NOA1;GFM2;SLC25A33;MRPS18A;MRPS12;FASTKD2;NDUFA7;MRPL57;MRPS18B;MRPS21;MRPS7
prerank,regulation of protein localization (GO:0032880),0.2989947064809957,0.8539927609736475,0.6859395532194481,0.9570448454372641,1.0,9/58,11.79%,RABGAP1L;WDPCP;DZIP1L;VIP;AFDN;PICALM;ITGB3;PLEKHM2;UFL1
prerank,mitotic cell cycle phase transition (GO:0044772),0.2556253597641502,0.8539681053650284,0.7411894273127754,0.9565568786162386,1.0,52/203,22.49%,CDK14;DYNLL1;NINL;CCNA2;OPTN;CEP152;PHLDA1;FBXL17;ACVR1;DYNC1H1;ALMS1;CUL4B;CUL5;BRSK1;FBXL3;FBXL12;YWHAE;MNAT1;ACVR1B;BTRC;DYNC1I2;HAUS1;HAUS3;PLK2;HAUS7;CEP192;CEP164;PHF8;CDKN2C;CDC7;CACUL1;ODF2;TAF2;PRKACA;CDKN1B;GSPT1;CDC23;USP37;CCND2;CEP250;PLCB1;AURKA;TUBG1;EPS8;CDK7;CCNG2;NES;NDE1;HAUS5;FBXW11;HAUS6;CCNE2
prerank,regulation of regulated secretory pathway (GO:1903305),-0.26036140479180103,-0.8539454442487494,0.7313915857605178,0.9690655820035454,1.0,13/34,23.15%,RIMS1;RAB27A;RIMS2;SYT1;SYT6;RAB3A;RAB15;SYN1;SYT4;SYT15;RIMS3;SYT5;GSK3B
prerank,mitochondrion localization (GO:0051646),0.3622798856689884,0.8537309429980264,0.6656,0.9564811636293449,1.0,4/19,13.78%,MARK1;LRRK2;MUL1;MARK2
prerank,negative regulation of immune effector process (GO:0002698),-0.33339972301514775,-0.8537011196587676,0.669833729216152,0.9684909505604562,1.0,2/13,6.27%,RPS19;CD55
prerank,regulation of ATP metabolic process (GO:1903578),0.2924289074833074,0.8532193441794611,0.6840052015604682,0.9569366742712365,1.0,15/54,20.39%,OGT;PRKAG2;NUP107;COX7A2;SPHK2;NUP42;EIF6;RAE1;NUP98;NUP214;GCK;SEH1L;TPR;PRKAG1;AAAS
prerank,inositol phosphate catabolic process (GO:0071545),0.4019997674598267,0.8530455423260538,0.6338514680483592,0.956739544409348,1.0,2/12,4.30%,INPP5A;SYNJ2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.2766895616540336,-0.8526269791366103,0.6887608069164265,0.96964040756656,1.0,12/29,27.76%,ELOVL7;PPT1;ELOVL5;TECR;HSD17B8;HACD2;PPT2;ACSL3;ACACA;CBR4;SCD5;ELOVL2
prerank,lymphocyte migration (GO:0072676),-0.2711982972674783,-0.8523213370089302,0.6994047619047619,0.9691516893810974,1.0,5/32,11.01%,S1PR1;CCL14;RET;CKLF;MSN
prerank,positive regulation of leukocyte activation (GO:0002696),-0.31133827281571136,-0.8516820749297196,0.6470588235294118,0.9694258418070159,1.0,6/18,16.96%,THBS1;IL33;LBP;KARS1;CRLF2;TLR4
prerank,response to steroid hormone (GO:0048545),0.3293311613904383,0.8514776339238698,0.6637426900584795,0.9591920051835724,1.0,4/31,5.52%,AR;ATP1A2;YAP1;TFPI
prerank,arachidonate transport (GO:1903963),0.40279598158723146,0.8510314314966564,0.6368515205724508,0.9589828767115374,1.0,2/10,7.90%,BDKRB2;DRD3
prerank,arachidonic acid secretion (GO:0050482),0.40279598158723146,0.8510314314966564,0.6368515205724508,0.9589828767115374,1.0,2/10,7.90%,BDKRB2;DRD3
prerank,DNA methylation (GO:0006306),0.3462439164439169,0.8508988781259583,0.6393939393939394,0.9586865453725659,1.0,10/23,25.25%,DNMT3A;SPOCD1;KMT2E;METTL4;DNMT3B;ATRX;N6AMT1;DNMT1;PPM1D;DMAP1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.38541809478267164,0.8507230515830245,0.6358885017421603,0.9584839285628223,1.0,4/12,13.80%,RESF1;TET1;PPHLN1;SETDB1
prerank,phosphate ion transport (GO:0006817),-0.3125498386964414,-0.8504494944345178,0.6838235294117647,0.9709318878309738,1.0,4/16,15.37%,SLC37A3;SLC25A30;SLC25A11;XPR1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.33583079286962264,0.8500075237797398,0.6295133437990581,0.9593048374582964,1.0,10/25,23.03%,RECQL5;WDR43;CDK12;TCERG1;NELFE;CDC73;HNRNPU;LEO1;HEXIM1;CDK13
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.2676805569214631,-0.8499839086570935,0.710801393728223,0.9708590240749649,1.0,4/30,10.86%,HSPA8;UGGT1;GAK;DNAJB14
prerank,regulation of keratinocyte migration (GO:0051547),0.4003681639488053,0.8494252922133453,0.6661211129296236,0.9598657815711854,1.0,5/12,16.18%,MAP4K4;MAPRE2;PTEN;ARF6;EPPK1
prerank,positive regulation of RNA splicing (GO:0033120),0.330753265825586,0.8494101281489324,0.6631892697466468,0.9593674306380072,1.0,6/29,16.14%,PIK3R1;HNRNPLL;RBM22;NUP98;DYRK1A;SLC38A2
prerank,outer dynein arm assembly (GO:0036158),0.38266262254226746,0.8491173054489702,0.6487394957983194,0.959386606891545,1.0,6/14,24.39%,DNAAF1;DNAAF5;DNAL1;DNAH8;ODAD1;ODAD4
prerank,positive regulation of cell adhesion (GO:0045785),0.28599432275830694,0.8486686652522867,0.7053682896379525,0.9597507827222589,1.0,17/74,17.28%,RHOD;TPM1;EPHA4;PPP3CA;ECM2;IL12B;AFDN;FOXC2;RSU1;ARL2;ITGAV;MDK;P4HB;FSTL3;ATM;CD47;LIF
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3217867498720875,-0.8483936924515987,0.6527093596059114,0.9730963282956518,1.0,9/16,40.37%,RAD17;TOPBP1;HUS1;HUS1B;CDC6;TICRR;RAD9A;RAD9B;CDT1
prerank,DNA repair (GO:0006281),0.24809370971057995,0.8479629260756433,0.8176100628930818,0.9605597511650101,1.0,89/284,25.50%,EYA1;PDS5B;OGG1;PSME4;HPF1;LIG4;RAD51B;USP47;NEIL1;INO80;CUL4B;GTF2H5;SPRTN;DCLRE1C;ERCC6L2;UBE2U;REXO4;POLL;RECQL5;KMT5B;UBE2V2;MLH1;COMMD1;ASCC3;ZBTB1;EXO5;ACTR8;BAZ1B;WDR33;TENT4A;TDP2;ERCC8;DCLRE1A;FANCC;RAD18;UVRAG;MNAT1;MBD4;FANCE;RAD51D;FANCI;HUWE1;XRCC2;ATM;TIMELESS;KPNA2;ALKBH1;PRIMPOL;ENDOV;DDX1;KAT5;XPA;RAD54L;UIMC1;FTO;SUMO1;KDM4A;RFC5;USP3;BRCC3;EXD2;LIG1;FAN1;UBE2T;EME2;MUTYH;RMI2;NSMCE4A;APLF;ERCC3;ERCC2;VCPIP1;FANCA;SETX;CENPX;POLI;BRCA1;MSH6;ATXN3;MPG;TDG;NABP2;MRE11;RAD51AP2;POLE2;ABL1;ATRIP;MMS19;RAD23B
prerank,positive regulation of macrophage activation (GO:0043032),-0.31214661042610425,-0.847741081948109,0.6590909090909091,0.9733725214626874,1.0,5/17,16.96%,THBS1;IL33;LBP;KARS1;TLR4
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3203337122678496,-0.8477367416579761,0.691358024691358,0.9722474646223531,1.0,1/15,0.26%,PRKCH
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.34767129766045546,-0.8475175225058783,0.6482412060301508,0.9715996150229098,1.0,4/11,12.30%,YBX3;ARHGEF2;CASP8;SLC25A4
prerank,ganglioside metabolic process (GO:0001573),0.36315972421098125,0.8473093347923871,0.6666666666666666,0.96128656924038,1.0,2/20,2.49%,ST6GALNAC5;ST3GAL5
prerank,histone acetylation (GO:0016573),-0.22695935579946627,-0.8470324216713708,0.7731481481481481,0.9714914934841277,1.0,18/69,18.84%,LEF1;JADE3;PHF20L1;TRIM16;KAT2A;TAF10;TADA2A;APBB1;PER1;RUVBL1;KAT6A;EP300;NAA60;BRCA2;MRGBP;SGF29;ZZZ3;YEATS2
prerank,regulation of DNA metabolic process (GO:0051052),-0.24749842742213723,-0.8469796040905232,0.7427652733118971,0.970502991160773,1.0,17/44,31.04%,POLH;SUB1;ALYREF;HNRNPD;PDGFA;MPHOSPH8;NBN;YLPM1;PARG;UBE2V1;WRNIP1;HELB;USP1;WDR18;PIF1;TICRR;IL7R
prerank,negative regulation of leukocyte migration (GO:0002686),-0.35489503197681704,-0.8463456050982149,0.6780045351473923,0.9707828343095501,1.0,1/10,0.43%,SLIT2
prerank,mitochondrial transport (GO:0006839),0.29633903258753336,0.8462007835438209,0.6859838274932615,0.9628577454829764,1.0,8/53,11.14%,BCL2;SLC25A24;TIMM17B;COX18;BCAP31;TIMM44;TIMM9;TSPO
prerank,response to acidic pH (GO:0010447),-0.339184696543272,-0.8460590990875622,0.6658986175115207,0.9702799348101384,1.0,5/13,25.56%,LGMN;GPR4;RAB11FIP5;CTSS;PKD2L1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.30578281007129826,0.8460078642860535,0.686429512516469,0.9626902181751952,1.0,7/47,12.01%,PID1;PDGFRB;AGTR1;TLR6;SLC5A3;DCXR;F2
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.35688847236620663,-0.8458067166549162,0.6614699331848553,0.9685667336121084,1.0,3/10,22.11%,VLDLR;AP2A1;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.35688847236620663,-0.8458067166549162,0.6614699331848553,0.9685667336121084,1.0,3/10,22.11%,VLDLR;AP2A1;AP2M1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.21936356818847308,-0.845720253399335,0.8073394495412844,0.9676398508454678,1.0,24/74,24.68%,NOTCH1;EGLN3;RBX1;EGLN2;VEGFA;PSMF1;PSMB8;PSMB2;PSMA4;PSMB10;HIF1A;HIGD1A;EP300;CUL2;CITED2;PSMC4;PSMD9;PSMD5;PSMA6;PSMD11;VHL;PSMA8;BACH1;PSMB1
prerank,cellular response to starvation (GO:0009267),0.2590239327257277,0.84564325564962,0.7631874298540965,0.9628669449449963,1.0,42/147,22.00%,PRKAG2;NPRL3;SFRP1;PRKAA2;NUAK1;LRRK2;SIK1;EIF2AK3;SREBF1;BRSK1;MTMR3;HNRNPA1;SLC38A9;ATP6V1E1;CASTOR2;RNF152;WIPI1;CEBPB;LAMTOR2;RRAGD;IMPACT;PIK3R4;ITFG2;NPRL2;LAMP2;TBL2;FADS1;SESN2;FNIP1;MAP1LC3A;FOXO3;BECN1;SEH1L;PRKAG1;RHEB;WDR45;CARTPT;SZT2;GCGR;MLST8;CPEB4;ATP6V1B2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.2407305246568295,-0.8449680624269875,0.7058823529411765,0.968128009437444,1.0,12/48,16.07%,FNIP2;HIPK2;SNW1;CRIP1;DDIT4;SIRT1;BCL2L1;MCL1;DYRK2;BAK1;EP300;PRKDC
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.307810536573923,-0.8449370762729478,0.671957671957672,0.9670933133948462,1.0,6/18,23.99%,NUP93;HHEX;DDX19B;MCM3AP;DDX25;POLDIP3
prerank,regulation of vasculogenesis (GO:2001212),0.38107448073715267,0.8447927953852845,0.6490939044481054,0.9640068988912014,1.0,2/14,4.45%,RIN2;RAPGEF2
prerank,regulation of cytokine production (GO:0001817),0.2638484699036797,0.844156264623475,0.7494279176201373,0.9646543712828435,1.0,26/126,16.67%,LYN;LGR4;PLA2R1;IGF2BP2;TWSG1;BCL6;BATF;DTX4;IL12B;CD28;MAST2;CCN4;NFAM1;CARD9;RGCC;ADRA2A;TBK1;SYT11;GLMN;ERMAP;ASB1;MAPKAPK2;PLD4;CD47;IGF2BP1;ZBP1
prerank,regulation of defense response to virus by host (GO:0050691),-0.2682736039622911,-0.8439877749264546,0.7203647416413373,0.9679609748846303,1.0,11/30,26.29%,TOMM70;AIM2;CGAS;TNFAIP3;PTPN22;TRIM6;DHX9;EIF2AK4;IFNLR1;TRIM44;LILRB1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.33758880919895884,0.8438844783904301,0.6708860759493671,0.9646616045808385,1.0,2/21,1.80%,RUNX1;LYN
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.32771643094119784,0.8438132414635198,0.6891495601173021,0.9642724861828227,1.0,3/26,6.90%,ACTN2;NEDD4;ATP1B2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3380031921794338,0.843294416764876,0.6656151419558359,0.9647078489471368,1.0,7/23,18.32%,REXO4;DNASE1L1;DNASE2;CECR2;KPNA1;KPNB1;DICER1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2912988673391418,0.8432584173916113,0.6918990703851262,0.9642460851586052,1.0,5/59,7.26%,CYP7B1;SLC27A5;ALDH1A2;HOGA1;CYP27A1
prerank,regulation of axon regeneration (GO:0048679),0.3844967706273352,0.842841260866451,0.6508474576271186,0.9645149054938956,1.0,2/12,5.20%,EPHA4;PTPRS
prerank,phagosome-lysosome fusion (GO:0090385),0.40237964969278184,0.8425878732193053,0.668488160291439,0.9644954593071466,1.0,3/10,15.43%,RAB7B;CLN3;PIKFYVE
prerank,regulation of mitochondrion organization (GO:0010821),0.3044165828391207,0.8424361636392981,0.7037037037037037,0.9642427777134209,1.0,8/47,13.40%,PID1;LRRK2;SREBF1;STAT2;PRKN;RHOT1;MUL1;VDAC1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.32758453916024133,0.842371075211144,0.6705882352941176,0.9638351395987251,1.0,3/30,4.62%,SLC27A5;ACSL1;ACOT2
prerank,regulation of mitotic cell cycle (GO:0007346),-0.19768794360785252,-0.8423375405450789,0.8877551020408163,0.9703348708167918,1.0,35/171,16.46%,AFAP1L2;CAV2;NEK7;IQGAP1;SDCBP;CUL1;BRINP3;EIF4E;ANGEL2;BRINP1;MEIS2;ANAPC16;ANAPC15;TAL1;ANAPC7;BORA;BTG2;SCRIB;KIF20B;BRINP2;LGMN;SIRT1;DYNLT3;TGFB1;PSMF1;THAP1;USP22;PSMB8;PSMB2;APP;PSMA4;PSMB10;BUB1B;UBE2S;TFAP4
prerank,myeloid cell differentiation (GO:0030099),-0.24290665569630074,-0.8422576513930177,0.765625,0.9694012650472483,1.0,16/47,20.00%,ZBTB16;RPS14;RPS19;HIPK2;PTPN2;TAL1;JAK2;UBA5;PRKX;INHA;KAT6A;JAK3;ZFPM1;INHBA;ALAS2;HCLS1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.22527490804513278,-0.8420780491256368,0.7971014492753623,0.9686663601420155,1.0,9/73,7.59%,CAV1;FNIP2;NGF;BCAR3;TFRC;NOS1;HSP90AB1;PAK1;ATP2B4
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.27038344191566155,0.841996563729974,0.7091346153846154,0.9640212946495198,1.0,26/94,23.12%,DYNLL1;NINL;CEP152;DYNC1H1;ALMS1;NPHP1;B9D1;FBF1;YWHAE;DYNC1I2;HAUS1;HAUS3;HAUS7;CEP192;CEP164;TMEM67;ODF2;AHI1;PRKACA;CEP250;TUBG1;KIF24;NDE1;HAUS5;HAUS6;SFI1
prerank,regulation of telomere capping (GO:1904353),-0.28365440928383345,-0.84171183177311,0.7114285714285714,0.9683391258368943,1.0,8/23,24.46%,NEK7;PKIB;HNRNPD;MAPK3;PNKP;NBN;MAPK1;USP7
prerank,phospholipid dephosphorylation (GO:0046839),0.3145099872812825,0.8416997569104301,0.6714285714285714,0.9640249486827493,1.0,6/37,10.69%,PLPP3;EPHX2;SYNJ2;MTMR3;MTMR7;PLPP5
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.22875252433799464,-0.8409985996763487,0.8148148148148148,0.9687516734714078,1.0,16/69,20.37%,PTPRJ;IFIH1;THBS1;PLCG2;IL33;ARHGEF2;LBP;JAK2;APP;NOD2;PTPRC;TLR4;CLU;DHX9;FZD5;AGER
prerank,regulation of sister chromatid cohesion (GO:0007063),0.37410633866650167,0.8409609251296138,0.6471600688468159,0.9648384873889528,1.0,3/12,15.39%,AXIN2;HDAC8;WAPL
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.38114931901483956,0.8406056871760299,0.6588235294117647,0.9649888115534431,1.0,4/13,20.09%,ARID1B;ZMIZ1;ELOF1;SERTAD1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3836927863345198,0.840182780401876,0.6440397350993378,0.965251055283554,1.0,5/13,28.27%,MDK;ETS1;NFAT5;RELA;IL6
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.3319976730606543,-0.840076468317508,0.6790123456790124,0.9695451038132246,1.0,5/13,29.82%,ANAPC15;CDK5RAP2;GEN1;LCMT1;DYNC1LI1
prerank,regulation of protein targeting to membrane (GO:0090313),0.32341579093675477,0.8397241359797563,0.6725403817914831,0.9655762330130947,1.0,1/28,0.61%,CEMIP
prerank,protein-DNA complex disassembly (GO:0032986),0.3701507768254284,0.8394803611064559,0.6530944625407166,0.9655042015892793,1.0,6/16,23.60%,SMARCC2;NFE2;SMARCD2;SMARCB1;ARID2;SMARCE1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3095613687782381,0.839044197299311,0.7045454545454546,0.9657856768101257,1.0,16/38,26.62%,LEPROT;LMAN1;LRRK2;RNF31;SREBF1;PRKN;HUWE1;RHOU;HPS4;ARIH2;HAX1;SREBF2;SH3GLB1;UBE2J2;VPS11;BAP1
prerank,negative regulation of intracellular protein transport (GO:0090317),0.3535062432931952,0.8390302247816297,0.6777777777777778,0.965286184219651,1.0,4/22,6.25%,SP100;RAB23;LMAN1;LRRK2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.3770588527091719,0.8389457884315037,0.6672240802675585,0.9649139555871887,1.0,2/14,4.13%,IL34;CSF1
prerank,positive regulation of cartilage development (GO:0061036),-0.30986083192368563,-0.838829642948248,0.7139175257731959,0.9709668471652468,1.0,3/17,5.24%,ZBTB16;ACVRL1;PKDCC
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3843032263691898,0.8384010578066002,0.6495575221238938,0.9654397430434292,1.0,5/12,21.82%,RECQL5;TCERG1;NELFE;HNRNPU;HEXIM1
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.27041776620315294,-0.8383364793119099,0.736986301369863,0.9708869335703272,1.0,12/26,29.00%,EIF4E;MEIS2;TAL1;HES1;LGMN;USP22;APP;CUL3;RPS6KB1;DUSP3;TTL;USP2
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.29974448621623045,-0.8381308641286701,0.7020725388601037,0.9701851310916816,1.0,7/18,29.78%,OTUD7B;APOD;CABP1;FLCN;GSK3B;MFHAS1;LATS1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.2753276754224727,-0.8377567110484243,0.7377521613832853,0.9698561980600632,1.0,4/26,13.25%,CAV1;LBP;IFI35;PTPN22
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3541949173206199,-0.837631655926185,0.672093023255814,0.9690107943126541,1.0,4/10,17.21%,NT5E;NT5C1A;UPB1;NT5C
prerank,endocardial cushion development (GO:0003197),-0.2952692480984984,-0.8372119071938254,0.7142857142857143,0.9687784687086916,1.0,10/21,21.00%,NOTCH1;NOS3;ACVRL1;TGFB2;TBX2;HEY1;BMPR2;HEYL;CRELD1;FOXF1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.25521786621473075,-0.8367445961399815,0.7436823104693141,0.9686224287349584,1.0,16/38,29.12%,NDUFC1;NDUFA6;NDUFA5;NDUFA8;NDUFB7;NDUFA7;NDUFA10;NDUFA3;NDUFS1;NDUFS5;NDUFS7;NDUFB3;NDUFAB1;NDUFV2;NDUFB4;NDUFV3
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.35608308809721656,-0.8366420187563556,0.6843373493975904,0.967725351598824,1.0,3/10,11.01%,MYO9A;OPHN1;MSN
prerank,megakaryocyte differentiation (GO:0030219),-0.34508037225571686,-0.836461739681984,0.6585365853658537,0.9669781909713965,1.0,4/11,16.70%,MED1;TAL1;UBA5;ZFPM1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.40706631758452555,0.8361547706331178,0.6535714285714286,0.9691958091231201,1.0,5/10,25.91%,TLR6;MIA3;AKT1;MYD88;TICAM1
prerank,protein localization to Golgi apparatus (GO:0034067),0.32363734585878523,0.8361487377882078,0.6732824427480916,0.9686789737697982,1.0,8/27,17.61%,OBSL1;OPTN;ARL1;ARL5A;GOLPH3;VPS13D;VPS13C;TMED10
prerank,positive regulation of TOR signaling (GO:0032008),0.3053952386933382,0.8359644976637896,0.6972222222222222,0.9685155268646292,1.0,12/40,21.04%,GAS6;TELO2;SLC38A9;LAMTOR2;RRAGD;FNIP1;GOLPH3;SEH1L;RICTOR;RHEB;GPR137B;MLST8
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.3075015756761223,-0.8359056340963572,0.699228791773779,0.967093895741115,1.0,6/18,13.57%,RDX;MTMR2;DNAJC13;RAB21;MSN;MAPK3
prerank,negative regulation of viral process (GO:0048525),-0.23422550349169033,-0.8358783647923596,0.7975206611570248,0.9660594773034862,1.0,21/57,30.72%,IFIH1;TRIM14;PPIA;SRPK1;FAM111A;TRIM11;N4BP1;TRIM6;TRIM62;PLSCR1;IFITM3;OASL;TRIM28;MID2;TRIM13;IFIT1;ISG20;ISG15;ZC3HAV1;TRIM35;UBP1
prerank,atrial septum morphogenesis (GO:0060413),0.39784871425175683,0.8358518545496597,0.6582278481012658,0.9681872538944273,1.0,2/10,4.60%,NOTCH2;ACVR1
prerank,DNA strand elongation (GO:0022616),-0.3032611353865916,-0.8357398223001984,0.6773399014778325,0.9652424697882356,1.0,9/18,35.59%,DCLRE1B;GINS3;NBN;MCM3;GINS2;POLD2;POLA1;TERT;MCM7
prerank,nucleoside catabolic process (GO:0009164),-0.34538388817866894,-0.8356756816773707,0.6843373493975904,0.9643106073556137,1.0,4/11,17.21%,NT5E;NT5C1A;UPB1;NT5C
prerank,regulation of macrophage differentiation (GO:0045649),0.3695690421209582,0.8355124664598637,0.6801292407108239,0.968286239560633,1.0,2/15,4.13%,IL34;CSF1
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.33919334864586514,-0.8354917276961622,0.6658653846153846,0.9635997950058587,1.0,8/11,37.72%,IP6K1;IPMK;PPIP5K1;ITPKB;ITPKC;IPPK;IP6K3;PPIP5K2
prerank,response to amino acid (GO:0043200),-0.2674283737346345,-0.8352404365530915,0.7253731343283583,0.963023327513871,1.0,7/31,12.18%,SH3BP4;GLRA1;GLRA2;SPAAR;LARS1;IPO5;MTOR
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.34158946793204903,0.8349431211387117,0.6837209302325581,0.9687963521694943,1.0,10/22,27.54%,ERI3;FTSJ3;ERI1;EXOSC7;EXOSC2;NOP14;ERI2;EXOSC8;KRI1;EXOSC9
prerank,fatty acid biosynthetic process (GO:0006633),-0.22269481525241946,-0.8348861611441079,0.8091286307053942,0.9626264035771348,1.0,25/63,32.46%,ELOVL7;ABHD2;ELOVL5;GPX4;DEGS1;TECR;HSD17B8;TECRL;PTGS2;ABCD3;HACD2;HACD3;ACACA;NDUFAB1;CBR4;LIPH;SCD5;LIPC;ELOVL2;ALOX5;XBP1;LPL;MLYCD;CYP2E1;HACD4
prerank,positive regulation of glucose metabolic process (GO:0010907),0.3753421212282232,0.8345226079265792,0.67008547008547,0.9690656949714775,1.0,2/14,4.56%,NNMT;SLC45A3
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.40328443811715187,0.8344164460973842,0.6590909090909091,0.9687516025383572,1.0,3/10,10.87%,KLF15;PRKAA2;SETD5
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.25141972568684834,0.8343503997983338,0.779134295227525,0.9683470423116218,1.0,49/184,23.26%,HECW2;DYNLL1;NINL;CEP152;APPL2;PSME4;DYNC1H1;ZFP36L1;INO80;ALMS1;ZW10;SIRT2;NPM2;NEK6;ANAPC5;RGCC;YWHAE;BTRC;DYNC1I2;HAUS1;HAUS3;HAUS7;CEP192;CEP164;UBE2D1;PSMB5;PSMC2;KLHL18;PSMD4;ODF2;PRKACA;PSMD1;APPL1;PSME3;CDC23;ZFP36L2;PSMA3;CEP250;AURKA;TUBG1;ERCC3;NDE1;HAUS5;HAUS6;ANAPC4;ERCC2;PSMC5;SFI1;PSMA2
prerank,sterol transport (GO:0015918),-0.2962994653446447,-0.8338066206422372,0.6895604395604396,0.9637069054087641,1.0,6/19,18.82%,CAV1;NPC2;OSBPL2;ARV1;OSBP;MSR1
prerank,positive regulation of catabolic process (GO:0009896),0.28060968117717,0.8337704555885248,0.7070967741935484,0.9689165216770701,1.0,6/65,5.67%,HECW2;DACT1;NKD1;NEDD4;SMURF2;VIP
prerank,protein dephosphorylation (GO:0006470),0.2563668141911682,0.8335026316236321,0.7724137931034483,0.968877900225628,1.0,15/135,10.29%,PPM1H;EYA2;PPM1E;PTPN13;EYA1;PPP3CA;PTPN21;PTPRS;PTPN9;MTMR3;MTMR7;RPAP2;STK11;CTDSP2;PTPRM
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.2817359742185956,-0.8334559478918111,0.7308868501529052,0.9633599905974526,1.0,7/23,15.73%,CBFA2T3;CRY1;GSK3A;PFKFB1;PLEK;GIT1;EP300
prerank,positive regulation of cholesterol efflux (GO:0010875),0.3478161754529389,0.8333963206692158,0.672782874617737,0.9685464579001885,1.0,3/21,4.39%,LRP1;APOE;APOA1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.38357135275670806,0.8332882248245261,0.6666666666666666,0.9682181202903727,1.0,3/12,8.37%,GMDS;SLC35A3;GFPT1
prerank,positive regulation of ERAD pathway (GO:1904294),0.3815393732782266,0.8320636780171875,0.6856649395509499,0.9699577175777967,1.0,5/13,13.12%,NFE2L2;RNF185;BCAP31;TMEM259;RNFT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.37434241287867565,0.831564688076827,0.6624605678233438,0.9698510476271345,1.0,3/15,7.09%,TNRC6B;ZFP36L1;CPEB3
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.37434241287867565,0.831564688076827,0.6624605678233438,0.9698510476271345,1.0,3/15,7.09%,TNRC6B;ZFP36L1;CPEB3
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.3051243663465301,-0.8313085440415627,0.6965174129353234,0.9664835515998877,1.0,5/16,27.29%,TUBB4B;LYST;RAET1E;CEBPG;CORO1A
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.33775805529093555,-0.8312544216441474,0.6577669902912622,0.9655110491196937,1.0,7/12,37.01%,PPARGC1A;MTLN;TWIST1;IRS2;MLYCD;NR4A3;PLIN5
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.3236364755333568,0.8311910494048282,0.6923076923076923,0.9700016464566733,1.0,5/29,9.87%,PLEKHH2;KANK1;LIMA1;MYADM;PRKN
prerank,cation transmembrane transport (GO:0098655),0.3040903362598936,0.8309194033891492,0.7111716621253406,0.9699795631699385,1.0,4/44,5.57%,SLC7A2;ATP1A2;SLC6A9;SFXN2
prerank,mammary gland epithelium development (GO:0061180),-0.31889010618696156,-0.830589817739143,0.6848341232227488,0.9657739664376186,1.0,4/14,10.10%,ERBB4;JAK2;ID2;SCRIB
prerank,stress-activated MAPK cascade (GO:0051403),-0.22534914353441723,-0.8303369674056962,0.8117154811715481,0.9652351976266942,1.0,26/61,30.60%,NOD1;TNFRSF19;CUL1;MAPK10;MAPK8;MAPK3;MAP4K3;ARHGEF6;NOD2;TAB1;MAP3K11;UBE2V1;MAP2K3;CHUK;MINK1;MAP3K7;MAPK1;MAPK11;MAP2K4;GPS2;TRAF6;RPS27A;UBC;PTGER4;IKBKG;MAP3K10
prerank,membrane raft organization (GO:0031579),0.365050900729234,0.8302340576344098,0.6475409836065574,0.970698663458641,1.0,6/15,19.81%,RFTN1;MYADM;CLN3;NPC1;YJEFN3;ABCA7
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.30140689723145203,0.8297884092395661,0.7123834886817576,0.9709612619764475,1.0,9/48,10.30%,POLR1G;ARID1B;ATAD2B;SPHK2;MYO1C;ZMIZ1;KAT2B;PHF2;BAZ1B
prerank,positive regulation of isotype switching (GO:0045830),-0.313926463684252,-0.8297143067868831,0.7050359712230215,0.9654094041523186,1.0,4/15,13.17%,TFRC;SHLD1;TGFB1;CD40
prerank,protein modification by small protein removal (GO:0070646),0.24529506181585584,0.8295057497305915,0.8148936170212766,0.9709698644150762,1.0,62/252,21.18%,SMAD3;AR;OGT;CCNA2;TGFBR1;SMURF2;USP11;PSME4;USP47;USP20;INO80;USP35;USP24;USP48;USPL1;KAT2B;SMAD1;PRKN;RHOT1;OTULINL;ACTR8;TNIP2;USP30;USP9X;USP38;USP9Y;GPS1;COPS3;USP32;USP10;SENP6;PTEN;TADA3;FOXK2;ADRM1;UBE2D1;SUDS3;SENP7;SENP8;COPS2;PSMB5;PSMC2;BECN1;TNIP1;PSMD4;PSMD1;UIMC1;CLSPN;MDM4;USP3;SMAD2;ASXL2;PSME3;USP37;BIRC3;USP46;MBD6;USP49;BRCC3;UCHL1;STAMBPL1;PSMA3
prerank,establishment of protein localization to membrane (GO:0090150),0.2833259757408954,0.8289520377185,0.7309184993531694,0.9715178536269011,1.0,17/66,17.96%,RFTN1;GORASP2;YIF1B;COX18;AFDN;MYO1C;EGFR;BRAF;GORASP1;VPS37D;RAB3GAP1;PIKFYVE;PARD3;NPC1;ZDHHC20;PRKCI;MICALL1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.25027624306977514,-0.8288897779357892,0.782312925170068,0.9659397952795492,1.0,15/40,24.81%,SMURF1;PTK2B;HIPK2;RPS7;RPL11;TAF1;FOXF2;RPL5;RAD23A;GNA12;CLU;RPL23;NUB1;DESI1;SGTA
prerank,phosphate-containing compound metabolic process (GO:0006796),0.24839091814547198,0.8288443001262138,0.8052516411378556,0.9711847681631168,1.0,19/198,9.26%,EPHA7;ENPP1;PLPP3;PXYLP1;ACYP2;PPP3CA;EPHX2;PFKFB4;PLCD1;INPP5A;PLA2G4A;LRRK2;SPHK2;PLCB4;GFPT1;EPHB2;XYLB;INPP4A;SLC20A1
prerank,regulation of neurogenesis (GO:0050767),0.2887533958631177,0.8287038724197956,0.7204724409448819,0.9709082702063893,1.0,7/55,6.28%,YAP1;ASCL1;NUMBL;APPL2;LIG4;SERPINF1;HES7
prerank,regulation of DNA recombination (GO:0000018),-0.26568795893408254,-0.8285745689689404,0.7428571428571429,0.9654801108842492,1.0,14/32,35.67%,KDM1A;MSH3;ALYREF;ZRANB3;RAD51;SHLD2;MSH2;RAD51AP1;H1-0;FIGNL1;IL7R;RPA2;SIRT6;IL4
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.37603144832384944,0.8281440317055876,0.6617161716171617,0.9714346747144849,1.0,4/13,14.87%,NUPR1;EIF2AK3;MANF;NR1H3
prerank,positive regulation of organelle assembly (GO:1902117),0.3071983535681051,0.8273667924265452,0.7133243606998654,0.9723275171098145,1.0,12/44,20.91%,ASAP1;DYNC1H1;SDC1;ARHGAP35;CROCC;RAB3GAP1;SDC4;PIP4K2C;HTT;NUMA1;CEP120;FSCN1
prerank,protein localization to cilium (GO:0061512),0.3169640372508448,0.827039721054066,0.7181688125894135,0.9724051217907586,1.0,11/32,26.38%,TULP1;WDR35;TULP3;INVS;ZNF423;EHD1;ODAD4;IFT140;TULP2;TTC21B;TCTN2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.3799910131816273,0.8269265861230148,0.6726618705035972,0.9720953333033683,1.0,1/13,0.59%,ADCY1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3322658201028815,-0.8265829659972049,0.6893939393939394,0.9683223664836674,1.0,6/12,26.51%,GCLM;OPLAH;GCLC;GGT1;GGCT;GSS
prerank,clathrin coat assembly (GO:0048268),-0.31529911135468813,-0.8264037180078408,0.6674698795180722,0.9675969382916897,1.0,2/15,6.31%,SGIP1;HIP1R
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.39178601793620826,0.8258412467967524,0.6597222222222222,0.9735776529221298,1.0,1/11,1.80%,LYN
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.36004484280784965,0.8257084759665053,0.6817447495961227,0.9732964080033916,1.0,5/16,18.13%,TERF2;TNKS2;RTEL1;ATM;NAF1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3473131799375,0.8252423105265314,0.6788553259141494,0.9735957668098345,1.0,2/18,3.41%,DACT1;APOE
prerank,nuclear pore complex assembly (GO:0051292),-0.3519961977696588,-0.8251368724436327,0.6833333333333333,0.9689955775535654,1.0,2/10,4.79%,NUP93;NUP153
prerank,development of primary male sexual characteristics (GO:0046546),0.31821305235299413,0.8247578450986388,0.6920863309352518,0.9739350290749895,1.0,5/34,6.67%,AR;KIT;WNT4;LHCGR;NR5A1
prerank,chromatin organization (GO:0006325),0.25529348177770533,0.8245702514076558,0.786697247706422,0.9737730231269246,1.0,25/132,15.11%,SETD7;BRWD1;NPM3;INO80;CBX3;SMARCA1;NPM2;SMARCC2;MTA2;DR1;TCF7L1;KDM5B;KAT2B;ZBTB1;PHF1;FOXA1;BAZ1B;KDM5C;SETD5;L3MBTL1;HDAC8;SMARCD2;SETDB1;HDAC4;SMARCB1
prerank,regulation of microtubule nucleation (GO:0010968),0.4038593333326547,0.8243051555871027,0.6751361161524501,0.9737241325194951,1.0,1/10,1.84%,EML2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.20935789712966268,-0.8236598836211553,0.8972972972972973,0.9708260809934376,1.0,36/94,30.35%,RPS6KA5;NOD1;CUL1;RBX1;ST18;NFKBIA;RPS6KA4;PSMF1;MAPK3;PSMB8;PSMB2;NOD2;PSMA4;PSMB10;MAP3K3;TAB1;PSMC4;UBE2V1;PSMD9;PSMD5;PSMA6;CHUK;PSMD11;MAP3K7;PELI1;PSMA8;PSMB1;EGR1;TRAF6;PSMD10;RPS27A;UBC;IKBKG;IL1R2;PSMC3;IL1A
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.25581081937044214,-0.8234949637746358,0.7689873417721519,0.9700574866620606,1.0,10/33,18.09%,HOXA5;MED1;TAL1;FES;ACVR2A;HIF1A;PRKDC;FAM210B;INHBA;HMGB2
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3150583998437788,-0.8227967222531122,0.7367149758454107,0.9703263976730379,1.0,6/15,24.75%,CEP83;STIL;SPAG5;CEP131;CCDC14;CSNK1D
prerank,regulation of mononuclear cell migration (GO:0071675),0.3363184259315627,0.8221573686334217,0.7019230769230769,0.9771366304655492,1.0,3/23,4.13%,LYN;IL34;CSF1
prerank,water transport (GO:0006833),0.3700731539095833,0.8221026896169205,0.6752136752136753,0.976707391873668,1.0,2/12,8.59%,PDPN;AQP6
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.2908604829435437,-0.82172953368557,0.7146666666666667,0.9713037188810447,1.0,7/21,18.79%,ADAM10;SPPL3;BACE2;ADAM19;RBMX;ADAM9;APH1A
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.343396611417893,0.8211164562181683,0.7027863777089783,0.977939665340662,1.0,7/19,23.23%,SRC;HNRNPA1;TERF2;TENT4B;HNRNPC;HNRNPU;XRN1
prerank,protein-containing complex subunit organization (GO:0043933),0.2593156051948037,0.8211142275226054,0.7662790697674419,0.9774215963101219,1.0,19/109,14.16%,TEAD1;MITF;LAMC1;YAP1;RANBP9;PML;ZW10;CD247;PARD6B;PICALM;TSPAN4;KMT2A;NUP98;FANCC;MNAT1;LLGL1;DLG4;WASF1;SNX9
prerank,positive regulation of DNA repair (GO:0045739),0.29068342790960155,0.8205510711773789,0.7140883977900553,0.9778999731269163,1.0,2/46,1.64%,EYA2;EYA1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2543138915940512,0.8200411345935109,0.7967853042479908,0.9782755428985445,1.0,19/140,13.89%,ADRA1B;SLC8A1;ADCY5;XCR1;PDGFRA;ACKR2;CCR9;CACNA1C;BDKRB2;AGTR1;LPAR1;DRD3;TRPM4;BCAP31;P2RX5;C1QTNF1;CXCR6;DLG4;CXCL13
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.38452854145743864,0.8196984946421677,0.6710526315789473,0.9783829355368181,1.0,2/10,12.03%,OGT;SELENOS
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3359984083141659,0.819687310897997,0.6993243243243243,0.9778808737272374,1.0,4/20,12.28%,PID1;DAB2;PICALM;RHOQ
prerank,neurogenesis (GO:0022008),0.2985167406247775,0.8193322378159956,0.7240896358543417,0.9779986295404166,1.0,8/43,10.19%,DAGLA;ASCL1;NEUROD1;THOC2;DCHS1;LPAR1;METTL14;RYK
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3376552181100565,0.8192024625155117,0.6786271450858035,0.9777171271415098,1.0,3/20,9.62%,BCL2;MOAP1;ITGAV
prerank,negative regulation of cation channel activity (GO:2001258),0.32373967817040117,0.8190635394333898,0.7136294027565084,0.9774332253172131,1.0,4/26,8.50%,SLC6A9;GSTM2;DRD3;EPHB2
prerank,cellular response to osmotic stress (GO:0071470),-0.28479526001569394,-0.8187984313334378,0.7321937321937322,0.9759554640823886,1.0,6/21,13.51%,LRRC8D;YBX3;ARHGEF2;SCN2A;RCSD1;TRPV4
prerank,glycine transport (GO:0015816),0.3953943268290219,0.8187464478557993,0.6678507992895204,0.9774798141719728,1.0,3/10,19.26%,SLC6A9;SLC6A5;SLC25A38
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.38291339313830186,0.8187211527509574,0.6780238500851788,0.9770043719590897,1.0,4/11,13.44%,BMPR1A;CD200;ATP6AP2;GATA6
prerank,regulation of protein catabolic process (GO:0042176),0.2608822926462046,0.8185067470959586,0.7624113475177305,0.9768980772057869,1.0,20/99,16.74%,HECW2;DACT1;NKD1;NEDD4;SMURF2;VIP;SIRT2;IRAK3;EGFR;WDR91;SNX12;PRKN;ITCH;BANP;PLK2;FLNA;HACE1;HUWE1;OAZ3;AGAP2
prerank,amide biosynthetic process (GO:0043604),0.28963747548536567,0.8181790966801867,0.7355704697986577,0.9769965878149719,1.0,6/47,10.00%,PAM;SMPD2;ALOXE3;CERS6;CERS5;NMRAL1
prerank,ncRNA catabolic process (GO:0034661),0.31712892223250305,0.8178796460867354,0.7054380664652568,0.9770072381589366,1.0,11/28,25.30%,SND1;PARN;EXOSC7;TUT4;MTREX;NUDT16L1;TENT4B;EXOSC2;DIS3L;XRN1;EXOSC8
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3725233148148138,0.8178391629544803,0.6631393298059964,0.9765696458592134,1.0,5/13,21.82%,RECQL5;TCERG1;NELFE;HNRNPU;HEXIM1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.3118457586052999,-0.8177976932508146,0.7213541666666666,0.9767699733849151,1.0,2/14,4.67%,THBS1;CMKLR1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.3270902850213579,0.8172703777856968,0.7062314540059347,0.9770989577523349,1.0,3/25,7.95%,SMAD3;NOS1AP;TLR6
prerank,selective autophagy (GO:0061912),0.2834530728761556,0.8171716330959803,0.7411924119241192,0.9767757354205512,1.0,19/56,24.63%,DYNLL1;DYNC1H1;ULK2;WDR81;PRKN;UFL1;USP30;DYNC1I2;UFC1;AUP1;ATM;BECN1;ATG2B;PHB2;AMBRA1;HDAC6;IFT88;LGALS8;DYNC1LI2
prerank,cellular response to dsRNA (GO:0071359),-0.30738036862151374,-0.8167801392715788,0.7386091127098321,0.9775954676204958,1.0,6/15,18.98%,CAV1;IFIH1;RALB;CGAS;DHX9;NPM1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.28773210154053563,0.8165602452580041,0.7430093209054593,0.9773538033245855,1.0,5/53,6.66%,XCR1;HTR1A;LHCGR;ADRB3;MTNR1A
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.258848355070562,-0.8165140404580767,0.7311475409836066,0.977079652840454,1.0,8/28,20.08%,NOTCH3;BEND6;GATA2;LFNG;HEY1;DLL4;DLL1;EGFL7
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.3101346629028043,0.8165039202075443,0.7,0.9769411170756762,1.0,14/32,24.87%,CDK5RAP3;BRSK1;TAOK3;MRNIP;ATM;TAOK1;UIMC1;CLSPN;BRCC3;TRIM39;BRCA1;RINT1;CDC14B;MRE11
prerank,Rap protein signal transduction (GO:0032486),0.39283156836918287,0.8163757725515121,0.6870503597122302,0.9766356647271467,1.0,4/10,14.58%,RAPGEF2;RAPGEF1;RAP2A;PLK2
prerank,regulation of urine volume (GO:0035809),0.38699901817971594,0.8162083857133297,0.6606170598911071,0.9764362033854252,1.0,2/10,9.70%,NPR3;ADM
prerank,regulation of exosomal secretion (GO:1903541),0.34173445432875654,0.816070791924707,0.706081081081081,0.9761683318322713,1.0,8/19,26.55%,ATP9A;SDC1;PRKN;SDC4;ATP13A2;TSG101;CHMP2A;SMPD3
prerank,RNA export from nucleus (GO:0006405),-0.20875893116118308,-0.8159629657358912,0.8622754491017964,0.9771224814109485,1.0,28/100,21.90%,NUP93;NUP35;NUP160;NUP153;EIF4E;NUP54;RBM8A;ALYREF;HHEX;CHTOP;YTHDC1;SRSF7;HNRNPA2B1;SEC13;NUP155;DDX19B;RANBP2;SMG7;DHX38;GLE1;NUP88;MCM3AP;THOC6;SRSF4;NUP62;DDX25;NUP85;SLBP
prerank,cellular response to nutrient levels (GO:0031669),-0.22164104528342166,-0.8156716966584546,0.8653846153846154,0.9766305872336202,1.0,20/62,22.59%,HSPA8;MFSD2A;ULK1;CLEC16A;SIRT1;WDR45B;RALB;FAM107A;MTOR;GAS2L1;ATG14;INHBB;FOXO1;WIPI2;BMPR2;NUPR2;VPS41;FLCN;ATG7;ZFYVE1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2680918043105845,0.8156676929675682,0.761723700887199,0.9763856593215351,1.0,20/80,19.04%,PLPP3;ATP9A;ARFGAP3;ZW10;COPZ2;COPB1;KDELR3;ERGIC2;COPA;ERGIC3;GOLPH3L;UVRAG;ARF4;ERGIC1;GOLPH3;COPG1;TAPBP;TMED10;HTT;RER1
prerank,B cell mediated immunity (GO:0019724),-0.34281748066319634,-0.8155780105542639,0.7164835164835165,0.9757625444620703,1.0,5/10,32.79%,FCER1G;CD27;MSH2;TLR8;FCGR2B
prerank,protein targeting (GO:0006605),-0.1959723064362418,-0.8146096708618125,0.9395973154362416,0.9765571163309323,1.0,45/118,29.61%,NLGN1;RASSF9;ZDHHC2;SDCBP;TOMM70;SORL1;AP4E1;AKAP6;RPL11;RTP4;ZDHHC15;AQP11;ZDHHC14;VPS37B;VPS37A;TRAK2;ATG3;GIPC1;ARL6;CDC37;TOMM7;HOMER3;CACNG3;ZFAND2B;TOMM40;SPCS1;PEX12;TIMM10;GABARAP;HAP1;FIS1;VPS37C;ZDHHC18;FBXO7;PEX16;EDEM1;AIP;HACL1;NACAD;SRPRA;ZDHHC24;TIMM22;SEC61G;TIMM17A;ZDHHC22
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.31811391450607523,-0.8142839611125192,0.7204030226700252,0.9761234827092973,1.0,6/13,28.06%,SORL1;CD81;BRSK2;TMEM30A;GCC2;TMEM30B
prerank,monocyte chemotaxis (GO:0002548),0.3152916892215165,0.814236062587934,0.7073863636363636,0.9784198306766757,1.0,3/32,6.27%,IL6R;CCL19;CCL4
prerank,protein targeting to membrane (GO:0006612),-0.2093510546454188,-0.8135109284421543,0.8958333333333334,0.9765093129350033,1.0,34/83,32.19%,ZDHHC2;SDCBP;RAB8B;RTP4;ZDHHC15;AQP11;ZDHHC14;VPS37B;PEX26;ARL6IP1;VPS37A;ABCD3;ATG3;ARL6;SGTB;PEX12;FIS1;VPS37C;ZDHHC18;PEX16;SGTA;CHMP4B;CHMP4A;PEX5;PXMP4;NACAD;SRPRA;ZDHHC24;GET3;ZDHHC22;ZDHHC12;NCF1;SEC63;ZDHHC6
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3199303612766218,0.8134416774397711,0.6935724962630793,0.979293566987701,1.0,1/26,0.44%,FBN1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.310042096896062,-0.8133985516720332,0.7146401985111662,0.9756420110612763,1.0,6/15,23.38%,KDR;CDH13;VEGFA;VEGFC;VEGFD;F3
prerank,positive regulation of locomotion (GO:0040017),-0.2622055200796744,-0.8131893616655731,0.7681159420289855,0.9749705030994424,1.0,5/27,11.72%,SPOCK2;THBS1;STX3;CAVIN1;TGFB1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.33059696958603213,0.8131892136448662,0.6965098634294385,0.9792194829610918,1.0,10/24,23.64%,LRRK2;CREB3;PRKN;SELENOS;NR1H3;TMBIM6;CREB3L1;OPA1;WFS1;TXNDC12
prerank,negative regulation of neuron death (GO:1901215),0.2652770796999354,0.8130239936084017,0.7955390334572491,0.9789989722566983,1.0,14/93,12.15%,GDNF;BCL2;APOE;CSF1;INPP5A;MT3;NTF3;LIG4;LRRK2;SLC30A10;CD200;PRKN;CLN3;REST
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.31749808601448637,-0.8125406371123878,0.7182741116751269,0.9751299939536605,1.0,3/14,11.47%,ADAM10;ABCG1;ADAM19
prerank,glutathione biosynthetic process (GO:0006750),-0.3364744381579108,-0.8124948928349546,0.6923076923076923,0.9741607960581423,1.0,6/11,26.51%,GCLM;OPLAH;GCLC;GGT1;GGCT;GSS
prerank,erythrocyte differentiation (GO:0030218),0.29651558037091347,0.8123670391129221,0.7411924119241192,0.9796155757170127,1.0,4/44,4.27%,TGFBR3;LYN;KIT;CDK5RAP3
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.2065015101721992,-0.8122002846161644,0.8736263736263736,0.9736737470253608,1.0,32/87,29.95%,SDHAF3;NDUFC1;COX17;NDUFAF2;SLC25A33;NDUFA6;DMAC2;NDUFA5;SURF1;TMEM126B;NDUFA8;COA3;NDUFB7;NDUFA7;NDUFA10;NDUFA3;NDUFAF8;NDUFS1;NDUFS5;NDUFS7;NDUFB3;NDUFAF3;NDUFAB1;UQCRFS1;NDUFV2;SDHAF1;DMAC1;NDUFB4;NDUFAF7;NDUFV3;COA5;CHCHD4
prerank,positive regulation of cell division (GO:0051781),0.30520066121388967,0.8121984963484898,0.7161764705882353,0.9794052370632014,1.0,5/38,7.90%,SVIL;FGFR2;CDC42;SIRT2;DRD3
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.38613121526984284,0.8115362729049893,0.6854545454545454,0.9800631513787519,1.0,3/11,12.15%,NONO;PRKN;REST
prerank,protein export from nucleus (GO:0006611),0.32021575780937855,0.8113701464226721,0.7067901234567902,0.9798367916576127,1.0,6/27,14.09%,RANBP17;NUP42;XPO7;CSE1L;STRADA;NUP214
prerank,cardiac cell development (GO:0055006),0.38131515433991525,0.8113044460854322,0.6762225969645869,0.9794234874869463,1.0,1/11,1.15%,SLC8A1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.3496967836871715,0.8111695844426877,0.7067545304777595,0.9791534625354205,1.0,4/17,15.65%,FAF2;DERL1;SELENOS;AUP1
prerank,positive regulation of interferon-beta production (GO:0032728),0.31022755789342565,0.8111098830146084,0.7108792846497765,0.978742016845587,1.0,9/33,17.67%,IRF1;OAS2;POLR3A;DDX3X;TBK1;RIPK2;RIOK3;RNF135;DHX58
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.24926838328789733,0.8107853815905122,0.7988700564971751,0.9787787881710885,1.0,23/151,13.56%,PAM;GAL3ST2;PLPP3;APOE;SLC44A1;LARGE1;APOA1;PLA2G4A;GSTM4;GSTM2;SPHK2;MGST1;GSTT1;CERS6;CERS5;NMRAL1;CDO1;CHKB;KDSR;ABHD3;MOCS1;GSTK1;LCAT
prerank,receptor catabolic process (GO:0032801),-0.27247662090237784,-0.8106495536473538,0.7147058823529412,0.9755172065816492,1.0,7/24,14.94%,SMURF1;KIF16B;RNF43;LGMN;TGFB1;VLDLR;AP2A1
prerank,regulation of calcium ion import (GO:0090279),0.3365823959610149,0.8105542850834726,0.6869009584664537,0.978662257613716,1.0,4/21,17.01%,PDGFRB;SPHK2;EGF;PSEN2
prerank,negative regulation of bone remodeling (GO:0046851),-0.3399562776032521,-0.8104000935467123,0.7199124726477024,0.9749396019676194,1.0,2/11,4.51%,UBASH3B;P2RX7
prerank,protein K48-linked ubiquitination (GO:0070936),0.2806481929520229,0.8102689263205382,0.7519582245430809,0.9786703103998551,1.0,20/54,20.99%,RFFL;BFAR;PRKN;ITCH;IFI27;RNF6;RNF152;KBTBD7;UBE2E2;FBXO38;AMFR;UBE2D1;UBR5;HACE1;UBE2R2;UBE3A;RNF34;TRIM32;ARIH2;UBE2T
prerank,sister chromatid segregation (GO:0000819),0.30985333026089695,0.8098960379940053,0.72953216374269,0.978814445984661,1.0,10/31,22.32%,INO80;ZW10;TOP2B;CHAMP1;ZWINT;SGO1;CDCA8;DSN1;TUBG1;TUBG2
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2928740459445465,0.809494113772161,0.7404795486600846,0.9790296285059112,1.0,13/41,20.39%,OGT;PRKAG2;NUP107;NUP42;EIF6;RAE1;NUP98;NUP214;GCK;SEH1L;TPR;PRKAG1;AAAS
prerank,female gamete generation (GO:0007292),0.3136208057763758,0.8091734180734149,0.7122093023255814,0.979096953874838,1.0,11/29,24.90%,DMC1;DIAPH2;PARN;BMP15;USP9X;MDK;GDF9;METTL3;TOB2;SPO11;NANOS3
prerank,protein sumoylation (GO:0016925),-0.2309888185387208,-0.8091663592948127,0.8302583025830258,0.976217552104803,1.0,13/49,18.00%,IFIH1;NUP93;NUP35;NUP160;NUP153;SAE1;NUP54;BCL11A;RANGAP1;NUP155;STX1A;RANBP2;NUP88
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.34367641229560075,-0.8091112098268343,0.7009132420091324,0.9752534501551781,1.0,8/11,56.13%,CCT8;CCT6A;CCT7;CCT2;TCP1;DKC1;WRAP53;CCT4
prerank,sodium ion import across plasma membrane (GO:0098719),0.35103076484688234,0.8086298596399046,0.676271186440678,0.9795261951902452,1.0,4/17,9.47%,SLC8A1;SLC9A9;TRPM4;SLC9A5
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.32804096972303165,0.8084262976854916,0.7173252279635258,0.9793581814682638,1.0,5/26,10.17%,SFRP1;STRN3;NCOR1;DAB2;NCOR2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3826045179341659,0.8083446224101696,0.6858638743455497,0.9789973444319727,1.0,1/11,1.85%,BCL2
prerank,pharyngeal system development (GO:0060037),0.3521139794629822,0.8076944474154645,0.6816666666666666,0.9796766265836008,1.0,2/15,3.55%,BMPR1A;TGFBR1
prerank,regulation of chromatin binding (GO:0035561),-0.35184875383170217,-0.8075676963464592,0.7196652719665272,0.9770548835094282,1.0,3/10,23.58%,BTAF1;KDM4D;HMBOX1
prerank,TOR signaling (GO:0031929),-0.26783453644536237,-0.8074712939310226,0.7634730538922155,0.9761744039071524,1.0,11/26,28.40%,PRR5L;CCDC88A;MTOR;RPS6;RPS6KB2;EIF4EBP2;FLCN;PRR5;RPS6KB1;CARD11;RHEBL1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3228213668992999,0.8068880569349923,0.706060606060606,0.9805908994245933,1.0,11/24,22.82%,CHD6;MT3;NFE2L2;RBPJ;CEBPB;SESN2;CREB3L1;MUC1;HSF1;DDIT3;HSPA5
prerank,response to lipid (GO:0033993),0.25544623918050047,0.8067818934237104,0.7932242990654206,0.980259629650484,1.0,16/105,15.90%,RBP4;WNT8B;FGFR4;ASCL1;CTSH;RARG;STRN3;IRAK3;STAT5B;FOXA1;LIAS;GPX3;GATA6;PAQR7;RXRA;MAPKAPK2
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.38642670830436454,0.8066421537782767,0.6756272401433692,0.9799869076551334,1.0,3/10,6.40%,CHADL;CST3;EMILIN1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.38513647670030066,0.8065859819498319,0.6842105263157895,0.9795748576714577,1.0,4/10,22.96%,PRKRA;TSNAX;DICER1;DROSHA
prerank,dendritic cell migration (GO:0036336),0.34296248468385626,0.8054167737755932,0.6991735537190082,0.9810988207610601,1.0,2/16,9.31%,CCL19;TRPM4
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.20521298095919732,-0.8038873175821799,0.9036144578313253,0.981662618854711,1.0,29/85,25.30%,RNF144B;CBFA2T3;RNF144A;RBX1;TRIB2;ECSCR;TAF1;GSK3A;HSPBP1;TMTC3;ZYG11B;COP1;RAD23A;RACK1;BBS7;CLU;DVL1;RNF14;DAB2IP;RCHY1;GABARAP;DDRGK1;USP5;NUB1;GSK3B;DDA1;VCP;CSNK1D;TREM2
prerank,regulation of defense response to virus (GO:0050688),-0.30336250813083465,-0.8037283027760798,0.75,0.9808801028261744,1.0,5/14,25.00%,TNFAIP3;PCBP2;DHX9;C1QBP;IFNLR1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.30154938208066134,0.8036862221558002,0.7320916905444126,0.9836439539521595,1.0,10/35,24.28%,OGG1;NEIL1;POLG;POLL;MBD4;RFC5;LIG1;MUTYH;MPG;TDG
prerank,atrioventricular valve development (GO:0003171),0.3579796411501876,0.8033488766261916,0.6856649395509499,0.9837037396804329,1.0,4/14,10.48%,BMPR1A;ACVR1;BMP2;SLIT3
prerank,translational termination (GO:0006415),-0.20140964183926968,-0.8029581983232948,0.893491124260355,0.9812155136640425,1.0,34/95,31.54%,MRRF;MTRF1L;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS12;MRPL4;MRPS26;MRPL21;MRPL44;MRPS33;MRPL48;MRPL55;MRPL57;MRPL42;MRPS18B;MRPS10;MRPS21;MRPS7;MRPL34;MRPL15;MRPL19;MRPS22;MRPS31;MRPL38;MRPL12;MRPL28;MRPL43;MRPL54;MRPS14;AURKAIP1;MRPL2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.19013729350404385,-0.8027213778455436,0.9523809523809523,0.9805816782013143,1.0,44/145,24.75%,FHL1;CUL1;RBX1;FBXL7;KCNH5;AVEN;MECP2;TUBB4B;RAB11A;PRKAR2B;PAFAH1B1;YWHAG;RAD51C;ACTR1A;CEP70;PSMF1;DCTN1;CEP135;SDCCAG8;PSMB8;CETN2;CDK5RAP2;PSMB2;CEP57;PSMA4;PSMB10;CCND1;CEP43;CEP63;PSMC4;CLASP1;HAUS2;PSMD9;PSMD5;CENPF;PSMA6;DTL;HMMR;PSMD11;KIF14;CEP131;PSMA8;PSMB1;CSNK1D
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.2782837318067675,0.8024436922904729,0.7371202113606341,0.984788322900758,1.0,10/55,11.40%,BCL2;TGFBR1;NUPR1;PML;ING5;TRAF7;BCL2L11;BCAP31;LTBR;GSDME
prerank,mRNA transport (GO:0051028),-0.2031718389239408,-0.802334268240561,0.9075144508670521,0.9801941858360013,1.0,28/101,21.90%,NUP93;NUP35;NUP160;NUP153;EIF4E;NUP54;RBM8A;ALYREF;HHEX;CHTOP;YTHDC1;SRSF7;HNRNPA2B1;SEC13;NUP155;DDX19B;RANBP2;SMG7;DHX38;GLE1;NUP88;MCM3AP;THOC6;SRSF4;NUP62;DDX25;NUP85;SLBP
prerank,regulation of catecholamine secretion (GO:0050433),0.3173701215153174,0.802121672964273,0.7276785714285714,0.9848200234488402,1.0,6/29,13.73%,DTNBP1;DRD3;SYT9;PRKN;SYT11;SYT12
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3553767155631388,0.8019873398480442,0.7054009819967266,0.9845179825834508,1.0,4/15,16.32%,SLC45A3;PPM1K;ADM;AKT1
prerank,mRNA polyadenylation (GO:0006378),0.3128563793469029,0.801496255960098,0.7207488299531981,0.9843061339139115,1.0,15/26,26.15%,WDR33;PAF1;PCF11;TENT4B;PAPOLG;CDC73;FIP1L1;CPSF2;LEO1;SCAF8;PAPOLA;PAPOLB;GRSF1;SSU72;AHCYL1
prerank,RNA polyadenylation (GO:0043631),0.3128563793469029,0.801496255960098,0.7207488299531981,0.9843061339139115,1.0,15/26,26.15%,WDR33;PAF1;PCF11;TENT4B;PAPOLG;CDC73;FIP1L1;CPSF2;LEO1;SCAF8;PAPOLA;PAPOLB;GRSF1;SSU72;AHCYL1
prerank,regulation of cholesterol efflux (GO:0010874),0.3096762623048328,0.8014392225365626,0.7379912663755459,0.9838911351489638,1.0,9/30,19.81%,LRP1;APOE;APOA1;ABCA3;NR1H3;RXRA;SHH;YJEFN3;ABCA7
prerank,dendritic spine organization (GO:0097061),0.3149163220033405,0.8012480274832527,0.7179104477611941,0.9837264604932495,1.0,8/26,13.81%,DOCK10;ITGA3;CDC42;EPHB2;EPHB3;INSR;DLG4;PTEN
prerank,regulation of protein dephosphorylation (GO:0035304),-0.24426999192448426,-0.8008008866921229,0.8062283737024222,0.9818648753151296,1.0,7/37,11.72%,PPP1R16B;PPIA;PPP2R5A;SPPL3;CALM1;CALM3;TGFB1
prerank,DNA replication initiation (GO:0006270),-0.24019904590957203,-0.8007995122027141,0.7942122186495176,0.9808180297774,1.0,16/37,35.74%,DBF4;TOPBP1;POLE4;ORC4;MCM8;LRWD1;MCM3;MCM5;ORC5;PRIM1;CDC6;POLA1;RPA2;CDC34;MCM7;PURA
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.25981523362298886,-0.8007908456937393,0.7746913580246914,0.9797889377450152,1.0,12/27,24.44%,KDM1A;PTTG1IP;SMYD2;SIRT1;DDX5;CD44;KMT5A;MSX1;SPRED2;TWIST1;MIF;SNAI2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.20537850329266139,-0.8005842074252022,0.9030612244897959,0.9791269194776347,1.0,27/86,24.81%,EGLN3;KLF2;RBX1;EGLN2;VEGFA;PSMF1;PSMB8;PSMB2;PSMA4;PSMB10;HIF1A;HIGD1A;EP300;CUL2;PSMC4;PSMD9;PSMD5;PSMA6;ATF3;PSMD11;VHL;ATF4;MAPK7;PSMA8;BACH1;PSMB1;DNAJB1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.31891687374209543,0.8004930962724349,0.7224669603524229,0.9845073792939573,1.0,3/26,7.95%,SMAD3;NOS1AP;TLR6
prerank,axon development (GO:0061564),0.2656075602363745,0.800405653634628,0.7679012345679013,0.984138643890543,1.0,15/78,13.78%,NREP;FGFR2;VASH2;SEMA5A;MTR;BRSK1;ARHGAP35;PARD6B;EPHB2;RYK;EPHB3;SLITRK2;NTNG2;LLGL1;MARK2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.3526528742333567,0.8002891650312453,0.7099494097807757,0.9838354244340143,1.0,3/16,7.37%,APOA1;LDLR;SREBF1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.36937115668918097,0.8002467908450334,0.667262969588551,0.9834007432169216,1.0,5/11,21.79%,RESF1;PPHLN1;SETDB1;TPR;DNMT1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.35587932687803275,0.8000797633799274,0.7179054054054054,0.9831889976912026,1.0,4/15,9.95%,FGFR1;SEMA5A;SMOC2;FGF2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.33842909434102114,0.7997265576250514,0.7145135566188198,0.9832722174772565,1.0,9/22,19.67%,RAPGEF2;NTF3;ACAP2;NTRK3;RAPGEF1;WASF1;AKT1;BDNF;EHD1
prerank,pore complex assembly (GO:0046931),0.3353107756194178,0.7996931328048836,0.721958925750395,0.9828280174747293,1.0,4/19,11.13%,PLEKHA7;NUP107;AFDN;NUP98
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3915368868115975,0.7996406861971831,0.6945898778359512,0.9824219984440676,1.0,2/10,7.23%,CDC42;SIRT2
prerank,regulation of telomere maintenance (GO:0032204),0.30890190597685874,0.7996333015906185,0.7287630402384501,0.9819252839897467,1.0,11/26,28.55%,PML;PPP1R10;HDAC8;TERF2;RTEL1;ATRX;MRE11;RAD50;UPF1;SMG1;SMG6
prerank,response to leucine (GO:0043201),0.38712737857795293,0.7995500808656156,0.6830508474576271,0.9810557992078128,1.0,3/10,15.84%,UBR2;RRAGD;SESN2
prerank,cellular response to leucine (GO:0071233),0.38712737857795293,0.7995500808656156,0.6830508474576271,0.9810557992078128,1.0,3/10,15.84%,UBR2;RRAGD;SESN2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.30901784169482993,-0.7994414556764182,0.7237163814180929,0.9800760709034717,1.0,6/14,25.96%,FAM98B;CLP1;CSTF2;TSEN54;TSEN34;CPSF1
prerank,negative regulation of viral genome replication (GO:0045071),-0.2384365714543338,-0.7992945741095258,0.8040540540540541,0.9792965363344814,1.0,16/40,29.76%,IFIH1;INPP5K;SRPK1;TASOR;MPHOSPH8;FAM111A;N4BP1;TRIM6;HMGA2;PLSCR1;IFITM3;OASL;IFIT1;ISG20;ISG15;ZC3HAV1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.2869571185564801,0.7989971864775539,0.7577903682719547,0.9815382634814572,1.0,7/44,12.94%,LYN;APOE;CDK5RAP3;IRAK3;SPRY2;DUSP19;PDCD4
prerank,response to UV-A (GO:0070141),0.35519051928480705,0.7989054528144616,0.7138103161397671,0.9812008435707651,1.0,2/14,8.41%,MMP2;EGFR
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.26120761424575584,-0.7986685664198225,0.78,0.9793831354079575,1.0,8/25,18.09%,MED1;TAL1;ACVR2A;HIF1A;PRKDC;FAM210B;INHBA;HMGB2
prerank,negative regulation of JUN kinase activity (GO:0043508),0.38717102748705,0.7984367597901498,0.7073608617594255,0.981511944448506,1.0,5/10,26.12%,DUSP19;PDCD4;AIDA;DNAJA1;HIPK3
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.34373248106832954,0.7982489022148929,0.6786885245901639,0.9813226199983673,1.0,3/16,18.33%,LEPROT;CHMP5;TMEM50B
prerank,positive regulation of intracellular transport (GO:0032388),0.2915337093174153,0.7979467761180501,0.7287157287157288,0.9813228898751823,1.0,4/38,9.71%,ACTN2;NEDD4;DYNC1H1;STK11
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2509040084921071,-0.797537362387155,0.7601156069364162,0.9803042929575392,1.0,13/31,31.93%,EDC3;LSM2;LSM6;DIS3L2;EXOSC5;CNOT7;DCP2;CNOT8;DCPS;EXOSC4;LSM7;LSM5;DCP1B
prerank,epithelial cell differentiation (GO:0030855),0.2584464483559367,0.7973231622616739,0.7917189460476788,0.9819265275513702,1.0,13/88,16.32%,MAF;FGFR2;ASCL1;CNN3;FSTL1;SCUBE1;DAB2;GLI1;GSTK1;VDAC1;GATA6;BMP4;AKT1
prerank,N-glycan processing (GO:0006491),0.3385146070423874,0.7971547719638862,0.7315112540192926,0.9817174753517155,1.0,2/18,2.62%,PRKCSH;MAN1C1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.32203516139039634,0.7969513660548886,0.6979472140762464,0.9815529193160062,1.0,9/24,24.13%,SRC;HNRNPA1;TERF2;TNKS2;TENT4B;HNRNPC;HNRNPU;XRN1;TNKS
prerank,regulation of astrocyte differentiation (GO:0048710),0.3729556597709652,0.7968804682675372,0.7094594594594594,0.9811573456635909,1.0,3/12,12.01%,EPHA4;BMP2;F2
prerank,regulation of viral entry into host cell (GO:0046596),-0.25202116855014584,-0.7967392832294374,0.7850746268656716,0.9806600536251638,1.0,9/30,21.16%,LY6E;TRIM14;HS3ST5;TRIM25;TRIM68;TRIM11;TRIM6;TRIM62;NECTIN2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.3493995175221003,0.7964887721784086,0.7093023255813954,0.9813591034666024,1.0,3/15,7.37%,LDLR;SIK1;SREBF1
prerank,positive regulation of embryonic development (GO:0040019),0.3352022395932492,0.7964504115578064,0.7062600321027287,0.9809203417841218,1.0,4/19,12.54%,WNT4;OSR1;RBM19;NIBAN2
prerank,snRNA 3'-end processing (GO:0034472),-0.28144726291211203,-0.7959762511009588,0.774798927613941,0.9810068445858726,1.0,7/19,27.58%,INTS6;INTS8;EXOSC5;USB1;INTS1;EXOSC4;TUT1
prerank,negative regulation of DNA replication (GO:0008156),0.36541835187113086,0.7957427668457873,0.689594356261023,0.9816221482384263,1.0,3/13,15.39%,TSPYL2;S100A11;WAPL
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.384829263885629,0.7954994206184427,0.7005347593582888,0.9815505555229354,1.0,2/10,10.19%,FZD1;RYK
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.30593891599603995,0.7954292888800423,0.7246376811594203,0.9811544377419954,1.0,2/32,4.80%,CDK14;CDK16
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.37901226589692544,0.7949914586127376,0.6747404844290658,0.9814081090179076,1.0,1/11,2.52%,NOS1AP
prerank,long-term memory (GO:0007616),0.33266266287894786,0.7949173025946045,0.71850699844479,0.9810332223791238,1.0,5/19,16.84%,APOE;LDLR;CPEB3;SLC2A4;PJA2
prerank,positive regulation of peptidase activity (GO:0010952),0.3239317030283394,0.79428889531742,0.7147385103011094,0.9815921285887278,1.0,6/20,25.00%,CTSH;APH1B;RCN3;PSME3;PRELID1;MAPK12
prerank,regulation of ERAD pathway (GO:1904292),0.37085356299952227,0.794283536886461,0.7287853577371048,0.9810993595835014,1.0,5/11,23.92%,RNF185;TMEM259;RNFT1;BAG6;ATXN3
prerank,regulation of amyloid fibril formation (GO:1905906),0.34680388701219833,0.7941560873489898,0.6892361111111112,0.9808200047262451,1.0,2/15,5.23%,APOE;LDLR
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.3204378059850631,-0.7937221816325702,0.7333333333333333,0.9838686814918356,1.0,6/13,27.58%,CPSF7;CSTF2;CPSF1;CPSF4L;CPSF6;TUT1
prerank,regulation of establishment of planar polarity (GO:0090175),0.25614158839309736,0.7937214720255146,0.8040201005025126,0.9810649149997566,1.0,7/88,6.01%,DACT1;FZD2;SMURF2;PRICKLE1;FZD1;PSME4;CDC42
prerank,autophagosome organization (GO:1905037),0.2833673843299338,0.793545007951172,0.763265306122449,0.9808422705514849,1.0,15/50,22.41%,RAB23;ULK2;UBXN2B;WIPI1;EMC6;RAB19;MAP1LC3A;BECN1;ATG2B;WDR45;NSFL1C;ATG9A;ATP13A2;AMBRA1;STX12
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.32711521729992765,0.7932341483153338,0.7296416938110749,0.9808588174385998,1.0,2/21,1.62%,DCN;BGN
prerank,mitotic metaphase plate congression (GO:0007080),0.27469970334935334,0.7930977017817029,0.7945205479452054,0.9805951469886773,1.0,13/51,20.29%,PIBF1;ZW10;SPDL1;CHAMP1;CENPC;EML4;CHMP5;BECN1;KPNB1;SEH1L;BOD1;CDCA8;CDC23
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.26060706162706776,0.7925832189748164,0.7812113720642769,0.9809946862601538,1.0,23/82,23.12%,DYNLL1;NINL;CEP152;DYNC1H1;ALMS1;YWHAE;DYNC1I2;HAUS1;HAUS3;HAUS7;CEP192;CEP164;ATF5;DYRK3;ODF2;PRKACA;CEP250;AURKA;TUBG1;NDE1;HAUS5;HAUS6;SFI1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2657147238691955,0.7923371309931729,0.7857142857142857,0.9809011267186096,1.0,25/69,27.29%,FAF2;DERL1;UBXN4;DERL3;UBE4B;RNF185;ECPAS;FOXRED2;SELENOS;AMFR;AUP1;TMUB1;TMEM67;ERLIN1;BAG6;JKAMP;HSPA5;ERLIN2;WFS1;OS9;FBXO2;UBE2J2;FBXO17;DNAJB12;TMUB2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.24579660322548458,0.792265628381899,0.8520642201834863,0.9805160174478552,1.0,23/132,18.50%,POLR2D;CELF2;SF1;TRAF7;ERAL1;EIF6;EIF3A;DDX23;EIF2S2;NOL3;SNRPD2;SRSF5;RBM5;GEMIN2;RRP7A;SF3B1;PRPF6;CDC73;KHDC4;NAF1;DDX1;DICER1;SRSF10
prerank,striated muscle cell development (GO:0055002),-0.3094851857132241,-0.7920813598782686,0.7393483709273183,0.9855745055944466,1.0,3/14,5.80%,TMOD2;PGM5;TMOD3
prerank,negative regulation of telomere maintenance (GO:0032205),0.3478867279049527,0.7917181815936638,0.7429519071310116,0.9809005414452383,1.0,7/15,28.55%,TERF2;TNKS2;RTEL1;ATM;TNKS;RAD50;SMG6
prerank,lipid droplet formation (GO:0140042),-0.33468295326430986,-0.7915512675785743,0.7177033492822966,0.9855157149673499,1.0,6/10,35.77%,PLA2G4C;ZFYVE1;FITM2;CDS2;CDS1;BSCL2
prerank,regulation of centrosome cycle (GO:0046605),-0.27637667821682455,-0.7904618235638513,0.7749360613810742,0.9864123131887892,1.0,8/21,28.39%,PDCD6IP;SIRT1;NPM1;CHMP2B;CEP131;GEN1;CHMP4B;CHMP4C
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.37136772934883566,0.7902827340961031,0.699812382739212,0.9828589872432034,1.0,4/10,19.87%,INO80;CDC7;ATRX;STOML2
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.2375038950453684,-0.7896472219050118,0.8469750889679716,0.9867430503957428,1.0,14/40,26.78%,CRY1;POLH;SMYD2;MCL1;WDR76;KMT5A;PARG;HMGA2;UBE2V1;WRNIP1;IER3;NSMCE1;USP1;FMR1
prerank,mitochondrial transcription (GO:0006390),0.3865077483852563,0.789343920781672,0.710431654676259,0.9838923633335597,1.0,4/10,17.59%,TFAM;POLRMT;TEFM;FOXO3
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.3225028677751848,0.7892984874572582,0.7234726688102894,0.982971234060227,1.0,4/23,9.71%,ZEB2;SLC2A10;DAB2;STK11
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.3225028677751848,0.7892984874572582,0.7234726688102894,0.982971234060227,1.0,4/23,9.71%,ZEB2;SLC2A10;DAB2;STK11
prerank,histone exchange (GO:0043486),-0.2396261016388806,-0.7890863391722722,0.8202614379084967,0.9866352474903508,1.0,14/37,28.47%,KNL1;MIS18BP1;RUVBL1;RSF1;VPS72;NPM1;CENPI;RNF8;ANP32E;CENPN;ZNHIT1;NASP;ITGB3BP;HJURP
prerank,cardiac atrium morphogenesis (GO:0003209),-0.29940733069078135,-0.788423276617471,0.783375314861461,0.9867591076866455,1.0,6/16,17.70%,NOTCH1;TGFB2;HEY2;ZFPM1;DLL4;BMPR2
prerank,endodermal cell fate commitment (GO:0001711),-0.34464016931781566,-0.7881223725935352,0.7397260273972602,0.9862003298448606,1.0,2/10,9.65%,SOX17;RTF1
prerank,endosome organization (GO:0007032),-0.2351480860984438,-0.7880089971371984,0.8271186440677966,0.9853466579518035,1.0,12/41,23.11%,RAB27A;CLCN3;DNAJC13;ALS2CL;WASHC5;EXOC8;AKTIP;CORO1C;DNM1;CHMP2B;ANXA8L1;ANXA8
prerank,non-motile cilium assembly (GO:1905515),-0.24974316931539398,-0.7877837178124077,0.7907692307692308,0.9847376795543815,1.0,9/30,27.23%,DISC1;TMEM216;DCTN1;FUZ;CCDC13;CSNK1D;VANGL2;GORAB;BBS10
prerank,regulation of viral release from host cell (GO:1902186),-0.2748393601517713,-0.787629570583856,0.7493036211699164,0.983982759755001,1.0,10/21,30.63%,TRIM25;VPS37B;TRIM11;TRIM62;VPS4A;CHMP2B;TRIM28;MID2;TRIM13;TRIM35
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.36653279232360547,0.7874399870267734,0.7116357504215851,0.9851020892153122,1.0,3/12,9.37%,KANK1;FBLN1;ACTN4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.36653279232360547,0.7874399870267734,0.7116357504215851,0.9851020892153122,1.0,3/12,9.37%,KANK1;FBLN1;ACTN4
prerank,dendritic spine morphogenesis (GO:0060997),0.3450936204952346,0.787341909875123,0.725752508361204,0.9847858147593233,1.0,6/15,13.81%,DOCK10;CDC42;EPHB2;EPHB3;DLG4;PTEN
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2604037195979934,0.7870133410593861,0.7959949937421777,0.9848156699022111,1.0,11/76,12.94%,UACA;SASH1;CCL19;IL12B;NMI;EGFR;ACTN4;DDX3X;TRIP6;CD14;PDCD4
prerank,regulation of RNA metabolic process (GO:0051252),0.2698619050531531,0.786798425466194,0.773209549071618,0.9846842331529754,1.0,6/59,5.75%,MITF;SON;HNRNPLL;IGF2BP2;OAS2;SNRNP70
prerank,regulation of platelet aggregation (GO:0090330),0.3384984650690344,0.7862709947343759,0.7119741100323624,0.9850631618210356,1.0,6/17,20.79%,LYN;PDPN;C1QTNF1;PRKCA;ALOX12;SERPINE2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.33189927591902424,0.7859531418102702,0.7385826771653543,0.9850928313733871,1.0,7/20,22.68%,AMPD3;GART;AMPD2;PPAT;PFAS;ADSS1;ADSL
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3090947475826789,0.7857709712804585,0.7373417721518988,0.9848835092781217,1.0,4/24,12.28%,PID1;DAB2;PICALM;RHOQ
prerank,negative regulation of interleukin-8 production (GO:0032717),0.33015351256830716,0.7856963755804403,0.7171052631578947,0.9845052624669355,1.0,5/17,12.65%,MAPKBP1;TLR6;ARRB1;CD33;SSC5D
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.34229560139420745,0.7849185415673476,0.7020602218700476,0.984809276956497,1.0,3/17,8.78%,BRWD1;TSLP;STAT5B
prerank,cellular response to interleukin-7 (GO:0098761),0.34229560139420745,0.7849185415673476,0.7020602218700476,0.984809276956497,1.0,3/17,8.78%,BRWD1;TSLP;STAT5B
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.32927513448164747,-0.7847421124515143,0.7435294117647059,0.98774370119317,1.0,2/10,6.67%,SORL1;HSP90AB1
prerank,regulation of cell division (GO:0051302),0.2605028852286977,0.7847219605463491,0.7844155844155845,0.9846557902724768,1.0,13/72,18.05%,TXNIP;FGFR2;KIF20A;EFHC1;MLLT3;SIRT2;UVRAG;PIK3R4;NCOA3;PLK2;SHH;CDK2AP2;BECN1
prerank,myelin assembly (GO:0032288),0.3713253784929954,0.7846510571468412,0.7313974591651543,0.9842768867750512,1.0,4/10,18.32%,PMP22;EPB41L3;NCMAP;DICER1
prerank,positive regulation of cholesterol transport (GO:0032376),0.31203188910750096,0.7843822265199122,0.7473363774733638,0.9842092006465204,1.0,3/27,4.39%,LRP1;APOE;APOA1
prerank,positive regulation of coagulation (GO:0050820),0.37578910820923184,0.7841559197857919,0.6882661996497373,0.9835755627379354,1.0,1/10,1.77%,SERPINE1
prerank,positive regulation of hemostasis (GO:1900048),0.37578910820923184,0.7841559197857919,0.6882661996497373,0.9835755627379354,1.0,1/10,1.77%,SERPINE1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.3063047253059637,-0.7841512841875242,0.7735368956743003,0.987629562516134,1.0,6/14,29.26%,ME1;AK5;AK7;PNP;AK3;NME2
prerank,regulation of secretion (GO:0051046),-0.3094701140620021,-0.7839981454620684,0.7439613526570048,0.986815286826878,1.0,4/13,12.55%,KCNQ1;SGK1;GPLD1;ERBB3
prerank,gas transport (GO:0015669),-0.3352196998730828,-0.7838662449097391,0.7417840375586855,0.9860067517389017,1.0,2/10,8.87%,IPCEF1;CYGB
prerank,positive regulation of viral life cycle (GO:1903902),0.31632463968759567,0.7837424610602093,0.7370078740157481,0.9837543785734931,1.0,6/22,22.15%,AXL;KPNA6;P4HB;KPNA2;LGALS9;TSG101
prerank,glutamate metabolic process (GO:0006536),0.3349762525420593,0.7835913552616331,0.7384105960264901,0.9835095370653528,1.0,2/19,7.61%,GLUL;ALDH18A1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.3504232376795753,0.7831859166868184,0.7147826086956521,0.9836443499658565,1.0,2/15,4.39%,APOE;APOA1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3629085733350874,0.783154735329442,0.7319587628865979,0.9831959294140687,1.0,2/12,9.28%,ACO1;IDH2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3591134513284498,0.7826182117799088,0.7015706806282722,0.9835742791211954,1.0,1/12,2.43%,ACSL1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2949992956412198,0.7823256946747629,0.7779390420899854,0.9835764672795952,1.0,8/32,18.82%,EML2;CDH5;KATNB1;FGF13;DYRK1A;HDGFL3;CAMSAP1;TAOK1
prerank,stem cell development (GO:0048864),-0.29456861112478183,-0.7822803998375109,0.7890625,0.9876137905485641,1.0,6/16,28.78%,CDH2;SOX8;PTPRC;SNAI2;NOLC1;WNT7A
prerank,regulation of histone deacetylation (GO:0031063),-0.3104035389915262,-0.7818776369987849,0.7511961722488039,0.9872702217175731,1.0,4/13,14.71%,CAMK2D;CTBP1;APLNR;PRMT6
prerank,regulation of calcium ion transport (GO:0051924),0.27440862922994563,0.7817165298157465,0.7951153324287653,0.9840967478289987,1.0,8/54,12.42%,BCL2;MYLK;STIM1;CCL4;CAMK2B;EGF;ADRA2A;CD33
prerank,regulation of programmed cell death (GO:0043067),0.23945228476557337,0.7813452654716041,0.8461538461538461,0.9842136331236913,1.0,37/161,22.23%,DAPK2;STEAP3;ACTN2;DAPK1;MOAP1;NTF3;RARG;BCL6;LRRK2;NDRG1;BCL2L11;ACTN4;PRKN;IGFBP3;FBXO11;TM7SF3;GAS1;NLRC4;AKT1;ATM;CASP1;KANK2;APAF1;RABGGTA;TMEM219;IFT57;NF2;BIRC3;ACTN1;TNFSF9;MADD;BRMS1;FBXO10;RABGGTB;HAX1;BIRC2;PRELID1
prerank,negative regulation of defense response to virus (GO:0050687),0.37731288677338726,0.7813048960418234,0.7178571428571429,0.9837945227978628,1.0,2/10,13.34%,ITCH;MUL1
prerank,regulation of mRNA catabolic process (GO:0061013),0.2444664169913769,0.7808649359704442,0.8483080513418904,0.9840206986907525,1.0,29/121,23.26%,SAMD4A;CSDC2;IGF2BP2;PSME4;ZFP36L1;EXOSC1;PARN;EXOSC7;SERBP1;RC3H2;NUP214;MAPKAPK2;AKT1;IGF2BP1;DCP1A;PSMB5;PSMC2;PSMD4;PRKCA;RC3H1;PSMD1;YTHDF2;PSME3;ZFP36L2;PSMA3;EXOSC2;PSMC5;XRN1;PSMA2
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.28569227963704713,-0.7806579946303052,0.773936170212766,0.9882850059942604,1.0,3/17,10.77%,SLC7A5;FCER1G;PRKCZ
prerank,zymogen activation (GO:0031638),-0.2311802084221959,-0.7805305559654939,0.8908450704225352,0.9874783012187163,1.0,8/39,14.53%,GRIN2A;PERP;KLK2;PRSS12;CYFIP2;CASP8;LGMN;BAK1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.26739079634972,0.7802602300552618,0.7934336525307798,0.9845173664336753,1.0,16/50,22.49%,CCNA2;CDK5RAP3;CCNK;TTBK1;MNAT1;CNPPD1;CDKN1C;CDKN2C;CCNT2;CDKN1B;SERTAD1;CCND2;CCNT1;CDK7;CCNG2;CCNE2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.26264546595468674,0.7800834726313702,0.7989821882951654,0.9843038280929491,1.0,8/70,8.31%,PIK3R1;LYN;MYO10;CDC42;SRC;CD247;MYO1C;PLD2
prerank,DNA methylation or demethylation (GO:0044728),0.3321636948817399,0.7795303101153667,0.7307086614173228,0.9841999410232621,1.0,8/19,25.25%,DNMT3A;SPOCD1;KMT2E;DNMT3B;ATRX;DNMT1;PPM1D;DMAP1
prerank,DNA alkylation (GO:0006305),0.3321636948817399,0.7795303101153667,0.7307086614173228,0.9841999410232621,1.0,8/19,25.25%,DNMT3A;SPOCD1;KMT2E;DNMT3B;ATRX;DNMT1;PPM1D;DMAP1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.3663952930804812,0.7792328912805687,0.688663282571912,0.9842109308483556,1.0,2/11,10.19%,FZD1;RYK
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.31683851864364593,0.7787484059292789,0.7515432098765432,0.9845426165269822,1.0,3/23,10.83%,UACA;NMI;DDX3X
prerank,cilium assembly (GO:0060271),0.22706132254846564,0.7782896799213468,0.9045643153526971,0.9848278892608822,1.0,42/296,14.87%,ASAP1;GSN;DYNLL1;PARVA;NINL;CEP152;WDPCP;DZIP1L;RAB23;DYNC1H1;CYS1;CPLANE1;ALMS1;PIBF1;NPHP1;WDR35;TTC39C;B9D1;IFT43;IFT27;DNAAF1;FBF1;TRIP11;CFAP46;IFT81;DYNC2I1;CFAP410;CFAP44;YWHAE;CCDC40;DYNC1I2;HAUS1;DYNLRB2;HAUS3;PTPN23;ARF4;PTPDC1;IFT22;FLNA;HAUS7;CEP192;CEP164
prerank,calcineurin-mediated signaling (GO:0097720),-0.3285237691531799,-0.7781049495325136,0.7626728110599078,0.9893695112718279,1.0,3/10,7.21%,NFATC2;NFATC3;NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3285237691531799,-0.7781049495325136,0.7626728110599078,0.9893695112718279,1.0,3/10,7.21%,NFATC2;NFATC3;NFATC1
prerank,UV-damage excision repair (GO:0070914),0.3573772419977338,0.7780974500393577,0.7145214521452146,0.9846806335349135,1.0,2/12,6.56%,INO80;CUL4B
prerank,carbohydrate derivative catabolic process (GO:1901136),0.331608423004329,0.7780863648545412,0.7523510971786834,0.9842102623989207,1.0,4/18,16.57%,ADAMTS9;NGLY1;BPGM;NEU4
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.2682378659228594,-0.7779031689698672,0.8057142857142857,0.9886705830154955,1.0,8/23,17.94%,MTMR2;INPP5F;INPP5K;MTMR9;SACM1L;MTMR6;INPP5B;SYNJ1
prerank,ncRNA export from nucleus (GO:0097064),-0.2411522653190683,-0.7778901132332313,0.85,0.9876672775747001,1.0,12/36,21.43%,NUP93;NUP35;NUP160;NUP153;NUP54;SEC13;NUP155;RANBP2;NUP88;NPM1;NUP62;NUP85
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.33146356852765113,-0.7778401567415892,0.7465116279069768,0.9867191308061398,1.0,4/10,24.94%,EMC3;EMC9;MMGT1;EMC4
prerank,regulation of interleukin-10 production (GO:0032653),-0.2303086297989294,-0.777825833367312,0.8608058608058609,0.9857159033418814,1.0,11/44,22.30%,CD34;PLCG2;TRIB2;PRKCZ;TNFRSF21;NOD2;JAK3;TLR4;DLL1;AGER;VSIR
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.32833170178776105,-0.7777262573532044,0.7616707616707616,0.9848466887591708,1.0,2/11,9.03%,PLA2G7;ABCG1
prerank,T cell receptor signaling pathway (GO:0050852),0.23958930541893347,0.7776473180090038,0.8369942196531792,0.9844062823173642,1.0,9/138,7.30%,PDPK1;THEMIS;PIK3R1;FYB1;RFTN1;PSME4;CD247;RNF31;CD28
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.37267154062912855,0.7771800011195956,0.7531531531531531,0.9846834736700762,1.0,3/11,16.45%,IL12B;CARD9;IL23A
prerank,regulation of cellular protein localization (GO:1903827),0.2801937061769921,0.7769551135920941,0.7774798927613941,0.9845552730856808,1.0,2/45,5.53%,GPC6;PRKAA2
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.24466559607862814,-0.7768275165873085,0.8095238095238095,0.985268411802279,1.0,6/33,15.66%,ANKRD28;HSP90AB1;DCLRE1B;CTC1;ZBTB48;RAD51
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.2987953342113142,0.7764317178536865,0.7733918128654971,0.9849633832696719,1.0,3/29,9.64%,SERPINE1;GAS6;CREB3
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.3152158569096215,0.7763741471043042,0.7445482866043613,0.9845631757624606,1.0,3/22,11.96%,PDGFD;DDX3X;RAP2A
prerank,substantia nigra development (GO:0021762),0.29416071370021907,0.7761830039740271,0.7908961593172119,0.9843706658080734,1.0,10/37,15.42%,DYNLL1;CDC42;SIRT2;CKB;TTBK1;YWHAE;SYNGR3;ZNF148;MAOB;SUDS3
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.29673511152277826,0.7761585671149182,0.7572674418604651,0.9839267874711449,1.0,15/33,21.27%,EGFR;DDX3X;RGCC;GLI1;PAF1;KMT2E;UBE2E2;ADAMTS1;TFDP1;AKT1;CDC73;LSM10;PHB2;CCND2;PLCB1
prerank,apoptotic process (GO:0006915),0.23585369265382117,0.7761511497170399,0.8700322234156821,0.9834500942436427,1.0,29/203,13.48%,DAPK2;DAPK1;DLC1;BCL2;OGT;DMPK;CASP12;NUDT2;CFLAR;NOTCH2;IRF1;LIG4;TRAF7;STK4;BCL2L11;AIFM1;STK11;IFI27;CASP7;RNF152;MCM2;JADE1;CD14;PAWR;PDCD4;TNFAIP1;VDAC1;TSC2;IFIT2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.26583758739457114,0.7760581953917887,0.7952443857331571,0.9830972630402964,1.0,15/58,20.56%,LIG4;SMC5;DCLRE1C;POLL;UBE2V2;NHEJ1;ERCC8;DCLRE1A;UVRAG;ATM;KAT5;UIMC1;SUMO1;NSMCE2;BRCC3
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.25921503140293,-0.7760508268003645,0.8095238095238095,0.9855426296078964,1.0,9/24,29.21%,TOMM70;AIM2;CGAS;PTPN22;TRIM6;EIF2AK4;TRIM44;LILRB1;TRAF3IP2
prerank,chemical homeostasis (GO:0048878),0.26506410446800077,0.7759521798348477,0.8005115089514067,0.982780521821522,1.0,10/61,16.70%,ZBTB20;RBP1;CEBPA;TLCD1;NR1D2;DDX3X;WNK1;NR1H3;THADA;TENT4B
prerank,histone H3 deacetylation (GO:0070932),0.3431471800904484,0.7759116341774537,0.7335526315789473,0.9823669912244464,1.0,7/15,24.50%,SIRT2;HDAC8;HDAC4;ELK4;SMARCAD1;HDAC1;SFPQ
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.3371513412104125,0.7758774710443971,0.7266775777414075,0.9819362699409315,1.0,1/17,2.52%,NOS1AP
prerank,ERBB2 signaling pathway (GO:0038128),0.2986155799402939,0.7757974378066774,0.7477611940298508,0.9815728251739615,1.0,6/31,11.78%,PIK3R1;SRC;CUL5;EGFR;HBEGF;EGF
prerank,positive regulation of vacuole organization (GO:0044090),0.3761206351681093,0.7752989469061732,0.7098540145985401,0.9818814223598814,1.0,6/10,26.13%,RAB3GAP1;PIP4K2C;ANXA2;PIP4K2A;SH3GLB1;PIP4K2B
prerank,organonitrogen compound catabolic process (GO:1901565),0.26821417859043223,0.7749385399644362,0.8117647058823529,0.9819562229966766,1.0,7/57,10.77%,CPQ;GGACT;PLA2G4A;SMPD2;NAALADL1;CLPX;RENBP
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2745817813431588,-0.7747112004463218,0.8118279569892473,0.9866832531494409,1.0,10/21,32.10%,RPS7;RPL11;RPL5;UBE2S;RPL23;BAG2;PLK1;FZR1;CDC20;UBE2C
prerank,positive regulation of double-strand break repair (GO:2000781),-0.23465592386675044,-0.7746463300767491,0.8327759197324415,0.9857817701383556,1.0,9/39,20.51%,SPIRE1;FMN2;SHLD1;SLF1;KDM4D;PRKDC;PNKP;PARP1;SHLD2
prerank,receptor internalization (GO:0031623),0.2806678521673603,0.7745086023495584,0.810966810966811,0.9821353412203778,1.0,7/44,9.70%,LRP1;GRK3;NEDD4;DRD3;ARRB1;PICALM;ADM
prerank,mucosal immune response (GO:0002385),0.3401572753524222,0.7744206586177537,0.7253634894991923,0.9817820480375776,1.0,2/15,8.02%,PIGR;CAMP
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.3193222172503859,-0.7741932569397595,0.7423887587822015,0.9855553932145215,1.0,4/10,33.11%,GNB1;PDE6A;SAG;PDE6B
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.3498492110931744,0.7739659555382152,0.7376760563380281,0.9819941667901523,1.0,7/12,28.05%,PCGF3;SMCHD1;METTL3;HNRNPU;BRCA1;LRIF1;RBM15
prerank,dicarboxylic acid metabolic process (GO:0043648),0.26675655455158115,0.7738029824349354,0.7984084880636605,0.9817600623676394,1.0,8/52,9.28%,MDH2;MTHFR;MDH1B;HOGA1;ALDH18A1;ALDH1L1;ADHFE1;IDH2
prerank,negative regulation of heart contraction (GO:0045822),0.36216016113387317,0.7737864584800547,0.7323943661971831,0.9812997862608105,1.0,1/11,1.88%,ATP1A2
prerank,positive regulation of lipid storage (GO:0010884),-0.2655295316987738,-0.7736636307315067,0.786096256684492,0.9853831263242846,1.0,8/21,32.22%,SCARB1;PLIN2;MSR1;HILPDA;OSBPL11;PLIN3;LPL;FITM2
prerank,negative regulation of interferon-gamma production (GO:0032689),0.30988405717508927,0.7735569955301952,0.7570093457943925,0.9811498632439811,1.0,2/23,4.80%,GAS6;AXL
prerank,serine family amino acid catabolic process (GO:0009071),-0.32767187276458887,-0.7730458894224108,0.7405660377358491,0.985400767785913,1.0,6/10,39.67%,GCSH;SHMT1;AMT;DAO;GLDC;THNSL2
prerank,positive regulation of myelination (GO:0031643),0.35963255388591464,0.7729189031693783,0.7373188405797102,0.9816546076241772,1.0,6/11,27.22%,RNF10;PARD3;NCMAP;DICER1;TNFRSF1B;TPPP
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.3324410135785242,-0.7726820443782322,0.7594339622641509,0.9849712398935826,1.0,2/10,10.10%,PRKAR1A;SCRIB
prerank,regulation of viral genome replication (GO:0045069),-0.2105258403896953,-0.7724581133638119,0.8734693877551021,0.9843563906143424,1.0,20/56,29.76%,IFIH1;PPIA;PABPC1;SRPK1;ADAR;FAM111A;NR5A2;RAD23A;N4BP1;TRIM6;CNOT7;PPID;PLSCR1;IFITM3;OASL;HACD3;IFIT1;ISG20;ISG15;ZC3HAV1
prerank,placenta development (GO:0001890),-0.3142245025926136,-0.7724274698890218,0.771889400921659,0.9833915560184449,1.0,6/12,32.41%,ADAM19;E2F7;PLAC1;SOD1;E2F8;PTK2
prerank,positive regulation of reproductive process (GO:2000243),0.29854244665466423,0.7719960404837256,0.7761194029850746,0.9826274951582732,1.0,6/31,12.48%,SMURF2;PDE3A;VIP;SIRT2;SYDE1;ACVR1B
prerank,positive regulation of macrophage migration (GO:1905523),0.3243533627558496,0.7719209671616191,0.7435897435897436,0.9822531824966205,1.0,2/19,4.13%,IL34;CSF1
prerank,protein deubiquitination (GO:0016579),0.22893030340073228,0.7718530523191188,0.9050160085378869,0.9818707444359349,1.0,57/242,21.18%,SMAD3;AR;OGT;CCNA2;TGFBR1;SMURF2;USP11;PSME4;ATXN7L3;USP47;USP20;INO80;USP35;USP24;USP48;KAT2B;SMAD1;PRKN;RHOT1;OTULINL;ACTR8;TNIP2;USP30;USP9X;USP38;USP9Y;USP32;USP10;PTEN;TADA3;FOXK2;ADRM1;UBE2D1;SUDS3;SENP8;PSMB5;PSMC2;BECN1;TNIP1;PSMD4;PSMD1;UIMC1;CLSPN;MDM4;USP3;SMAD2;ASXL2;PSME3;USP37;BIRC3;USP46;MBD6;USP49;BRCC3;UCHL1;STAMBPL1;PSMA3
prerank,regulation of organelle assembly (GO:1902115),0.25639538757997266,0.7712332968631747,0.8292046936114733,0.9823901209687482,1.0,13/72,15.43%,GSN;USP6NL;NPRL3;ALMS1;TBC1D19;ADPRH;MTMR3;TBC1D2B;SENP6;TBC1D20;PLK2;NPRL2;PIKFYVE
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.2846511796401946,-0.7710127726843595,0.7756563245823389,0.984560660128124,1.0,5/16,20.51%,SHLD1;KDM4D;PRKDC;PNKP;SHLD2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.29577768697849,0.7707911057362016,0.7810650887573964,0.982592515150917,1.0,5/31,11.08%,FGFR2;PDGFRA;TGFBR1;OSR1;DYNC2I1
prerank,protein targeting to mitochondrion (GO:0006626),0.2732824422160606,0.769639875951272,0.7837837837837838,0.9838963263023218,1.0,9/52,13.87%,TIMM17B;PMPCB;AIFM1;BCAP31;TIMM44;TIMM9;TSPO;IMMP1L;TOMM22
prerank,positive regulation of calcium ion transport (GO:0051928),0.2887741828136691,0.769132332810452,0.7724719101123596,0.984200508016777,1.0,5/36,10.43%,MYLK;PDGFRB;CCL4;SPHK2;P2RX5
prerank,positive regulation of T cell activation (GO:0050870),0.2608376825334979,0.7691255827975568,0.8253968253968254,0.983729830583133,1.0,6/62,9.50%,RHOH;CCL19;IL12B;CD28;ZMIZ1;ZBTB1
prerank,regulation of cholesterol storage (GO:0010885),0.3439711089575201,0.7690644302323417,0.7560975609756098,0.9833502852068206,1.0,1/15,1.62%,ABCA1
prerank,gene silencing by miRNA (GO:0035195),0.2926836589225594,0.7686011693201463,0.7743362831858407,0.9835820856094825,1.0,13/32,26.82%,ZC3H7B;TNRC6B;WTIP;TNRC6A;EIF6;PRKRA;DICER1;AGO4;RBM4;AGO3;AJUBA;PUM1;CNOT1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.20389298180249785,-0.7685155823144306,0.9174311926605505,0.9874908679345122,1.0,20/70,24.68%,B2M;VAMP8;NCF2;FCER1G;MFSD6;PSMF1;PSMB8;PSMB2;PSMA4;PSMB10;PSMC4;FCGR1A;PSMD9;PSMD5;PSMA6;CHUK;PSMD11;PSMA8;LNPEP;PSMB1
prerank,regulation of glycogen metabolic process (GO:0070873),0.35527429990178927,0.7680064030739148,0.7382671480144405,0.9840381195566775,1.0,6/12,21.11%,PPP1R3C;PPP1R3D;AKT1;PPP1R3E;GCGR;RUBCNL
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.29666660946972867,0.7678046056413225,0.7870778267254038,0.9838743782124086,1.0,12/30,26.62%,LEPROT;PDCD5;RNF31;HUWE1;RHOU;HPS4;ARIH2;SREBF2;SH3GLB1;UBE2J2;VPS11;BAP1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.3273086029069202,0.7677334190437545,0.7627677100494233,0.983506941977941,1.0,5/17,18.82%,LYN;TAOK3;CARD9;RNF13;TAOK1
prerank,nuclear membrane reassembly (GO:0031468),-0.21638247526237203,-0.7676671200970591,0.8735177865612648,0.9878021764168522,1.0,19/54,29.36%,NUP93;NUP35;NUP160;VRK1;PPP2R2A;RANGAP1;EMD;SEC13;NUP155;CCNB2;VPS4A;CHMP2B;NUP85;NUP43;CHMP4B;CHMP4A;CHMP4C;CDK1;LBR
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.2960310648003372,0.7676367865414411,0.7772795216741405,0.9831637201057892,1.0,11/29,23.01%,COPZ2;COPB1;COG8;GOSR2;TRAPPC10;COPA;GOLGA5;COPG1;TRAPPC3;COG2;NAPA
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.3465131541257571,0.7670921769902831,0.7574692442882249,0.9835008459406768,1.0,4/13,12.90%,ERLEC1;DERL3;BCAP31;UBAC2
prerank,regulation of gluconeogenesis (GO:0006111),0.29386416129216897,0.7667912125005226,0.7776096822995462,0.9834821633336394,1.0,3/27,6.93%,OGT;NNMT;SIK1
prerank,plasma membrane organization (GO:0007009),0.26288159156197805,0.7667633722489999,0.7862903225806451,0.9830461650917588,1.0,13/61,15.29%,PLSCR2;COL5A1;PLSCR5;SNX33;PLSCR4;TLCD1;ANXA6;CLN3;SYT11;ABCD2;SNX9;FER1L5;EPB41L3
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.34153785594714436,0.7666974492006448,0.7542662116040956,0.982656224580164,1.0,3/16,9.79%,LEPROT;PIBF1;PARP14
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3271628168558176,0.7666550380223259,0.7579113924050633,0.982242869229862,1.0,6/18,25.21%,ZFP36L1;METTL3;ZFP36L2;PRELID1;NCKAP1L;ABL1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.30439397396765605,-0.7666188618219583,0.8,0.9884892707385049,1.0,4/14,13.25%,CD55;TGFBR2;CD81;PTPN22
prerank,glucose metabolic process (GO:0006006),0.2664450451418537,0.7665654809053185,0.8112712975098296,0.9818978023498123,1.0,6/58,11.65%,RBP4;MDH2;ENO2;GAA;DCXR;GALM
prerank,nerve growth factor signaling pathway (GO:0038180),0.3737913412279399,0.766468906092513,0.7112676056338029,0.9815684256989701,1.0,3/10,9.39%,RAPGEF2;NTF3;RAPGEF1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.3195920280831932,0.766398311667829,0.7407407407407407,0.9811963034241441,1.0,3/19,9.11%,OBSL1;CUX2;CAMK2B
prerank,regulation of myotube differentiation (GO:0010830),-0.2633854348912228,-0.7661670771286914,0.8360655737704918,0.9881443172356994,1.0,5/24,11.51%,PIEZO1;NOTCH1;CCN3;ATP11A;SMYD1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.26001463553010223,0.7659018060041167,0.8212877792378449,0.9815197142221682,1.0,10/69,11.57%,GDNF;BCL2;APOE;MT3;NTF3;LIG4;SLC30A10;NONO;PRKN;CLN3
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.34066937508293865,0.7656382708608762,0.7406807131280388,0.9814471762934442,1.0,4/15,14.87%,APOA1;SLC45A3;LPGAT1;NR1H3
prerank,zinc ion transmembrane transport (GO:0071577),0.3164431959480499,0.7655583094517981,0.7745839636913767,0.9810810944530545,1.0,7/22,19.12%,SLC30A8;SLC30A2;SLC30A10;SLC39A13;SLC39A1;SLC39A12;SLC39A6
prerank,glutamine family amino acid catabolic process (GO:0009065),0.348540543755881,0.7646289025581451,0.7504393673110721,0.9820572359937041,1.0,1/13,1.32%,GLUL
prerank,protein deneddylation (GO:0000338),0.36563691230908685,0.7645007955350707,0.7576271186440678,0.9817850392837961,1.0,3/10,16.72%,GPS1;COPS3;COPS2
prerank,positive regulation of heart contraction (GO:0045823),0.3198851682383438,0.7644301264942522,0.7479935794542536,0.9814109366147786,1.0,3/19,9.70%,ATP1A2;TRPM4;ADM
prerank,membrane protein proteolysis (GO:0033619),-0.23260753051257588,-0.7639980073851226,0.8493589743589743,0.9904296490295705,1.0,11/37,18.79%,ADAM10;RET;SPPL3;BACE2;ADAM19;MBTPS2;TGFB1;RBMX;ADAM9;RHBDD1;APH1A
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.3673736893891458,0.7638494569737445,0.7318339100346021,0.9818304869999617,1.0,2/10,7.97%,APOA1;IRAK3
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.27231505365626474,-0.7637928357480301,0.7974025974025974,0.9897278028033617,1.0,3/16,13.94%,SIX1;SIRT1;PTGS2
prerank,regulation of cell aging (GO:0090342),0.3615132943695898,0.7634549163269289,0.740072202166065,0.9819567285453943,1.0,2/11,9.13%,NUAK1;NEK6
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.3073002500717804,0.763315381768512,0.7581903276131046,0.9816791954088748,1.0,3/25,8.61%,MOAP1;PDCD5;BCL2L11
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.33527503698736627,0.7632670294022897,0.7612687813021702,0.9812704022556534,1.0,3/15,11.34%,LARGE1;RENBP;MGAT3
prerank,cellular response to unfolded protein (GO:0034620),0.3002233453050684,0.7630284817448099,0.7712121212121212,0.9811702365439763,1.0,9/26,23.86%,OPTN;PRKN;TM7SF3;HSPA9;TMBIM6;HSF1;HSPA14;HSPA5;BAG3
prerank,response to glucocorticoid (GO:0051384),0.3028912894674227,0.7629757210471585,0.776416539050536,0.9807729141601088,1.0,5/26,12.15%,HSD3B2;ZFP36L1;BCL2L11;SLIT3;REST
prerank,cellular defense response (GO:0006968),0.2825311626707949,0.7622444396339654,0.7784172661870503,0.9814050392782435,1.0,3/40,5.22%,LSP1;RAB23;CCR9
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.2104702843169703,-0.7620526001238809,0.9320388349514563,0.9914033498413041,1.0,15/63,20.98%,CRADD;PLAGL1;CNOT6L;BTG2;RPL26;EP300;PRKDC;CCND1;FBXO31;CDKN1A;CNOT7;E2F7;CNOT8;PLK3;TRIAP1
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.1898456115595482,-0.7617999444759332,0.9464285714285714,0.990756840941906,1.0,20/95,20.45%,MEF2C;PDE4B;CYRIB;VIM;LBP;SIRPA;MAPK8;CX3CR1;CD80;GIT1;TNFAIP3;NOD2;SBNO2;CARD16;TLR4;ADAM9;HMGB2;CD86;FZD5;DAB2IP
prerank,negative regulation of ATPase activity (GO:0032780),-0.28452220017117225,-0.7614512617879691,0.805,0.9902987062626315,1.0,5/16,28.37%,PXK;SIRT1;PLN;ATP5IF1;IFIT1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.36798988422229206,0.7614297027436876,0.7323420074349443,0.982206176021235,1.0,3/10,9.14%,RIPOR2;CD200;MIA3
prerank,histone mRNA metabolic process (GO:0008334),0.29899903332947675,0.7613457352807971,0.7969465648854962,0.98186642617378,1.0,12/27,27.15%,TUT7;ERI1;TUT4;ATM;TENT4B;LSM10;CPSF2;NCBP2;XRN1;SNRPE;UPF1;NCBP1
prerank,import into nucleus (GO:0051170),0.2541955876071881,0.761266775623273,0.8449809402795425,0.9815166904155498,1.0,19/73,19.11%,RANBP17;NUP107;APPL2;PRICKLE1;FAM53C;HNRNPA1;HEATR3;CSE1L;PPP1R10;TSC2;NUP214;SNRPD2;GEMIN2;AKT1;KPNB1;TPR;PHB2;APPL1;BACH2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.24737204710083502,-0.7611013239261596,0.8412698412698413,0.9898258402990406,1.0,3/29,6.67%,ANKRD28;PPIA;HSP90AB1
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.2350357729796415,-0.7610735320807916,0.8539682539682539,0.9888671573299971,1.0,10/33,21.90%,SNRPB;CPSF7;CSTF3;CSTF1;CLP1;CSTF2;SNRPD3;MED18;MAZ;SLBP
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.28881231225297554,0.7607621201454791,0.7873900293255132,0.9818001292187184,1.0,6/32,11.11%,SRPX2;MEOX2;AKT3;FOXC2;FGF2;FGFBP1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.3272951312319109,0.7600798765968649,0.75,0.9823522048259575,1.0,1/17,1.85%,BCL2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.2987108709808208,0.7599451222288681,0.7797619047619048,0.9820866129687181,1.0,4/30,9.75%,INSIG2;APOA1;MVK;IDI1
prerank,DNA recombination (GO:0006310),0.2787812515447568,0.7598878742538258,0.8014084507042254,0.9816967570749047,1.0,16/37,29.01%,LIG4;RAD51B;DMC1;RECQL5;RAD51D;RTEL1;XRCC2;RAD54L;HMGB3;MRE11;RAD50;HMGB1;RPAIN;RECQL;RPA1;XRCC3
prerank,oligodendrocyte development (GO:0014003),-0.29322467931380275,-0.7598841481009304,0.7506426735218509,0.9895616060451407,1.0,4/15,14.33%,B4GALT5;EIF2B5;EIF2B1;PLP1
prerank,positive regulation of T cell migration (GO:2000406),-0.2624546246688255,-0.7595392996861052,0.8320209973753281,0.9890792008057284,1.0,1/20,1.02%,ADAM10
prerank,autophagy of peroxisome (GO:0030242),0.35243363192168237,0.7593778740412824,0.7534246575342466,0.981993771251862,1.0,3/12,16.40%,USP30;PIK3R4;ATM
prerank,negative regulation of viral release from host cell (GO:1902187),0.34158452760992286,0.7593230823445407,0.7609841827768014,0.9816087445703592,1.0,4/13,19.31%,PML;TRIM21;TRIM26;TRIM32
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.3209942744822384,0.7591530495809276,0.7713815789473685,0.9813861237843109,1.0,1/18,1.85%,BCL2
prerank,response to interferon-beta (GO:0035456),-0.26274665010290355,-0.7590792423703658,0.841688654353562,0.988760506499772,1.0,7/22,24.51%,AIM2;PNPT1;UBE2K;UBE2G2;TRIM6;PLSCR1;IFITM3
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.2452734401043228,-0.7590543425112297,0.8544891640866873,0.9878164736112708,1.0,7/30,16.35%,CAV1;SRCIN1;PTPN2;INPP5F;PRKCZ;PTPN6;PTPRC
prerank,regulation of chromosome organization (GO:0033044),0.30385917212553487,0.75866762410033,0.7739938080495357,0.9816309928857796,1.0,9/22,28.55%,LIG4;HDAC8;TERF2;WAPL;RMI2;CENPV;UPF1;SMG1;SMG6
prerank,rRNA transcription (GO:0009303),0.3367470863411044,0.7586567673110977,0.7483552631578947,0.9811782300207869,1.0,3/17,6.10%,POLR1G;BRF1;GTF3C1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.2569719832180382,-0.7584272660244535,0.8430769230769231,0.9877768604251824,1.0,12/26,29.71%,IFIH1;NOD1;CASP8;TNFAIP3;NOD2;TAB1;UBE2V1;MAP3K7;TRAF6;RPS27A;UBC;IKBKG
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2854094416188131,0.758390043711529,0.8078034682080925,0.9811071844773698,1.0,12/32,23.25%,SLC44A1;APOA1;CHKB;ABHD3;LCAT;SLC44A3;PCYT1A;LPIN3;PEMT;CEPT1;LPIN2;SLC27A1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.33547709740750414,0.7577821380953114,0.761744966442953,0.9815697435458233,1.0,3/15,14.28%,BCL2;PRKN;TAF9
prerank,protein homotetramerization (GO:0051289),0.26747774375789946,0.7577523149299034,0.8188105117565698,0.9811357331236419,1.0,6/49,9.31%,TRPA1;TDO2;APPL2;ALDH1A2;CBY1;TRPM4
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.3370289052050336,0.757460975052727,0.7603993344425957,0.9811155746619059,1.0,5/15,19.68%,DCST1;STAT2;MUL1;METTL3;YTHDF2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.34800820133114313,0.7572984132494534,0.7258620689655172,0.9808856466753044,1.0,5/12,24.44%,PIBF1;ERLIN1;ERLIN2;BRCA1;ACADVL
prerank,regulation of response to biotic stimulus (GO:0002831),0.28411663305836143,0.7572619208452323,0.7727272727272727,0.9804652699351849,1.0,11/28,22.79%,IRF1;APPL2;GATA6;CX3CL1;RNF135;DHX58;APPL1;TIRAP;BIRC3;BIRC2;XIAP
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.3018939296283652,-0.7571880315985062,0.7893401015228426,0.9885466510525702,1.0,10/13,50.46%,TGFB1;SOD1;MAPT;GSTP1;ITGB2;F2RL1;CD177;SYK;TYROBP;FPR2
prerank,positive regulation of immune effector process (GO:0002699),0.29621899776894217,0.7569195096770727,0.7660550458715596,0.9804951787731779,1.0,4/27,7.28%,MYO18A;APPL2;IL12B;DDX60
prerank,glutathione metabolic process (GO:0006749),0.2715623883023536,0.7565488382622163,0.8043775649794802,0.9805732895225177,1.0,5/38,9.05%,CHAC2;GSTM4;GSTM2;DPEP1;GSTT1
prerank,cellular respiration (GO:0045333),-0.22420010133596538,-0.756548812850711,0.8602941176470589,0.9884646508375238,1.0,16/41,25.23%,SLC25A13;PPARGC1A;MTFR1;UQCRH;NDUFA5;CYCS;SURF1;MTFR2;SDHB;NDUFS1;MTLN;UQCR10;NDUFS7;COQ10A;ETFRF1;UQCRFS1
prerank,endothelial tube morphogenesis (GO:0061154),-0.33078052516811796,-0.7563496783342333,0.7635135135135135,0.9877389756068009,1.0,2/10,7.56%,ACVRL1;RHOB
prerank,maintenance of protein location in nucleus (GO:0051457),-0.2707621753779578,-0.7562840581110064,0.7910863509749304,0.986843294394634,1.0,4/20,13.38%,SYNE1;SUN2;RANGAP1;MORC3
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.3580183955214208,0.7562658642919473,0.7457912457912458,0.9805076766987635,1.0,3/12,18.71%,NUPR1;TTBK1;IL18
prerank,mitotic spindle assembly (GO:0090307),-0.22326068855318637,-0.7560665143083107,0.8636363636363636,0.9861535845942507,1.0,23/42,42.20%,KIF2A;STAG1;RAB11A;CCDC61;LSM14A;PRC1;KIF23;MISP;CLASP1;KIF4A;SPICE1;KIF11;TOGARAM2;WRAP73;MAP10;RACGAP1;AURKB;BCCIP;KIFC2;CLASP2;STAG2;TOGARAM1;AURKC
prerank,phosphatidylinositol metabolic process (GO:0046488),0.24464590095793687,0.7560453860542701,0.8759124087591241,0.9803696069544182,1.0,14/109,10.70%,PIK3R1;PTPN13;PDGFRB;PLCD1;SYNJ2;PLA2G4A;PLEKHA8;PLEKHA2;MTMR3;LPGAT1;INPP4A;MTMR7;FGF2;PI4KA
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.3707036191822145,0.7560329734349722,0.7320143884892086,0.9799188647932162,1.0,2/10,4.30%,SERPINE1;CYP1B1
prerank,negative regulation of cell communication (GO:0010648),-0.2566993804391666,-0.7558418111528579,0.8351648351648352,0.9855058517769621,1.0,2/21,4.45%,UBASH3B;GLRA1
prerank,cellular response to interferon-gamma (GO:0071346),0.24704931919472575,0.7551554403521952,0.8405438813349815,0.9807891935437665,1.0,8/88,6.57%,DAPK1;SP100;CCL19;IRF1;NCAM1;OAS2;CCL4;PML
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2183789211127395,0.7550554945483665,0.9362795477903392,0.9804699052653908,1.0,92/341,23.28%,SPSB1;TBL1XR1;HECW2;DCST1;FBXL17;FBXL19;NEDD4;SMURF2;RFFL;RNF213;PSME4;BFAR;ZNRF3;PML;NFE2L2;SIRT2;TRIP12;UBE4B;UBE2U;UBXN2B;RNF185;UBR4;ARRB1;UBXN11;WDR91;ANAPC5;WDR81;PRKN;ITCH;IFI27;MIB1;RNF6;FBXO11;ERCC8;KBTBD7;VPS37D;USP9X;FEM1C;RNF217;BTRC;COPS3;TNFAIP1;APPBP2;RC3H2;PTPN23;RNF19A;ADRM1;UBA6;AMFR;UBE2D1;HACE1;SPOP;RNF13;HUWE1;UBE2R2;NHLRC3;UBE3B;UBR3;PSMB5;PSMC2;PSMD4;KAT5;RNF34;RC3H1;PSMD1;TRIM32;RNF11;ARIH2;DCAF11;NSFL1C;PSME3;ZSWIM8;CDC23;FEM1B;UCHL1;KCTD13;PSMA3;BAG6;AURKA;FBXO10;DDIT3;TSG101;BIRC2;FBXW11;RNF20;RNF216;KLHL20;ANAPC4;BIRC6;PSMC5;PSMA2;KLHL8
prerank,hexose transmembrane transport (GO:0008645),-0.25829939741925845,-0.7549846614576058,0.8126721763085399,0.9858348433306122,1.0,2/21,2.95%,SLC2A1;PPARD
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.3375122830651488,0.7549495605172408,0.737649063032368,0.9801548090448341,1.0,2/13,5.21%,SP100;RAB23
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.2375192427144372,-0.7547807752625747,0.8482142857142857,0.9851288964041995,1.0,2/29,2.99%,CADM1;CYRIB
prerank,regulation of RNA export from nucleus (GO:0046831),0.3580625202774643,0.7546366909459663,0.7495590828924162,0.9801658156781167,1.0,5/11,21.89%,NSUN2;AKAP8L;TPR;NRDE2;NCBP2
prerank,retinal metabolic process (GO:0042574),0.34526613180509114,0.7539084977247863,0.7203065134099617,0.9807572466138369,1.0,1/12,4.30%,CYP1B1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.23643584543185914,0.753429124804564,0.8967587034813925,0.981009525102559,1.0,5/109,4.86%,PDPK1;PIK3R1;LYN;PPP3CA;PSME4
prerank,cellular response to amino acid stimulus (GO:0071230),0.2889808102748533,0.7528841293365958,0.7714285714285715,0.981374047476531,1.0,7/33,12.11%,UBR2;CPEB1;CPEB3;SLC38A9;CASTOR2;LAMTOR2;RRAGD
prerank,fluid transport (GO:0042044),0.3455062702047481,0.7528004743355845,0.7589743589743589,0.981026318001053,1.0,2/12,8.59%,PDPN;AQP6
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.20529071848750213,-0.752485319533301,0.8879668049792531,0.9873785807603268,1.0,24/57,30.25%,RAD17;FOXN3;TOPBP1;HUS1;MDC1;BABAM1;PRKDC;CCND1;NBN;FBXO31;CDKN1A;HMGA2;DTL;FANCD2;BABAM2;SDE2;ATF2;HUS1B;DONSON;CDK1;PLK1;FZR1;TICRR;NEK11
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.26678413631494674,-0.7523046841157969,0.8076923076923077,0.9866416901331424,1.0,5/19,21.87%,IFIH1;IRF5;TLR4;DHX9;CHUK
prerank,negative regulation of cytokine production (GO:0001818),0.23040620718656438,0.7519546073216185,0.9025755879059351,0.9818312757769591,1.0,28/163,14.08%,ADCY7;LGR4;GAS6;SLC2A10;TWSG1;APOA1;APPL2;AXL;PIBF1;MAPKBP1;IL12B;TLR6;IRAK3;UBA7;ARRB1;CD200;ITCH;IKBKE;RGCC;TBK1;F2;SELENOS;CD33;SSC5D;PDCD4;SYT11;CHID1;ABCD2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.2903150065535734,-0.7506801273902063,0.8198924731182796,0.9879321245717156,1.0,9/14,37.03%,NT5E;NT5C1A;UPB1;NT5C;UPP1;DHODH;DPYS;ERH;CAD
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.31171563084295995,0.7506374308587461,0.768503937007874,0.9833384583620479,1.0,7/17,25.28%,IL12B;EBI3;IL18BP;IL18;BACH2;JAG1;MYO1G
prerank,response to growth factor (GO:0070848),0.27292231508796316,0.7506173649710618,0.7994542974079127,0.9828983437832838,1.0,7/41,13.44%,BMPR1A;TGFBR1;ACVR1;SFRP1;STAT5B;ACVR1B;GATA6
prerank,negative regulation of response to stimulus (GO:0048585),0.2573411275276088,0.7506046050285519,0.8382541720154044,0.9824494587866629,1.0,12/60,12.19%,LYN;APOA1;APPL2;ACVR1;CASK;AKT3;SLC30A10;ZKSCAN3;IGFBP3;COL3A1;ADRA2A;TERF2
prerank,vitamin D metabolic process (GO:0042359),-0.2920482741713065,-0.7504495213614221,0.7919621749408984,0.9872759077800096,1.0,2/13,11.35%,CUBN;LGMN
prerank,heme biosynthetic process (GO:0006783),-0.26489271671953174,-0.7503071763926279,0.8218390804597702,0.9864923429839555,1.0,1/22,0.42%,ABCG2
prerank,negative regulation of cell cycle process (GO:0010948),0.25990979415108895,0.7500786420269875,0.8519480519480519,0.9827837280318554,1.0,15/61,17.79%,TOM1L2;CBX3;RBBP7;PPP1R10;NME6;TERF2;L3MBTL2;YAF2;RNF2;WAPL;BMP4;CBX5;TFDP1;CDC7;APAF1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3067536250578301,0.7498891482167865,0.750788643533123,0.982602552926836,1.0,3/22,7.90%,NOS1AP;CACNB1;DRD3
prerank,peptidyl-lysine methylation (GO:0018022),0.29396392020781,0.7494601758151276,0.7921092564491654,0.9827900811939065,1.0,5/26,16.45%,SETD7;SETD4;SMYD3;TRMT112;EEF2KMT
prerank,translesion synthesis (GO:0019985),-0.22009933498189066,-0.7490642154027637,0.8797250859106529,0.9872755735203583,1.0,15/42,30.05%,REV3L;TRIM25;POLH;UFD1;POLN;POLD4;POLK;RCHY1;DTL;FAAP20;VCP;ISG15;RPS27A;UBC;POLD2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.25636424497958615,0.7482783534668834,0.8387942332896461,0.9840559447112572,1.0,14/62,16.49%,BCL2;LRRK2;SRC;NFE2L2;CREB3;PRKN;DDX3X;SELENOS;NOL3;VNN1;BAG5;TMBIM6;AKT1;CREB3L1
prerank,protein insertion into membrane (GO:0051205),0.2830625147387365,0.7478928736852724,0.7965367965367965,0.9841605708365947,1.0,5/32,11.69%,TRAM2;COX18;EGFR;CYB5A;TRAM1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.2903413717117148,0.7476190862516897,0.7811094452773614,0.9840982170334548,1.0,4/30,8.32%,DCN;BGN;DSE;CSPG5
prerank,cellular response to calcium ion (GO:0071277),0.25322828804457553,0.7468630256838331,0.8293963254593176,0.9847026448614619,1.0,7/67,8.05%,ADCY1;ADGRV1;SLC25A24;PRKAA2;DPEP1;CPNE2;SYT9
prerank,response to estradiol (GO:0032355),0.29215456113612104,0.7467632156929781,0.8166915052160953,0.9843847095724991,1.0,6/31,10.21%,WNT8B;SFRP1;STRN3;EGFR;STAT5B;FOXA1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2315279187009568,0.7462039940830897,0.8938679245283019,0.9847601364849096,1.0,30/125,22.44%,DYNLL1;NUP107;EFHC1;DYNC1H1;SPC24;ZW10;SPDL1;DCTN6;PMF1;ZWINT;NEK6;CENPC;NUP98;CENPH;EML4;DYNC1I2;PLK2;SGO1;PTPA;KPNB1;SEH1L;CENPA;TAOK1;CDCA8;CENPM;DSN1;AURKA;TUBG1;TUBG2;NDE1
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.2373334094319949,-0.7460355897672936,0.84472049689441,0.9904583828662734,1.0,5/28,16.07%,CYRIB;SIRPA;SH3KBP1;NOD2;PRKDC
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.3316149818323117,0.7455962419497514,0.7677419354838709,0.9851592769223487,1.0,4/15,10.66%,TNRC6B;CPEB3;TNRC6A;TENT4A
prerank,eosinophil migration (GO:0072677),0.332437994611477,0.7455525282296612,0.7781456953642384,0.9842947703667443,1.0,2/14,16.92%,CCL4;CX3CL1
prerank,eosinophil chemotaxis (GO:0048245),0.332437994611477,0.7455525282296612,0.7781456953642384,0.9842947703667443,1.0,2/14,16.92%,CCL4;CX3CL1
prerank,regulation of mRNA metabolic process (GO:1903311),-0.30580062651349815,-0.745475117935008,0.7819025522041764,0.9902741656750617,1.0,4/11,22.68%,SRPK1;PTCD2;DHX9;SRPK3
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.2542779274760096,-0.7449796212018275,0.8263473053892215,0.9899449595696406,1.0,1/24,0.42%,ABCG2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.3384201102642808,0.7447843978553484,0.7829181494661922,0.9849161341073227,1.0,4/13,13.47%,EIF6;ABCE1;NMD3;SDAD1
prerank,negative regulation of platelet activation (GO:0010544),0.3163232525117852,0.7446998591058145,0.7652733118971061,0.9845783404605086,1.0,4/16,12.01%,PDGFRA;APOE;C1QTNF1;F2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3440008969112525,0.7446103227968729,0.754653130287648,0.9842447087585163,1.0,3/13,12.28%,RAB23;LRRK2;RHOQ
prerank,pre-miRNA processing (GO:0031054),0.3357170926376585,0.7444201055919967,0.775,0.984041481185322,1.0,7/14,24.63%,TUT7;TUT4;PRKRA;DICER1;AGO4;DROSHA;AGO3
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.2866775703569179,0.7438497650854945,0.8133535660091047,0.9844041344423773,1.0,4/29,11.77%,SYCE2;TEX12;MAJIN;STAG3
prerank,organic cation transport (GO:0015695),0.3087877934410497,0.7433579622940987,0.7569331158238173,0.984664774474369,1.0,4/20,10.92%,SLC44A1;SLC22A2;SLC22A4;SLC22A18
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.34755891350915824,0.7433359576888579,0.7634782608695653,0.984233945167683,1.0,1/12,1.85%,BCL2
prerank,heterotypic cell-cell adhesion (GO:0034113),0.29557244680581274,0.743148372289136,0.8058551617873652,0.9840545837352175,1.0,4/25,9.62%,PARVA;CD200;ITGB3;ITGAV
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.27298069215845516,-0.7431456350270972,0.8076923076923077,0.9915738548952645,1.0,9/17,26.61%,INPP5K;CALM1;DDIT4;CALM3;DGKQ;SPRED2;PPEF2;DMTN;CALM2
prerank,lysosome localization (GO:0032418),0.2789507912963934,0.7429974557908606,0.8076923076923077,0.9838140927844096,1.0,13/37,26.03%,KIT;PLEKHM1;BLOC1S1;PLEKHM2;TMEM106B;SNAPIN;DEF8;HDAC6;MYH9;RAB34;VPS33B;BLOC1S2;MAP6
prerank,spinal cord development (GO:0021510),0.3450871156614778,0.7428690480795092,0.7601957585644372,0.9835326630653515,1.0,1/12,1.89%,GLI2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.302296133475483,0.7427839158221405,0.8215962441314554,0.9832070033899094,1.0,4/23,14.58%,CDK5RAP3;ZW10;ZWINT;PLK2
prerank,positive regulation of cellular protein localization (GO:1903829),0.25261780674222806,0.7427289942121764,0.8396946564885496,0.9828127870884878,1.0,23/69,24.04%,YAP1;CDK5RAP3;PRKAA2;SNX33;WWTR1;EIF2AK3;CROCC;SLC5A3;PRKN;F2;SYT11;SESN2;AKT1;LIF;TM9SF4;NUMA1;ABCA7;GPR137B;CEP250;GPD1L;RANGRF;PARD6A;CARD10
prerank,synaptic vesicle membrane organization (GO:0048499),-0.2765843499336126,-0.7422164259052279,0.8126649076517151,0.9918462332547884,1.0,2/17,6.84%,STX3;SYP
prerank,response to nutrient levels (GO:0031667),-0.272618374390646,-0.7420593668102657,0.8355795148247979,0.9910883564706433,1.0,5/17,25.78%,ULK1;FAM107A;MTOR;ATF4;RPS6KB1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3287504710457147,0.7413908908419565,0.7766497461928934,0.9842759522385199,1.0,3/15,10.78%,IL17D;TLR6;CARD9
prerank,mRNA export from nucleus (GO:0006406),0.2385242966922385,0.74126563139223,0.8722627737226277,0.9839977018362539,1.0,11/102,12.23%,POLR2D;NUP107;U2AF1L4;THOC2;NUP42;DDX39A;DDX19A;WDR33;RAE1;NUP98;MAGOHB
prerank,positive regulation of blood coagulation (GO:0030194),-0.27307257877250957,-0.7409306924591703,0.8497267759562842,0.9916292841570955,1.0,9/17,28.37%,THBS1;THBD;ANO6;ST3GAL4;ENPP4;F3;DMTN;HPSE;F2R
prerank,regulation of cellular response to stress (GO:0080135),0.2333943345448764,0.7404950059116929,0.8820809248554913,0.9846385095138387,1.0,30/115,21.21%,ROCK2;NUP107;NUPR1;NUAK1;NUP42;CAMK2B;NEK6;PRKN;RAE1;MANF;NUP98;CEBPB;CLN3;YWHAE;NPAS2;NUP214;HSBP1;AMFR;BAG5;MAPKAPK2;CASP9;SLC38A2;ATM;DYRK3;SEH1L;TPR;HSF1;AAAS;MLST8;DNAJC7
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2623001462732062,0.7400563293714446,0.8460508701472557,0.9847999621083063,1.0,9/54,16.71%,CFLAR;GAS6;RFFL;APOA1;RNF31;PRKN;CCDC3;TNFRSF1A;CASP1
prerank,endocytic recycling (GO:0032456),0.26036359744973636,0.7397910673103254,0.8322056833558863,0.9847270089310898,1.0,13/50,19.67%,VPS26C;ACAP2;TRARG1;EPS15;SNX12;VPS35L;DENND1A;PTPN23;ARF6;SNX31;ANKRD50;MICALL1;EHD1
prerank,pre-replicative complex assembly (GO:0036388),-0.19843061241546087,-0.7396794150510856,0.9341085271317829,0.9923937228923566,1.0,22/64,30.27%,ORC4;PSMF1;PSMB8;PSMB2;MCM8;PSMA4;PSMB10;PSMC4;MCM3;PSMD9;PSMD5;PSMA6;PSMD11;MCM5;PSMA8;PSMB1;ORC5;PSMD10;RPS27A;UBC;CDC6;PSMC3
prerank,positive regulation of fat cell differentiation (GO:0045600),0.265778557206658,0.7396204249655703,0.8571428571428571,0.9844900806617526,1.0,16/47,21.99%,MEDAG;SFRP1;ZFP36L1;BMP2;CREBL2;TRPM4;CEBPB;NAPEPLD;TMEM64;AKT1;PIM1;CARM1;ASXL2;HNRNPU;WDFY2;NOCT
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.2402082664454655,-0.7395880812430592,0.8498402555910544,0.9915272621621399,1.0,6/30,10.83%,TAF1B;TBP;CAVIN1;GTF2H1;TAF1C;UBTF
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.3161570043676433,0.7394137812212718,0.7843137254901961,0.9842857870719177,1.0,4/18,14.70%,RNF185;RNF139;UGGT2;AMFR
prerank,positive regulation of immune response (GO:0050778),-0.19857718678373457,-0.7382287609377991,0.9570815450643777,0.9923681812050842,1.0,24/64,35.62%,IL15;TGFB2;GBP5;SKAP1;IFI35;SIRT1;CD81;KARS1;NOD2;PTPRC;DHX9;EIF2AK4;PLSCR1;POLR3C;SLC15A4;LILRB1;XBP1;NLRP3;TLR8;SASH3;FCGR2B;CD226;MYB;IL12RB1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.24058234684987445,-0.7379665472505762,0.851063829787234,0.9917700478249356,1.0,3/25,10.86%,HSPA8;GAK;DNAJB14
prerank,nucleocytoplasmic transport (GO:0006913),0.26791024210520226,0.7377625380809043,0.851063829787234,0.9861950987715361,1.0,9/40,21.89%,ATXN1;PHAX;HNRNPA1;NUP98;SNRPD2;GEMIN2;BACH2;AAAS;NCBP2
prerank,histone H3-K9 demethylation (GO:0033169),0.34802113040504035,0.7374924553814718,0.788659793814433,0.9861330563908239,1.0,6/11,23.24%,KDM7A;PHF8;KDM3B;KDM4A;KDM4C;KDM3A
prerank,regulation of translation (GO:0006417),0.22618516663260727,0.7373608421117573,0.9384615384615385,0.9858516472667922,1.0,30/173,18.64%,SAMD4A;DAPK1;PLD1;IGF2BP2;IGFBP5;CPEB3;EIF2AK3;CD28;RNF139;METTL14;EIF4A2;EIF6;DDX3X;EIF2B4;EIF5B;IMPACT;LARP1;MTPN;PLXNB2;ENC1;RBM4B;NSUN5;SYNCRIP;IGF2BP1;ALKBH1;FOXO3;DDX1;CTIF;METTL3;EIF3C
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.35452365792655405,0.7372964494635555,0.7702205882352942,0.9854691667772499,1.0,3/10,19.55%,SP100;KAT5;MUC1
prerank,regulation of interleukin-6 production (GO:0032675),0.23809568937888942,0.7372363403944693,0.8811524609843937,0.9850894225681036,1.0,17/96,16.92%,IL6R;IL17D;GAS6;TSLP;SPHK2;TLR6;IRAK3;ARRB1;CD200;RAB7B;CARD9;SETD4;SELENOS;SYT11;MAPKAPK2;CD47;CX3CL1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.3327150641249564,0.7370238250110963,0.7614213197969543,0.984946261809734,1.0,3/13,12.54%,NEDD4;EMILIN1;NIBAN2
prerank,regulation of chromosome segregation (GO:0051983),0.3224762023696263,0.7369137113368422,0.7629382303839732,0.9846312546363015,1.0,5/16,21.70%,SMC5;SMC6;RAD18;NUMA1;RMI2
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.23706657681641757,-0.7368312931172907,0.892128279883382,0.9923304171376714,1.0,7/27,17.83%,PHF20L1;KAT2A;RUVBL1;KAT6A;EP300;MRGBP;SGF29
prerank,positive regulation of histone deacetylation (GO:0031065),-0.29535161994826786,-0.7367928698056846,0.814385150812065,0.9914011141599409,1.0,5/12,26.67%,CTBP1;VEGFA;APLNR;AKAP8;PRKD1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3153164701661578,0.7367565748683167,0.7709677419354839,0.9843801739081819,1.0,2/17,8.63%,PLA2G4A;LPGAT1
prerank,protein hydroxylation (GO:0018126),0.3211517452371714,0.7366111726222332,0.7833622183708839,0.9841022737019375,1.0,3/15,14.23%,ASPH;P3H3;JMJD7
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.2710180081316599,-0.7358906723623594,0.8202247191011236,0.9915870766913305,1.0,2/17,4.00%,MEF2C;PRKG1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.33318997815447304,0.735800725553035,0.7910714285714285,0.9848000362290937,1.0,2/12,7.37%,H6PD;SREBF1
prerank,RNA splicing (GO:0008380),-0.18828364941477452,-0.7355080748300487,0.9621621621621622,0.9911092245569351,1.0,20/95,20.62%,MBNL1;IVNS1ABP;PPARGC1A;SNRPB;ZCRB1;SRPK1;RBM8A;SNRPD1;SNRNP40;LSM6;SRSF7;SNRPA1;PPIG;MPHOSPH10;SNRPD3;SNRPN;SF3B4;WDR83;SRSF4;USB1
prerank,endoderm development (GO:0007492),0.3352338327389521,0.7352919437678734,0.7899159663865546,0.9850485570194035,1.0,1/13,2.55%,LAMC1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.29001496424290396,0.7347856708628242,0.8137404580152672,0.9853257579801397,1.0,6/25,16.64%,B3GALT1;B3GALNT1;EXT1;NDST1;EXT2;HS2ST1
prerank,activation of phospholipase C activity (GO:0007202),0.28332390665151896,0.7345918542505043,0.808955223880597,0.985146949677765,1.0,3/29,8.41%,ARHGAP6;LPAR1;EGFR
prerank,purine nucleotide biosynthetic process (GO:0006164),0.33944766207354654,0.7345335648052276,0.7869415807560137,0.9847713191194535,1.0,7/12,28.73%,GART;AMPD2;PPAT;PRPSAP2;ADSL;PRPSAP1;ADA
prerank,signal transduction by p53 class mediator (GO:0072331),-0.2370216273573808,-0.734413554926171,0.8683385579937304,0.9916029085584861,1.0,2/30,1.35%,PPP1R13B;ACER2
prerank,cellular response to topologically incorrect protein (GO:0035967),0.2809115180963188,0.7344038071637986,0.8112094395280236,0.9844987475675433,1.0,11/31,23.92%,OPTN;PRKN;TM7SF3;HSPA9;TMBIM6;HSF1;HSPA14;HSPA5;HDAC6;BAG3;ATXN3
prerank,osteoclast differentiation (GO:0030316),0.30298011263324226,0.7344023193371226,0.7805255023183926,0.9840405058989216,1.0,5/22,17.14%,CSF1;SRC;EFNA2;OSTM1;GLO1
prerank,regulation of cilium movement (GO:0003352),0.34982720155214564,0.734362350011499,0.7818853974121996,0.9836399087015832,1.0,2/10,12.66%,DNAAF1;CCDC40
prerank,negative regulation of cellular senescence (GO:2000773),0.3273205705748306,0.7343405555650626,0.7716262975778547,0.9832099079525483,1.0,4/13,12.19%,AKT3;SLC30A10;ZKSCAN3;TERF2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.29997219053148094,-0.7340538426092675,0.810304449648712,0.9910674881750378,1.0,3/12,22.03%,MFSD2A;LPCAT3;ACSL3
prerank,regulation of T cell activation (GO:0050863),-0.20642324728422978,-0.7338292784140764,0.925531914893617,0.9903992956780818,1.0,13/42,34.93%,CYRIB;SIRPA;KAT2A;PTPN22;JAK3;CCL2;LAX1;DUSP3;IL4I1;LAT;TNFSF8;PRKCQ;CRTAM
prerank,actin crosslink formation (GO:0051764),-0.29813410695318654,-0.7332060183139856,0.8052884615384616,0.9902501816868361,1.0,3/12,13.31%,BAIAP2L1;GAS2;GAS2L1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.25412878887305035,0.7328391899388201,0.8526727509778357,0.984823563103937,1.0,6/57,9.87%,DCN;MOAP1;PDCD5;MCU;BCL2L11;PRKN
prerank,regulation of phosphatase activity (GO:0010921),0.2963019514929548,0.7322338248840937,0.803834808259587,0.9852353603995503,1.0,5/24,19.26%,CDK5RAP3;BMP2;PTPA;HTT;PPP1R26
prerank,actin filament polymerization (GO:0030041),0.2883991260875669,0.7321965685158625,0.8112633181126332,0.9848231531085678,1.0,3/29,6.47%,GSN;ARHGAP6;WASHC3
prerank,regulation of cellular protein metabolic process (GO:0032268),0.26102497503163785,0.7320415911563294,0.8331071913161465,0.9845835252349443,1.0,10/47,17.59%,APOE;CSF1;AGTR1;WDR91;EIF2B4;MTPN;RBM4B;NR1H3;AKT1;FOXO3
prerank,thymus development (GO:0048538),0.3398722194206284,0.7316871548451682,0.7965517241379311,0.9846015867138662,1.0,4/13,15.58%,TGFBR1;ZBTB1;EPHB3;SHH
prerank,ATP transport (GO:0015867),0.3559503663240715,0.7310664004924208,0.7764298093587522,0.9849820851994558,1.0,2/10,16.63%,SLC25A24;CD47
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.31608026798726907,0.7308565310486148,0.8015873015873016,0.9848162109416418,1.0,7/16,29.96%,RECQL5;MCM2;MCMDC2;MCM6;RECQL;RPA1;MCM4
prerank,secondary palate development (GO:0062009),0.33212261874540916,0.7304998542691107,0.7956448911222781,0.9848666309053918,1.0,1/14,1.05%,TGFBR3
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.25258567415059247,-0.7304320272782381,0.8285714285714286,0.9926943431269731,1.0,13/22,34.21%,GATA2;TAFA1;KDM1A;ID2;DLL4;TOX;SHCBP1;FZD9;PTPRZ1;DISP3;NAP1L1;RASSF10;TRIM71
prerank,positive regulation of protein acetylation (GO:1901985),0.3372653777517183,0.7299662023297852,0.7770034843205574,0.9851674032734822,1.0,4/12,18.82%,PRKAA2;DDX3X;KAT5;TAOK1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.32043619081656627,0.7288275000767263,0.7689713322091062,0.9863086030665065,1.0,2/15,10.61%,RIPOR2;CD53
prerank,positive regulation of interleukin-10 production (GO:0032733),0.2849419690082276,0.7281837723427241,0.8333333333333334,0.9867480889600494,1.0,4/30,7.30%,TSLP;PIBF1;IL12B;CD28
prerank,base-excision repair (GO:0006284),0.25820860384098804,0.728081554495505,0.8586666666666667,0.986442654498923,1.0,13/48,24.28%,OGG1;USP47;NEIL1;POLG;POLL;MBD4;HUWE1;XPA;RFC5;LIG1;MUTYH;MPG;TDG
prerank,response to cholesterol (GO:0070723),0.3083151877887066,0.7278965315042731,0.7774140752864157,0.9862422690830263,1.0,4/17,15.28%,TGFBR1;SMO;GRAMD1A;GRAMD1C
prerank,microvillus organization (GO:0032528),0.32258132294665753,0.7277001478055553,0.7860780984719864,0.986057095950236,1.0,4/13,15.63%,RAPGEF2;MAP4K4;RAP2A;RAPGEF6
prerank,early endosome to late endosome transport (GO:0045022),0.2956474679282132,0.727625566934641,0.7880794701986755,0.9857096927429105,1.0,10/20,27.59%,WDR91;WDR81;PTPN23;HOOK2;BECN1;RILP;STX8;ANKRD27;HOOK1;RAB5A
prerank,magnesium ion transport (GO:0015693),0.3375847961238326,0.7275770667180653,0.7808219178082192,0.9853180415380827,1.0,2/12,8.79%,SLC41A1;NIPAL4
prerank,cell cycle checkpoint signaling (GO:0000075),0.33647435113230767,0.7273377517538239,0.8037542662116041,0.9852029548084742,1.0,5/12,24.38%,ZW10;ZWINT;PLK2;PRCC;NABP2
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.35406130485226095,0.7272830106511463,0.7757352941176471,0.9843635802812619,1.0,3/10,14.34%,NUPR1;NCOR1;HDAC4
prerank,negative regulation of glycolytic process (GO:0045820),0.35406130485226095,0.7272830106511463,0.7757352941176471,0.9843635802812619,1.0,3/10,14.34%,NUPR1;NCOR1;HDAC4
prerank,fatty acid metabolic process (GO:0006631),0.22990108096142392,0.72716516509317,0.9028103044496487,0.9840697405037881,1.0,21/115,19.76%,SLC27A5;ACSL1;ACOT11;ACOT6;CPT1C;ACOT2;ALOXE3;AASDH;ACSF2;PEX2;FASN;ACSF3;ABCD2;ACADSB;CYP1A1;OXSM;NUDT19;ACSL4;ALOX5AP;LPIN3;ALOX12
prerank,calcium ion transport into cytosol (GO:0060402),0.29878232774379304,0.7268842032028154,0.8124006359300477,0.9840013129989286,1.0,2/21,6.40%,SLC8A1;CACNA1C
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.2814122991882191,0.7268569845278818,0.8169838945827232,0.9835829946726428,1.0,3/30,4.31%,SERPINE1;CFLAR;RFFL
prerank,leukotriene metabolic process (GO:0006691),0.30804456900294114,0.7268223322901995,0.8028169014084507,0.9831772206373686,1.0,6/19,19.76%,PLA2G4A;DPEP2;DPEP1;MAPKAPK2;ALOX5AP;ALOX12
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.23287238755539497,-0.7264569445134009,0.8888888888888888,0.9967226354531352,1.0,12/29,31.93%,EDC3;LSM2;LSM6;EXOSC5;CNOT7;DCP2;CNOT8;DCPS;EXOSC4;LSM7;LSM5;DCP1B
prerank,regulation of inclusion body assembly (GO:0090083),0.33907237810411583,0.7263172753384768,0.804920913884007,0.9834117208519104,1.0,3/11,15.30%,SNCAIP;DNAJA4;BAG5
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.30051511997720354,-0.7256188883139644,0.7918552036199095,0.9968269173863168,1.0,2/11,6.90%,PLCG2;CDH13
prerank,protein deacylation (GO:0035601),0.28995160805118164,0.7255277792572327,0.8094512195121951,0.9840010818751516,1.0,9/23,24.02%,ABHD17C;LYPLAL1;SIRT2;HDAC4;SIRT5;NOTUM;HDAC5;HDAC6;HDAC1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.2903436939330945,0.7254434084739328,0.8284023668639053,0.9836652575097959,1.0,7/26,15.43%,SPHK2;TLR6;SLC30A10;SLC5A3;SLC18A2;ABCD2;PIKFYVE
prerank,positive regulation of cell killing (GO:0031343),-0.2858600089812221,-0.7245506840999385,0.8507462686567164,0.9971917017665689,1.0,4/13,28.60%,MAPK8;NOX1;DVL2;NOS2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.2728514108739207,-0.7244094044648169,0.8247422680412371,0.9963856202776467,1.0,4/16,18.85%,CELF4;RBM17;DDX5;DHX9
prerank,negative regulation of transferase activity (GO:0051348),0.28056009633207085,0.7240707603588359,0.8404099560761347,0.9850152716535531,1.0,7/28,20.89%,SRC;EIF4A2;NPRL2;BAG5;CDKN1C;CDKN1B;HNRNPU
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.2541574655875132,-0.7239499728584339,0.862533692722372,0.9959742030869325,1.0,8/21,29.06%,MECP2;RAB11A;RAD51C;CCND1;NPM1;DTL;RCC2;CDK1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3015039091319776,-0.7238967835506287,0.8048780487804879,0.9950820156709551,1.0,9/12,56.13%,CCT8;GNL3;CCT6A;CCT7;CCT2;TCP1;DKC1;WRAP53;CCT4
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.250491018298051,0.7236470624144375,0.8651832460732984,0.985108059879476,1.0,9/59,16.32%,ROCK2;IRAK2;RNF31;TBK1;CD14;RIPK2;TNFRSF1A;PRDX4;AKT1
prerank,negative regulation of organelle assembly (GO:1902116),0.2680708869223506,0.7233612973772234,0.8414096916299559,0.9850515316993127,1.0,5/35,11.48%,YAP1;NUPR1;LRRK2;KAT2B;MDM1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3108474754381241,0.7233375074190413,0.8198051948051948,0.9846240137486904,1.0,4/18,12.15%,SFRP1;PRKN;ADRA2A;REST
prerank,tRNA processing (GO:0008033),0.24650232930764898,0.7233296288971299,0.8619302949061662,0.9841787177273627,1.0,14/61,19.19%,PUS3;ADAT2;ZBTB8OS;NSUN2;ADAT1;URM1;TRMT9B;RPP30;DTWD1;ELP5;ANKRD16;DDX1;TRUB1;METTL1
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.211589514266457,-0.7230932441997432,0.9100719424460432,0.9950836815240357,1.0,19/43,30.04%,RAD17;FOXN3;TOPBP1;HUS1;BABAM1;NBN;CDKN1A;CHFR;HMGA2;DTL;NABP1;BABAM2;HUS1B;DONSON;CDK1;PLK1;FZR1;CDC6;TICRR
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3407474418506731,0.7222238393170529,0.7707581227436823,0.9852268801495732,1.0,3/11,19.55%,SP100;KAT5;MUC1
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.19562146318592355,-0.7214144417737256,0.9519230769230769,0.9961138137136603,1.0,15/68,17.95%,TAF1B;SNRPB;TBP;CPSF7;CAVIN1;GTF2H1;TAF1C;UBTF;CSTF3;CSTF1;CLP1;CSTF2;SNRPD3;POLR2E;MED18
prerank,cholesterol biosynthetic process (GO:0006695),0.281691323622159,0.7213018309039262,0.8350668647845468,0.9859868725291365,1.0,4/31,9.75%,INSIG2;APOA1;MVK;IDI1
prerank,peripheral nervous system development (GO:0007422),0.29674498979988917,0.7209328217222304,0.8419452887537994,0.9859933486201361,1.0,3/23,7.21%,GDNF;NTF3;PMP22
prerank,DNA dealkylation (GO:0035510),0.34774123834713255,0.7203434153807141,0.8064516129032258,0.9858607846114006,1.0,4/10,24.09%,ASCC3;ALKBH1;FTO;MPG
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.34774123834713255,0.7203434153807141,0.8064516129032258,0.9858607846114006,1.0,4/10,24.09%,ASCC3;ALKBH1;FTO;MPG
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.32217102907020134,0.7201555024313727,0.7811993517017828,0.9856619395115033,1.0,5/14,24.38%,TERF2;TNKS2;ATRX;TNKS;NABP2
prerank,response to peptide (GO:1901652),0.2775353951242034,0.7197558914711892,0.8546511627906976,0.9857252124162577,1.0,8/33,17.94%,MMP2;STAT5B;STAT2;EIF2B4;STAT6;STAT4;EIF2B3;GNAI1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.2580324171378375,0.7195207347338425,0.8545706371191135,0.9855851021882446,1.0,6/45,9.11%,SP100;IRF1;NCAM1;OAS2;PML;CAMK2B
prerank,cilium organization (GO:0044782),0.21440522811285556,0.7194687462969649,0.9418103448275862,0.9852019839041218,1.0,16/209,7.92%,ASAP1;GSN;DYNLL1;PARVA;WDPCP;DZIP1L;RAB23;CYS1;CPLANE1;PIBF1;WDR35;TTC39C;B9D1;IFT43;DNAAF1;FBF1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2808437495783871,0.7193236208392261,0.8343465045592705,0.9849495404931252,1.0,5/28,14.70%,BCL2;MOAP1;DDX3X;CASP8AP2;TNFRSF1A
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.2652495987720352,-0.7190853925726449,0.8724489795918368,0.9979223679443618,1.0,4/18,14.68%,ELOVL7;ELOVL5;TECR;HACD2
prerank,DNA packaging (GO:0006323),0.3114342304891202,0.7190415005750042,0.8115449915110357,0.9848809040634902,1.0,2/16,8.84%,CHAF1B;AIFM1
prerank,vitamin transport (GO:0051180),0.28222939399961444,0.71891111669677,0.8206686930091185,0.9846001093758139,1.0,4/29,5.32%,SLC2A10;APOA1;SLC35F3;PDPN
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.2624668885019083,-0.7183235971301978,0.8598382749326146,0.9978523733098609,1.0,3/16,11.51%,MEF2C;RANBP3L;SMYD1
prerank,double-strand break repair (GO:0006302),0.21928984313867386,0.7178789678497322,0.9375,0.9855311793113558,1.0,43/158,25.03%,EYA1;ZSWIM7;HPF1;LIG4;RAD51B;INO80;SMC5;DCLRE1C;POLL;RECQL5;UBE2V2;NHEJ1;SMC6;ACTR8;BAZ1B;TENT4A;TDP2;DCLRE1A;RAD51D;XRCC2;ATM;RNF138;AP5Z1;KPNA2;DDX1;KAT5;UIMC1;SUMO1;KDM4A;NSMCE2;BRCC3;EXD2;FAN1;EME2;APLF;SETX;SMARCAD1;BRCA1;NABP2;SFPQ;MRE11;RAD51AP2;SWI5
prerank,mitotic cytokinetic process (GO:1902410),0.2918588905731315,0.7178158950145193,0.8171521035598706,0.985153589354257,1.0,3/20,13.42%,KIF20A;KLHDC8B;CHMP5
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.26318765644016906,0.7178082443585007,0.8460471567267683,0.9847148007712887,1.0,8/39,17.77%,PIK3R1;TTC7B;EFR3A;PI4KA;TMEM150A;PIK3R2;PIP4K2C;ITPKA
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.28334645305642364,0.7177037784146308,0.8455538221528861,0.9844045302312022,1.0,7/25,25.87%,LEPROT;CHMP5;LAPTM4B;TMEM50B;RILP;SORT1;CHMP2A
prerank,positive regulation of JUN kinase activity (GO:0043507),0.2938458240303966,0.7174468174961238,0.8031746031746032,0.9842965713754123,1.0,4/23,12.77%,SASH1;TLR6;TAOK3;DUSP19
prerank,DNA damage checkpoint signaling (GO:0000077),-0.23004437704565664,-0.7173313953606673,0.8895184135977338,0.9979956182431347,1.0,12/28,34.77%,RAD17;RAD1;HUS1;CEP63;NBN;HINFP;RHNO1;E2F1;DONSON;FBXO6;DOT1L;RAD9A
prerank,peroxisome organization (GO:0007031),0.28910453102724215,0.717309151218054,0.8282208588957055,0.9840186588384872,1.0,8/25,21.59%,LONP2;PEX6;PEX2;ABCD2;SEC16B;PEX11B;PEX7;PEX1
prerank,hexose metabolic process (GO:0019318),-0.21919968084182817,-0.7167999786684369,0.9071428571428571,0.997648637031177,1.0,5/39,10.88%,PPARD;APOD;ALDOA;GDPGP1;SLC35A2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.22610914756123546,-0.7164152735128189,0.884375,0.9971574255362229,1.0,7/30,21.58%,DACH1;ACVRL1;CTC1;BMPR2;CDKN1A;DCP2;TEN1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.22663417685261283,0.7163029666375661,0.9049295774647887,0.9849007990034381,1.0,7/110,6.32%,TRABD2B;GSN;ABCA1;APOE;CDH5;CDC42;SRC
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.28696801640465225,0.7158691693488375,0.8035143769968051,0.9850226769743916,1.0,2/24,3.41%,EPHA4;APOE
prerank,histone H2A monoubiquitination (GO:0035518),0.3105150548187301,0.7155949653293093,0.8221528861154446,0.9849270929704,1.0,4/17,14.99%,BCOR;CUL4B;PCGF3;RNF2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.21640540305839975,0.71523920559616,0.9340782122905028,0.9849413751615219,1.0,10/163,7.30%,PDPK1;THEMIS;PIK3R1;FYB1;BCL2;RFTN1;PSME4;CD247;RNF31;CD28
prerank,tRNA 5'-leader removal (GO:0001682),0.3254551145917947,0.7151921699584625,0.813588850174216,0.9845462339784563,1.0,4/13,16.13%,RPP25L;PRORP;RPP30;RPP38
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.31678119460430654,0.7150370484934999,0.785031847133758,0.9843076760232666,1.0,3/14,11.79%,BFAR;BCL2L11;UFL1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.3205452187473071,0.714022870586036,0.7889273356401384,0.9847179785507322,1.0,2/15,9.82%,DTNBP1;BLOC1S1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.3205452187473071,0.714022870586036,0.7889273356401384,0.9847179785507322,1.0,2/15,9.82%,DTNBP1;BLOC1S1
prerank,folic acid metabolic process (GO:0046655),0.30696530160483715,0.7139135432204433,0.8293918918918919,0.9844101755279796,1.0,3/18,12.75%,MTHFR;ALDH1L1;FOLR2
prerank,mitotic spindle organization (GO:0007052),0.21623908377927736,0.7135698031611197,0.945823927765237,0.9844232732788439,1.0,36/153,22.44%,DYNLL1;NUP107;EFHC1;DYNC1H1;SPC24;PIBF1;ZW10;SPDL1;DCTN6;PMF1;ZWINT;NEK6;CENPC;NUP98;CENPH;EML4;ARHGEF10;DYNC1I2;PLK2;FLNA;CEP192;SGO1;PTPA;KPNB1;SEH1L;CENPA;TAOK1;CDCA8;CENPM;AAAS;DSN1;AURKA;TUBG1;ABRAXAS2;TUBG2;NDE1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.19912379511456754,-0.7124376896055234,0.9713114754098361,1.0,1.0,12/54,20.98%,CRADD;PLAGL1;CNOT6L;BTG2;RPL26;EP300;CDKN1A;CNOT7;E2F7;CNOT8;PLK3;TRIAP1
prerank,cellular response to reactive oxygen species (GO:0034614),0.2494705813446499,0.7120944118366354,0.871222076215506,0.9857950496979584,1.0,7/59,8.41%,TPM1;PDGFRA;CYP1B1;NFE2L2;ERCC6L2;OSER1;EGFR
prerank,positive regulation of dephosphorylation (GO:0035306),0.2840331336950467,0.7120762554093801,0.8398791540785498,0.9853695231829049,1.0,5/27,12.53%,DLC1;CDH5;SRC;BMP2;CAMTA1
prerank,positive regulation of mRNA processing (GO:0050685),-0.24701141321198442,-0.711321025570873,0.8729729729729729,1.0,1.0,5/21,18.60%,CELF4;SNW1;THRAP3;RBMX;SF3B4
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.2947732106557706,0.7110857924327056,0.8257575757575758,0.9861461130575722,1.0,6/22,18.87%,DYNLL1;CDA;CDKN1C;BMP4;CDKN2C;CDKN1B
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3069288346982572,-0.7108125075657772,0.8179611650485437,1.0,1.0,5/10,23.12%,HOMER1;HOMER3;EFHB;GRAMD2A;CASQ1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.327524150164006,0.709771476792674,0.7975986277873071,0.9873944850449922,1.0,2/13,5.51%,PRICKLE1;TBX3
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.33872425145638296,0.7096241029045252,0.8061224489795918,0.9871202697521995,1.0,1/10,4.43%,APPL2
prerank,positive regulation of interleukin-12 production (GO:0032735),0.2716504960016583,0.7094254344567645,0.8547655068078669,0.9869426408388905,1.0,8/31,21.27%,CCL19;IL12B;RIPK2;MDK;IL23A;TIRAP;LGALS9;PLCB1
prerank,mitochondrion disassembly (GO:0061726),0.26878196842896673,0.7092900124938036,0.8357558139534884,0.9866725461224819,1.0,12/34,21.68%,ULK2;PRKN;WIPI1;USP30;MARK2;MAP1LC3A;BECN1;ATG2B;WDR45;ATG9A;FUNDC2;AMBRA1
prerank,regulation of chemokine production (GO:0032642),-0.21409758383889183,-0.7089505514616778,0.9249146757679181,1.0,1.0,12/36,27.12%,IL33;FOXP1;SIGIRR;APP;HIF1A;TLR4;ACKR1;AGER;AIF1;SNAI2;TREM2;EGR1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.25956793154116,-0.7088810508676088,0.8600508905852418,1.0,1.0,7/18,29.06%,MECP2;RAB11A;RAD51C;CCND1;DTL;RCC2;CDK1
prerank,organophosphate biosynthetic process (GO:0090407),-0.21106988158035755,-0.708360301317253,0.9273356401384083,1.0,1.0,7/37,15.25%,MBOAT1;LPCAT1;TPI1;IP6K1;IPMK;GPHN;AGPAT5
prerank,cellular response to chemical stress (GO:0062197),0.22788370861288632,0.7082688408148001,0.9120481927710843,0.987546252227284,1.0,15/96,13.22%,PYCR1;NUDT2;MT3;SLC25A24;PRKAA2;GPX8;LRRK2;NFE2L2;SIRT2;DDX3X;MGAT3;FANCC;SELENOS;GPX3;NOX4
prerank,cell cycle G1/S phase transition (GO:0044843),-0.19250280212743806,-0.7074398410386895,0.9741379310344828,1.0,1.0,19/61,23.86%,CDK6;USP29;CUL1;EIF4E;DBF4;BCAT1;CUL2;CCND1;INHBA;CDKN1A;MAP3K11;CUL3;E2F3;PLK3;HINFP;CDKN3;MAX;PIM2;NASP
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24656637435063203,0.707411054786652,0.8437917222963952,0.9881580336372818,1.0,15/48,21.11%,OGT;PRKAG2;NUP107;NUP42;EIF6;RAE1;NUP98;NUP214;GCK;SEH1L;TPR;PRKAG1;AAAS;GCGR;RUBCNL
prerank,regulation of supramolecular fiber organization (GO:1902903),0.2906000181214481,0.7072113925890605,0.8185975609756098,0.9879527814510591,1.0,6/22,19.53%,AEBP1;APOE;ARL2;AKAP13;CAMSAP1;EFEMP2
prerank,microvillus assembly (GO:0030033),0.3092871602089381,0.7068846999432518,0.8017094017094017,0.9879275980273391,1.0,4/14,15.63%,RAPGEF2;MAP4K4;RAP2A;RAPGEF6
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.3235930426001793,0.7068307182855993,0.8113821138211382,0.987552897838011,1.0,3/13,8.68%,TNRC6B;CPEB3;TNRC6A
prerank,regulation of interleukin-1 production (GO:0032652),-0.268510130849072,-0.7066723108874977,0.8647342995169082,1.0,1.0,5/15,21.11%,SIRPA;FOXP1;CEACAM1;TLR4;ANXA1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.19368768411661771,-0.7064897594124558,0.9574468085106383,0.9997946432131234,1.0,10/56,16.96%,PLCG2;NOD1;LBP;CTSB;S100A1;LGMN;UNC93B1;NOD2;TAB1;TLR4
prerank,regulation of protein metabolic process (GO:0051246),0.2562120851377033,0.7064495246140182,0.8707386363636364,0.9875782210882283,1.0,3/44,5.23%,ROCK2;APOE;LDLR
prerank,regulation of phospholipid metabolic process (GO:1903725),0.33891430430641495,0.7061208178012311,0.7971274685816876,0.9875235290048668,1.0,4/10,18.91%,GNB3;MTMR3;ABCA3;PHB2
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.29196668041108564,-0.7060522200953304,0.813953488372093,0.9984158083008056,1.0,7/11,54.03%,CCT8;CCT6A;CCT7;CCT2;LARP7;TCP1;DKC1
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.29196668041108564,-0.7060522200953304,0.813953488372093,0.9984158083008056,1.0,7/11,54.03%,CCT8;CCT6A;CCT7;CCT2;LARP7;TCP1;DKC1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3055604379404626,0.7058262440900791,0.8271028037383178,0.987457920733964,1.0,9/17,30.99%,DOLPP1;ALG6;DHDDS;SRD5A3;DPAGT1;MPDU1;ALG9;ALG2;ALG3
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.33652894737693295,0.7055213501207713,0.8165784832451499,0.9864707210663303,1.0,6/11,27.54%,PANK1;COASY;SLC25A16;DCAKD;PANK2;ACOT7
prerank,coenzyme A biosynthetic process (GO:0015937),0.33652894737693295,0.7055213501207713,0.8165784832451499,0.9864707210663303,1.0,6/11,27.54%,PANK1;COASY;SLC25A16;DCAKD;PANK2;ACOT7
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.33652894737693295,0.7055213501207713,0.8165784832451499,0.9864707210663303,1.0,6/11,27.54%,PANK1;COASY;SLC25A16;DCAKD;PANK2;ACOT7
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.30722947567722253,0.7054664347656694,0.8198051948051948,0.986092838513267,1.0,2/16,4.44%,DPYSL3;DPYD
prerank,regulation of mRNA processing (GO:0050684),0.26953388772561193,0.7051532370285608,0.8423357664233576,0.9860257413465169,1.0,14/32,27.91%,SON;ZFP36L1;SF1;SAFB2;RBM39;SRSF10;SRSF3;PAPOLA;METTL16;CWC22;CDK11B;AHCYL1;NCBP1;PABPN1
prerank,regulation of protein localization to centrosome (GO:1904779),-0.3014960813716615,-0.7049473789832982,0.847682119205298,0.9986870165771474,1.0,1/10,1.60%,BICD1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3426799535936428,0.7048245387116353,0.8274647887323944,0.9859833102469179,1.0,2/10,9.79%,PIBF1;PARP14
prerank,regulation of spindle organization (GO:0090224),0.30135026327893105,0.7045484462891366,0.82793867120954,0.9858876286644802,1.0,5/18,19.18%,DYNC1H1;RAE1;SENP6;GNAI1;NUMA1
prerank,peptidyl-proline modification (GO:0018208),-0.23404079176029788,-0.7045173368721837,0.8746268656716418,0.9982228768449433,1.0,9/25,23.60%,PPIA;FKBP5;PPIG;P3H2;FKBP1A;PPIL1;PPIB;PPID;PPIL6
prerank,reticulophagy (GO:0061709),0.3255458814974065,0.7038648745231185,0.8076225045372051,0.9862550258835374,1.0,4/12,18.24%,ULK2;UFL1;UFC1;ATG2B
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.26458577090940033,0.7032058558839415,0.8695035460992908,0.9866280090922033,1.0,7/36,13.57%,DACT1;NCOR1;PRKN;ITCH;TAOK3;DUSP19;IGBP1
prerank,defense response to fungus (GO:0050832),-0.2554461763446893,-0.7018638710724973,0.8681318681318682,1.0,1.0,2/17,11.10%,PLCG2;CX3CR1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.2368958344416914,0.7014774554136696,0.8925,0.988247843602092,1.0,8/68,11.02%,IL6R;IL17D;TSLP;SPHK2;TLR6;RAB7B;CARD9;SETD4
prerank,negative regulation of centrosome duplication (GO:0010826),-0.28795554075111457,-0.7012339305492633,0.8386363636363636,0.9998299580538935,1.0,4/11,18.98%,RBM14;KAT2A;CDK5RAP2;NPM1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.29272110892982106,0.7012250453052823,0.8335949764521193,0.9881154018655977,1.0,5/22,16.40%,PLA2R1;CDK5RAP3;SPRED3;SPRED1;ATM
prerank,neutrophil mediated immunity (GO:0002446),0.20078795142509243,0.7010661954300839,0.9855371900826446,0.9878699238088493,1.0,59/432,13.51%,AMPD3;GSN;AHSG;PLD1;DYNLL1;CRISPLD2;PLEKHO2;PIGR;CLEC12A;TXNDC5;CNN2;FGL2;GALNS;IQGAP2;CTSH;STXBP3;FAF2;DYNC1H1;TOM1;CST3;PDXK;KCMF1;VCL;B4GALT1;TIMP2;CD63;COPB1;CAMP;UBR4;GAA;SPTAN1;DNAJC3;ARHGAP9;MGST1;AGL;ANXA3;IGF2R;APEH;ITGAV;S100A11;NFAM1;VPS35L;AP1M1;CD53;DNASE1L1;CARD9;DDX3X;TMEM179B;LAMTOR2;TNFAIP6;DDOST;CD33;CD14;CTSZ;CDA;MVP;KMT2E;ATP6AP2;FRK
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.27300305263816305,-0.7003008769000494,0.8592233009708737,0.9999131059204779,1.0,4/14,15.14%,TFB2M;PNPT1;SLC25A33;FASTKD1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.23818580711342063,0.7000466217835497,0.8766404199475065,0.9886198927998275,1.0,18/56,21.27%,RAD51B;EGFR;ANAPC5;DDX3X;RGCC;KMT2E;UBE2E2;ADAMTS1;TFDP1;AKT1;CDC7;KLHL18;LSM10;PHB2;NSMCE2;CDC23;CCND2;PLCB1
prerank,regulation of receptor recycling (GO:0001919),-0.26575047608252134,-0.6996232996016729,0.8664987405541562,0.9997109472785467,1.0,4/16,11.28%,INPP5F;SCRIB;KIF16B;NSF
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.30106017959971554,0.6994014471106927,0.829073482428115,0.9889973390735503,1.0,2/17,8.63%,PLA2G4A;LPGAT1
prerank,nuclear envelope organization (GO:0006998),0.29295935275696705,0.6993637785546566,0.8336025848142165,0.9885974944797783,1.0,5/20,17.17%,DMPK;LEMD3;TOR1AIP1;TOR1B;REEP4
prerank,DNA-dependent DNA replication (GO:0006261),-0.16874949437386355,-0.6991160661898298,0.9931972789115646,0.999311030137005,1.0,39/128,30.74%,REV3L;DBF4;TOPBP1;POLE4;ORC4;PSMF1;POLB;PSMB8;PSMB2;MCM8;PSMA4;PSMB10;RAD51;MCMBP;GINS3;LRWD1;PNKP;PSMC4;MCM3;POLD4;WRNIP1;PSMD9;PSMD5;PSMA6;HELB;PSMD11;MCM5;PSMA8;PSMB1;ORC5;PRIM1;PSMD10;GINS2;RPS27A;UBC;CDC6;POLD2;PSMC3;POLA1
prerank,positive regulation of cellular respiration (GO:1901857),0.3278488500981806,0.6989190441923205,0.8104906937394247,0.988702891915429,1.0,1/11,3.62%,NUPR1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3024883806830957,0.6988147420295456,0.8347386172006745,0.9883860592350253,1.0,6/17,16.32%,NFE2L2;NOL3;P4HB;VNN1;BAG5;AKT1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.2654515145863072,-0.6987029403233493,0.8713592233009708,0.9988060467216185,1.0,2/13,13.94%,SIX1;PTGS2
prerank,superoxide metabolic process (GO:0006801),-0.22689324150067552,-0.6982002971561186,0.8888888888888888,0.9983676300969675,1.0,2/29,2.30%,SH3PXD2A;NOS3
prerank,ether lipid biosynthetic process (GO:0008611),0.34088690237056346,0.6981627561870469,0.8054054054054054,0.9887076426114662,1.0,4/10,22.17%,PLA2G4A;PEX7;DHRS7B;PEDS1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2945300672755463,0.6980394190595104,0.8465266558966075,0.9884178188238344,1.0,3/19,12.75%,MTHFR;ALDH1L1;FOLR2
prerank,fatty acid beta-oxidation (GO:0006635),0.24664891035634884,0.6979368862862433,0.8836265223274695,0.9880983680344952,1.0,14/51,24.44%,IVD;ECHDC2;ECI1;ECHS1;PEX2;DECR1;ABCD2;ETFDH;DECR2;ETFB;ETFA;ACADM;CPT2;ACADVL
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.29163393826663064,0.6976445393435221,0.8370253164556962,0.9880091295844469,1.0,1/20,1.80%,LYN
prerank,positive regulation of transmembrane transport (GO:0034764),0.31790647541947126,0.6973510510606513,0.8304498269896193,0.9879177086864924,1.0,2/13,10.73%,ACSL1;BRAF
prerank,endoplasmic reticulum organization (GO:0007029),0.23480468992031042,0.69729086357856,0.9070063694267516,0.987549617333263,1.0,18/72,21.23%,LMAN2L;SEC31A;TRAM2;LMAN1;LRRK2;EIF2AK3;CYB5A;MIA3;TRAM1;TOR1B;SEC16B;TOR1AIP2;REEP4;MOSPD3;SMPD4;CCDC47;SEC61A1;SEC16A
prerank,sensory perception of taste (GO:0050909),-0.2968682185690883,-0.6972438482370589,0.8436781609195402,0.9984044130972971,1.0,5/10,43.77%,PKD2L1;CD36;TAS1R1;TAS1R2;GNAT3
prerank,response to ionizing radiation (GO:0010212),0.2347612960110961,0.69702494033293,0.9043927648578811,0.9874083098473821,1.0,8/70,10.70%,EYA1;LIG4;IKBIP;INO80;BRSK1;NHEJ1;STK11;MRNIP
prerank,neurotrophin signaling pathway (GO:0038179),0.2927215501266177,0.6968850055392286,0.8309636650868878,0.9871130623181786,1.0,4/21,9.39%,RAPGEF2;NTF3;FRS2;RAPGEF1
prerank,cardiolipin metabolic process (GO:0032048),-0.2829670767545125,-0.6962354556659051,0.8629441624365483,0.9985202675092851,1.0,4/13,18.12%,PNPLA8;PGS1;CRLS1;PTPMT1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.2384281503563787,-0.6962130581336042,0.8736559139784946,0.9976062260122149,1.0,9/22,29.83%,ERBB2;PWP1;UBTF;MTOR;UTP15;ATF4;SMARCA4;PIH1D1;IPPK
prerank,mRNA processing (GO:0006397),0.2029286630966463,0.6960408553970558,0.9811715481171548,0.9876788369908788,1.0,72/287,23.32%,POLR2D;SON;RBMXL2;U2AF1L4;SNRNP70;THOC2;GTF2H5;SF1;PNN;RBM22;NONO;METTL14;HNRNPR;HNRNPA1;RAVER2;DDX39A;POLR2C;WDR33;SMU1;DDX23;SUGP1;PRMT9;RBM19;MAGOHB;MNAT1;MTREX;SNRPD2;TCERG1;AKAP8L;RBM4B;SRSF5;GPKOW;PCF11;RNPC3;RBM6;SYNCRIP;RBM5;CMTR2;GEMIN2;PSPC1;LSM8;RBM41;HNRNPC;SF3B1;SF3B2;SRRM2;PRPF6;SRSF10;PPIE;POLR2L;FIP1L1;METTL3;CPSF2;PRKACA;USP49;GCFC2;HNRNPH1;HNRNPU;PRCC;SRSF3;PPWD1;NCBP2;ESS2;CDK7;PAPOLA;RBM4;ERCC3;IK;ERCC2;PRPF8;ZRSR2;SART1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.20105794171656458,-0.6949187868825145,0.9368029739776952,0.9980013532607407,1.0,19/45,31.75%,GBP5;P2RX7;AIM2;JAK2;TRIM16;CASP8;APP;NOD2;TLR4;FZD5;AGER;MALT1;EGR1;TMEM106A;CD36;HSPB1;NLRP3;LPL;TLR8
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.24708388993301184,0.6944124233528991,0.8970792767732962,0.9891532359463387,1.0,8/47,13.57%,TGFBR3;MAP2K1;MAP4K4;EGFR;TAOK3;CARD9;RAP2A;IGBP1
prerank,modification-dependent protein catabolic process (GO:0019941),0.2083264999322184,0.6943892194807406,0.9739978331527628,0.9887416469696438,1.0,42/193,19.41%,SPSB1;DCST1;NEDD4;SMURF2;RFFL;RNF213;BFAR;ZNRF3;TRIP12;UBE4B;RNF185;UBR4;ARRB1;WDR91;ANAPC5;WDR81;PRKN;ITCH;MIB1;RNF6;FBXO11;FEM1C;RNF217;BTRC;COPS3;RC3H2;RNF19A;ADRM1;UBA6;AMFR;UBE2D1;HACE1;RNF13;UBE2R2;UBE3B;UBR3;LONP1;PSMC2;RNF34;RC3H1;TRIM32;RNF11
prerank,negative regulation of histone modification (GO:0031057),-0.2692351630903459,-0.6938740891247307,0.8543689320388349,0.9981508225659198,1.0,6/14,29.03%,CTBP1;PRMT6;THAP7;TWIST1;SET;AASS
prerank,protein-DNA complex assembly (GO:0065004),0.2177645514217155,0.6931295480440935,0.9271844660194175,0.9897776916038873,1.0,6/116,6.65%,TCF4;PSME4;CHAF1B;CUL4B;DMC1;GTF2H5
prerank,regulation of cell killing (GO:0031341),-0.25874932536666667,-0.6926655165484366,0.8931297709923665,0.9983997015557564,1.0,3/16,9.50%,TGFB2;CD55;MAPK8
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3197749256223101,0.6922606396791947,0.8432708688245315,0.9903349649440215,1.0,8/13,30.99%,ALG11;ALG6;SRD5A3;DPAGT1;MPDU1;ALG9;ALG2;ALG3
prerank,negative regulation of cell aging (GO:0090344),0.29507513535964613,0.691311830854649,0.8429054054054054,0.9909904249802746,1.0,4/16,12.19%,AKT3;SLC30A10;ZKSCAN3;TERF2
prerank,regulation of innate immune response (GO:0045088),0.235632658941955,0.6912619460431553,0.91268758526603,0.990607126582269,1.0,17/57,22.79%,IRF1;APPL2;IRAK3;NMI;RNASEL;ABCE1;IFNK;MUL1;RIOK3;RNF135;DHX58;TRIM21;APPL1;TIRAP;BIRC3;BIRC2;XIAP
prerank,positive regulation of viral genome replication (GO:0045070),-0.2213913213445575,-0.6906631308414894,0.9247648902821317,0.9994494098005952,1.0,9/29,21.79%,PPIA;PABPC1;SRPK1;ADAR;NR5A2;TOP2A;RAD23A;CNOT7;PPID
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.295980143665438,0.6901791907964171,0.8516666666666667,0.9914293590935234,1.0,5/16,19.18%,KAT2B;NAA50;NAA40;NAA20;NAA80
prerank,neutrophil degranulation (GO:0043312),0.19756263592285014,0.6899096510603534,0.9855670103092784,0.991314857394871,1.0,57/425,13.51%,AMPD3;GSN;AHSG;PLD1;DYNLL1;CRISPLD2;PLEKHO2;PIGR;CLEC12A;TXNDC5;CNN2;FGL2;GALNS;IQGAP2;CTSH;STXBP3;FAF2;DYNC1H1;TOM1;CST3;PDXK;KCMF1;VCL;B4GALT1;TIMP2;CD63;COPB1;CAMP;UBR4;GAA;SPTAN1;DNAJC3;ARHGAP9;MGST1;AGL;ANXA3;IGF2R;APEH;ITGAV;S100A11;NFAM1;VPS35L;AP1M1;CD53;DNASE1L1;DDX3X;TMEM179B;LAMTOR2;TNFAIP6;DDOST;CD33;CD14;CTSZ;CDA;MVP;ATP6AP2;FRK
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2671261680004875,0.688994874842322,0.8806404657933042,0.9919417320502512,1.0,5/32,7.83%,DTNBP1;MCTP2;BAIAP3;LRRK2;SNCAIP
prerank,positive regulation of bone resorption (GO:0045780),-0.2853446090348204,-0.6880818855672513,0.8677494199535963,1.0,1.0,2/11,12.82%,TNFRSF11A;SPP1
prerank,neutrophil activation involved in immune response (GO:0002283),0.19712669819793197,0.6875309134453639,0.988659793814433,0.993168720960516,1.0,57/428,13.51%,AMPD3;GSN;AHSG;PLD1;DYNLL1;CRISPLD2;PLEKHO2;PIGR;CLEC12A;TXNDC5;CNN2;FGL2;GALNS;IQGAP2;CTSH;STXBP3;FAF2;DYNC1H1;TOM1;CST3;PDXK;KCMF1;VCL;B4GALT1;TIMP2;CD63;COPB1;CAMP;UBR4;GAA;SPTAN1;DNAJC3;ARHGAP9;MGST1;AGL;ANXA3;IGF2R;APEH;ITGAV;S100A11;NFAM1;VPS35L;AP1M1;CD53;DNASE1L1;DDX3X;TMEM179B;LAMTOR2;TNFAIP6;DDOST;CD33;CD14;CTSZ;CDA;MVP;ATP6AP2;FRK
prerank,phagolysosome assembly (GO:0001845),0.31324247284148937,0.6868930293830019,0.8330522765598651,0.9934302014288992,1.0,3/12,15.43%,RAB7B;CLN3;PIKFYVE
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.27520090689174065,-0.6866494761143462,0.8497536945812808,1.0,1.0,2/13,6.67%,STX3;HSP90AB1
prerank,cellular response to superoxide (GO:0071451),-0.2974571108408383,-0.6864691542750873,0.8541176470588235,1.0,1.0,5/10,26.94%,NOS3;ATP7A;SOD2;SOD1;CCS
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.3107662215293251,0.6864357299516108,0.8222222222222222,0.9935000889389253,1.0,6/13,23.91%,BFAR;UFL1;ABCA7;HSPA5;WFS1;PPP1R15A
prerank,regulation of T cell proliferation (GO:0042129),-0.18983143074494085,-0.6855673800816278,0.9777777777777777,1.0,1.0,16/61,26.48%,SLC7A1;IL15;TFRC;CD80;TNFRSF21;PTPRC;JAK3;PNP;CD86;NCK2;ANXA1;VCAM1;CD276;AIF1;LILRB1;IL4I1
prerank,establishment of protein localization to organelle (GO:0072594),0.22942752065843605,0.6855535665259849,0.9274092615769712,0.9940436161224137,1.0,16/72,19.09%,RANBP17;NUP107;APPL2;PRICKLE1;FAM53C;HEATR3;CSE1L;PPP1R10;TSC2;NUP214;LAMP2;AKT1;KPNB1;TPR;PHB2;APPL1
prerank,regulation of dephosphorylation (GO:0035303),0.3045312018819737,0.6852895843142234,0.8352180936995154,0.9939125533960715,1.0,4/15,13.57%,CDK5RAP3;SRC;MTMR3;IGBP1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.29755571414201376,-0.6852475627035024,0.8758169934640523,1.0,1.0,4/10,32.35%,DLGAP2;BEGAIN;CACNG5;DLGAP1
prerank,regulation of nervous system development (GO:0051960),0.2550216849510292,0.684982586856965,0.8867924528301887,0.9938080745360292,1.0,9/37,19.77%,YAP1;ASCL1;HES7;SIRT2;BHLHE41;NSUN5;CX3CL1;YTHDF2;WNT3
prerank,cellular component maintenance (GO:0043954),0.31932185480569275,0.6842431483109704,0.8424543946932007,0.9941664479039283,1.0,2/12,12.98%,ITGA3;INSR
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.2563530761715287,-0.684206392970207,0.8743961352657005,1.0,1.0,6/16,28.30%,GSK3A;GPER1;ACP3;CHGA;NECAB2;GRP
prerank,epidermal cell differentiation (GO:0009913),0.2509897552814233,0.6840934075781866,0.8881019830028328,0.9938853534384318,1.0,11/41,24.02%,TXNIP;USH2A;KRT10;GLI1;GATA6;ST14;ERCC3;ERCC2;JAG1;ACER1;HDAC1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.3118170447726312,0.6831241385632761,0.8528428093645485,0.9945274173353972,1.0,6/14,28.46%,MRNIP;TIMELESS;ARID2;FUS;MMS19;FANCB
prerank,regulation of interferon-beta production (GO:0032648),0.24457605104819888,0.6831156886718173,0.8915492957746479,0.9940977365354456,1.0,11/46,19.46%,IRF1;PTPRS;OAS2;POLR3A;DDX3X;TBK1;RIPK2;RIOK3;RNF135;DHX58;TIRAP
prerank,glial cell differentiation (GO:0010001),0.26870013246769187,0.6824643848307909,0.8696296296296296,0.9943689589657616,1.0,2/28,3.34%,SLC8A3;NFIB
prerank,endochondral bone morphogenesis (GO:0060350),-0.28192327819903984,-0.6820899928579643,0.847457627118644,1.0,1.0,1/11,0.57%,MEF2C
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.2827325554149298,0.6819602200482756,0.853030303030303,0.9944752909273241,1.0,3/22,9.31%,APOA1;SPHK2;TRPM4
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.26135730039762994,-0.6814611979906481,0.9074550128534704,1.0,1.0,5/15,22.19%,PLCG2;EZH2;CUL3;NPM1;DDRGK1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2439540910939877,0.6814288729916916,0.9050131926121372,0.9946123876078196,1.0,3/44,7.18%,GSN;CDC42EP4;CARMIL1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.1761597856467065,-0.6811699328255779,0.9770642201834863,1.0,1.0,21/72,24.68%,CUL1;REL;CARD14;PSMF1;PSMB8;PSMB2;RELB;PSMA4;PSMB10;PSMC4;TNFRSF10B;PSMD9;PSMD5;PSMA6;TRAF2;CHUK;PSMD11;MAP3K7;MALT1;PSMA8;PSMB1
prerank,mRNA methylation (GO:0080009),0.3073371138305535,0.6804731402926517,0.8489932885906041,0.9952415405399615,1.0,6/15,24.80%,NSUN2;METTL14;WTAP;METTL3;METTL16;PCIF1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.2205196382593719,-0.6795813878094699,0.9140401146131805,1.0,1.0,11/27,29.71%,CUL1;MAPK8;MAPK3;CCDC88C;CHUK;MAP3K7;MAPK1;MAPK11;RPS27A;UBC;IKBKG
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.24516327425004333,-0.6792403651328343,0.910941475826972,1.0,1.0,11/17,42.52%,CADM1;PVR;RAET1E;NECTIN2;SLAMF6;CD226;CRTAM;LAMP1;CD160;KLRK1;AP1G1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.2735933166641252,0.6792358950526938,0.8784615384615385,0.996115449045133,1.0,8/27,21.79%,IRAK2;TLR6;IRAK3;CD14;TNIP1;TLR5;TIRAP;MYD88
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.2914218175010647,0.679129216517099,0.8491803278688524,0.9958063486519603,1.0,4/17,23.61%,APOA1;NR1H3;LMF1;SORT1
prerank,RNA biosynthetic process (GO:0032774),-0.21196860860300543,-0.6787465000633622,0.9326923076923077,0.9995455777262492,1.0,13/31,32.39%,TBP;TAF10;RSF1;HELB;TAF5;GTF2B;TCEA2;TAF4;PRIM1;TBPL1;POLA1;SMN1;TERT
prerank,cellular lipid catabolic process (GO:0044242),0.2654753834076814,0.6784872687412994,0.875748502994012,0.9960573524389711,1.0,7/27,21.72%,CYP1B1;MT3;SIRT2;SMPDL3B;NUDT19;LPIN3;LPIN2
prerank,negative regulation of phagocytosis (GO:0050765),-0.2510321993896821,-0.6784612414661546,0.8923076923076924,0.9988775003540563,1.0,6/17,24.16%,DYSF;SIRPA;RACK1;CD300A;CD300LF;PLSCR1
prerank,RNA 3'-end processing (GO:0031123),-0.18184934446951323,-0.6780862633397012,0.981042654028436,0.9982758966710985,1.0,17/69,19.76%,LIN28B;CPSF7;RBM8A;ALYREF;CHTOP;PNPT1;CSTF3;RPRD1A;CSTF1;SUPV3L1;CLP1;SRSF7;CSTF2;DHX38;THOC6;TENT2;SRSF4
prerank,cytosolic transport (GO:0016482),0.21363903985681423,0.6777587408850291,0.9613059250302297,0.9963924748539775,1.0,19/108,15.43%,DENND2A;BAIAP3;RHOBTB3;MON2;STX16;RBSN;DENND5A;EPS15;HEATR5A;GOSR2;WDR91;WDR81;ARL1;CLN3;TMEM87B;PTPN23;HOOK2;BET1L;PIKFYVE
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.2498173823902414,-0.677454503238737,0.8891752577319587,0.9979289898075753,1.0,9/18,37.30%,CCT8;RUVBL1;DCP2;RUVBL2;SHQ1;CCT6A;NHP2;EXOSC10;NOP10
prerank,protein targeting to peroxisome (GO:0006625),0.2655576935286178,0.6771393292891122,0.8789712556732224,0.9966291727529349,1.0,10/29,23.96%,PXMP2;LONP2;PEX6;PEX2;ABCD2;PEX11B;PEX7;ZFAND6;PEX1;ATAD1
prerank,mRNA catabolic process (GO:0006402),-0.19453569729380432,-0.677046598151558,0.9444444444444444,0.9973998398272392,1.0,13/44,22.02%,PNPT1;LSM2;LSM6;SUPV3L1;THRAP3;ERN1;DIS3L2;NBAS;AGO1;DDX5;RNH1;DCP2;NUDT16
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.3139780064872342,0.6763813515609197,0.8418367346938775,0.9970283972175813,1.0,3/13,15.79%,NFIB;REST;BMP4
prerank,cochlea morphogenesis (GO:0090103),-0.2851126433239286,-0.6761864379279898,0.8755555555555555,0.9972246094604238,1.0,6/10,39.40%,TBX1;MYO3B;MYO3A;HOXA1;TBX18;PAX2
prerank,pyroptosis (GO:0070269),0.29511464443281477,0.6760707044206582,0.8564273789649416,0.9969236835790241,1.0,5/15,16.71%,GSDME;GSDMD;NLRC4;ZBP1;CASP1
prerank,regulation of response to stress (GO:0080134),-0.29399945545110995,-0.6758862037600605,0.8627450980392157,0.9965733020323957,1.0,3/10,20.92%,ADCY8;MLC1;CORO2B
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.21940487125926592,-0.6758140541298384,0.9174603174603174,0.995705224697434,1.0,9/27,29.26%,GSR;AK6;AK5;TYMS;AK7;DCTD;AK2;RRM1;NME2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.2847820188493205,0.675557178866279,0.8624161073825504,0.9970155083425876,1.0,8/17,25.98%,APOE;SREBF1;KPNB1;ERLIN1;SEC14L2;ERLIN2;SREBF2;SCAP
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.20290655022581108,-0.6754654006943491,0.9490909090909091,0.9951107203773123,1.0,8/45,14.78%,EIF4E;GRM5;LARP4;TDRD7;PER1;ATG14;YTHDC1;APP
prerank,snRNA processing (GO:0016180),-0.2544881169227529,-0.6745081686748123,0.9061728395061729,0.9950501162275109,1.0,6/16,32.40%,INTS6;INTS8;INTS1;INTS10;TUT1;INTS11
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.27020463291619473,-0.6741340879121058,0.8524229074889867,0.9944368917688808,1.0,2/12,11.19%,NOTCH1;HES1
prerank,organelle assembly (GO:0070925),0.19422622101622072,0.6740528099390464,0.9949031600407747,0.99813625112831,1.0,85/384,22.48%,ASAP1;GSN;DYNLL1;PARVA;TMOD4;SH3PXD2B;GORASP2;WDPCP;DZIP1L;RAB23;DYNC1H1;CYS1;CPLANE1;INO80;PIBF1;WDR35;TTC39C;ULK2;B9D1;IFT43;UBXN2B;DNAAF1;FBF1;NCOR1;IFT81;NEK6;MAPRE2;DDX3X;CENPC;DYNC2I1;WIPI1;CFAP410;CFAP44;EMC6;VPS37D;GOLGA8B;SYNPO;HAUS1;CHMP5;HAUS3;PTPN23;ARF4;PTPDC1;ABCA3;FLNA;HAUS7;PRRC2C;CEP164;IFT74;AUP1;POGZ;RAB19;DZIP1;RAB32;PATL1;MAP1LC3A;ABCB6;INTU;BECN1;TMEM67;ATG2B;RP2;AHI1;CENPA;RC3H1;TTC36;HPS4;TMEM231;EHD1;YTHDF2;WDR45;HYLS1;NSFL1C;ATG9A;STK36;OCRL;CEP250;AMBRA1;CEP20;KIF24;TSG101;RILP;STX12;HAUS5;HAUS6
prerank,autophagosome assembly (GO:0000045),0.23785910123699022,0.673989970714995,0.9130434782608695,0.9977668201156453,1.0,15/52,22.41%,RAB23;ULK2;UBXN2B;WIPI1;EMC6;RAB19;MAP1LC3A;BECN1;ATG2B;STX17;WDR45;NSFL1C;ATG9A;AMBRA1;STX12
prerank,regulation of RNA splicing (GO:0043484),0.22786414282404663,0.6735245994185506,0.9151670951156813,0.9978234543518046,1.0,13/69,16.14%,PIK3R1;SON;HNRNPLL;SNRNP70;SF1;RBM22;RBM39;CLK4;DYRK1A;CLK3;TMBIM6;METTL4;SLC38A2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.1912537341351752,-0.6735245474315048,0.9757085020242915,0.9940605693814389,1.0,21/53,27.78%,ECSCR;HSP90AB1;OPHN1;FOXF2;PSMF1;USP14;TMTC3;TMF1;RAD23A;GNA12;GPX1;DAB2IP;USP19;DDRGK1;DESI1;PRKCG;TREM2;UCHL5;FMR1;PKD1;BAG2
prerank,microtubule depolymerization (GO:0007019),0.2882487870421763,0.6726319083407302,0.8472668810289389,0.9983073721727538,1.0,6/17,25.22%,NCKAP5;KATNB1;KIF19;KIF24;CCSAP;NCKAP5L
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.2793153579534846,0.6723193658596589,0.8567073170731707,0.9981877055285772,1.0,3/22,12.52%,APOA1;MYADM;WNK1
prerank,peptidyl-lysine acetylation (GO:0018394),0.3206595863510272,0.6719763554788061,0.8369747899159664,0.9981192366113945,1.0,5/10,24.67%,KAT2B;BLOC1S1;KAT5;BAG6;ESCO1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.22273083119704667,0.6715478756288419,0.9255874673629243,0.9981147768277001,1.0,16/70,21.18%,RUNX1;YAP1;PSME4;SETD1A;ITCH;KMT2A;TCF12;PSMB5;PSMC2;PSMD4;METTL3;PSMD1;YTHDF2;PSME3;FOXC1;PSMA3
prerank,nuclear membrane organization (GO:0071763),0.28096596255668943,0.6714132816466432,0.8644628099173554,0.9978155732302149,1.0,5/19,20.04%,UBXN2B;TOR1AIP1;AKAP8L;TOR1B;NSFL1C
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.20577552939449756,-0.6713224562155052,0.9522184300341296,0.9950336870370747,1.0,17/42,34.89%,KDM1A;SHLD1;CGAS;RAD51;PARPBP;PARP1;POLQ;SHLD2;HELB;RAD51AP1;KLHL15;WDR48;FIGNL1;RPA2;WAS;SIRT6;RADX
prerank,response to amino acid starvation (GO:1990928),0.22353832371366075,0.6711444571739341,0.9384615384615385,0.9976617222788926,1.0,19/72,22.00%,NPRL3;EIF2AK3;SLC38A9;ATP6V1E1;CASTOR2;RNF152;CEBPB;LAMTOR2;RRAGD;IMPACT;LARP1;ITFG2;NPRL2;SESN2;SEH1L;RHEB;SZT2;MLST8;ATP6V1B2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.28327546007207455,0.6709318888596659,0.875,0.9974476886511466,1.0,3/20,9.52%,BCL2;PML;BCAP31
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.26057874860706487,-0.6705087493089253,0.9019138755980861,0.9948397719247364,1.0,4/14,21.16%,TFRC;SHLD1;SHLD2;NECTIN2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.28822233331409214,0.6704573354476143,0.8622950819672132,0.9975162338545908,1.0,9/18,28.82%,EIF2AK3;WDR43;FLNA;PHF8;POLR2L;MAF1;HEATR1;SIRT7;LYAR
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.19741983165865706,0.670074479249712,0.9904357066950054,0.9974921067820023,1.0,59/241,23.32%,POLR2D;RBMXL2;U2AF1L4;SNRNP70;SF1;PNN;RBM22;NONO;METTL14;HNRNPR;HNRNPA1;RAVER2;DDX39A;POLR2C;WDR33;SMU1;DDX23;SUGP1;RBM19;MAGOHB;MTREX;SNRPD2;RBM4B;SRSF5;GPKOW;PCF11;RNPC3;RBM6;SYNCRIP;RBM5;PSPC1;LSM8;RBM41;HNRNPC;SF3B1;SF3B2;SRRM2;PRPF6;SRSF10;PPIE;POLR2L;FIP1L1;METTL3;CPSF2;USP49;GCFC2;HNRNPH1;HNRNPU;PRCC;SRSF3;PPWD1;NCBP2;ESS2;PAPOLA;RBM4;IK;PRPF8;ZRSR2;SART1
prerank,autophagy of nucleus (GO:0044804),-0.25328450500767363,-0.6697340199226945,0.8894348894348895,0.994645326050797,1.0,6/16,22.41%,ULK1;WDR45B;ATG3;WIPI2;ATG13;ATG7
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.319761041167163,0.6696857076377208,0.8288288288288288,0.9974680007810929,1.0,4/11,23.07%,EBI3;STAT4;STAT1;CANX
prerank,cellular response to virus (GO:0098586),-0.21078584872501716,-0.6680942522677642,0.91875,0.9950774032648324,1.0,6/30,15.43%,IFIH1;TOMM70;EIF5A;ARF1;POU2F2;HIF1A
prerank,regulation of protein transport (GO:0051223),0.26274228590642706,0.6679104338775509,0.8761467889908257,0.9988336598057466,1.0,9/27,25.81%,DNAJC1;SNX12;LLGL1;RHBDF2;ATP13A2;LLGL2;SCFD1;DNAJA1;P3H1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.27850027370839225,0.667743280606587,0.8616144975288303,0.9985735574643908,1.0,1/18,1.80%,LYN
prerank,metanephros development (GO:0001656),0.2632764424251368,0.6663964702998025,0.8650793650793651,0.9994863477597109,1.0,6/26,16.89%,GDNF;CTSH;OSR1;SHH;BMP4;NIPBL
prerank,regulation of JUN kinase activity (GO:0043506),0.2534742914890056,0.6663496937456346,0.8948148148148148,0.9991001733109816,1.0,5/33,12.94%,SASH1;TLR6;TAOK3;DUSP19;PDCD4
prerank,protein K63-linked ubiquitination (GO:0070534),0.2445506084895108,0.6660606683942564,0.8896746817538896,0.9989507855878482,1.0,11/41,20.99%,NEDD4;BFAR;UBE2V2;PRKN;ITCH;RNF152;UBE2E2;RNF135;TRIM21;ARIH2;UBE2T
prerank,cilium-dependent cell motility (GO:0060285),0.2701785005578604,0.6658040890368213,0.8689320388349514,0.9987582344863909,1.0,3/22,11.31%,EFHC1;DNAI3;CFAP44
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.23544226849005018,-0.6656563957813316,0.9246753246753247,0.9962198847101166,1.0,4/20,18.74%,HSP90AB1;BBS12;PFDN6;CLU
prerank,cell-cell junction maintenance (GO:0045217),-0.27304454588641897,-0.6653086635540055,0.8958837772397095,0.9955945099271128,1.0,1/11,2.58%,TJP1
prerank,mitochondrion organization (GO:0007005),0.20235134090494578,0.6651081424012296,0.9766407119021134,0.998992857114889,1.0,35/165,19.87%,PID1;PYROXD2;COX7A2;MIGA2;LRRK2;AKT3;TIMM17B;AIFM1;WDR81;BCAP31;PRKN;TIMM44;RHOT1;TIMM9;TFAM;POLRMT;TSPO;NUBPL;SLC25A36;USP30;RAB5IF;MUL1;WASF1;IFIT2;TOMM22;FMC1;VPS13D;VPS13C;RAB32;LONP1;YME1L1;PHB2;SIRT5;AFG3L2;STOML2
prerank,innate immune response (GO:0045087),0.1979183326267481,0.66492098495571,0.9816810344827587,0.9987373370894298,1.0,18/217,10.83%,MFAP4;COLEC12;LYN;SP100;CXCL16;WFDC3;COLEC11;SRC;PML;KYNU;KLRD1;CAMP;MASP1;POLR3A;IFI27;RNASE7;CARD9;DDX3X
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.20302643968510056,-0.6640050574192969,0.9365079365079365,0.9957656037332504,1.0,14/36,34.77%,RAD17;RAD1;HUS1;CEP63;NBN;HINFP;RHNO1;HUS1B;E2F1;DONSON;CDC6;FBXO6;DOT1L;RAD9A
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3175537940091603,0.6638929846187377,0.8502772643253235,0.9993511915449731,1.0,4/10,18.44%,ERLEC1;DERL3;UBAC2;INSIG1
prerank,regulation of interleukin-12 production (GO:0032655),0.2370152074972847,0.6635843195334227,0.9063829787234042,0.9992174545158066,1.0,12/47,21.27%,CCL19;PIBF1;IL12B;IRAK3;MAST2;RIPK2;MDK;IL23A;CD47;TIRAP;LGALS9;PLCB1
prerank,myelination in peripheral nervous system (GO:0022011),0.29812757373045173,0.6630480452681451,0.8646362098138748,0.99931393682394,1.0,7/13,21.39%,SKI;SIRT2;ARHGEF10;PARD3;NCMAP;DICER1;PRX
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.3098946102785711,0.6622901992348502,0.8694158075601375,0.9996760285861006,1.0,3/12,13.81%,GORASP1;BTRC;PTEN
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2081433039866464,-0.661896531986225,0.9569230769230769,0.9966007643495425,1.0,9/31,22.95%,NEK7;PKIB;HNRNPD;MAPK3;HNRNPA2B1;PNKP;NBN;SLX4;MAPK1
prerank,phospholipid metabolic process (GO:0006644),0.22254175811470608,0.6609207681370608,0.9332493702770781,1.0,1.0,5/71,6.11%,PLPP3;PLCD1;PLA2G4A;SMPD2;AGPAT3
prerank,glucose import (GO:0046323),0.29616671163555414,0.6608783440818796,0.8411371237458194,1.0,1.0,2/13,6.78%,SLC2A10;TRARG1
prerank,negative regulation of secretion (GO:0051048),-0.28414415399544046,-0.6606014930823925,0.8873563218390804,0.9967257989422525,1.0,2/10,12.55%,VAMP8;ERBB3
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.21474055171011336,0.6600537214071083,0.9483627204030227,1.0,1.0,22/88,23.26%,FBXO48;FBXL17;PSME4;CUL4B;CUL5;FBXL3;FBXO9;FBXL12;FBXO4;BTRC;FBXO38;AMN1;PSMB5;PSMC2;PSMD4;PSMD1;FBXL18;PSME3;PSMA3;FBXW11;PSMC5;PSMA2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.28588874993419955,0.6591202626042415,0.8614864864864865,1.0,1.0,8/18,24.02%,FRS2;BMP2;TMEM119;BHLHE41;HDAC4;BDNF;HDAC5;HDAC1
prerank,maintenance of protein localization in organelle (GO:0072595),0.2771437627728985,0.6590467511614493,0.8604651162790697,1.0,1.0,8/19,28.30%,PML;ARL2;AKT1;HNRNPU;TAF8;HSPA5;HK1;TAPT1
prerank,regulation of peptidase activity (GO:0052547),0.27303805631509503,0.6589437816402421,0.884375,1.0,1.0,7/19,25.00%,CTSH;CST3;RCN3;ATP13A2;PSMA3;HDAC1;MAPK12
prerank,myeloid cell development (GO:0061515),0.2782580219915328,0.658879273242131,0.853035143769968,0.999925962626056,1.0,2/18,6.32%,KIT;SRC
prerank,autophagy of mitochondrion (GO:0000422),0.24608897114057607,0.6586151704057802,0.9019886363636364,0.9997547937212995,1.0,13/38,21.68%,ULK2;PRKN;WIPI1;USP30;MARK2;MAP1LC3A;BECN1;ATG2B;PHB2;WDR45;ATG9A;FUNDC2;AMBRA1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.21090455522003299,0.6579604253666721,0.9502487562189055,0.9999647408252904,1.0,17/88,19.49%,TRABD2B;SMAD3;SYNPO2;CDH5;EMILIN1;SDC1;BCL2L11;SYNPO2L;RGCC;SYNPO;SDC4;FNIP1;CX3CL1;TPR;PRKCA;TIRAP;SUMO1
prerank,positive regulation of protein depolymerization (GO:1901881),0.30724802945575624,0.6578820301979588,0.8535714285714285,0.9996098823685119,1.0,2/11,9.59%,SEMA5A;KATNB1
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.2521630956024332,-0.6577520502771911,0.912568306010929,0.9980241187519393,1.0,9/15,39.77%,PNPLA2;PLIN2;OSBPL11;TREM2;PLIN3;LPL;FITM2;PLIN5;APOC4
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.20862803614550812,0.6573533821375855,0.9677804295942721,0.9992451778112154,1.0,5/104,7.11%,PDPK1;LYN;PSME4;SRC;KLRD1
prerank,cellular response to lectin (GO:1990858),0.20862803614550812,0.6573533821375855,0.9677804295942721,0.9992451778112154,1.0,5/104,7.11%,PDPK1;LYN;PSME4;SRC;KLRD1
prerank,glial cell development (GO:0021782),0.2615233800789403,0.6567727371490149,0.9051204819277109,0.9993664770591416,1.0,8/25,18.75%,MT3;CSPG5;EIF2B4;MDK;NSUN5;EIF2B3;SOX11;MXRA8
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.26729600025047123,0.6563841956685148,0.8849693251533742,0.9992805185896563,1.0,5/24,13.13%,IRAK2;AAMP;ITCH;MAP2K6;RIPK2
prerank,nucleoside salvage (GO:0043174),0.31302681340931693,0.6559301008604145,0.8450450450450451,0.99927299452489,1.0,3/10,16.91%,CDA;UPP2;DCK
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2019028651176633,0.6554815232065904,0.9852941176470589,0.9992593508647111,1.0,42/148,26.14%,PDPK1;PRKAG2;CDK5RAP3;RFFL;PRKAA2;NUAK1;PML;ING5;MTA2;PPP1R13L;STK11;RBBP7;L3MBTL1;BANP;MAP2K6;TAF9;AKT1;ATM;RICTOR;KAT5;TAF2;RNF34;PRKAG1;RFC5;MDM4;MAPKAP1;MLST8;AURKA;RMI2;MEAF6;HEXIM1;TAF4B;BRCA1;HDAC1;PIP4K2A;PRKAB2;TAF15;MRE11;ATRIP;PRKAG3;PIP4K2B;RAD50
prerank,regulation of microtubule depolymerization (GO:0031114),-0.2145912473973926,-0.6551748086336414,0.9415204678362573,0.9991665138142818,1.0,5/25,18.64%,NAV3;ARHGEF2;TRPV4;MAP1B;CLASP1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.2077495090637388,0.6538902067332498,0.9726516052318668,1.0,1.0,5/105,7.11%,PDPK1;LYN;PSME4;SRC;KLRD1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.21557716463367188,-0.6538170424979908,0.9441176470588235,0.9993081811883224,1.0,9/25,27.71%,HMGN1;ALYREF;LDB1;EAF2;ZNF326;TCEA2;EAF1;CCAR2;HTATSF1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.24807715103933992,-0.6531538991133828,0.8975609756097561,0.9989213656818074,1.0,6/15,30.50%,ZC3H12C;RNASEH1;NUDT16;POP7;RPP40;ZC3H12D
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.22085867965040457,-0.653075302853028,0.9292035398230089,0.9980950177860758,1.0,8/24,28.25%,LPCAT1;PNPLA8;PGS1;CRLS1;PLA2G4F;PLA2G4B;LPCAT4;PLA2G5
prerank,response to light stimulus (GO:0009416),0.22685796987147552,0.6528137358216548,0.9185888738127544,1.0,1.0,7/55,13.00%,SLC24A1;PCLAF;SPRTN;UBE4B;BRSK1;ERCC8;COPS3
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.2388267997483986,-0.6520914212513227,0.9171270718232044,0.9979460856482987,1.0,9/17,30.97%,KDM1A;PTTG1IP;SIRT1;CD44;TWIST1;MIF;SNAI2;PSMD10;SNAI1
prerank,monoacylglycerol metabolic process (GO:0046462),0.2976970711953212,0.6518548566044513,0.8674496644295302,1.0,1.0,3/13,14.90%,PLA2G4A;MOGAT3;DGAT2
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.22400732965509038,-0.6517372143436568,0.9302949061662198,0.9972959561700909,1.0,13/21,42.67%,TNFAIP3;PTPN22;JAK3;LST1;LAX1;DUSP3;IL4I1;FOXJ1;FCGR2B;SAMSN1;FGL1;TNFAIP8L2;BANK1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.25166904355457403,-0.6515439483984035,0.9232804232804233,0.9965457456750689,1.0,8/14,31.31%,LIMS2;EMP2;LIMS1;ITGB1BP1;DMTN;PRKD1;BST1;PHACTR4
prerank,lipid droplet organization (GO:0034389),-0.22266029747493982,-0.6507351030413611,0.9385964912280702,0.9962590768207771,1.0,11/22,37.01%,PPIA;PNPLA3;PLA2G4C;PPID;ZFYVE1;HILPDA;FITM2;CDS2;CDS1;BSCL2;PLIN5
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.24626427293558925,0.6506998240101933,0.9049645390070922,1.0,1.0,7/38,16.32%,DAG1;DRD3;PHLPP2;MUL1;TSC2;PTEN;AKT1
prerank,respiratory chain complex IV assembly (GO:0008535),0.2643933312127962,0.6497535476252353,0.8930232558139535,1.0,1.0,5/21,19.61%,COX18;COX10;COA6;PET100;FASTKD3
prerank,mitochondrial fusion (GO:0008053),0.276773989647892,0.6488954429149295,0.8791946308724832,1.0,1.0,5/18,21.34%,MIGA2;USP30;AFG3L2;STOML2;OPA1
prerank,regulation of centriole replication (GO:0046599),0.27791548892236556,0.6488882208290833,0.8909395973154363,1.0,1.0,4/17,14.58%,ALMS1;KAT2B;MDM1;PLK2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.29253785528512005,0.6482929195356177,0.8629441624365483,1.0,1.0,6/14,22.68%,ADK;GART;PPAT;PFAS;ADSS1;ADSL
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.24870975394322725,0.6478723213952263,0.8940493468795355,1.0,1.0,9/31,17.95%,DACT1;RBL2;JADE1;PTEN;KANK2;CDK2AP2;CDKN2C;CDC73;MYO16
prerank,protein alkylation (GO:0008213),-0.22250725508247782,-0.6473110182871039,0.9249329758713136,0.9978505320818066,1.0,11/22,43.53%,SNRPB;FAM98B;SNRPD3;PRMT3;LCMT1;CAMKMT;EEF1AKMT1;PRMT2;ETF1;EEF1AKMT2;FAM98A
prerank,motile cilium assembly (GO:0044458),0.29705191595361224,0.6470551312996189,0.8741007194244604,1.0,1.0,2/12,12.66%,DNAAF1;CCDC40
prerank,double-strand break repair via break-induced replication (GO:0000727),0.3002227389854531,0.646598105733774,0.8718381112984823,1.0,1.0,5/12,25.44%,MCM2;CDC7;GINS4;MCMDC2;MCM6
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.2606299198062335,0.6465914796636092,0.8968133535660091,1.0,1.0,4/24,10.37%,DNMT3A;PHF1;RBBP7;PPHLN1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.2526962090241973,-0.6465459151071322,0.9007263922518159,0.9974866033015946,1.0,2/13,12.22%,CYRIB;PVR
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.20403463529929122,-0.6461785815316292,0.9501661129568106,0.996862411007763,1.0,14/28,40.23%,MAP2;GAS2L1;MAP1B;CLASP1;SKA3;PRUNE1;MAPRE1;STMN1;MAP1A;STMN4;MAPT;CAMSAP2;SKA1;CLASP2
prerank,sensory perception of smell (GO:0007608),-0.26431949424879997,-0.6455675066782627,0.8948497854077253,0.996386187269666,1.0,1/11,11.07%,ADCY3
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.2052932753685323,-0.6447980879953089,0.9462686567164179,0.9960306219745975,1.0,9/27,25.51%,NAAA;PLAAT3;PNPLA8;ETNK1;SELENOI;CHKA;PLA2G4E;ABHD4;PLAAT1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.3060694647171651,0.6437810138115206,0.868421052631579,1.0,1.0,3/11,14.87%,LDLR;SREBF1;NR1H3
prerank,myelin maintenance (GO:0043217),0.31301148600873824,0.6435844866228259,0.8540925266903915,1.0,1.0,4/10,21.39%,PTEN;ABCD2;EPB41L3;PRX
prerank,microtubule polymerization or depolymerization (GO:0031109),0.2631532779378203,0.6435747417787347,0.8955696202531646,1.0,1.0,3/24,9.95%,NCKAP5;KATNB1;FGF13
prerank,androgen metabolic process (GO:0008209),0.27133437490768075,0.6432146478390822,0.8812709030100334,1.0,1.0,3/18,15.58%,HSD3B2;SRD5A1;SHH
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.2803631332143837,-0.6426777674712758,0.9065420560747663,0.9966506355843346,1.0,4/10,25.04%,DHFR;TYMS;MTHFD2;SHMT1
prerank,regulation of organelle organization (GO:0033043),0.21425591926942625,0.6426256836352789,0.9565772669220945,1.0,1.0,14/80,16.37%,ZEB2;USP6NL;LMAN1;RBSN;SYDE1;PRKN;RHOT1;NEXN;CLN3;MUL1;SYT11;MARK2;ARMH3;GOLPH3
prerank,regulation of synapse maturation (GO:0090128),0.30831955827579194,0.6422240444300185,0.8591549295774648,1.0,1.0,2/10,9.11%,ADGRL1;CAMK2B
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.20319199115281233,-0.6421658773090122,0.9642857142857143,0.996130812659261,1.0,13/35,26.61%,ITGA1;HSP90AB1;PPP1R15B;CALM1;CALM3;MTOR;FKBP1A;CD300A;GSK3B;PPP1R11;PPP6R3;PPP1R1B;CALM2
prerank,proteasome assembly (GO:0043248),-0.2635371057747424,-0.6420366252941737,0.9068181818181819,0.9953149340956512,1.0,6/11,33.43%,PSMD9;PSMD5;PSMD11;POMP;PSMD10;PSMD13
prerank,regulation of stem cell population maintenance (GO:2000036),0.27624397095393455,0.6420140198992333,0.8989441930618401,1.0,1.0,5/18,14.84%,REST;WDR43;NCOA3;TAF5L;CNOT3
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.2504244147750291,0.6418072479263435,0.9157894736842105,1.0,1.0,8/29,19.68%,DCST1;STAT2;RNASEL;ABCE1;MUL1;ZBP1;METTL3;YTHDF2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.21471441180526762,0.6414706015671502,0.9609079445145019,1.0,1.0,18/72,19.70%,SP100;BATF;NDRG1;PML;RBL2;RGCC;USP10;PLK2;CNOT3;SESN2;TFDP1;ATM;CARM1;KAT5;CDKN1B;ATRX;MUC1;MDM4
prerank,regulation of multicellular organismal development (GO:2000026),-0.21330144569777132,-0.6413712806318889,0.967741935483871,0.9948733542330033,1.0,4/25,11.45%,SOX17;SPAAR;PTN;KAT2A
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.24577949280472505,-0.6412699515616929,0.9071925754060325,0.9940401695847233,1.0,7/15,29.04%,RYR2;ZFAND2B;SPCS1;RAB3GAP2;EDEM1;SRPRA;SEC61G
prerank,positive regulation of interleukin-8 production (GO:0032757),0.22912622712217878,0.6412632449858141,0.9462915601023018,1.0,1.0,2/49,2.84%,SERPINE1;IL17D
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.2584803587140381,0.6412117335504359,0.9135220125786163,1.0,1.0,8/22,27.71%,PSME4;NFE2L2;ENC1;PSMB5;PSMA3;PSMA2;PSMB9;PSMB4
prerank,regulation of lysosomal lumen pH (GO:0035751),0.2991430002168107,0.6410493544193137,0.8682432432432432,1.0,1.0,3/12,13.32%,LRRK2;CLN3;ATP6AP2
prerank,regulation of cytoplasmic translation (GO:2000765),0.28816233267775926,0.6408707092478667,0.871304347826087,1.0,1.0,2/14,7.09%,CPEB1;CPEB3
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.27649930422928953,0.6404290345728764,0.8793650793650793,1.0,1.0,2/16,7.54%,SHOC1;TOP2B
prerank,macroautophagy (GO:0016236),0.20002303242001115,0.639361761234736,0.9714285714285714,1.0,1.0,28/118,22.15%,DYNLL1;PRKAG2;PRKAA2;SRC;ATG10;MTMR3;PLEKHM1;PRKN;WIPI1;CLN3;VPS37D;UVRAG;PIK3R4;VDAC1;TOMM22;LAMP2;MAP1LC3A;BECN1;EPG5;PRKAG1;STX17;ATG4B;TOMM5;RUBCNL;ATP13A2;LIX1;AMBRA1;TSG101
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.16629391756603853,-0.6386858192080221,0.9948979591836735,0.9948871676165691,1.0,33/84,34.61%,ANAPC16;ANAPC15;ANAPC7;PSMF1;PSMB8;PSMB2;PSMA4;PSMB10;BUB1B;UBE2S;FBXO31;PSMC4;CUL3;PSMD9;PSMD5;PSMA6;PSMD11;PSMA8;PSMB1;PSMD10;CDK1;RPS27A;UBC;PLK1;FZR1;PSMC3;CDC20;UBE2C;PSMD13;SKP2;BUB3;ANAPC11;ECRG4
prerank,cellular response to tumor necrosis factor (GO:0071356),0.1919300919417365,0.6382628866770484,0.9866518353726362,1.0,1.0,12/175,9.74%,ADAMTS12;PID1;CCL19;EDAR;SFRP1;PSME4;ZFP36L1;CCL4;NFE2L2;NR1D1;ACTN4;LTBR
prerank,protein palmitoylation (GO:0018345),0.2468051063620908,0.6377362640282644,0.9215116279069767,1.0,1.0,1/30,1.32%,GLUL
prerank,histone H4 acetylation (GO:0043967),0.22668756075692803,0.63746379898,0.9510204081632653,1.0,1.0,11/47,19.31%,OGT;ING3;BRD8;ING5;KMT2A;JADE1;TADA3;WDR5;MSL2;NAA40;KANSL1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.2830404823970184,0.6374196513533793,0.8769968051118211,1.0,1.0,2/15,7.97%,APOA1;IRAK3
prerank,spermatid development (GO:0007286),0.24147947030975256,0.6373620915273146,0.908284023668639,1.0,1.0,3/32,11.77%,GALNTL5;ZMYND15;SYCP3
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.2627854793663552,-0.6362630767496423,0.8871681415929203,0.9955756373175307,1.0,6/12,40.37%,NBN;WRNIP1;WDR18;TICRR;KAT7;CDT1
prerank,establishment of spindle localization (GO:0051293),0.2781183554198548,0.6350975120328827,0.8762711864406779,1.0,1.0,4/14,22.53%,DYNC1H1;LLGL1;KPNB1;LLGL2
prerank,nuclear membrane disassembly (GO:0051081),-0.24189616716764617,-0.6350800726671048,0.9170854271356784,0.9954707106788209,1.0,7/14,29.64%,VRK1;DCTN1;CCNB2;CNEP1R1;CTDNEP1;CDK1;PLK1
prerank,cellular macromolecule catabolic process (GO:0044265),0.22372106764053165,0.6333189555241565,0.9353562005277045,1.0,1.0,9/49,16.57%,SND1;ADAMTS9;NGLY1;PRKN;DNASE1L1;EXOSC7;MTREX;RNASEH2C;NEU4
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.26544414271735717,-0.6327374921337627,0.8775981524249422,0.9961539959003554,1.0,2/10,11.42%,KDM1A;SIRT1
prerank,keratinocyte differentiation (GO:0030216),0.24810479633049254,0.6325656861127241,0.9263322884012539,1.0,1.0,1/29,1.04%,TXNIP
prerank,defense response to symbiont (GO:0140546),0.2038617285963265,0.6324247047735452,0.9805825242718447,1.0,1.0,15/92,17.60%,BCL2;MLKL;IRF1;OAS2;STAT2;RNASEL;IFI27;ABCE1;IFIT2;FLNA;SERINC3;ZBP1;IFI44L;TTC4;IRF2
prerank,cellular response to ionizing radiation (GO:0071479),0.22656411949246183,0.632303109740547,0.9560439560439561,1.0,1.0,4/47,6.07%,YAP1;LIG4;MAP3K20;INO80
prerank,negative regulation of insulin secretion (GO:0046676),0.2769007688195917,0.6322367347216066,0.899671052631579,1.0,1.0,4/17,12.15%,SFRP1;PRKN;ADRA2A;REST
prerank,global genome nucleotide-excision repair (GO:0070911),-0.20674457840885357,-0.6320502453721142,0.9452887537993921,0.9957123000842022,1.0,10/26,30.41%,RBX1;DDB2;GTF2H1;CETN2;PARP1;CHD1L;RNF111;RPS27A;UBC;XPC
prerank,negative regulation of signaling (GO:0023057),0.2513897555771233,0.6318580203953219,0.9171779141104295,1.0,1.0,5/25,18.42%,OPTN;ACVR1;IGFBP3;LIF;HHIP
prerank,regulation of nuclear division (GO:0051783),0.2627937476594935,0.6312610941306716,0.9125412541254125,1.0,1.0,3/20,15.76%,OBSL1;L3MBTL1;CUL7
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.271954444602044,0.6311915763314534,0.8929159802306426,1.0,1.0,6/17,21.33%,ARFIP2;DNAI3;WASF1;FCHSD2;CORO1B;BRK1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.2029301876600646,-0.6310254013859603,0.9526813880126183,0.9954880322753039,1.0,3/27,10.19%,CYRIB;SIRPA;SKAP1
prerank,cellular response to amino acid starvation (GO:0034198),0.21040527530073777,0.6308855377469549,0.963963963963964,1.0,1.0,18/71,22.00%,NPRL3;EIF2AK3;SLC38A9;ATP6V1E1;CASTOR2;RNF152;CEBPB;LAMTOR2;RRAGD;IMPACT;ITFG2;NPRL2;SESN2;SEH1L;RHEB;SZT2;MLST8;ATP6V1B2
prerank,negative regulation of macroautophagy (GO:0016242),0.2547947072625235,0.630493988830066,0.9375,1.0,1.0,4/26,16.32%,NUPR1;LRRK2;TSC2;AKT1
prerank,estrogen metabolic process (GO:0008210),0.2762726439351067,0.6303410550036731,0.8909395973154363,1.0,1.0,1/15,4.30%,CYP1B1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.3040196700466469,0.6298931558736232,0.867513611615245,1.0,1.0,3/10,23.38%,IL12B;DDIT3;NCKAP1L
prerank,GTP metabolic process (GO:0046039),0.2804418174008689,0.6295895100615476,0.8657718120805369,1.0,1.0,3/15,12.28%,RAB23;LRRK2;RHOQ
prerank,chemokine-mediated signaling pathway (GO:0070098),0.23052492982972494,0.6295302204892611,0.9256661991584852,1.0,1.0,6/42,16.92%,CCL19;CCL4;OXSR1;WNK1;CXCL13;CX3CL1
prerank,regulation of intracellular transport (GO:0032386),0.23452071092707033,0.6292350458235966,0.9339080459770115,1.0,1.0,13/38,25.71%,ATP9A;DYNC1H1;LRRK2;RNF139;NUP214;GAS1;NUMA1;AAAS;ATP13A2;RBM4;RINT1;SCFD1;TTC21B
prerank,cellular response to arsenic-containing substance (GO:0071243),0.273783543428277,0.6286898452840194,0.8821548821548821,1.0,1.0,4/15,20.33%,HNRNPA1;DDX3X;HSF1;PPIF
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.2627175250492238,0.628577576401429,0.9153094462540716,1.0,1.0,1/21,2.52%,NOS1AP
prerank,mitotic sister chromatid segregation (GO:0000070),0.19981770569168866,0.6280263504997993,0.9730392156862745,1.0,1.0,24/98,22.32%,PDS5B;INO80;PIBF1;ZW10;SPDL1;ZWINT;TENT4A;EML4;CHMP5;AKAP8L;PHF8;POGZ;SGO1;NIPBL;NAA50;BECN1;KPNB1;SEH1L;BOD1;CDCA8;CDC23;DSN1;TUBG1;TUBG2
prerank,regulation of myoblast differentiation (GO:0045661),0.2427706822113101,0.6276748247592605,0.9249291784702549,1.0,1.0,7/32,15.79%,RIPOR2;TBX3;ZFP36L1;IGFBP3;TRIP4;LRRC8A;BMP4
prerank,regulation of interleukin-8 production (GO:0032677),0.21045846567406987,0.627475905600526,0.9606879606879607,1.0,1.0,8/69,12.65%,SERPINE1;IL17D;MAPKBP1;TLR6;ARRB1;CD33;CD14;SSC5D
prerank,transcription by RNA polymerase III (GO:0006383),0.2523534895238897,0.6273305955895364,0.9145427286356822,1.0,1.0,12/27,28.93%,BRF1;GTF3C1;SNAPC1;SNAPC5;SNAPC4;POLR2L;GTF3C3;ICE1;GTF3C5;POLR3K;ICE2;POLR3GL
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.23868898468087227,0.6272779344186628,0.9251412429378532,0.9998311920319225,1.0,9/33,17.95%,DACT1;RBL2;JADE1;PTEN;KANK2;CDK2AP2;CDKN2C;CDC73;MYO16
prerank,positive regulation of keratinocyte migration (GO:0051549),0.30677779773039615,0.6265350514701943,0.8747826086956522,1.0,1.0,3/10,15.76%,MAP4K4;MAPRE2;ARF6
prerank,regulation of centrosome duplication (GO:0010824),-0.20023783146820145,-0.6264189195068649,0.968299711815562,0.9975575412722302,1.0,10/29,28.39%,PDCD6IP;SIRT1;STIL;NPM1;CHMP2B;CEP131;GEN1;CHMP4B;SPICE1;CHMP4C
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.2512480502595308,-0.6253504484101856,0.9287531806615776,0.9973354712708297,1.0,6/12,29.64%,VRK1;CCNB2;CNEP1R1;CTDNEP1;CDK1;PLK1
prerank,tRNA 5'-end processing (GO:0099116),0.27471888984280607,0.6242497620032968,0.8836424957841484,1.0,1.0,4/15,16.13%,RPP25L;PRORP;RPP30;RPP38
prerank,CENP-A containing chromatin organization (GO:0061641),-0.19930164033323614,-0.6241157008931536,0.9642857142857143,0.996309115397793,1.0,10/29,28.47%,KNL1;MIS18BP1;RUVBL1;RSF1;NPM1;CENPI;CENPN;NASP;ITGB3BP;HJURP
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.19930164033323614,-0.6241157008931536,0.9642857142857143,0.996309115397793,1.0,10/29,28.47%,KNL1;MIS18BP1;RUVBL1;RSF1;NPM1;CENPI;CENPN;NASP;ITGB3BP;HJURP
prerank,atrial septum development (GO:0003283),-0.2503254661204301,-0.6240429465295906,0.9134396355353075,0.9954767552863106,1.0,5/13,21.45%,TGFB2;HEY2;ZFPM1;BMPR2;GJA5
prerank,apoptotic DNA fragmentation (GO:0006309),0.2677665467780882,0.6240301106008416,0.8903878583473862,1.0,1.0,5/16,18.32%,DNASE2;CECR2;KPNA1;KPNB1;DICER1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.23638475252623078,-0.6240058591236636,0.9128329297820823,0.9946210622521935,1.0,6/15,28.23%,GBP5;NLRP2B;TLR4;TREM2;CPTP;CD36
prerank,V(D)J recombination (GO:0033151),-0.2554773919983842,-0.6230248176192584,0.9373493975903614,0.9943256579615315,1.0,4/11,22.96%,TCF3;PRKDC;HMGB2;DCAF1
prerank,positive regulation of organelle organization (GO:0010638),-0.19758555965024546,-0.6227791917210813,0.9592476489028213,0.9935919942925399,1.0,11/32,29.38%,P2RX7;PPARGC1A;SORBS3;ADRB2;SYNJ1;ANXA1;RAB3GAP2;GSK3B;TREM2;PLA2G5;STX18
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.18219993120171177,0.6224353423242751,0.9968586387434555,1.0,1.0,63/264,23.32%,POLR2D;RBMXL2;U2AF1L4;SNRNP70;SF1;DDX17;PNN;RBM22;NONO;METTL14;HNRNPR;HNRNPA1;RAVER2;DDX39A;POLR2C;WDR33;SMU1;DDX23;SUGP1;RBM19;MAGOHB;MTREX;SNRPD2;RBM4B;SRSF5;GPKOW;PCF11;RNPC3;RBM6;SYNCRIP;RBM5;GEMIN2;PSPC1;LSM8;RBM41;HNRNPC;SF3B1;SF3B2;SRRM2;PRPF6;DDX1;SRSF10;PPIE;POLR2L;FIP1L1;METTL3;CPSF2;USP49;GCFC2;HNRNPH1;HNRNPU;PRCC;SRSF3;PPWD1;NCBP2;ESS2;PAPOLA;RBM4;IK;PRPF8;CDK13;ZRSR2;SART1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.2467184212998912,0.6222178776477737,0.9246676514032496,1.0,1.0,6/28,15.51%,IRAK2;AAMP;ITCH;MAP2K6;RIPK2;LACC1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.22211417756928772,0.6221817334857944,0.9492455418381345,1.0,1.0,8/46,16.32%,TIMM17B;AIFM1;BCAP31;TIMM44;TIMM9;TSPO;TOMM22;AKT1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.27821465923682803,0.6216328170126877,0.8710247349823321,1.0,1.0,4/13,14.62%,ATG10;UBA7;SENP6;UBA6
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.23252861518951434,0.621407903140581,0.9482014388489208,1.0,1.0,5/37,11.40%,BCL2;NUPR1;BCL2L11;BCAP31;GSDME
prerank,centromere complex assembly (GO:0034508),-0.18618489814261352,-0.6212932701909518,0.9810725552050473,0.9936221175346578,1.0,12/36,28.47%,KNL1;MIS18BP1;RUVBL1;RSF1;NPM1;CENPI;CENPF;CENPN;NASP;ITGB3BP;DLGAP5;HJURP
prerank,regulation of telomerase activity (GO:0051972),-0.18110670688104988,-0.6209787011876648,0.9929328621908127,0.9929218896048045,1.0,7/45,16.96%,NEK7;HSP90AB1;PKIB;KLF4;NVL;MAPK3;PNKP
prerank,mitochondrial genome maintenance (GO:0000002),0.2942638289507462,0.6206322045836563,0.8863636363636364,1.0,1.0,4/11,21.34%,AKT3;SLC25A36;LONP1;OPA1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.2030810385265499,-0.6201564189397865,0.9678362573099415,0.9925557911334689,1.0,6/27,18.64%,UBE2H;ANAPC7;UBE2D3;UBE2B;UBE2S;RNF4
prerank,intracellular lipid transport (GO:0032365),0.25515533702747595,0.6197874319314909,0.8981481481481481,1.0,1.0,3/21,6.07%,PRKAG2;PRKAA2;PLEKHA8
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.2553964050982251,0.6197485818578431,0.9217527386541471,1.0,1.0,8/23,26.49%,MYO10;DYNC1I2;HOOK2;MAP6D1;KIF1C;KIF5C;MAP6;HOOK1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.20019070640406128,0.6196678085004166,0.975,1.0,1.0,6/85,6.01%,FZD2;SMURF2;PRICKLE1;FZD1;PSME4;CDC42
prerank,nuclear transport (GO:0051169),-0.23450939716924632,-0.6196485172352529,0.9522613065326633,0.9919691620019091,1.0,11/16,47.80%,NXT2;PSIP1;NPM1;NUTF2;RBM15B;NXT1;HMGA1;XPO1;CITED1;ANP32A;RGS14
prerank,regulation of macroautophagy (GO:0016241),0.19665930844246948,0.6192666647931051,0.9870892018779343,1.0,1.0,32/105,25.56%,DCN;PRKAG2;NEDD4;PRKAA2;LRRK2;SLC38A9;ATP6V1E1;CLN3;LAMTOR2;TBK1;RRAGD;LARP1;TSC2;SESN2;AKT1;WAC;PRKACA;PRKAG1;GPSM1;RHEB;SNX6;UCHL1;MLST8;ATP13A2;ATP6V1B2;HDAC6;ATP6V0D1;ATP6V1G1;PRKAB2;VPS35;PRKAG3;SH3GLB1
prerank,DNA replication (GO:0006260),0.19722202946274575,0.6192575572874491,0.9891826923076923,1.0,1.0,7/105,8.44%,RBMS1;PCLAF;ING5;POLG;POLL;RECQL5;POLE3
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.2672284116330634,0.6189725138099783,0.9072847682119205,0.9998392816292688,1.0,5/16,23.11%,IRAK3;CLN3;INSR;GSPT1;HDAC6
prerank,mismatch repair (GO:0006298),-0.20043509995496478,-0.6177102318571149,0.9732142857142857,0.9922326284170515,1.0,10/27,33.36%,MSH3;PMS2;PMS1;POLD4;MSH2;EXO1;POLD2;XPC;MLH3;RPA2
prerank,dopaminergic neuron differentiation (GO:0071542),0.262768172832599,0.617056355182853,0.8885350318471338,1.0,1.0,4/19,15.58%,RYK;FOXA1;MANF;SHH
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.24417291739947516,0.6162062813654491,0.9227272727272727,1.0,1.0,3/27,7.90%,AGTR1;LPAR1;DRD3
prerank,regulation of B cell differentiation (GO:0045577),0.2666255435125,0.6159821105275981,0.9040247678018576,1.0,1.0,2/17,5.80%,SFRP1;ZFP36L1
prerank,natural killer cell mediated immunity (GO:0002228),0.2699409460803995,0.6157826392267681,0.9045226130653267,1.0,1.0,2/15,10.12%,KLRD1;PLEKHM2
prerank,postreplication repair (GO:0006301),0.2236522412241887,0.6149731750535222,0.9653679653679653,1.0,1.0,7/45,13.16%,PCLAF;SPRTN;UBE2V2;ZBTB1;WDR33;RAD18;USP10
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.16535585118974994,-0.6138835943510373,0.9953917050691244,0.9936199408720573,1.0,22/67,31.12%,B2M;VAMP8;NCF2;PSMF1;PSMB8;PSMB2;PSMA4;PSMB10;PSMC4;FCGR1A;PSMD9;PSMD5;PSMA6;CHUK;PSMD11;PSMA8;PSMB1;CD36;PSMD10;IKBKG;PSMC3;NCF1
prerank,Golgi to lysosome transport (GO:0090160),0.2903095884127449,0.613740158316396,0.8855633802816901,1.0,1.0,2/11,11.57%,RBSN;CLN3
prerank,lymphocyte proliferation (GO:0046651),0.24943451099763547,0.6129499186586101,0.9145161290322581,1.0,1.0,1/22,1.85%,BCL2
prerank,negative regulation of double-strand break repair (GO:2000780),0.23741042987312208,0.6128620907477238,0.9451038575667656,1.0,1.0,8/30,21.70%,OGG1;TRIP12;NUDT16L1;UBR5;SHLD3;SMCHD1;HSF1;RMI2
prerank,positive regulation of DNA recombination (GO:0045911),0.24308468977147463,0.6127320638435292,0.9445300462249615,1.0,1.0,9/27,25.45%,KMT5B;MRNIP;HMCES;SHLD3;TIMELESS;ARID2;ERCC2;FUS;MMS19
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.1738878983148439,-0.6121394813036517,0.9917355371900827,0.9937355733507868,1.0,18/51,30.32%,GBP5;P2RX7;AIM2;JAK2;TRIM16;CASP8;APP;NOD2;TLR4;FZD5;AGER;MALT1;EGR1;TMEM106A;CD36;HSPB1;NLRP3;LPL
prerank,positive regulation of protein sumoylation (GO:0033235),-0.2608984026793931,-0.6119959254811419,0.9116997792494481,0.9929507557612474,1.0,5/10,32.64%,SAE1;RWDD3;UBA2;RASD2;GNL3
prerank,regulation of interferon-alpha production (GO:0032647),0.2506415621145801,0.6118993732558439,0.9217791411042945,1.0,1.0,4/23,13.13%,PTPRS;DDX3X;TBK1;RIPK2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.2022673028377262,0.6117214191803475,0.9730077120822622,1.0,1.0,17/73,21.18%,RUNX1;YAP1;PSME4;SETD1A;METTL14;ITCH;KMT2A;TCF12;PSMB5;PSMC2;PSMD4;METTL3;PSMD1;YTHDF2;PSME3;FOXC1;PSMA3
prerank,myeloid dendritic cell activation (GO:0001773),-0.25288511256927615,-0.6115824500302105,0.9244851258581236,0.9923011261789152,1.0,2/12,9.66%,CAMK4;TGFBR2
prerank,apoptotic nuclear changes (GO:0030262),0.244407801792023,0.6113315440491821,0.9085173501577287,1.0,1.0,6/24,18.32%,CDK5RAP3;DNASE2;CECR2;KPNA1;KPNB1;DICER1
prerank,cilium movement (GO:0003341),0.21814640258933746,0.61098160374271,0.956989247311828,1.0,1.0,8/47,15.74%,CFAP73;DNAAF1;DNAI3;CCDC40;CABYR;SPEF2;CFAP53;DNAAF5
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.2952307990656351,0.6106278905238274,0.8940754039497307,1.0,1.0,2/10,16.32%,SLC45A3;AKT1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.25941914619181494,0.6104686148275399,0.9086460032626428,0.9997100879058446,1.0,4/18,18.90%,MIA3;WNK1;AKT1;VTCN1
prerank,DNA geometric change (GO:0032392),-0.20582167528023126,-0.6092843595738803,0.9523809523809523,0.9926663926744206,1.0,7/24,21.11%,ZRANB3;SUPV3L1;HNRNPA2B1;NBN;HMGB2;DHX9;ANXA1
prerank,tRNA metabolic process (GO:0006399),-0.22856351650239526,-0.6092127292089423,0.9616306954436451,0.991843974495372,1.0,4/17,16.22%,YARS2;KARS1;RPP21;FARS2
prerank,protein localization to centrosome (GO:0071539),0.25837543803910723,0.6086791184637715,0.907563025210084,1.0,1.0,2/17,6.32%,GOLGB1;PIBF1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.25967981203329304,-0.6084912170673487,0.9119638826185101,0.9913693313258941,1.0,6/10,39.16%,RUVBL1;ZNHIT3;RUVBL2;PIH1D1;SHQ1;PIH1D2
prerank,positive regulation of cilium assembly (GO:0045724),-0.22477295053773416,-0.6070944066139022,0.9508196721311475,0.9912204557863419,1.0,4/18,16.68%,CCDC88A;KCTD17;CEP135;FUZ
prerank,defense response to virus (GO:0051607),0.1937244855747164,0.6070168033595303,0.9927710843373494,1.0,1.0,23/100,23.19%,BCL2;MLKL;IRF1;OAS2;STAT2;RNASEL;IFI27;ABCE1;IFIT2;FLNA;SERINC3;ZBP1;IFI44L;TTC4;RNF135;IRF2;PHB2;NDUFAF4;RSAD2;MYD88;STAT1;ZDHHC1;AGBL5
prerank,necroptotic process (GO:0070266),0.2670711758112887,0.6044369054749977,0.9048414023372288,1.0,1.0,2/16,12.46%,MLKL;CD14
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.23845208663302306,0.6035968424596175,0.9299552906110283,1.0,1.0,5/28,13.81%,NUPR1;CDK5RAP3;RNF139;PRKN;PTEN
prerank,negative regulation of T cell proliferation (GO:0042130),-0.19631321128546472,-0.6010327777753859,0.9813084112149533,0.9934937170942917,1.0,8/28,27.09%,PRKAR1A;SCRIB;CD80;TNFRSF21;CD86;LILRB1;IL4I1;PRNP
prerank,mitotic DNA replication (GO:1902969),0.28757323344804353,0.5998130427708749,0.8846815834767642,1.0,1.0,6/10,30.39%,MCM2;MCMDC2;LIG1;MCM6;MCM4;GINS1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.2772832106152664,0.59859789015551,0.8802083333333334,1.0,1.0,4/13,23.07%,OAS2;EBI3;STAT1;CANX
prerank,cytoplasmic microtubule organization (GO:0031122),0.20723841048837582,0.5985577868652009,0.9616908850726552,1.0,1.0,3/54,5.46%,FIGN;CLIP4;DYNC1H1
prerank,cell junction maintenance (GO:0034331),0.26927644397168093,0.5984447227384723,0.9182282793867121,1.0,1.0,4/14,23.77%,CBLN1;MYADM;PRTN3;PARD6A
prerank,L-serine metabolic process (GO:0006563),0.2916116033911731,0.5981173684728524,0.8913043478260869,1.0,1.0,4/10,21.78%,PSPH;SERINC3;PHGDH;CBS
prerank,telomere maintenance (GO:0000723),0.21098365722286797,0.5977176618889992,0.964332892998679,1.0,1.0,8/50,16.40%,SP100;SMC5;SMC6;TERF2;TEP1;RAD51D;RTEL1;ATM
prerank,P-body assembly (GO:0033962),0.27883625739902246,0.5977025662330282,0.9260504201680673,1.0,1.0,5/12,25.54%,DYNC1H1;PATL1;RC3H1;DDX6;ATXN2
prerank,protein-containing complex disassembly (GO:0032984),0.21006519819331876,0.5975857543921603,0.9679572763684913,1.0,1.0,14/54,22.15%,FZD2;WNT8B;FZD1;CLN3;UVRAG;LAMP2;MAP1LC3A;CSNK1A1;EPG5;STX17;FRAT1;RUBCNL;LIX1;TSG101
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.20114778449954546,-0.595600296248698,0.9584487534626038,0.9953838886185992,1.0,9/22,30.41%,RBX1;DDB2;GTF2H1;CETN2;PARP1;CHD1L;RPS27A;UBC;XPC
prerank,amyloid precursor protein metabolic process (GO:0042982),0.24708970244304165,0.5942852827915667,0.9264705882352942,1.0,1.0,3/18,11.57%,APOE;APH1B;CLN3
prerank,cellular response to interleukin-15 (GO:0071350),-0.2349056945835016,-0.5941973935102642,0.9475,0.9943324917375351,1.0,7/13,35.93%,IL15;STAT5A;JAK3;IL2RG;SHC1;STAT3;GRB2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.2349056945835016,-0.5941973935102642,0.9475,0.9943324917375351,1.0,7/13,35.93%,IL15;STAT5A;JAK3;IL2RG;SHC1;STAT3;GRB2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.19199444269825885,0.5941228049070457,0.9792176039119804,1.0,1.0,25/87,23.26%,DACT1;PSME4;USP47;ZFP36L1;RBL2;RGCC;JADE1;PTEN;KANK2;CDK2AP2;PSMB5;CDKN2C;PSMC2;CDC73;MYO16;PSMD4;PSMD1;PSME3;ZFP36L2;PSMA3;AURKA;DLG1;PKD2;PSMC5;PSMA2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.2329620410327871,-0.5923463726980874,0.9605568445475638,0.9943497655571106,1.0,5/13,28.06%,SORL1;CD81;TMEM30A;EDEM1;TMEM30B
prerank,spindle assembly (GO:0051225),0.19623739767492035,0.5922986020421573,0.9809885931558935,1.0,1.0,18/67,22.48%,INO80;PIBF1;NCOR1;NEK6;MAPRE2;ARHGEF10;GOLGA8B;HAUS1;HAUS3;FLNA;HAUS7;CEP192;KPNB1;NUMA1;AAAS;ABRAXAS2;HAUS5;HAUS6
prerank,mRNA metabolic process (GO:0016071),0.19087248122505238,0.5909151985589096,0.9926739926739927,1.0,1.0,29/90,26.21%,SON;DXO;NONO;HNRNPR;PRMT9;TCERG1;AKAP8L;NUDT16L1;SRSF5;PCF11;GEMIN2;SF3B2;LSM10;METTL3;PRKACA;YTHDF2;HSF1;AGO4;ZFP36L2;NUDT12;NCBP2;PRPF8;METTL16;SFPQ;AGO3;SNRPE;CNOT10;HIPK3;RNASE4
prerank,mitotic nuclear division (GO:0140014),0.19486448282208313,0.5896750694829261,0.981651376146789,1.0,1.0,18/71,22.44%,INO80;PIBF1;ZW10;ZWINT;KLHDC8B;ARHGEF10;FLNA;CEP192;SGO1;KPNB1;CDCA8;AAAS;DSN1;TUBG1;EPS8;ABRAXAS2;TUBG2;NDE1
prerank,nucleotide metabolic process (GO:0009117),0.238999742267535,0.5895467968293242,0.9418070444104135,1.0,1.0,9/23,26.00%,REXO2;CTPS2;AK8;DCK;NMNAT2;NUDT5;AK1;NMNAT1;CMPK1
prerank,protein catabolic process (GO:0030163),0.20484981681673226,0.5895347361021759,0.9758576874205845,1.0,1.0,7/59,9.87%,APOE;ADAMTS9;CUL4B;NR1D1;CLPX;NGLY1;PRKN
prerank,positive regulation of cell cycle (GO:0045787),0.1979328854215188,0.5863597271446572,0.9726918075422627,1.0,1.0,15/62,21.44%,FGFR2;NUPR1;SMOC2;TBX3;EGFR;FOXA1;RGCC;AKT1;PRKCA;CDKN1B;TRIM21;TRIM32;HSF1;CCND2;PKN2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.25456128943740386,-0.5861475744299779,0.9409090909090909,0.9962561656682615,1.0,3/10,16.35%,CX3CR1;CEACAM1;PTPRC
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.23868836713254243,-0.5857153262077851,0.96875,0.9955897218771115,1.0,7/11,39.83%,CRY1;EP300;C1QTNF12;C1QTNF3;CLK2;PGP;ERFE
prerank,regulation of lymphocyte proliferation (GO:0050670),0.26031564122567774,0.5842741840493063,0.9093851132686084,1.0,1.0,4/16,20.68%,IL12B;SOX11;TNFSF9;AHR
prerank,serine family amino acid metabolic process (GO:0009069),0.2560732502135967,0.5840671443691139,0.9134615384615384,1.0,1.0,5/16,25.12%,CDO1;PSPH;SARS1;CBS;SEPSECS
prerank,organelle transport along microtubule (GO:0072384),0.22205312089367563,0.5833663179843719,0.9530791788856305,1.0,1.0,10/31,24.75%,ARHGAP21;CDC42;RHOT1;CLN3;COPG1;HTT;NDE1;FBXW11;TMEM201;MAP1S
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.2205043705760056,0.5832249515789476,0.9546703296703297,1.0,1.0,9/36,17.79%,CBX3;RBBP7;L3MBTL2;YAF2;RNF2;CBX5;TFDP1;CDC7;APAF1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.23681063880130832,-0.5831285588203146,0.9507042253521126,0.9958455832585924,1.0,7/13,41.11%,BOLA2;GLRX5;CIAO2B;CIAO2A;ISCA1;LTO1;ISCA2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.21633538604819313,0.5829745756493961,0.9584527220630372,1.0,1.0,3/39,6.65%,OGG1;CUL4B;GTF2H5
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.27619890562203864,0.5823306769014367,0.901060070671378,1.0,1.0,3/11,17.36%,CTPS2;DCK;SLC25A19
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.19725725216958412,0.5809583903113436,0.9867899603698811,1.0,1.0,20/61,27.71%,FGFR4;PRKAG2;PSME4;NCOR2;OAZ3;PSMB5;PSMC2;PSMD4;PSMD1;SIRT5;PSME3;PSMA3;PSMC5;PSMA2;PDK4;NR1H4;PSMD12;PSMB9;PANK2;PSMB4
prerank,DNA conformation change (GO:0071103),0.25252907614300385,0.5806780066207107,0.9224137931034483,1.0,1.0,2/17,7.54%,TOP3B;TOP2B
prerank,protein acetylation (GO:0006473),0.21859968410717062,0.5799105219467688,0.9534534534534534,1.0,1.0,7/30,19.18%,ING5;KAT2B;BLOC1S1;NAA50;NAA40;KAT5;NAA80
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.22158110850774998,0.5798659836629143,0.9554531490015361,1.0,1.0,6/28,19.82%,KMT5B;MRNIP;NUDT16L1;SHLD3;SMCHD1;HSF1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.23515727919972396,0.5793215217728938,0.9427312775330396,1.0,1.0,6/22,21.79%,RFTN1;IL12B;CARD9;IL23A;IL18;MYD88
prerank,chromatin remodeling at centromere (GO:0031055),-0.18126327628097888,-0.5784734914589368,0.9907407407407407,0.996959391060551,1.0,10/31,28.47%,KNL1;MIS18BP1;RUVBL1;RSF1;NPM1;CENPI;CENPN;NASP;ITGB3BP;HJURP
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.23304986448696893,0.5756775060621739,0.9547581903276131,1.0,1.0,6/21,21.57%,KATNB1;FGF13;HDGFL3;CAMSAP1;TAOK1;ATXN7
prerank,regulation of lipase activity (GO:0060191),0.2654906146022977,0.5745432176895242,0.9248251748251748,1.0,1.0,13/13,73.47%,LMF1;PCSK5;FURIN;ANGPTL3;RHOA;SNCA;APOA2;ANGPTL8;PLIN5;RHOC;LPL;PCSK6;LIPC
prerank,regulation of cell cycle phase transition (GO:1901987),-0.1496738991104694,-0.5744953076894094,1.0,0.9977683823495431,1.0,36/91,34.46%,CUL1;ANAPC16;TAF1;ANAPC15;ATP2B4;ANAPC7;DBF4;PSMF1;PSMB8;PSMB2;PSMA4;PSMB10;BUB1B;UBE2S;TFAP4;PSMC4;CDKN1A;PSMD9;PSMD5;PSMA6;PSMD11;PSMA8;PSMB1;PSMD10;CDK1;PLK1;FZR1;NEK11;PSMC3;XPC;CDC20;UBE2C;PSMD13;BUB3;ANAPC11;FBXW7
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2381457375815711,-0.5736314554156225,0.9386363636363636,0.9972483977168464,1.0,1/11,4.99%,TOMM70
prerank,midbody abscission (GO:0061952),0.2413822501478156,0.5715728079978096,0.9383333333333334,1.0,1.0,2/17,13.42%,KIF20A;CHMP5
prerank,aromatic amino acid family metabolic process (GO:0009072),0.2774659174308284,0.5712160745061688,0.9392361111111112,1.0,1.0,1/10,6.98%,KYNU
prerank,receptor recycling (GO:0001881),-0.24939332105166945,-0.5705910501351443,0.9292452830188679,0.9975846445702937,1.0,3/10,20.56%,SORL1;LMTK2;EHD3
prerank,cellular response to estradiol stimulus (GO:0071392),-0.20911679746449163,-0.570397038206014,0.972568578553616,0.9967877998817251,1.0,10/18,36.17%,ESR1;NRIP1;GPER1;FAM210B;RUVBL2;SSTR2;POU4F1;RAMP3;CRHBP;SSTR1
prerank,carboxylic acid catabolic process (GO:0046395),0.2648462021343378,0.5703530600659459,0.9241379310344827,1.0,1.0,12/12,73.54%,RENBP;BCKDK;NAGK;GNPDA1;NPL;ACOT4;PON1;AMDHD2;ACOT8;GNPDA2;PON3;IL4I1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.26307801637804806,0.5703215435698309,0.9269565217391305,1.0,1.0,3/12,16.91%,CDA;UPP2;DCK
prerank,protein acylation (GO:0043543),0.21264487546247174,0.5702504123869301,0.9768115942028985,1.0,1.0,3/38,9.03%,GLUL;ING5;KAT2B
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.24674085178825364,0.5700956757522859,0.9412724306688418,1.0,1.0,5/18,19.31%,SFRP1;SKI;PEX2;CDC73;TRIM32
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.23184968414934704,-0.5694565696485349,0.9484029484029484,0.9963050197230766,1.0,1/12,3.17%,SERINC5
prerank,snRNA metabolic process (GO:0016073),-0.20997716187569185,-0.5691699000554168,0.972568578553616,0.9955564640213438,1.0,7/17,34.76%,INTS6;INTS8;INTS1;INTS10;TUT1;INTS11;ZCCHC8
prerank,regulation of oxidoreductase activity (GO:0051341),0.257828074471781,0.567921503026489,0.9298245614035088,1.0,1.0,1/13,4.67%,MT3
prerank,regulation of biosynthetic process (GO:0009889),0.2718407915618529,0.5678700415214943,0.9392361111111112,1.0,1.0,2/11,15.43%,SPHK2;PIKFYVE
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.22111657753645408,0.5675456700434769,0.9675036927621861,1.0,1.0,10/31,25.30%,TIMM17B;AIFM1;TIMM44;PEX6;PEX2;PEX7;PEX1;PAM16;DNLZ;ROMO1
prerank,exit from mitosis (GO:0010458),-0.2319177138870604,-0.5674801527379482,0.9534368070953437,0.9953511003595018,1.0,4/12,32.10%,UBE2S;CLASP1;CHMP4B;UBE2C
prerank,signal peptide processing (GO:0006465),0.2647843858900339,0.5654212195600484,0.9163763066202091,1.0,1.0,6/11,31.31%,SEC11C;SEC11A;SPCS2;PCSK5;HM13;FURIN
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.23539011989203437,-0.5654026838767859,0.9484777517564403,0.9952974600082893,1.0,11/11,76.48%,CAMK4;STAP1;ITGB2;F2RL1;CD177;TYROBP;SPI1;MAVS;TICAM1;STX4;ITGAM
prerank,regulation of protein acetylation (GO:1901983),0.26554223807951427,0.5650646946876342,0.9392361111111112,1.0,1.0,3/12,18.82%,DDX3X;KAT5;TAOK1
prerank,peptidyl-methionine modification (GO:0018206),0.2578288226666601,0.5650453737980531,0.9493006993006993,1.0,1.0,1/12,4.39%,APOA1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.18464740812867425,0.5649585899387476,0.9925742574257426,1.0,1.0,16/83,20.32%,CDK14;ACVR1;CDK16;CUL4B;CUL5;MNAT1;ACVR1B;PLK2;PHF8;TFDP1;CDKN2C;CDC7;CACUL1;CDKN1B;GSPT1;USP37
prerank,Golgi to endosome transport (GO:0006895),0.24360852608297,0.5640083034956013,0.9398373983739837,1.0,1.0,6/16,23.61%,MON2;EPS15;WIPI1;VPS13C;KLHL20;SORT1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.1980354763151847,0.5633829067498984,0.9798115746971736,1.0,1.0,10/51,18.13%,SRC;HNRNPA1;PARN;FBXO4;TERF2;TNKS2;ATM;TENT4B;HNRNPC;NAF1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.2664116416266247,0.5623862843788241,0.922509225092251,1.0,1.0,1/10,5.08%,KLF15
prerank,metallo-sulfur cluster assembly (GO:0031163),0.23404920889464204,0.561517173608497,0.9531502423263328,1.0,1.0,5/22,15.68%,IBA57;NUBPL;NFU1;HSPA9;LYRM4
prerank,regulation of G0 to G1 transition (GO:0070316),0.21000798163513096,0.5611508240882994,0.9660326086956522,1.0,1.0,9/38,17.79%,CBX3;RBBP7;L3MBTL2;YAF2;RNF2;CBX5;TFDP1;CDC7;APAF1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.17904897762168312,0.5604833643197021,0.9964328180737217,1.0,1.0,16/101,19.01%,SERPINE1;LYN;AXL;NR1D1;TNIP2;SELENOS;CD14;PAF1;PDCD4;CHMP5;CXCL13;NR1H3;CASP1;CDC73;IL18;TRIM41
prerank,regulation of autophagosome maturation (GO:1901096),0.2583914851705582,0.5597237295358211,0.9383802816901409,1.0,1.0,2/13,12.12%,CLN3;UVRAG
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.24915524905437963,0.5589849509509167,0.9405772495755518,1.0,1.0,3/15,11.57%,BAIAP3;STXBP1;CLN3
prerank,cellular response to leucine starvation (GO:1990253),0.26638147452083516,0.5589348962722529,0.9298245614035088,1.0,1.0,3/10,15.84%,RRAGD;IMPACT;SESN2
prerank,cellular response to misfolded protein (GO:0071218),0.2359611253724005,0.5588170991970691,0.9643962848297214,1.0,1.0,4/20,15.65%,DERL1;RNF185;UGGT2;AUP1
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.16434181305249673,-0.5587500392283181,0.993421052631579,0.9969042468769777,1.0,17/42,34.04%,TRIM25;POLH;SIRT1;POLN;POLD4;POLK;WRNIP1;DTL;FAAP20;VCP;ISG15;RPS27A;UBC;POLD2;POLA1;RPA2;USP43
prerank,negative regulation by host of viral transcription (GO:0043922),-0.22723223412214993,-0.5587243362046437,0.9597156398104265,0.9960655779830393,1.0,4/12,20.30%,INPP5K;JUN;TFAP4;HMGA2
prerank,T cell activation involved in immune response (GO:0002286),0.25702120814766766,0.5584886105463865,0.9252971137521222,1.0,1.0,3/12,18.40%,IFNK;MDK;ICAM1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.18134431390580483,0.5581471127892753,0.9916963226571768,1.0,1.0,36/95,29.40%,ZSWIM7;RAD51B;INO80;SMC5;POLL;RECQL5;SMC6;MCM2;RAD51D;XRCC2;RNF138;AP5Z1;NIPBL;CDC7;RAD54L;GINS4;NSMCE2;MCMDC2;EXD2;FAN1;BRCA1;NABP2;SFPQ;MRE11;RAD51AP2;SWI5;MCM6;RAD50;TONSL;RECQL;RPA1;FANCB;UBE2N;XRCC3;RBBP8;SEM1
prerank,telomere capping (GO:0016233),0.2382514525798841,0.5577027779671734,0.9304897314375987,1.0,1.0,3/16,12.19%,DCLRE1C;DCLRE1A;TERF2
prerank,RNA interference (GO:0016246),0.24288759847412172,0.5574490103377465,0.934931506849315,1.0,1.0,7/17,24.63%,PRKRA;TSNAX;DICER1;NRDE2;AGO4;DROSHA;AGO3
prerank,sulfur amino acid catabolic process (GO:0000098),-0.23685870660854294,-0.5568579247505702,0.9314420803782506,0.995819831948566,1.0,5/10,41.55%,BLMH;MPST;MTRR;TST;GADL1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.2711402579694852,0.5564129857367034,0.9505494505494505,1.0,1.0,2/10,12.60%,TUT7;TUT4
prerank,positive regulation of chemokine production (GO:0032722),0.20175979242733788,0.5552111037932956,0.9743243243243244,1.0,1.0,3/44,10.83%,IL6R;TSLP;DDX3X
prerank,aerobic respiration (GO:0009060),0.23052466932211463,0.5549879467910928,0.9553158705701078,1.0,1.0,3/20,9.97%,MDH2;BLOC1S1;SDHC
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.16860364767022004,-0.5548409828726739,0.9967532467532467,0.9956772854814908,1.0,11/37,30.05%,RBX1;DDB2;GTF2H1;POLD4;PARP1;POLK;CHD1L;RPS27A;UBC;ERCC5;POLD2
prerank,histone deubiquitination (GO:0016578),0.24051493703056187,0.5545503815742208,0.9681208053691275,1.0,1.0,6/18,21.57%,ATXN7L3;UIMC1;USP3;USP49;BRCC3;ATXN7
prerank,protein insertion into ER membrane (GO:0045048),0.20495520147166849,0.5539028230611635,0.9775910364145658,1.0,1.0,5/37,14.79%,TRAM2;CYB5A;EMC6;TRAM1;EMC7
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.2593158132121014,0.5517669896699295,0.92894280762565,1.0,1.0,2/10,12.36%,SIRT2;IMPACT
prerank,leukotriene biosynthetic process (GO:0019370),-0.20871100282804966,-0.5513943230067129,0.9605263157894737,0.9958944047974135,1.0,6/14,32.28%,GGT5;GGTA1;GGT1;ALOX5;PLA2G5;GGT7
prerank,regulation of exit from mitosis (GO:0007096),0.20702119099053468,0.5511843980819948,0.9694323144104804,1.0,1.0,13/38,26.60%,ZW10;SIRT2;NPM2;ANAPC5;RGCC;UBE2D1;PHB2;CDC23;ANAPC4;CDC14B;UBE2E1;ANAPC2;CDC16
prerank,mitochondrion distribution (GO:0048311),0.25267592874135447,0.5493733987640874,0.9413735343383585,1.0,1.0,1/12,6.25%,LRRK2
prerank,regulation of spindle assembly (GO:0090169),0.21606545146961284,0.5492771200955863,0.96274217585693,1.0,1.0,7/25,22.43%,DYNC1H1;SENP6;CHMP5;TPR;NUMA1;HNRNPU;CCSAP
prerank,tyrosine metabolic process (GO:0006570),0.26482957755319814,0.5489771628681861,0.9274336283185841,1.0,1.0,11/11,73.54%,FAH;GSTZ1;TYR;HGD;TAT;PAH;TH;THAP4;IYD;DCT;IL4I1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.1953904370562307,-0.5486149668272499,0.9782016348773842,0.9958960152310767,1.0,4/19,16.96%,LBP;PIK3AP1;PRKCE;TLR4
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2574222227756775,0.5483774227211636,0.9336734693877551,1.0,1.0,3/11,22.19%,PARN;TENT4B;EXOSC2
prerank,RNA catabolic process (GO:0006401),0.19631959696314152,0.5482061622777379,0.9871611982881597,1.0,1.0,15/46,25.59%,SND1;DXO;EXOSC7;MTREX;NUDT16L1;RNASEH2C;METTL3;YTHDF2;AGO4;ZFP36L2;SIDT2;NUDT12;METTL16;AGO3;CNOT10
prerank,heterochromatin assembly (GO:0031507),0.23283642930588408,0.5474023901824571,0.9686028257456829,1.0,1.0,8/20,26.22%,MBD2;SIRT2;POLE3;SMCHD1;NRDE2;CENPV;HDAC1;RRP8
prerank,regulation of B cell activation (GO:0050864),0.21619045750685814,0.5472230264623075,0.9735202492211839,1.0,1.0,3/25,11.67%,ZFP36L1;TNIP2;THEMIS2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.23574382293878274,0.5459917692650119,0.9436152570480929,1.0,1.0,4/16,23.32%,RBM22;DDX23;NCBP2;SART1
prerank,regulation of mitochondrial translation (GO:0070129),-0.1890641390955004,-0.5440969862813273,0.986737400530504,0.9964052484476429,1.0,9/21,33.59%,MALSU1;COA3;FASTKD2;C1QBP;NSUN3;TRMT10C;MTG2;NGRN;TSFM
prerank,hydrogen peroxide catabolic process (GO:0042744),0.25699773371529117,0.5439065156385542,0.9582637729549248,1.0,1.0,3/11,22.01%,GPX3;PRDX4;PXDN
prerank,ubiquinone biosynthetic process (GO:0006744),0.24243423301806452,0.5434821236640803,0.9590443686006825,1.0,1.0,4/15,19.95%,UBIAD1;COQ10B;NDUFA9;COQ7
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.19742962646578532,-0.5420364006514189,0.9818181818181818,0.996176780020794,1.0,6/19,29.64%,CEP97;PDCD6IP;CHMP2B;CHMP4B;CHMP4C;PLK1
prerank,microtubule polymerization (GO:0046785),0.21180240451416704,0.541030470545483,0.974512743628186,1.0,1.0,7/28,22.44%,RANBP9;FGF13;HDGFL3;SLAIN2;TUBG1;TUBG2;NDE1
prerank,regulation of cell cycle process (GO:0010564),0.1726129258440134,0.5406302572905165,0.9976019184652278,1.0,1.0,6/104,6.01%,OBSL1;SND1;KIF20A;SFRP1;DYNC1H1;CDC42
prerank,axoneme assembly (GO:0035082),0.20755852370372302,0.5399983693500534,0.9791044776119403,1.0,1.0,4/30,12.66%,SPAG1;DNAAF1;CFAP46;CCDC40
prerank,protein localization to phagophore assembly site (GO:0034497),0.2541855654687662,0.5393053649690748,0.9352014010507881,1.0,1.0,4/11,20.75%,WIPI1;STX17;WDR45;ATG9A
prerank,positive regulation of lipid catabolic process (GO:0050996),0.2282056879108717,0.5371473070019976,0.9630225080385852,1.0,1.0,2/19,14.08%,APOA1;ABCD2
prerank,regulation of myelination (GO:0031641),0.21650496783380038,0.5367648390249283,0.9663608562691132,1.0,1.0,7/25,18.32%,SIRT2;EIF2AK3;RNF10;NSUN5;PARD3;NCMAP;DICER1
prerank,iron-sulfur cluster assembly (GO:0016226),0.2188959875135519,0.536108894489063,0.9716981132075472,1.0,1.0,9/24,25.45%,IBA57;NUBPL;NFU1;HSPA9;LYRM4;GLRX3;NUBP2;NUBP1;MMS19
prerank,innate immune response in mucosa (GO:0002227),-0.22967383282260456,-0.5359470356512839,0.9722222222222222,0.9970554886374067,1.0,1/10,5.69%,RPL39
prerank,positive regulation of chromatin organization (GO:1905269),-0.21485682876331677,-0.5345044056408533,0.9559902200488998,0.9966454342079294,1.0,2/12,13.98%,TAL1;H3-3A
prerank,2-oxoglutarate metabolic process (GO:0006103),0.24502727980559907,0.5339582677086798,0.958904109589041,1.0,1.0,4/13,21.80%,ADHFE1;IDH2;PHYH;L2HGDH
prerank,mitochondrion transport along microtubule (GO:0047497),-0.21133366198006756,-0.533511339735821,0.96875,0.9960572800386297,1.0,2/13,15.43%,SYBU;HIF1A
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.2349199613747016,0.5323052440994358,0.9633943427620633,1.0,1.0,2/16,7.11%,IL12B;KLRD1
prerank,mitochondrial membrane organization (GO:0007006),0.2012231303622925,0.5320854420860319,0.9836552748885586,1.0,1.0,2/32,8.95%,BCL2;MICOS10
prerank,intracellular protein transmembrane transport (GO:0065002),0.1952769160193918,0.5310743859364139,0.9832635983263598,1.0,1.0,13/42,25.30%,TIMM17B;AIFM1;TIMM44;PEX6;PEX2;PEX7;SEC61A1;PEX1;HSPA5;PAM16;RTN2;DNLZ;ROMO1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.20498531713866916,-0.5291931386057387,0.9733009708737864,0.9963567590062995,1.0,7/14,31.19%,CARD14;TNFRSF10B;TRAF2;MAP3K7;MALT1;TRAF6;ZFP91
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.18255233443583607,-0.5289215849640994,0.9819819819819819,0.9955913534651105,1.0,4/23,14.18%,RBX1;COPS7A;DDB2;CETN2
prerank,interstrand cross-link repair (GO:0036297),0.18491996435917787,0.5283740326281883,0.9907651715039578,1.0,1.0,15/53,25.42%,DCLRE1C;ERCC6L2;EXO5;DCLRE1A;FANCC;FANCE;FANCI;XPA;FAN1;UBE2T;FANCA;CENPX;MSH6;RAD51AP2;ATRIP
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.21734624216310677,-0.528009308243309,0.9755501222493888,0.9949727118146502,1.0,5/13,30.77%,NOL9;RPS21;RRS1;RPP40;TSR1
prerank,microtubule nucleation (GO:0007020),0.22431318857511542,0.5279525144803783,0.9639344262295082,1.0,1.0,5/19,22.44%,RANBP9;SLAIN2;TUBG1;TUBG2;NDE1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.18947681250483006,-0.527460457436572,0.9892183288409704,0.9942697167049662,1.0,6/19,26.85%,ACOX1;CAT;GPX1;NOX1;PRDX5;SOD1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.2164863180029073,-0.5259636665578826,0.9693396226415094,0.993808305436146,1.0,4/11,22.81%,MBTPS2;ATF6B;ATF3;ATF4
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.21333085451007672,-0.5251317827608681,0.9767441860465116,0.9931763418631601,1.0,2/12,8.98%,PAICS;IMPDH1
prerank,regulation of interleukin-17 production (GO:0032660),0.20331453614530087,0.5248699413956811,0.9814020028612304,1.0,1.0,10/31,26.13%,RFTN1;IL12B;CARD9;IL23A;IL18;DDIT3;MYD88;NCKAP1L;ZBTB7B;NR1H4
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.2124619349994291,-0.5234304114842198,0.9803921568627451,0.9927510332684375,1.0,1/12,3.74%,STX3
prerank,programmed necrotic cell death (GO:0097300),0.22545221067462629,0.5212819768283068,0.974025974025974,1.0,1.0,2/18,12.46%,MLKL;CD14
prerank,quinone biosynthetic process (GO:1901663),0.23214347975655575,0.5196342077391511,0.9643463497453311,1.0,1.0,2/14,9.86%,UBIAD1;COQ10B
prerank,signal transduction in response to DNA damage (GO:0042770),0.18251960434922043,0.5174828314818904,0.9890260631001372,1.0,1.0,11/49,20.43%,MAP3K20;BATF;NDRG1;USP10;SESN2;CASP9;ATM;ATRX;CLSPN;MDM4;STK33
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.21042296714694148,0.5170628213795166,0.9746031746031746,1.0,1.0,3/21,17.68%,H6PD;GCK;PGD
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.23150571182381469,0.5164742633351468,0.9636048526863085,1.0,1.0,5/14,26.72%,DDX60;DHX58;TLR5;ANKRD17;PUM1
prerank,regulation of superoxide anion generation (GO:0032928),-0.2026144251777516,-0.5158241505239112,0.9765013054830287,0.9936399523208947,1.0,10/14,50.46%,TGFB1;SOD1;MAPT;GSTP1;ITGB2;F2RL1;CD177;SYK;TYROBP;FPR2
prerank,peroxisomal membrane transport (GO:0015919),0.20594433786972693,0.5145856337703849,0.9752321981424149,1.0,1.0,8/27,23.96%,PXMP2;PEX6;PEX2;ABCD2;PEX11B;PEX7;PEX1;ATAD1
prerank,cellular response to oxygen levels (GO:0071453),-0.21899322119005774,-0.514548623242174,0.9802197802197802,0.9930751435590606,1.0,10/10,78.12%,ATP6V0A2;PICK1;CCDC115;NDUFS2;TMEM199;ATP6V1A;ATP6AP1;ATP6V1G1;ATP6V0D1;CPEB4
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.21333505575021305,0.514490549104123,0.9620253164556962,1.0,1.0,8/20,25.81%,EGFR;TTBK1;RGCC;AKT1;CCND2;PKD2;CCNY;MAPRE3
prerank,DNA duplex unwinding (GO:0032508),0.18153415544995755,0.5143499714241856,0.9919571045576407,1.0,1.0,22/50,31.48%,CUL4B;GTF2H5;RECQL5;ASCC3;MCM2;RTEL1;DDX1;XPA;MCMDC2;ERCC3;ERCC2;MRE11;MCM6;RAD23B;RAD50;RECQL;RPA1;GTF2H2;MCM4;MCM9;DDB1;DDX11
prerank,replication fork processing (GO:0031297),0.18920495554941047,0.51275526790053,0.9914040114613181,1.0,1.0,16/38,31.78%,BOD1L1;RTEL1;PRIMPOL;ATRX;ETAA1;ZGRF1;EXD2;EME2;CENPX;MRE11;TONSL;DNA2;CDK9;PCNA;DDX11;NUCKS1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.23376512479480224,0.5125580677827639,0.965034965034965,1.0,1.0,4/12,26.19%,UVRAG;INSR;SETX;JMJD4
prerank,microtubule bundle formation (GO:0001578),0.1866773427013924,0.5118033968151874,0.9957507082152974,1.0,1.0,4/42,12.66%,NCKAP5;KIF20A;CFAP46;CCDC40
prerank,protein import into mitochondrial matrix (GO:0030150),-0.18469956284723862,-0.5106772521561601,0.9837837837837838,0.9930554135190872,1.0,5/18,23.35%,TOMM70;GRPEL1;TOMM40;TOMM40L;GRPEL2
prerank,organelle fusion (GO:0048284),0.20768663379843832,0.5105783970792838,0.9784615384615385,1.0,1.0,6/22,26.18%,MIGA2;USP30;AFG3L2;OPA1;STX4;VPS11
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.1872376736795287,-0.5102334925680604,0.9868073878627969,0.9923295984244366,1.0,3/18,14.69%,COX17;SURF1;COA3
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.2172920396979127,0.5073552963662922,0.9804878048780488,1.0,1.0,7/17,25.81%,EGFR;RGCC;AKT1;CCND2;PKD2;CCNY;MAPRE3
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.1897017219413466,0.5072537977496377,0.9839181286549707,1.0,1.0,7/35,18.13%,HNRNPA1;PARN;FBXO4;TNKS2;RTEL1;ATM;NAF1
prerank,ubiquinone metabolic process (GO:0006743),0.22256302062802816,0.5064321372479687,0.9767827529021559,1.0,1.0,2/15,9.86%,UBIAD1;COQ10B
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.23123976437779897,0.5063509251273728,0.9703832752613241,1.0,1.0,1/13,7.00%,SPHK2
prerank,telomere maintenance via telomerase (GO:0007004),-0.1652861263550718,-0.5056364292131061,0.9908536585365854,0.9924622362897119,1.0,2/28,6.67%,ANKRD28;HSP90AB1
prerank,regulation of mitotic spindle organization (GO:0060236),0.18812353971795215,0.5017857868968324,0.9803328290468987,1.0,1.0,10/35,25.87%,DYNC1H1;RAE1;CHMP5;GNAI1;TPR;NUMA1;HNRNPU;CCSAP;FSD1;CHMP2A
prerank,nucleosome organization (GO:0034728),0.1734961920212531,0.5012968330842247,0.9972936400541272,1.0,1.0,11/55,20.19%,CHAF1B;INO80;SMARCC2;POLE3;NFE2;PAF1;SMARCD2;SMARCB1;SRCAP;ATRX;ARID2
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.14080585367134268,-0.4990555890048314,1.0,0.9929018878918844,1.0,15/50,30.27%,PSMF1;PSMB8;PSMB2;PSMA4;PSMB10;PSMC4;PSMD9;PSMD5;PSMA6;PSMD11;PSMA8;PSMB1;NQO1;PSMD10;PSMC3
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.19446211911588113,0.49776629572085396,0.9734904270986745,1.0,1.0,10/29,26.79%,TLR6;IKBKE;TBK1;CD14;UBE2D1;BIRC3;BIRC2;FADD;TICAM1;RIPK1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.20711839159403306,0.4947566120695633,0.9811912225705329,1.0,1.0,2/21,6.65%,CUL4B;GTF2H5
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.20711839159403306,0.4947566120695633,0.9811912225705329,1.0,1.0,2/21,6.65%,CUL4B;GTF2H5
prerank,positive regulation of type I interferon production (GO:0032481),0.16455913249380236,0.49244243208546046,0.9987389659520807,1.0,1.0,13/73,18.55%,IRF1;OAS2;POLR3A;DDX3X;TBK1;STAT6;CD14;RIPK2;RIOK3;ZBP1;RNF135;DHX58;POLR2L
prerank,spindle assembly checkpoint signaling (GO:0071173),0.19962587474332882,0.4917104024064037,0.9873817034700315,1.0,1.0,5/20,22.50%,ZW10;ZWINT;ATM;TPR;IK
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.19962587474332882,0.4917104024064037,0.9873817034700315,1.0,1.0,5/20,22.50%,ZW10;ZWINT;ATM;TPR;IK
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.19962587474332882,0.4917104024064037,0.9873817034700315,1.0,1.0,5/20,22.50%,ZW10;ZWINT;ATM;TPR;IK
prerank,regulation of protein sumoylation (GO:0033233),0.21578536640130025,0.49011221699146756,0.9832214765100671,1.0,1.0,3/17,14.34%,ZMIZ1;MUL1;HDAC4
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.21373854075097323,0.4894457701137649,0.9771986970684039,1.0,1.0,16/16,78.65%,MDK;ETS1;NFAT5;RELA;IL6;IRAK1;FUT7;RHOA;TNF;FUT4;ITGB2;SELE;ALOX5;TRAF6;SELP;ST3GAL4
prerank,recombinational repair (GO:0000725),0.16255048572198139,0.4878460556211805,1.0,1.0,1.0,28/77,29.40%,ZSWIM7;RAD51B;INO80;SMC5;POLL;RECQL5;SMC6;RAD51D;XRCC2;RNF138;AP5Z1;NSMCE2;EXD2;FAN1;BRCA1;NABP2;SFPQ;MRE11;RAD51AP2;SWI5;RAD50;TONSL;RECQL;RPA1;UBE2N;XRCC3;RBBP8;SEM1
prerank,regulation of hormone secretion (GO:0046883),0.21776611099378196,0.487768603451921,0.9741518578352181,1.0,1.0,6/15,28.92%,LIF;SOX11;SNX6;SCG5;VAMP3;EDN3
prerank,regulation of cellular amide metabolic process (GO:0034248),0.18466958222019858,0.4857900757857039,0.9941690962099126,1.0,1.0,12/32,27.70%,PICALM;EIF2B4;MTPN;RBM4B;FOXO3;TMED10;PCIF1;NANOS3;ATXN2;NR1H4;METAP1;PRKCD
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.21955262988504187,0.4853937609115767,0.9803921568627451,1.0,1.0,3/14,16.32%,LONP2;ABCD2;AKT1
prerank,positive regulation of mitochondrial translation (GO:0070131),0.2148252301307714,0.4852967442412131,0.9742710120068611,1.0,1.0,3/14,19.61%,RPUSD4;TRUB2;FASTKD3
prerank,positive regulation of TORC1 signaling (GO:1904263),0.2104599380194288,0.4845200782404783,0.9795221843003413,1.0,1.0,4/16,20.46%,TELO2;RRAGD;SEH1L;GPR137B
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.21532358322111733,-0.48264647303326585,0.986046511627907,0.9947331986783923,1.0,5/10,38.15%,NDFIP2;CORO2B;WWP2;PPM1F;MAPT
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.19212145586824836,0.4812019723590859,0.9905660377358491,1.0,1.0,5/21,22.50%,ZW10;ZWINT;ATM;TPR;IK
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.1995680055776205,0.48016581542268133,0.9800613496932515,1.0,1.0,8/21,26.40%,PPP4R4;YWHAE;BOD1L1;PTPA;BOD1;PPP1R15A;MASTL;STYXL1
prerank,negative regulation of T cell activation (GO:0050868),0.18094702487487282,0.47789358849743946,0.9911894273127754,1.0,1.0,4/35,14.50%,RIPOR2;CEBPB;SDC4;GLMN
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.18562285883253313,0.4771335730029383,0.986784140969163,1.0,1.0,10/30,26.79%,TLR6;IKBKE;TBK1;CD14;UBE2D1;BIRC3;BIRC2;FADD;TICAM1;RIPK1
prerank,regulation of lipid storage (GO:0010883),0.19428801582542016,0.47519632398369693,0.984779299847793,1.0,1.0,3/22,10.91%,ITGB3;ITGAV;IKBKE
prerank,protein import into peroxisome matrix (GO:0016558),0.22468836582018872,0.47434896539783916,0.9870848708487084,1.0,1.0,4/12,21.59%,PEX6;PEX2;PEX7;PEX1
prerank,regulation of isotype switching (GO:0045191),0.21091439821346636,0.47322458473348306,0.9775086505190311,1.0,1.0,3/14,16.01%,KMT5B;HMCES;SHLD3
prerank,regulation of double-strand break repair (GO:2000779),0.17346031161009753,0.472830063008061,0.9971830985915493,1.0,1.0,6/39,16.47%,PML;TRIP12;MRNIP;RTEL1;UBR5;TIMELESS
prerank,N-terminal protein amino acid modification (GO:0031365),-0.18689822862822544,-0.471993398786005,0.997624703087886,0.9953573341202877,1.0,7/14,40.40%,METAP2;NAA60;NAA15;AANAT;PDF;NTMT1;NAA11
prerank,autophagosome maturation (GO:0097352),0.17917884526874808,0.4708270648787998,0.9856527977044476,1.0,1.0,11/32,25.77%,CLN3;UVRAG;LAMP2;MAP1LC3A;EPG5;STX17;RUBCNL;LIX1;TSG101;VPS16;VPS33B
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.16342953000098687,0.46841400521535675,0.9972337482710927,1.0,1.0,12/53,23.26%,PSME4;PPM1K;OAZ3;PSMB5;PSMC2;PSMD4;PSMD1;PSME3;BCKDK;PSMA3;PSMC5;PSMA2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.1772556332602534,0.4631186561339064,0.992503748125937,1.0,1.0,6/32,18.13%,HNRNPA1;PARN;FBXO4;TNKS2;ATM;NAF1
prerank,negative regulation of translational initiation (GO:0045947),0.21313327892523054,0.4629079434418903,0.9782608695652174,1.0,1.0,13/13,78.70%,LARP1;TPR;RBM4;EIF3E;EIF4EBP1;EIF2AK1;AGO2;PAIP2;EIF4EBP3;PAIP2B;FMR1;EIF2AK4;EIF4EBP2
prerank,lymphocyte mediated immunity (GO:0002449),0.20672613216451372,0.4605011773842359,0.9894366197183099,1.0,1.0,1/12,7.11%,KLRD1
prerank,positive regulation of exosomal secretion (GO:1903543),0.20064374201475083,0.45811477093250286,0.9847198641765704,1.0,1.0,6/15,26.55%,SDC1;SDC4;ATP13A2;TSG101;CHMP2A;SMPD3
prerank,error-free translesion synthesis (GO:0070987),-0.1597472142406015,-0.4577853130888643,1.0,0.9961714563693957,1.0,7/22,33.36%,POLH;UFD1;RCHY1;VCP;RPS27A;UBC;RPA2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.191954456359652,0.4554642714117542,0.9886914378029079,1.0,1.0,4/18,20.84%,POLE3;GINS4;MCMDC2;LIG1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.20876932710598978,0.45312749061030233,0.9822695035460993,1.0,1.0,5/12,26.60%,ANAPC5;NSMCE2;CDC23;ANAPC4;CDC16
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.20876932710598978,0.45312749061030233,0.9822695035460993,1.0,1.0,5/12,26.60%,ANAPC5;NSMCE2;CDC23;ANAPC4;CDC16
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.20876932710598978,0.45312749061030233,0.9822695035460993,1.0,1.0,5/12,26.60%,ANAPC5;NSMCE2;CDC23;ANAPC4;CDC16
prerank,negative regulation of phosphatase activity (GO:0010923),0.17998380316378643,0.4516393822033604,0.992503748125937,1.0,1.0,9/25,26.40%,PPP4R4;BOD1L1;PTPA;BOD1;PPP1R26;SEMA4D;PPP1R15A;MASTL;STYXL1
prerank,protein import into peroxisome membrane (GO:0045046),0.1871274919406667,0.4509859836751878,0.9920255183413078,1.0,1.0,4/22,15.45%,PXMP2;PEX2;ABCD2;PEX11B
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.20901748796173192,0.45053668915218287,0.9882352941176471,0.9997018950678223,1.0,1/11,7.11%,KLRD1
prerank,superoxide anion generation (GO:0042554),0.2030894579202576,0.44695354846070906,0.9748322147651006,0.9998194403158003,1.0,3/13,19.76%,NOX4;NOX3;ALOX12
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.2017674389839123,0.43274166921097984,0.9913194444444444,1.0,1.0,1/11,7.97%,WTIP
prerank,protein localization to chromosome (GO:0034502),0.1646187815080475,0.428059044084866,0.9971305595408895,1.0,1.0,9/34,24.13%,MRNIP;TERF2;TNKS2;WAPL;BOD1;CENPA;ATRX;CTCF;TNKS
prerank,ESCRT III complex disassembly (GO:1904903),0.20229726336931958,0.425979775462101,0.9893617021276596,1.0,1.0,10/10,79.78%,CHMP5;CHMP2A;IST1;CHMP7;CHMP1B;CHMP1A;VTA1;VPS4B;CHMP2B;VPS4A
prerank,ESCRT complex disassembly (GO:1904896),0.20229726336931958,0.425979775462101,0.9893617021276596,1.0,1.0,10/10,79.78%,CHMP5;CHMP2A;IST1;CHMP7;CHMP1B;CHMP1A;VTA1;VPS4B;CHMP2B;VPS4A
prerank,nucleotide biosynthetic process (GO:0009165),0.1790829415503104,0.41920003430223096,0.9966101694915255,1.0,1.0,7/18,26.06%,GART;NMNAT2;PPAT;PRPSAP2;ADSL;NMNAT1;PRPSAP1
prerank,regulation of lymphocyte activation (GO:0051249),-0.16706682559620326,-0.4181153614446967,0.9928057553956835,0.9983446895643154,1.0,4/12,34.93%,KAT2A;LAT;IKZF3;CRTAM
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.1670503655640576,0.41455091175472825,0.9954476479514416,1.0,1.0,10/25,29.29%,DDX23;GEMIN2;SF3B1;PRPF6;SRSF10;PRPF8;SLU7;SCAF11;TXNL4A;SF3B3
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.15093818285169883,0.4105336342789538,0.998587570621469,1.0,1.0,16/40,31.78%,BOD1L1;RTEL1;TIMELESS;PRIMPOL;ATRX;ETAA1;EXD2;EME2;CENPX;TONSL;TIPIN;CDK9;MCM9;PCNA;DDX11;NUCKS1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.15848355990923604,0.4105275995537302,0.9941002949852508,1.0,1.0,7/29,22.78%,CUL4B;GTF2H5;MNAT1;XPA;CDK7;ERCC3;ERCC2
prerank,homologous chromosome segregation (GO:0045143),0.16753409171582262,0.405584202455935,0.9918433931484503,1.0,1.0,3/20,16.80%,CENPC;MAJIN;SGO1
prerank,telomere organization (GO:0032200),0.14569718410000881,0.4049287463519827,1.0,0.999974345925082,1.0,5/43,16.40%,SP100;TERF2;RAD51D;RTEL1;ATM
prerank,lipoxygenase pathway (GO:0019372),0.18349089373649174,0.40244663655000895,0.995049504950495,0.9997517252153422,1.0,4/14,23.28%,ALOXE3;ALOX5AP;ALOX12;HPGD
prerank,T cell homeostasis (GO:0043029),0.19226909623313615,0.3960109529766685,0.998165137614679,0.9997708738552136,1.0,4/10,25.33%,AKT1;NCKAP1L;PMAIP1;FADD
prerank,rRNA catabolic process (GO:0016075),0.166701459117047,0.38628926085602666,0.9952,0.999914321277044,1.0,6/16,27.54%,EXOSC7;EXOSC2;DIS3L;XRN1;EXOSC8;EXOSC9
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.1529089395200278,0.3826709128270082,1.0,0.9996868398265711,1.0,1/24,5.16%,LIG4
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.1751192568415769,0.36575472394570147,0.9963031423290203,0.999914469818098,1.0,10/10,82.50%,RC3H2;RC3H1;SMAD7;ZC3H12A;TBX21;FOXP3;IL4;NFKBID;MALT1;NFKBIZ
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.16508693741761346,0.35477978035494573,0.9982142857142857,0.9998002616816308,1.0,11/11,83.50%,RC3H2;RC3H1;TNFSF4;SMAD7;ZC3H12A;TBX21;FOXP3;IL4;SOCS5;ANXA1;JAK3
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.13410186723748357,0.34146174892399733,1.0,0.9996458233441154,1.0,8/27,26.21%,PARN;PCF11;RPP30;DICER1;TOE1;XRN1;LACTB2;RNASE4
